data_2i38_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i38 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -80.17 94.36 6.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 97.22 4.35 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.385 -151.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 46.0 tp -87.57 86.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.068 1.347 . . . . 0.0 109.903 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -56.33 101.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.351 2.261 . . . . 0.0 109.155 163.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.2 mp -78.99 136.09 37.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 165.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -145.33 54.8 1.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.721 2.008 . . . . 0.0 108.576 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.54 -177.91 21.82 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -171.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -51.11 -48.37 61.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.486 1.114 . . . . 0.0 110.608 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 m -74.79 -63.34 1.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.732 2.413 . . . . 0.0 113.679 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.57 141.69 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.252 1.021 . . . . 0.0 110.456 -168.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 96.6 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.752 2.021 . . . . 0.0 108.833 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.45 23.87 0.02 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 120.684 3.033 . . . . 0.0 120.684 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HA ' ' H ' ' A' ' 7' ' ' LEU 0.255 0.6 OUTLIER 54.61 -175.96 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.084 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -154.81 -32.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 164.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p 59.0 161.96 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 t -160.82 -162.07 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.331 2.252 . . . . 0.0 108.835 153.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -148.23 151.32 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 111.783 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.13 -177.67 6.06 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.355 1.862 . . . . 0.0 111.143 -167.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.37 -18.32 9.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 112.203 -2.271 . . . . 0.0 112.6 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -148.65 -9.01 0.36 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 23.13 13.49 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.111 1.765 . . . . 0.0 114.462 -168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.03 -38.47 1.1 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.309 1.844 . . . . 0.0 110.571 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.0 m -57.66 -21.21 38.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.356 1.862 . . . . 0.0 112.458 149.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.87 -47.65 16.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.264 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -48.03 80.42 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -68.22 -7.53 31.15 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -166.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.29 -38.22 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.76 2.424 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -53.13 -43.01 66.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.679 1.127 . . . . 0.0 112.083 162.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -43.63 -56.18 3.89 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.061 2.144 . . . . 0.0 111.277 168.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.75 -34.69 67.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -57.94 -42.96 86.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.756 1.162 . . . . 0.0 110.952 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.95 -33.46 39.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.371 -0.83 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.3 -26.76 63.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.177 0.898 . . . . 0.0 112.528 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.48 -40.4 77.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.111 1.364 . . . . 0.0 112.638 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -64.62 -43.58 93.28 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.764 -0.585 . . . . 0.0 111.655 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 27.79 1.29 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.713 1.625 . . . . 0.0 114.095 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 139.86 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.276 1.83 . . . . 0.0 111.287 -168.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 6.28 4.03 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 157.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.9 -130.34 10.14 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.203 1.859 . . . . 0.0 116.55 159.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -92.86 -13.29 29.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.017 1.727 . . . . 0.0 111.759 167.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.498 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 47.3 m95 6.61 82.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.041 1.736 . . . . 0.0 115.68 -127.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 m -82.2 156.86 24.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.692 1.234 . . . . 0.0 110.642 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -148.31 151.48 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.191 1.797 . . . . 0.0 110.559 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -124.31 143.62 50.46 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.955 1.702 . . . . 0.0 109.065 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.24 -15.94 12.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.14 57.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.376 1.87 . . . . 0.0 111.638 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.0 p -120.12 -7.4 9.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.417 1.887 . . . . 0.0 112.65 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.378 35.6 mttm 65.27 12.69 8.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.519 1.528 . . . . 0.0 114.759 -174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -54.56 153.84 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.36 2.264 . . . . 0.0 113.913 166.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -125.09 166.14 16.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.719 2.408 . . . . 0.0 112.318 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.5 m -151.75 139.16 19.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.421 -1.424 . . . . 0.0 112.086 167.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.0 89.06 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.055 1.342 . . . . 0.0 113.463 171.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -99.77 79.13 2.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.071 0.948 . . . . 0.0 112.643 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 124.498 1.119 . . . . 0.0 114.001 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.0 137.21 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 163.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -137.53 143.79 41.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.156 1.783 . . . . 0.0 109.822 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.06 145.23 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.267 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.81 -178.98 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.133 0.852 . . . . 0.0 115.193 161.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 72.84 13.65 5.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 115.418 -171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 28.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.358 1.863 . . . . 0.0 112.102 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.14 -18.42 27.52 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 117.28 1.672 . . . . 0.0 117.28 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -89.69 -9.1 50.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.595 1.158 . . . . 0.0 113.901 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -154.65 -21.46 0.12 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.34 109.54 0.7 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -149.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -138.17 164.11 29.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.235 1.414 . . . . 0.0 112.057 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -67.93 -37.0 81.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.9 m -66.48 -48.11 70.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.186 0.994 . . . . 0.0 112.556 -169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.24 -37.63 80.95 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.678 -0.639 . . . . 0.0 111.69 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.96 -37.17 29.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.495 1.118 . . . . 0.0 112.319 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -47.43 -39.17 14.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.845 1.258 . . . . 0.0 111.338 169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -106.9 -26.98 10.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.335 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.3 93.7 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.688 0.677 . . . . 0.0 111.58 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -81.58 -35.24 30.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.819 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.06 -37.1 5.5 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.658 1.599 . . . . 0.0 114.863 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -59.45 -44.99 92.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.29 -23.68 40.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.525 0.73 . . . . 0.0 110.878 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.28 166.45 30.1 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.102 1.334 . . . . 0.0 113.869 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 153.16 56.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.34 2.693 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.64 122.12 46.07 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 109.176 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -74.75 -33.57 62.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.565 0.746 . . . . 0.0 111.454 166.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -142.67 157.5 44.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.303 0.502 . . . . 0.0 111.916 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.66 144.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.553 1.541 . . . . 0.0 110.825 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.11 151.24 17.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.919 1.688 . . . . 0.0 110.951 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.72 144.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 170.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 126.266 1.826 . . . . 0.0 112.181 175.714 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.36 132.32 56.61 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.975 1.71 . . . . 0.0 109.385 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -128.57 163.87 24.06 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.592 1.557 . . . . 0.0 113.865 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -140.82 147.06 38.44 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.833 165.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.98 177.93 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 121.102 -0.999 . . . . 0.0 111.995 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.33 102.79 4.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.326 1.05 . . . . 0.0 110.701 172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -70.22 165.11 22.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 110.605 140.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.02 -36.95 11.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.583 -0.698 . . . . 0.0 112.796 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.04 131.47 83.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.113 0.965 . . . . 0.0 112.313 -172.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.79 -8.99 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.429 2.753 . . . . 0.0 115.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -112.62 -41.42 3.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.347 1.859 . . . . 0.0 110.851 -160.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 -29.96 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.534 0.606 . . . . 0.0 111.225 159.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.01 70.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.777 0.831 . . . . 0.0 112.399 168.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.04 -30.41 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.07 -1.019 . . . . 0.0 111.226 170.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.02 -35.46 69.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.524 1.057 . . . . 0.0 113.693 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.95 -27.71 69.32 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.181 -1.575 . . . . 0.0 112.824 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.43 -37.26 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 119.205 -2.184 . . . . 0.0 110.926 165.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -62.46 -34.36 76.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.725 -1.235 . . . . 0.0 112.998 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -128.82 -14.33 4.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -158.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -17.07 7.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.203 1.001 . . . . 0.0 113.604 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -82.91 159.86 22.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.092 1.314 . . . . 0.0 112.24 165.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.78 5.47 88.51 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.601 1.096 . . . . 0.0 115.175 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.98 -137.64 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.933 1.693 . . . . 0.0 112.134 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 m -141.41 123.8 15.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.721 2.409 . . . . 0.0 108.616 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.58 131.85 56.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.195 1.398 . . . . 0.0 108.88 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 9.0 t 59.44 -58.14 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.656 2.382 . . . . 0.0 115.906 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.45 35.58 0.08 OUTLIER Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.0 1.285 . . . . 0.0 114.362 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.5 p -129.66 -163.57 1.31 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.85 1.26 . . . . 0.0 113.941 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -130.98 63.82 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.34 1.856 . . . . 0.0 109.558 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.82 161.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 130.012 3.325 . . . . 0.0 117.657 -165.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.87 149.15 41.58 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.922 1.289 . . . . 0.0 110.21 140.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.48 145.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.678 1.191 . . . . 0.0 110.12 -167.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 109.62 -179.39 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.385 0.612 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -136.51 100.3 4.32 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.92 116.08 14.31 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -157.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.9 tp -101.62 95.02 6.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.683 1.193 . . . . 0.0 110.432 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -55.65 108.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 128.122 2.569 . . . . 0.0 109.37 159.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.417 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.9 mp -86.08 139.85 30.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 167.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -147.82 47.77 1.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.419 1.887 . . . . 0.0 108.496 172.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.68 -169.94 23.57 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 -162.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -43.71 -31.89 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.953 2.101 . . . . 0.0 114.308 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -126.26 -44.59 1.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.773 1.629 . . . . 0.0 112.589 -148.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -154.7 142.85 20.3 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.705 1.602 . . . . 0.0 108.22 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -136.91 127.18 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.709 1.604 . . . . 0.0 109.084 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.59 31.82 0.26 Allowed Glycine 0 N--CA 1.477 1.404 0 N-CA-C 117.896 1.918 . . . . 0.0 117.896 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER 56.59 -177.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -144.73 -27.53 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p 61.83 161.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -164.57 -175.06 3.68 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.32 2.248 . . . . 0.0 108.561 163.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -142.68 134.44 26.81 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.894 1.678 . . . . 0.0 108.416 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.7 6.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.133 0.968 . . . . 0.0 113.514 -161.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 t -47.57 -59.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.742 2.017 . . . . 0.0 111.052 167.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -172.96 177.94 2.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.005 2.122 . . . . 0.0 108.997 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.89 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.774 2.03 . . . . 0.0 113.735 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 -58.74 2.05 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -67.13 -29.98 69.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.169 1.788 . . . . 0.0 113.165 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.76 -46.61 29.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.829 -0.544 . . . . 0.0 110.468 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.33 -44.16 83.98 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -54.08 -28.76 41.2 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.67 -38.28 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.088 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -54.94 -42.38 72.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 -53.72 2.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.909 2.083 . . . . 0.0 110.54 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -82.32 -31.47 29.89 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.581 1.952 . . . . 0.0 114.737 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.42 -41.75 98.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.349 0.977 . . . . 0.0 111.212 168.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.75 56.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.278 -0.889 . . . . 0.0 109.855 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.35 -28.41 67.94 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.235 0.925 . . . . 0.0 112.501 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.9 -39.96 75.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 113.093 168.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -63.95 -34.26 77.57 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 121.707 -0.621 . . . . 0.0 111.957 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.59 17.92 5.45 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.128 1.823 . . . . 0.0 113.656 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -107.3 140.3 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.749 1.62 . . . . 0.0 111.956 -167.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.08 -9.2 3.01 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.623 1.169 . . . . 0.0 113.132 156.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.14 -99.03 0.01 OUTLIER Glycine 0 C--N 1.34 0.805 0 C-N-CA 129.699 3.523 . . . . 0.0 118.767 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.86 11.13 3.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.377 1.871 . . . . 0.0 110.298 -167.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -16.62 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.937 2.495 . . . . 0.0 115.502 -156.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -116.89 163.29 16.41 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.744 1.618 . . . . 0.0 110.944 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -145.63 157.69 43.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.964 2.106 . . . . 0.0 111.11 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -135.7 125.79 26.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.572 2.349 . . . . 0.0 110.479 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.24 -21.07 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.78 60.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.659 0.784 . . . . 0.0 112.23 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.1 p -136.71 -2.39 2.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.428 1.491 . . . . 0.0 113.033 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.355 34.6 mtpt 65.16 17.54 11.08 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.904 2.482 . . . . 0.0 113.787 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -66.96 159.44 28.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.994 2.918 . . . . 0.0 114.478 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -122.14 164.53 17.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 130.056 3.342 . . . . 0.0 112.779 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.4 m -150.14 143.89 25.34 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.64 -1.288 . . . . 0.0 112.527 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.51 128.65 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.216 1.006 . . . . 0.0 112.939 160.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -132.61 100.6 5.01 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.259 1.824 . . . . 0.0 110.748 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -174.347 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.0 142.02 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 120.651 -1.281 . . . . 0.0 108.455 161.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.29 133.7 24.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.706 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.69 148.58 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.419 0.688 . . . . 0.0 109.624 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.37 -166.9 20.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 60.99 14.65 5.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.917 1.687 . . . . 0.0 113.737 -157.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.66 46.37 1.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.01 1.724 . . . . 0.0 113.3 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.96 93.82 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.923 -1.11 . . . . 0.0 115.569 -166.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.82 -35.57 78.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -167.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -146.06 -28.31 0.42 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -163.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.68 111.89 1.06 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.599 0.618 . . . . 0.0 113.757 -155.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -129.05 -31.22 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 116.516 -1.707 . . . . 0.0 113.898 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.8 tttm 153.12 -60.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 129.374 3.07 . . . . 0.0 112.876 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.8 m -74.16 -26.14 60.13 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -161.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -26.65 65.77 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.873 -1.142 . . . . 0.0 113.682 167.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.8 mt -89.48 -34.55 16.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.966 1.306 . . . . 0.0 111.564 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -54.35 -35.39 62.7 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.747 -0.596 . . . . 0.0 112.321 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -88.06 -42.33 12.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.29 -30.24 64.55 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.037 1.29 . . . . 0.0 113.16 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -106.86 -22.91 12.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.968 0.907 . . . . 0.0 112.102 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.7 -35.11 7.36 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.039 1.78 . . . . 0.0 114.383 161.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -53.6 -42.58 67.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.641 1.176 . . . . 0.0 113.18 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -85.29 -24.52 27.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.878 0.871 . . . . 0.0 110.895 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 124.81 -74.13 0.41 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 153.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.5 43.98 1.6 Allowed 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.269 3.312 . . . . 0.0 114.831 -158.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.84 154.28 15.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.439 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -139.13 -20.9 0.96 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.047 1.739 . . . . 0.0 113.314 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -163.95 149.7 11.01 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.758 0.823 . . . . 0.0 110.812 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -151.1 121.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.091 1.756 . . . . 0.0 107.986 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -148.19 150.59 34.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.317 1.447 . . . . 0.0 110.304 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.51 157.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.718 -1.239 . . . . 0.0 113.582 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 126.487 1.915 . . . . 0.0 113.055 -173.6 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 CA-C-O 117.961 -1.466 . . . . 0.0 116.597 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.93 145.94 40.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.844 1.822 . . . . 0.0 114.048 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 161.9 35.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.451 3.1 . . . . 0.0 113.287 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.3 144.0 23.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.24 1.416 . . . . 0.0 110.731 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.36 174.51 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.137 -0.977 . . . . 0.0 110.93 -161.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.34 120.44 13.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.085 1.354 . . . . 0.0 109.588 167.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.73 159.78 20.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.338 1.055 . . . . 0.0 110.046 153.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.82 -22.61 31.71 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.427 -1.421 . . . . 0.0 114.276 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.92 136.7 29.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.733 0.813 . . . . 0.0 112.678 -162.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.4 -33.67 17.46 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.934 2.423 . . . . 0.0 114.827 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -41.1 44.43 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.728 1.604 . . . . 0.0 113.444 -166.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.17 -26.82 60.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.701 0.682 . . . . 0.0 112.36 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.22 -45.13 67.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.368 0.667 . . . . 0.0 111.809 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.24 81.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 120.685 -1.26 . . . . 0.0 110.322 172.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -39.82 78.42 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.96 -17.99 58.85 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.904 -1.122 . . . . 0.0 113.914 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 -53.08 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.548 -1.345 . . . . 0.0 110.004 160.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -61.06 -24.47 66.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.168 1.787 . . . . 0.0 113.97 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.86 -8.21 15.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.158 1.383 . . . . 0.0 112.091 -168.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -152.07 -30.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -154.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -63.99 132.95 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.913 0.779 . . . . 0.0 111.772 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.35 79.15 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.749 0.69 . . . . 0.0 114.323 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -111.56 -117.43 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.325 1.45 . . . . 0.0 110.114 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -154.33 148.88 26.3 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.495 1.498 . . . . 0.0 110.257 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.83 -48.4 0.46 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.6 m -134.52 35.97 3.17 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.212 1.405 . . . . 0.0 112.163 -167.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.22 24.76 67.81 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.335 -0.853 . . . . 0.0 113.165 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.8 p -134.41 144.47 48.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.878 2.071 . . . . 0.0 110.755 -172.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -75.49 67.75 2.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.406 1.082 . . . . 0.0 111.133 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 p -54.67 151.54 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.844 2.057 . . . . 0.0 113.943 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.3 132.61 35.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.275 1.83 . . . . 0.0 109.434 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -148.63 129.91 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 117.973 0.351 . . . . 0.0 111.209 -152.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.477 0.904 0 O-C-N 119.954 -1.716 . . . . 0.0 111.629 167.388 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.91 110.46 10.81 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.39 101.83 5.31 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.023 0.929 . . . . 0.0 111.488 -165.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.1 tp -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.922 0.889 . . . . 0.0 109.851 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.6 mt -59.53 113.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.576 2.35 . . . . 0.0 109.37 160.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.04 136.6 32.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.744 164.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -144.02 42.84 1.44 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.84 2.056 . . . . 0.0 107.403 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.49 173.99 33.08 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 120.743 -1.223 . . . . 0.0 113.865 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -58.69 -42.15 87.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.619 0.723 . . . . 0.0 112.029 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -69.49 -62.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.641 2.376 . . . . 0.0 112.48 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -141.55 140.09 33.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.928 0.891 . . . . 0.0 110.801 -166.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 103.95 7.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.228 2.211 . . . . 0.0 107.884 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.3 95.95 0.16 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.619 1.581 . . . . 0.0 112.49 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -28.58 160.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.751 2.82 . . . . 0.0 118.024 166.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -135.47 -25.03 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 11.3 p 57.07 162.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 t -164.14 -171.94 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.31 3.044 . . . . 0.0 108.222 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.35 136.28 27.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 109.282 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.43 177.45 10.59 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.136 0.97 . . . . 0.0 113.453 -164.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.18 -56.56 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.503 1.921 . . . . 0.0 111.214 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -174.36 -174.85 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.196 2.998 . . . . 0.0 107.464 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.92 24.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.932 2.093 . . . . 0.0 114.941 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.01 4.18 7.98 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.39 1.076 . . . . 0.0 112.117 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.6 m -126.4 -22.22 4.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.245 1.818 . . . . 0.0 111.389 168.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.3 11.43 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 121.362 -0.837 . . . . 0.0 111.315 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.4 -45.63 90.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -51.53 -22.34 3.12 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.51 -39.02 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.724 1.61 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -55.57 -39.38 70.59 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -57.23 3.14 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.999 2.12 . . . . 0.0 110.074 168.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.91 -35.22 64.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -61.48 -40.31 94.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.362 0.983 . . . . 0.0 111.132 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.06 -37.03 47.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.58 -0.7 . . . . 0.0 109.85 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -69.92 -25.92 63.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.756 0.707 . . . . 0.0 112.258 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.96 -36.57 69.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.103 1.361 . . . . 0.0 112.809 168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -63.91 -31.18 72.27 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.707 -0.62 . . . . 0.0 111.566 164.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.59 -3.18 15.43 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.811 2.148 . . . . 0.0 113.038 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.01 127.9 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.251 1.82 . . . . 0.0 111.358 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -143.76 82.65 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 124.184 1.945 . . . . 0.0 108.305 152.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.95 -136.43 9.11 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 110.328 -3.124 . . . . 0.0 112.777 -155.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.78 39.75 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 127.865 2.466 . . . . 0.0 110.785 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -37.8 98.2 0.01 OUTLIER 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.053 2.541 . . . . 0.0 112.902 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.6 m -116.61 157.93 24.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.25 1.82 . . . . 0.0 108.385 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -141.95 146.38 35.58 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.83 1.252 . . . . 0.0 109.952 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.42 54.36 1.96 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.855 1.262 . . . . 0.0 110.607 -156.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -41.56 -31.16 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.948 3.299 . . . . 0.0 117.253 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -20.93 59.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.268 1.827 . . . . 0.0 112.601 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -133.2 5.1 3.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.26 1.824 . . . . 0.0 112.894 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.293 46.6 mttm 49.8 13.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 129.404 3.081 . . . . 0.0 116.519 -168.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 m -47.51 158.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.974 2.51 . . . . 0.0 113.505 156.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.4 160.91 30.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 129.439 3.096 . . . . 0.0 111.383 168.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.5 m -145.62 124.32 12.57 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.291 -0.88 . . . . 0.0 110.896 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 100.67 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.857 0.837 . . . . 0.0 112.293 160.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.37 131.83 37.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.11 0.957 . . . . 0.0 110.123 157.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 112.449 161.901 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 118.547 -0.74 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.5 135.28 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 121.274 1.852 . . . . 0.0 111.953 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.21 118.1 9.97 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.504 1.922 . . . . 0.0 108.589 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.81 143.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.26 -170.11 41.37 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 23.5 t30 119.94 -13.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 131.646 3.978 . . . . 0.0 110.995 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.2 -27.43 63.89 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -165.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.68 -27.02 0.28 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.782 2.135 . . . . 0.0 117.662 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.46 -13.61 12.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.858 1.663 . . . . 0.0 112.793 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -169.77 -177.79 2.78 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.231 2.612 . . . . 0.0 109.059 -163.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.91 15.79 0.25 Allowed Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.978 -0.901 . . . . 0.0 114.819 164.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -49.38 163.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.36 3.064 . . . . 0.0 113.987 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -59.31 -35.88 74.62 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.403 -0.811 . . . . 0.0 112.662 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.7 m -92.15 -32.56 15.07 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.587 1.085 . . . . 0.0 113.87 -168.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.48 -31.73 69.61 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.432 -1.418 . . . . 0.0 111.728 165.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.85 -28.01 20.67 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.123 1.156 . . . . 0.0 114.123 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.56 -33.19 71.11 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.607 1.548 . . . . 0.0 109.154 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -82.3 -47.23 12.64 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.487 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.42 -28.46 65.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.161 0.891 . . . . 0.0 112.874 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.57 -37.58 8.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.743 0.817 . . . . 0.0 112.672 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.82 -36.91 3.81 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.263 1.887 . . . . 0.0 114.978 167.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -55.03 -45.65 75.19 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -75.06 -35.65 61.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.141 0.577 . . . . 0.0 110.401 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.56 178.45 40.75 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.507 1.051 . . . . 0.0 115.473 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.4 155.73 63.21 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.053 3.169 . . . . 0.0 114.822 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.56 148.26 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.746 2.418 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -103.55 -37.82 7.4 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.648 1.979 . . . . 0.0 112.759 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -161.38 157.81 25.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 p -167.6 131.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.46 1.104 . . . . 0.0 112.155 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -155.48 159.32 39.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.288 1.835 . . . . 0.0 111.317 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.91 157.67 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.223 -1.548 . . . . 0.0 113.431 -171.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 125.513 1.525 . . . . 0.0 113.665 -178.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.779 0 CA-C-O 118.363 -1.243 . . . . 0.0 115.201 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.72 132.62 21.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.671 1.236 . . . . 0.0 112.773 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.88 163.05 28.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.854 2.462 . . . . 0.0 113.379 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -135.61 138.71 43.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.01 1.724 . . . . 0.0 109.23 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.283 2.0 m -146.9 -177.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.234 -0.916 . . . . 0.0 112.404 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.09 117.31 10.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.733 2.013 . . . . 0.0 107.196 162.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.06 -174.87 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.002 1.321 . . . . 0.0 114.067 165.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -124.12 -8.54 7.67 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -149.58 123.37 4.56 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 120.562 1.528 . . . . 0.0 113.01 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.64 -24.32 48.19 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.271 2.648 . . . . 0.0 114.934 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -63.06 -55.08 28.55 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.765 1.166 . . . . 0.0 110.451 172.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.73 -34.06 76.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.014 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.09 92.26 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.32 80.59 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.549 -1.344 . . . . 0.0 110.27 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.94 -42.52 48.45 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -14.28 41.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.83 1.252 . . . . 0.0 114.084 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.17 -60.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.396 0.998 . . . . 0.0 109.705 155.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -19.92 62.29 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -160.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -98.34 1.64 47.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.276 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.05 -31.13 0.5 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -159.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.48 104.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.317 1.447 . . . . 0.0 110.671 156.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.12 24.15 25.44 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.42 -1.211 . . . . 0.0 114.76 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -116.59 164.18 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.583 1.691 . . . . 0.0 112.985 -168.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -95.4 128.35 42.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.513 1.525 . . . . 0.0 110.844 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.1 -12.79 11.89 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.153 1.381 . . . . 0.0 114.344 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.32 -65.31 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.985 0.914 . . . . 0.0 111.811 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -165.69 32.8 0.23 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.756 2.122 . . . . 0.0 111.059 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 3.7 m -142.77 -158.9 0.91 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.198 2.199 . . . . 0.0 109.192 -158.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -149.26 153.43 37.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.128 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -137.81 160.66 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -165.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.61 142.64 41.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.492 2.717 . . . . 0.0 109.55 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.37 125.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.565 -0.71 . . . . 0.0 110.907 -152.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 126.965 2.106 . . . . 0.0 106.96 168.841 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.015 0.435 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.15 106.6 9.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.49 99.82 4.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.177 0.991 . . . . 0.0 111.496 -163.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.09 95.64 10.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.335 1.054 . . . . 0.0 108.952 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.38 117.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.625 1.57 . . . . 0.0 108.912 160.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.22 129.63 39.19 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.655 174.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -143.18 109.51 5.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.84 177.47 27.05 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 121.803 0.669 . . . . 0.0 114.617 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.952 1.301 . . . . 0.0 110.655 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.3 m -63.12 -55.87 21.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.634 2.373 . . . . 0.0 113.216 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -165.08 144.21 6.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.792 1.637 . . . . 0.0 109.687 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -131.73 150.24 52.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.885 1.274 . . . . 0.0 112.459 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.14 -134.64 4.51 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.957 1.742 . . . . 0.0 111.294 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -161.25 -166.6 1.58 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.22 2.608 . . . . 0.0 107.801 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -145.9 -39.68 0.23 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 161.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p 57.62 163.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -165.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -159.96 -169.36 2.5 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.592 2.357 . . . . 0.0 106.754 153.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -137.92 132.02 31.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.289 -1.507 . . . . 0.0 108.146 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.84 -178.72 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.147 0.979 . . . . 0.0 112.417 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -44.41 -57.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.677 1.991 . . . . 0.0 110.809 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -178.97 -164.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 129.521 3.128 . . . . 0.0 108.751 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 20.47 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.178 2.191 . . . . 0.0 115.189 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.24 5.13 5.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.442 1.097 . . . . 0.0 112.233 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -125.63 -14.62 6.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 111.713 161.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.46 7.34 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.453 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.25 -47.88 65.51 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -56.37 -19.43 14.69 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.6 -168.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.67 -34.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.712 1.605 . . . . 0.0 110.296 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -54.08 -44.67 71.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.701 1.2 . . . . 0.0 112.071 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -43.48 -56.49 3.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.326 1.85 . . . . 0.0 111.564 168.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -75.23 -31.51 60.87 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.034 0.834 . . . . 0.0 111.134 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -35.07 57.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.346 -0.846 . . . . 0.0 110.013 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -66.73 -31.09 71.52 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.003 0.819 . . . . 0.0 112.173 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.59 -38.31 80.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.016 1.326 . . . . 0.0 113.168 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.99 -33.15 74.94 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 121.682 -0.636 . . . . 0.0 112.525 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.28 27.12 2.28 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.894 1.711 . . . . 0.0 114.021 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.359 1.463 . . . . 0.0 111.88 -165.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.78 3.89 6.05 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 121.818 0.818 . . . . 0.0 112.243 152.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.71 -112.12 0.98 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.181 2.324 . . . . 0.0 118.396 150.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -147.33 37.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.972 2.509 . . . . 0.0 107.223 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.513 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 18.4 m95 -40.67 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.497 1.519 . . . . 0.0 114.152 -160.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 m -125.08 160.2 29.63 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.918 1.687 . . . . 0.0 110.012 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -148.15 154.03 39.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.598 1.559 . . . . 0.0 111.151 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -129.88 139.6 51.13 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 126.361 1.864 . . . . 0.0 109.18 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -108.38 -16.83 14.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.31 -26.42 61.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 111.856 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.3 p -122.28 -6.9 8.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.429 1.891 . . . . 0.0 112.953 167.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.421 45.1 mttm 66.13 12.63 8.64 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 126.992 2.117 . . . . 0.0 115.376 -173.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -59.67 155.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 127.229 2.211 . . . . 0.0 114.361 170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -123.91 166.33 15.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.925 2.49 . . . . 0.0 112.318 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -150.01 137.57 19.91 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.769 -1.207 . . . . 0.0 110.793 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.63 153.94 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.512 155.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.14 88.42 1.45 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.313 1.845 . . . . 0.0 113.957 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 113.913 177.685 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -118.9 141.93 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.818 -1.176 . . . . 0.0 109.716 150.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -141.81 128.25 20.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.07 1.348 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.7 t -133.38 122.58 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.06 -171.09 12.2 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.998 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.42 41.33 24.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.416 0.686 . . . . 0.0 112.27 -158.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.34 -30.76 42.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.899 0.88 . . . . 0.0 111.75 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.14 -51.65 0.56 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 127.927 2.68 . . . . 0.0 117.404 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -124.1 -56.62 1.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.382 1.091 . . . . 0.0 113.795 -152.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.62 -27.84 28.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -165.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -7.03 82.83 0.0 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 128.943 3.163 . . . . 0.0 117.039 -165.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -118.21 -66.62 1.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 147.36 -46.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 131.386 3.874 . . . . 0.0 111.93 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -74.73 -27.16 60.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.57 0.623 . . . . 0.0 112.166 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.97 -38.4 50.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.742 0.817 . . . . 0.0 112.759 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.6 -34.97 18.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.665 1.586 . . . . 0.0 111.585 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -56.34 -35.5 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.544 0.738 . . . . 0.0 110.496 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -83.91 -53.46 5.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.801 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.03 47.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -115.88 -26.48 7.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.344 1.058 . . . . 0.0 112.424 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.04 -33.3 21.42 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.533 1.063 . . . . 0.0 114.145 165.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -55.23 -43.77 74.86 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.03 -34.18 44.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.511 0.324 . . . . 0.0 111.024 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.25 -171.04 44.0 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -168.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.13 126.06 8.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.217 3.278 . . . . 0.0 113.322 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -99.83 144.0 29.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 109.416 167.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.92 -5.23 1.15 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.764 1.626 . . . . 0.0 113.272 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -156.78 160.55 39.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.741 1.216 . . . . 0.0 110.638 154.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.4 t -159.91 136.19 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.774 2.03 . . . . 0.0 110.145 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -157.03 160.18 38.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.95 1.7 . . . . 0.0 111.444 161.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.13 148.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 120.705 -1.247 . . . . 0.0 112.823 171.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 126.293 1.837 . . . . 0.0 114.153 176.556 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 116.288 1.275 . . . . 0.0 116.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.8 139.32 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.79 1.295 . . . . 0.0 111.964 -168.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -133.98 154.58 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 129.077 2.951 . . . . 0.0 112.082 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.56 138.8 36.56 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.813 1.245 . . . . 0.0 109.462 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.278 2.0 m -141.6 -179.65 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.247 -0.908 . . . . 0.0 110.834 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -141.45 102.74 4.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.506 1.522 . . . . 0.0 108.314 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -64.61 175.92 1.28 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.447 0.699 . . . . 0.0 111.698 159.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -124.96 9.89 8.18 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.555 -1.34 . . . . 0.0 112.741 166.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.66 126.61 11.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.363 . . . . 0.0 110.991 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.08 -22.15 6.2 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.748 2.299 . . . . 0.0 113.914 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -70.82 -51.78 24.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.781 1.173 . . . . 0.0 110.358 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.85 -37.23 81.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.53 1.132 . . . . 0.0 110.589 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.64 67.19 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.133 1.373 . . . . 0.0 112.49 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.7 -30.88 67.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.724 -1.235 . . . . 0.0 111.033 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.88 -40.2 65.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.97 1.259 . . . . 0.0 113.483 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -17.34 36.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 0.0 113.898 166.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.33 -55.79 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.405 1.457 . . . . 0.0 110.131 159.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -54.96 -29.4 56.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.895 2.078 . . . . 0.0 114.068 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.36 -11.99 16.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.85 1.26 . . . . 0.0 112.075 -169.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.17 -20.54 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -154.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.18 136.82 48.28 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.756 0.822 . . . . 0.0 112.687 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.18 43.39 21.23 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.074 0.845 . . . . 0.0 112.622 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.12 -154.96 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.368 1.467 . . . . 0.0 111.671 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.2 m -129.46 -42.45 1.32 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.786 1.234 . . . . 0.0 110.744 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 tp 41.55 -99.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.771 2.828 . . . . 0.0 114.217 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.5 m -77.86 41.2 0.34 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.545 2.338 . . . . 0.0 113.475 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.87 75.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.745 1.164 . . . . 0.0 114.386 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.41 -119.22 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 111.489 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.72 32.27 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.597 0.713 . . . . 0.0 112.652 -153.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.13 140.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.232 2.213 . . . . 0.0 115.864 -156.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -134.32 113.76 12.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 129.385 3.074 . . . . 0.0 107.584 -170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.18 132.51 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.919 0.488 . . . . 0.0 112.077 -150.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 125.958 1.703 . . . . 0.0 109.938 171.306 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -130.55 95.67 3.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.06 102.27 7.16 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.159 -154.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.4 tp -88.71 93.58 9.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.16 1.384 . . . . 0.0 109.053 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 mt -58.22 118.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.65 1.98 . . . . 0.0 108.757 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.92 139.36 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.76 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -145.89 51.33 1.17 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.223 0.609 . . . . 0.0 109.879 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.56 -168.0 18.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 -165.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -41.11 -28.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.416 3.086 . . . . 0.0 116.014 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -134.44 -40.47 0.8 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.253 1.421 . . . . 0.0 111.871 -144.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.54 137.77 15.7 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.244 1.818 . . . . 0.0 107.82 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -127.93 124.43 37.32 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.907 1.283 . . . . 0.0 109.464 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.44 -134.89 4.47 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.287 1.423 . . . . 0.0 109.929 -152.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -164.05 -174.06 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.166 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -142.82 -29.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p 57.98 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -166.03 -179.38 5.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.84 2.856 . . . . 0.0 107.76 166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -140.02 134.89 32.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.751 1.621 . . . . 0.0 108.403 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.28 -178.74 6.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.935 0.894 . . . . 0.0 112.131 -163.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -43.32 -57.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.564 1.945 . . . . 0.0 110.741 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -171.22 -163.39 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.93 2.892 . . . . 0.0 107.681 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.37 24.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.231 1.812 . . . . 0.0 114.249 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.0 -59.03 1.81 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.1 m -65.03 -21.97 66.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.13 -49.05 10.6 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 119.071 0.85 . . . . 0.0 111.67 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -62.51 -44.99 95.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.92 -20.38 51.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.94 -42.1 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.423 1.889 . . . . 0.0 111.282 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -54.9 -36.46 65.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.3 mmpt? -48.49 -50.09 33.08 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.494 1.918 . . . . 0.0 110.186 171.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -74.92 -37.71 61.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.839 1.655 . . . . 0.0 114.721 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -58.56 -39.4 80.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.463 1.029 . . . . 0.0 111.366 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.13 -32.22 26.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.449 -0.782 . . . . 0.0 110.858 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.03 -31.44 72.67 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.21 -41.9 80.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 113.084 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.27 -35.29 80.02 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.775 -0.578 . . . . 0.0 112.488 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.74 29.8 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.619 1.58 . . . . 0.0 113.798 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.99 127.17 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.938 1.295 . . . . 0.0 111.99 -165.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -122.75 -3.56 8.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.583 152.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 18.6 -78.68 0.0 OUTLIER Glycine 0 CA--C 1.528 0.892 1 C-N-CA 131.31 4.291 . . . . 0.0 119.256 170.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -134.61 2.33 3.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.391 1.877 . . . . 0.0 111.615 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 m95 -19.29 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.911 2.084 . . . . 0.0 115.518 -149.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 t -129.91 170.44 13.92 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.074 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -157.38 157.65 34.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.274 1.829 . . . . 0.0 111.679 -166.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -110.91 -48.98 3.07 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -164.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 58.44 -38.12 0.06 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 129.046 2.938 . . . . 0.0 117.624 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.02 61.96 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.969 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 p -122.26 -5.54 8.86 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.081 1.753 . . . . 0.0 113.091 165.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 48.5 mttm 60.2 6.31 0.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.46 2.304 . . . . 0.0 116.52 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.8 m -46.85 146.36 1.66 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.632 1.973 . . . . 0.0 114.054 156.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.52 163.07 15.89 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.632 2.773 . . . . 0.0 111.516 164.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -148.95 144.33 26.74 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.311 -1.493 . . . . 0.0 111.599 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.93 128.3 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.963 161.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -132.1 107.5 8.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 126.832 2.053 . . . . 0.0 109.802 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.45 139.78 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 121.129 -0.982 . . . . 0.0 111.38 152.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -144.56 133.25 22.28 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.981 1.312 . . . . 0.0 109.556 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.2 161.59 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.646 0.736 . . . . 0.0 112.469 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.55 -166.1 27.04 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 80.84 -1.28 1.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.155 2.582 . . . . 0.0 114.312 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.463 ' CD1' ' H ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -71.27 -172.59 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.778 1.231 . . . . 0.0 111.363 175.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.463 ' H ' ' CD1' ' A' ' 81' ' ' LEU . . . 168.47 -24.18 0.11 Allowed Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.546 1.07 . . . . 0.0 113.938 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.96 -30.65 71.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.464 1.506 . . . . 0.0 114.303 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -150.64 -18.03 0.23 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -172.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.61 115.28 6.92 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 120.131 1.332 . . . . 0.0 113.508 -150.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -131.2 -19.44 2.81 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 140.0 -52.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 131.164 3.786 . . . . 0.0 111.239 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -91.53 -23.45 19.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -158.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.75 -35.53 70.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.868 -1.77 . . . . 0.0 111.472 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.7 mt -89.73 -29.33 18.79 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.978 2.511 . . . . 0.0 111.157 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.85 -33.01 69.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.24 1.382 . . . . 0.0 110.605 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -84.04 -48.59 9.76 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.714 0.805 . . . . 0.0 112.432 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.28 67.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -96.9 -27.84 14.49 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -56.67 -35.16 66.14 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.577 1.56 . . . . 0.0 113.989 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -57.36 -31.54 65.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -96.97 17.84 16.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.194 0.997 . . . . 0.0 112.14 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 -160.99 14.12 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.865 -1.147 . . . . 0.0 115.603 163.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -49.79 117.41 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 125.409 4.072 . . . . 0.0 114.471 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -110.14 149.97 29.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.864 1.666 . . . . 0.0 109.514 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -124.7 -25.97 3.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.713 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -163.56 152.61 14.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.076 0.95 . . . . 0.0 109.621 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -151.46 127.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.85 1.66 . . . . 0.0 108.316 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -138.64 168.71 19.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.754 1.222 . . . . 0.0 111.512 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 t -150.09 142.51 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.581 1.153 . . . . 0.0 111.093 -164.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 126.171 1.788 . . . . 0.0 113.391 173.229 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 115.368 0.907 . . . . 0.0 115.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -138.99 143.13 38.38 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.665 1.586 . . . . 0.0 109.451 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.7 153.1 47.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -141.32 120.94 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.924 0.89 . . . . 0.0 109.655 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.33 -177.39 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -161.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -145.47 110.2 5.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.562 1.945 . . . . 0.0 109.635 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -71.31 -175.71 1.31 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.121 0.968 . . . . 0.0 110.056 151.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -150.33 70.04 1.02 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.707 -1.246 . . . . 0.0 111.675 150.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.75 138.39 10.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.517 1.527 . . . . 0.0 110.393 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -73.5 -38.2 2.68 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.381 2.054 . . . . 0.0 115.435 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -60.38 1.67 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.64 1.109 . . . . 0.0 113.49 -154.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.4 -21.28 66.22 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.398 -0.814 . . . . 0.0 111.488 173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.64 -37.66 41.53 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.06 74.5 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 120.304 -1.498 . . . . 0.0 109.369 163.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.03 -36.75 84.09 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 3.5 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 168.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.47 -41.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 120.413 1.46 . . . . 0.0 113.112 144.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -62.83 -23.74 67.43 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.985 1.266 . . . . 0.0 113.213 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.74 -10.52 14.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.298 1.839 . . . . 0.0 110.883 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.58 -28.71 0.64 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -154.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.31 136.96 54.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.966 0.888 . . . . 0.0 111.728 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.12 13.15 52.51 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.377 0.989 . . . . 0.0 114.775 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 134' ' ' THR . 5.8 ttt180 -85.42 -159.5 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.451 1.5 . . . . 0.0 111.259 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.402 ' H ' ' HG2' ' A' ' 133' ' ' ARG . 55.3 m -147.64 134.6 20.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.418 2.287 . . . . 0.0 106.218 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.0 tp -133.44 -36.32 0.98 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -156.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 36.2 m -138.63 8.05 2.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.829 1.251 . . . . 0.0 114.191 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.31 26.69 3.37 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.79 -82.06 0.3 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.926 1.363 . . . . 0.0 110.401 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 175.13 165.05 0.28 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.019 3.327 . . . . 0.0 107.467 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.86 155.27 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.873 0.761 . . . . 0.0 111.574 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.5 127.14 17.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.783 2.433 . . . . 0.0 108.063 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.9 t -141.37 134.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.532 0.605 . . . . 0.0 111.389 -152.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.061 1.744 . . . . 0.0 108.804 175.594 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -143.41 107.25 4.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.2 ttpt -117.9 132.69 56.39 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 112.623 -171.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.85 102.56 14.33 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.608 1.163 . . . . 0.0 109.283 165.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 mt -64.95 119.33 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 128.461 2.705 . . . . 0.0 109.854 158.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.0 128.92 42.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.766 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -140.37 48.51 1.75 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.565 1.946 . . . . 0.0 109.469 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.75 160.69 13.16 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 122.807 1.226 . . . . 0.0 114.565 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -53.78 -39.3 65.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.687 2.395 . . . . 0.0 112.781 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -59.65 -55.35 35.58 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.759 2.824 . . . . 0.0 112.862 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.0 139.74 8.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.054 1.342 . . . . 0.0 110.789 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.72 111.02 16.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.89 2.076 . . . . 0.0 109.001 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.29 0.05 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.117 0.865 . . . . 0.0 113.253 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.34 157.84 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.05 2.14 . . . . 0.0 115.914 161.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -135.39 -22.09 1.53 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.4 p 62.49 161.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -170.55 -170.68 0.95 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.722 2.809 . . . . 0.0 109.116 168.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -143.57 141.22 30.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.658 2.383 . . . . 0.0 108.387 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.36 172.8 13.83 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -163.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.49 -44.14 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.042 2.137 . . . . 0.0 112.077 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -140.13 -64.17 0.48 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -152.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 130.2 2.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 131.309 3.844 . . . . 0.0 112.637 -160.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.41 -44.3 1.12 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.05 0.94 . . . . 0.0 110.119 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.2 m -63.5 -20.48 65.64 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.611 1.565 . . . . 0.0 113.887 164.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.49 10.65 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 118.804 0.729 . . . . 0.0 110.938 167.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.99 -45.77 93.45 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -64.06 -13.88 50.48 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.66 -40.43 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.197 2.199 . . . . 0.0 110.563 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -57.87 -39.99 79.16 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 13.9 mmtp -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.331 2.252 . . . . 0.0 111.014 166.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -75.95 -31.44 59.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -60.43 -43.28 96.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.687 1.13 . . . . 0.0 111.022 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.62 -34.97 58.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.513 -0.742 . . . . 0.0 109.962 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.06 -30.45 69.66 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.353 0.524 . . . . 0.0 112.101 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.92 -36.76 70.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.214 1.405 . . . . 0.0 113.402 170.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -64.62 -49.26 71.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.632 -0.667 . . . . 0.0 111.683 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.97 31.92 0.57 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.795 1.664 . . . . 0.0 114.181 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.67 146.36 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.4 1.88 . . . . 0.0 111.015 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -138.72 -6.79 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.204 1.002 . . . . 0.0 113.47 154.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.84 -129.06 6.47 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 126.155 1.836 . . . . 0.0 116.228 160.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.51 34.9 4.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.288 2.235 . . . . 0.0 108.428 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 13.9 m95 -19.66 97.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.762 2.825 . . . . 0.0 114.953 -169.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -118.11 162.4 18.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.454 1.501 . . . . 0.0 110.898 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -146.38 151.2 37.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.732 2.013 . . . . 0.0 111.114 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -107.07 -40.05 5.55 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -164.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 60.5 -33.43 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 119.185 3.031 . . . . 0.0 119.185 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.57 61.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.796 1.638 . . . . 0.0 112.266 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -135.24 13.17 3.55 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.49 1.916 . . . . 0.0 111.849 162.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.264 36.8 mttm 54.9 11.43 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 127.836 2.455 . . . . 0.0 116.581 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -44.57 156.14 0.09 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.574 1.949 . . . . 0.0 114.363 150.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.2 160.18 34.6 Favored 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.69 4.796 . . . . 0.0 110.107 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -147.82 134.69 20.14 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 112.073 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 m -108.94 96.58 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 122.215 1.007 . . . . 0.0 112.483 156.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -79.98 114.22 18.72 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.516 0.726 . . . . 0.0 109.855 160.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 125.397 1.479 . . . . 0.0 110.82 170.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.32 163.77 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 135.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -137.86 152.33 48.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.912 1.285 . . . . 0.0 111.284 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.2 152.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 111.242 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 -176.16 32.71 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.162 1.625 . . . . 0.0 117.162 161.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 91.53 1.85 0.12 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 130.805 3.642 . . . . 0.0 113.279 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.09 174.21 1.64 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.358 1.463 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.85 -37.76 0.18 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.564 1.078 . . . . 0.0 113.287 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -69.26 -57.57 5.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.733 0.813 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.5 -54.69 4.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.024 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.81 62.43 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 128.394 2.902 . . . . 0.0 117.004 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -132.66 -52.02 0.92 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.746 1.773 . . . . 0.0 115.67 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? 150.74 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 130.73 3.612 . . . . 0.0 112.625 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -87.63 -24.84 23.82 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.476 -0.765 . . . . 0.0 112.228 -164.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -55.43 -38.34 68.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.819 162.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.6 mt -82.67 -34.25 27.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.242 1.017 . . . . 0.0 112.569 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -54.68 -36.27 64.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.867 0.758 . . . . 0.0 111.102 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtm-85 -78.26 -57.05 3.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -20.67 41.9 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -113.91 -29.93 6.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.884 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.24 -35.19 26.71 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.765 1.174 . . . . 0.0 114.054 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -58.39 -41.72 85.47 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -78.44 -32.2 48.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.586 0.355 . . . . 0.0 111.235 -171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -177.68 44.67 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.036 0.826 . . . . 0.0 115.086 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.01 136.71 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.704 3.603 . . . . 0.0 114.509 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 152.38 23.87 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.27 1.828 . . . . 0.0 109.95 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -122.74 -22.36 5.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.556 1.542 . . . . 0.0 113.253 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -167.92 156.75 9.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.335 1.454 . . . . 0.0 109.655 173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -152.71 131.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.799 1.239 . . . . 0.0 110.843 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -147.28 153.9 40.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.305 1.442 . . . . 0.0 111.367 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.84 144.81 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.107 -0.996 . . . . 0.0 112.032 171.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.579 1.152 . . . . 0.0 111.386 175.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -142.52 139.38 31.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.521 1.661 . . . . 0.0 112.417 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.88 162.5 26.57 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.126 1.771 . . . . 0.0 113.448 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -149.28 136.91 20.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.728 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.89 177.9 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -172.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -137.77 147.06 44.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.594 1.158 . . . . 0.0 110.065 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -177.72 3.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.177 2.591 . . . . 0.0 111.466 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.42 -22.15 6.59 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.54 106.11 54.41 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 120.557 1.526 . . . . 0.0 113.352 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 -20.79 36.27 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.416 2.744 . . . . 0.0 114.639 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -41.87 17.63 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.056 1.298 . . . . 0.0 111.308 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -67.33 -33.3 74.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.622 0.769 . . . . 0.0 112.257 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.508 0.723 . . . . 0.0 112.863 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.22 -34.73 70.73 Favored 'General case' 0 C--O 1.226 -0.165 0 O-C-N 121.002 -1.061 . . . . 0.0 110.142 168.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -38.2 76.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 172.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.9 -15.0 39.41 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.766 -1.209 . . . . 0.0 113.721 166.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.55 -54.34 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.462 -1.399 . . . . 0.0 109.594 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -58.32 -26.79 63.47 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 113.816 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.23 -10.64 17.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.245 1.418 . . . . 0.0 112.299 -170.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 -33.98 0.19 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -154.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -60.43 133.84 56.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.71 0.804 . . . . 0.0 112.492 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.88 13.63 83.21 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.231 -0.761 . . . . 0.0 114.305 160.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -113.19 -106.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.158 1.783 . . . . 0.0 109.736 -173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -156.64 136.89 12.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 109.038 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 tp -154.41 155.17 34.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.325 1.45 . . . . 0.0 109.375 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.1 m 51.76 25.57 3.01 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.41 73.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.11 1.338 . . . . 0.0 115.164 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.5 p -121.95 156.21 33.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.567 1.547 . . . . 0.0 111.579 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.21 53.04 0.78 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.05 1.74 . . . . 0.0 112.953 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -46.99 152.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.833 2.453 . . . . 0.0 115.957 -163.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -137.31 137.24 38.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.122 2.569 . . . . 0.0 108.687 167.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.54 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.477 0.58 . . . . 0.0 111.406 -163.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.477 0.916 0 O-C-N 119.624 -1.922 . . . . 0.0 110.207 167.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.68 109.37 5.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 37.5 ttpt -133.99 150.5 51.26 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 125.85 1.66 . . . . 0.0 113.018 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.9 tp -117.62 109.97 17.32 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.443 1.897 . . . . 0.0 110.211 161.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.25 120.33 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 129.739 3.216 . . . . 0.0 110.259 158.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.12 128.19 40.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.134 165.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -139.49 40.35 2.05 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.983 2.113 . . . . 0.0 110.226 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.99 171.65 42.94 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 120.25 -1.531 . . . . 0.0 116.169 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -66.0 -43.15 88.54 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 152.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.7 m -53.45 -57.12 11.78 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.482 3.113 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -162.33 141.23 9.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.0 110.008 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.92 110.45 13.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.614 1.566 . . . . 0.0 109.466 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.64 77.6 0.03 OUTLIER Glycine 0 N--CA 1.465 0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.004 -161.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.87 160.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.117 1.367 . . . . 0.0 114.222 162.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -124.28 -37.26 2.56 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.6 p 58.62 166.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -155.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -155.38 -25.15 0.11 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.35 136.39 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 127.17 2.188 . . . . 0.0 116.541 -162.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.77 -179.68 7.47 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.4 -1.438 . . . . 0.0 112.924 -166.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.81 -50.91 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.289 1.836 . . . . 0.0 111.876 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -167.93 167.93 12.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.568 1.547 . . . . 0.0 109.661 -152.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.04 15.81 0.5 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.43 -31.33 0.81 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.103 -0.998 . . . . 0.0 111.865 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.3 m -76.34 -21.29 56.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.0 111.837 163.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -50.42 15.46 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.617 -0.677 . . . . 0.0 110.123 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -48.26 58.09 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.084 1.354 . . . . 0.0 108.6 173.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -24.8 15.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.551 1.157 . . . . 0.0 114.068 -170.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.05 -38.77 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.607 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -55.11 -41.83 72.15 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.046 0.938 . . . . 0.0 113.471 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE2' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -48.86 -55.06 12.78 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 110.051 169.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -68.87 -34.17 75.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -60.38 -40.91 92.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.286 0.948 . . . . 0.0 110.842 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.84 52.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 110.358 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.21 -32.72 73.15 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.359 0.527 . . . . 0.0 111.857 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.81 -38.88 87.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.192 . . . . 0.0 113.186 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -67.1 -34.54 77.85 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.567 -0.708 . . . . 0.0 112.741 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.31 22.83 1.83 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.895 1.712 . . . . 0.0 114.684 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.88 134.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.58 1.552 . . . . 0.0 111.92 -161.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.23 10.44 3.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 149.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.08 -139.06 1.19 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 149.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -119.46 53.87 1.02 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.899 2.479 . . . . 0.0 106.276 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.475 ' CE2' ' HE2' ' A' ' 31' ' ' LYS . 13.9 m95 -45.65 104.28 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.334 1.454 . . . . 0.0 112.631 -172.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.1 m -124.44 158.6 32.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.351 1.861 . . . . 0.0 108.672 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 38.9 t80 -137.91 144.04 41.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.83 1.252 . . . . 0.0 110.11 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -130.59 60.79 1.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 110.094 -156.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -47.0 -28.06 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.581 2.752 . . . . 0.0 116.128 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.7 -24.06 46.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.573 2.349 . . . . 0.0 112.852 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -132.9 7.8 4.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 112.854 165.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 51.0 mttm 45.78 25.16 0.26 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.555 2.742 . . . . 0.0 115.097 -164.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 m -63.43 168.98 4.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.235 1.814 . . . . 0.0 111.351 160.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 60.7 m-85 -135.73 156.41 48.87 Favored 'General case' 0 C--N 1.324 -0.509 1 C-N-CA 132.573 4.349 . . . . 0.0 108.903 175.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.8 m -143.35 129.72 19.96 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 m -103.51 93.21 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.21 1.005 . . . . 0.0 112.281 160.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.99 59.02 3.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.41 1.084 . . . . 0.0 112.457 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 . . . . . 0 N--CA 1.481 1.09 0 O-C-N 120.551 -1.343 . . . . 0.0 113.284 -176.465 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -113.56 141.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.19 -1.569 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -139.88 127.59 21.81 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.637 1.575 . . . . 0.0 109.116 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.22 146.91 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.41 -177.78 38.62 Favored Glycine 0 CA--C 1.518 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 115.249 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.65 16.66 9.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.316 1.446 . . . . 0.0 113.969 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 38.47 0.16 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 127.152 2.181 . . . . 0.0 111.714 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.49 -25.63 50.12 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.513 1.53 . . . . 0.0 115.762 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.74 -31.16 72.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.365 1.466 . . . . 0.0 113.223 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -134.02 -88.31 0.39 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.067 1.347 . . . . 0.0 110.192 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.22 56.33 2.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.817 1.199 . . . . 0.0 113.453 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -128.93 163.99 24.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.631 1.572 . . . . 0.0 111.555 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -72.56 -40.18 66.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.165 -0.959 . . . . 0.0 112.918 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.1 m -74.2 -34.62 63.78 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -168.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -54.38 -36.03 63.45 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.969 1.259 . . . . 0.0 111.64 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.98 -27.94 30.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.934 1.293 . . . . 0.0 112.826 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.92 -36.69 72.83 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.119 1.327 . . . . 0.0 109.94 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -103.18 -39.59 6.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.404 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.38 -30.88 68.74 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.547 0.612 . . . . 0.0 112.417 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -97.87 -30.16 12.91 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.22 -33.78 16.14 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.001 1.286 . . . . 0.0 114.439 167.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -58.94 -41.57 87.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -78.63 -24.75 45.13 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.971 0.509 . . . . 0.0 112.354 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.72 -177.49 41.48 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.031 0.824 . . . . 0.0 114.925 -171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.55 147.6 46.25 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.74 2.96 . . . . 0.0 113.149 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.97 164.25 18.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.676 2.391 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 116' ' ' GLU . 5.1 tmm_? -122.99 -36.88 2.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.434 1.494 . . . . 0.0 112.403 173.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -161.98 154.41 19.69 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.259 0.936 . . . . 0.0 111.068 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.5 t -153.02 123.56 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.233 1.413 . . . . 0.0 110.151 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -145.27 159.93 42.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.695 1.198 . . . . 0.0 111.671 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.76 153.3 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.397 -0.815 . . . . 0.0 111.897 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.148 1.379 . . . . 0.0 114.267 -177.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.324 0 N-CA-C 117.318 1.687 . . . . 0.0 117.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -133.54 130.28 38.25 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.254 1.527 . . . . 0.0 111.06 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.44 160.81 38.96 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.128 2.171 . . . . 0.0 114.489 -158.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -155.08 119.71 4.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.957 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 m -137.22 -171.03 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.832 0.853 . . . . 0.0 111.764 -168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 101' ' ' ARG . 15.6 tt0 -153.75 115.88 4.32 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.427 1.091 . . . . 0.0 111.239 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -67.28 179.94 1.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.077 1.751 . . . . 0.0 112.457 165.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -115.08 -50.29 2.76 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.46 -0.775 . . . . 0.0 112.549 155.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -75.96 123.69 88.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 O-C-N 121.296 -0.877 . . . . 0.0 112.261 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -26.22 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.97 2.447 . . . . 0.0 114.724 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -27.54 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.302 1.41 . . . . 0.0 112.378 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.43 -37.46 83.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.801 0.84 . . . . 0.0 111.445 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.51 96.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.269 0.628 . . . . 0.0 112.132 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.39 91.53 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.151 -0.968 . . . . 0.0 110.516 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -40.33 81.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.85 0.75 . . . . 0.0 112.687 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.46 -20.14 58.92 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 168.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.9 t -77.84 -53.88 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 120.403 1.456 . . . . 0.0 109.383 160.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.28 -24.0 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.932 1.693 . . . . 0.0 113.972 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -111.68 -6.89 14.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.451 1.5 . . . . 0.0 111.814 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.49 -22.66 0.28 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -156.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -74.5 144.98 43.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.892 0.853 . . . . 0.0 111.831 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.95 34.11 71.0 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.033 -171.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -132.36 -140.53 0.2 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.038 1.335 . . . . 0.0 110.977 -171.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.4 m -154.05 144.21 22.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.208 2.203 . . . . 0.0 109.395 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mp -118.26 -37.56 3.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.483 1.113 . . . . 0.0 113.031 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.2 t -144.87 43.67 1.35 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.077 0.951 . . . . 0.0 112.811 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.65 4.81 88.08 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.322 0.963 . . . . 0.0 114.512 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.9 p -72.61 -176.29 1.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.544 1.537 . . . . 0.0 112.185 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.44 115.51 10.93 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.539 1.536 . . . . 0.0 106.939 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.36 162.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -143.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.43 125.58 20.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.17 1.788 . . . . 0.0 109.758 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.58 132.31 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -158.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -173.293 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.864 0.364 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.29 112.44 13.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.21 111.97 9.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -159.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.3 101.99 13.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.475 1.11 . . . . 0.0 110.136 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.42 117.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 128.535 2.734 . . . . 0.0 110.02 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -90.98 127.73 36.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.605 165.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -136.72 43.26 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.71 1.604 . . . . 0.0 110.554 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.98 171.54 22.67 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.493 -1.379 . . . . 0.0 116.418 -168.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -67.06 -37.04 83.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.627 1.171 . . . . 0.0 110.175 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -66.16 -53.82 32.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.072 1.349 . . . . 0.0 112.307 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -157.87 142.91 16.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.898 0.879 . . . . 0.0 111.552 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.24 111.43 16.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.937 2.095 . . . . 0.0 109.92 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.54 93.07 0.11 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.632 1.11 . . . . 0.0 113.496 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -31.81 166.24 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.891 2.477 . . . . 0.0 116.898 163.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -133.08 -38.98 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.2 p 55.7 164.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -152.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -152.65 -17.54 0.16 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.72 154.23 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.255 2.622 . . . . 0.0 117.476 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.12 175.89 9.78 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.805 -1.185 . . . . 0.0 112.949 -164.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.92 -45.06 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.106 0.955 . . . . 0.0 110.296 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -166.73 178.17 6.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.949 -158.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.37 -10.1 40.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.03 -1.89 18.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 120.549 1.522 . . . . 0.0 110.526 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -112.33 -20.25 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 128.219 2.608 . . . . 0.0 112.092 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.68 9.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.082 0.953 . . . . 0.0 110.387 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.95 -48.19 82.72 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.13 -18.53 48.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.586 -167.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.43 -45.92 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.021 1.728 . . . . 0.0 110.858 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -54.13 -40.9 67.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.39 -39.61 10.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.941 1.696 . . . . 0.0 111.624 171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -104.65 -20.57 13.6 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -55.76 -42.1 74.98 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.997 1.271 . . . . 0.0 109.507 159.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.97 -36.19 49.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.591 -0.693 . . . . 0.0 110.521 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -78.65 -22.83 46.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.474 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.17 -37.42 66.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.028 1.331 . . . . 0.0 113.134 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -59.88 -47.18 86.79 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.656 0.662 . . . . 0.0 110.777 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.61 10.28 6.01 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.361 1.934 . . . . 0.0 113.667 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.96 150.76 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.38 1.072 . . . . 0.0 110.597 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.74 128.11 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.222 1.011 . . . . 0.0 111.25 134.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.18 -154.0 7.13 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-O 123.701 1.723 . . . . 0.0 115.13 -158.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.04 53.09 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.648 2.379 . . . . 0.0 109.766 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -46.06 103.28 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.981 1.712 . . . . 0.0 112.836 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.47 156.38 30.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.897 1.679 . . . . 0.0 111.72 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -149.69 142.19 24.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.073 1.349 . . . . 0.0 110.464 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.29 -36.58 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -162.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.08 -45.56 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 129.065 2.946 . . . . 0.0 117.96 -171.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.99 -25.05 64.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.206 1.803 . . . . 0.0 112.117 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.5 p -128.66 7.2 5.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 113.125 167.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.254 16.0 mttp 51.39 8.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -51.54 152.53 2.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.08 2.552 . . . . 0.0 113.338 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -126.3 165.44 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 131.45 3.9 . . . . 0.0 110.235 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -145.75 150.55 36.44 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.885 0.85 . . . . 0.0 111.231 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.77 95.07 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 122.296 1.046 . . . . 0.0 113.249 158.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.46 101.56 10.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.179 0.992 . . . . 0.0 110.643 172.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 N--CA 1.48 1.053 0 O-C-N 120.929 -1.107 . . . . 0.0 113.006 173.595 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.5 168.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.629 2.013 . . . . 0.0 114.934 169.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -138.03 118.32 13.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.332 2.253 . . . . 0.0 108.848 168.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.2 t -126.7 141.75 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.538 . . . . 0.0 110.481 -174.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.86 -162.77 25.53 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 78.47 12.1 1.63 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.284 2.634 . . . . 0.0 113.971 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 33.16 5.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 -152.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.53 -26.31 44.95 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.119 1.342 . . . . 0.0 116.222 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.53 -30.13 68.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.725 1.21 . . . . 0.0 113.986 170.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.3 -119.35 0.3 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.28 55.25 27.02 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 121.112 1.778 . . . . 0.0 113.72 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.2 -60.79 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.323 1.449 . . . . 0.0 111.868 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 170.79 -60.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.954 2.502 . . . . 0.0 112.934 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -95.75 -26.98 15.47 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.327 0.967 . . . . 0.0 113.218 -162.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -57.57 -36.82 72.18 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.289 -0.882 . . . . 0.0 111.676 163.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.2 mt -74.05 -36.32 64.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.967 0.907 . . . . 0.0 112.36 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -57.28 -30.69 64.91 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.973 1.261 . . . . 0.0 112.216 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -84.22 -46.3 12.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.56 -28.18 63.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.523 0.729 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -98.21 -35.05 10.49 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.827 0.851 . . . . 0.0 112.649 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.85 -30.93 37.83 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.546 1.546 . . . . 0.0 115.463 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -58.23 -36.35 73.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.212 1.006 . . . . 0.0 113.603 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -78.52 -16.27 57.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.82 178.55 25.77 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.44 1.972 . . . . 0.0 112.213 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -58.58 151.29 63.61 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.523 2.816 . . . . 0.0 113.393 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.51 154.99 31.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.78 2.032 . . . . 0.0 109.877 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -120.74 -22.76 6.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.501 1.52 . . . . 0.0 113.441 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -168.99 155.16 6.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.844 1.258 . . . . 0.0 109.845 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -151.21 130.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.077 1.751 . . . . 0.0 108.939 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -141.91 149.3 40.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.363 1.865 . . . . 0.0 109.584 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.55 147.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.746 -1.222 . . . . 0.0 113.956 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 126.539 1.936 . . . . 0.0 110.861 175.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.097 0 N-CA-C 114.834 0.693 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -59.16 131.71 51.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.404 1.081 . . . . 0.0 111.801 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.53 155.9 31.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 112.274 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.18 131.21 36.47 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.951 1.3 . . . . 0.0 107.724 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.56 175.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.217 1.007 . . . . 0.0 110.86 -165.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -140.88 125.6 17.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.309 1.044 . . . . 0.0 109.588 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -86.85 173.01 9.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.413 1.885 . . . . 0.0 112.417 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.57 -68.63 0.74 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.96 155.96 74.89 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-N 120.965 1.711 . . . . 0.0 114.364 -170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.92 -42.82 62.98 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 116.008 -163.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -35.68 81.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.252 0.933 . . . . 0.0 112.375 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.54 -45.07 84.82 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.517 0.727 . . . . 0.0 110.535 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.13 -48.04 46.68 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.06 69.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.284 1.033 . . . . 0.0 111.252 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -74.09 -40.93 62.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.189 0.904 . . . . 0.0 112.286 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.9 -7.5 16.9 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 164.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.05 -55.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.566 1.53 . . . . 0.0 110.212 153.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -49.04 -36.54 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.783 2.033 . . . . 0.0 112.847 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -103.47 -13.17 16.71 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.164 0.986 . . . . 0.0 112.276 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mp -147.36 -8.46 0.44 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -152.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -63.08 -19.32 64.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -179.76 70.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.438 1.018 . . . . 0.0 111.621 -159.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -132.86 -132.9 0.18 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.594 1.558 . . . . 0.0 111.942 -163.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -151.22 -36.56 0.13 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.456 1.902 . . . . 0.0 110.682 -173.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.9 tp 62.17 -48.6 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 130.302 3.441 . . . . 0.0 118.869 156.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.21 29.02 1.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.846 1.658 . . . . 0.0 112.01 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.68 55.27 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.157 -0.965 . . . . 0.0 113.301 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 p -133.85 -129.89 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.588 1.955 . . . . 0.0 110.254 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -154.63 150.86 28.13 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 130.065 3.346 . . . . 0.0 106.813 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.69 151.88 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.151 0.98 . . . . 0.0 109.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -144.35 123.26 12.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 0.0 109.1 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 2.3 t -144.55 136.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.686 -161.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 125.986 1.714 . . . . 0.0 107.522 163.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.717 0.294 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -129.05 103.65 7.12 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.33 111.88 9.3 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 125.764 1.625 . . . . 0.0 111.28 -160.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.31 91.45 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.578 1.551 . . . . 0.0 110.076 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 mt -52.67 119.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.994 2.117 . . . . 0.0 109.207 159.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.58 134.04 40.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.429 1.092 . . . . 0.0 109.625 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -146.34 63.62 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.442 1.097 . . . . 0.0 108.767 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.72 178.54 16.35 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 122.045 0.803 . . . . 0.0 114.37 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -57.57 -43.56 84.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.33 1.052 . . . . 0.0 112.492 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -68.18 -50.67 52.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.283 2.233 . . . . 0.0 113.223 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -156.48 140.59 16.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.191 0.996 . . . . 0.0 110.397 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 131.11 47.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.798 1.639 . . . . 0.0 110.056 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.39 -134.74 4.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.347 1.451 . . . . 0.0 110.318 -158.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -161.71 -167.08 1.61 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.235 2.214 . . . . 0.0 108.892 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -144.82 -41.49 0.24 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 161.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p 56.12 166.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -156.47 -25.66 0.1 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 47.86 139.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.049 2.54 . . . . 0.0 117.049 -161.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.88 -178.0 7.03 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.576 -1.328 . . . . 0.0 112.118 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -51.01 -51.1 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.368 1.867 . . . . 0.0 111.88 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -173.68 174.84 3.06 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.111 1.765 . . . . 0.0 110.903 -157.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.7 19.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.524 1.13 . . . . 0.0 113.697 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.31 11.36 6.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.096 0.959 . . . . 0.0 111.388 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -135.43 -24.49 1.38 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.499 1.92 . . . . 0.0 111.153 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.52 8.45 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.686 -0.633 . . . . 0.0 111.025 164.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -59.86 -46.35 89.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -49.3 -25.0 2.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.818 1.647 . . . . 0.0 114.267 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.2 -40.12 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.886 1.674 . . . . 0.0 110.339 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -53.7 -36.38 62.14 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.8 mtpp -49.74 -56.99 8.18 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.536 1.534 . . . . 0.0 109.832 172.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.48 -38.82 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.883 -0.58 . . . . 0.0 112.491 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -56.94 -36.25 70.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.044 0.838 . . . . 0.0 111.439 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.79 -37.29 24.73 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 121.662 -0.649 . . . . 0.0 110.512 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -67.02 -29.01 68.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.288 0.949 . . . . 0.0 112.469 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.11 -41.8 76.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.551 1.54 . . . . 0.0 113.181 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -63.53 -44.94 92.77 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.619 -0.676 . . . . 0.0 111.308 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.37 22.76 1.06 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.987 1.756 . . . . 0.0 113.212 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.17 129.94 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.271 1.828 . . . . 0.0 110.879 -164.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.84 3.1 16.21 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.894 150.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.97 -123.01 12.79 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.531 1.539 . . . . 0.0 113.256 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -132.05 48.85 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.077 2.151 . . . . 0.0 106.49 161.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 9.8 m95 -18.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.112 2.565 . . . . 0.0 115.607 -173.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.5 m -120.22 160.53 22.76 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.42 152.41 35.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.689 1.996 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.24 -39.93 5.09 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -166.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 t70 64.35 -33.45 0.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.07 64.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.694 1.598 . . . . 0.0 111.715 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -119.49 -7.64 10.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.277 2.231 . . . . 0.0 112.513 165.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.29 39.0 mttm 61.56 17.46 8.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.502 2.321 . . . . 0.0 115.37 -171.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -57.65 150.05 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.385 1.474 . . . . 0.0 112.713 162.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -118.35 164.68 14.86 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.569 2.747 . . . . 0.0 112.06 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -150.39 138.32 20.08 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.748 -1.22 . . . . 0.0 112.248 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.37 90.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.581 1.181 . . . . 0.0 113.468 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 84.17 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.228 1.811 . . . . 0.0 113.069 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 N--CA 1.477 0.895 0 O-C-N 120.83 -1.169 . . . . 0.0 110.529 163.556 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.82 155.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.879 1.218 . . . . 0.0 110.482 158.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -134.51 147.77 50.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.88 147.18 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.053 1.341 . . . . 0.0 111.106 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.36 -157.2 15.26 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.113 -0.992 . . . . 0.0 114.559 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -16.51 0.17 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.64 2.376 . . . . 0.0 114.239 -166.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.63 153.3 20.32 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.863 -1.148 . . . . 0.0 112.036 164.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.04 29.78 0.53 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.956 1.265 . . . . 0.0 113.225 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.86 -56.55 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.46 1.904 . . . . 0.0 109.735 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.36 -166.19 1.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 140.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.61 168.83 21.47 Favored Glycine 0 CA--C 1.531 1.085 1 C-N-CA 131.011 4.148 . . . . 0.0 114.117 -9.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -137.86 -23.39 1.05 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.209 2.203 . . . . 0.0 110.784 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.251 2.4 pttp 131.7 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 1 C-N-CA 134.866 5.266 . . . . 0.0 110.822 163.723 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.6 m -74.93 -45.6 41.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.153 1.381 . . . . 0.0 111.329 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -42.32 93.67 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.246 1.018 . . . . 0.0 112.179 172.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.23 -32.76 64.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.761 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -51.92 -37.0 50.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.316 1.417 . . . . 0.0 110.579 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -102.87 -34.3 9.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.86 79.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.279 0.631 . . . . 0.0 111.952 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -83.75 -28.08 28.47 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.811 -0.556 . . . . 0.0 110.918 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.34 -32.64 37.68 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.911 1.72 . . . . 0.0 114.411 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -51.84 -40.72 61.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -78.69 -24.12 45.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.7 179.38 30.75 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.321 1.438 . . . . 0.0 113.068 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.2 118.76 5.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.335 2.69 . . . . 0.0 113.038 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.13 156.39 25.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.899 0.857 . . . . 0.0 110.856 162.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -124.34 -23.9 4.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.604 2.362 . . . . 0.0 112.251 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -165.8 153.95 10.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.558 1.943 . . . . 0.0 108.95 163.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.73 125.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.542 1.137 . . . . 0.0 109.387 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -141.64 167.91 21.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.31 1.052 . . . . 0.0 112.505 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 t -144.34 141.84 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.624 1.57 . . . . 0.0 110.231 -170.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 C-N-CA 124.314 1.046 . . . . 0.0 113.361 176.56 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -84.3 149.89 25.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.262 1.425 . . . . 0.0 110.543 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.84 41.73 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.627 1.171 . . . . 0.0 113.917 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.26 122.14 10.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.459 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 m -138.85 -179.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.759 0.824 . . . . 0.0 111.845 -168.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.31 152.2 29.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.186 1.394 . . . . 0.0 110.863 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.63 167.21 12.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.678 2.391 . . . . 0.0 112.41 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -72.06 -20.79 61.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -143.0 133.54 12.34 Favored Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 121.001 -1.062 . . . . 0.0 112.429 -162.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.89 -27.99 9.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.756 2.304 . . . . 0.0 114.335 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.2 mtm105 -71.54 -49.36 41.59 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.432 1.015 . . . . 0.0 110.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.88 -37.36 84.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.856 0.862 . . . . 0.0 110.718 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.2 70.07 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.02 -26.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.219 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.58 -41.87 37.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.304 1.411 . . . . 0.0 113.866 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.66 -8.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.484 1.514 . . . . 0.0 114.087 163.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.5 t -96.7 -53.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.704 1.202 . . . . 0.0 111.109 160.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -53.36 -35.2 60.01 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.294 1.838 . . . . 0.0 113.102 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.36 -7.89 49.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.892 1.277 . . . . 0.0 112.103 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.51 -2.9 0.94 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -155.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -58.25 -24.28 58.82 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -170.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.91 75.77 0.11 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.31 1.91 . . . . 0.0 111.508 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 70.0 mmt-85 -132.51 -146.6 0.29 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.119 1.768 . . . . 0.0 111.238 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.4 m -151.19 139.33 20.16 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.392 2.277 . . . . 0.0 106.661 168.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 tp -142.27 -66.21 0.4 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -158.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.8 m -152.79 49.29 0.73 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.549 1.939 . . . . 0.0 109.97 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.79 26.74 0.34 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 130.635 3.969 . . . . 0.0 111.526 16.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.0 t -90.35 172.23 8.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.054 1.342 . . . . 0.0 110.027 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -43.64 132.95 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.247 1.019 . . . . 0.0 111.144 150.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.4 t -109.09 154.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.836 1.654 . . . . 0.0 110.012 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.0 135.7 27.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.762 1.225 . . . . 0.0 108.593 159.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.3 t -133.07 155.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.987 1.315 . . . . 0.0 110.244 -166.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 125.103 1.361 . . . . 0.0 110.482 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -134.61 110.37 9.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -123.89 108.54 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.312 1.445 . . . . 0.0 112.18 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.23 89.37 6.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.121 0.968 . . . . 0.0 109.231 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 mt -51.52 115.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.006 1.722 . . . . 0.0 108.576 159.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.87 128.04 38.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.379 174.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -140.34 58.82 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.35 -179.12 15.62 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-N 120.809 1.641 . . . . 0.0 115.693 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -56.83 -23.83 46.7 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.6 1.96 . . . . 0.0 115.187 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -99.04 -42.86 6.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.494 1.917 . . . . 0.0 112.542 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -160.43 140.2 11.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.118 1.367 . . . . 0.0 109.43 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -130.51 130.64 44.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.267 1.427 . . . . 0.0 110.097 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -133.58 4.21 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.088 1.804 . . . . 0.0 111.295 -148.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -161.87 -167.77 1.76 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.774 2.43 . . . . 0.0 107.965 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -139.35 -39.24 0.48 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 158.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p 53.9 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -158.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -160.48 179.68 8.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.906 2.482 . . . . 0.0 107.557 166.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -139.42 136.18 34.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.873 1.269 . . . . 0.0 109.138 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.19 -177.7 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.776 0.83 . . . . 0.0 111.992 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -46.04 -57.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.071 1.748 . . . . 0.0 110.6 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -172.15 -163.67 0.25 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.964 3.306 . . . . 0.0 107.149 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.13 -14.8 11.32 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.41 4.88 53.26 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.695 1.589 . . . . 0.0 111.951 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -126.49 -14.54 5.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.941 166.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.76 -49.94 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.555 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -57.02 -46.98 81.96 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -53.64 -21.05 6.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.866 1.354 . . . . 0.0 113.93 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.5 -35.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.138 1.775 . . . . 0.0 110.19 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -53.35 -41.17 65.52 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.473 1.033 . . . . 0.0 113.599 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.79 -52.33 11.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.096 1.758 . . . . 0.0 110.624 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -80.31 -34.04 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.568 1.547 . . . . 0.0 114.863 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.73 -39.4 88.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.041 1.291 . . . . 0.0 111.225 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.05 61.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.617 -0.677 . . . . 0.0 109.696 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -71.9 -23.51 61.5 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -77.09 -37.0 55.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.689 . . . . 0.0 112.931 170.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -58.69 -44.21 90.22 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.738 -0.601 . . . . 0.0 110.464 164.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.01 5.72 8.77 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.074 1.797 . . . . 0.0 113.459 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.53 146.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.437 1.095 . . . . 0.0 110.719 172.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.12 125.19 9.27 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.726 0.775 . . . . 0.0 110.836 135.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.07 -147.04 4.61 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-O 123.878 1.821 . . . . 0.0 115.456 -157.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -19.16 62.87 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.689 2.396 . . . . 0.0 114.181 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CD2' ' CG1' ' A' ' 54' ' ' VAL 0.267 10.7 m95 36.58 52.79 1.0 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.541 2.736 . . . . 0.0 115.514 170.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 m -75.41 156.42 35.39 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.047 0.927 . . . . 0.0 111.638 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -144.36 146.11 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.592 1.557 . . . . 0.0 110.448 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -106.03 -40.03 5.8 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -163.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.04 -34.8 0.06 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.78 65.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.334 1.853 . . . . 0.0 111.466 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -125.88 -0.29 7.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.709 2.003 . . . . 0.0 112.809 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 42.2 mttm 56.13 7.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.204 2.602 . . . . 0.0 116.512 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -43.44 152.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.205 2.202 . . . . 0.0 113.972 150.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.88 173.54 8.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 130.557 3.543 . . . . 0.0 110.914 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -146.1 156.23 43.31 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.764 -1.21 . . . . 0.0 110.433 158.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -130.46 128.91 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 152.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 m -125.34 117.57 24.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.057 1.408 . . . . 0.0 112.353 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.437 0 C-N-CA 130.744 3.618 . . . . 0.0 108.509 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.71 121.52 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 140.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -144.36 141.56 29.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.514 -1.366 . . . . 0.0 111.273 -167.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.59 159.71 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.98 -163.91 12.97 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.822 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 65.77 20.97 11.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.983 1.713 . . . . 0.0 114.692 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 132.74 34.66 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.014 -1.054 . . . . 0.0 110.105 170.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.31 34.01 1.2 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.048 1.308 . . . . 0.0 112.099 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -143.29 -40.61 0.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 110.549 -162.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -124.15 -111.34 0.31 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.299 2.64 . . . . 0.0 108.125 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.04 61.92 0.56 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.902 1.715 . . . . 0.0 111.111 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.35 166.12 26.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.261 1.025 . . . . 0.0 112.243 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -30.08 65.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 m -75.89 -39.6 56.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.348 -0.845 . . . . 0.0 113.156 -169.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.29 -35.93 65.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.138 -0.976 . . . . 0.0 111.467 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 mt -83.86 -30.07 26.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.324 1.449 . . . . 0.0 111.859 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -56.79 -36.52 69.96 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.804 0.729 . . . . 0.0 109.797 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -91.24 -52.55 4.76 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.179 0.992 . . . . 0.0 111.584 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.77 54.09 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.372 1.069 . . . . 0.0 113.475 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.17 -26.53 9.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.22 -33.21 37.94 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 124.869 1.223 . . . . 0.0 114.502 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -57.01 -37.82 72.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -79.63 -20.99 45.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.387 0.675 . . . . 0.0 112.656 -170.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.49 175.91 26.19 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 125.553 1.549 . . . . 0.0 113.556 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.24 116.44 2.68 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.186 3.924 . . . . 0.0 115.173 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.39 161.26 29.4 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 110.502 159.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -126.93 -29.73 2.79 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.633 1.973 . . . . 0.0 112.585 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -154.54 164.08 39.23 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.709 0.686 . . . . 0.0 111.195 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.38 131.22 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.719 1.208 . . . . 0.0 111.766 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -158.32 165.6 34.37 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.39 1.476 . . . . 0.0 110.983 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . 0.263 1.3 m -142.76 143.97 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.965 -1.085 . . . . 0.0 112.808 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 126.334 1.854 . . . . 0.0 112.732 -178.127 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.185 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -139.64 134.28 31.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.487 1.515 . . . . 0.0 110.808 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.54 151.24 51.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.28 1.832 . . . . 0.0 113.743 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.42 129.38 31.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.63 -178.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 110.764 -166.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -141.41 152.01 43.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.168 -0.957 . . . . 0.0 112.257 170.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -117.45 169.01 9.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.018 2.527 . . . . 0.0 110.764 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.48 3.28 40.1 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -156.44 137.18 9.13 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.2 -38.42 33.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 125.221 3.947 . . . . 0.0 117.517 168.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.8 -59.33 5.39 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 120.42 1.464 . . . . 0.0 110.127 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.16 -41.91 76.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.989 1.716 . . . . 0.0 110.907 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.75 -52.71 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.029 1.732 . . . . 0.0 113.255 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.41 65.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.195 1.361 . . . . 0.0 111.503 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -47.92 82.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.894 . . . . 0.0 111.868 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.36 -9.7 58.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.703 1.601 . . . . 0.0 114.617 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.2 -46.62 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.288 -1.508 . . . . 0.0 108.953 157.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.72 -20.9 65.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -114.62 -12.5 12.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.64 1.176 . . . . 0.0 111.899 -173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.21 -10.22 0.57 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -156.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -71.92 141.79 49.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.966 0.803 . . . . 0.0 111.96 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.63 15.52 62.01 Favored Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.433 1.492 . . . . 0.0 114.958 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.3 179.04 6.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.337 1.455 . . . . 0.0 112.49 -168.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.8 m -136.16 89.67 2.5 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.101 1.36 . . . . 0.0 110.686 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.4 -32.47 42.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 112.777 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.5 m -145.75 17.07 1.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.858 1.263 . . . . 0.0 114.122 -165.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.94 -4.41 65.53 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 113.827 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.1 p -63.99 -179.51 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.545 1.938 . . . . 0.0 113.538 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -130.74 63.29 1.58 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.581 1.152 . . . . 0.0 108.75 155.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 p -50.53 141.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.269 1.828 . . . . 0.0 112.048 -169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.1 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.292 1.437 . . . . 0.0 109.346 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.8 t -144.25 129.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -148.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.479 0.988 0 O-C-N 120.706 -1.246 . . . . 0.0 111.335 167.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -130.87 130.82 44.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 133.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.03 112.91 12.77 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.974 -1.079 . . . . 0.0 113.527 -174.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 34.9 tp -85.61 111.79 20.38 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.594 172.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -77.2 117.23 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 129.189 2.995 . . . . 0.0 110.419 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.15 123.77 30.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.798 161.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.32 34.6 3.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.196 1.799 . . . . 0.0 110.911 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 150.37 20.98 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.033 -1.042 . . . . 0.0 114.422 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -49.16 -37.54 22.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 110.655 155.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 m -57.71 -55.17 38.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.815 2.846 . . . . 0.0 113.419 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -165.26 140.16 5.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.99 1.716 . . . . 0.0 109.824 -172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -128.7 119.52 24.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.901 1.28 . . . . 0.0 110.745 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.52 85.41 0.06 OUTLIER Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.163 0.887 . . . . 0.0 112.949 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -31.77 159.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 158.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 t -140.43 -27.7 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 7.1 p 61.86 162.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -171.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -158.96 -172.41 3.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.374 2.27 . . . . 0.0 107.733 159.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -138.16 146.72 43.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 120.189 -1.569 . . . . 0.0 111.531 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.41 -174.77 5.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 111.972 -163.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.8 -50.91 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.11 166.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -165.99 175.85 8.23 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.284 1.516 . . . . 0.0 112.045 -156.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.13 17.92 0.09 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.567 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.69 7.84 6.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.111 1.364 . . . . 0.0 111.545 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.8 p -135.42 -26.27 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.958 2.503 . . . . 0.0 112.29 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.5 -47.03 16.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.618 163.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.42 -47.5 75.87 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -21.31 6.76 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.982 1.313 . . . . 0.0 114.408 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.02 -34.57 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.032 1.733 . . . . 0.0 110.914 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -54.39 -43.0 71.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.339 0.972 . . . . 0.0 113.549 165.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -37.25 -57.28 0.9 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.423 2.289 . . . . 0.0 110.452 166.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -80.39 -32.25 37.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.975 1.71 . . . . 0.0 114.729 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -59.0 -44.7 91.71 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.431 1.014 . . . . 0.0 111.087 168.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.66 58.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.46 -31.39 72.1 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.051 0.841 . . . . 0.0 112.272 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.9 -37.99 76.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.718 1.207 . . . . 0.0 113.219 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -66.05 -44.2 85.28 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.695 -0.628 . . . . 0.0 111.784 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.07 13.66 0.59 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.984 1.754 . . . . 0.0 114.052 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.87 144.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.957 1.703 . . . . 0.0 111.877 -166.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -132.56 8.22 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.957 0.903 . . . . 0.0 112.849 158.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.12 -132.2 8.26 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 123.018 1.343 . . . . 0.0 114.193 166.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -136.16 42.22 2.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.191 1.796 . . . . 0.0 106.615 167.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 26.3 m95 -3.22 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 130.525 3.53 . . . . 0.0 115.939 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.0 m -83.89 157.97 21.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.109 0.956 . . . . 0.0 109.774 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -137.64 145.53 42.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.211 1.404 . . . . 0.0 110.112 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -133.2 56.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.447 1.499 . . . . 0.0 110.278 -155.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.88 -32.35 1.56 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.084 2.953 . . . . 0.0 116.822 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.82 -21.88 61.48 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.061 2.144 . . . . 0.0 112.624 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 51' ' ' THR . 71.4 p -131.78 7.91 4.45 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 112.846 167.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm 63.76 2.24 1.27 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.975 2.51 . . . . 0.0 114.61 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 49' ' ' THR . 53.5 m -52.52 161.98 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 129.741 3.216 . . . . 0.0 113.127 166.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -132.1 155.33 48.32 Favored 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 132.053 4.141 . . . . 0.0 110.039 171.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -144.92 121.22 10.9 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.999 0.428 . . . . 0.0 111.786 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.97 90.91 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 122.535 1.159 . . . . 0.0 112.53 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.56 39.23 0.82 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -163.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -170.659 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.441 0.639 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.04 144.28 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.711 0.804 . . . . 0.0 109.651 168.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -121.94 147.56 45.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.61 0.764 . . . . 0.0 111.61 -158.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.28 151.87 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.952 0.901 . . . . 0.0 110.56 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA3' ' CD2' ' A' ' 112' ' ' PHE . . . -169.47 -172.57 36.25 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 118.336 2.094 . . . . 0.0 118.336 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t30 53.28 36.22 22.17 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.378 1.871 . . . . 0.0 113.542 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.85 9.55 43.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.089 1.756 . . . . 0.0 113.238 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.94 -21.03 6.95 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.018 1.771 . . . . 0.0 117.034 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -54.52 -33.11 59.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 113.233 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -131.78 -45.74 0.96 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.104 1.762 . . . . 0.0 111.545 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.73 77.3 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 129.111 3.243 . . . . 0.0 115.661 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -139.75 167.53 21.88 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.557 1.143 . . . . 0.0 111.518 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -68.9 -37.43 78.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -79.86 -29.19 40.01 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.974 -1.079 . . . . 0.0 113.462 -163.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.95 -18.54 63.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.2 mt -96.67 -34.19 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.316 1.446 . . . . 0.0 111.666 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -54.12 -36.47 63.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.733 0.697 . . . . 0.0 110.893 168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.88 -55.98 4.87 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.77 45.25 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -117.19 -30.29 5.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.863 1.265 . . . . 0.0 111.091 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.72 -35.58 17.21 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.033 1.301 . . . . 0.0 114.804 164.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -54.04 -41.95 68.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -78.43 -30.97 47.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.255 -171.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.59 40.74 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 -170.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.45 112.22 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.168 3.245 . . . . 0.0 112.072 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.13 156.69 37.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.737 0.78 . . . . 0.0 111.003 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -134.01 -21.89 1.85 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 112.878 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 m -163.74 166.52 22.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.006 1.322 . . . . 0.0 111.558 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.67 131.29 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.906 1.282 . . . . 0.0 110.519 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -150.05 144.11 25.57 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.25 1.42 . . . . 0.0 111.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.76 149.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.594 -1.316 . . . . 0.0 113.73 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 127.19 2.196 . . . . 0.0 110.45 174.729 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CD2' ' HA3' ' A' ' 79' ' ' GLY . 36.4 m-85 -132.89 142.97 49.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.704 1.202 . . . . 0.0 111.566 -170.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.2 161.8 27.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.513 1.925 . . . . 0.0 113.227 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.5 137.13 30.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.911 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.02 168.55 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 109.506 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -139.42 149.74 44.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.86 178.13 5.66 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.315 2.246 . . . . 0.0 111.3 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -126.63 29.24 5.75 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.825 1.25 . . . . 0.0 112.543 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -160.24 119.37 1.6 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.132 1.373 . . . . 0.0 111.312 163.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.04 -43.29 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 125.168 3.912 . . . . 0.0 116.165 167.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -58.5 -38.74 78.31 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.013 1.725 . . . . 0.0 113.408 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.65 -37.38 19.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.32 92.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.741 0.701 . . . . 0.0 112.156 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.92 93.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.81 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.62 -40.39 66.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.433 1.015 . . . . 0.0 113.649 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.99 -10.57 10.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 114.333 169.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.75 -50.92 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.619 1.1 . . . . 0.0 110.571 158.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -54.19 -31.83 53.98 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.39 1.876 . . . . 0.0 113.688 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.65 -2.07 42.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.841 1.656 . . . . 0.0 112.937 -173.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.54 -24.45 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -153.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.88 109.76 0.23 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.098 1.759 . . . . 0.0 112.427 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.34 85.07 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -105.15 -122.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.814 1.307 . . . . 0.0 111.796 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -150.69 142.52 23.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.413 1.485 . . . . 0.0 109.317 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.88 -35.93 2.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.425 1.09 . . . . 0.0 113.465 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 89.8 m -146.61 23.7 1.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.535 1.934 . . . . 0.0 111.811 -163.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.31 -10.41 63.93 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.817 1.675 . . . . 0.0 114.412 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.0 p -70.11 -179.69 2.03 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.837 2.455 . . . . 0.0 113.223 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -126.5 135.39 51.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.678 1.591 . . . . 0.0 108.048 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.79 171.67 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.127 0.571 . . . . 0.0 112.252 -145.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -133.11 147.49 52.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.635 1.974 . . . . 0.0 109.525 159.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.88 130.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.939 0.896 . . . . 0.0 108.639 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 125.911 1.684 . . . . 0.0 112.507 -170.425 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.749 0.785 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -140.91 106.51 5.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.6 ttpt -123.32 128.45 49.94 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 124.307 1.043 . . . . 0.0 112.279 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.34 103.76 15.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.178 1.791 . . . . 0.0 108.878 162.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -72.23 114.63 11.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 128.498 2.719 . . . . 0.0 110.135 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.99 125.1 34.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.33 166.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -134.96 48.41 2.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.125 1.77 . . . . 0.0 109.88 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -112.2 150.89 18.17 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.925 1.25 . . . . 0.0 113.331 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -59.97 -24.06 64.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.148 1.379 . . . . 0.0 111.075 162.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.6 m -57.47 -56.59 19.95 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.315 1.846 . . . . 0.0 111.91 162.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -164.37 139.53 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.311 1.845 . . . . 0.0 111.126 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 9' ' ' GLY . 24.0 mtmt -122.49 110.12 15.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.311 1.844 . . . . 0.0 110.259 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.19 83.82 0.04 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.039 0.828 . . . . 0.0 112.825 -166.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -29.48 155.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.919 1.688 . . . . 0.0 115.513 155.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -134.38 -26.07 1.47 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.047 2.239 . . . . 0.0 117.047 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.0 p 57.46 167.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 -175.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -160.84 -171.48 3.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.02 2.528 . . . . 0.0 107.623 162.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -140.12 131.66 27.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.517 1.527 . . . . 0.0 108.464 170.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.74 176.53 8.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.384 1.088 . . . . 0.0 113.439 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 t -58.54 -50.74 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.362 1.865 . . . . 0.0 111.259 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.82 172.57 4.06 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.187 1.795 . . . . 0.0 109.824 -154.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.68 -3.28 11.48 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.8 -43.21 3.65 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 120.552 1.524 . . . . 0.0 108.503 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -63.66 -21.37 66.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.708 1.14 . . . . 0.0 112.818 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.35 8.19 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.796 0.725 . . . . 0.0 111.663 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -61.3 -46.22 91.2 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -58.58 -20.19 44.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 -41.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.479 1.911 . . . . 0.0 110.868 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -54.73 -38.77 67.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -45.77 -52.8 10.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.178 1.791 . . . . 0.0 110.318 171.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -75.75 -34.05 60.26 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.118 1.767 . . . . 0.0 114.525 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -59.26 -42.24 90.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.797 1.181 . . . . 0.0 111.211 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.56 -34.17 47.23 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.254 -0.904 . . . . 0.0 110.488 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -70.45 -27.24 64.09 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.725 0.693 . . . . 0.0 112.542 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.95 -37.61 75.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.979 1.312 . . . . 0.0 112.863 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -66.36 -53.03 40.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.18 0.592 . . . . 0.0 111.318 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.22 20.2 0.3 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.734 1.635 . . . . 0.0 114.474 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.1 150.27 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 112.526 -167.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.56 -0.27 2.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.642 1.177 . . . . 0.0 112.746 161.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 41.45 -113.79 0.54 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-O 124.422 2.123 . . . . 0.0 113.739 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -2.45 7.11 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 131.318 3.847 . . . . 0.0 109.652 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 41.6 m95 27.25 72.47 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.912 2.885 . . . . 0.0 114.26 -153.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.3 m -71.31 157.11 38.66 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 110.452 170.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -146.17 156.14 43.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.915 1.686 . . . . 0.0 111.423 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -133.77 135.39 43.87 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 127.365 2.266 . . . . 0.0 109.858 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.24 -16.05 14.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.2 60.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.465 1.506 . . . . 0.0 112.106 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -125.2 -1.63 7.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.394 1.878 . . . . 0.0 112.52 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.384 55.2 mttm 60.07 19.47 8.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.427 1.891 . . . . 0.0 114.259 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -67.03 162.77 21.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.111 2.564 . . . . 0.0 113.957 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.98 158.72 41.98 Favored 'General case' 0 C--N 1.327 -0.404 1 C-N-CA 132.34 4.256 . . . . 0.0 110.514 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -145.19 144.56 30.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.757 -0.589 . . . . 0.0 111.292 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.2 94.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.087 1.355 . . . . 0.0 112.443 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -95.79 58.93 2.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.0 113.605 -169.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 O-C-N 120.921 -1.112 . . . . 0.0 113.298 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.334 9.8 ptpt . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 t -130.88 143.37 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 119.785 1.175 . . . . 0.0 112.629 -160.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -135.67 132.87 37.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.613 1.965 . . . . 0.0 108.711 172.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.64 150.64 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.188 0.518 . . . . 0.0 109.854 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.37 -169.34 29.85 Favored Glycine 0 N--CA 1.465 0.631 0 O-C-N 121.337 -0.852 . . . . 0.0 114.402 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 60.87 4.86 0.85 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.59 -49.61 74.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.471 1.032 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.82 -60.11 0.34 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.536 2.017 . . . . 0.0 116.923 168.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -81.75 -13.74 57.38 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -159.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.89 -57.79 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 109.134 165.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 38.26 62.67 1.05 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.794 2.14 . . . . 0.0 114.885 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -127.77 -42.61 1.59 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 pttp 139.75 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 1 C-N-CA 131.709 4.003 . . . . 0.0 112.171 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 m -79.57 -35.71 39.33 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.75 -0.594 . . . . 0.0 111.497 -167.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -40.76 76.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.118 -0.989 . . . . 0.0 111.519 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.0 mt -78.24 -31.3 49.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.617 0.767 . . . . 0.0 112.606 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.67 -37.96 68.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.943 1.247 . . . . 0.0 110.078 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -104.43 -42.44 5.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.386 -164.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.26 -34.55 66.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.138 0.575 . . . . 0.0 112.007 168.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -95.65 -29.83 14.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.73 -33.21 26.71 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.02 1.295 . . . . 0.0 114.205 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -57.52 -40.1 77.99 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -76.71 -27.61 55.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.07 -171.14 37.91 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 114.817 0.687 . . . . 0.0 114.817 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.09 135.02 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.828 3.019 . . . . 0.0 112.56 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.99 157.97 17.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.963 1.705 . . . . 0.0 110.043 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -127.67 -27.5 2.84 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.446 1.899 . . . . 0.0 112.669 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -168.32 155.84 8.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.808 1.243 . . . . 0.0 110.226 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -153.21 129.08 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.223 1.809 . . . . 0.0 108.902 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -148.85 160.38 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.923 0.889 . . . . 0.0 111.953 166.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.4 147.03 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.406 -0.809 . . . . 0.0 112.945 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 125.561 1.544 . . . . 0.0 111.319 169.579 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.064 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -127.31 139.49 52.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.924 1.69 . . . . 0.0 110.225 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.35 158.85 43.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.547 1.539 . . . . 0.0 114.685 -157.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.93 125.63 17.96 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.449 1.1 . . . . 0.0 108.869 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.26 -175.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -172.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -147.47 110.83 4.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.47 1.908 . . . . 0.0 109.547 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.02 173.02 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 111.224 158.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.13 37.37 2.12 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.883 0.849 . . . . 0.0 113.171 166.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.25 130.72 7.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 120.952 -1.092 . . . . 0.0 110.906 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 -37.76 4.85 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.133 2.555 . . . . 0.0 113.671 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -71.23 -44.65 64.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.396 1.078 . . . . 0.0 110.758 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.17 -34.86 78.43 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.382 0.673 . . . . 0.0 112.354 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.55 -46.98 68.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -31.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.991 -1.068 . . . . 0.0 110.959 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.13 -43.89 60.99 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 119.228 0.922 . . . . 0.0 112.508 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.65 -2.5 6.92 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.861 1.264 . . . . 0.0 113.964 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.49 -56.83 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 120.558 -1.339 . . . . 0.0 109.921 151.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -55.2 -29.75 58.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.522 1.529 . . . . 0.0 113.651 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -102.47 -12.04 18.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.725 1.61 . . . . 0.0 112.367 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.46 -5.48 0.65 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -154.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.91 -6.86 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 166.01 62.64 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.56 -0.712 . . . . 0.0 112.316 -151.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -135.68 -165.73 1.74 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.743 1.617 . . . . 0.0 111.719 -167.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.4 m -131.01 115.9 17.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.76 1.624 . . . . 0.0 109.288 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.37 -34.92 6.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.7 m -140.43 24.75 2.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.047 1.339 . . . . 0.0 112.739 -165.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.36 29.67 39.69 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 121.024 -1.047 . . . . 0.0 112.96 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.77 -165.98 1.55 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.77 2.428 . . . . 0.0 111.357 -167.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -139.64 55.56 1.66 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.842 0.857 . . . . 0.0 112.061 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.3 p -46.11 146.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 127.034 2.134 . . . . 0.0 114.091 -174.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.85 133.05 35.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.803 2.441 . . . . 0.0 109.441 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.42 136.42 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.785 0.434 . . . . 0.0 111.493 -158.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 127.504 2.322 . . . . 0.0 108.513 173.511 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.6 104.34 5.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 164.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.06 113.85 9.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.878 1.271 . . . . 0.0 112.836 -163.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.0 tp -99.84 101.85 13.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 110.434 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.03 124.09 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 128.343 2.657 . . . . 0.0 110.012 158.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.16 133.74 45.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.736 168.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -148.14 49.5 1.04 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.93 2.092 . . . . 0.0 109.723 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.58 157.48 21.32 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 120.539 -1.35 . . . . 0.0 112.924 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -55.49 -37.47 67.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.152 0.981 . . . . 0.0 110.179 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -56.78 -72.24 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.913 2.485 . . . . 0.0 112.967 164.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.59 132.71 27.97 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.441 1.096 . . . . 0.0 110.613 -161.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 123.23 26.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.244 1.818 . . . . 0.0 109.169 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.84 99.11 0.81 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.469 1.033 . . . . 0.0 112.024 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -32.22 164.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.019 2.528 . . . . 0.0 116.941 165.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -129.06 -38.72 1.61 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.2 p 57.58 162.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -158.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -151.03 -6.94 0.26 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 28.17 99.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.806 3.242 . . . . 0.0 117.549 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.77 -159.6 0.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.447 1.499 . . . . 0.0 113.353 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.77 -17.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.537 1.935 . . . . 0.0 111.936 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -145.13 -11.1 0.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.58 -0.41 3.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.431 2.692 . . . . 0.0 115.445 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.51 -46.2 4.83 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 125.51 1.524 . . . . 0.0 107.956 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.64 -19.72 58.86 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.629 1.972 . . . . 0.0 113.455 162.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -54.2 6.61 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 119.402 1.001 . . . . 0.0 110.922 167.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.65 -43.95 91.97 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -60.77 -16.85 44.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.34 -41.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.427 2.291 . . . . 0.0 110.295 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -53.63 -43.8 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.606 1.094 . . . . 0.0 113.701 168.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -58.15 1.44 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.944 2.097 . . . . 0.0 110.866 168.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.6 -30.89 46.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 114.918 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -59.5 -43.61 93.29 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.543 1.065 . . . . 0.0 110.928 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.95 -32.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.406 -0.809 . . . . 0.0 110.864 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.84 -26.74 67.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 118.335 0.516 . . . . 0.0 112.307 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.85 -48.39 59.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.837 1.655 . . . . 0.0 113.324 164.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.33 -38.61 87.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.595 0.634 . . . . 0.0 111.975 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.62 28.37 0.82 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.524 1.535 . . . . 0.0 113.648 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.49 142.72 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.713 1.605 . . . . 0.0 111.176 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.86 113.71 5.41 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.376 1.084 . . . . 0.0 109.797 143.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -152.83 8.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-O 124.369 2.094 . . . . 0.0 115.387 -156.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.37 58.43 2.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 111.334 -2.433 . . . . 0.0 108.519 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 22.1 m95 -47.35 98.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.691 2.397 . . . . 0.0 112.019 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -121.98 159.28 27.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.341 1.856 . . . . 0.0 109.943 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.32 156.81 42.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.628 1.571 . . . . 0.0 111.127 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -135.29 113.1 10.95 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.729 2.012 . . . . 0.0 110.141 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.01 -18.6 53.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.61 -25.35 56.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.457 1.103 . . . . 0.0 111.863 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -120.69 -4.05 9.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.298 1.439 . . . . 0.0 112.949 167.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.385 37.8 mttm 56.42 24.66 8.71 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.86 2.064 . . . . 0.0 114.286 -171.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -73.12 155.06 40.07 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.553 1.941 . . . . 0.0 111.923 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.66 159.15 36.5 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 129.35 3.06 . . . . 0.0 111.37 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -143.8 136.76 27.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 2.3 m -111.89 96.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.514 1.15 . . . . 0.0 112.847 157.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 106.15 15.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.68 1.192 . . . . 0.0 109.324 165.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 . . . . . 0 CA--C 1.549 0.911 0 O-C-N 120.878 -1.139 . . . . 0.0 112.277 174.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -118.92 145.69 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.091 -1.006 . . . . 0.0 112.712 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -131.59 147.09 52.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.65 2.78 . . . . 0.0 108.808 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -138.01 150.42 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.442 1.097 . . . . 0.0 109.591 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.22 -168.73 20.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.36 -6.79 1.94 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.59 2.356 . . . . 0.0 114.646 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 51.76 2.31 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 122.747 1.261 . . . . 0.0 113.353 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.22 -20.34 69.14 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -67.89 -32.05 72.27 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.134 1.467 . . . . 0.0 113.213 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.94 -21.48 0.18 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -49.09 109.85 0.65 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 119.84 1.2 . . . . 0.0 115.081 -157.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -133.39 -25.58 1.72 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.678 1.991 . . . . 0.0 113.545 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 139.22 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 1 C-N-CA 132.787 4.435 . . . . 0.0 111.685 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -66.62 -44.11 82.93 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.814 0.734 . . . . 0.0 112.17 -163.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -53.96 -34.82 60.77 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 169.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.8 mt -83.94 -37.74 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.469 1.107 . . . . 0.0 111.836 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -55.41 -36.5 66.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.941 1.297 . . . . 0.0 109.896 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.66 -54.79 5.33 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.04 -11.57 40.75 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -119.29 -30.66 4.87 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.369 1.068 . . . . 0.0 113.001 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.3 -31.5 50.34 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 119.509 1.049 . . . . 0.0 113.784 168.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -62.5 -41.02 98.54 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 172.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.87 -25.23 48.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.902 0.481 . . . . 0.0 111.955 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.62 -172.98 43.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.245 0.858 . . . . 0.0 115.245 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.69 131.03 17.86 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.643 2.895 . . . . 0.0 112.361 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.16 148.91 28.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.215 1.806 . . . . 0.0 109.478 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -123.83 -22.03 5.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.022 1.729 . . . . 0.0 113.188 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -164.29 153.15 13.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.034 1.334 . . . . 0.0 110.358 172.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.0 t -151.98 135.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.0 108.767 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -150.58 152.6 34.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.559 1.544 . . . . 0.0 111.137 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.54 146.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.991 -1.068 . . . . 0.0 111.472 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.994 . . . . 0.0 111.669 -177.399 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 119.649 -0.529 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.5 139.39 49.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.183 1.793 . . . . 0.0 110.798 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.82 166.19 21.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.725 2.01 . . . . 0.0 113.74 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.97 142.12 34.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.237 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.27 1.3 m -141.45 178.85 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.291 1.043 . . . . 0.0 112.296 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.05 104.63 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.767 2.027 . . . . 0.0 108.07 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.89 174.82 0.44 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.794 0.838 . . . . 0.0 112.584 155.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -115.72 -12.51 11.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.303 1.041 . . . . 0.0 112.71 164.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.91 140.76 21.38 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.052 1.341 . . . . 0.0 111.885 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.45 -37.59 0.94 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.694 2.93 . . . . 0.0 114.969 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -28.57 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.71 -1.244 . . . . 0.0 113.991 -159.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.23 -24.03 63.96 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.594 -0.691 . . . . 0.0 111.052 161.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 -47.16 66.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.807 1.243 . . . . 0.0 113.647 161.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.36 65.08 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 120.275 -1.516 . . . . 0.0 110.739 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -43.21 77.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 172.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.73 -8.62 2.16 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 166.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.48 -53.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.863 1.665 . . . . 0.0 110.743 157.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -59.86 -21.85 61.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.148 1.779 . . . . 0.0 112.882 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -107.51 -9.06 16.03 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.089 1.756 . . . . 0.0 111.537 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.12 -4.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -153.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -5.67 41.07 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.861 1.21 . . . . 0.0 113.763 168.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.75 46.89 0.53 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.418 1.485 . . . . 0.0 113.773 -159.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -132.19 177.97 7.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.155 0.982 . . . . 0.0 113.007 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.6 m -113.55 123.06 49.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.448 1.499 . . . . 0.0 109.129 168.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mp -129.52 145.59 51.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.007 2.523 . . . . 0.0 107.99 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.0 m 52.41 18.96 1.03 Allowed 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.96 60.18 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.277 1.418 . . . . 0.0 114.01 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.14 147.28 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.148 1.779 . . . . 0.0 111.226 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -52.58 148.07 7.58 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.99 152.01 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.316 . . . . 0.0 109.915 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 147.25 50.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.349 1.059 . . . . 0.0 108.342 167.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.48 158.15 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.308 0.643 . . . . 0.0 111.817 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 125.339 1.456 . . . . 0.0 107.584 165.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.781 0.324 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.51 109.68 8.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 160.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -131.13 135.72 47.72 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 127.018 2.127 . . . . 0.0 109.18 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -114.41 98.82 7.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.358 1.863 . . . . 0.0 108.554 162.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.36 124.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.903 1.681 . . . . 0.0 108.738 158.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.24 135.22 38.36 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.934 166.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -144.84 53.19 1.22 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.26 1.024 . . . . 0.0 109.078 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.83 175.8 21.74 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.739 1.188 . . . . 0.0 114.044 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -49.42 77.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 109.758 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -56.2 -52.1 65.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.931 1.692 . . . . 0.0 113.339 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.82 142.43 13.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.474 1.11 . . . . 0.0 110.649 -170.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.12 138.04 53.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.649 1.58 . . . . 0.0 110.256 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.52 -133.38 4.84 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.343 1.449 . . . . 0.0 110.138 -157.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -162.64 -169.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.146 1.778 . . . . 0.0 109.433 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -136.29 -45.26 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 158.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 p 55.94 164.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.281 1.432 . . . . 0.0 114.633 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -155.46 -19.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.44 142.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 128.051 2.54 . . . . 0.0 116.062 -161.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.75 177.92 9.1 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.035 -1.666 . . . . 0.0 114.368 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.24 -39.28 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.258 1.823 . . . . 0.0 111.823 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -151.03 -8.06 0.25 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -146.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.39 27.09 15.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.287 1.835 . . . . 0.0 114.01 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.37 -38.31 0.61 Allowed 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 124.417 1.087 . . . . 0.0 111.039 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -64.53 -15.61 61.2 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.251 2.22 . . . . 0.0 112.453 155.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.95 7.21 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 110.8 165.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.35 -47.34 86.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.91 -15.75 24.11 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -171.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.5 -43.96 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.48 1.912 . . . . 0.0 111.034 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.7 -43.31 68.86 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.232 1.013 . . . . 0.0 112.753 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.4 mmpt? -40.97 -49.61 3.28 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.813 2.045 . . . . 0.0 112.111 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -94.92 -21.33 18.71 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.77 -37.75 74.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.051 0.841 . . . . 0.0 110.077 160.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.84 -39.16 27.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.524 -0.735 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.4 -23.18 61.06 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.245 -0.909 . . . . 0.0 111.539 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.06 -36.32 79.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.916 1.287 . . . . 0.0 113.374 164.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -69.33 -15.81 63.41 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.792 0.837 . . . . 0.0 112.73 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.35 25.54 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.638 1.59 . . . . 0.0 112.859 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -112.44 124.2 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 125.386 1.474 . . . . 0.0 112.225 -161.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.3 9.87 7.96 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.271 152.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 35.8 -134.98 0.56 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 128.189 2.804 . . . . 0.0 119.889 151.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -124.19 49.32 1.79 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.84 2.456 . . . . 0.0 106.673 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 20.7 m95 -42.75 104.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.285 1.834 . . . . 0.0 113.225 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 m -125.37 157.49 36.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 109.668 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -148.18 155.8 41.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.619 1.568 . . . . 0.0 111.335 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -134.73 130.46 36.26 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 126.106 1.762 . . . . 0.0 110.278 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -97.72 -18.16 18.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.461 1.104 . . . . 0.0 113.12 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.55 63.21 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.819 1.248 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -122.7 -2.79 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.574 1.549 . . . . 0.0 113.156 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.375 35.8 mttm 59.78 21.29 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.825 1.65 . . . . 0.0 114.321 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.4 m -73.69 160.06 32.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.746 2.418 . . . . 0.0 113.362 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -134.21 158.19 44.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 130.862 3.665 . . . . 0.0 110.705 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.3 m -146.88 133.73 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.187 0.595 . . . . 0.0 110.991 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.1 96.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 159.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.59 62.29 7.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.311 1.529 . . . . 0.0 112.612 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 124.058 0.943 . . . . 0.0 113.477 -176.525 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 116' ' ' GLU . 20.2 tttt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 116.039 -1.934 . . . . 0.0 107.402 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.93 146.92 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 123.492 2.86 . . . . 0.0 116.714 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -140.57 156.97 46.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.922 2.089 . . . . 0.0 111.814 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.75 158.27 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 120.957 -1.09 . . . . 0.0 112.908 -176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.31 -167.42 30.71 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 169.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.24 20.81 7.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.588 1.555 . . . . 0.0 115.036 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.55 51.42 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 111.716 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.41 -17.76 33.75 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.386 1.946 . . . . 0.0 115.895 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.47 -55.31 10.61 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.57 1.185 . . . . 0.0 111.467 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -131.94 -22.55 2.32 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 8.47 74.15 0.01 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.68 3.038 . . . . 0.0 117.839 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -135.27 162.79 31.56 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.415 1.107 . . . . 0.0 113.646 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -60.5 -43.84 96.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.596 1.558 . . . . 0.0 113.158 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -86.46 -29.77 22.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -163.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.81 -31.38 64.65 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.316 -1.49 . . . . 0.0 111.727 164.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.93 -22.25 22.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.044 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.13 -34.77 75.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.259 1.391 . . . . 0.0 109.359 167.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -80.2 -64.91 1.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.638 1.175 . . . . 0.0 111.206 174.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -4.28 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -123.6 -30.62 3.59 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.487 1.039 . . . . 0.0 112.18 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.98 -27.71 30.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.174 1.352 . . . . 0.0 115.189 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -55.03 -38.79 68.41 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.0 -16.97 54.06 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.18 -170.82 33.9 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.105 0.86 . . . . 0.0 114.741 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.27 101.91 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.13 3.22 . . . . 0.0 112.443 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.18 68.23 2.57 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.288 1.835 . . . . 0.0 111.808 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -12.43 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.076 2.15 . . . . 0.0 114.342 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.3 m -150.44 150.25 31.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.541 1.064 . . . . 0.0 110.819 161.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.14 116.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 110.143 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -146.43 147.11 30.91 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.34 1.856 . . . . 0.0 109.219 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.06 154.33 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.387 -0.821 . . . . 0.0 112.391 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 125.735 1.614 . . . . 0.0 111.902 173.904 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.539 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.09 136.67 49.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.703 1.201 . . . . 0.0 111.213 -171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -132.44 156.59 46.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.62 1.2 . . . . 0.0 113.586 -167.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 136.88 54.29 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.444 1.498 . . . . 0.0 108.533 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.24 164.97 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.934 0.894 . . . . 0.0 111.373 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 44.7 mt-10 -144.34 142.33 30.31 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 109.526 170.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -119.2 140.57 49.98 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 156.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.4 29.16 0.3 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.259 -0.9 . . . . 0.0 112.94 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -152.79 137.83 11.15 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 126.083 1.753 . . . . 0.0 111.559 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.73 -51.35 9.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.553 3.502 . . . . 0.0 117.203 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.35 -14.61 22.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -160.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.31 -45.22 66.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.551 0.614 . . . . 0.0 110.536 165.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.74 77.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 111.935 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.97 78.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.44 -1.267 . . . . 0.0 110.849 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.55 -40.84 61.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.356 1.435 . . . . 0.0 113.172 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.02 -14.33 6.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.588 1.555 . . . . 0.0 114.03 166.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.6 -47.92 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 120.127 1.33 . . . . 0.0 111.699 161.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.84 -36.27 62.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.868 2.067 . . . . 0.0 112.987 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.19 -11.64 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.024 1.329 . . . . 0.0 112.516 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.09 -27.89 0.63 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -148.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -45.07 101.65 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.055 2.542 . . . . 0.0 112.114 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.4 27.01 73.31 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.075 -0.847 . . . . 0.0 114.568 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -97.16 -138.51 0.27 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.611 1.205 . . . . 0.0 111.452 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.9 m -152.91 143.17 22.47 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.683 2.793 . . . . 0.0 108.346 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.53 -42.32 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 112.377 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 87.1 m -137.23 29.51 2.74 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.493 1.117 . . . . 0.0 112.744 -155.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.27 44.76 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.369 -0.832 . . . . 0.0 112.415 -170.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.4 -174.91 3.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.17 2.188 . . . . 0.0 112.314 -166.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 89.96 2.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 108.346 174.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.7 172.39 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.063 0.945 . . . . 0.0 112.756 -168.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.657 1.583 . . . . 0.0 108.932 151.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 t -136.7 134.66 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 C--O 1.235 0.334 0 C-N-CA 124.186 0.995 . . . . 0.0 109.55 -171.851 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.481 0.658 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.86 105.37 8.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.95 107.21 8.55 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.716 0.807 . . . . 0.0 112.116 -164.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 tp -97.63 92.39 5.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.625 1.57 . . . . 0.0 109.84 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.25 105.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.602 2.361 . . . . 0.0 109.203 162.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.43 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 mp -82.53 132.01 35.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -137.08 44.73 2.28 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.938 2.095 . . . . 0.0 108.183 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.85 51.34 Favored Glycine 0 C--N 1.338 0.685 0 O-C-N 120.439 -1.413 . . . . 0.0 115.451 -161.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -56.23 -48.03 77.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.856 1.662 . . . . 0.0 109.857 160.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m -78.99 -62.48 1.69 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.449 2.3 . . . . 0.0 113.849 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.87 145.01 34.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.511 1.124 . . . . 0.0 110.409 -166.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 119.98 21.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.549 1.94 . . . . 0.0 110.144 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.62 23.1 0.09 OUTLIER Glycine 0 N--CA 1.477 1.407 0 N-CA-C 119.898 2.719 . . . . 0.0 119.898 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 57.34 -176.46 0.06 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -150.79 -32.49 0.17 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p 59.22 163.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 t -161.5 -163.51 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.358 2.663 . . . . 0.0 106.994 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.12 138.7 35.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 120.092 -1.63 . . . . 0.0 108.924 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.04 -171.13 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 123.508 1.623 . . . . 0.0 112.887 -165.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.31 -22.69 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 112.474 -2.148 . . . . 0.0 111.343 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -140.28 -57.69 0.54 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 129.89 -30.55 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 131.138 3.775 . . . . 0.0 112.243 -162.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.9 -36.01 25.67 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.723 1.209 . . . . 0.0 110.293 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -76.19 -20.97 57.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.444 3.098 . . . . 0.0 112.447 167.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.47 -52.83 8.44 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.457 -0.777 . . . . 0.0 109.968 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -47.05 47.21 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 125.685 1.594 . . . . 0.0 108.596 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -20.29 16.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -170.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.94 -40.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.386 1.474 . . . . 0.0 109.629 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -51.51 -46.0 63.1 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.56 1.144 . . . . 0.0 112.922 166.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.7 mmpt? -42.0 -46.84 4.28 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.572 1.549 . . . . 0.0 112.277 170.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -100.21 -19.08 16.57 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.29 -39.07 74.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.023 0.829 . . . . 0.0 110.51 156.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.04 -33.28 22.53 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.537 -0.727 . . . . 0.0 110.705 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -75.3 -22.12 57.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.0 1.273 . . . . 0.0 112.047 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.2 1.0 . . . . 0.0 112.649 163.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -64.84 -31.47 72.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.71 -0.618 . . . . 0.0 111.94 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.17 5.41 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.337 1.923 . . . . 0.0 113.698 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.03 134.01 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.506 1.922 . . . . 0.0 111.746 -163.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.41 12.24 3.81 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 157.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 2.06 -93.02 0.0 OUTLIER Glycine 0 N--CA 1.473 1.149 0 C-N-CA 130.114 3.721 . . . . 0.0 117.639 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -6.64 1.32 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.8 1.64 . . . . 0.0 111.988 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.49 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 30.0 m95 23.05 67.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.257 3.423 . . . . 0.0 116.254 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 m -75.33 153.63 37.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.331 1.062 . . . . 0.0 110.858 170.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -145.8 146.08 31.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.334 1.453 . . . . 0.0 110.363 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -134.62 56.14 1.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.296 1.038 . . . . 0.0 112.026 -155.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -40.56 -27.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 130.392 3.477 . . . . 0.0 119.034 -173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.33 -20.54 66.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.583 1.953 . . . . 0.0 112.505 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -128.93 -15.95 4.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.125 2.17 . . . . 0.0 113.058 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.344 36.3 mttm 65.47 14.39 9.44 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.211 3.004 . . . . 0.0 115.144 -170.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.4 m -53.76 159.07 1.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.951 1.7 . . . . 0.0 112.624 157.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.14 170.01 14.06 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 130.109 3.364 . . . . 0.0 111.07 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.4 m -147.09 153.63 40.18 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.009 -1.057 . . . . 0.0 110.525 159.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.404 HG12 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.49 113.77 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.443 0.64 . . . . 0.0 111.666 153.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -106.12 114.8 29.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.697 0.799 . . . . 0.0 110.253 172.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 124.708 1.203 . . . . 0.0 113.205 179.201 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . 0.282 4.5 p -122.74 146.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 125.071 3.578 . . . . 0.0 112.327 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -134.33 153.35 51.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.174 -167.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.9 153.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.408 1.083 . . . . 0.0 111.304 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.98 26.87 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.272 0.939 . . . . 0.0 115.128 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 70.37 33.07 2.61 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.095 1.758 . . . . 0.0 113.549 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.8 160.86 17.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 114.039 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.18 -30.54 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.857 1.694 . . . . 0.0 113.653 168.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -50.83 -36.48 37.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.733 2.413 . . . . 0.0 114.675 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.64 -50.66 0.24 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.114 2.166 . . . . 0.0 110.427 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -10.3 95.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.535 2.493 . . . . 0.0 116.316 -163.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -132.68 -29.91 1.48 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -168.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 pttp 135.26 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 1 C-N-CA 132.581 4.352 . . . . 0.0 110.578 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 m -69.46 -39.49 77.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.5 0.72 . . . . 0.0 111.525 -167.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -37.07 76.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.186 -0.947 . . . . 0.0 112.466 173.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.8 mt -79.96 -31.75 39.92 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.026 0.931 . . . . 0.0 111.856 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -57.93 -34.9 70.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.014 0.825 . . . . 0.0 110.016 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -91.75 -51.97 4.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.725 0.81 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.23 -28.28 66.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.959 0.904 . . . . 0.0 113.411 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.74 -25.98 13.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.535 0.734 . . . . 0.0 110.31 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.7 -34.14 20.58 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 126.547 2.023 . . . . 0.0 115.231 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -53.26 -37.82 62.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.041 0.921 . . . . 0.0 113.461 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -84.69 -12.01 54.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.009 0.923 . . . . 0.0 111.528 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.87 168.56 14.29 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.792 1.663 . . . . 0.0 113.042 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.68 117.02 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.96 2.44 . . . . 0.0 111.044 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.14 153.1 35.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.331 0.586 . . . . 0.0 110.602 168.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -124.31 1.33 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.737 1.615 . . . . 0.0 113.278 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -161.81 152.97 18.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.6 1.16 . . . . 0.0 109.913 147.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.5 t -153.56 124.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.449 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -152.0 149.1 28.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.956 0.902 . . . . 0.0 111.363 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.58 146.54 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -171.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 127.029 2.132 . . . . 0.0 111.454 170.098 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.159 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -142.96 149.35 38.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.494 1.118 . . . . 0.0 112.574 -155.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -129.67 164.37 24.09 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.435 1.894 . . . . 0.0 113.906 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.15 149.34 51.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.701 -1.59 . . . . 0.0 109.146 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.47 150.41 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 122.346 1.069 . . . . 0.0 111.769 -171.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -143.37 138.88 29.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.08 1.352 . . . . 0.0 110.466 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.77 -21.54 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.758 2.423 . . . . 0.0 112.78 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.272 8.9 tm-20 39.06 53.07 2.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 -153.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -150.95 137.15 11.08 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.514 1.525 . . . . 0.0 109.864 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.47 -45.06 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.913 1.742 . . . . 0.0 113.299 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.11 -54.61 10.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.898 1.279 . . . . 0.0 112.816 -165.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.86 -21.49 54.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.39 1.076 . . . . 0.0 113.406 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.55 -45.21 54.83 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.943 0.792 . . . . 0.0 112.387 169.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.98 74.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -45.46 72.74 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.65 -0.656 . . . . 0.0 112.054 173.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -6.82 3.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 114.4 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.92 -54.47 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.138 -0.977 . . . . 0.0 111.594 153.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -33.86 67.47 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.254 1.388 . . . . 0.0 114.23 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.55 1.73 23.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.051 1.741 . . . . 0.0 111.803 -163.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.45 -19.94 0.48 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.962 1.705 . . . . 0.0 113.594 -162.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -76.91 146.27 37.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.984 1.313 . . . . 0.0 113.236 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.01 37.8 81.51 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.183 0.897 . . . . 0.0 112.844 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.48 158.96 34.73 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.166 1.787 . . . . 0.0 111.702 -165.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 m -88.11 56.68 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 111.642 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.25 -28.86 65.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -160.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 70.1 m -142.48 22.5 2.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.047 1.339 . . . . 0.0 113.847 -162.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.04 11.32 70.03 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 120.341 -1.474 . . . . 0.0 113.217 -166.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 19.1 p -122.97 165.34 16.9 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.041 2.536 . . . . 0.0 107.806 164.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -89.36 102.0 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.77 163.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.981 1.313 . . . . 0.0 111.962 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -124.09 135.06 53.28 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.343 1.457 . . . . 0.0 107.357 162.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.42 138.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 108.585 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 124.002 0.921 . . . . 0.0 111.397 -166.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -132.7 124.6 28.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 136.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 34.2 ttmt -125.02 152.94 43.59 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 125.218 1.407 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.9 tp -129.21 100.77 5.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.806 2.843 . . . . 0.0 108.503 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.36 118.46 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 127.423 2.289 . . . . 0.0 109.054 158.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.442 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.3 mp -94.27 137.14 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -147.51 42.96 1.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.768 2.027 . . . . 0.0 109.282 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.01 -172.81 25.37 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.721 -1.237 . . . . 0.0 115.586 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -60.13 -45.13 94.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.041 0.924 . . . . 0.0 111.393 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -68.59 -60.49 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.833 2.053 . . . . 0.0 112.193 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.07 144.19 26.52 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.174 0.99 . . . . 0.0 110.355 -166.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -129.72 122.27 28.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.213 1.805 . . . . 0.0 108.649 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.07 23.92 0.12 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 119.006 2.363 . . . . 0.0 119.006 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER 59.65 -175.22 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.098 2.259 . . . . 0.0 117.098 175.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -145.22 -40.72 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 162.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 15.0 p 60.75 151.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 126.035 1.734 . . . . 0.0 115.405 -165.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.2 126.15 0.66 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.026 1.73 . . . . 0.0 106.747 163.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.69 148.65 33.03 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 121.848 -0.533 . . . . 0.0 110.692 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.82 176.35 11.14 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.07 -1.019 . . . . 0.0 112.814 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.79 -54.75 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.134 1.774 . . . . 0.0 111.428 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -165.18 174.53 10.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.045 1.738 . . . . 0.0 109.966 -158.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.73 -39.93 1.59 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.772 1.169 . . . . 0.0 110.699 -173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -71.32 -23.13 61.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.755 1.622 . . . . 0.0 112.129 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.36 -50.79 14.82 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 109.802 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -47.68 61.32 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.771 1.228 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -23.17 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -169.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.02 -36.97 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.22 1.408 . . . . 0.0 109.609 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -53.41 -45.52 69.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.444 1.098 . . . . 0.0 112.75 164.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.1 mmpt? -44.75 -53.97 6.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 111.224 168.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -72.21 -36.43 69.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.38 -41.58 94.07 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.655 1.116 . . . . 0.0 111.309 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.55 -38.38 59.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.0 -29.5 69.89 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.17 0.895 . . . . 0.0 112.235 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.08 -38.28 85.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 113.009 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -67.33 -12.96 61.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.667 0.787 . . . . 0.0 112.511 165.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.25 10.0 52.32 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.04 1.781 . . . . 0.0 112.756 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.08 128.04 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 125.93 1.692 . . . . 0.0 112.362 -161.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 68.18 1.31 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 125.074 2.369 . . . . 0.0 110.569 156.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.5 -153.14 0.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 109.696 -3.411 . . . . 0.0 115.15 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.99 52.66 0.72 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.768 2.827 . . . . 0.0 109.824 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.519 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 21.9 m95 -43.74 100.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.247 2.619 . . . . 0.0 112.916 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.3 m -125.95 162.2 25.76 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.38 1.872 . . . . 0.0 110.125 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -147.23 155.88 42.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.627 1.571 . . . . 0.0 111.536 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.42 129.76 35.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.715 2.006 . . . . 0.0 109.275 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.61 -18.11 23.5 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.13 61.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.079 0.951 . . . . 0.0 111.824 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -122.93 -2.15 8.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.242 1.817 . . . . 0.0 112.601 166.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.317 49.8 mttm 58.86 24.8 12.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.596 1.558 . . . . 0.0 113.372 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.2 m -79.22 157.22 27.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.523 2.329 . . . . 0.0 112.36 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.71 159.52 32.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.596 2.758 . . . . 0.0 109.658 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -145.15 132.79 20.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.09 -0.381 . . . . 0.0 111.274 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 3.1 m -112.87 100.52 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.983 0.897 . . . . 0.0 112.014 156.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 115.04 18.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 155.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 124.025 1.869 . . . . 0.0 109.335 170.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.418 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.44 155.82 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 108.849 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -137.34 152.27 49.52 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.854 -1.154 . . . . 0.0 112.126 -162.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.98 149.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 110.207 -177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.62 38.11 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.515 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 3.2 t30 81.86 5.6 1.18 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.1 2.56 . . . . 0.0 113.918 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 61.51 5.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.389 1.476 . . . . 0.0 112.83 -167.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.23 63.95 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 114.649 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 114.234 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -136.16 -61.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.608 1.163 . . . . 0.0 111.076 -167.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.96 54.38 4.41 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.513 2.006 . . . . 0.0 114.556 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.09 -40.88 2.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 pttp 138.48 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 1 C-N-CA 132.461 4.305 . . . . 0.0 111.586 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.3 m -82.46 -26.12 32.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.13 0.877 . . . . 0.0 112.293 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -53.65 -35.14 60.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.78 -1.2 . . . . 0.0 112.321 159.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.71 -29.62 17.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.682 1.193 . . . . 0.0 113.129 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -60.08 -32.21 70.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.671 1.123 . . . . 0.0 109.301 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -85.23 -54.67 4.46 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.481 1.112 . . . . 0.0 112.51 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 -21.22 59.17 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.09 -29.47 8.53 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.013 0.925 . . . . 0.0 111.499 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -51.66 -36.47 40.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.632 1.111 . . . . 0.0 114.196 167.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -57.0 -36.02 69.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.51 -24.39 50.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.02 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.68 -169.54 34.54 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.69 106.54 2.13 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.881 3.054 . . . . 0.0 111.927 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.92 143.2 52.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.228 1.011 . . . . 0.0 111.22 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.1 ttp-105 -94.33 -35.19 12.51 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.172 1.389 . . . . 0.0 111.705 163.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -172.4 160.44 4.9 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.767 1.167 . . . . 0.0 111.011 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.8 t -151.31 134.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 107.846 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -146.06 148.45 32.67 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.297 1.839 . . . . 0.0 109.982 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.14 145.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 112.876 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.75 1.22 . . . . 0.0 114.044 -173.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 CA-C-O 119.37 -0.683 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.52 135.67 48.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 0.0 111.063 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.12 162.6 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.515 1.926 . . . . 0.0 113.707 -168.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.74 156.23 47.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.504 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.53 160.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.163 . . . . 0.0 110.488 -162.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.56 154.34 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.66 1.584 . . . . 0.0 110.764 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -132.64 151.55 51.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.972 2.109 . . . . 0.0 111.681 -173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -84.62 -2.23 57.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.811 -1.18 . . . . 0.0 113.821 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.88 129.03 23.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.486 1.114 . . . . 0.0 111.608 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.23 -27.85 13.2 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.381 2.721 . . . . 0.0 114.043 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.98 -34.0 12.53 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.252 1.021 . . . . 0.0 110.875 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -68.93 -29.5 67.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.609 1.095 . . . . 0.0 112.895 164.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.44 -45.28 91.61 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.84 1.2 . . . . 0.0 111.802 165.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.92 89.12 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.614 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.33 -42.98 61.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.87 -12.31 7.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.552 1.141 . . . . 0.0 113.536 168.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 87.6 t -89.89 -52.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 119.408 1.004 . . . . 0.0 112.312 159.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -59.31 -25.5 64.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.327 1.851 . . . . 0.0 113.156 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.54 -7.37 34.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 112.162 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.59 -15.82 0.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -153.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -23.74 0.92 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.314 2.246 . . . . 0.0 115.645 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -161.4 40.14 0.41 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.684 1.135 . . . . 0.0 114.199 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.25 34.5 ttp180 -113.42 -123.37 0.29 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.353 1.077 . . . . 0.0 112.283 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.5 m -161.07 142.39 11.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.372 1.869 . . . . 0.0 107.621 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.9 tp -138.38 -36.93 0.57 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -163.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.8 m -140.47 21.42 2.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.158 1.383 . . . . 0.0 113.216 -171.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.89 47.47 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.499 -0.751 . . . . 0.0 113.397 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 11.9 t -137.15 152.61 50.15 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 108.327 157.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.515 ' HE ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 tmm_? -35.5 134.67 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.477 1.511 . . . . 0.0 109.902 150.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.18 157.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.195 0.598 . . . . 0.0 110.259 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -128.21 159.37 35.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.104 159.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.1 t -149.24 148.59 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.975 1.31 . . . . 0.0 108.493 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.122 1.369 . . . . 0.0 110.815 -178.749 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 120.731 0.301 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.35 111.33 12.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -138.21 99.69 3.93 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.765 0.826 . . . . 0.0 112.096 -163.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.54 90.76 8.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 119.021 0.828 . . . . 0.0 109.486 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -53.8 120.39 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 126.431 1.892 . . . . 0.0 109.056 159.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.41 128.77 38.38 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.012 168.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -144.1 59.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 111.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.15 152.13 18.01 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.136 0.874 . . . . 0.0 113.366 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -52.24 -29.84 24.77 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.811 1.244 . . . . 0.0 110.11 156.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 m -59.43 -55.39 35.21 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.981 2.513 . . . . 0.0 113.596 167.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -167.35 141.5 3.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.258 1.823 . . . . 0.0 110.123 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -132.59 140.79 48.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.087 1.355 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.7 -136.07 5.87 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 125.702 1.62 . . . . 0.0 110.586 -163.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -161.57 -169.66 2.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.352 2.261 . . . . 0.0 109.076 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -138.33 -43.32 0.5 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 160.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p 62.06 164.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.428 2.011 . . . . 0.0 116.428 -168.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -161.68 -167.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.64 2.776 . . . . 0.0 105.864 156.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -134.97 140.13 45.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.147 -1.595 . . . . 0.0 108.948 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.79 10.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 0.0 112.329 -162.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -61.48 -49.19 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 110.191 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -164.04 178.99 7.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 123.507 1.623 . . . . 0.0 111.611 -160.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 16.85 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.844 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 p -61.28 -25.46 67.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.252 1.821 . . . . 0.0 115.885 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 -46.87 12.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.112 0.415 . . . . 0.0 111.221 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.37 -47.5 85.2 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -58.89 -22.43 59.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.62 -47.21 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.045 1.738 . . . . 0.0 110.946 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -52.26 -43.1 64.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.61 1.164 . . . . 0.0 113.136 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 5.6 mmmm -46.81 -50.58 18.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.967 2.107 . . . . 0.0 111.409 171.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.84 -38.83 70.06 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.69 -36.68 83.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.108 0.867 . . . . 0.0 111.786 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.54 -26.54 32.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.35 -0.844 . . . . 0.0 111.95 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.3 -37.95 81.15 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.051 0.841 . . . . 0.0 111.744 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.44 -40.01 89.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.374 1.47 . . . . 0.0 112.396 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -66.74 -38.44 86.65 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.001 -0.437 . . . . 0.0 111.635 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.07 22.03 9.09 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.173 1.844 . . . . 0.0 113.88 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.31 -65.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.645 1.212 . . . . 0.0 113.021 -163.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.265 23.0 m-20 22.79 64.76 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 130.816 3.646 . . . . 0.0 113.816 -168.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.8 -134.94 6.55 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 108.872 -3.785 . . . . 0.0 113.106 -165.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.43 59.08 0.58 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.353 1.461 . . . . 0.0 109.46 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 5.7 m95 -50.84 100.2 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.933 1.693 . . . . 0.0 112.617 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -136.86 162.86 32.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.542 1.137 . . . . 0.0 111.557 -170.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 55.8 t80 -143.75 153.06 42.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.139 1.776 . . . . 0.0 110.867 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.46 77.79 1.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.367 1.467 . . . . 0.0 112.27 -168.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -22.86 23.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.5 64.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.5 1.92 . . . . 0.0 112.697 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -130.58 -4.91 4.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.824 1.25 . . . . 0.0 113.147 167.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.374 36.2 mttm 57.28 18.09 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.462 3.105 . . . . 0.0 114.748 -167.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -60.85 157.91 14.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.328 1.851 . . . . 0.0 111.538 165.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 37.7 m-85 -122.91 167.81 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.863 2.465 . . . . 0.0 110.942 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -149.73 146.17 27.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.598 -1.314 . . . . 0.0 110.665 167.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.86 88.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.232 1.013 . . . . 0.0 112.678 161.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 58.11 4.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.949 1.3 . . . . 0.0 113.34 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.151 0 O-C-N 120.785 -1.197 . . . . 0.0 113.204 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.42 138.6 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.846 1.657 . . . . 0.0 112.768 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -126.33 140.69 52.32 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.269 1.828 . . . . 0.0 108.632 158.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.94 135.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 108.915 175.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.27 -147.39 5.19 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.702 -0.623 . . . . 0.0 114.193 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.79 -6.12 0.45 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.918 1.687 . . . . 0.0 113.701 -152.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' CD2' ' HG ' ' A' ' 138' ' ' CYS . 17.1 mt -80.67 55.27 2.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.907 1.683 . . . . 0.0 112.264 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.37 42.15 0.4 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 127.788 2.613 . . . . 0.0 114.558 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -157.21 -50.3 0.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.11 2.564 . . . . 0.0 110.482 -167.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.09 -112.63 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.644 2.378 . . . . 0.0 108.182 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.21 69.08 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.486 1.993 . . . . 0.0 116.543 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.25 161.27 5.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.036 2.534 . . . . 0.0 113.639 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -34.82 52.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -71.46 -46.35 60.18 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.101 0.96 . . . . 0.0 112.939 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -33.05 75.03 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.886 -1.134 . . . . 0.0 111.406 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.8 mt -83.54 -36.08 24.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.114 0.965 . . . . 0.0 112.663 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -44.57 -42.87 7.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.456 1.103 . . . . 0.0 110.092 165.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -105.48 -39.57 6.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 118.32 -0.848 . . . . 0.0 112.645 -162.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.4 70.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.809 0.731 . . . . 0.0 112.092 168.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -95.12 -30.8 13.85 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.22 -35.44 6.72 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.996 1.284 . . . . 0.0 114.432 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -58.18 -37.15 74.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -81.27 -20.98 39.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 111.641 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.25 -173.49 33.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.65 0.643 . . . . 0.0 114.124 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.02 156.46 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.306 2.671 . . . . 0.0 112.457 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.51 143.49 50.86 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.089 2.556 . . . . 0.0 108.206 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -95.1 -32.75 12.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.905 1.282 . . . . 0.0 112.247 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 t -166.33 169.28 14.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.992 0.917 . . . . 0.0 111.954 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 t -159.89 127.0 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.279 3.032 . . . . 0.0 107.311 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -156.86 144.71 19.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.613 1.165 . . . . 0.0 111.943 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.14 139.86 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.682 -1.261 . . . . 0.0 113.004 -166.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 125.423 1.489 . . . . 0.0 109.569 167.592 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 CA-C-O 121.446 0.47 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -155.82 158.48 38.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.575 1.95 . . . . 0.0 109.139 -166.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.72 156.78 35.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.379 1.472 . . . . 0.0 113.497 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -131.83 148.05 52.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.872 165.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -143.64 -179.47 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -141.42 106.72 5.01 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 107.731 166.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.94 169.36 0.53 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 165.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.08 25.48 5.88 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.051 0.929 . . . . 0.0 113.244 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.93 132.23 10.25 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.616 -1.303 . . . . 0.0 110.295 160.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.8 -34.01 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.638 2.226 . . . . 0.0 114.639 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.07 -31.77 20.31 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.061 1.3 . . . . 0.0 112.289 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.52 -24.04 60.09 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 167.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.52 -51.04 62.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.533 1.06 . . . . 0.0 111.875 163.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.81 -32.11 63.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.607 -1.308 . . . . 0.0 110.998 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -43.25 55.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.77 -10.65 9.43 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 113.618 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.78 -62.23 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.893 . . . . 0.0 110.732 153.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -49.48 -33.63 14.86 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.672 1.989 . . . . 0.0 114.309 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.7 -13.52 16.45 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 112.193 -164.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.63 -33.09 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.545 1.138 . . . . 0.0 114.025 -161.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -56.75 139.34 51.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.901 1.28 . . . . 0.0 113.125 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.76 4.62 54.45 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.523 1.058 . . . . 0.0 114.898 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -117.38 -109.72 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.292 1.437 . . . . 0.0 110.703 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 m -143.92 153.61 42.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.569 1.547 . . . . 0.0 109.573 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.69 -44.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.029 0.932 . . . . 0.0 112.956 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.5 t -149.66 68.09 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.551 1.54 . . . . 0.0 110.713 -170.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.63 93.34 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.432 1.015 . . . . 0.0 114.651 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.435 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 30.0 p -145.59 -174.57 4.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 113.05 -159.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.7 136.77 51.89 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 153.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.82 163.03 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.227 1.411 . . . . 0.0 112.104 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -135.46 138.01 42.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.947 2.099 . . . . 0.0 108.659 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -139.11 137.05 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.463 0.705 . . . . 0.0 111.121 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.475 0.796 0 O-C-N 120.711 -1.243 . . . . 0.0 109.302 164.827 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 120.554 0.216 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.83 112.05 18.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 166.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -128.32 108.14 10.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.451 1.1 . . . . 0.0 111.906 -168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.4 tp -95.23 98.77 10.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.073 1.349 . . . . 0.0 109.371 172.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.81 115.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.167 2.187 . . . . 0.0 108.888 163.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 136.06 33.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.959 168.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -142.64 51.03 1.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.662 1.185 . . . . 0.0 108.501 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.85 176.36 25.97 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 122.504 1.058 . . . . 0.0 114.4 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -60.28 -40.95 92.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.065 1.346 . . . . 0.0 111.494 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -71.12 -48.63 51.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.639 2.376 . . . . 0.0 113.533 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.42 139.73 14.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.273 1.029 . . . . 0.0 110.482 -169.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -126.45 132.31 51.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.923 1.689 . . . . 0.0 109.79 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.39 -137.78 5.76 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.404 1.478 . . . . 0.0 110.334 -153.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -159.46 -161.22 0.9 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.897 1.679 . . . . 0.0 109.467 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -143.88 -42.34 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 156.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.6 p 55.97 164.41 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -158.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -160.31 -164.36 1.25 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.76 2.424 . . . . 0.0 106.364 156.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -140.35 130.62 25.13 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.697 1.599 . . . . 0.0 107.778 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.48 23.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -157.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.71 -42.14 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.128 1.771 . . . . 0.0 111.825 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -144.31 -58.86 0.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -161.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 134.49 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 131.679 3.991 . . . . 0.0 111.659 -162.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -36.95 10.9 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.592 1.157 . . . . 0.0 109.749 -170.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -74.88 -17.22 60.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.04 2.936 . . . . 0.0 112.457 164.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.7 -54.6 5.71 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.717 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.07 -46.07 44.0 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 125.25 1.42 . . . . 0.0 109.087 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -20.94 13.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -171.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.56 -38.81 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.473 1.509 . . . . 0.0 109.788 -169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -50.38 -46.72 56.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.019 1.328 . . . . 0.0 112.326 163.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.4 mmpt? -43.8 -55.46 4.46 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.949 1.699 . . . . 0.0 112.024 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.07 -35.21 64.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -60.74 -39.94 90.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.445 1.02 . . . . 0.0 111.302 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 -32.4 38.01 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.181 -0.949 . . . . 0.0 111.168 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.22 -26.29 61.97 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.872 0.76 . . . . 0.0 112.554 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.7 -39.26 77.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 166.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -67.18 -50.58 60.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.197 0.599 . . . . 0.0 111.576 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.8 33.14 0.39 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.269 1.414 . . . . 0.0 113.844 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.77 134.2 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.785 1.234 . . . . 0.0 112.001 -168.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.72 -4.28 5.25 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.54 158.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.45 -127.17 4.61 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.317 1.913 . . . . 0.0 116.365 161.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.89 -14.56 39.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 112.118 171.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.522 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 26.0 m95 8.32 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.271 1.829 . . . . 0.0 114.694 -130.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -73.17 151.09 41.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.629 1.204 . . . . 0.0 110.141 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -154.19 142.52 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 109.961 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -104.76 -37.6 6.99 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 56.61 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.447 3.099 . . . . 0.0 117.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.64 -28.5 69.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.434 1.893 . . . . 0.0 111.965 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.2 p -125.08 5.03 7.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.158 1.783 . . . . 0.0 113.274 166.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt 57.55 -5.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 128.177 2.591 . . . . 0.0 116.81 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -39.57 150.45 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.055 2.542 . . . . 0.0 114.473 156.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -131.99 162.9 29.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 131.252 3.821 . . . . 0.0 110.645 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.0 m -148.79 141.3 24.33 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 167.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.45 111.46 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.54 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 m -119.94 96.5 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.565 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.914 1.286 . . . . 0.0 113.972 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.76 143.87 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 120.877 1.672 . . . . 0.0 107.34 156.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.39 146.29 25.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.409 1.083 . . . . 0.0 110.941 -168.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.14 157.41 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.222 158.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -165.16 14.86 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 114.836 0.694 . . . . 0.0 114.836 170.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.01 -5.47 2.17 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 127.205 2.202 . . . . 0.0 113.262 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 84' ' ' ASN . 0.2 OUTLIER -94.63 46.24 1.14 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.639 1.576 . . . . 0.0 113.316 -150.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.36 -29.7 75.32 Favored Glycine 0 CA--C 1.537 1.466 0 N-CA-C 118.418 2.127 . . . . 0.0 118.418 -160.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -70.87 -35.01 72.18 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.239 2.019 . . . . 0.0 113.682 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.462 HD22 ' CD1' ' A' ' 81' ' ' LEU . 1.6 p-10 -129.35 -16.69 3.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.95 108.17 0.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -157.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -138.66 169.04 18.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.833 2.053 . . . . 0.0 111.003 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.87 -47.91 70.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.2 m -76.14 -30.93 58.35 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -160.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -58.76 -34.71 71.73 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.034 -1.041 . . . . 0.0 112.411 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.46 -35.14 40.79 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 111.778 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.07 -29.46 65.44 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.442 0.697 . . . . 0.0 111.595 171.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.47 -48.94 7.54 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.01 -23.6 54.82 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -117.54 -19.04 9.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 113.25 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.28 -38.16 18.99 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.644 1.116 . . . . 0.0 114.048 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -55.94 -36.95 68.35 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.84 1.42 55.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.186 1.394 . . . . 0.0 112.29 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.34 166.77 12.32 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.773 1.178 . . . . 0.0 114.779 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.87 116.15 4.61 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.334 2.689 . . . . 0.0 111.505 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.83 138.58 58.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.466 0.651 . . . . 0.0 110.528 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -14.31 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.136 2.174 . . . . 0.0 112.665 -167.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -151.92 150.04 29.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.265 1.826 . . . . 0.0 108.539 159.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 91.5 t -155.58 128.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.27 1.028 . . . . 0.0 110.987 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -150.21 148.25 28.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.12 2.168 . . . . 0.0 110.19 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.69 155.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.156 -0.965 . . . . 0.0 112.296 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 125.74 1.616 . . . . 0.0 112.718 174.95 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -124.99 129.43 50.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.97 1.308 . . . . 0.0 109.025 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.32 160.85 25.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.41 1.484 . . . . 0.0 112.228 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -141.34 148.89 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.387 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.99 171.95 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 -165.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.97 141.95 36.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 109.311 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -151.76 157.39 41.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.202 1.401 . . . . 0.0 110.701 150.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.77 47.4 0.88 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.053 0.93 . . . . 0.0 113.016 -148.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.0 142.33 24.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.409 1.884 . . . . 0.0 110.602 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.65 -28.47 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.085 2.523 . . . . 0.0 114.836 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.67 -57.49 3.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.96 1.255 . . . . 0.0 113.09 -164.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.4 -27.18 65.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.585 1.154 . . . . 0.0 111.647 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.21 68.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.96 -31.42 70.98 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.662 -1.274 . . . . 0.0 110.562 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.36 -45.83 82.58 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.769 -0.582 . . . . 0.0 112.55 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -15.9 54.88 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.2 t -79.27 -52.89 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.768 -1.208 . . . . 0.0 109.673 159.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -25.29 65.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.033 1.733 . . . . 0.0 115.017 -175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -97.37 -19.64 18.35 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.339 1.856 . . . . 0.0 112.018 -174.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 -18.1 0.34 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -148.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.69 130.28 37.53 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.149 -0.969 . . . . 0.0 113.285 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.25 86.54 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.076 1.322 . . . . 0.0 115.05 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -78.63 -161.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 128.028 2.531 . . . . 0.0 112.678 -173.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.9 m -112.8 137.52 51.0 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.716 1.606 . . . . 0.0 107.969 155.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.75 133.4 35.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 110.398 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 8.6 t 58.52 -55.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.983 2.513 . . . . 0.0 115.151 -170.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.58 18.24 0.05 OUTLIER Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.509 1.528 . . . . 0.0 115.432 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.2 p -151.38 159.82 44.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.999 1.399 . . . . 0.0 112.659 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -58.04 144.35 40.18 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.494 1.117 . . . . 0.0 110.475 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.88 159.59 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.243 1.417 . . . . 0.0 112.793 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.53 135.96 40.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 164.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -143.92 138.86 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.337 0.971 . . . . 0.0 110.917 -162.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 N--CA 1.475 0.82 0 O-C-N 120.88 -1.137 . . . . 0.0 111.824 -178.369 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.355 0.597 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -131.76 112.85 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 157.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -130.05 146.13 51.7 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 127.199 2.2 . . . . 0.0 108.885 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.6 tp -122.16 99.38 6.4 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.559 1.944 . . . . 0.0 109.305 162.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -62.12 130.31 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.759 1.624 . . . . 0.0 109.514 160.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.63 132.09 48.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.646 171.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -145.62 54.96 1.19 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.811 1.244 . . . . 0.0 111.296 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 11' ' ' THR . . . -116.52 179.89 17.78 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -73.67 15.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 128.499 2.72 . . . . 0.0 112.954 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.1 p -142.22 -57.34 0.45 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 127.533 2.333 . . . . 0.0 108.932 -144.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -156.6 146.77 21.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.869 2.068 . . . . 0.0 109.321 162.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -128.83 142.41 50.98 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.884 1.274 . . . . 0.0 111.828 167.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.66 -136.55 6.28 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 125.149 1.357 . . . . 0.0 109.985 -159.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -160.83 -158.92 0.63 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.483 1.513 . . . . 0.0 110.113 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -143.84 -47.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 154.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p 57.09 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.774 1.63 . . . . 0.0 115.263 -158.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -157.93 -18.0 0.08 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.59 141.63 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.627 2.371 . . . . 0.0 116.942 -163.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.28 -164.24 1.97 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.354 1.461 . . . . 0.0 111.47 -174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.44 -15.76 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.407 1.883 . . . . 0.0 111.676 -163.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -145.22 -9.08 0.59 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.19 30.97 19.25 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.989 1.316 . . . . 0.0 113.337 -167.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.1 -37.52 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.765 1.626 . . . . 0.0 112.012 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.84 -24.61 66.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.51 2.724 . . . . 0.0 112.456 158.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.83 -53.82 9.38 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.85 -0.531 . . . . 0.0 109.813 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -49.96 -46.86 52.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 125.525 1.53 . . . . 0.0 109.229 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -54.88 -25.02 26.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.21 -40.32 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 109.146 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -50.72 -48.45 58.89 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.289 1.436 . . . . 0.0 112.431 165.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.6 mmpt? -43.8 -55.03 4.74 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.867 1.667 . . . . 0.0 112.089 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -73.52 -35.25 65.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -63.48 -41.23 98.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.863 0.756 . . . . 0.0 110.99 172.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.49 -36.4 63.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.314 -0.866 . . . . 0.0 109.926 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.33 -33.21 75.43 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.283 0.492 . . . . 0.0 111.543 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.78 -36.44 78.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.031 1.332 . . . . 0.0 113.603 169.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.59 -20.78 64.52 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.01 20.12 7.33 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.904 1.716 . . . . 0.0 113.385 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.59 123.03 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.942 1.297 . . . . 0.0 111.925 -161.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.61 69.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 124.924 2.297 . . . . 0.0 108.897 155.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -149.98 0.24 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 109.413 -3.54 . . . . 0.0 114.046 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.88 24.38 0.4 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.371 1.868 . . . . 0.0 111.954 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.531 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 32.5 m95 -6.42 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.451 3.501 . . . . 0.0 115.368 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.9 m -103.4 158.68 16.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 109.298 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -137.14 143.76 42.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.591 1.556 . . . . 0.0 109.826 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.13 60.01 1.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.439 1.496 . . . . 0.0 110.012 -155.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.89 -25.71 0.83 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.608 3.163 . . . . 0.0 117.372 -172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.88 -21.64 66.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.147 2.179 . . . . 0.0 112.559 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -131.27 -3.42 3.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.366 1.867 . . . . 0.0 112.86 168.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.299 35.6 mttm 54.94 20.03 2.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.415 2.686 . . . . 0.0 114.732 -169.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.7 m -60.34 165.04 3.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.754 1.621 . . . . 0.0 111.682 157.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -132.84 152.63 51.79 Favored 'General case' 0 C--N 1.324 -0.534 1 C-N-CA 132.327 4.251 . . . . 0.0 108.03 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -145.82 116.11 7.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.696 0.284 . . . . 0.0 110.247 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -96.98 88.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-O 122.144 0.973 . . . . 0.0 112.081 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -69.96 113.74 7.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.18 156.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.511 1.125 . . . . 0.0 112.289 173.878 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.91 150.65 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.098 -1.001 . . . . 0.0 111.357 -169.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -125.98 139.09 53.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.765 0.826 . . . . 0.0 110.098 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.64 136.29 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.413 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.94 31.96 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 121.524 -0.735 . . . . 0.0 114.672 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 63.63 17.6 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.474 1.11 . . . . 0.0 113.96 -170.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -33.91 76.89 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.163 -0.96 . . . . 0.0 111.622 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.79 -60.38 0.34 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.652 2.549 . . . . 0.0 116.215 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.57 -29.32 37.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.434 1.894 . . . . 0.0 112.957 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -153.67 -153.65 0.48 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.703 2.401 . . . . 0.0 109.044 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.18 -17.52 5.11 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 128.068 2.747 . . . . 0.0 112.58 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -37.37 74.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 132.421 4.288 . . . . 0.0 116.781 169.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 tttm 52.11 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.626 3.171 . . . . 0.0 116.847 167.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.9 m -66.96 -26.86 67.04 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 121.07 1.759 . . . . 0.0 114.648 -158.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.73 -30.6 70.88 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.435 -1.416 . . . . 0.0 113.198 168.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.9 mt -90.83 -25.21 20.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.85 1.66 . . . . 0.0 111.998 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.41 -30.63 69.73 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.384 0.993 . . . . 0.0 109.81 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.87 -47.23 8.74 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.685 1.194 . . . . 0.0 113.085 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.76 -25.09 64.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.085 1.311 . . . . 0.0 113.373 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -105.24 -31.09 9.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.592 1.157 . . . . 0.0 110.943 174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.23 -32.92 44.7 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.345 1.45 . . . . 0.0 115.512 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -57.36 -39.49 76.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.329 1.064 . . . . 0.0 112.589 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -75.31 -25.9 58.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.865 0.466 . . . . 0.0 111.944 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.95 -176.5 40.71 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -174.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 147.6 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.851 3.034 . . . . 0.0 112.493 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mp -113.79 141.42 47.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.041 1.736 . . . . 0.0 110.671 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -114.94 -16.22 11.71 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.402 1.881 . . . . 0.0 114.434 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -159.68 150.96 19.72 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.065 1.346 . . . . 0.0 110.347 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.7 t -154.86 134.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 126.158 1.783 . . . . 0.0 109.81 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -153.79 158.55 41.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.493 1.517 . . . . 0.0 111.455 166.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.29 143.67 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 126.648 1.979 . . . . 0.0 111.059 166.338 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 112.101 -0.399 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -109.72 112.74 24.98 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.005 1.322 . . . . 0.0 109.961 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.02 158.06 16.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.554 1.169 . . . . 0.0 112.092 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -139.34 130.34 26.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.013 163.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.42 -178.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.689 0.795 . . . . 0.0 111.235 -171.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -154.01 136.06 14.7 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.452 -1.405 . . . . 0.0 110.797 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.87 154.2 27.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.441 1.497 . . . . 0.0 112.548 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.88 -7.6 58.82 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.101 -0.999 . . . . 0.0 112.595 164.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.05 109.43 27.47 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.815 1.646 . . . . 0.0 110.805 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.75 -31.7 95.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.154 3.236 . . . . 0.0 115.718 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -73.66 -41.88 62.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 110.547 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.54 -30.28 71.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.802 0.728 . . . . 0.0 112.415 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.78 78.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.762 0.825 . . . . 0.0 112.189 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.25 74.12 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.496 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -49.97 48.17 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.68 -11.03 31.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.552 1.541 . . . . 0.0 114.465 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.28 -52.8 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 157.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -31.53 69.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.833 1.253 . . . . 0.0 114.089 -172.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.61 -0.8 20.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.634 1.574 . . . . 0.0 111.924 -163.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -23.64 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.577 1.551 . . . . 0.0 113.233 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.31 125.18 23.01 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.138 -0.977 . . . . 0.0 111.436 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.7 9.1 87.36 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -84.78 -176.23 6.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.319 1.448 . . . . 0.0 112.44 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.7 m -134.9 93.07 2.96 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.042 1.737 . . . . 0.0 108.806 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.59 -39.51 31.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.754 1.222 . . . . 0.0 112.686 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 76.3 m -144.49 46.1 1.4 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.822 1.249 . . . . 0.0 112.926 -162.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.31 72.58 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.139 -0.976 . . . . 0.0 113.119 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.5 p -112.04 -166.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.456 2.303 . . . . 0.0 111.862 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -147.03 53.07 1.08 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.2 1.0 . . . . 0.0 111.373 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.56 156.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 126.98 2.112 . . . . 0.0 113.936 -170.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.23 152.11 42.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.35 1.46 . . . . 0.0 110.183 158.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.2 t -144.51 128.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.891 0.876 . . . . 0.0 109.531 -162.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 126.026 1.73 . . . . 0.0 110.219 177.477 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -156.6 -62.95 0.1 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -167.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -80.17 94.36 6.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 97.22 4.35 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.385 -151.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 46.0 tp -87.57 86.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.068 1.347 . . . . 0.0 109.903 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -56.33 101.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.351 2.261 . . . . 0.0 109.155 163.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.2 mp -78.99 136.09 37.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 165.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -145.33 54.8 1.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.721 2.008 . . . . 0.0 108.576 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.54 -177.91 21.82 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -171.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -51.11 -48.37 61.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.486 1.114 . . . . 0.0 110.608 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 m -74.79 -63.34 1.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.732 2.413 . . . . 0.0 113.679 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.57 141.69 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.252 1.021 . . . . 0.0 110.456 -168.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 96.6 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.752 2.021 . . . . 0.0 108.833 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.45 23.87 0.02 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 120.684 3.033 . . . . 0.0 120.684 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HA ' ' H ' ' A' ' 7' ' ' LEU 0.255 0.6 OUTLIER 54.61 -175.96 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.084 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -154.81 -32.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 164.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p 59.0 161.96 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.2 t -160.82 -162.07 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.331 2.252 . . . . 0.0 108.835 153.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -148.23 151.32 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 111.783 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.13 -177.67 6.06 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.355 1.862 . . . . 0.0 111.143 -167.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.37 -18.32 9.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 112.203 -2.271 . . . . 0.0 112.6 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -148.65 -9.01 0.36 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 23.13 13.49 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.111 1.765 . . . . 0.0 114.462 -168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.03 -38.47 1.1 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.309 1.844 . . . . 0.0 110.571 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.0 m -57.66 -21.21 38.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.356 1.862 . . . . 0.0 112.458 149.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.87 -47.65 16.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.264 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -48.03 80.42 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -68.22 -7.53 31.15 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -166.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.29 -38.22 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.76 2.424 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -53.13 -43.01 66.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.679 1.127 . . . . 0.0 112.083 162.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -43.63 -56.18 3.89 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.061 2.144 . . . . 0.0 111.277 168.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.75 -34.69 67.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -57.94 -42.96 86.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.756 1.162 . . . . 0.0 110.952 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.95 -33.46 39.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.371 -0.83 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.3 -26.76 63.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.177 0.898 . . . . 0.0 112.528 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.48 -40.4 77.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.111 1.364 . . . . 0.0 112.638 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -64.62 -43.58 93.28 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.764 -0.585 . . . . 0.0 111.655 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 27.79 1.29 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.713 1.625 . . . . 0.0 114.095 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 139.86 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.276 1.83 . . . . 0.0 111.287 -168.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 6.28 4.03 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 157.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.9 -130.34 10.14 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.203 1.859 . . . . 0.0 116.55 159.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -92.86 -13.29 29.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.017 1.727 . . . . 0.0 111.759 167.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.498 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 47.3 m95 6.61 82.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.041 1.736 . . . . 0.0 115.68 -127.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 m -82.2 156.86 24.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.692 1.234 . . . . 0.0 110.642 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -148.31 151.48 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.191 1.797 . . . . 0.0 110.559 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -124.31 143.62 50.46 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.955 1.702 . . . . 0.0 109.065 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.24 -15.94 12.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.14 57.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.376 1.87 . . . . 0.0 111.638 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.0 p -120.12 -7.4 9.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.417 1.887 . . . . 0.0 112.65 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.378 35.6 mttm 65.27 12.69 8.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.519 1.528 . . . . 0.0 114.759 -174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -54.56 153.84 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.36 2.264 . . . . 0.0 113.913 166.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -125.09 166.14 16.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.719 2.408 . . . . 0.0 112.318 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.5 m -151.75 139.16 19.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.421 -1.424 . . . . 0.0 112.086 167.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.0 89.06 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.055 1.342 . . . . 0.0 113.463 171.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -99.77 79.13 2.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.071 0.948 . . . . 0.0 112.643 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.66 -16.24 64.06 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.498 1.119 . . . . 0.0 114.001 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.21 -28.26 3.04 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.068 0.842 . . . . 0.0 114.754 160.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -66.72 2.44 1.37 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.673 1.989 . . . . 0.0 114.917 172.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -129.32 18.13 5.94 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.753 2.021 . . . . 0.0 110.963 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.98 -50.51 0.23 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.95 -1.094 . . . . 0.0 113.837 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -135.11 -7.28 2.32 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.322 1.449 . . . . 0.0 113.88 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.33 -172.71 2.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 140.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 155.35 46.76 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -157.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -163.52 168.44 20.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.242 1.417 . . . . 0.0 110.573 166.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.38 178.44 9.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.379 1.072 . . . . 0.0 110.353 162.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -129.89 62.91 1.54 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.127 2.171 . . . . 0.0 109.327 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -143.02 -49.62 0.34 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.692 2.797 . . . . 0.0 109.272 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -128.89 -101.68 0.33 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.984 1.713 . . . . 0.0 107.937 158.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.5 p -152.16 -5.24 0.24 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.967 1.307 . . . . 0.0 114.396 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 59.1 m -78.4 165.18 51.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.308 1.043 . . . . 0.0 111.303 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.19 -55.18 2.76 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.479 2.786 . . . . 0.0 113.036 167.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -154.38 -61.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.04 1.736 . . . . 0.0 107.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -162.9 171.19 16.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.401 2.281 . . . . 0.0 110.639 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.5 -8.74 20.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 127.932 2.493 . . . . 0.0 117.477 -150.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.73 179.74 0.12 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.328 2.651 . . . . 0.0 108.808 -161.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.0 137.21 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 163.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -137.53 143.79 41.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.156 1.783 . . . . 0.0 109.822 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.06 145.23 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.267 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.81 -178.98 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.133 0.852 . . . . 0.0 115.193 161.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 72.84 13.65 5.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 115.418 -171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.09 28.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.358 1.863 . . . . 0.0 112.102 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.14 -18.42 27.52 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 117.28 1.672 . . . . 0.0 117.28 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -89.69 -9.1 50.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.595 1.158 . . . . 0.0 113.901 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -154.65 -21.46 0.12 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.34 109.54 0.7 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -149.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -138.17 164.11 29.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.235 1.414 . . . . 0.0 112.057 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -67.93 -37.0 81.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.9 m -66.48 -48.11 70.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.186 0.994 . . . . 0.0 112.556 -169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.24 -37.63 80.95 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.678 -0.639 . . . . 0.0 111.69 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.96 -37.17 29.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.495 1.118 . . . . 0.0 112.319 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -47.43 -39.17 14.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.845 1.258 . . . . 0.0 111.338 169.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -106.9 -26.98 10.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.335 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.3 93.7 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.688 0.677 . . . . 0.0 111.58 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -81.58 -35.24 30.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.819 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.06 -37.1 5.5 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.658 1.599 . . . . 0.0 114.863 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -59.45 -44.99 92.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.29 -23.68 40.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.525 0.73 . . . . 0.0 110.878 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.28 166.45 30.1 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.102 1.334 . . . . 0.0 113.869 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 153.16 56.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.34 2.693 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.64 122.12 46.07 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 109.176 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -74.75 -33.57 62.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.565 0.746 . . . . 0.0 111.454 166.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -142.67 157.5 44.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.303 0.502 . . . . 0.0 111.916 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.66 144.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.553 1.541 . . . . 0.0 110.825 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.11 151.24 17.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.919 1.688 . . . . 0.0 110.951 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.72 144.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 170.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.28 138.91 35.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.266 1.826 . . . . 0.0 112.181 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -25.28 47.5 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.767 -0.583 . . . . 0.0 112.5 163.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -140.18 115.29 7.74 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 126.267 1.827 . . . . 0.0 109.201 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.73 149.91 9.16 Favored 'Cis proline' 0 C--N 1.356 0.941 0 CA-C-N 121.616 1.613 . . . . 0.0 115.078 1.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.74 -19.31 3.45 Favored 'Trans proline' 0 C--N 1.352 0.719 1 C-N-CA 125.318 4.012 . . . . 0.0 118.853 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.78 63.6 0.12 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.392 0.996 . . . . 0.0 112.341 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.36 132.32 56.61 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.975 1.71 . . . . 0.0 109.385 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -128.57 163.87 24.06 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.592 1.557 . . . . 0.0 113.865 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -140.82 147.06 38.44 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.833 165.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.98 177.93 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 121.102 -0.999 . . . . 0.0 111.995 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.33 102.79 4.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.326 1.05 . . . . 0.0 110.701 172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -70.22 165.11 22.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 110.605 140.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.02 -36.95 11.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.583 -0.698 . . . . 0.0 112.796 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.04 131.47 83.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.113 0.965 . . . . 0.0 112.313 -172.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.79 -8.99 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.429 2.753 . . . . 0.0 115.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -112.62 -41.42 3.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.347 1.859 . . . . 0.0 110.851 -160.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 -29.96 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.534 0.606 . . . . 0.0 111.225 159.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.01 70.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.777 0.831 . . . . 0.0 112.399 168.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.04 -30.41 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.07 -1.019 . . . . 0.0 111.226 170.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.02 -35.46 69.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.524 1.057 . . . . 0.0 113.693 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.95 -27.71 69.32 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.181 -1.575 . . . . 0.0 112.824 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.43 -37.26 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 119.205 -2.184 . . . . 0.0 110.926 165.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -62.46 -34.36 76.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.725 -1.235 . . . . 0.0 112.998 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -128.82 -14.33 4.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -158.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -17.07 7.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.203 1.001 . . . . 0.0 113.604 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -82.91 159.86 22.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.092 1.314 . . . . 0.0 112.24 165.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.78 5.47 88.51 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.601 1.096 . . . . 0.0 115.175 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.98 -137.64 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.933 1.693 . . . . 0.0 112.134 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 m -141.41 123.8 15.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.721 2.409 . . . . 0.0 108.616 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.58 131.85 56.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.195 1.398 . . . . 0.0 108.88 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 9.0 t 59.44 -58.14 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.656 2.382 . . . . 0.0 115.906 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.45 35.58 0.08 OUTLIER Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.0 1.285 . . . . 0.0 114.362 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.5 p -129.66 -163.57 1.31 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.85 1.26 . . . . 0.0 113.941 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -130.98 63.82 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.34 1.856 . . . . 0.0 109.558 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.82 161.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 130.012 3.325 . . . . 0.0 117.657 -165.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.87 149.15 41.58 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.922 1.289 . . . . 0.0 110.21 140.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.48 145.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.678 1.191 . . . . 0.0 110.12 -167.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 134.99 20.34 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 109.62 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -146.12 128.42 15.82 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.915 1.688 . . . . 0.0 115.227 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.0 p -159.35 -111.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.568 128.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -152.88 4.67 0.35 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -171.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.89 -169.22 40.55 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.486 1.039 . . . . 0.0 115.623 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -154.48 -23.31 0.13 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 118.707 -2.643 . . . . 0.0 114.317 6.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -135.72 21.05 3.32 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -164.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 124.533 1.133 . . . . 0.0 112.789 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -141.51 175.83 9.36 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 131.658 3.983 . . . . 0.0 111.923 21.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -136.51 100.3 4.32 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.92 116.08 14.31 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -157.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.9 tp -101.62 95.02 6.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.683 1.193 . . . . 0.0 110.432 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -55.65 108.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 128.122 2.569 . . . . 0.0 109.37 159.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.9 mp -86.08 139.85 30.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 167.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -147.82 47.77 1.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.419 1.887 . . . . 0.0 108.496 172.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.68 -169.94 23.57 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 -162.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -43.71 -31.89 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.953 2.101 . . . . 0.0 114.308 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -126.26 -44.59 1.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.773 1.629 . . . . 0.0 112.589 -148.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -154.7 142.85 20.3 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.705 1.602 . . . . 0.0 108.22 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -136.91 127.18 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.709 1.604 . . . . 0.0 109.084 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.59 31.82 0.26 Allowed Glycine 0 N--CA 1.477 1.404 0 N-CA-C 117.896 1.918 . . . . 0.0 117.896 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER 56.59 -177.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -144.73 -27.53 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p 61.83 161.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -164.57 -175.06 3.68 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.32 2.248 . . . . 0.0 108.561 163.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -142.68 134.44 26.81 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.894 1.678 . . . . 0.0 108.416 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.7 6.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.133 0.968 . . . . 0.0 113.514 -161.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 t -47.57 -59.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.742 2.017 . . . . 0.0 111.052 167.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -172.96 177.94 2.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.005 2.122 . . . . 0.0 108.997 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.89 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.774 2.03 . . . . 0.0 113.735 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 -58.74 2.05 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -67.13 -29.98 69.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.169 1.788 . . . . 0.0 113.165 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.76 -46.61 29.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.829 -0.544 . . . . 0.0 110.468 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.33 -44.16 83.98 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -54.08 -28.76 41.2 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.67 -38.28 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.088 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -54.94 -42.38 72.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 -53.72 2.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.909 2.083 . . . . 0.0 110.54 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -82.32 -31.47 29.89 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.581 1.952 . . . . 0.0 114.737 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.42 -41.75 98.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.349 0.977 . . . . 0.0 111.212 168.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.75 56.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.278 -0.889 . . . . 0.0 109.855 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.35 -28.41 67.94 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.235 0.925 . . . . 0.0 112.501 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.9 -39.96 75.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 113.093 168.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -63.95 -34.26 77.57 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 121.707 -0.621 . . . . 0.0 111.957 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.59 17.92 5.45 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.128 1.823 . . . . 0.0 113.656 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -107.3 140.3 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.749 1.62 . . . . 0.0 111.956 -167.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.08 -9.2 3.01 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.623 1.169 . . . . 0.0 113.132 156.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.14 -99.03 0.01 OUTLIER Glycine 0 C--N 1.34 0.805 0 C-N-CA 129.699 3.523 . . . . 0.0 118.767 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.86 11.13 3.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.377 1.871 . . . . 0.0 110.298 -167.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -16.62 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.937 2.495 . . . . 0.0 115.502 -156.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -116.89 163.29 16.41 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.744 1.618 . . . . 0.0 110.944 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -145.63 157.69 43.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.964 2.106 . . . . 0.0 111.11 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -135.7 125.79 26.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.572 2.349 . . . . 0.0 110.479 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.24 -21.07 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.78 60.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.659 0.784 . . . . 0.0 112.23 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.1 p -136.71 -2.39 2.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.428 1.491 . . . . 0.0 113.033 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.355 34.6 mtpt 65.16 17.54 11.08 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.904 2.482 . . . . 0.0 113.787 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -66.96 159.44 28.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.994 2.918 . . . . 0.0 114.478 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -122.14 164.53 17.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 130.056 3.342 . . . . 0.0 112.779 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.4 m -150.14 143.89 25.34 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.64 -1.288 . . . . 0.0 112.527 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.51 128.65 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.216 1.006 . . . . 0.0 112.939 160.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -132.61 100.6 5.01 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.259 1.824 . . . . 0.0 110.748 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -105.44 -20.21 13.55 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.15 -161.46 12.93 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.82 1.191 . . . . 0.0 115.306 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.56 76.59 1.48 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.657 1.183 . . . . 0.0 112.195 -165.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -140.58 -39.38 0.43 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.353 3.061 . . . . 0.0 111.966 -0.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -145.2 165.67 27.69 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.275 1.43 . . . . 0.0 112.594 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -78.21 47.34 0.67 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.052 1.741 . . . . 0.0 114.984 -167.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -138.48 -53.81 0.61 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -59.01 -26.95 64.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -61.42 -15.54 37.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.5 ptp -135.45 21.69 3.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.654 1.582 . . . . 0.0 112.645 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 144.05 36.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.564 0.746 . . . . 0.0 111.946 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -159.55 -27.37 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.767 1.627 . . . . 0.0 113.104 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -0.05 -58.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 130.389 3.476 . . . . 0.0 118.08 157.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 m -146.78 155.11 42.12 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.531 1.132 . . . . 0.0 112.32 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.31 120.51 62.59 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.564 1.546 . . . . 0.0 113.353 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.12 -43.17 1.67 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.848 2.365 . . . . 0.0 111.984 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.02 -43.73 0.26 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.124 2.57 . . . . 0.0 106.569 156.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -174.68 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.744 1.218 . . . . 0.0 112.727 136.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 51.7 t -156.41 120.56 4.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.351 0.66 . . . . 0.0 112.113 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.05 -175.46 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.975 2.51 . . . . 0.0 113.757 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.0 142.02 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 120.651 -1.281 . . . . 0.0 108.455 161.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.29 133.7 24.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.706 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.69 148.58 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.419 0.688 . . . . 0.0 109.624 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.37 -166.9 20.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 60.99 14.65 5.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.917 1.687 . . . . 0.0 113.737 -157.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.66 46.37 1.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.01 1.724 . . . . 0.0 113.3 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.96 93.82 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.923 -1.11 . . . . 0.0 115.569 -166.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.82 -35.57 78.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -167.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -146.06 -28.31 0.42 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -163.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.68 111.89 1.06 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.599 0.618 . . . . 0.0 113.757 -155.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -129.05 -31.22 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 116.516 -1.707 . . . . 0.0 113.898 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.8 tttm 153.12 -60.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 129.374 3.07 . . . . 0.0 112.876 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.8 m -74.16 -26.14 60.13 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -161.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -26.65 65.77 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.873 -1.142 . . . . 0.0 113.682 167.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.8 mt -89.48 -34.55 16.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.966 1.306 . . . . 0.0 111.564 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -54.35 -35.39 62.7 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.747 -0.596 . . . . 0.0 112.321 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -88.06 -42.33 12.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.29 -30.24 64.55 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.037 1.29 . . . . 0.0 113.16 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -106.86 -22.91 12.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.968 0.907 . . . . 0.0 112.102 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.7 -35.11 7.36 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.039 1.78 . . . . 0.0 114.383 161.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -53.6 -42.58 67.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.641 1.176 . . . . 0.0 113.18 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -85.29 -24.52 27.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.878 0.871 . . . . 0.0 110.895 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 124.81 -74.13 0.41 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 153.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.5 43.98 1.6 Allowed 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.269 3.312 . . . . 0.0 114.831 -158.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.84 154.28 15.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.439 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -139.13 -20.9 0.96 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.047 1.739 . . . . 0.0 113.314 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -163.95 149.7 11.01 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.758 0.823 . . . . 0.0 110.812 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -151.1 121.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.091 1.756 . . . . 0.0 107.986 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -148.19 150.59 34.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.317 1.447 . . . . 0.0 110.304 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.51 157.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.718 -1.239 . . . . 0.0 113.582 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.82 170.18 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.487 1.915 . . . . 0.0 113.055 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -127.03 28.11 5.84 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.267 1.827 . . . . 0.0 110.509 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -156.17 72.42 5.1 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 126.077 1.751 . . . . 0.0 113.534 -162.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -68.25 153.24 88.48 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 120.613 1.255 . . . . 0.0 114.559 -0.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.33 71.49 5.8 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.554 3.502 . . . . 0.0 113.569 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.64 24.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.961 -1.466 . . . . 0.0 116.597 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.93 145.94 40.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.844 1.822 . . . . 0.0 114.048 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 161.9 35.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.451 3.1 . . . . 0.0 113.287 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.3 144.0 23.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.24 1.416 . . . . 0.0 110.731 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.36 174.51 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.137 -0.977 . . . . 0.0 110.93 -161.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.34 120.44 13.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.085 1.354 . . . . 0.0 109.588 167.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.73 159.78 20.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.338 1.055 . . . . 0.0 110.046 153.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.82 -22.61 31.71 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.427 -1.421 . . . . 0.0 114.276 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.92 136.7 29.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.733 0.813 . . . . 0.0 112.678 -162.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.4 -33.67 17.46 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.934 2.423 . . . . 0.0 114.827 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -41.1 44.43 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.728 1.604 . . . . 0.0 113.444 -166.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.17 -26.82 60.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.701 0.682 . . . . 0.0 112.36 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.22 -45.13 67.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.368 0.667 . . . . 0.0 111.809 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.24 81.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 120.685 -1.26 . . . . 0.0 110.322 172.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -39.82 78.42 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.96 -17.99 58.85 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.904 -1.122 . . . . 0.0 113.914 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 -53.08 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.548 -1.345 . . . . 0.0 110.004 160.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -61.06 -24.47 66.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.168 1.787 . . . . 0.0 113.97 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.86 -8.21 15.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.158 1.383 . . . . 0.0 112.091 -168.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -152.07 -30.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -154.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -63.99 132.95 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.913 0.779 . . . . 0.0 111.772 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.35 79.15 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.749 0.69 . . . . 0.0 114.323 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -111.56 -117.43 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.325 1.45 . . . . 0.0 110.114 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -154.33 148.88 26.3 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.495 1.498 . . . . 0.0 110.257 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.83 -48.4 0.46 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.6 m -134.52 35.97 3.17 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.212 1.405 . . . . 0.0 112.163 -167.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.22 24.76 67.81 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.335 -0.853 . . . . 0.0 113.165 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.8 p -134.41 144.47 48.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.878 2.071 . . . . 0.0 110.755 -172.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -75.49 67.75 2.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.406 1.082 . . . . 0.0 111.133 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 p -54.67 151.54 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.844 2.057 . . . . 0.0 113.943 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.3 132.61 35.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.275 1.83 . . . . 0.0 109.434 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -148.63 129.91 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 117.973 0.351 . . . . 0.0 111.209 -152.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -140.84 137.68 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 119.954 -1.716 . . . . 0.0 111.629 167.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.0 mp -140.03 124.75 18.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -152.35 -81.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.062 0.945 . . . . 0.0 112.945 140.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.3 p30 132.1 -176.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.293 3.037 . . . . 0.0 106.964 -135.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.84 -0.09 2.63 Favored Glycine 0 N--CA 1.474 1.225 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -21.39 23.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.42 1.11 . . . . 0.0 112.948 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 -173.74 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.391 2.276 . . . . 0.0 111.855 -165.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 125.059 1.344 . . . . 0.0 111.328 151.105 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -150.53 167.51 26.99 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.267 2.627 . . . . 0.0 111.138 -9.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.91 110.46 10.81 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.39 101.83 5.31 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.023 0.929 . . . . 0.0 111.488 -165.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.1 tp -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.922 0.889 . . . . 0.0 109.851 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.6 mt -59.53 113.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.576 2.35 . . . . 0.0 109.37 160.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.04 136.6 32.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.744 164.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -144.02 42.84 1.44 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.84 2.056 . . . . 0.0 107.403 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.49 173.99 33.08 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 120.743 -1.223 . . . . 0.0 113.865 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -58.69 -42.15 87.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.619 0.723 . . . . 0.0 112.029 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -69.49 -62.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.641 2.376 . . . . 0.0 112.48 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -141.55 140.09 33.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.928 0.891 . . . . 0.0 110.801 -166.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 103.95 7.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.228 2.211 . . . . 0.0 107.884 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.3 95.95 0.16 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.619 1.581 . . . . 0.0 112.49 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -28.58 160.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.751 2.82 . . . . 0.0 118.024 166.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -135.47 -25.03 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 11.3 p 57.07 162.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 t -164.14 -171.94 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.31 3.044 . . . . 0.0 108.222 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.35 136.28 27.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 109.282 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.43 177.45 10.59 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.136 0.97 . . . . 0.0 113.453 -164.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.18 -56.56 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.503 1.921 . . . . 0.0 111.214 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -174.36 -174.85 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.196 2.998 . . . . 0.0 107.464 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.92 24.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.932 2.093 . . . . 0.0 114.941 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.01 4.18 7.98 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.39 1.076 . . . . 0.0 112.117 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.6 m -126.4 -22.22 4.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.245 1.818 . . . . 0.0 111.389 168.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.3 11.43 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 121.362 -0.837 . . . . 0.0 111.315 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.4 -45.63 90.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -51.53 -22.34 3.12 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.51 -39.02 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.724 1.61 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -55.57 -39.38 70.59 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 169.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -57.23 3.14 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.999 2.12 . . . . 0.0 110.074 168.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.91 -35.22 64.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -61.48 -40.31 94.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.362 0.983 . . . . 0.0 111.132 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.06 -37.03 47.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.58 -0.7 . . . . 0.0 109.85 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -69.92 -25.92 63.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.756 0.707 . . . . 0.0 112.258 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.96 -36.57 69.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.103 1.361 . . . . 0.0 112.809 168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -63.91 -31.18 72.27 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.707 -0.62 . . . . 0.0 111.566 164.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.59 -3.18 15.43 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.811 2.148 . . . . 0.0 113.038 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.01 127.9 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.251 1.82 . . . . 0.0 111.358 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -143.76 82.65 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 124.184 1.945 . . . . 0.0 108.305 152.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.95 -136.43 9.11 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 110.328 -3.124 . . . . 0.0 112.777 -155.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.78 39.75 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 127.865 2.466 . . . . 0.0 110.785 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -37.8 98.2 0.01 OUTLIER 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.053 2.541 . . . . 0.0 112.902 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.6 m -116.61 157.93 24.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.25 1.82 . . . . 0.0 108.385 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -141.95 146.38 35.58 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.83 1.252 . . . . 0.0 109.952 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.42 54.36 1.96 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.855 1.262 . . . . 0.0 110.607 -156.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -41.56 -31.16 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.948 3.299 . . . . 0.0 117.253 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -20.93 59.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.268 1.827 . . . . 0.0 112.601 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -133.2 5.1 3.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.26 1.824 . . . . 0.0 112.894 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.293 46.6 mttm 49.8 13.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 129.404 3.081 . . . . 0.0 116.519 -168.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 m -47.51 158.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.974 2.51 . . . . 0.0 113.505 156.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.4 160.91 30.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 129.439 3.096 . . . . 0.0 111.383 168.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.5 m -145.62 124.32 12.57 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.291 -0.88 . . . . 0.0 110.896 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 100.67 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.857 0.837 . . . . 0.0 112.293 160.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.37 131.83 37.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.11 0.957 . . . . 0.0 110.123 157.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 20.1 tt0 -148.37 -42.95 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 112.449 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 -20.68 67.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.042 1.306 . . . . 0.0 113.12 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -131.69 44.7 2.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.462 166.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -43.08 147.74 0.32 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.379 1.472 . . . . 0.0 112.663 168.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -121.88 -21.87 5.92 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.382 1.073 . . . . 0.0 112.431 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -69.21 117.57 11.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.609 1.164 . . . . 0.0 109.522 160.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -65.2 145.68 55.94 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.371 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -151.31 169.78 21.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 111.053 -165.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -140.59 15.42 2.35 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -129.38 -24.43 2.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -159.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -130.26 35.56 4.07 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.896 1.278 . . . . 0.0 112.198 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.41 -47.89 0.64 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -171.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.67 173.12 15.92 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.349 0.977 . . . . 0.0 113.414 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.1 p -117.73 -36.29 3.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.416 1.886 . . . . 0.0 112.453 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 p -131.41 154.32 81.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 129.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 -43.77 5.12 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.319 1.346 . . . . 0.0 110.536 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.98 -36.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.81 2.444 . . . . 0.0 108.64 155.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -139.33 -79.5 0.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.015 1.326 . . . . 0.0 110.57 164.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 30.4 p -163.34 -12.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.995 1.718 . . . . 0.0 115.528 159.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.9 -169.81 2.51 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 120.838 1.654 . . . . 0.0 111.082 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.5 135.28 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 121.274 1.852 . . . . 0.0 111.953 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.21 118.1 9.97 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.504 1.922 . . . . 0.0 108.589 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.81 143.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.26 -170.11 41.37 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 23.5 t30 119.94 -13.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 131.646 3.978 . . . . 0.0 110.995 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.2 -27.43 63.89 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -165.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.68 -27.02 0.28 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.782 2.135 . . . . 0.0 117.662 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.46 -13.61 12.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.858 1.663 . . . . 0.0 112.793 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -169.77 -177.79 2.78 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.231 2.612 . . . . 0.0 109.059 -163.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.91 15.79 0.25 Allowed Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.978 -0.901 . . . . 0.0 114.819 164.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -49.38 163.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.36 3.064 . . . . 0.0 113.987 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -59.31 -35.88 74.62 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.403 -0.811 . . . . 0.0 112.662 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.7 m -92.15 -32.56 15.07 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.587 1.085 . . . . 0.0 113.87 -168.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.48 -31.73 69.61 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.432 -1.418 . . . . 0.0 111.728 165.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.85 -28.01 20.67 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.123 1.156 . . . . 0.0 114.123 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.56 -33.19 71.11 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.607 1.548 . . . . 0.0 109.154 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -82.3 -47.23 12.64 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.487 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.42 -28.46 65.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.161 0.891 . . . . 0.0 112.874 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.57 -37.58 8.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.743 0.817 . . . . 0.0 112.672 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.82 -36.91 3.81 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.263 1.887 . . . . 0.0 114.978 167.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -55.03 -45.65 75.19 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -75.06 -35.65 61.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.141 0.577 . . . . 0.0 110.401 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.56 178.45 40.75 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.507 1.051 . . . . 0.0 115.473 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.4 155.73 63.21 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.053 3.169 . . . . 0.0 114.822 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.56 148.26 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.746 2.418 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -103.55 -37.82 7.4 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.648 1.979 . . . . 0.0 112.759 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -161.38 157.81 25.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 p -167.6 131.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.46 1.104 . . . . 0.0 112.155 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -155.48 159.32 39.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.288 1.835 . . . . 0.0 111.317 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.91 157.67 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.223 -1.548 . . . . 0.0 113.431 -171.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.93 -44.9 74.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.513 1.525 . . . . 0.0 113.665 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? 61.45 -37.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 129.55 3.14 . . . . 0.0 115.908 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.44 83.71 30.63 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 127.721 2.408 . . . . 0.0 110.571 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.04 160.98 91.68 Favored 'Cis proline' 0 CA--C 1.544 0.983 0 CA-C-N 119.57 0.882 . . . . 0.0 113.458 6.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.63 172.28 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.353 2.702 . . . . 0.0 113.1 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.37 -18.82 9.38 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.363 -1.243 . . . . 0.0 115.201 163.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.72 132.62 21.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.671 1.236 . . . . 0.0 112.773 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.88 163.05 28.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.854 2.462 . . . . 0.0 113.379 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -135.61 138.71 43.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.01 1.724 . . . . 0.0 109.23 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.283 2.0 m -146.9 -177.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.234 -0.916 . . . . 0.0 112.404 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.09 117.31 10.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.733 2.013 . . . . 0.0 107.196 162.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.06 -174.87 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.002 1.321 . . . . 0.0 114.067 165.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -124.12 -8.54 7.67 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -149.58 123.37 4.56 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 120.562 1.528 . . . . 0.0 113.01 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.64 -24.32 48.19 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.271 2.648 . . . . 0.0 114.934 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -63.06 -55.08 28.55 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.765 1.166 . . . . 0.0 110.451 172.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.73 -34.06 76.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.014 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.09 92.26 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.32 80.59 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.549 -1.344 . . . . 0.0 110.27 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.94 -42.52 48.45 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -14.28 41.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.83 1.252 . . . . 0.0 114.084 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.17 -60.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.396 0.998 . . . . 0.0 109.705 155.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -19.92 62.29 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -160.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -98.34 1.64 47.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.276 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.05 -31.13 0.5 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -159.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.48 104.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.317 1.447 . . . . 0.0 110.671 156.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.12 24.15 25.44 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.42 -1.211 . . . . 0.0 114.76 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -116.59 164.18 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.583 1.691 . . . . 0.0 112.985 -168.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -95.4 128.35 42.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.513 1.525 . . . . 0.0 110.844 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.1 -12.79 11.89 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.153 1.381 . . . . 0.0 114.344 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.32 -65.31 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.985 0.914 . . . . 0.0 111.811 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -165.69 32.8 0.23 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.756 2.122 . . . . 0.0 111.059 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 3.7 m -142.77 -158.9 0.91 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.198 2.199 . . . . 0.0 109.192 -158.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -149.26 153.43 37.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.128 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.413 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -137.81 160.66 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -165.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.61 142.64 41.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.492 2.717 . . . . 0.0 109.55 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.37 125.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.565 -0.71 . . . . 0.0 110.907 -152.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.42 120.44 33.96 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.965 2.106 . . . . 0.0 106.96 168.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.5 tt -153.85 112.25 3.62 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.933 1.242 . . . . 0.0 113.445 -161.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 p -153.34 -161.72 1.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.418 1.887 . . . . 0.0 114.733 171.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.58 93.42 1.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.651 1.58 . . . . 0.0 112.554 -164.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.53 -145.03 9.74 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 123.596 1.664 . . . . 0.0 116.948 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.4 -179.49 6.69 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 129.409 3.083 . . . . 0.0 107.827 173.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -131.13 85.77 2.3 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.06 -1.025 . . . . 0.0 113.107 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.467 1.507 . . . . 0.0 111.304 151.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -135.29 166.94 21.97 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.833 2.853 . . . . 0.0 110.943 1.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.15 106.6 9.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.49 99.82 4.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.177 0.991 . . . . 0.0 111.496 -163.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.09 95.64 10.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.335 1.054 . . . . 0.0 108.952 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.38 117.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.625 1.57 . . . . 0.0 108.912 160.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.22 129.63 39.19 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.655 174.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -143.18 109.51 5.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.84 177.47 27.05 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 121.803 0.669 . . . . 0.0 114.617 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.952 1.301 . . . . 0.0 110.655 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.3 m -63.12 -55.87 21.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.634 2.373 . . . . 0.0 113.216 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -165.08 144.21 6.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.792 1.637 . . . . 0.0 109.687 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -131.73 150.24 52.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.885 1.274 . . . . 0.0 112.459 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.14 -134.64 4.51 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.957 1.742 . . . . 0.0 111.294 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -161.25 -166.6 1.58 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.22 2.608 . . . . 0.0 107.801 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -145.9 -39.68 0.23 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 161.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p 57.62 163.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -165.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -159.96 -169.36 2.5 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.592 2.357 . . . . 0.0 106.754 153.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -137.92 132.02 31.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.289 -1.507 . . . . 0.0 108.146 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.84 -178.72 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.147 0.979 . . . . 0.0 112.417 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -44.41 -57.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.677 1.991 . . . . 0.0 110.809 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -178.97 -164.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 129.521 3.128 . . . . 0.0 108.751 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 20.47 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.178 2.191 . . . . 0.0 115.189 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.24 5.13 5.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.442 1.097 . . . . 0.0 112.233 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -125.63 -14.62 6.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 111.713 161.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.46 7.34 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.453 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.25 -47.88 65.51 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -56.37 -19.43 14.69 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.6 -168.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.67 -34.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.712 1.605 . . . . 0.0 110.296 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -54.08 -44.67 71.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.701 1.2 . . . . 0.0 112.071 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -43.48 -56.49 3.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.326 1.85 . . . . 0.0 111.564 168.135 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -75.23 -31.51 60.87 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.034 0.834 . . . . 0.0 111.134 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -35.07 57.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.346 -0.846 . . . . 0.0 110.013 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -66.73 -31.09 71.52 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.003 0.819 . . . . 0.0 112.173 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.59 -38.31 80.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.016 1.326 . . . . 0.0 113.168 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.99 -33.15 74.94 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 121.682 -0.636 . . . . 0.0 112.525 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.28 27.12 2.28 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.894 1.711 . . . . 0.0 114.021 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.359 1.463 . . . . 0.0 111.88 -165.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.78 3.89 6.05 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 121.818 0.818 . . . . 0.0 112.243 152.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.71 -112.12 0.98 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.181 2.324 . . . . 0.0 118.396 150.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -147.33 37.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.972 2.509 . . . . 0.0 107.223 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.513 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 18.4 m95 -40.67 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.497 1.519 . . . . 0.0 114.152 -160.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 m -125.08 160.2 29.63 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.918 1.687 . . . . 0.0 110.012 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -148.15 154.03 39.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.598 1.559 . . . . 0.0 111.151 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -129.88 139.6 51.13 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 126.361 1.864 . . . . 0.0 109.18 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -108.38 -16.83 14.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.31 -26.42 61.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 111.856 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.3 p -122.28 -6.9 8.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.429 1.891 . . . . 0.0 112.953 167.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.421 45.1 mttm 66.13 12.63 8.64 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 126.992 2.117 . . . . 0.0 115.376 -173.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -59.67 155.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 127.229 2.211 . . . . 0.0 114.361 170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -123.91 166.33 15.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.925 2.49 . . . . 0.0 112.318 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -150.01 137.57 19.91 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.769 -1.207 . . . . 0.0 110.793 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.63 153.94 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.512 155.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.14 88.42 1.45 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.313 1.845 . . . . 0.0 113.957 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -93.85 -1.08 55.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 113.913 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.0 168.16 34.99 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.519 -1.363 . . . . 0.0 113.365 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 p -46.13 115.74 1.07 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.602 1.961 . . . . 0.0 115.868 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.405 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 97.3 m-70 100.33 133.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 131.21 3.804 . . . . 0.0 113.087 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -90.17 -11.98 39.51 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -133.5 -2.76 3.03 Favored 'General case' 0 N--CA 1.474 0.727 3 C-N-CA 134.154 4.981 . . . . 0.0 113.44 2.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -66.03 -19.0 65.71 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.405 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 5.9 p80 -58.74 -13.42 5.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.357 1.463 . . . . 0.0 114.911 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -62.18 -12.32 19.31 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.696 1.598 . . . . 0.0 113.851 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 87.6 mtp -53.02 145.25 13.37 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.642 -1.286 . . . . 0.0 113.557 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -157.28 173.45 16.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.666 2.386 . . . . 0.0 109.622 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 -173.6 4.1 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -72.26 24.83 0.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.141 2.177 . . . . 0.0 115.696 -163.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 t -152.72 152.51 31.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.5 1.92 . . . . 0.0 110.531 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -64.64 138.25 97.4 Favored Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.559 -0.713 . . . . 0.0 110.404 161.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.39 -38.6 25.54 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.272 1.981 . . . . 0.0 112.888 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.34 -45.77 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.94 2.496 . . . . 0.0 108.156 170.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -146.21 -130.71 0.07 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.403 2.281 . . . . 0.0 108.286 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.4 m -135.49 -11.9 2.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.041 1.336 . . . . 0.0 114.238 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -149.95 -157.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.886 2.475 . . . . 0.0 108.892 -167.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -118.9 141.93 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.818 -1.176 . . . . 0.0 109.716 150.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -141.81 128.25 20.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.07 1.348 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.7 t -133.38 122.58 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.06 -171.09 12.2 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.998 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.42 41.33 24.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.416 0.686 . . . . 0.0 112.27 -158.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.34 -30.76 42.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.899 0.88 . . . . 0.0 111.75 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.14 -51.65 0.56 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 127.927 2.68 . . . . 0.0 117.404 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -124.1 -56.62 1.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.382 1.091 . . . . 0.0 113.795 -152.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.62 -27.84 28.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -165.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -7.03 82.83 0.0 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 128.943 3.163 . . . . 0.0 117.039 -165.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -118.21 -66.62 1.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 147.36 -46.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 131.386 3.874 . . . . 0.0 111.93 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -74.73 -27.16 60.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.57 0.623 . . . . 0.0 112.166 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.97 -38.4 50.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.742 0.817 . . . . 0.0 112.759 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.6 -34.97 18.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.665 1.586 . . . . 0.0 111.585 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -56.34 -35.5 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.544 0.738 . . . . 0.0 110.496 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -83.91 -53.46 5.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.801 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.03 47.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -115.88 -26.48 7.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.344 1.058 . . . . 0.0 112.424 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.04 -33.3 21.42 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.533 1.063 . . . . 0.0 114.145 165.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -55.23 -43.77 74.86 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.03 -34.18 44.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.511 0.324 . . . . 0.0 111.024 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.25 -171.04 44.0 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -168.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.13 126.06 8.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.217 3.278 . . . . 0.0 113.322 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -99.83 144.0 29.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 109.416 167.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.92 -5.23 1.15 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.764 1.626 . . . . 0.0 113.272 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -156.78 160.55 39.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.741 1.216 . . . . 0.0 110.638 154.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.4 t -159.91 136.19 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.774 2.03 . . . . 0.0 110.145 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -157.03 160.18 38.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.95 1.7 . . . . 0.0 111.444 161.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.13 148.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 120.705 -1.247 . . . . 0.0 112.823 171.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.11 169.35 2.08 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.293 1.837 . . . . 0.0 114.153 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -145.63 31.44 1.07 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.801 2.04 . . . . 0.0 110.366 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -150.02 44.71 0.33 Allowed Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 127.139 2.175 . . . . 0.0 114.921 -161.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -78.83 171.0 67.75 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 CA-C-N 121.979 1.742 . . . . 0.0 114.451 0.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.63 21.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 1 C-N-CA 126.245 4.63 . . . . 0.0 117.011 170.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.86 -3.52 59.25 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.288 1.275 . . . . 0.0 116.288 -165.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.8 139.32 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.79 1.295 . . . . 0.0 111.964 -168.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -133.98 154.58 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 129.077 2.951 . . . . 0.0 112.082 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.56 138.8 36.56 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.813 1.245 . . . . 0.0 109.462 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.278 2.0 m -141.6 -179.65 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.247 -0.908 . . . . 0.0 110.834 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -141.45 102.74 4.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.506 1.522 . . . . 0.0 108.314 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -64.61 175.92 1.28 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.447 0.699 . . . . 0.0 111.698 159.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -124.96 9.89 8.18 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.555 -1.34 . . . . 0.0 112.741 166.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.66 126.61 11.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.363 . . . . 0.0 110.991 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.08 -22.15 6.2 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.748 2.299 . . . . 0.0 113.914 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -70.82 -51.78 24.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.781 1.173 . . . . 0.0 110.358 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.85 -37.23 81.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.53 1.132 . . . . 0.0 110.589 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.64 67.19 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.133 1.373 . . . . 0.0 112.49 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.7 -30.88 67.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.724 -1.235 . . . . 0.0 111.033 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.88 -40.2 65.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.97 1.259 . . . . 0.0 113.483 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -17.34 36.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 0.0 113.898 166.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.33 -55.79 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.405 1.457 . . . . 0.0 110.131 159.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -54.96 -29.4 56.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.895 2.078 . . . . 0.0 114.068 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.36 -11.99 16.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.85 1.26 . . . . 0.0 112.075 -169.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.17 -20.54 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -154.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.18 136.82 48.28 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.756 0.822 . . . . 0.0 112.687 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.18 43.39 21.23 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.074 0.845 . . . . 0.0 112.622 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.12 -154.96 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.368 1.467 . . . . 0.0 111.671 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.2 m -129.46 -42.45 1.32 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.786 1.234 . . . . 0.0 110.744 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 tp 41.55 -99.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.771 2.828 . . . . 0.0 114.217 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.5 m -77.86 41.2 0.34 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.545 2.338 . . . . 0.0 113.475 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.87 75.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.745 1.164 . . . . 0.0 114.386 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.41 -119.22 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 111.489 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.72 32.27 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.597 0.713 . . . . 0.0 112.652 -153.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.13 140.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.232 2.213 . . . . 0.0 115.864 -156.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -134.32 113.76 12.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 129.385 3.074 . . . . 0.0 107.584 -170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.18 132.51 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.919 0.488 . . . . 0.0 112.077 -150.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.48 132.7 29.81 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.958 1.703 . . . . 0.0 109.938 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 mp -144.11 137.94 27.87 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.958 -1.089 . . . . 0.0 112.348 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 p -172.18 -32.31 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 162.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.96 56.25 6.16 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.56 1.944 . . . . 0.0 115.45 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.48 62.93 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.87 123.43 11.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.691 1.746 . . . . 0.0 110.313 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -112.31 1.54 16.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 119.372 3.101 . . . . 0.0 119.372 -128.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 120.365 1.438 . . . . 0.0 113.748 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -147.07 165.65 29.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.873 2.869 . . . . 0.0 110.064 -8.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -130.55 95.67 3.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.06 102.27 7.16 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.159 -154.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.4 tp -88.71 93.58 9.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.16 1.384 . . . . 0.0 109.053 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 mt -58.22 118.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.65 1.98 . . . . 0.0 108.757 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.92 139.36 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.76 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -145.89 51.33 1.17 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.223 0.609 . . . . 0.0 109.879 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.56 -168.0 18.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 -165.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -41.11 -28.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.416 3.086 . . . . 0.0 116.014 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -134.44 -40.47 0.8 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.253 1.421 . . . . 0.0 111.871 -144.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.54 137.77 15.7 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.244 1.818 . . . . 0.0 107.82 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HE3' ' NE2' ' A' ' 59' ' ' HIS . 25.4 mttt -127.93 124.43 37.32 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.907 1.283 . . . . 0.0 109.464 171.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.44 -134.89 4.47 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.287 1.423 . . . . 0.0 109.929 -152.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -164.05 -174.06 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.166 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -142.82 -29.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p 57.98 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -166.03 -179.38 5.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.84 2.856 . . . . 0.0 107.76 166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -140.02 134.89 32.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.751 1.621 . . . . 0.0 108.403 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.28 -178.74 6.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.935 0.894 . . . . 0.0 112.131 -163.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -43.32 -57.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.564 1.945 . . . . 0.0 110.741 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -171.22 -163.39 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.93 2.892 . . . . 0.0 107.681 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.37 24.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.231 1.812 . . . . 0.0 114.249 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.0 -59.03 1.81 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.1 m -65.03 -21.97 66.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.13 -49.05 10.6 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 119.071 0.85 . . . . 0.0 111.67 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -62.51 -44.99 95.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.92 -20.38 51.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.94 -42.1 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.423 1.889 . . . . 0.0 111.282 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -54.9 -36.46 65.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.3 mmpt? -48.49 -50.09 33.08 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.494 1.918 . . . . 0.0 110.186 171.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -74.92 -37.71 61.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.839 1.655 . . . . 0.0 114.721 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -58.56 -39.4 80.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.463 1.029 . . . . 0.0 111.366 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.13 -32.22 26.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.449 -0.782 . . . . 0.0 110.858 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.03 -31.44 72.67 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.21 -41.9 80.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 113.084 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.27 -35.29 80.02 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.775 -0.578 . . . . 0.0 112.488 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.74 29.8 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.619 1.58 . . . . 0.0 113.798 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.99 127.17 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.938 1.295 . . . . 0.0 111.99 -165.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -122.75 -3.56 8.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.583 152.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 18.6 -78.68 0.0 OUTLIER Glycine 0 CA--C 1.528 0.892 1 C-N-CA 131.31 4.291 . . . . 0.0 119.256 170.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -134.61 2.33 3.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.391 1.877 . . . . 0.0 111.615 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 m95 -19.29 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.911 2.084 . . . . 0.0 115.518 -149.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 t -129.91 170.44 13.92 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.074 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -157.38 157.65 34.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.274 1.829 . . . . 0.0 111.679 -166.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -110.91 -48.98 3.07 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -164.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 58.44 -38.12 0.06 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 129.046 2.938 . . . . 0.0 117.624 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.02 61.96 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.969 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 p -122.26 -5.54 8.86 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.081 1.753 . . . . 0.0 113.091 165.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 48.5 mttm 60.2 6.31 0.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.46 2.304 . . . . 0.0 116.52 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.8 m -46.85 146.36 1.66 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.632 1.973 . . . . 0.0 114.054 156.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.52 163.07 15.89 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.632 2.773 . . . . 0.0 111.516 164.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -148.95 144.33 26.74 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.311 -1.493 . . . . 0.0 111.599 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.93 128.3 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.963 161.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -132.1 107.5 8.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.33 -138.66 0.31 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.832 2.053 . . . . 0.0 109.802 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.31 36.8 0.05 OUTLIER Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.231 -1.543 . . . . 0.0 115.702 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -75.27 61.72 1.21 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.423 1.612 . . . . 0.0 112.592 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.443 ' NE2' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -140.31 144.23 36.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.113 2.165 . . . . 0.0 110.298 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -135.93 51.07 2.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.256 1.022 . . . . 0.0 111.578 -165.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.03 21.23 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.524 2.329 . . . . 0.0 116.652 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.65 69.81 1.31 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.951 -1.718 . . . . 0.0 111.733 166.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -135.69 48.78 2.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.532 1.933 . . . . 0.0 110.866 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 57.09 -161.92 0.2 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.729 1.612 . . . . 0.0 113.418 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 ttp -77.82 57.04 1.62 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.739 1.616 . . . . 0.0 112.793 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -71.12 48.26 0.12 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.69 1.996 . . . . 0.0 113.737 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -125.89 155.99 40.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.143 1.377 . . . . 0.0 114.355 -159.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -58.71 -17.79 25.7 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.765 2.826 . . . . 0.0 115.35 167.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.2 p -150.45 166.63 29.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.938 1.295 . . . . 0.0 112.865 -170.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.9 p -148.34 157.85 41.7 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.697 1.599 . . . . 0.0 111.888 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.58 -43.12 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.539 2.826 . . . . 0.0 113.254 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -173.4 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.79 2.836 . . . . 0.0 107.469 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -137.24 -124.63 0.14 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.438 2.295 . . . . 0.0 108.007 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.9 t -162.27 -23.49 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.042 2.137 . . . . 0.0 113.072 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.88 -168.46 2.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 129.959 3.304 . . . . 0.0 108.638 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.45 139.78 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 121.129 -0.982 . . . . 0.0 111.38 152.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -144.56 133.25 22.28 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.981 1.312 . . . . 0.0 109.556 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 m -140.2 161.59 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.646 0.736 . . . . 0.0 112.469 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.55 -166.1 27.04 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 80.84 -1.28 1.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.155 2.582 . . . . 0.0 114.312 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.463 ' CD1' ' H ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -71.27 -172.59 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.778 1.231 . . . . 0.0 111.363 175.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.463 ' H ' ' CD1' ' A' ' 81' ' ' LEU . . . 168.47 -24.18 0.11 Allowed Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.546 1.07 . . . . 0.0 113.938 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.96 -30.65 71.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.464 1.506 . . . . 0.0 114.303 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -150.64 -18.03 0.23 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -172.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.61 115.28 6.92 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 120.131 1.332 . . . . 0.0 113.508 -150.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -131.2 -19.44 2.81 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 140.0 -52.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 131.164 3.786 . . . . 0.0 111.239 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -91.53 -23.45 19.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -158.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.75 -35.53 70.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.868 -1.77 . . . . 0.0 111.472 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.7 mt -89.73 -29.33 18.79 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.978 2.511 . . . . 0.0 111.157 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.85 -33.01 69.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.24 1.382 . . . . 0.0 110.605 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -84.04 -48.59 9.76 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.714 0.805 . . . . 0.0 112.432 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.28 67.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -96.9 -27.84 14.49 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -56.67 -35.16 66.14 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.577 1.56 . . . . 0.0 113.989 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -57.36 -31.54 65.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -96.97 17.84 16.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.194 0.997 . . . . 0.0 112.14 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 -160.99 14.12 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.865 -1.147 . . . . 0.0 115.603 163.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -49.79 117.41 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 125.409 4.072 . . . . 0.0 114.471 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -110.14 149.97 29.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.864 1.666 . . . . 0.0 109.514 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -124.7 -25.97 3.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.713 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -163.56 152.61 14.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.076 0.95 . . . . 0.0 109.621 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -151.46 127.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.85 1.66 . . . . 0.0 108.316 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -138.64 168.71 19.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.754 1.222 . . . . 0.0 111.512 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 t -150.09 142.51 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.581 1.153 . . . . 0.0 111.093 -164.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.89 165.84 24.14 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.171 1.788 . . . . 0.0 113.391 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -126.38 16.56 7.69 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.496 1.518 . . . . 0.0 111.935 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -155.95 43.59 0.2 Allowed Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.535 1.534 . . . . 0.0 114.446 -152.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -86.95 174.4 30.38 Favored 'Cis proline' 0 CA--C 1.547 1.149 0 CA-C-N 121.725 1.652 . . . . 0.0 113.757 10.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.09 47.62 0.37 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 125.239 3.959 . . . . 0.0 112.436 165.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.25 4.59 5.26 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.028 1.775 . . . . 0.0 115.368 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -138.99 143.13 38.38 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.665 1.586 . . . . 0.0 109.451 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.7 153.1 47.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -141.32 120.94 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.924 0.89 . . . . 0.0 109.655 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.33 -177.39 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -161.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -145.47 110.2 5.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.562 1.945 . . . . 0.0 109.635 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -71.31 -175.71 1.31 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.121 0.968 . . . . 0.0 110.056 151.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -150.33 70.04 1.02 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.707 -1.246 . . . . 0.0 111.675 150.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.75 138.39 10.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.517 1.527 . . . . 0.0 110.393 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -73.5 -38.2 2.68 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.381 2.054 . . . . 0.0 115.435 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -60.38 1.67 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.64 1.109 . . . . 0.0 113.49 -154.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.4 -21.28 66.22 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.398 -0.814 . . . . 0.0 111.488 173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.64 -37.66 41.53 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.06 74.5 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 120.304 -1.498 . . . . 0.0 109.369 163.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.03 -36.75 84.09 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 3.5 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 168.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.47 -41.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 120.413 1.46 . . . . 0.0 113.112 144.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -62.83 -23.74 67.43 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.985 1.266 . . . . 0.0 113.213 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.74 -10.52 14.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.298 1.839 . . . . 0.0 110.883 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.58 -28.71 0.64 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -154.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.31 136.96 54.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.966 0.888 . . . . 0.0 111.728 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.12 13.15 52.51 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.377 0.989 . . . . 0.0 114.775 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 134' ' ' THR . 5.8 ttt180 -85.42 -159.5 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.451 1.5 . . . . 0.0 111.259 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.402 ' H ' ' HG2' ' A' ' 133' ' ' ARG . 55.3 m -147.64 134.6 20.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.418 2.287 . . . . 0.0 106.218 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.0 tp -133.44 -36.32 0.98 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -156.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 36.2 m -138.63 8.05 2.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.829 1.251 . . . . 0.0 114.191 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.31 26.69 3.37 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.79 -82.06 0.3 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.926 1.363 . . . . 0.0 110.401 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 175.13 165.05 0.28 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.019 3.327 . . . . 0.0 107.467 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.86 155.27 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.873 0.761 . . . . 0.0 111.574 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.5 127.14 17.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.783 2.433 . . . . 0.0 108.063 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.9 t -141.37 134.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.532 0.605 . . . . 0.0 111.389 -152.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -132.93 99.2 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.061 1.744 . . . . 0.0 108.804 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 tt -147.41 120.56 8.88 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.107 -0.996 . . . . 0.0 112.63 -153.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.7 m -165.87 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 144.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.3 t30 62.04 145.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.271 1.828 . . . . 0.0 114.592 -166.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.7 20.46 0.06 OUTLIER Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -9.03 26.12 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.585 2.193 . . . . 0.0 116.27 -166.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.306 0.0 OUTLIER 44.04 19.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 128.726 2.811 . . . . 0.0 117.516 -176.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? . . . . . 0 C--O 1.25 1.119 0 C-N-CA 129.962 3.305 . . . . 0.0 114.078 -164.262 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -160.46 155.56 24.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.775 1.23 . . . . 0.0 110.22 164.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -143.41 107.25 4.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.2 ttpt -117.9 132.69 56.39 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 112.623 -171.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.85 102.56 14.33 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.608 1.163 . . . . 0.0 109.283 165.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 mt -64.95 119.33 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 128.461 2.705 . . . . 0.0 109.854 158.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.0 128.92 42.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.766 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -140.37 48.51 1.75 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.565 1.946 . . . . 0.0 109.469 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.75 160.69 13.16 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 122.807 1.226 . . . . 0.0 114.565 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -53.78 -39.3 65.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.687 2.395 . . . . 0.0 112.781 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -59.65 -55.35 35.58 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.759 2.824 . . . . 0.0 112.862 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.0 139.74 8.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.054 1.342 . . . . 0.0 110.789 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.72 111.02 16.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.89 2.076 . . . . 0.0 109.001 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.29 0.05 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.117 0.865 . . . . 0.0 113.253 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.34 157.84 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.05 2.14 . . . . 0.0 115.914 161.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -135.39 -22.09 1.53 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.4 p 62.49 161.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -170.55 -170.68 0.95 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.722 2.809 . . . . 0.0 109.116 168.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -143.57 141.22 30.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.658 2.383 . . . . 0.0 108.387 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.36 172.8 13.83 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -163.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.49 -44.14 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.042 2.137 . . . . 0.0 112.077 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -140.13 -64.17 0.48 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -152.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 130.2 2.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 131.309 3.844 . . . . 0.0 112.637 -160.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.41 -44.3 1.12 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.05 0.94 . . . . 0.0 110.119 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.2 m -63.5 -20.48 65.64 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.611 1.565 . . . . 0.0 113.887 164.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.49 10.65 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 118.804 0.729 . . . . 0.0 110.938 167.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.99 -45.77 93.45 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -64.06 -13.88 50.48 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.66 -40.43 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.197 2.199 . . . . 0.0 110.563 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -57.87 -39.99 79.16 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 13.9 mmtp -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.331 2.252 . . . . 0.0 111.014 166.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -75.95 -31.44 59.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -60.43 -43.28 96.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.687 1.13 . . . . 0.0 111.022 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.62 -34.97 58.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.513 -0.742 . . . . 0.0 109.962 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.06 -30.45 69.66 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.353 0.524 . . . . 0.0 112.101 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.92 -36.76 70.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.214 1.405 . . . . 0.0 113.402 170.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -64.62 -49.26 71.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.632 -0.667 . . . . 0.0 111.683 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.97 31.92 0.57 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.795 1.664 . . . . 0.0 114.181 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.67 146.36 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.4 1.88 . . . . 0.0 111.015 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -138.72 -6.79 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.204 1.002 . . . . 0.0 113.47 154.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.84 -129.06 6.47 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 126.155 1.836 . . . . 0.0 116.228 160.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.51 34.9 4.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.288 2.235 . . . . 0.0 108.428 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 13.9 m95 -19.66 97.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.762 2.825 . . . . 0.0 114.953 -169.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -118.11 162.4 18.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.454 1.501 . . . . 0.0 110.898 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -146.38 151.2 37.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.732 2.013 . . . . 0.0 111.114 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -107.07 -40.05 5.55 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -164.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 60.5 -33.43 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 119.185 3.031 . . . . 0.0 119.185 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.57 61.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.796 1.638 . . . . 0.0 112.266 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -135.24 13.17 3.55 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.49 1.916 . . . . 0.0 111.849 162.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.264 36.8 mttm 54.9 11.43 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 127.836 2.455 . . . . 0.0 116.581 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -44.57 156.14 0.09 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.574 1.949 . . . . 0.0 114.363 150.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.2 160.18 34.6 Favored 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.69 4.796 . . . . 0.0 110.107 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -147.82 134.69 20.14 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 112.073 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 m -108.94 96.58 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 122.215 1.007 . . . . 0.0 112.483 156.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -79.98 114.22 18.72 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.516 0.726 . . . . 0.0 109.855 160.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -126.78 57.83 1.43 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.397 1.479 . . . . 0.0 110.82 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.32 -167.94 14.24 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 129.449 3.404 . . . . 0.0 112.07 15.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -60.07 -27.94 67.4 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.389 -1.065 . . . . 0.0 111.997 161.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -63.65 -7.44 7.38 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.386 1.875 . . . . 0.0 113.912 169.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -127.9 10.98 6.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.267 1.427 . . . . 0.0 112.36 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 45.2 42.92 7.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.002 2.121 . . . . 0.0 113.9 -170.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -65.16 10.15 0.09 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 126.902 2.081 . . . . 0.0 114.48 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -161.45 170.72 19.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.662 3.185 . . . . 0.0 109.254 -170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.01 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 119.527 3.158 . . . . 0.0 119.527 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.7 tpp -162.18 171.19 17.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.315 1.87 . . . . 0.0 111.519 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -120.95 158.32 27.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.419 1.487 . . . . 0.0 112.626 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.5 0.86 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.605 2.362 . . . . 0.0 111.168 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -152.99 -58.14 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.489 1.516 . . . . 0.0 113.092 -165.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 m -165.79 -172.39 2.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.347 2.659 . . . . 0.0 108.916 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.3 p -53.03 138.78 45.21 Favored Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 121.1 -1.0 . . . . 0.0 112.218 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.92 -47.51 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.85 2.367 . . . . 0.0 113.633 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -160.05 -46.0 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.76 1.624 . . . . 0.0 110.264 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -148.84 -30.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.7 m 109.49 -11.07 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 131.668 3.987 . . . . 0.0 114.657 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 -137.41 0.15 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.32 163.77 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 135.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -137.86 152.33 48.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.912 1.285 . . . . 0.0 111.284 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.2 152.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 111.242 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 -176.16 32.71 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.162 1.625 . . . . 0.0 117.162 161.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 91.53 1.85 0.12 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 130.805 3.642 . . . . 0.0 113.279 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.09 174.21 1.64 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.358 1.463 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.85 -37.76 0.18 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.564 1.078 . . . . 0.0 113.287 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -69.26 -57.57 5.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.733 0.813 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.5 -54.69 4.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.024 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.81 62.43 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 128.394 2.902 . . . . 0.0 117.004 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -132.66 -52.02 0.92 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.746 1.773 . . . . 0.0 115.67 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? 150.74 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 130.73 3.612 . . . . 0.0 112.625 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -87.63 -24.84 23.82 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.476 -0.765 . . . . 0.0 112.228 -164.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -55.43 -38.34 68.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.819 162.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.6 mt -82.67 -34.25 27.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.242 1.017 . . . . 0.0 112.569 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -54.68 -36.27 64.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.867 0.758 . . . . 0.0 111.102 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtm-85 -78.26 -57.05 3.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -20.67 41.9 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -113.91 -29.93 6.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.884 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.24 -35.19 26.71 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.765 1.174 . . . . 0.0 114.054 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -58.39 -41.72 85.47 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -78.44 -32.2 48.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.586 0.355 . . . . 0.0 111.235 -171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -177.68 44.67 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.036 0.826 . . . . 0.0 115.086 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.01 136.71 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.704 3.603 . . . . 0.0 114.509 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 152.38 23.87 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.27 1.828 . . . . 0.0 109.95 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -122.74 -22.36 5.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.556 1.542 . . . . 0.0 113.253 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -167.92 156.75 9.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.335 1.454 . . . . 0.0 109.655 173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -152.71 131.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.799 1.239 . . . . 0.0 110.843 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -147.28 153.9 40.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.305 1.442 . . . . 0.0 111.367 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.84 144.81 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.107 -0.996 . . . . 0.0 112.032 171.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.47 130.32 39.4 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.579 1.152 . . . . 0.0 111.386 175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -93.69 -1.73 54.82 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 166.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -150.57 102.88 3.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.487 1.515 . . . . 0.0 111.247 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.52 146.79 66.75 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 CA-C-N 119.977 1.028 . . . . 0.0 111.433 -5.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.95 15.07 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.421 3.414 . . . . 0.0 116.039 -167.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.75 16.21 5.88 Favored Glycine 0 N--CA 1.466 0.678 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -142.52 139.38 31.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.521 1.661 . . . . 0.0 112.417 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.88 162.5 26.57 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.126 1.771 . . . . 0.0 113.448 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -149.28 136.91 20.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.728 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.89 177.9 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -172.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -137.77 147.06 44.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.594 1.158 . . . . 0.0 110.065 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -177.72 3.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.177 2.591 . . . . 0.0 111.466 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.42 -22.15 6.59 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.54 106.11 54.41 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 120.557 1.526 . . . . 0.0 113.352 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 -20.79 36.27 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.416 2.744 . . . . 0.0 114.639 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -41.87 17.63 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.056 1.298 . . . . 0.0 111.308 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -67.33 -33.3 74.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.622 0.769 . . . . 0.0 112.257 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.508 0.723 . . . . 0.0 112.863 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.22 -34.73 70.73 Favored 'General case' 0 C--O 1.226 -0.165 0 O-C-N 121.002 -1.061 . . . . 0.0 110.142 168.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -38.2 76.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 172.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.9 -15.0 39.41 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.766 -1.209 . . . . 0.0 113.721 166.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.55 -54.34 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.462 -1.399 . . . . 0.0 109.594 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -58.32 -26.79 63.47 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 113.816 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.23 -10.64 17.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.245 1.418 . . . . 0.0 112.299 -170.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 -33.98 0.19 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -154.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -60.43 133.84 56.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.71 0.804 . . . . 0.0 112.492 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.88 13.63 83.21 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.231 -0.761 . . . . 0.0 114.305 160.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -113.19 -106.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.158 1.783 . . . . 0.0 109.736 -173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -156.64 136.89 12.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 109.038 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 tp -154.41 155.17 34.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.325 1.45 . . . . 0.0 109.375 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.1 m 51.76 25.57 3.01 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.41 73.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.11 1.338 . . . . 0.0 115.164 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.5 p -121.95 156.21 33.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.567 1.547 . . . . 0.0 111.579 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.21 53.04 0.78 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.05 1.74 . . . . 0.0 112.953 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -46.99 152.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.833 2.453 . . . . 0.0 115.957 -163.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -137.31 137.24 38.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.122 2.569 . . . . 0.0 108.687 167.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.54 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.477 0.58 . . . . 0.0 111.406 -163.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.45 131.84 14.66 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 119.624 -1.922 . . . . 0.0 110.207 167.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.19 145.63 32.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.126 0.876 . . . . 0.0 113.023 -173.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 p -154.25 -92.05 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.726 1.211 . . . . 0.0 114.083 167.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.5 t30 118.25 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 131.18 3.792 . . . . 0.0 108.532 -160.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.58 37.92 0.62 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.089 0.852 . . . . 0.0 113.658 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.77 -12.63 60.76 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -74.33 151.33 39.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.115 1.366 . . . . 0.0 110.638 164.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.231 1.812 . . . . 0.0 111.133 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -155.76 161.31 40.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 129.427 3.091 . . . . 0.0 109.576 -15.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.68 109.37 5.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 37.5 ttpt -133.99 150.5 51.26 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 125.85 1.66 . . . . 0.0 113.018 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.9 tp -117.62 109.97 17.32 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.443 1.897 . . . . 0.0 110.211 161.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.25 120.33 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 129.739 3.216 . . . . 0.0 110.259 158.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.12 128.19 40.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.134 165.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -139.49 40.35 2.05 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.983 2.113 . . . . 0.0 110.226 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.99 171.65 42.94 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 120.25 -1.531 . . . . 0.0 116.169 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -66.0 -43.15 88.54 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 152.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.7 m -53.45 -57.12 11.78 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.482 3.113 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -162.33 141.23 9.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.0 110.008 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.92 110.45 13.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.614 1.566 . . . . 0.0 109.466 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.64 77.6 0.03 OUTLIER Glycine 0 N--CA 1.465 0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.004 -161.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.87 160.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.117 1.367 . . . . 0.0 114.222 162.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -124.28 -37.26 2.56 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.6 p 58.62 166.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -155.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -155.38 -25.15 0.11 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.35 136.39 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 127.17 2.188 . . . . 0.0 116.541 -162.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.77 -179.68 7.47 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.4 -1.438 . . . . 0.0 112.924 -166.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.81 -50.91 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.289 1.836 . . . . 0.0 111.876 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -167.93 167.93 12.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.568 1.547 . . . . 0.0 109.661 -152.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.04 15.81 0.5 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.43 -31.33 0.81 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.103 -0.998 . . . . 0.0 111.865 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.3 m -76.34 -21.29 56.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.0 111.837 163.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -50.42 15.46 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.617 -0.677 . . . . 0.0 110.123 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -48.26 58.09 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.084 1.354 . . . . 0.0 108.6 173.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -24.8 15.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.551 1.157 . . . . 0.0 114.068 -170.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.05 -38.77 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.607 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -55.11 -41.83 72.15 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.046 0.938 . . . . 0.0 113.471 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE2' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -48.86 -55.06 12.78 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 110.051 169.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -68.87 -34.17 75.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -60.38 -40.91 92.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.286 0.948 . . . . 0.0 110.842 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 -35.84 52.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 110.358 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.21 -32.72 73.15 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.359 0.527 . . . . 0.0 111.857 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.81 -38.88 87.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.192 . . . . 0.0 113.186 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -67.1 -34.54 77.85 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.567 -0.708 . . . . 0.0 112.741 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.31 22.83 1.83 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.895 1.712 . . . . 0.0 114.684 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.88 134.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.58 1.552 . . . . 0.0 111.92 -161.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.23 10.44 3.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 149.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.08 -139.06 1.19 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 149.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -119.46 53.87 1.02 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.899 2.479 . . . . 0.0 106.276 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.475 ' CE2' ' HE2' ' A' ' 31' ' ' LYS . 13.9 m95 -45.65 104.28 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.334 1.454 . . . . 0.0 112.631 -172.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.1 m -124.44 158.6 32.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.351 1.861 . . . . 0.0 108.672 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 38.9 t80 -137.91 144.04 41.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.83 1.252 . . . . 0.0 110.11 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -130.59 60.79 1.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 110.094 -156.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -47.0 -28.06 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.581 2.752 . . . . 0.0 116.128 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.7 -24.06 46.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.573 2.349 . . . . 0.0 112.852 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -132.9 7.8 4.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 112.854 165.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 51.0 mttm 45.78 25.16 0.26 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.555 2.742 . . . . 0.0 115.097 -164.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 m -63.43 168.98 4.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.235 1.814 . . . . 0.0 111.351 160.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 60.7 m-85 -135.73 156.41 48.87 Favored 'General case' 0 C--N 1.324 -0.509 1 C-N-CA 132.573 4.349 . . . . 0.0 108.903 175.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.8 m -143.35 129.72 19.96 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 m -103.51 93.21 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.21 1.005 . . . . 0.0 112.281 160.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.99 59.02 3.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.41 1.084 . . . . 0.0 112.457 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -65.67 -16.15 63.47 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.551 -1.343 . . . . 0.0 113.284 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.44 -1.3 55.57 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.08 1.324 . . . . 0.0 114.482 168.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.8 t 48.14 -53.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 131.433 3.893 . . . . 0.0 118.298 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -129.01 -5.64 5.0 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.477 1.911 . . . . 0.0 112.636 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -64.82 -11.7 39.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.383 1.873 . . . . 0.0 113.97 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -139.99 171.95 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.205 1.402 . . . . 0.0 111.586 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.94 134.82 43.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.715 1.206 . . . . 0.0 111.409 -169.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -66.08 -17.82 64.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -93.12 -4.46 52.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.527 1.131 . . . . 0.0 113.395 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -56.02 132.94 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.204 0.911 . . . . 0.0 111.084 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -93.64 133.59 36.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.965 0.906 . . . . 0.0 113.251 -165.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 9.82 3.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.009 1.724 . . . . 0.0 112.651 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -105.17 -4.15 22.13 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -149.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.1 p 160.79 -86.89 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 129.947 3.299 . . . . 0.0 111.15 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -148.97 148.41 27.13 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.277 1.431 . . . . 0.0 112.236 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.05 -49.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.176 2.584 . . . . 0.0 113.664 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 179.47 -46.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 129.676 3.191 . . . . 0.0 108.043 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 74' ' ' CYS . 4.4 p-10 -146.28 -91.3 0.09 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.692 2.797 . . . . 0.0 111.041 164.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.462 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 31.9 p -157.15 -31.72 0.08 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -148.39 -165.21 2.21 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.796 1.638 . . . . 0.0 110.097 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -113.56 141.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.19 -1.569 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -139.88 127.59 21.81 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.637 1.575 . . . . 0.0 109.116 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.22 146.91 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.41 -177.78 38.62 Favored Glycine 0 CA--C 1.518 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 115.249 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.65 16.66 9.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.316 1.446 . . . . 0.0 113.969 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 38.47 0.16 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 127.152 2.181 . . . . 0.0 111.714 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.49 -25.63 50.12 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.513 1.53 . . . . 0.0 115.762 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.74 -31.16 72.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.365 1.466 . . . . 0.0 113.223 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -134.02 -88.31 0.39 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.067 1.347 . . . . 0.0 110.192 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.22 56.33 2.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.817 1.199 . . . . 0.0 113.453 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -128.93 163.99 24.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.631 1.572 . . . . 0.0 111.555 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -72.56 -40.18 66.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.165 -0.959 . . . . 0.0 112.918 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.1 m -74.2 -34.62 63.78 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -168.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -54.38 -36.03 63.45 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.969 1.259 . . . . 0.0 111.64 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.98 -27.94 30.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.934 1.293 . . . . 0.0 112.826 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.92 -36.69 72.83 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.119 1.327 . . . . 0.0 109.94 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -103.18 -39.59 6.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.404 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.38 -30.88 68.74 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.547 0.612 . . . . 0.0 112.417 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -97.87 -30.16 12.91 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.22 -33.78 16.14 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.001 1.286 . . . . 0.0 114.439 167.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -58.94 -41.57 87.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -78.63 -24.75 45.13 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.971 0.509 . . . . 0.0 112.354 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.72 -177.49 41.48 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.031 0.824 . . . . 0.0 114.925 -171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.55 147.6 46.25 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.74 2.96 . . . . 0.0 113.149 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.97 164.25 18.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.676 2.391 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 116' ' ' GLU . 5.1 tmm_? -122.99 -36.88 2.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.434 1.494 . . . . 0.0 112.403 173.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -161.98 154.41 19.69 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.259 0.936 . . . . 0.0 111.068 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.5 t -153.02 123.56 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.233 1.413 . . . . 0.0 110.151 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -145.27 159.93 42.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.695 1.198 . . . . 0.0 111.671 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.76 153.3 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.397 -0.815 . . . . 0.0 111.897 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.68 66.6 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.148 1.379 . . . . 0.0 114.267 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 42.23 38.21 1.09 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.024 2.53 . . . . 0.0 115.197 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.33 -42.98 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.495 1.518 . . . . 0.0 113.901 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.78 -37.48 54.79 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.651 2.234 . . . . 0.0 115.274 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -74.51 170.48 71.19 Favored 'Cis proline' 0 CA--C 1.544 1.003 0 CA-C-N 121.275 1.491 . . . . 0.0 111.412 -27.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.83 19.12 2.53 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 117.318 1.687 . . . . 0.0 117.318 168.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -133.54 130.28 38.25 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.254 1.527 . . . . 0.0 111.06 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.44 160.81 38.96 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.128 2.171 . . . . 0.0 114.489 -158.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -155.08 119.71 4.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.957 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 m -137.22 -171.03 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.832 0.853 . . . . 0.0 111.764 -168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 101' ' ' ARG . 15.6 tt0 -153.75 115.88 4.32 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.427 1.091 . . . . 0.0 111.239 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -67.28 179.94 1.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.077 1.751 . . . . 0.0 112.457 165.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -115.08 -50.29 2.76 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.46 -0.775 . . . . 0.0 112.549 155.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -75.96 123.69 88.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 O-C-N 121.296 -0.877 . . . . 0.0 112.261 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -26.22 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.97 2.447 . . . . 0.0 114.724 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -27.54 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.302 1.41 . . . . 0.0 112.378 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.43 -37.46 83.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.801 0.84 . . . . 0.0 111.445 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.51 96.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.269 0.628 . . . . 0.0 112.132 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.39 91.53 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.151 -0.968 . . . . 0.0 110.516 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -40.33 81.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.85 0.75 . . . . 0.0 112.687 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.46 -20.14 58.92 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 168.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.9 t -77.84 -53.88 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 120.403 1.456 . . . . 0.0 109.383 160.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.28 -24.0 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.932 1.693 . . . . 0.0 113.972 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -111.68 -6.89 14.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.451 1.5 . . . . 0.0 111.814 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.49 -22.66 0.28 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -156.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -74.5 144.98 43.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.892 0.853 . . . . 0.0 111.831 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.95 34.11 71.0 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.033 -171.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -132.36 -140.53 0.2 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.038 1.335 . . . . 0.0 110.977 -171.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.4 m -154.05 144.21 22.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.208 2.203 . . . . 0.0 109.395 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mp -118.26 -37.56 3.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.483 1.113 . . . . 0.0 113.031 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.2 t -144.87 43.67 1.35 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.077 0.951 . . . . 0.0 112.811 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.65 4.81 88.08 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.322 0.963 . . . . 0.0 114.512 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.9 p -72.61 -176.29 1.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.544 1.537 . . . . 0.0 112.185 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.44 115.51 10.93 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.539 1.536 . . . . 0.0 106.939 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.36 162.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -143.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.43 125.58 20.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.17 1.788 . . . . 0.0 109.758 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.58 132.31 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -158.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -144.37 119.25 9.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.09 131.62 32.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.089 1.768 . . . . 0.0 115.257 -169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.4 m -147.47 176.27 10.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.178 2.191 . . . . 0.0 114.973 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -150.55 104.34 3.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.865 2.466 . . . . 0.0 109.549 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.29 -15.15 0.04 OUTLIER Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 -170.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.24 133.9 30.3 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.341 1.57 . . . . 0.0 110.6 165.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -116.58 90.25 3.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.961 1.304 . . . . 0.0 110.983 -151.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.41 ' C ' HH22 ' A' ' 101' ' ' ARG . 55.6 mmt-85 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.875 2.47 . . . . 0.0 109.003 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -150.46 158.9 44.67 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.717 2.807 . . . . 0.0 111.312 -3.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.29 112.44 13.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.21 111.97 9.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -159.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.3 101.99 13.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.475 1.11 . . . . 0.0 110.136 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.42 117.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 128.535 2.734 . . . . 0.0 110.02 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -90.98 127.73 36.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.605 165.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -136.72 43.26 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.71 1.604 . . . . 0.0 110.554 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.98 171.54 22.67 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.493 -1.379 . . . . 0.0 116.418 -168.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -67.06 -37.04 83.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.627 1.171 . . . . 0.0 110.175 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -66.16 -53.82 32.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.072 1.349 . . . . 0.0 112.307 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -157.87 142.91 16.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.898 0.879 . . . . 0.0 111.552 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.24 111.43 16.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.937 2.095 . . . . 0.0 109.92 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.54 93.07 0.11 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.632 1.11 . . . . 0.0 113.496 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -31.81 166.24 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.891 2.477 . . . . 0.0 116.898 163.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -133.08 -38.98 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.2 p 55.7 164.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -152.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -152.65 -17.54 0.16 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.72 154.23 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.255 2.622 . . . . 0.0 117.476 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.12 175.89 9.78 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.805 -1.185 . . . . 0.0 112.949 -164.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.92 -45.06 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.106 0.955 . . . . 0.0 110.296 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -166.73 178.17 6.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.949 -158.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.37 -10.1 40.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.03 -1.89 18.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 120.549 1.522 . . . . 0.0 110.526 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -112.33 -20.25 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 128.219 2.608 . . . . 0.0 112.092 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.68 9.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.082 0.953 . . . . 0.0 110.387 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.95 -48.19 82.72 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.13 -18.53 48.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.586 -167.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.43 -45.92 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.021 1.728 . . . . 0.0 110.858 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -54.13 -40.9 67.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.39 -39.61 10.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.941 1.696 . . . . 0.0 111.624 171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -104.65 -20.57 13.6 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -55.76 -42.1 74.98 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.997 1.271 . . . . 0.0 109.507 159.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.97 -36.19 49.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.591 -0.693 . . . . 0.0 110.521 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -78.65 -22.83 46.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.474 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.17 -37.42 66.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.028 1.331 . . . . 0.0 113.134 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -59.88 -47.18 86.79 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.656 0.662 . . . . 0.0 110.777 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.61 10.28 6.01 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.361 1.934 . . . . 0.0 113.667 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.96 150.76 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.38 1.072 . . . . 0.0 110.597 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.74 128.11 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.222 1.011 . . . . 0.0 111.25 134.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.18 -154.0 7.13 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-O 123.701 1.723 . . . . 0.0 115.13 -158.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.04 53.09 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.648 2.379 . . . . 0.0 109.766 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -46.06 103.28 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.981 1.712 . . . . 0.0 112.836 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.47 156.38 30.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.897 1.679 . . . . 0.0 111.72 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -149.69 142.19 24.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.073 1.349 . . . . 0.0 110.464 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.29 -36.58 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -162.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.08 -45.56 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 129.065 2.946 . . . . 0.0 117.96 -171.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.99 -25.05 64.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.206 1.803 . . . . 0.0 112.117 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.5 p -128.66 7.2 5.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 113.125 167.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.254 16.0 mttp 51.39 8.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -51.54 152.53 2.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.08 2.552 . . . . 0.0 113.338 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -126.3 165.44 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 131.45 3.9 . . . . 0.0 110.235 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -145.75 150.55 36.44 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.885 0.85 . . . . 0.0 111.231 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.77 95.07 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 122.296 1.046 . . . . 0.0 113.249 158.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.46 101.56 10.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.179 0.992 . . . . 0.0 110.643 172.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -112.98 -19.95 11.73 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.929 -1.107 . . . . 0.0 113.006 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.34 58.01 0.06 OUTLIER Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.704 -1.247 . . . . 0.0 114.778 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.0 m -47.77 -21.41 0.39 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.88 -57.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.571 1.078 . . . . 0.0 110.896 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -60.83 150.74 31.87 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -171.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 140.19 166.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 133.902 4.881 . . . . 0.0 108.556 -177.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -76.79 59.99 1.66 Allowed 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -161.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -66.37 -11.6 52.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.504 2.322 . . . . 0.0 114.477 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.0 t60 67.52 -8.1 0.51 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.55 2.34 . . . . 0.0 116.757 170.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 tpt -51.66 -34.33 37.68 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.525 1.53 . . . . 0.0 113.853 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.3 117.26 17.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.802 159.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 41.77 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 131.159 3.783 . . . . 0.0 118.09 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.19 -65.65 0.12 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.533 1.933 . . . . 0.0 109.579 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.1 p -155.81 74.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.383 1.073 . . . . 0.0 112.973 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.13 146.54 52.33 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.91 0.884 . . . . 0.0 111.472 166.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.94 -47.16 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.514 2.143 . . . . 0.0 113.812 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -156.88 -45.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.431 1.892 . . . . 0.0 109.09 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.261 3.7 p30 -145.57 -98.06 0.1 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.112 1.765 . . . . 0.0 110.14 162.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.4 t -153.99 -23.49 0.14 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 120.728 1.604 . . . . 0.0 114.918 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -162.62 -155.15 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 129.701 3.2 . . . . 0.0 104.052 -170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.5 168.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.629 2.013 . . . . 0.0 114.934 169.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -138.03 118.32 13.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.332 2.253 . . . . 0.0 108.848 168.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.2 t -126.7 141.75 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.538 . . . . 0.0 110.481 -174.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.86 -162.77 25.53 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 78.47 12.1 1.63 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.284 2.634 . . . . 0.0 113.971 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 33.16 5.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 -152.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.53 -26.31 44.95 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.119 1.342 . . . . 0.0 116.222 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.53 -30.13 68.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.725 1.21 . . . . 0.0 113.986 170.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.3 -119.35 0.3 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.28 55.25 27.02 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 121.112 1.778 . . . . 0.0 113.72 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.2 -60.79 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.323 1.449 . . . . 0.0 111.868 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 170.79 -60.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.954 2.502 . . . . 0.0 112.934 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -95.75 -26.98 15.47 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.327 0.967 . . . . 0.0 113.218 -162.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -57.57 -36.82 72.18 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.289 -0.882 . . . . 0.0 111.676 163.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.2 mt -74.05 -36.32 64.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.967 0.907 . . . . 0.0 112.36 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -57.28 -30.69 64.91 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.973 1.261 . . . . 0.0 112.216 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -84.22 -46.3 12.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.56 -28.18 63.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.523 0.729 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -98.21 -35.05 10.49 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.827 0.851 . . . . 0.0 112.649 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.85 -30.93 37.83 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.546 1.546 . . . . 0.0 115.463 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -58.23 -36.35 73.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.212 1.006 . . . . 0.0 113.603 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -78.52 -16.27 57.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.82 178.55 25.77 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.44 1.972 . . . . 0.0 112.213 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -58.58 151.29 63.61 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.523 2.816 . . . . 0.0 113.393 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.51 154.99 31.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.78 2.032 . . . . 0.0 109.877 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -120.74 -22.76 6.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.501 1.52 . . . . 0.0 113.441 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -168.99 155.16 6.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.844 1.258 . . . . 0.0 109.845 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -151.21 130.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.077 1.751 . . . . 0.0 108.939 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -141.91 149.3 40.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.363 1.865 . . . . 0.0 109.584 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.55 147.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.746 -1.222 . . . . 0.0 113.956 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.25 101.04 13.77 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.539 1.936 . . . . 0.0 110.861 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -67.89 -29.44 68.55 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.647 1.579 . . . . 0.0 113.685 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . 0.287 9.0 p30 -90.61 -29.02 0.33 Allowed Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -61.44 178.49 0.62 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.508 2.805 . . . . 0.0 113.185 152.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.24 43.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.461 1 C-N-CA 126.559 4.839 . . . . 0.0 117.809 168.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.17 79.6 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.189 -1.569 . . . . 0.0 114.834 169.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -59.16 131.71 51.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.404 1.081 . . . . 0.0 111.801 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.53 155.9 31.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 112.274 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.18 131.21 36.47 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.951 1.3 . . . . 0.0 107.724 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.56 175.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.217 1.007 . . . . 0.0 110.86 -165.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -140.88 125.6 17.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.309 1.044 . . . . 0.0 109.588 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -86.85 173.01 9.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.413 1.885 . . . . 0.0 112.417 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.57 -68.63 0.74 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.96 155.96 74.89 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-N 120.965 1.711 . . . . 0.0 114.364 -170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.92 -42.82 62.98 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 116.008 -163.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -35.68 81.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.252 0.933 . . . . 0.0 112.375 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.54 -45.07 84.82 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.517 0.727 . . . . 0.0 110.535 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.13 -48.04 46.68 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.06 69.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.284 1.033 . . . . 0.0 111.252 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -74.09 -40.93 62.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.189 0.904 . . . . 0.0 112.286 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.9 -7.5 16.9 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 164.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.05 -55.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.566 1.53 . . . . 0.0 110.212 153.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -49.04 -36.54 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.783 2.033 . . . . 0.0 112.847 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -103.47 -13.17 16.71 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.164 0.986 . . . . 0.0 112.276 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mp -147.36 -8.46 0.44 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -152.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -63.08 -19.32 64.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -179.76 70.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.438 1.018 . . . . 0.0 111.621 -159.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -132.86 -132.9 0.18 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.594 1.558 . . . . 0.0 111.942 -163.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -151.22 -36.56 0.13 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.456 1.902 . . . . 0.0 110.682 -173.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.9 tp 62.17 -48.6 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 130.302 3.441 . . . . 0.0 118.869 156.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.21 29.02 1.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.846 1.658 . . . . 0.0 112.01 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.68 55.27 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.157 -0.965 . . . . 0.0 113.301 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 p -133.85 -129.89 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.588 1.955 . . . . 0.0 110.254 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -154.63 150.86 28.13 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 130.065 3.346 . . . . 0.0 106.813 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.69 151.88 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.151 0.98 . . . . 0.0 109.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -144.35 123.26 12.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 0.0 109.1 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 2.3 t -144.55 136.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.686 -161.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.89 48.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.986 1.714 . . . . 0.0 107.522 163.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 108.14 4.03 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.383 -0.823 . . . . 0.0 111.62 -150.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -148.23 -173.65 4.37 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.617 1.967 . . . . 0.0 114.805 -176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -159.94 17.72 0.15 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.232 1.813 . . . . 0.0 114.217 -158.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.75 45.13 0.39 Allowed Glycine 0 N--CA 1.482 1.709 0 C-N-CA 127.123 2.297 . . . . 0.0 116.689 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -141.01 50.31 1.64 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.693 2.797 . . . . 0.0 109.147 -166.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -73.68 35.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.421 1.888 . . . . 0.0 115.466 -168.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 C-N-CA 127.25 2.22 . . . . 0.0 109.624 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -151.26 164.98 35.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.242 2.617 . . . . 0.0 110.305 -6.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -129.05 103.65 7.12 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.33 111.88 9.3 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 125.764 1.625 . . . . 0.0 111.28 -160.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.31 91.45 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.578 1.551 . . . . 0.0 110.076 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 mt -52.67 119.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.994 2.117 . . . . 0.0 109.207 159.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.58 134.04 40.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.429 1.092 . . . . 0.0 109.625 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -146.34 63.62 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.442 1.097 . . . . 0.0 108.767 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.72 178.54 16.35 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 122.045 0.803 . . . . 0.0 114.37 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -57.57 -43.56 84.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.33 1.052 . . . . 0.0 112.492 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -68.18 -50.67 52.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.283 2.233 . . . . 0.0 113.223 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -156.48 140.59 16.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.191 0.996 . . . . 0.0 110.397 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 131.11 47.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.798 1.639 . . . . 0.0 110.056 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.39 -134.74 4.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.347 1.451 . . . . 0.0 110.318 -158.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -161.71 -167.08 1.61 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.235 2.214 . . . . 0.0 108.892 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -144.82 -41.49 0.24 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 161.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p 56.12 166.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -156.47 -25.66 0.1 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 47.86 139.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.049 2.54 . . . . 0.0 117.049 -161.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.88 -178.0 7.03 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.576 -1.328 . . . . 0.0 112.118 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -51.01 -51.1 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.368 1.867 . . . . 0.0 111.88 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -173.68 174.84 3.06 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.111 1.765 . . . . 0.0 110.903 -157.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.7 19.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.524 1.13 . . . . 0.0 113.697 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.31 11.36 6.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.096 0.959 . . . . 0.0 111.388 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -135.43 -24.49 1.38 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.499 1.92 . . . . 0.0 111.153 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.52 8.45 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.686 -0.633 . . . . 0.0 111.025 164.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -59.86 -46.35 89.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -49.3 -25.0 2.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.818 1.647 . . . . 0.0 114.267 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.2 -40.12 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.886 1.674 . . . . 0.0 110.339 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -53.7 -36.38 62.14 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.8 mtpp -49.74 -56.99 8.18 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.536 1.534 . . . . 0.0 109.832 172.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.48 -38.82 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.883 -0.58 . . . . 0.0 112.491 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -56.94 -36.25 70.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.044 0.838 . . . . 0.0 111.439 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.79 -37.29 24.73 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 121.662 -0.649 . . . . 0.0 110.512 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -67.02 -29.01 68.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.288 0.949 . . . . 0.0 112.469 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.11 -41.8 76.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.551 1.54 . . . . 0.0 113.181 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -63.53 -44.94 92.77 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.619 -0.676 . . . . 0.0 111.308 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.37 22.76 1.06 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.987 1.756 . . . . 0.0 113.212 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.17 129.94 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.271 1.828 . . . . 0.0 110.879 -164.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.84 3.1 16.21 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.894 150.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.97 -123.01 12.79 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.531 1.539 . . . . 0.0 113.256 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -132.05 48.85 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.077 2.151 . . . . 0.0 106.49 161.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 9.8 m95 -18.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.112 2.565 . . . . 0.0 115.607 -173.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.5 m -120.22 160.53 22.76 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.42 152.41 35.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.689 1.996 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.24 -39.93 5.09 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -166.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 t70 64.35 -33.45 0.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.07 64.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.694 1.598 . . . . 0.0 111.715 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -119.49 -7.64 10.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.277 2.231 . . . . 0.0 112.513 165.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.29 39.0 mttm 61.56 17.46 8.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.502 2.321 . . . . 0.0 115.37 -171.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -57.65 150.05 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.385 1.474 . . . . 0.0 112.713 162.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -118.35 164.68 14.86 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.569 2.747 . . . . 0.0 112.06 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -150.39 138.32 20.08 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.748 -1.22 . . . . 0.0 112.248 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.37 90.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.581 1.181 . . . . 0.0 113.468 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 84.17 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.228 1.811 . . . . 0.0 113.069 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -70.87 -31.86 68.67 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.83 -1.169 . . . . 0.0 110.529 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.58 67.22 1.29 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.873 1.225 . . . . 0.0 111.089 152.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -40.09 128.19 2.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.293 2.237 . . . . 0.0 113.992 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 119.38 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 1 C-N-CA 132.51 4.324 . . . . 0.0 112.139 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 153.7 10.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 121.015 -1.053 . . . . 0.0 112.312 167.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -145.62 148.62 33.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 -174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 57.76 -11.99 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 129.423 3.089 . . . . 0.0 118.047 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -123.03 40.11 3.79 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.182 -1.574 . . . . 0.0 111.278 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -146.21 151.38 37.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.562 1.945 . . . . 0.0 111.307 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.7 tpp -148.17 38.57 0.89 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.124 1.769 . . . . 0.0 110.945 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -74.82 39.75 0.14 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.162 1.785 . . . . 0.0 114.676 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 67' ' ' ARG . 24.0 ttp85 46.79 57.1 5.87 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.404 1.882 . . . . 0.0 111.565 -162.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -9.22 9.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.699 2.399 . . . . 0.0 115.237 -166.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -67.05 52.82 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.806 2.842 . . . . 0.0 113.77 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 m 62.58 147.35 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 129.555 3.142 . . . . 0.0 113.808 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -79.97 -95.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.089 2.526 . . . . 0.0 111.821 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.97 -56.36 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.972 2.109 . . . . 0.0 107.546 163.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -138.77 -119.82 0.13 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.762 2.025 . . . . 0.0 107.804 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 13.2 m -150.18 14.51 0.8 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.327 2.651 . . . . 0.0 111.956 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 173.25 2.82 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.198 1.399 . . . . 0.0 109.978 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.82 155.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.879 1.218 . . . . 0.0 110.482 158.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -134.51 147.77 50.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.88 147.18 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.053 1.341 . . . . 0.0 111.106 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.36 -157.2 15.26 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.113 -0.992 . . . . 0.0 114.559 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -16.51 0.17 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.64 2.376 . . . . 0.0 114.239 -166.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.63 153.3 20.32 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.863 -1.148 . . . . 0.0 112.036 164.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.04 29.78 0.53 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.956 1.265 . . . . 0.0 113.225 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.86 -56.55 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.46 1.904 . . . . 0.0 109.735 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.36 -166.19 1.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 140.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.61 168.83 21.47 Favored Glycine 0 CA--C 1.531 1.085 1 C-N-CA 131.011 4.148 . . . . 0.0 114.117 -9.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -137.86 -23.39 1.05 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.209 2.203 . . . . 0.0 110.784 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.251 2.4 pttp 131.7 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 1 C-N-CA 134.866 5.266 . . . . 0.0 110.822 163.723 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.6 m -74.93 -45.6 41.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.153 1.381 . . . . 0.0 111.329 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -42.32 93.67 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.246 1.018 . . . . 0.0 112.179 172.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.23 -32.76 64.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.761 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -51.92 -37.0 50.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.316 1.417 . . . . 0.0 110.579 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -102.87 -34.3 9.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.86 79.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.279 0.631 . . . . 0.0 111.952 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -83.75 -28.08 28.47 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.811 -0.556 . . . . 0.0 110.918 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.34 -32.64 37.68 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.911 1.72 . . . . 0.0 114.411 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -51.84 -40.72 61.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -78.69 -24.12 45.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.7 179.38 30.75 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.321 1.438 . . . . 0.0 113.068 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.2 118.76 5.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.335 2.69 . . . . 0.0 113.038 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.13 156.39 25.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.899 0.857 . . . . 0.0 110.856 162.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -124.34 -23.9 4.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.604 2.362 . . . . 0.0 112.251 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -165.8 153.95 10.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.558 1.943 . . . . 0.0 108.95 163.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -150.73 125.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.542 1.137 . . . . 0.0 109.387 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -141.64 167.91 21.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.31 1.052 . . . . 0.0 112.505 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 t -144.34 141.84 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.624 1.57 . . . . 0.0 110.231 -170.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.94 -30.1 31.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.314 1.046 . . . . 0.0 113.361 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? 59.85 -25.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 129.817 3.247 . . . . 0.0 116.815 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -109.39 -42.38 0.11 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.959 1.704 . . . . 0.0 112.007 -167.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -52.28 104.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 129.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 4.01 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.152 2.568 . . . . 0.0 117.425 -129.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.89 14.33 0.04 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.224 1.869 . . . . 0.0 114.609 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -84.3 149.89 25.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.262 1.425 . . . . 0.0 110.543 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.84 41.73 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.627 1.171 . . . . 0.0 113.917 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.26 122.14 10.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.459 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 m -138.85 -179.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.759 0.824 . . . . 0.0 111.845 -168.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.31 152.2 29.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.186 1.394 . . . . 0.0 110.863 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.63 167.21 12.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.678 2.391 . . . . 0.0 112.41 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -72.06 -20.79 61.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -143.0 133.54 12.34 Favored Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 121.001 -1.062 . . . . 0.0 112.429 -162.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.89 -27.99 9.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.756 2.304 . . . . 0.0 114.335 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.2 mtm105 -71.54 -49.36 41.59 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.432 1.015 . . . . 0.0 110.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.88 -37.36 84.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.856 0.862 . . . . 0.0 110.718 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.2 70.07 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.02 -26.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.219 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.58 -41.87 37.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.304 1.411 . . . . 0.0 113.866 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.66 -8.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.484 1.514 . . . . 0.0 114.087 163.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.5 t -96.7 -53.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.704 1.202 . . . . 0.0 111.109 160.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -53.36 -35.2 60.01 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.294 1.838 . . . . 0.0 113.102 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.36 -7.89 49.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.892 1.277 . . . . 0.0 112.103 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.51 -2.9 0.94 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -155.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.401 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -58.25 -24.28 58.82 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -170.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.91 75.77 0.11 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.31 1.91 . . . . 0.0 111.508 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 70.0 mmt-85 -132.51 -146.6 0.29 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.119 1.768 . . . . 0.0 111.238 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.4 m -151.19 139.33 20.16 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.392 2.277 . . . . 0.0 106.661 168.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 tp -142.27 -66.21 0.4 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -158.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.8 m -152.79 49.29 0.73 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.549 1.939 . . . . 0.0 109.97 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.79 26.74 0.34 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 130.635 3.969 . . . . 0.0 111.526 16.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.0 t -90.35 172.23 8.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.054 1.342 . . . . 0.0 110.027 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -43.64 132.95 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.247 1.019 . . . . 0.0 111.144 150.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.4 t -109.09 154.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.836 1.654 . . . . 0.0 110.012 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.0 135.7 27.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.762 1.225 . . . . 0.0 108.593 159.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.3 t -133.07 155.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.987 1.315 . . . . 0.0 110.244 -166.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.51 159.26 43.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.103 1.361 . . . . 0.0 110.482 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 161.74 15.01 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -152.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.4 t -155.77 -23.42 0.11 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.558 2.743 . . . . 0.0 117.303 -24.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -175.98 144.86 0.62 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 122.738 2.517 . . . . 0.0 110.961 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 166.71 111.9 0.25 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.207 0.908 . . . . 0.0 113.455 157.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -141.2 134.75 29.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 109.906 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.3 1.62 52.68 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -159.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 127.115 2.166 . . . . 0.0 114.064 174.503 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -145.77 165.75 27.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 129.934 3.293 . . . . 0.0 111.06 -0.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -134.61 110.37 9.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -123.89 108.54 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.312 1.445 . . . . 0.0 112.18 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.23 89.37 6.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.121 0.968 . . . . 0.0 109.231 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 mt -51.52 115.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.006 1.722 . . . . 0.0 108.576 159.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.87 128.04 38.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.379 174.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -140.34 58.82 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.35 -179.12 15.62 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-N 120.809 1.641 . . . . 0.0 115.693 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -56.83 -23.83 46.7 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.6 1.96 . . . . 0.0 115.187 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -99.04 -42.86 6.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.494 1.917 . . . . 0.0 112.542 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -160.43 140.2 11.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.118 1.367 . . . . 0.0 109.43 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -130.51 130.64 44.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.267 1.427 . . . . 0.0 110.097 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -133.58 4.21 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.088 1.804 . . . . 0.0 111.295 -148.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -161.87 -167.77 1.76 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.774 2.43 . . . . 0.0 107.965 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -139.35 -39.24 0.48 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 158.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p 53.9 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -158.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -160.48 179.68 8.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.906 2.482 . . . . 0.0 107.557 166.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -139.42 136.18 34.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.873 1.269 . . . . 0.0 109.138 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.19 -177.7 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.776 0.83 . . . . 0.0 111.992 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -46.04 -57.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.071 1.748 . . . . 0.0 110.6 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -172.15 -163.67 0.25 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.964 3.306 . . . . 0.0 107.149 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.13 -14.8 11.32 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.41 4.88 53.26 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.695 1.589 . . . . 0.0 111.951 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -126.49 -14.54 5.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.941 166.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.76 -49.94 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.555 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -57.02 -46.98 81.96 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -53.64 -21.05 6.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.866 1.354 . . . . 0.0 113.93 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.5 -35.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.138 1.775 . . . . 0.0 110.19 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -53.35 -41.17 65.52 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.473 1.033 . . . . 0.0 113.599 165.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.79 -52.33 11.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.096 1.758 . . . . 0.0 110.624 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -80.31 -34.04 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.568 1.547 . . . . 0.0 114.863 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.73 -39.4 88.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.041 1.291 . . . . 0.0 111.225 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.05 61.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.617 -0.677 . . . . 0.0 109.696 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -71.9 -23.51 61.5 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -77.09 -37.0 55.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.689 . . . . 0.0 112.931 170.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -58.69 -44.21 90.22 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.738 -0.601 . . . . 0.0 110.464 164.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.01 5.72 8.77 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.074 1.797 . . . . 0.0 113.459 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.53 146.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.437 1.095 . . . . 0.0 110.719 172.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.12 125.19 9.27 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.726 0.775 . . . . 0.0 110.836 135.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.07 -147.04 4.61 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-O 123.878 1.821 . . . . 0.0 115.456 -157.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -19.16 62.87 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.689 2.396 . . . . 0.0 114.181 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CD2' ' CG1' ' A' ' 54' ' ' VAL 0.267 10.7 m95 36.58 52.79 1.0 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.541 2.736 . . . . 0.0 115.514 170.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 m -75.41 156.42 35.39 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.047 0.927 . . . . 0.0 111.638 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -144.36 146.11 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.592 1.557 . . . . 0.0 110.448 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -106.03 -40.03 5.8 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -163.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.04 -34.8 0.06 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.78 65.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.334 1.853 . . . . 0.0 111.466 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -125.88 -0.29 7.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.709 2.003 . . . . 0.0 112.809 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 42.2 mttm 56.13 7.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.204 2.602 . . . . 0.0 116.512 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -43.44 152.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.205 2.202 . . . . 0.0 113.972 150.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.88 173.54 8.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 130.557 3.543 . . . . 0.0 110.914 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -146.1 156.23 43.31 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.764 -1.21 . . . . 0.0 110.433 158.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -130.46 128.91 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 152.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 m -125.34 117.57 24.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.057 1.408 . . . . 0.0 112.353 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -149.9 -164.47 2.03 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 130.744 3.618 . . . . 0.0 108.509 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 56' ' ' GLU . . . 73.17 121.9 0.08 OUTLIER Glycine 0 CA--C 1.539 1.586 0 O-C-N 119.737 -1.852 . . . . 0.0 115.436 171.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.0 p -165.89 165.08 18.46 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 130.419 3.488 . . . . 0.0 110.167 -7.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -55.21 -43.79 74.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.218 1.007 . . . . 0.0 112.494 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -160.27 160.39 32.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.808 1.243 . . . . 0.0 111.868 144.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -97.79 170.53 8.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.083 1.353 . . . . 0.0 113.037 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -62.37 -12.45 21.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.726 2.01 . . . . 0.0 115.073 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -163.98 -173.31 3.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.115 2.566 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -68.47 33.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.141 2.274 . . . . 0.0 117.141 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.57 81.7 0.06 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.373 -1.455 . . . . 0.0 111.627 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -51.23 -35.29 36.14 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.315 1.046 . . . . 0.0 112.497 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -52.54 -27.95 18.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.31 2.244 . . . . 0.0 115.627 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -39.38 76.68 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -126.86 -0.51 6.65 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 93.8 m -123.98 -92.77 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 115.202 -2.332 . . . . 0.0 109.789 171.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -76.78 -33.52 3.9 Favored 'Cis proline' 0 C--N 1.362 1.265 0 CA-C-N 124.582 2.672 . . . . 0.0 115.725 -0.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -170.04 -51.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.897 2.479 . . . . 0.0 107.19 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -163.77 163.92 23.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.39 2.276 . . . . 0.0 109.316 -165.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.3 m -108.48 29.68 7.16 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.369 2.668 . . . . 0.0 111.898 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -155.03 -178.22 7.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.212 1.805 . . . . 0.0 109.755 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.71 121.52 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 140.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -144.36 141.56 29.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.514 -1.366 . . . . 0.0 111.273 -167.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.59 159.71 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.98 -163.91 12.97 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.822 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 65.77 20.97 11.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.983 1.713 . . . . 0.0 114.692 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 132.74 34.66 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.014 -1.054 . . . . 0.0 110.105 170.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.31 34.01 1.2 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.048 1.308 . . . . 0.0 112.099 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -143.29 -40.61 0.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 110.549 -162.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -124.15 -111.34 0.31 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.299 2.64 . . . . 0.0 108.125 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.04 61.92 0.56 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.902 1.715 . . . . 0.0 111.111 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.35 166.12 26.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.261 1.025 . . . . 0.0 112.243 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -30.08 65.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 m -75.89 -39.6 56.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.348 -0.845 . . . . 0.0 113.156 -169.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.29 -35.93 65.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.138 -0.976 . . . . 0.0 111.467 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 mt -83.86 -30.07 26.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.324 1.449 . . . . 0.0 111.859 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -56.79 -36.52 69.96 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.804 0.729 . . . . 0.0 109.797 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -91.24 -52.55 4.76 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.179 0.992 . . . . 0.0 111.584 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.77 54.09 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.372 1.069 . . . . 0.0 113.475 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.17 -26.53 9.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.22 -33.21 37.94 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 124.869 1.223 . . . . 0.0 114.502 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -57.01 -37.82 72.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -79.63 -20.99 45.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.387 0.675 . . . . 0.0 112.656 -170.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.49 175.91 26.19 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 125.553 1.549 . . . . 0.0 113.556 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.24 116.44 2.68 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.186 3.924 . . . . 0.0 115.173 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.39 161.26 29.4 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 110.502 159.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -126.93 -29.73 2.79 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.633 1.973 . . . . 0.0 112.585 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -154.54 164.08 39.23 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.709 0.686 . . . . 0.0 111.195 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.38 131.22 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.719 1.208 . . . . 0.0 111.766 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -158.32 165.6 34.37 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.39 1.476 . . . . 0.0 110.983 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . 0.263 1.3 m -142.76 143.97 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.965 -1.085 . . . . 0.0 112.808 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.79 161.98 11.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.334 1.854 . . . . 0.0 112.732 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -122.41 19.27 10.53 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 127.1 2.16 . . . . 0.0 110.928 171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -155.54 50.67 0.51 Allowed Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -153.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -76.01 166.48 82.81 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 CA-C-N 122.231 1.833 . . . . 0.0 114.164 0.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.93 -6.76 18.5 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.432 2.755 . . . . 0.0 115.611 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.55 18.39 49.9 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.877 1.227 . . . . 0.0 116.166 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -139.64 134.28 31.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.487 1.515 . . . . 0.0 110.808 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.54 151.24 51.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.28 1.832 . . . . 0.0 113.743 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.42 129.38 31.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.63 -178.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 110.764 -166.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -141.41 152.01 43.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.168 -0.957 . . . . 0.0 112.257 170.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -117.45 169.01 9.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.018 2.527 . . . . 0.0 110.764 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.48 3.28 40.1 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -156.44 137.18 9.13 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.2 -38.42 33.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 125.221 3.947 . . . . 0.0 117.517 168.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.8 -59.33 5.39 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 120.42 1.464 . . . . 0.0 110.127 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.16 -41.91 76.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.989 1.716 . . . . 0.0 110.907 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.75 -52.71 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.029 1.732 . . . . 0.0 113.255 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.41 65.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.195 1.361 . . . . 0.0 111.503 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -47.92 82.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.894 . . . . 0.0 111.868 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.36 -9.7 58.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.703 1.601 . . . . 0.0 114.617 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.2 -46.62 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.288 -1.508 . . . . 0.0 108.953 157.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.72 -20.9 65.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -114.62 -12.5 12.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.64 1.176 . . . . 0.0 111.899 -173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.21 -10.22 0.57 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -156.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -71.92 141.79 49.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.966 0.803 . . . . 0.0 111.96 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.63 15.52 62.01 Favored Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.433 1.492 . . . . 0.0 114.958 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.3 179.04 6.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.337 1.455 . . . . 0.0 112.49 -168.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.8 m -136.16 89.67 2.5 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.101 1.36 . . . . 0.0 110.686 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.4 -32.47 42.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 112.777 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.5 m -145.75 17.07 1.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.858 1.263 . . . . 0.0 114.122 -165.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.94 -4.41 65.53 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 113.827 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.1 p -63.99 -179.51 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.545 1.938 . . . . 0.0 113.538 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -130.74 63.29 1.58 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.581 1.152 . . . . 0.0 108.75 155.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 p -50.53 141.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.269 1.828 . . . . 0.0 112.048 -169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.1 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.292 1.437 . . . . 0.0 109.346 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.8 t -144.25 129.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -148.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.19 130.6 21.06 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.706 -1.246 . . . . 0.0 111.335 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.6 mt -147.99 127.15 12.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.307 1.043 . . . . 0.0 110.245 -159.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.5 m -173.81 -12.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 155.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.28 56.87 3.63 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.776 1.171 . . . . 0.0 112.622 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.11 -4.1 2.21 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 -170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -67.96 -21.65 65.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.412 2.285 . . . . 0.0 112.098 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.35 148.77 35.08 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.81 1.644 . . . . 0.0 109.31 165.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 . . . . . 0 C--O 1.244 0.798 0 C-N-CA 125.94 1.696 . . . . 0.0 111.198 -173.127 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.448 0.166 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -65.32 -179.02 0.55 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.666 1.986 . . . . 0.0 112.928 -11.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -130.87 130.82 44.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 133.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.03 112.91 12.77 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.974 -1.079 . . . . 0.0 113.527 -174.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 34.9 tp -85.61 111.79 20.38 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.594 172.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -77.2 117.23 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 129.189 2.995 . . . . 0.0 110.419 158.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.15 123.77 30.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.798 161.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.32 34.6 3.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.196 1.799 . . . . 0.0 110.911 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 150.37 20.98 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.033 -1.042 . . . . 0.0 114.422 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -49.16 -37.54 22.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 110.655 155.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 m -57.71 -55.17 38.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.815 2.846 . . . . 0.0 113.419 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -165.26 140.16 5.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.99 1.716 . . . . 0.0 109.824 -172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -128.7 119.52 24.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.901 1.28 . . . . 0.0 110.745 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.52 85.41 0.06 OUTLIER Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.163 0.887 . . . . 0.0 112.949 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -31.77 159.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 158.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 t -140.43 -27.7 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 7.1 p 61.86 162.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -171.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -158.96 -172.41 3.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.374 2.27 . . . . 0.0 107.733 159.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -138.16 146.72 43.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 120.189 -1.569 . . . . 0.0 111.531 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.41 -174.77 5.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 111.972 -163.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.8 -50.91 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.11 166.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -165.99 175.85 8.23 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.284 1.516 . . . . 0.0 112.045 -156.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.13 17.92 0.09 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.567 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.69 7.84 6.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.111 1.364 . . . . 0.0 111.545 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.8 p -135.42 -26.27 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.958 2.503 . . . . 0.0 112.29 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.5 -47.03 16.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.618 163.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.42 -47.5 75.87 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -21.31 6.76 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.982 1.313 . . . . 0.0 114.408 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.02 -34.57 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.032 1.733 . . . . 0.0 110.914 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -54.39 -43.0 71.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.339 0.972 . . . . 0.0 113.549 165.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -37.25 -57.28 0.9 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.423 2.289 . . . . 0.0 110.452 166.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -80.39 -32.25 37.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.975 1.71 . . . . 0.0 114.729 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -59.0 -44.7 91.71 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.431 1.014 . . . . 0.0 111.087 168.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.66 58.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.46 -31.39 72.1 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.051 0.841 . . . . 0.0 112.272 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.9 -37.99 76.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.718 1.207 . . . . 0.0 113.219 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -66.05 -44.2 85.28 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.695 -0.628 . . . . 0.0 111.784 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.07 13.66 0.59 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.984 1.754 . . . . 0.0 114.052 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.87 144.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.957 1.703 . . . . 0.0 111.877 -166.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -132.56 8.22 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.957 0.903 . . . . 0.0 112.849 158.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.12 -132.2 8.26 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 123.018 1.343 . . . . 0.0 114.193 166.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -136.16 42.22 2.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.191 1.796 . . . . 0.0 106.615 167.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 26.3 m95 -3.22 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 130.525 3.53 . . . . 0.0 115.939 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.0 m -83.89 157.97 21.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.109 0.956 . . . . 0.0 109.774 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -137.64 145.53 42.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.211 1.404 . . . . 0.0 110.112 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -133.2 56.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.447 1.499 . . . . 0.0 110.278 -155.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.88 -32.35 1.56 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.084 2.953 . . . . 0.0 116.822 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.82 -21.88 61.48 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.061 2.144 . . . . 0.0 112.624 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 51' ' ' THR . 71.4 p -131.78 7.91 4.45 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 112.846 167.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm 63.76 2.24 1.27 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.975 2.51 . . . . 0.0 114.61 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 49' ' ' THR . 53.5 m -52.52 161.98 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 129.741 3.216 . . . . 0.0 113.127 166.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -132.1 155.33 48.32 Favored 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 132.053 4.141 . . . . 0.0 110.039 171.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -144.92 121.22 10.9 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.999 0.428 . . . . 0.0 111.786 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.97 90.91 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 122.535 1.159 . . . . 0.0 112.53 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.56 39.23 0.82 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -163.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -62.11 -14.53 37.67 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.0 5.01 45.81 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.974 1.75 . . . . 0.0 114.949 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -142.14 -15.41 0.78 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.01 1.405 . . . . 0.0 114.436 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -128.44 100.47 5.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.651 1.581 . . . . 0.0 107.254 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -135.21 117.93 16.07 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.959 0.904 . . . . 0.0 112.696 -159.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -155.52 132.79 10.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.703 2.801 . . . . 0.0 109.001 -14.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -141.25 -5.32 1.1 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 172.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . 0.272 0.0 OUTLIER 57.05 -9.74 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.624 2.77 . . . . 0.0 116.87 -176.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 62' ' ' HIS . 17.1 t-80 -60.71 -19.6 59.16 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.533 1.933 . . . . 0.0 113.889 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.0 ptm 55.91 -26.27 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 130.447 3.499 . . . . 0.0 119.588 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -160.02 166.86 29.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.094 2.158 . . . . 0.0 110.264 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.5 24.13 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 173.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p30 21.56 -100.27 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 128.601 2.76 . . . . 0.0 116.194 164.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 m -164.43 -43.98 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.936 2.494 . . . . 0.0 109.755 163.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.8 p -143.26 136.27 13.83 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.852 2.061 . . . . 0.0 107.937 156.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.99 -30.07 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 114.88 1.069 . . . . 0.0 114.88 -158.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 mp 50.17 -65.5 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 127.128 2.171 . . . . 0.0 114.404 -149.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -66.73 -7.12 18.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -120.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.4 m -109.21 46.88 0.95 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.436 1.895 . . . . 0.0 111.357 163.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -148.42 178.68 8.39 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.47 -0.769 . . . . 0.0 110.505 57.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.04 144.28 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.711 0.804 . . . . 0.0 109.651 168.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -121.94 147.56 45.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.61 0.764 . . . . 0.0 111.61 -158.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.28 151.87 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.952 0.901 . . . . 0.0 110.56 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA3' ' CD2' ' A' ' 112' ' ' PHE . . . -169.47 -172.57 36.25 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 118.336 2.094 . . . . 0.0 118.336 174.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t30 53.28 36.22 22.17 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.378 1.871 . . . . 0.0 113.542 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.85 9.55 43.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.089 1.756 . . . . 0.0 113.238 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.94 -21.03 6.95 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.018 1.771 . . . . 0.0 117.034 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -54.52 -33.11 59.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 113.233 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -131.78 -45.74 0.96 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.104 1.762 . . . . 0.0 111.545 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.73 77.3 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 129.111 3.243 . . . . 0.0 115.661 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -139.75 167.53 21.88 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.557 1.143 . . . . 0.0 111.518 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -68.9 -37.43 78.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -79.86 -29.19 40.01 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.974 -1.079 . . . . 0.0 113.462 -163.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.95 -18.54 63.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.2 mt -96.67 -34.19 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.316 1.446 . . . . 0.0 111.666 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -54.12 -36.47 63.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.733 0.697 . . . . 0.0 110.893 168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.88 -55.98 4.87 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.77 45.25 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -117.19 -30.29 5.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.863 1.265 . . . . 0.0 111.091 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.72 -35.58 17.21 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.033 1.301 . . . . 0.0 114.804 164.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -54.04 -41.95 68.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -78.43 -30.97 47.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.255 -171.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.59 40.74 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 -170.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.45 112.22 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.168 3.245 . . . . 0.0 112.072 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.13 156.69 37.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.737 0.78 . . . . 0.0 111.003 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -134.01 -21.89 1.85 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 112.878 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 m -163.74 166.52 22.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.006 1.322 . . . . 0.0 111.558 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.67 131.29 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.906 1.282 . . . . 0.0 110.519 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -150.05 144.11 25.57 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.25 1.42 . . . . 0.0 111.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.76 149.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.594 -1.316 . . . . 0.0 113.73 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.15 124.5 49.64 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.19 2.196 . . . . 0.0 110.45 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -153.94 162.07 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -154.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.61 -42.61 14.61 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 126.36 1.864 . . . . 0.0 112.089 -17.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.66 143.8 82.15 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.558 2.172 . . . . 0.0 110.906 149.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.24 -15.96 24.11 Favored 'Cis proline' 0 CA--C 1.543 0.959 0 CA-C-N 120.314 1.148 . . . . 0.0 113.427 -7.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.35 42.02 3.55 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 124.391 0.996 . . . . 0.0 112.731 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CD2' ' HA3' ' A' ' 79' ' ' GLY . 36.4 m-85 -132.89 142.97 49.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.704 1.202 . . . . 0.0 111.566 -170.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.2 161.8 27.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.513 1.925 . . . . 0.0 113.227 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.5 137.13 30.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.911 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.02 168.55 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 109.506 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -139.42 149.74 44.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.86 178.13 5.66 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.315 2.246 . . . . 0.0 111.3 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -126.63 29.24 5.75 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.825 1.25 . . . . 0.0 112.543 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -160.24 119.37 1.6 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.132 1.373 . . . . 0.0 111.312 163.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.04 -43.29 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 125.168 3.912 . . . . 0.0 116.165 167.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -58.5 -38.74 78.31 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.013 1.725 . . . . 0.0 113.408 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.65 -37.38 19.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.32 92.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.741 0.701 . . . . 0.0 112.156 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.92 93.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.81 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.62 -40.39 66.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.433 1.015 . . . . 0.0 113.649 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.99 -10.57 10.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 114.333 169.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.75 -50.92 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.619 1.1 . . . . 0.0 110.571 158.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -54.19 -31.83 53.98 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.39 1.876 . . . . 0.0 113.688 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.65 -2.07 42.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.841 1.656 . . . . 0.0 112.937 -173.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.54 -24.45 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -153.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.88 109.76 0.23 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.098 1.759 . . . . 0.0 112.427 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.34 85.07 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -105.15 -122.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.814 1.307 . . . . 0.0 111.796 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -150.69 142.52 23.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.413 1.485 . . . . 0.0 109.317 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.88 -35.93 2.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.425 1.09 . . . . 0.0 113.465 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 89.8 m -146.61 23.7 1.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.535 1.934 . . . . 0.0 111.811 -163.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.31 -10.41 63.93 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.817 1.675 . . . . 0.0 114.412 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.0 p -70.11 -179.69 2.03 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.837 2.455 . . . . 0.0 113.223 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -126.5 135.39 51.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.678 1.591 . . . . 0.0 108.048 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.79 171.67 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.127 0.571 . . . . 0.0 112.252 -145.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -133.11 147.49 52.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.635 1.974 . . . . 0.0 109.525 159.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.88 130.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.939 0.896 . . . . 0.0 108.639 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -139.26 -179.53 5.93 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.911 1.684 . . . . 0.0 112.507 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -98.39 169.46 9.53 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.856 2.062 . . . . 0.0 114.901 -175.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 m -142.03 -122.4 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.704 1.201 . . . . 0.0 111.995 154.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -125.8 -26.66 3.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -137.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.36 171.51 6.5 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 120.095 1.316 . . . . 0.0 112.56 -158.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -35.34 5.97 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.005 -1.291 . . . . 0.0 113.043 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.13 -31.96 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.015 2.526 . . . . 0.0 113.421 168.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 129.665 3.186 . . . . 0.0 115.807 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -149.71 172.79 14.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.378 2.671 . . . . 0.0 110.966 -8.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -140.91 106.51 5.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.6 ttpt -123.32 128.45 49.94 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 124.307 1.043 . . . . 0.0 112.279 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.34 103.76 15.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.178 1.791 . . . . 0.0 108.878 162.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -72.23 114.63 11.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 128.498 2.719 . . . . 0.0 110.135 160.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.99 125.1 34.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.33 166.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -134.96 48.41 2.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.125 1.77 . . . . 0.0 109.88 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -112.2 150.89 18.17 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.925 1.25 . . . . 0.0 113.331 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -59.97 -24.06 64.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.148 1.379 . . . . 0.0 111.075 162.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.6 m -57.47 -56.59 19.95 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.315 1.846 . . . . 0.0 111.91 162.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -164.37 139.53 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.311 1.845 . . . . 0.0 111.126 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 9' ' ' GLY . 24.0 mtmt -122.49 110.12 15.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.311 1.844 . . . . 0.0 110.259 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.19 83.82 0.04 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.039 0.828 . . . . 0.0 112.825 -166.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -29.48 155.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.919 1.688 . . . . 0.0 115.513 155.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -134.38 -26.07 1.47 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.047 2.239 . . . . 0.0 117.047 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.0 p 57.46 167.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 -175.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -160.84 -171.48 3.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.02 2.528 . . . . 0.0 107.623 162.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -140.12 131.66 27.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.517 1.527 . . . . 0.0 108.464 170.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.74 176.53 8.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.384 1.088 . . . . 0.0 113.439 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 t -58.54 -50.74 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.362 1.865 . . . . 0.0 111.259 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.82 172.57 4.06 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.187 1.795 . . . . 0.0 109.824 -154.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.68 -3.28 11.48 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.8 -43.21 3.65 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 120.552 1.524 . . . . 0.0 108.503 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -63.66 -21.37 66.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.708 1.14 . . . . 0.0 112.818 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.35 8.19 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.796 0.725 . . . . 0.0 111.663 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -61.3 -46.22 91.2 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -58.58 -20.19 44.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 -41.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.479 1.911 . . . . 0.0 110.868 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -54.73 -38.77 67.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -45.77 -52.8 10.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.178 1.791 . . . . 0.0 110.318 171.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -75.75 -34.05 60.26 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.118 1.767 . . . . 0.0 114.525 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -59.26 -42.24 90.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.797 1.181 . . . . 0.0 111.211 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.56 -34.17 47.23 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.254 -0.904 . . . . 0.0 110.488 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -70.45 -27.24 64.09 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.725 0.693 . . . . 0.0 112.542 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.95 -37.61 75.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.979 1.312 . . . . 0.0 112.863 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -66.36 -53.03 40.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.18 0.592 . . . . 0.0 111.318 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.22 20.2 0.3 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.734 1.635 . . . . 0.0 114.474 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.1 150.27 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 112.526 -167.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.56 -0.27 2.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.642 1.177 . . . . 0.0 112.746 161.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 41.45 -113.79 0.54 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-O 124.422 2.123 . . . . 0.0 113.739 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -2.45 7.11 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 131.318 3.847 . . . . 0.0 109.652 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 41.6 m95 27.25 72.47 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.912 2.885 . . . . 0.0 114.26 -153.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.3 m -71.31 157.11 38.66 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 110.452 170.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -146.17 156.14 43.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.915 1.686 . . . . 0.0 111.423 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -133.77 135.39 43.87 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 127.365 2.266 . . . . 0.0 109.858 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.24 -16.05 14.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.2 60.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.465 1.506 . . . . 0.0 112.106 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -125.2 -1.63 7.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.394 1.878 . . . . 0.0 112.52 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.384 55.2 mttm 60.07 19.47 8.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.427 1.891 . . . . 0.0 114.259 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -67.03 162.77 21.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.111 2.564 . . . . 0.0 113.957 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.98 158.72 41.98 Favored 'General case' 0 C--N 1.327 -0.404 1 C-N-CA 132.34 4.256 . . . . 0.0 110.514 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -145.19 144.56 30.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.757 -0.589 . . . . 0.0 111.292 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.2 94.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.087 1.355 . . . . 0.0 112.443 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -95.79 58.93 2.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.0 113.605 -169.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.97 65.96 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.921 -1.112 . . . . 0.0 113.298 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.56 -7.07 45.46 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.312 1.91 . . . . 0.0 114.933 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.8 p -64.24 -18.23 64.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.902 1.351 . . . . 0.0 113.93 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.02 72.27 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.416 1.486 . . . . 0.0 112.661 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 63.5 -20.63 0.06 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.519 3.128 . . . . 0.0 118.533 164.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -141.46 141.93 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.099 1.318 . . . . 0.0 110.353 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -138.93 -14.45 1.19 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -156.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -153.61 14.98 0.5 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.797 2.039 . . . . 0.0 111.731 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -153.85 151.5 29.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.596 1.558 . . . . 0.0 111.513 -166.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.1 tpt -155.02 158.37 39.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.035 2.134 . . . . 0.0 108.655 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.932 0.787 . . . . 0.0 112.839 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.49 -178.84 4.14 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 128.328 2.651 . . . . 0.0 110.178 159.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.98 -48.88 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.701 1.6 . . . . 0.0 113.584 -165.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m 134.23 -21.36 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 1 C-N-CA 132.954 4.502 . . . . 0.0 113.013 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 53.7 m -154.58 166.74 15.33 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.991 1.716 . . . . 0.0 112.091 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.25 -30.04 0.34 Allowed 'Cis proline' 0 C--N 1.352 0.721 0 N-CA-C 114.271 0.835 . . . . 0.0 114.271 -8.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -156.43 -53.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.087 2.555 . . . . 0.0 106.607 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -172.2 -89.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.344 1.857 . . . . 0.0 112.052 150.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.2 t -144.24 116.54 8.49 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.582 1.553 . . . . 0.0 112.161 -172.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.334 9.8 ptpt 43.08 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 128.635 2.774 . . . . 0.0 114.472 -175.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.8 t -130.88 143.37 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 119.785 1.175 . . . . 0.0 112.629 -160.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -135.67 132.87 37.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.613 1.965 . . . . 0.0 108.711 172.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.64 150.64 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.188 0.518 . . . . 0.0 109.854 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.37 -169.34 29.85 Favored Glycine 0 N--CA 1.465 0.631 0 O-C-N 121.337 -0.852 . . . . 0.0 114.402 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 60.87 4.86 0.85 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.59 -49.61 74.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.471 1.032 . . . . 0.0 110.458 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.82 -60.11 0.34 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.536 2.017 . . . . 0.0 116.923 168.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -81.75 -13.74 57.38 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -159.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.89 -57.79 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 109.134 165.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 38.26 62.67 1.05 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.794 2.14 . . . . 0.0 114.885 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -127.77 -42.61 1.59 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 pttp 139.75 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 1 C-N-CA 131.709 4.003 . . . . 0.0 112.171 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 m -79.57 -35.71 39.33 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.75 -0.594 . . . . 0.0 111.497 -167.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -40.76 76.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.118 -0.989 . . . . 0.0 111.519 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.0 mt -78.24 -31.3 49.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.617 0.767 . . . . 0.0 112.606 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.67 -37.96 68.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.943 1.247 . . . . 0.0 110.078 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -104.43 -42.44 5.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.386 -164.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.26 -34.55 66.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.138 0.575 . . . . 0.0 112.007 168.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -95.65 -29.83 14.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.73 -33.21 26.71 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.02 1.295 . . . . 0.0 114.205 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -57.52 -40.1 77.99 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -76.71 -27.61 55.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.07 -171.14 37.91 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 114.817 0.687 . . . . 0.0 114.817 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.09 135.02 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.828 3.019 . . . . 0.0 112.56 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.99 157.97 17.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.963 1.705 . . . . 0.0 110.043 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -127.67 -27.5 2.84 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.446 1.899 . . . . 0.0 112.669 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -168.32 155.84 8.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.808 1.243 . . . . 0.0 110.226 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -153.21 129.08 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.223 1.809 . . . . 0.0 108.902 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -148.85 160.38 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.923 0.889 . . . . 0.0 111.953 166.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.4 147.03 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.406 -0.809 . . . . 0.0 112.945 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.95 129.87 34.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.561 1.544 . . . . 0.0 111.319 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -68.22 -19.46 64.76 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.88 1.272 . . . . 0.0 112.895 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.95 113.37 5.36 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 127.234 2.213 . . . . 0.0 110.163 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.58 156.27 6.53 Favored 'Cis proline' 0 C--N 1.358 1.066 0 CA-C-N 121.734 1.655 . . . . 0.0 115.393 -1.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -53.65 2.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 1 C-N-CA 126.277 4.651 . . . . 0.0 121.818 -153.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.61 61.13 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 120.954 1.707 . . . . 0.0 111.822 -174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -127.31 139.49 52.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.924 1.69 . . . . 0.0 110.225 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.35 158.85 43.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.547 1.539 . . . . 0.0 114.685 -157.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.93 125.63 17.96 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.449 1.1 . . . . 0.0 108.869 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.26 -175.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -172.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -147.47 110.83 4.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.47 1.908 . . . . 0.0 109.547 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.02 173.02 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 111.224 158.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.13 37.37 2.12 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.883 0.849 . . . . 0.0 113.171 166.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.25 130.72 7.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 120.952 -1.092 . . . . 0.0 110.906 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 -37.76 4.85 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.133 2.555 . . . . 0.0 113.671 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -71.23 -44.65 64.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.396 1.078 . . . . 0.0 110.758 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.17 -34.86 78.43 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.382 0.673 . . . . 0.0 112.354 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.55 -46.98 68.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -31.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.991 -1.068 . . . . 0.0 110.959 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.13 -43.89 60.99 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 119.228 0.922 . . . . 0.0 112.508 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.65 -2.5 6.92 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.861 1.264 . . . . 0.0 113.964 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.49 -56.83 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 120.558 -1.339 . . . . 0.0 109.921 151.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -55.2 -29.75 58.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.522 1.529 . . . . 0.0 113.651 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -102.47 -12.04 18.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.725 1.61 . . . . 0.0 112.367 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.46 -5.48 0.65 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -154.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.91 -6.86 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 166.01 62.64 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.56 -0.712 . . . . 0.0 112.316 -151.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -135.68 -165.73 1.74 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.743 1.617 . . . . 0.0 111.719 -167.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.4 m -131.01 115.9 17.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.76 1.624 . . . . 0.0 109.288 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.37 -34.92 6.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.7 m -140.43 24.75 2.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.047 1.339 . . . . 0.0 112.739 -165.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.36 29.67 39.69 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 121.024 -1.047 . . . . 0.0 112.96 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.77 -165.98 1.55 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.77 2.428 . . . . 0.0 111.357 -167.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -139.64 55.56 1.66 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.842 0.857 . . . . 0.0 112.061 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.3 p -46.11 146.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 127.034 2.134 . . . . 0.0 114.091 -174.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.85 133.05 35.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.803 2.441 . . . . 0.0 109.441 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.42 136.42 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.785 0.434 . . . . 0.0 111.493 -158.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -134.05 112.13 10.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.504 2.322 . . . . 0.0 108.513 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 115.63 7.42 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.981 -1.074 . . . . 0.0 112.672 -152.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -149.74 -172.17 4.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.042 1.737 . . . . 0.0 113.951 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -140.21 10.28 2.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.185 1.794 . . . . 0.0 113.038 167.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.46 31.79 4.39 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 120.702 -1.249 . . . . 0.0 116.088 -160.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.65 -11.7 3.37 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.916 1.358 . . . . 0.0 114.214 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -64.93 -11.18 35.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.785 2.434 . . . . 0.0 115.583 -160.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.874 0 C-N-CA 126.231 1.812 . . . . 0.0 110.797 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -149.37 161.57 41.8 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.943 2.497 . . . . 0.0 111.38 -1.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.6 104.34 5.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 164.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.06 113.85 9.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.878 1.271 . . . . 0.0 112.836 -163.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.0 tp -99.84 101.85 13.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 110.434 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.03 124.09 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 128.343 2.657 . . . . 0.0 110.012 158.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.16 133.74 45.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.736 168.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -148.14 49.5 1.04 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.93 2.092 . . . . 0.0 109.723 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.58 157.48 21.32 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 120.539 -1.35 . . . . 0.0 112.924 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -55.49 -37.47 67.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.152 0.981 . . . . 0.0 110.179 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -56.78 -72.24 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.913 2.485 . . . . 0.0 112.967 164.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.59 132.71 27.97 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.441 1.096 . . . . 0.0 110.613 -161.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 123.23 26.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.244 1.818 . . . . 0.0 109.169 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.84 99.11 0.81 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.469 1.033 . . . . 0.0 112.024 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -32.22 164.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.019 2.528 . . . . 0.0 116.941 165.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -129.06 -38.72 1.61 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.2 p 57.58 162.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -158.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -151.03 -6.94 0.26 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 28.17 99.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.806 3.242 . . . . 0.0 117.549 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.77 -159.6 0.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.447 1.499 . . . . 0.0 113.353 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.77 -17.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.537 1.935 . . . . 0.0 111.936 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -145.13 -11.1 0.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.58 -0.41 3.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.431 2.692 . . . . 0.0 115.445 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.51 -46.2 4.83 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 125.51 1.524 . . . . 0.0 107.956 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.64 -19.72 58.86 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.629 1.972 . . . . 0.0 113.455 162.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -54.2 6.61 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 119.402 1.001 . . . . 0.0 110.922 167.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.65 -43.95 91.97 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -60.77 -16.85 44.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.34 -41.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.427 2.291 . . . . 0.0 110.295 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -53.63 -43.8 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.606 1.094 . . . . 0.0 113.701 168.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -58.15 1.44 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.944 2.097 . . . . 0.0 110.866 168.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.6 -30.89 46.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 114.918 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -59.5 -43.61 93.29 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.543 1.065 . . . . 0.0 110.928 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.95 -32.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.406 -0.809 . . . . 0.0 110.864 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.84 -26.74 67.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 118.335 0.516 . . . . 0.0 112.307 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.85 -48.39 59.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.837 1.655 . . . . 0.0 113.324 164.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.33 -38.61 87.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.595 0.634 . . . . 0.0 111.975 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.62 28.37 0.82 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.524 1.535 . . . . 0.0 113.648 173.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.49 142.72 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.713 1.605 . . . . 0.0 111.176 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.86 113.71 5.41 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.376 1.084 . . . . 0.0 109.797 143.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -152.83 8.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-O 124.369 2.094 . . . . 0.0 115.387 -156.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.37 58.43 2.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 111.334 -2.433 . . . . 0.0 108.519 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 22.1 m95 -47.35 98.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.691 2.397 . . . . 0.0 112.019 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -121.98 159.28 27.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.341 1.856 . . . . 0.0 109.943 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.32 156.81 42.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.628 1.571 . . . . 0.0 111.127 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -135.29 113.1 10.95 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.729 2.012 . . . . 0.0 110.141 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.01 -18.6 53.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.61 -25.35 56.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.457 1.103 . . . . 0.0 111.863 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -120.69 -4.05 9.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.298 1.439 . . . . 0.0 112.949 167.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.385 37.8 mttm 56.42 24.66 8.71 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.86 2.064 . . . . 0.0 114.286 -171.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -73.12 155.06 40.07 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.553 1.941 . . . . 0.0 111.923 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.66 159.15 36.5 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 129.35 3.06 . . . . 0.0 111.37 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -143.8 136.76 27.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 2.3 m -111.89 96.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.514 1.15 . . . . 0.0 112.847 157.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 106.15 15.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.68 1.192 . . . . 0.0 109.324 165.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -118.67 -6.89 10.62 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.878 -1.139 . . . . 0.0 112.277 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.63 42.65 1.9 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 127.244 2.354 . . . . 0.0 112.311 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -156.11 169.63 24.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.113 2.165 . . . . 0.0 111.315 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -121.43 -162.68 0.99 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.186 1.794 . . . . 0.0 109.876 171.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -54.31 -25.29 22.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -164.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -50.79 -18.34 0.72 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.127 1.771 . . . . 0.0 115.353 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.0 t60 49.47 -127.26 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.39 1.476 . . . . 0.0 109.249 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 65' ' ' MET . 2.3 m-70 -116.19 167.54 10.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 139.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -64.75 14.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.423 ' H ' ' C ' ' A' ' 63' ' ' HIS . 62.2 mtt -87.63 -9.55 53.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.575 2.35 . . . . 0.0 113.029 168.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -53.99 139.13 35.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.515 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.77 158.43 15.18 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.482 1.113 . . . . 0.0 112.683 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.52 135.19 36.56 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.368 2.267 . . . . 0.0 109.758 -24.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -140.48 169.37 17.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.493 1.117 . . . . 0.0 113.938 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.2 p -158.91 99.21 1.64 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.0 110.09 158.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.05 -31.26 6.29 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.221 1.947 . . . . 0.0 115.144 -169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -163.87 -51.41 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.999 2.12 . . . . 0.0 107.652 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.49 -124.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.42 2.288 . . . . 0.0 107.325 169.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.8 p -155.81 15.79 0.36 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 -179.19 4.85 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 128.004 2.522 . . . . 0.0 110.509 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -118.92 145.69 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.091 -1.006 . . . . 0.0 112.712 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -131.59 147.09 52.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.65 2.78 . . . . 0.0 108.808 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -138.01 150.42 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.442 1.097 . . . . 0.0 109.591 172.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.22 -168.73 20.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.36 -6.79 1.94 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.59 2.356 . . . . 0.0 114.646 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 51.76 2.31 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 122.747 1.261 . . . . 0.0 113.353 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.22 -20.34 69.14 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -67.89 -32.05 72.27 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.134 1.467 . . . . 0.0 113.213 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.94 -21.48 0.18 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -49.09 109.85 0.65 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 119.84 1.2 . . . . 0.0 115.081 -157.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -133.39 -25.58 1.72 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.678 1.991 . . . . 0.0 113.545 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 139.22 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 1 C-N-CA 132.787 4.435 . . . . 0.0 111.685 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -66.62 -44.11 82.93 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.814 0.734 . . . . 0.0 112.17 -163.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -53.96 -34.82 60.77 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 169.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.8 mt -83.94 -37.74 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.469 1.107 . . . . 0.0 111.836 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -55.41 -36.5 66.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.941 1.297 . . . . 0.0 109.896 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.66 -54.79 5.33 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.04 -11.57 40.75 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -119.29 -30.66 4.87 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.369 1.068 . . . . 0.0 113.001 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.3 -31.5 50.34 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 119.509 1.049 . . . . 0.0 113.784 168.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -62.5 -41.02 98.54 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 172.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.87 -25.23 48.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.902 0.481 . . . . 0.0 111.955 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.62 -172.98 43.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.245 0.858 . . . . 0.0 115.245 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.69 131.03 17.86 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.643 2.895 . . . . 0.0 112.361 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.16 148.91 28.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.215 1.806 . . . . 0.0 109.478 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -123.83 -22.03 5.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.022 1.729 . . . . 0.0 113.188 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -164.29 153.15 13.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.034 1.334 . . . . 0.0 110.358 172.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.0 t -151.98 135.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.0 108.767 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -150.58 152.6 34.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.559 1.544 . . . . 0.0 111.137 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.54 146.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.991 -1.068 . . . . 0.0 111.472 172.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -66.42 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.994 . . . . 0.0 111.669 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.53 -178.87 0.22 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 130.315 3.446 . . . . 0.0 109.079 164.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -64.77 -28.17 2.72 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -83.76 120.04 2.67 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 122.826 2.35 . . . . 0.0 110.345 143.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -87.39 -1.37 64.87 Favored 'Cis proline' 0 CA--C 1.55 1.281 0 CA-C-N 120.841 1.336 . . . . 0.0 114.462 -4.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.54 30.69 9.52 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.533 1.063 . . . . 0.0 113.271 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.5 139.39 49.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.183 1.793 . . . . 0.0 110.798 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.82 166.19 21.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.725 2.01 . . . . 0.0 113.74 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.97 142.12 34.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.237 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.27 1.3 m -141.45 178.85 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.291 1.043 . . . . 0.0 112.296 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.05 104.63 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.767 2.027 . . . . 0.0 108.07 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.89 174.82 0.44 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.794 0.838 . . . . 0.0 112.584 155.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -115.72 -12.51 11.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.303 1.041 . . . . 0.0 112.71 164.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.91 140.76 21.38 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.052 1.341 . . . . 0.0 111.885 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.45 -37.59 0.94 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.694 2.93 . . . . 0.0 114.969 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -28.57 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.71 -1.244 . . . . 0.0 113.991 -159.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.23 -24.03 63.96 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.594 -0.691 . . . . 0.0 111.052 161.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 -47.16 66.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.807 1.243 . . . . 0.0 113.647 161.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.36 65.08 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 120.275 -1.516 . . . . 0.0 110.739 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -43.21 77.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 172.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.73 -8.62 2.16 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 166.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.48 -53.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.863 1.665 . . . . 0.0 110.743 157.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -59.86 -21.85 61.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.148 1.779 . . . . 0.0 112.882 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -107.51 -9.06 16.03 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.089 1.756 . . . . 0.0 111.537 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.12 -4.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -153.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -5.67 41.07 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.861 1.21 . . . . 0.0 113.763 168.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.75 46.89 0.53 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.418 1.485 . . . . 0.0 113.773 -159.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -132.19 177.97 7.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.155 0.982 . . . . 0.0 113.007 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.6 m -113.55 123.06 49.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.448 1.499 . . . . 0.0 109.129 168.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mp -129.52 145.59 51.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.007 2.523 . . . . 0.0 107.99 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.0 m 52.41 18.96 1.03 Allowed 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.96 60.18 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.277 1.418 . . . . 0.0 114.01 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.14 147.28 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.148 1.779 . . . . 0.0 111.226 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -52.58 148.07 7.58 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.99 152.01 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.316 . . . . 0.0 109.915 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 147.25 50.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.349 1.059 . . . . 0.0 108.342 167.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.48 158.15 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.308 0.643 . . . . 0.0 111.817 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -148.19 104.91 3.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.339 1.456 . . . . 0.0 107.584 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tt -142.74 94.91 2.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.843 -0.536 . . . . 0.0 111.646 -151.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.8 t -166.76 140.55 3.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.549 0.69 . . . . 0.0 112.852 143.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -61.15 157.1 16.73 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 130.279 3.432 . . . . 0.0 111.148 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.67 -160.67 28.21 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.019 0.819 . . . . 0.0 111.486 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -162.9 165.42 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.316 1.046 . . . . 0.0 111.752 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.53 82.17 0.67 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.513 1.125 . . . . 0.0 111.2 153.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 125.406 1.482 . . . . 0.0 110.41 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -155.65 162.07 40.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.632 2.773 . . . . 0.0 110.447 -8.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.51 109.68 8.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 160.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -131.13 135.72 47.72 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 127.018 2.127 . . . . 0.0 109.18 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -114.41 98.82 7.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.358 1.863 . . . . 0.0 108.554 162.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.36 124.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.903 1.681 . . . . 0.0 108.738 158.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.24 135.22 38.36 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.934 166.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -144.84 53.19 1.22 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.26 1.024 . . . . 0.0 109.078 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.83 175.8 21.74 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.739 1.188 . . . . 0.0 114.044 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -49.42 77.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 109.758 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -56.2 -52.1 65.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.931 1.692 . . . . 0.0 113.339 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.82 142.43 13.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.474 1.11 . . . . 0.0 110.649 -170.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.12 138.04 53.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.649 1.58 . . . . 0.0 110.256 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.52 -133.38 4.84 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.343 1.449 . . . . 0.0 110.138 -157.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -162.64 -169.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.146 1.778 . . . . 0.0 109.433 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -136.29 -45.26 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 158.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 p 55.94 164.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.281 1.432 . . . . 0.0 114.633 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -155.46 -19.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.44 142.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 128.051 2.54 . . . . 0.0 116.062 -161.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.75 177.92 9.1 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.035 -1.666 . . . . 0.0 114.368 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.24 -39.28 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.258 1.823 . . . . 0.0 111.823 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -151.03 -8.06 0.25 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -146.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.39 27.09 15.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.287 1.835 . . . . 0.0 114.01 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.37 -38.31 0.61 Allowed 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 124.417 1.087 . . . . 0.0 111.039 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m -64.53 -15.61 61.2 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.251 2.22 . . . . 0.0 112.453 155.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.95 7.21 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 110.8 165.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.35 -47.34 86.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.91 -15.75 24.11 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -171.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.5 -43.96 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.48 1.912 . . . . 0.0 111.034 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.7 -43.31 68.86 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.232 1.013 . . . . 0.0 112.753 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.4 mmpt? -40.97 -49.61 3.28 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.813 2.045 . . . . 0.0 112.111 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -94.92 -21.33 18.71 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.77 -37.75 74.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.051 0.841 . . . . 0.0 110.077 160.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.84 -39.16 27.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.524 -0.735 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.4 -23.18 61.06 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.245 -0.909 . . . . 0.0 111.539 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.06 -36.32 79.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.916 1.287 . . . . 0.0 113.374 164.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -69.33 -15.81 63.41 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.792 0.837 . . . . 0.0 112.73 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.35 25.54 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.638 1.59 . . . . 0.0 112.859 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -112.44 124.2 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 125.386 1.474 . . . . 0.0 112.225 -161.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.3 9.87 7.96 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.271 152.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 35.8 -134.98 0.56 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 128.189 2.804 . . . . 0.0 119.889 151.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -124.19 49.32 1.79 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.84 2.456 . . . . 0.0 106.673 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 20.7 m95 -42.75 104.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.285 1.834 . . . . 0.0 113.225 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 m -125.37 157.49 36.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 109.668 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -148.18 155.8 41.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.619 1.568 . . . . 0.0 111.335 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -134.73 130.46 36.26 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 126.106 1.762 . . . . 0.0 110.278 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -97.72 -18.16 18.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.461 1.104 . . . . 0.0 113.12 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.55 63.21 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.819 1.248 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -122.7 -2.79 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.574 1.549 . . . . 0.0 113.156 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.375 35.8 mttm 59.78 21.29 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.825 1.65 . . . . 0.0 114.321 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.4 m -73.69 160.06 32.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.746 2.418 . . . . 0.0 113.362 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -134.21 158.19 44.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 130.862 3.665 . . . . 0.0 110.705 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.3 m -146.88 133.73 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.187 0.595 . . . . 0.0 110.991 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.1 96.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 159.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.59 62.29 7.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.311 1.529 . . . . 0.0 112.612 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -69.19 -20.49 63.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.058 0.943 . . . . 0.0 113.477 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.62 88.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.322 0.963 . . . . 0.0 113.798 166.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -80.5 -38.55 29.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.633 1.173 . . . . 0.0 112.865 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 63.08 1.99 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 123.3 1.524 . . . . 0.0 113.273 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -60.16 -15.25 22.37 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.171 2.588 . . . . 0.0 115.193 170.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -47.99 121.39 4.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 111.073 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.31 107.13 2.71 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -156.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -146.83 -178.25 6.08 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.029 1.732 . . . . 0.0 112.328 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -51.31 -21.14 1.99 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -26.11 41.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 172.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -58.73 -47.42 84.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.5 mmp_? -121.58 84.34 2.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.509 1.124 . . . . 0.0 111.869 -164.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -140.38 153.89 46.52 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.069 2.947 . . . . 0.0 112.396 2.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.8 p -152.11 -45.02 0.11 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.777 1.631 . . . . 0.0 111.613 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.1 m -110.43 163.0 18.24 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.142 1.777 . . . . 0.0 109.674 154.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.9 -79.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.162 2.575 . . . . 0.0 114.877 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 74' ' ' CYS . 0.9 OUTLIER -80.32 33.18 0.29 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 120.411 1.46 . . . . 0.0 111.905 -175.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 60.08 -18.44 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.54 1.936 . . . . 0.0 114.471 -153.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 72' ' ' LEU . 68.7 m -129.34 -80.55 0.56 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.553 1.941 . . . . 0.0 110.52 153.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 116' ' ' GLU . 20.2 tttt 177.09 -143.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 129.022 2.929 . . . . 0.0 107.402 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.93 146.92 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 123.492 2.86 . . . . 0.0 116.714 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -140.57 156.97 46.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.922 2.089 . . . . 0.0 111.814 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.75 158.27 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 120.957 -1.09 . . . . 0.0 112.908 -176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.31 -167.42 30.71 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 169.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.24 20.81 7.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.588 1.555 . . . . 0.0 115.036 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.55 51.42 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 111.716 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.41 -17.76 33.75 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.386 1.946 . . . . 0.0 115.895 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.47 -55.31 10.61 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.57 1.185 . . . . 0.0 111.467 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -131.94 -22.55 2.32 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 8.47 74.15 0.01 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.68 3.038 . . . . 0.0 117.839 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -135.27 162.79 31.56 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.415 1.107 . . . . 0.0 113.646 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -60.5 -43.84 96.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.596 1.558 . . . . 0.0 113.158 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -86.46 -29.77 22.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -163.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.81 -31.38 64.65 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.316 -1.49 . . . . 0.0 111.727 164.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.93 -22.25 22.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.044 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.13 -34.77 75.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.259 1.391 . . . . 0.0 109.359 167.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -80.2 -64.91 1.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.638 1.175 . . . . 0.0 111.206 174.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -4.28 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -123.6 -30.62 3.59 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.487 1.039 . . . . 0.0 112.18 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.98 -27.71 30.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.174 1.352 . . . . 0.0 115.189 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -55.03 -38.79 68.41 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.0 -16.97 54.06 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.18 -170.82 33.9 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.105 0.86 . . . . 0.0 114.741 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.27 101.91 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.13 3.22 . . . . 0.0 112.443 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.18 68.23 2.57 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.288 1.835 . . . . 0.0 111.808 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -12.43 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.076 2.15 . . . . 0.0 114.342 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.3 m -150.44 150.25 31.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.541 1.064 . . . . 0.0 110.819 161.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.14 116.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 110.143 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -146.43 147.11 30.91 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.34 1.856 . . . . 0.0 109.219 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.06 154.33 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.387 -0.821 . . . . 0.0 112.391 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.94 154.77 30.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.735 1.614 . . . . 0.0 111.902 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -112.09 25.1 11.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.782 1.233 . . . . 0.0 111.815 163.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 90.93 7.26 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 128.054 2.542 . . . . 0.0 107.513 164.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.32 159.33 85.15 Favored 'Cis proline' 0 CA--C 1.55 1.317 0 CA-C-N 120.244 1.123 . . . . 0.0 113.765 5.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -53.02 6.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.256 2 C-N-CA 127.119 5.213 . . . . 0.0 122.626 -159.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.43 58.78 0.02 OUTLIER Glycine 0 N--CA 1.474 1.18 0 CA-C-N 121.756 2.071 . . . . 0.0 113.539 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -130.09 136.67 49.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.703 1.201 . . . . 0.0 111.213 -171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -132.44 156.59 46.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.62 1.2 . . . . 0.0 113.586 -167.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 136.88 54.29 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.444 1.498 . . . . 0.0 108.533 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.24 164.97 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.934 0.894 . . . . 0.0 111.373 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 44.7 mt-10 -144.34 142.33 30.31 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 109.526 170.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -119.2 140.57 49.98 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 156.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.4 29.16 0.3 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.259 -0.9 . . . . 0.0 112.94 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -152.79 137.83 11.15 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 126.083 1.753 . . . . 0.0 111.559 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.73 -51.35 9.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.553 3.502 . . . . 0.0 117.203 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.35 -14.61 22.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -160.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.31 -45.22 66.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.551 0.614 . . . . 0.0 110.536 165.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.74 77.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 111.935 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.97 78.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.44 -1.267 . . . . 0.0 110.849 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.55 -40.84 61.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.356 1.435 . . . . 0.0 113.172 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.02 -14.33 6.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.588 1.555 . . . . 0.0 114.03 166.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.6 -47.92 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 120.127 1.33 . . . . 0.0 111.699 161.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.84 -36.27 62.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.868 2.067 . . . . 0.0 112.987 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.19 -11.64 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.024 1.329 . . . . 0.0 112.516 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.09 -27.89 0.63 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -148.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -45.07 101.65 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.055 2.542 . . . . 0.0 112.114 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.4 27.01 73.31 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.075 -0.847 . . . . 0.0 114.568 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -97.16 -138.51 0.27 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.611 1.205 . . . . 0.0 111.452 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.9 m -152.91 143.17 22.47 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.683 2.793 . . . . 0.0 108.346 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.53 -42.32 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 112.377 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 87.1 m -137.23 29.51 2.74 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.493 1.117 . . . . 0.0 112.744 -155.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.27 44.76 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.369 -0.832 . . . . 0.0 112.415 -170.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.4 -174.91 3.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.17 2.188 . . . . 0.0 112.314 -166.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 89.96 2.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 108.346 174.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.7 172.39 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.063 0.945 . . . . 0.0 112.756 -168.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.657 1.583 . . . . 0.0 108.932 151.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 t -136.7 134.66 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -130.37 149.24 52.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.186 0.995 . . . . 0.0 109.55 -171.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.93 148.64 49.05 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.004 -1.06 . . . . 0.0 111.14 152.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . 0.294 11.8 t 126.93 101.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.32 2.648 . . . . 0.0 114.734 144.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -149.02 6.48 0.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.464 1.505 . . . . 0.0 114.532 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -97.79 13.48 63.78 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.05 1.786 . . . . 0.0 112.104 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 -52.87 2.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 110.471 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.3 3.93 8.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.592 1.957 . . . . 0.0 113.431 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.492 0.187 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -152.21 169.24 22.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.144 2.578 . . . . 0.0 110.951 -7.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.86 105.37 8.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.95 107.21 8.55 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.716 0.807 . . . . 0.0 112.116 -164.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 tp -97.63 92.39 5.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.625 1.57 . . . . 0.0 109.84 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.25 105.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.602 2.361 . . . . 0.0 109.203 162.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 mp -82.53 132.01 35.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -137.08 44.73 2.28 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.938 2.095 . . . . 0.0 108.183 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.85 51.34 Favored Glycine 0 C--N 1.338 0.685 0 O-C-N 120.439 -1.413 . . . . 0.0 115.451 -161.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -56.23 -48.03 77.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.856 1.662 . . . . 0.0 109.857 160.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m -78.99 -62.48 1.69 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.449 2.3 . . . . 0.0 113.849 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.87 145.01 34.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.511 1.124 . . . . 0.0 110.409 -166.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 119.98 21.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.549 1.94 . . . . 0.0 110.144 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.62 23.1 0.09 OUTLIER Glycine 0 N--CA 1.477 1.407 0 N-CA-C 119.898 2.719 . . . . 0.0 119.898 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 57.34 -176.46 0.06 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -150.79 -32.49 0.17 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p 59.22 163.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 t -161.5 -163.51 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.358 2.663 . . . . 0.0 106.994 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.12 138.7 35.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 120.092 -1.63 . . . . 0.0 108.924 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.04 -171.13 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 123.508 1.623 . . . . 0.0 112.887 -165.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.31 -22.69 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 112.474 -2.148 . . . . 0.0 111.343 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -140.28 -57.69 0.54 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 129.89 -30.55 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 131.138 3.775 . . . . 0.0 112.243 -162.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.9 -36.01 25.67 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.723 1.209 . . . . 0.0 110.293 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -76.19 -20.97 57.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.444 3.098 . . . . 0.0 112.447 167.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.47 -52.83 8.44 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.457 -0.777 . . . . 0.0 109.968 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -47.05 47.21 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 125.685 1.594 . . . . 0.0 108.596 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -20.29 16.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -170.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.94 -40.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.386 1.474 . . . . 0.0 109.629 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -51.51 -46.0 63.1 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.56 1.144 . . . . 0.0 112.922 166.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.7 mmpt? -42.0 -46.84 4.28 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.572 1.549 . . . . 0.0 112.277 170.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -100.21 -19.08 16.57 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.29 -39.07 74.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.023 0.829 . . . . 0.0 110.51 156.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.04 -33.28 22.53 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.537 -0.727 . . . . 0.0 110.705 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -75.3 -22.12 57.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.0 1.273 . . . . 0.0 112.047 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.2 1.0 . . . . 0.0 112.649 163.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -64.84 -31.47 72.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.71 -0.618 . . . . 0.0 111.94 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.17 5.41 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.337 1.923 . . . . 0.0 113.698 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.03 134.01 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.506 1.922 . . . . 0.0 111.746 -163.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.41 12.24 3.81 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 157.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 2.06 -93.02 0.0 OUTLIER Glycine 0 N--CA 1.473 1.149 0 C-N-CA 130.114 3.721 . . . . 0.0 117.639 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -6.64 1.32 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.8 1.64 . . . . 0.0 111.988 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.49 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 30.0 m95 23.05 67.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.257 3.423 . . . . 0.0 116.254 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 m -75.33 153.63 37.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.331 1.062 . . . . 0.0 110.858 170.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -145.8 146.08 31.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.334 1.453 . . . . 0.0 110.363 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -134.62 56.14 1.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.296 1.038 . . . . 0.0 112.026 -155.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -40.56 -27.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 130.392 3.477 . . . . 0.0 119.034 -173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.33 -20.54 66.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.583 1.953 . . . . 0.0 112.505 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -128.93 -15.95 4.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.125 2.17 . . . . 0.0 113.058 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.344 36.3 mttm 65.47 14.39 9.44 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.211 3.004 . . . . 0.0 115.144 -170.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.4 m -53.76 159.07 1.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.951 1.7 . . . . 0.0 112.624 157.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.14 170.01 14.06 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 130.109 3.364 . . . . 0.0 111.07 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.4 m -147.09 153.63 40.18 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.009 -1.057 . . . . 0.0 110.525 159.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.404 HG12 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.49 113.77 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.443 0.64 . . . . 0.0 111.666 153.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -106.12 114.8 29.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.697 0.799 . . . . 0.0 110.253 172.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -124.03 -22.32 4.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.708 1.203 . . . . 0.0 113.205 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.21 -45.58 0.04 OUTLIER Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.51 -0.744 . . . . 0.0 114.117 -174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 p 55.08 -18.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.204 2.601 . . . . 0.0 117.682 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -61.18 130.64 47.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.525 1.93 . . . . 0.0 113.068 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -106.74 55.6 0.66 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.764 3.626 . . . . 0.0 111.007 0.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -136.39 22.25 3.19 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.726 2.01 . . . . 0.0 111.728 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -67.2 -11.34 57.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -166.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -131.95 161.22 33.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.536 1.535 . . . . 0.0 111.594 169.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.9 m170 63.59 -51.15 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 129.155 2.982 . . . . 0.0 115.305 -172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . 0.302 3.1 ppp? 49.21 -14.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 130.188 3.395 . . . . 0.0 119.062 -172.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -116.42 -17.44 10.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.218 1.807 . . . . 0.0 113.447 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.4 tpt85 -140.75 55.32 1.58 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.892 2.077 . . . . 0.0 110.138 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.33 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 1 C-N-CA 132.174 4.19 . . . . 0.0 109.112 1.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -141.21 146.01 36.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 128.858 2.863 . . . . 0.0 108.1 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.18 176.3 0.86 Allowed Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.26 0.624 . . . . 0.0 110.484 156.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.86 -133.38 0.03 OUTLIER 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-O 118.111 -0.87 . . . . 0.0 112.759 -29.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.9 tt -37.5 -22.06 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 131.069 3.748 . . . . 0.0 117.216 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.6 t0 112.47 -22.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 1 C-N-CA 133.659 4.784 . . . . 0.0 106.573 -155.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.9 m -128.71 -119.88 0.24 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 128.415 2.686 . . . . 0.0 107.661 160.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -144.63 179.64 7.16 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 131.256 3.822 . . . . 0.0 104.196 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . 0.282 4.5 p -122.74 146.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 125.071 3.578 . . . . 0.0 112.327 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -134.33 153.35 51.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.174 -167.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.9 153.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.408 1.083 . . . . 0.0 111.304 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.98 26.87 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.272 0.939 . . . . 0.0 115.128 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 70.37 33.07 2.61 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.095 1.758 . . . . 0.0 113.549 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.8 160.86 17.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 114.039 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.18 -30.54 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.857 1.694 . . . . 0.0 113.653 168.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -50.83 -36.48 37.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.733 2.413 . . . . 0.0 114.675 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.64 -50.66 0.24 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.114 2.166 . . . . 0.0 110.427 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -10.3 95.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.535 2.493 . . . . 0.0 116.316 -163.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -132.68 -29.91 1.48 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -168.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 pttp 135.26 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 1 C-N-CA 132.581 4.352 . . . . 0.0 110.578 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 m -69.46 -39.49 77.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.5 0.72 . . . . 0.0 111.525 -167.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -37.07 76.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.186 -0.947 . . . . 0.0 112.466 173.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.8 mt -79.96 -31.75 39.92 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.026 0.931 . . . . 0.0 111.856 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -57.93 -34.9 70.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.014 0.825 . . . . 0.0 110.016 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -91.75 -51.97 4.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.725 0.81 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.23 -28.28 66.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.959 0.904 . . . . 0.0 113.411 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.74 -25.98 13.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.535 0.734 . . . . 0.0 110.31 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.7 -34.14 20.58 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 126.547 2.023 . . . . 0.0 115.231 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -53.26 -37.82 62.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.041 0.921 . . . . 0.0 113.461 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -84.69 -12.01 54.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.009 0.923 . . . . 0.0 111.528 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.87 168.56 14.29 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.792 1.663 . . . . 0.0 113.042 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.68 117.02 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.96 2.44 . . . . 0.0 111.044 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.14 153.1 35.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.331 0.586 . . . . 0.0 110.602 168.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -124.31 1.33 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.737 1.615 . . . . 0.0 113.278 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -161.81 152.97 18.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.6 1.16 . . . . 0.0 109.913 147.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.5 t -153.56 124.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.449 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -152.0 149.1 28.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.956 0.902 . . . . 0.0 111.363 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.58 146.54 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -171.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.18 83.12 0.23 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.029 2.132 . . . . 0.0 111.454 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 25.68 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.586 2.754 . . . . 0.0 114.669 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.12 67.09 26.27 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 127.704 2.401 . . . . 0.0 109.936 -166.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.04 143.1 42.06 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.349 3.366 . . . . 0.0 115.7 -161.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.65 145.98 85.33 Favored 'Cis proline' 0 CA--C 1.548 1.222 0 CA-C-N 118.842 0.622 . . . . 0.0 112.052 -2.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.21 36.56 0.02 OUTLIER Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.408 2.432 . . . . 0.0 113.423 -2.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -142.96 149.35 38.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.494 1.118 . . . . 0.0 112.574 -155.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -129.67 164.37 24.09 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.435 1.894 . . . . 0.0 113.906 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.15 149.34 51.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.701 -1.59 . . . . 0.0 109.146 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.47 150.41 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 122.346 1.069 . . . . 0.0 111.769 -171.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -143.37 138.88 29.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.08 1.352 . . . . 0.0 110.466 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.77 -21.54 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.758 2.423 . . . . 0.0 112.78 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.272 8.9 tm-20 39.06 53.07 2.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 -153.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -150.95 137.15 11.08 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.514 1.525 . . . . 0.0 109.864 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.47 -45.06 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.913 1.742 . . . . 0.0 113.299 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.11 -54.61 10.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.898 1.279 . . . . 0.0 112.816 -165.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.86 -21.49 54.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.39 1.076 . . . . 0.0 113.406 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.55 -45.21 54.83 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.943 0.792 . . . . 0.0 112.387 169.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.98 74.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -45.46 72.74 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.65 -0.656 . . . . 0.0 112.054 173.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -6.82 3.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 114.4 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.92 -54.47 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.138 -0.977 . . . . 0.0 111.594 153.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -33.86 67.47 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.254 1.388 . . . . 0.0 114.23 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.55 1.73 23.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.051 1.741 . . . . 0.0 111.803 -163.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.45 -19.94 0.48 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.962 1.705 . . . . 0.0 113.594 -162.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -76.91 146.27 37.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.984 1.313 . . . . 0.0 113.236 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.01 37.8 81.51 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.183 0.897 . . . . 0.0 112.844 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.48 158.96 34.73 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.166 1.787 . . . . 0.0 111.702 -165.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 m -88.11 56.68 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 111.642 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.25 -28.86 65.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -160.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 70.1 m -142.48 22.5 2.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.047 1.339 . . . . 0.0 113.847 -162.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.04 11.32 70.03 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 120.341 -1.474 . . . . 0.0 113.217 -166.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 19.1 p -122.97 165.34 16.9 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.041 2.536 . . . . 0.0 107.806 164.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -89.36 102.0 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.77 163.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.981 1.313 . . . . 0.0 111.962 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -124.09 135.06 53.28 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.343 1.457 . . . . 0.0 107.357 162.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.42 138.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 108.585 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -139.82 172.11 13.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.002 0.921 . . . . 0.0 111.397 -166.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 165.7 24.16 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.713 -0.617 . . . . 0.0 112.353 156.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -130.32 -73.87 0.55 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -148.7 -78.38 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.808 1.185 . . . . 0.0 112.941 -170.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.07 120.23 0.03 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.876 2.655 . . . . 0.0 113.408 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -62.91 -7.04 4.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.82 -4.42 57.62 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.071 1.748 . . . . 0.0 115.288 173.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . 0.303 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 130.346 3.458 . . . . 0.0 118.471 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 tpp . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.494 0.188 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -156.59 170.18 22.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.862 2.865 . . . . 0.0 110.355 -11.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -132.7 124.6 28.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 136.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 34.2 ttmt -125.02 152.94 43.59 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 125.218 1.407 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.9 tp -129.21 100.77 5.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.806 2.843 . . . . 0.0 108.503 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.36 118.46 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 127.423 2.289 . . . . 0.0 109.054 158.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.442 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.3 mp -94.27 137.14 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -147.51 42.96 1.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.768 2.027 . . . . 0.0 109.282 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.01 -172.81 25.37 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.721 -1.237 . . . . 0.0 115.586 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -60.13 -45.13 94.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.041 0.924 . . . . 0.0 111.393 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -68.59 -60.49 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.833 2.053 . . . . 0.0 112.193 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.07 144.19 26.52 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.174 0.99 . . . . 0.0 110.355 -166.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -129.72 122.27 28.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.213 1.805 . . . . 0.0 108.649 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.07 23.92 0.12 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 119.006 2.363 . . . . 0.0 119.006 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER 59.65 -175.22 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.098 2.259 . . . . 0.0 117.098 175.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -145.22 -40.72 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 162.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 15.0 p 60.75 151.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 126.035 1.734 . . . . 0.0 115.405 -165.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.2 126.15 0.66 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.026 1.73 . . . . 0.0 106.747 163.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.69 148.65 33.03 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 121.848 -0.533 . . . . 0.0 110.692 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.82 176.35 11.14 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.07 -1.019 . . . . 0.0 112.814 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.79 -54.75 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.134 1.774 . . . . 0.0 111.428 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -165.18 174.53 10.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.045 1.738 . . . . 0.0 109.966 -158.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.73 -39.93 1.59 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.772 1.169 . . . . 0.0 110.699 -173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -71.32 -23.13 61.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.755 1.622 . . . . 0.0 112.129 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.36 -50.79 14.82 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 109.802 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -47.68 61.32 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.771 1.228 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -23.17 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -169.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.02 -36.97 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.22 1.408 . . . . 0.0 109.609 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -53.41 -45.52 69.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.444 1.098 . . . . 0.0 112.75 164.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.1 mmpt? -44.75 -53.97 6.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 111.224 168.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -72.21 -36.43 69.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.38 -41.58 94.07 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.655 1.116 . . . . 0.0 111.309 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.55 -38.38 59.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.0 -29.5 69.89 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.17 0.895 . . . . 0.0 112.235 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.08 -38.28 85.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 113.009 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -67.33 -12.96 61.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.667 0.787 . . . . 0.0 112.511 165.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.25 10.0 52.32 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.04 1.781 . . . . 0.0 112.756 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.08 128.04 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 125.93 1.692 . . . . 0.0 112.362 -161.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 68.18 1.31 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 125.074 2.369 . . . . 0.0 110.569 156.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.5 -153.14 0.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 109.696 -3.411 . . . . 0.0 115.15 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.99 52.66 0.72 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.768 2.827 . . . . 0.0 109.824 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.519 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 21.9 m95 -43.74 100.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.247 2.619 . . . . 0.0 112.916 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.3 m -125.95 162.2 25.76 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.38 1.872 . . . . 0.0 110.125 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -147.23 155.88 42.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.627 1.571 . . . . 0.0 111.536 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.42 129.76 35.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.715 2.006 . . . . 0.0 109.275 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.61 -18.11 23.5 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.13 61.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.079 0.951 . . . . 0.0 111.824 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -122.93 -2.15 8.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.242 1.817 . . . . 0.0 112.601 166.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.317 49.8 mttm 58.86 24.8 12.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.596 1.558 . . . . 0.0 113.372 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.2 m -79.22 157.22 27.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.523 2.329 . . . . 0.0 112.36 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.71 159.52 32.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.596 2.758 . . . . 0.0 109.658 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -145.15 132.79 20.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.09 -0.381 . . . . 0.0 111.274 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 3.1 m -112.87 100.52 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.983 0.897 . . . . 0.0 112.014 156.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 115.04 18.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 155.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.21 45.57 2.16 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 124.025 1.869 . . . . 0.0 109.335 170.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.84 59.75 0.06 OUTLIER Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.534 2.969 . . . . 0.0 108.168 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -23.04 89.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.994 3.318 . . . . 0.0 116.267 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t60 57.56 22.35 8.07 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.892 1.677 . . . . 0.0 115.361 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -137.66 156.27 48.22 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.656 -1.278 . . . . 0.0 114.064 -172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -96.93 49.12 1.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.22 2.608 . . . . 0.0 111.164 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -37.11 134.77 0.53 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.86 2.064 . . . . 0.0 115.509 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.06 -43.46 3.39 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.001 1.72 . . . . 0.0 113.253 -174.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -59.05 132.65 54.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -164.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.7 mtm 51.74 33.83 11.85 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.614 2.366 . . . . 0.0 113.925 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -158.97 -49.36 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -141.54 29.61 1.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.766 2.026 . . . . 0.0 111.6 -170.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.11 11.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 129.26 3.024 . . . . 0.0 117.689 -167.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.4 p -58.47 125.92 25.38 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.278 -1.514 . . . . 0.0 111.8 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 p -54.68 113.09 4.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.326 0.65 . . . . 0.0 111.568 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -103.37 -10.67 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 121.687 1.591 . . . . 0.0 114.883 -158.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tt 60.68 -49.74 0.1 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.514 1.926 . . . . 0.0 114.581 -158.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.61 -26.38 21.66 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -148.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . 0.304 5.0 t -79.93 14.58 1.74 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.25 149.68 7.39 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 117.202 -1.799 . . . . 0.0 112.005 117.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.44 155.82 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 108.849 170.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -137.34 152.27 49.52 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.854 -1.154 . . . . 0.0 112.126 -162.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.98 149.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 110.207 -177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.62 38.11 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.515 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 3.2 t30 81.86 5.6 1.18 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.1 2.56 . . . . 0.0 113.918 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 61.51 5.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.389 1.476 . . . . 0.0 112.83 -167.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.23 63.95 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 114.649 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 114.234 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -136.16 -61.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.608 1.163 . . . . 0.0 111.076 -167.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.96 54.38 4.41 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.513 2.006 . . . . 0.0 114.556 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.09 -40.88 2.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 pttp 138.48 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 1 C-N-CA 132.461 4.305 . . . . 0.0 111.586 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.3 m -82.46 -26.12 32.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.13 0.877 . . . . 0.0 112.293 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -53.65 -35.14 60.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.78 -1.2 . . . . 0.0 112.321 159.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.71 -29.62 17.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.682 1.193 . . . . 0.0 113.129 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -60.08 -32.21 70.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.671 1.123 . . . . 0.0 109.301 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -85.23 -54.67 4.46 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.481 1.112 . . . . 0.0 112.51 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 -21.22 59.17 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.09 -29.47 8.53 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.013 0.925 . . . . 0.0 111.499 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -51.66 -36.47 40.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.632 1.111 . . . . 0.0 114.196 167.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -57.0 -36.02 69.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.51 -24.39 50.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.02 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.68 -169.54 34.54 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.69 106.54 2.13 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.881 3.054 . . . . 0.0 111.927 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.92 143.2 52.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.228 1.011 . . . . 0.0 111.22 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.1 ttp-105 -94.33 -35.19 12.51 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.172 1.389 . . . . 0.0 111.705 163.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -172.4 160.44 4.9 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.767 1.167 . . . . 0.0 111.011 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.8 t -151.31 134.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 107.846 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -146.06 148.45 32.67 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.297 1.839 . . . . 0.0 109.982 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.14 145.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 112.876 173.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' A' ' 108' ' ' ASN . . . -80.48 -37.58 31.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.75 1.22 . . . . 0.0 114.044 -173.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 50.58 -1.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.074 2.549 . . . . 0.0 116.659 -165.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -140.52 99.52 7.0 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 127.673 2.389 . . . . 0.0 108.133 166.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.35 159.05 70.26 Favored 'Cis proline' 0 CA--C 1.549 1.252 0 CA-C-N 120.372 1.168 . . . . 0.0 114.47 9.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -53.44 6.59 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 1 C-N-CA 126.969 5.112 . . . . 0.0 121.865 -157.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.74 54.32 0.03 OUTLIER Glycine 0 N--CA 1.47 0.908 0 CA-C-N 122.162 2.256 . . . . 0.0 113.746 -172.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.52 135.67 48.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 0.0 111.063 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.12 162.6 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.515 1.926 . . . . 0.0 113.707 -168.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.74 156.23 47.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.504 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.53 160.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.163 . . . . 0.0 110.488 -162.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.56 154.34 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.66 1.584 . . . . 0.0 110.764 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -132.64 151.55 51.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.972 2.109 . . . . 0.0 111.681 -173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -84.62 -2.23 57.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.811 -1.18 . . . . 0.0 113.821 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.88 129.03 23.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.486 1.114 . . . . 0.0 111.608 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.23 -27.85 13.2 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.381 2.721 . . . . 0.0 114.043 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.98 -34.0 12.53 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.252 1.021 . . . . 0.0 110.875 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -68.93 -29.5 67.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.609 1.095 . . . . 0.0 112.895 164.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.44 -45.28 91.61 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.84 1.2 . . . . 0.0 111.802 165.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.92 89.12 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.614 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.33 -42.98 61.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.87 -12.31 7.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.552 1.141 . . . . 0.0 113.536 168.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 87.6 t -89.89 -52.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 119.408 1.004 . . . . 0.0 112.312 159.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -59.31 -25.5 64.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.327 1.851 . . . . 0.0 113.156 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.54 -7.37 34.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 112.162 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.59 -15.82 0.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -153.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -23.74 0.92 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.314 2.246 . . . . 0.0 115.645 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -161.4 40.14 0.41 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.684 1.135 . . . . 0.0 114.199 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.25 34.5 ttp180 -113.42 -123.37 0.29 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.353 1.077 . . . . 0.0 112.283 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.5 m -161.07 142.39 11.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.372 1.869 . . . . 0.0 107.621 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.9 tp -138.38 -36.93 0.57 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -163.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.8 m -140.47 21.42 2.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.158 1.383 . . . . 0.0 113.216 -171.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.89 47.47 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.499 -0.751 . . . . 0.0 113.397 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 11.9 t -137.15 152.61 50.15 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 108.327 157.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.515 ' HE ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 tmm_? -35.5 134.67 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.477 1.511 . . . . 0.0 109.902 150.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.18 157.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.195 0.598 . . . . 0.0 110.259 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -128.21 159.37 35.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.104 159.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.1 t -149.24 148.59 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.975 1.31 . . . . 0.0 108.493 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -138.53 175.8 9.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.122 1.369 . . . . 0.0 110.815 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.62 150.04 35.63 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -157.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t 92.22 123.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 130.333 3.453 . . . . 0.0 116.031 151.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -134.6 -59.93 0.8 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.674 134.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.87 -4.38 61.53 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 118.95 2.34 . . . . 0.0 118.95 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -138.38 157.16 46.77 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.378 2.089 . . . . 0.0 113.224 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -95.88 131.1 42.56 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.24 2.616 . . . . 0.0 111.72 0.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 125.776 1.63 . . . . 0.0 111.513 164.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.5 tp60 -143.46 162.29 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.177 2.591 . . . . 0.0 110.678 -3.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.35 111.33 12.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -138.21 99.69 3.93 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.765 0.826 . . . . 0.0 112.096 -163.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.54 90.76 8.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 119.021 0.828 . . . . 0.0 109.486 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -53.8 120.39 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 126.431 1.892 . . . . 0.0 109.056 159.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.41 128.77 38.38 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.012 168.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -144.1 59.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 111.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.15 152.13 18.01 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.136 0.874 . . . . 0.0 113.366 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -52.24 -29.84 24.77 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.811 1.244 . . . . 0.0 110.11 156.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 m -59.43 -55.39 35.21 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.981 2.513 . . . . 0.0 113.596 167.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -167.35 141.5 3.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.258 1.823 . . . . 0.0 110.123 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -132.59 140.79 48.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.087 1.355 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.7 -136.07 5.87 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 125.702 1.62 . . . . 0.0 110.586 -163.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -161.57 -169.66 2.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.352 2.261 . . . . 0.0 109.076 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -138.33 -43.32 0.5 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 160.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p 62.06 164.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.428 2.011 . . . . 0.0 116.428 -168.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -161.68 -167.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.64 2.776 . . . . 0.0 105.864 156.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -134.97 140.13 45.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.147 -1.595 . . . . 0.0 108.948 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.79 10.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 0.0 112.329 -162.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -61.48 -49.19 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 110.191 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -164.04 178.99 7.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 123.507 1.623 . . . . 0.0 111.611 -160.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 16.85 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.844 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 p -61.28 -25.46 67.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.252 1.821 . . . . 0.0 115.885 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 -46.87 12.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.112 0.415 . . . . 0.0 111.221 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.37 -47.5 85.2 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -58.89 -22.43 59.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.62 -47.21 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.045 1.738 . . . . 0.0 110.946 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -52.26 -43.1 64.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.61 1.164 . . . . 0.0 113.136 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 5.6 mmmm -46.81 -50.58 18.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.967 2.107 . . . . 0.0 111.409 171.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.84 -38.83 70.06 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.69 -36.68 83.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.108 0.867 . . . . 0.0 111.786 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.54 -26.54 32.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.35 -0.844 . . . . 0.0 111.95 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.3 -37.95 81.15 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.051 0.841 . . . . 0.0 111.744 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.44 -40.01 89.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.374 1.47 . . . . 0.0 112.396 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -66.74 -38.44 86.65 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.001 -0.437 . . . . 0.0 111.635 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.07 22.03 9.09 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.173 1.844 . . . . 0.0 113.88 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.31 -65.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.645 1.212 . . . . 0.0 113.021 -163.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.265 23.0 m-20 22.79 64.76 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 130.816 3.646 . . . . 0.0 113.816 -168.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.8 -134.94 6.55 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 108.872 -3.785 . . . . 0.0 113.106 -165.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.43 59.08 0.58 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.353 1.461 . . . . 0.0 109.46 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 5.7 m95 -50.84 100.2 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.933 1.693 . . . . 0.0 112.617 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -136.86 162.86 32.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.542 1.137 . . . . 0.0 111.557 -170.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 55.8 t80 -143.75 153.06 42.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.139 1.776 . . . . 0.0 110.867 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.46 77.79 1.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.367 1.467 . . . . 0.0 112.27 -168.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -22.86 23.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.5 64.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.5 1.92 . . . . 0.0 112.697 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -130.58 -4.91 4.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.824 1.25 . . . . 0.0 113.147 167.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.374 36.2 mttm 57.28 18.09 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.462 3.105 . . . . 0.0 114.748 -167.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -60.85 157.91 14.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.328 1.851 . . . . 0.0 111.538 165.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 37.7 m-85 -122.91 167.81 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.863 2.465 . . . . 0.0 110.942 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -149.73 146.17 27.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.598 -1.314 . . . . 0.0 110.665 167.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.86 88.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.232 1.013 . . . . 0.0 112.678 161.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 58.11 4.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.949 1.3 . . . . 0.0 113.34 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -29.37 59.5 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.785 -1.197 . . . . 0.0 113.204 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.2 -4.7 71.11 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.567 1.556 . . . . 0.0 115.109 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p 51.83 -172.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.966 1.706 . . . . 0.0 113.623 -164.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m80 56.9 19.54 4.61 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.97 54.0 1.22 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 128.47 2.708 . . . . 0.0 107.538 161.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.15 160.12 31.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 113.835 -165.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -49.9 157.46 0.61 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.377 2.271 . . . . 0.0 114.865 169.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 t60 42.92 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.508 2.323 . . . . 0.0 114.889 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -64.76 170.16 4.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.477 1.511 . . . . 0.0 112.888 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.9 tpt -77.36 65.32 2.9 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.455 1.102 . . . . 0.0 112.011 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -60.99 -9.82 4.89 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -167.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -153.79 153.89 32.99 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.981 1.264 . . . . 0.0 113.79 -169.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -154.61 -49.36 0.09 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 129.715 3.206 . . . . 0.0 112.743 -21.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.6 m -104.12 -12.83 16.51 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -158.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.3 p -155.21 152.34 24.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.988 1.715 . . . . 0.0 110.133 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.38 -61.71 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.875 1.717 . . . . 0.0 111.65 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -171.6 -57.4 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.887 1.675 . . . . 0.0 108.001 -171.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -143.28 -108.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.934 2.094 . . . . 0.0 108.651 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 18.7 p -141.65 -6.45 1.01 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.14 -175.92 5.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.193 1.397 . . . . 0.0 111.351 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.42 138.6 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.846 1.657 . . . . 0.0 112.768 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -126.33 140.69 52.32 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.269 1.828 . . . . 0.0 108.632 158.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.94 135.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 108.915 175.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.27 -147.39 5.19 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.702 -0.623 . . . . 0.0 114.193 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.79 -6.12 0.45 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.918 1.687 . . . . 0.0 113.701 -152.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' CD2' ' HG ' ' A' ' 138' ' ' CYS . 17.1 mt -80.67 55.27 2.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.907 1.683 . . . . 0.0 112.264 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.37 42.15 0.4 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 127.788 2.613 . . . . 0.0 114.558 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -157.21 -50.3 0.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.11 2.564 . . . . 0.0 110.482 -167.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.09 -112.63 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.644 2.378 . . . . 0.0 108.182 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.21 69.08 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.486 1.993 . . . . 0.0 116.543 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.25 161.27 5.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.036 2.534 . . . . 0.0 113.639 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -34.82 52.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -71.46 -46.35 60.18 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.101 0.96 . . . . 0.0 112.939 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -33.05 75.03 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.886 -1.134 . . . . 0.0 111.406 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.8 mt -83.54 -36.08 24.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.114 0.965 . . . . 0.0 112.663 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -44.57 -42.87 7.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.456 1.103 . . . . 0.0 110.092 165.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -105.48 -39.57 6.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 118.32 -0.848 . . . . 0.0 112.645 -162.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.4 70.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.809 0.731 . . . . 0.0 112.092 168.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -95.12 -30.8 13.85 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.22 -35.44 6.72 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.996 1.284 . . . . 0.0 114.432 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -58.18 -37.15 74.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -81.27 -20.98 39.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 111.641 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.25 -173.49 33.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.65 0.643 . . . . 0.0 114.124 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.02 156.46 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.306 2.671 . . . . 0.0 112.457 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.51 143.49 50.86 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.089 2.556 . . . . 0.0 108.206 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -95.1 -32.75 12.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.905 1.282 . . . . 0.0 112.247 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 t -166.33 169.28 14.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.992 0.917 . . . . 0.0 111.954 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 t -159.89 127.0 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.279 3.032 . . . . 0.0 107.311 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -156.86 144.71 19.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.613 1.165 . . . . 0.0 111.943 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.14 139.86 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.682 -1.261 . . . . 0.0 113.004 -166.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.59 118.64 20.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.423 1.489 . . . . 0.0 109.569 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 2.67 29.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.76 151.58 92.23 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.2 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.31 143.6 75.46 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.373 2.715 . . . . 0.0 114.627 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.77 -44.78 0.35 Allowed 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.232 0.761 . . . . 0.0 112.37 -18.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.69 140.64 7.9 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.292 1.901 . . . . 0.0 112.937 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -155.82 158.48 38.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.575 1.95 . . . . 0.0 109.139 -166.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.72 156.78 35.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.379 1.472 . . . . 0.0 113.497 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -131.83 148.05 52.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.872 165.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.252 0.7 OUTLIER -143.64 -179.47 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -141.42 106.72 5.01 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 107.731 166.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.94 169.36 0.53 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 165.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.08 25.48 5.88 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.051 0.929 . . . . 0.0 113.244 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.93 132.23 10.25 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.616 -1.303 . . . . 0.0 110.295 160.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.8 -34.01 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.638 2.226 . . . . 0.0 114.639 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.07 -31.77 20.31 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.061 1.3 . . . . 0.0 112.289 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.52 -24.04 60.09 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 167.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.52 -51.04 62.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.533 1.06 . . . . 0.0 111.875 163.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.81 -32.11 63.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.607 -1.308 . . . . 0.0 110.998 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -43.25 55.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.77 -10.65 9.43 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 113.618 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.78 -62.23 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.893 . . . . 0.0 110.732 153.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -49.48 -33.63 14.86 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.672 1.989 . . . . 0.0 114.309 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.7 -13.52 16.45 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 112.193 -164.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.63 -33.09 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.545 1.138 . . . . 0.0 114.025 -161.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -56.75 139.34 51.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.901 1.28 . . . . 0.0 113.125 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.76 4.62 54.45 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.523 1.058 . . . . 0.0 114.898 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -117.38 -109.72 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.292 1.437 . . . . 0.0 110.703 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 m -143.92 153.61 42.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.569 1.547 . . . . 0.0 109.573 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.69 -44.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.029 0.932 . . . . 0.0 112.956 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.5 t -149.66 68.09 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.551 1.54 . . . . 0.0 110.713 -170.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.63 93.34 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.432 1.015 . . . . 0.0 114.651 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.435 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 30.0 p -145.59 -174.57 4.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 113.05 -159.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.7 136.77 51.89 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 153.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.82 163.03 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.227 1.411 . . . . 0.0 112.104 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -135.46 138.01 42.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.947 2.099 . . . . 0.0 108.659 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -139.11 137.05 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.463 0.705 . . . . 0.0 111.121 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -141.2 105.75 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.711 -1.243 . . . . 0.0 109.302 164.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tt -141.77 116.01 9.45 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.961 0.886 . . . . 0.0 110.926 -147.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.7 177.03 9.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.603 2.361 . . . . 0.0 113.407 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -153.41 104.95 2.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.349 2.66 . . . . 0.0 107.54 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.57 38.61 0.32 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.284 0.468 . . . . 0.0 112.53 -167.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.88 1.74 0.25 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.771 1.629 . . . . 0.0 115.214 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.256 8.2 tptp -130.86 50.04 2.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.164 1.386 . . . . 0.0 112.878 165.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 O-C-N 121.234 -0.916 . . . . 0.0 111.109 130.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -151.06 164.19 37.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 129.021 2.929 . . . . 0.0 110.886 -4.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.83 112.05 18.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 166.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -128.32 108.14 10.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.451 1.1 . . . . 0.0 111.906 -168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.4 tp -95.23 98.77 10.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.073 1.349 . . . . 0.0 109.371 172.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.81 115.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.167 2.187 . . . . 0.0 108.888 163.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 136.06 33.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.959 168.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -142.64 51.03 1.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.662 1.185 . . . . 0.0 108.501 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.85 176.36 25.97 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 122.504 1.058 . . . . 0.0 114.4 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -60.28 -40.95 92.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.065 1.346 . . . . 0.0 111.494 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -71.12 -48.63 51.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.639 2.376 . . . . 0.0 113.533 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.42 139.73 14.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.273 1.029 . . . . 0.0 110.482 -169.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -126.45 132.31 51.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.923 1.689 . . . . 0.0 109.79 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.39 -137.78 5.76 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.404 1.478 . . . . 0.0 110.334 -153.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -159.46 -161.22 0.9 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.897 1.679 . . . . 0.0 109.467 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -143.88 -42.34 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 156.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.6 p 55.97 164.41 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -158.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -160.31 -164.36 1.25 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.76 2.424 . . . . 0.0 106.364 156.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -140.35 130.62 25.13 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.697 1.599 . . . . 0.0 107.778 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.48 23.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -157.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.71 -42.14 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.128 1.771 . . . . 0.0 111.825 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -144.31 -58.86 0.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -161.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 134.49 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 131.679 3.991 . . . . 0.0 111.659 -162.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -36.95 10.9 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.592 1.157 . . . . 0.0 109.749 -170.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -74.88 -17.22 60.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.04 2.936 . . . . 0.0 112.457 164.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.7 -54.6 5.71 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.717 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.07 -46.07 44.0 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 125.25 1.42 . . . . 0.0 109.087 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -20.94 13.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -171.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.56 -38.81 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.473 1.509 . . . . 0.0 109.788 -169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -50.38 -46.72 56.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.019 1.328 . . . . 0.0 112.326 163.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.522 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.4 mmpt? -43.8 -55.46 4.46 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.949 1.699 . . . . 0.0 112.024 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.07 -35.21 64.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -60.74 -39.94 90.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.445 1.02 . . . . 0.0 111.302 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 -32.4 38.01 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.181 -0.949 . . . . 0.0 111.168 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.22 -26.29 61.97 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.872 0.76 . . . . 0.0 112.554 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.7 -39.26 77.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 166.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -67.18 -50.58 60.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.197 0.599 . . . . 0.0 111.576 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.8 33.14 0.39 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.269 1.414 . . . . 0.0 113.844 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.77 134.2 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.785 1.234 . . . . 0.0 112.001 -168.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.72 -4.28 5.25 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.54 158.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.45 -127.17 4.61 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.317 1.913 . . . . 0.0 116.365 161.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.89 -14.56 39.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 112.118 171.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.522 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 26.0 m95 8.32 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.271 1.829 . . . . 0.0 114.694 -130.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -73.17 151.09 41.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.629 1.204 . . . . 0.0 110.141 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -154.19 142.52 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 109.961 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -104.76 -37.6 6.99 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 56.61 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.447 3.099 . . . . 0.0 117.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.64 -28.5 69.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.434 1.893 . . . . 0.0 111.965 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.2 p -125.08 5.03 7.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.158 1.783 . . . . 0.0 113.274 166.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt 57.55 -5.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 128.177 2.591 . . . . 0.0 116.81 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -39.57 150.45 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.055 2.542 . . . . 0.0 114.473 156.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -131.99 162.9 29.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 131.252 3.821 . . . . 0.0 110.645 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.0 m -148.79 141.3 24.33 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 167.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.45 111.46 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.54 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 m -119.94 96.5 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.565 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.71 14.6 5.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.914 1.286 . . . . 0.0 113.972 172.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.36 38.06 0.57 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.479 1.99 . . . . 0.0 114.065 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 m -65.06 2.16 0.82 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.71 3.204 . . . . 0.0 115.579 -170.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -59.76 -22.73 62.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.328 1.051 . . . . 0.0 113.419 170.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 52.63 -10.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -140.84 7.13 2.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.909 1.684 . . . . 0.0 113.364 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.11 153.97 40.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.241 1.016 . . . . 0.0 112.905 174.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -82.56 46.68 1.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.858 1.663 . . . . 0.0 114.799 -166.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -69.56 33.91 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 O-C-N 120.688 -1.257 . . . . 0.0 114.235 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 tpp -77.81 53.43 1.14 Allowed 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.202 -2.186 . . . . 0.0 109.61 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -132.12 6.41 4.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.677 1.591 . . . . 0.0 113.311 -167.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.77 139.07 22.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.216 1.006 . . . . 0.0 111.591 168.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.72 -79.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.113 2.165 . . . . 0.0 113.201 -2.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 p -146.5 -59.66 0.3 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 71' ' ' PRO . 65.7 m 57.06 -171.62 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 124.89 1.276 . . . . 0.0 112.447 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 70' ' ' CYS . 71.5 Cg_endo -130.0 -99.39 0.0 OUTLIER 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 122.089 1.782 . . . . 0.0 112.619 -6.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -128.72 -45.29 1.31 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.755 2.022 . . . . 0.0 109.557 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -149.78 -71.76 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 150.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.8 t -159.22 -18.12 0.07 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -157.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -179.18 7.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.845 2.058 . . . . 0.0 110.573 -172.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.76 143.87 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 120.877 1.672 . . . . 0.0 107.34 156.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.39 146.29 25.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.409 1.083 . . . . 0.0 110.941 -168.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.14 157.41 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.222 158.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -165.16 14.86 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 114.836 0.694 . . . . 0.0 114.836 170.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.01 -5.47 2.17 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 127.205 2.202 . . . . 0.0 113.262 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 84' ' ' ASN . 0.2 OUTLIER -94.63 46.24 1.14 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.639 1.576 . . . . 0.0 113.316 -150.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.36 -29.7 75.32 Favored Glycine 0 CA--C 1.537 1.466 0 N-CA-C 118.418 2.127 . . . . 0.0 118.418 -160.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -70.87 -35.01 72.18 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.239 2.019 . . . . 0.0 113.682 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 HD22 ' CD1' ' A' ' 81' ' ' LEU . 1.6 p-10 -129.35 -16.69 3.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.95 108.17 0.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -157.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -138.66 169.04 18.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.833 2.053 . . . . 0.0 111.003 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.87 -47.91 70.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.2 m -76.14 -30.93 58.35 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -160.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -58.76 -34.71 71.73 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.034 -1.041 . . . . 0.0 112.411 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.46 -35.14 40.79 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 111.778 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.07 -29.46 65.44 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.442 0.697 . . . . 0.0 111.595 171.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.47 -48.94 7.54 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.01 -23.6 54.82 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -117.54 -19.04 9.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 113.25 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.28 -38.16 18.99 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.644 1.116 . . . . 0.0 114.048 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -55.94 -36.95 68.35 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.84 1.42 55.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.186 1.394 . . . . 0.0 112.29 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.34 166.77 12.32 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.773 1.178 . . . . 0.0 114.779 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.87 116.15 4.61 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.334 2.689 . . . . 0.0 111.505 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.83 138.58 58.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.466 0.651 . . . . 0.0 110.528 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -14.31 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.136 2.174 . . . . 0.0 112.665 -167.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -151.92 150.04 29.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.265 1.826 . . . . 0.0 108.539 159.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 91.5 t -155.58 128.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.27 1.028 . . . . 0.0 110.987 -176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -150.21 148.25 28.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.12 2.168 . . . . 0.0 110.19 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.69 155.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.156 -0.965 . . . . 0.0 112.296 168.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -130.41 161.5 31.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.74 1.616 . . . . 0.0 112.718 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -111.38 12.34 21.56 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.033 1.333 . . . . 0.0 113.279 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -142.03 104.74 5.68 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.683 1.593 . . . . 0.0 108.568 157.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.74 153.05 16.41 Favored 'Cis proline' 0 CA--C 1.546 1.119 0 CA-C-N 120.792 1.318 . . . . 0.0 115.336 -1.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.55 84.32 0.99 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.469 3.446 . . . . 0.0 113.947 -166.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.07 53.73 1.85 Allowed Glycine 0 N--CA 1.466 0.685 0 C-N-CA 123.885 0.755 . . . . 0.0 112.585 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -124.99 129.43 50.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.97 1.308 . . . . 0.0 109.025 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.32 160.85 25.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.41 1.484 . . . . 0.0 112.228 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -141.34 148.89 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.387 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.99 171.95 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 -165.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.97 141.95 36.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 109.311 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -151.76 157.39 41.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.202 1.401 . . . . 0.0 110.701 150.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.77 47.4 0.88 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.053 0.93 . . . . 0.0 113.016 -148.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.0 142.33 24.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.409 1.884 . . . . 0.0 110.602 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.65 -28.47 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.085 2.523 . . . . 0.0 114.836 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.67 -57.49 3.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.96 1.255 . . . . 0.0 113.09 -164.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.4 -27.18 65.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.585 1.154 . . . . 0.0 111.647 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.21 68.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.96 -31.42 70.98 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.662 -1.274 . . . . 0.0 110.562 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.36 -45.83 82.58 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.769 -0.582 . . . . 0.0 112.55 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -15.9 54.88 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.2 t -79.27 -52.89 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.768 -1.208 . . . . 0.0 109.673 159.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -25.29 65.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.033 1.733 . . . . 0.0 115.017 -175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -97.37 -19.64 18.35 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.339 1.856 . . . . 0.0 112.018 -174.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 -18.1 0.34 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -148.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.69 130.28 37.53 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.149 -0.969 . . . . 0.0 113.285 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.25 86.54 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.076 1.322 . . . . 0.0 115.05 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -78.63 -161.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 128.028 2.531 . . . . 0.0 112.678 -173.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.9 m -112.8 137.52 51.0 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.716 1.606 . . . . 0.0 107.969 155.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.75 133.4 35.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 110.398 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 8.6 t 58.52 -55.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.983 2.513 . . . . 0.0 115.151 -170.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.58 18.24 0.05 OUTLIER Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.509 1.528 . . . . 0.0 115.432 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.2 p -151.38 159.82 44.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.999 1.399 . . . . 0.0 112.659 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -58.04 144.35 40.18 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.494 1.117 . . . . 0.0 110.475 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.88 159.59 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.243 1.417 . . . . 0.0 112.793 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.53 135.96 40.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 164.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -143.92 138.86 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.337 0.971 . . . . 0.0 110.917 -162.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -153.54 126.12 8.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.88 -1.137 . . . . 0.0 111.824 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -135.16 109.06 8.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 m 131.44 134.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 129.439 3.096 . . . . 0.0 114.693 134.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.423 ' H ' ' CA ' ' A' ' 147' ' ' GLY . 17.7 p-10 -154.38 -23.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.082 2.953 . . . . 0.0 115.36 -12.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' CA ' ' H ' ' A' ' 146' ' ' ASN . . . -158.78 -65.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 130.021 3.676 . . . . 0.0 112.109 -19.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -88.75 54.5 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.455 -1.027 . . . . 0.0 112.607 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 19.89 6.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.574 1.949 . . . . 0.0 113.203 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.323 0 C-N-CA 127.636 2.374 . . . . 0.0 112.517 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -152.42 162.56 41.02 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.15 2.58 . . . . 0.0 111.357 -6.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -131.76 112.85 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 157.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -130.05 146.13 51.7 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 127.199 2.2 . . . . 0.0 108.885 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.6 tp -122.16 99.38 6.4 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.559 1.944 . . . . 0.0 109.305 162.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -62.12 130.31 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.759 1.624 . . . . 0.0 109.514 160.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.63 132.09 48.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.646 171.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -145.62 54.96 1.19 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.811 1.244 . . . . 0.0 111.296 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 11' ' ' THR . . . -116.52 179.89 17.78 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -73.67 15.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 128.499 2.72 . . . . 0.0 112.954 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 9' ' ' GLY . 2.1 p -142.22 -57.34 0.45 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 127.533 2.333 . . . . 0.0 108.932 -144.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -156.6 146.77 21.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.869 2.068 . . . . 0.0 109.321 162.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -128.83 142.41 50.98 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.884 1.274 . . . . 0.0 111.828 167.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.66 -136.55 6.28 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 125.149 1.357 . . . . 0.0 109.985 -159.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -160.83 -158.92 0.63 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.483 1.513 . . . . 0.0 110.113 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -143.84 -47.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 154.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.9 p 57.09 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.774 1.63 . . . . 0.0 115.263 -158.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -157.93 -18.0 0.08 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.59 141.63 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.627 2.371 . . . . 0.0 116.942 -163.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.28 -164.24 1.97 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.354 1.461 . . . . 0.0 111.47 -174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.44 -15.76 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.407 1.883 . . . . 0.0 111.676 -163.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -145.22 -9.08 0.59 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.19 30.97 19.25 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.989 1.316 . . . . 0.0 113.337 -167.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.1 -37.52 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.765 1.626 . . . . 0.0 112.012 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.84 -24.61 66.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.51 2.724 . . . . 0.0 112.456 158.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.83 -53.82 9.38 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.85 -0.531 . . . . 0.0 109.813 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -49.96 -46.86 52.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 125.525 1.53 . . . . 0.0 109.229 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -54.88 -25.02 26.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.21 -40.32 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 109.146 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -50.72 -48.45 58.89 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.289 1.436 . . . . 0.0 112.431 165.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.6 mmpt? -43.8 -55.03 4.74 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.867 1.667 . . . . 0.0 112.089 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -73.52 -35.25 65.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -63.48 -41.23 98.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.863 0.756 . . . . 0.0 110.99 172.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.49 -36.4 63.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.314 -0.866 . . . . 0.0 109.926 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.33 -33.21 75.43 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.283 0.492 . . . . 0.0 111.543 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.78 -36.44 78.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.031 1.332 . . . . 0.0 113.603 169.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.59 -20.78 64.52 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.01 20.12 7.33 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.904 1.716 . . . . 0.0 113.385 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.59 123.03 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.942 1.297 . . . . 0.0 111.925 -161.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.61 69.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 124.924 2.297 . . . . 0.0 108.897 155.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -149.98 0.24 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 109.413 -3.54 . . . . 0.0 114.046 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.88 24.38 0.4 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.371 1.868 . . . . 0.0 111.954 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.531 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 32.5 m95 -6.42 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.451 3.501 . . . . 0.0 115.368 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.9 m -103.4 158.68 16.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 109.298 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -137.14 143.76 42.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.591 1.556 . . . . 0.0 109.826 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.13 60.01 1.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.439 1.496 . . . . 0.0 110.012 -155.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.89 -25.71 0.83 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.608 3.163 . . . . 0.0 117.372 -172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.88 -21.64 66.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.147 2.179 . . . . 0.0 112.559 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -131.27 -3.42 3.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.366 1.867 . . . . 0.0 112.86 168.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.299 35.6 mttm 54.94 20.03 2.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.415 2.686 . . . . 0.0 114.732 -169.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.7 m -60.34 165.04 3.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.754 1.621 . . . . 0.0 111.682 157.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -132.84 152.63 51.79 Favored 'General case' 0 C--N 1.324 -0.534 1 C-N-CA 132.327 4.251 . . . . 0.0 108.03 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -145.82 116.11 7.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.696 0.284 . . . . 0.0 110.247 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -96.98 88.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-O 122.144 0.973 . . . . 0.0 112.081 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -69.96 113.74 7.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.18 156.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -116.78 -20.27 9.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.511 1.125 . . . . 0.0 112.289 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.58 -3.83 62.53 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 121.212 -0.93 . . . . 0.0 115.224 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.3 p -33.23 -37.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 129.477 3.111 . . . . 0.0 118.041 -167.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -19.14 61.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.408 2.283 . . . . 0.0 114.122 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -159.19 -44.67 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.683 1.193 . . . . 0.0 112.55 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.29 62.12 0.93 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.169 1.787 . . . . 0.0 110.03 159.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -53.99 169.07 0.18 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.424 1.49 . . . . 0.0 114.741 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -66.38 -33.8 76.53 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.616 -1.303 . . . . 0.0 111.375 164.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.43 174.75 3.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.929 1.292 . . . . 0.0 111.917 164.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 58.6 mtp -56.27 133.47 52.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.987 -1.071 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -67.1 150.03 49.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.41 -0.806 . . . . 0.0 112.319 -166.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -0.21 50.94 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -121.63 -5.59 9.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.929 1.691 . . . . 0.0 114.773 -169.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -145.99 152.41 39.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.676 1.191 . . . . 0.0 112.243 -167.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.12 154.93 80.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.533 1.533 . . . . 0.0 108.241 160.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.71 -42.9 42.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.609 1.539 . . . . 0.0 111.164 168.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.8 tt -158.49 -50.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.501 2.32 . . . . 0.0 109.385 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.26 19.3 t70 135.92 136.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 1 C-N-CA 133.6 4.76 . . . . 0.0 111.464 161.384 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . 0.313 1.5 t 61.81 21.13 12.0 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 121.479 3.881 . . . . 0.0 121.479 154.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp 75.98 159.86 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 120.256 1.389 . . . . 0.0 109.176 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.91 150.65 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.098 -1.001 . . . . 0.0 111.357 -169.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -125.98 139.09 53.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.765 0.826 . . . . 0.0 110.098 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.64 136.29 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.413 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.94 31.96 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 121.524 -0.735 . . . . 0.0 114.672 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 63.63 17.6 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.474 1.11 . . . . 0.0 113.96 -170.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -33.91 76.89 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.163 -0.96 . . . . 0.0 111.622 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.79 -60.38 0.34 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.652 2.549 . . . . 0.0 116.215 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.57 -29.32 37.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.434 1.894 . . . . 0.0 112.957 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -153.67 -153.65 0.48 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.703 2.401 . . . . 0.0 109.044 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.18 -17.52 5.11 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 128.068 2.747 . . . . 0.0 112.58 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -37.37 74.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 132.421 4.288 . . . . 0.0 116.781 169.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.2 tttm 52.11 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.626 3.171 . . . . 0.0 116.847 167.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.9 m -66.96 -26.86 67.04 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 121.07 1.759 . . . . 0.0 114.648 -158.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.73 -30.6 70.88 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.435 -1.416 . . . . 0.0 113.198 168.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.9 mt -90.83 -25.21 20.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.85 1.66 . . . . 0.0 111.998 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.41 -30.63 69.73 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.384 0.993 . . . . 0.0 109.81 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.87 -47.23 8.74 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.685 1.194 . . . . 0.0 113.085 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.76 -25.09 64.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.085 1.311 . . . . 0.0 113.373 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -105.24 -31.09 9.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.592 1.157 . . . . 0.0 110.943 174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.23 -32.92 44.7 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.345 1.45 . . . . 0.0 115.512 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -57.36 -39.49 76.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.329 1.064 . . . . 0.0 112.589 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -75.31 -25.9 58.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.865 0.466 . . . . 0.0 111.944 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.95 -176.5 40.71 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -174.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 147.6 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.851 3.034 . . . . 0.0 112.493 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mp -113.79 141.42 47.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.041 1.736 . . . . 0.0 110.671 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -114.94 -16.22 11.71 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.402 1.881 . . . . 0.0 114.434 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -159.68 150.96 19.72 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.065 1.346 . . . . 0.0 110.347 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.7 t -154.86 134.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 126.158 1.783 . . . . 0.0 109.81 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -153.79 158.55 41.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.493 1.517 . . . . 0.0 111.455 166.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -149.29 143.67 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.15 130.72 38.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.648 1.979 . . . . 0.0 111.059 166.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 -1.69 5.71 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.22 -46.68 85.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.333 158.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.81 173.85 13.29 Favored 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.071 2.514 . . . . 0.0 111.571 162.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -57.22 35.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.554 1.491 1 C-N-CA 126.663 4.909 . . . . 0.0 119.677 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.47 63.43 1.56 Allowed Glycine 0 N--CA 1.47 0.939 0 O-C-N 119.686 -1.884 . . . . 0.0 112.101 168.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -109.72 112.74 24.98 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.005 1.322 . . . . 0.0 109.961 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.02 158.06 16.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.554 1.169 . . . . 0.0 112.092 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -139.34 130.34 26.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.013 163.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.42 -178.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.689 0.795 . . . . 0.0 111.235 -171.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -154.01 136.06 14.7 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.452 -1.405 . . . . 0.0 110.797 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.87 154.2 27.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.441 1.497 . . . . 0.0 112.548 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.88 -7.6 58.82 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.101 -0.999 . . . . 0.0 112.595 164.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.05 109.43 27.47 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.815 1.646 . . . . 0.0 110.805 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.75 -31.7 95.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.154 3.236 . . . . 0.0 115.718 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -73.66 -41.88 62.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 110.547 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.54 -30.28 71.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.802 0.728 . . . . 0.0 112.415 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.78 78.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.762 0.825 . . . . 0.0 112.189 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.25 74.12 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.496 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -49.97 48.17 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.68 -11.03 31.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.552 1.541 . . . . 0.0 114.465 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.28 -52.8 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 157.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -31.53 69.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.833 1.253 . . . . 0.0 114.089 -172.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.61 -0.8 20.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.634 1.574 . . . . 0.0 111.924 -163.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -23.64 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.577 1.551 . . . . 0.0 113.233 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.31 125.18 23.01 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.138 -0.977 . . . . 0.0 111.436 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.7 9.1 87.36 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -84.78 -176.23 6.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.319 1.448 . . . . 0.0 112.44 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.7 m -134.9 93.07 2.96 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.042 1.737 . . . . 0.0 108.806 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.59 -39.51 31.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.754 1.222 . . . . 0.0 112.686 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 76.3 m -144.49 46.1 1.4 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.822 1.249 . . . . 0.0 112.926 -162.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.31 72.58 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.139 -0.976 . . . . 0.0 113.119 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.5 p -112.04 -166.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.456 2.303 . . . . 0.0 111.862 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -147.03 53.07 1.08 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.2 1.0 . . . . 0.0 111.373 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.56 156.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 126.98 2.112 . . . . 0.0 113.936 -170.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.23 152.11 42.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.35 1.46 . . . . 0.0 110.183 158.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.2 t -144.51 128.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.891 0.876 . . . . 0.0 109.531 -162.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.7 170.51 8.72 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.026 1.73 . . . . 0.0 110.219 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -130.56 140.78 50.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.218 -1.552 . . . . 0.0 112.481 -145.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -174.67 -28.59 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 1 C-N-CA 132.068 4.147 . . . . 0.0 115.315 -7.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.19 129.98 4.55 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 119.694 -1.879 . . . . 0.0 113.064 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.62 102.46 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.043 0.83 . . . . 0.0 112.525 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.02 54.17 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.622 1.569 . . . . 0.0 110.934 162.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -105.26 149.6 25.86 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.189 1.796 . . . . 0.0 113.879 -161.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.254 1.339 0 C-N-CA 128.236 2.614 . . . . 0.0 110.565 162.488 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -80.17 94.36 6.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 97.22 4.35 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.385 -151.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -87.57 86.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.068 1.347 . . . . 0.0 109.903 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -56.33 101.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.351 2.261 . . . . 0.0 109.155 163.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.2 mp -78.99 136.09 37.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 165.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -145.33 54.8 1.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.721 2.008 . . . . 0.0 108.576 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.54 -177.91 21.82 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -171.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -51.11 -48.37 61.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.486 1.114 . . . . 0.0 110.608 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 m -74.79 -63.34 1.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.732 2.413 . . . . 0.0 113.679 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.57 141.69 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.252 1.021 . . . . 0.0 110.456 -168.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 96.6 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.752 2.021 . . . . 0.0 108.833 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.45 23.87 0.02 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 120.684 3.033 . . . . 0.0 120.684 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU 0.255 0.6 OUTLIER 54.61 -175.96 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.084 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -154.81 -32.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 164.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p 59.0 161.96 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.2 t -160.82 -162.07 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.331 2.252 . . . . 0.0 108.835 153.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -148.23 151.32 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 111.783 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.13 -177.67 6.06 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.355 1.862 . . . . 0.0 111.143 -167.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.37 -18.32 9.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 112.203 -2.271 . . . . 0.0 112.6 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -148.65 -9.01 0.36 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 23.13 13.49 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.111 1.765 . . . . 0.0 114.462 -168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.03 -38.47 1.1 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.309 1.844 . . . . 0.0 110.571 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.0 m -57.66 -21.21 38.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.356 1.862 . . . . 0.0 112.458 149.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.87 -47.65 16.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.264 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -48.03 80.42 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -68.22 -7.53 31.15 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -166.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.29 -38.22 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.76 2.424 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 18' ' ' THR . 18.1 m-30 -53.13 -43.01 66.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.679 1.127 . . . . 0.0 112.083 162.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -43.63 -56.18 3.89 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.061 2.144 . . . . 0.0 111.277 168.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.75 -34.69 67.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -57.94 -42.96 86.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.756 1.162 . . . . 0.0 110.952 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.95 -33.46 39.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.371 -0.83 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.3 -26.76 63.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.177 0.898 . . . . 0.0 112.528 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.48 -40.4 77.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.111 1.364 . . . . 0.0 112.638 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -64.62 -43.58 93.28 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.764 -0.585 . . . . 0.0 111.655 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 27.79 1.29 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.713 1.625 . . . . 0.0 114.095 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 139.86 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.276 1.83 . . . . 0.0 111.287 -168.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 6.28 4.03 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 157.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.9 -130.34 10.14 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.203 1.859 . . . . 0.0 116.55 159.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -92.86 -13.29 29.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.017 1.727 . . . . 0.0 111.759 167.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.497 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 47.3 m95 6.61 82.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.041 1.736 . . . . 0.0 115.68 -127.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 m -82.2 156.86 24.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.692 1.234 . . . . 0.0 110.642 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -148.31 151.48 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.191 1.797 . . . . 0.0 110.559 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 23.8 t70 -124.31 143.62 50.46 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.955 1.702 . . . . 0.0 109.065 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.24 -15.94 12.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.14 57.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.376 1.87 . . . . 0.0 111.638 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.0 p -120.12 -7.4 9.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.417 1.887 . . . . 0.0 112.65 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.378 35.6 mttm 65.27 12.69 8.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.519 1.528 . . . . 0.0 114.759 -174.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -54.56 153.84 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.36 2.264 . . . . 0.0 113.913 166.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -125.09 166.14 16.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.719 2.408 . . . . 0.0 112.318 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.5 m -151.75 139.16 19.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.421 -1.424 . . . . 0.0 112.086 167.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.0 89.06 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.055 1.342 . . . . 0.0 113.463 171.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -99.77 79.13 2.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.071 0.948 . . . . 0.0 112.643 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 124.498 1.119 . . . . 0.0 114.001 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.0 137.21 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 163.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -137.53 143.79 41.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.156 1.783 . . . . 0.0 109.822 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 23.1 t -138.06 145.23 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.267 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.81 -178.98 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.133 0.852 . . . . 0.0 115.193 161.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 72.84 13.65 5.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 115.418 -171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.5 OUTLIER -76.09 28.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.358 1.863 . . . . 0.0 112.102 178.037 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.14 -18.42 27.52 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 117.28 1.672 . . . . 0.0 117.28 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -89.69 -9.1 50.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.595 1.158 . . . . 0.0 113.901 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' LEU . 2.6 p-10 -154.65 -21.46 0.12 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -164.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.34 109.54 0.7 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -149.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -138.17 164.11 29.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.235 1.414 . . . . 0.0 112.057 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -67.93 -37.0 81.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.9 m -66.48 -48.11 70.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.186 0.994 . . . . 0.0 112.556 -169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.24 -37.63 80.95 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.678 -0.639 . . . . 0.0 111.69 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.96 -37.17 29.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.495 1.118 . . . . 0.0 112.319 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -47.43 -39.17 14.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.845 1.258 . . . . 0.0 111.338 169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -106.9 -26.98 10.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.335 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.3 93.7 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.688 0.677 . . . . 0.0 111.58 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -81.58 -35.24 30.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.819 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.06 -37.1 5.5 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.658 1.599 . . . . 0.0 114.863 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -59.45 -44.99 92.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.29 -23.68 40.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.525 0.73 . . . . 0.0 110.878 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.28 166.45 30.1 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.102 1.334 . . . . 0.0 113.869 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 153.16 56.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.34 2.693 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.64 122.12 46.07 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 109.176 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -74.75 -33.57 62.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.565 0.746 . . . . 0.0 111.454 166.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -142.67 157.5 44.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.303 0.502 . . . . 0.0 111.916 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.66 144.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.553 1.541 . . . . 0.0 110.825 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.11 151.24 17.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.919 1.688 . . . . 0.0 110.951 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.72 144.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 170.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 126.266 1.826 . . . . 0.0 112.181 175.714 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.36 132.32 56.61 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.975 1.71 . . . . 0.0 109.385 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -128.57 163.87 24.06 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.592 1.557 . . . . 0.0 113.865 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -140.82 147.06 38.44 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.833 165.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.98 177.93 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 121.102 -0.999 . . . . 0.0 111.995 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.33 102.79 4.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.326 1.05 . . . . 0.0 110.701 172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -70.22 165.11 22.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 110.605 140.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.02 -36.95 11.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.583 -0.698 . . . . 0.0 112.796 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.04 131.47 83.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.113 0.965 . . . . 0.0 112.313 -172.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.79 -8.99 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.429 2.753 . . . . 0.0 115.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -112.62 -41.42 3.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.347 1.859 . . . . 0.0 110.851 -160.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 -29.96 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.534 0.606 . . . . 0.0 111.225 159.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.01 70.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.777 0.831 . . . . 0.0 112.399 168.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.04 -30.41 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.07 -1.019 . . . . 0.0 111.226 170.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.02 -35.46 69.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.524 1.057 . . . . 0.0 113.693 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.95 -27.71 69.32 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.181 -1.575 . . . . 0.0 112.824 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.43 -37.26 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 119.205 -2.184 . . . . 0.0 110.926 165.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -62.46 -34.36 76.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.725 -1.235 . . . . 0.0 112.998 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -128.82 -14.33 4.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -158.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -17.07 7.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.203 1.001 . . . . 0.0 113.604 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -82.91 159.86 22.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.092 1.314 . . . . 0.0 112.24 165.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.78 5.47 88.51 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.601 1.096 . . . . 0.0 115.175 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.98 -137.64 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.933 1.693 . . . . 0.0 112.134 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 m -141.41 123.8 15.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.721 2.409 . . . . 0.0 108.616 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.58 131.85 56.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.195 1.398 . . . . 0.0 108.88 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 9.0 t 59.44 -58.14 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.656 2.382 . . . . 0.0 115.906 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.45 35.58 0.08 OUTLIER Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.0 1.285 . . . . 0.0 114.362 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.5 p -129.66 -163.57 1.31 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.85 1.26 . . . . 0.0 113.941 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -130.98 63.82 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.34 1.856 . . . . 0.0 109.558 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.82 161.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 130.012 3.325 . . . . 0.0 117.657 -165.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.87 149.15 41.58 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.922 1.289 . . . . 0.0 110.21 140.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.48 145.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.678 1.191 . . . . 0.0 110.12 -167.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 109.62 -179.39 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.385 0.612 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -136.51 100.3 4.32 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.92 116.08 14.31 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -157.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.9 tp -101.62 95.02 6.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.683 1.193 . . . . 0.0 110.432 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -55.65 108.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 128.122 2.569 . . . . 0.0 109.37 159.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.565 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.9 mp -86.08 139.85 30.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 167.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -147.82 47.77 1.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.419 1.887 . . . . 0.0 108.496 172.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.68 -169.94 23.57 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 -162.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -43.71 -31.89 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.953 2.101 . . . . 0.0 114.308 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -126.26 -44.59 1.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.773 1.629 . . . . 0.0 112.589 -148.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -154.7 142.85 20.3 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.705 1.602 . . . . 0.0 108.22 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -136.91 127.18 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.709 1.604 . . . . 0.0 109.084 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.59 31.82 0.26 Allowed Glycine 0 N--CA 1.477 1.404 0 N-CA-C 117.896 1.918 . . . . 0.0 117.896 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER 56.59 -177.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -144.73 -27.53 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p 61.83 161.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.439 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -164.57 -175.06 3.68 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.32 2.248 . . . . 0.0 108.561 163.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -142.68 134.44 26.81 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.894 1.678 . . . . 0.0 108.416 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.7 6.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.133 0.968 . . . . 0.0 113.514 -161.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 21' ' ' VAL . 27.5 t -47.57 -59.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.742 2.017 . . . . 0.0 111.052 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -172.96 177.94 2.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.005 2.122 . . . . 0.0 108.997 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.89 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.774 2.03 . . . . 0.0 113.735 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 -58.74 2.05 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -67.13 -29.98 69.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.169 1.788 . . . . 0.0 113.165 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.76 -46.61 29.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.829 -0.544 . . . . 0.0 110.468 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.33 -44.16 83.98 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -54.08 -28.76 41.2 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.67 -38.28 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.088 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HG22 ' A' ' 18' ' ' THR . 10.9 m-85 -54.94 -42.38 72.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -39.74 -53.72 2.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.909 2.083 . . . . 0.0 110.54 167.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -82.32 -31.47 29.89 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.581 1.952 . . . . 0.0 114.737 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.42 -41.75 98.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.349 0.977 . . . . 0.0 111.212 168.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -76.79 -36.75 56.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.278 -0.889 . . . . 0.0 109.855 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.35 -28.41 67.94 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.235 0.925 . . . . 0.0 112.501 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.9 -39.96 75.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 113.093 168.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -63.95 -34.26 77.57 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 121.707 -0.621 . . . . 0.0 111.957 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.59 17.92 5.45 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.128 1.823 . . . . 0.0 113.656 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 1.3 t -107.3 140.3 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.749 1.62 . . . . 0.0 111.956 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.08 -9.2 3.01 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.623 1.169 . . . . 0.0 113.132 156.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.14 -99.03 0.01 OUTLIER Glycine 0 C--N 1.34 0.805 0 C-N-CA 129.699 3.523 . . . . 0.0 118.767 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.86 11.13 3.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.377 1.871 . . . . 0.0 110.298 -167.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.41 ' CE3' HG13 ' A' ' 54' ' ' VAL . 10.6 m95 -16.62 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.937 2.495 . . . . 0.0 115.502 -156.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -116.89 163.29 16.41 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.744 1.618 . . . . 0.0 110.944 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -145.63 157.69 43.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.964 2.106 . . . . 0.0 111.11 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -135.7 125.79 26.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.572 2.349 . . . . 0.0 110.479 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.24 -21.07 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.78 60.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.659 0.784 . . . . 0.0 112.23 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.1 p -136.71 -2.39 2.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.428 1.491 . . . . 0.0 113.033 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.355 34.6 mtpt 65.16 17.54 11.08 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.904 2.482 . . . . 0.0 113.787 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -66.96 159.44 28.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.994 2.918 . . . . 0.0 114.478 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -122.14 164.53 17.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 130.056 3.342 . . . . 0.0 112.779 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.4 m -150.14 143.89 25.34 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.64 -1.288 . . . . 0.0 112.527 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -127.51 128.65 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.216 1.006 . . . . 0.0 112.939 160.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -132.61 100.6 5.01 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.259 1.824 . . . . 0.0 110.748 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -174.347 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 115' ' ' VAL . 43.9 t -109.0 142.02 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 120.651 -1.281 . . . . 0.0 108.455 161.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.29 133.7 24.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.706 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 142' ' ' VAL . 50.9 t -137.69 148.58 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.419 0.688 . . . . 0.0 109.624 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.37 -166.9 20.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 60.99 14.65 5.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.917 1.687 . . . . 0.0 113.737 -157.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.66 46.37 1.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.01 1.724 . . . . 0.0 113.3 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.96 93.82 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.923 -1.11 . . . . 0.0 115.569 -166.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.82 -35.57 78.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -167.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -146.06 -28.31 0.42 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -163.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.68 111.89 1.06 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.599 0.618 . . . . 0.0 113.757 -155.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -129.05 -31.22 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 116.516 -1.707 . . . . 0.0 113.898 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.8 tttm 153.12 -60.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 129.374 3.07 . . . . 0.0 112.876 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.8 m -74.16 -26.14 60.13 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -161.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -26.65 65.77 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.873 -1.142 . . . . 0.0 113.682 167.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.8 mt -89.48 -34.55 16.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.966 1.306 . . . . 0.0 111.564 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -54.35 -35.39 62.7 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.747 -0.596 . . . . 0.0 112.321 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -88.06 -42.33 12.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.29 -30.24 64.55 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.037 1.29 . . . . 0.0 113.16 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -106.86 -22.91 12.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.968 0.907 . . . . 0.0 112.102 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.7 -35.11 7.36 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.039 1.78 . . . . 0.0 114.383 161.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -53.6 -42.58 67.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.641 1.176 . . . . 0.0 113.18 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -85.29 -24.52 27.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.878 0.871 . . . . 0.0 110.895 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 124.81 -74.13 0.41 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 153.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.5 43.98 1.6 Allowed 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.269 3.312 . . . . 0.0 114.831 -158.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.84 154.28 15.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.439 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -139.13 -20.9 0.96 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.047 1.739 . . . . 0.0 113.314 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -163.95 149.7 11.01 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.758 0.823 . . . . 0.0 110.812 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -151.1 121.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.091 1.756 . . . . 0.0 107.986 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -148.19 150.59 34.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.317 1.447 . . . . 0.0 110.304 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.51 157.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.718 -1.239 . . . . 0.0 113.582 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 126.487 1.915 . . . . 0.0 113.055 -173.6 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 CA-C-O 117.961 -1.466 . . . . 0.0 116.597 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.93 145.94 40.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.844 1.822 . . . . 0.0 114.048 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 161.9 35.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.451 3.1 . . . . 0.0 113.287 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.3 144.0 23.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.24 1.416 . . . . 0.0 110.731 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG13 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -152.36 174.51 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.137 -0.977 . . . . 0.0 110.93 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.34 120.44 13.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.085 1.354 . . . . 0.0 109.588 167.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.73 159.78 20.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.338 1.055 . . . . 0.0 110.046 153.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.82 -22.61 31.71 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.427 -1.421 . . . . 0.0 114.276 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.92 136.7 29.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.733 0.813 . . . . 0.0 112.678 -162.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.4 -33.67 17.46 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.934 2.423 . . . . 0.0 114.827 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -41.1 44.43 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.728 1.604 . . . . 0.0 113.444 -166.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.17 -26.82 60.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.701 0.682 . . . . 0.0 112.36 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.22 -45.13 67.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.368 0.667 . . . . 0.0 111.809 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.24 81.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 120.685 -1.26 . . . . 0.0 110.322 172.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -39.82 78.42 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.96 -17.99 58.85 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.904 -1.122 . . . . 0.0 113.914 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 -53.08 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.548 -1.345 . . . . 0.0 110.004 160.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -61.06 -24.47 66.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.168 1.787 . . . . 0.0 113.97 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.86 -8.21 15.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.158 1.383 . . . . 0.0 112.091 -168.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -152.07 -30.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -154.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -63.99 132.95 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.913 0.779 . . . . 0.0 111.772 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.35 79.15 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.749 0.69 . . . . 0.0 114.323 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -111.56 -117.43 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.325 1.45 . . . . 0.0 110.114 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -154.33 148.88 26.3 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.495 1.498 . . . . 0.0 110.257 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.83 -48.4 0.46 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.6 m -134.52 35.97 3.17 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.212 1.405 . . . . 0.0 112.163 -167.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.22 24.76 67.81 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.335 -0.853 . . . . 0.0 113.165 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.8 p -134.41 144.47 48.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.878 2.071 . . . . 0.0 110.755 -172.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -75.49 67.75 2.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.406 1.082 . . . . 0.0 111.133 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 p -54.67 151.54 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.844 2.057 . . . . 0.0 113.943 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.3 132.61 35.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.275 1.83 . . . . 0.0 109.434 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 78' ' ' VAL . 4.9 t -148.63 129.91 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 117.973 0.351 . . . . 0.0 111.209 -152.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.477 0.904 0 O-C-N 119.954 -1.716 . . . . 0.0 111.629 167.388 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.91 110.46 10.81 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.39 101.83 5.31 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.023 0.929 . . . . 0.0 111.488 -165.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.922 0.889 . . . . 0.0 109.851 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.6 mt -59.53 113.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.576 2.35 . . . . 0.0 109.37 160.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.04 136.6 32.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.744 164.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -144.02 42.84 1.44 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.84 2.056 . . . . 0.0 107.403 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.49 173.99 33.08 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 120.743 -1.223 . . . . 0.0 113.865 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -58.69 -42.15 87.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.619 0.723 . . . . 0.0 112.029 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -69.49 -62.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.641 2.376 . . . . 0.0 112.48 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -141.55 140.09 33.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.928 0.891 . . . . 0.0 110.801 -166.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 103.95 7.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.228 2.211 . . . . 0.0 107.884 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.3 95.95 0.16 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.619 1.581 . . . . 0.0 112.49 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -28.58 160.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.751 2.82 . . . . 0.0 118.024 166.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -135.47 -25.03 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 11.3 p 57.07 162.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.552 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.1 t -164.14 -171.94 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.31 3.044 . . . . 0.0 108.222 169.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.35 136.28 27.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 109.282 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.43 177.45 10.59 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.136 0.97 . . . . 0.0 113.453 -164.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.18 -56.56 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.503 1.921 . . . . 0.0 111.214 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -174.36 -174.85 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.196 2.998 . . . . 0.0 107.464 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.92 24.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.932 2.093 . . . . 0.0 114.941 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.01 4.18 7.98 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.39 1.076 . . . . 0.0 112.117 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.6 m -126.4 -22.22 4.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.245 1.818 . . . . 0.0 111.389 168.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.3 11.43 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 121.362 -0.837 . . . . 0.0 111.315 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.4 -45.63 90.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -51.53 -22.34 3.12 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.51 -39.02 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.724 1.61 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -55.57 -39.38 70.59 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 169.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -57.23 3.14 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.999 2.12 . . . . 0.0 110.074 168.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.91 -35.22 64.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -61.48 -40.31 94.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.362 0.983 . . . . 0.0 111.132 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -78.06 -37.03 47.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.58 -0.7 . . . . 0.0 109.85 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -69.92 -25.92 63.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.756 0.707 . . . . 0.0 112.258 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.96 -36.57 69.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.103 1.361 . . . . 0.0 112.809 168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -63.91 -31.18 72.27 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.707 -0.62 . . . . 0.0 111.566 164.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.59 -3.18 15.43 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.811 2.148 . . . . 0.0 113.038 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.6 t -81.01 127.9 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.251 1.82 . . . . 0.0 111.358 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -143.76 82.65 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 124.184 1.945 . . . . 0.0 108.305 152.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.95 -136.43 9.11 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 110.328 -3.124 . . . . 0.0 112.777 -155.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.78 39.75 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 127.865 2.466 . . . . 0.0 110.785 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CD2' HG13 ' A' ' 54' ' ' VAL . 32.6 m95 -37.8 98.2 0.01 OUTLIER 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.053 2.541 . . . . 0.0 112.902 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.6 m -116.61 157.93 24.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.25 1.82 . . . . 0.0 108.385 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -141.95 146.38 35.58 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.83 1.252 . . . . 0.0 109.952 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.42 54.36 1.96 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.855 1.262 . . . . 0.0 110.607 -156.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -41.56 -31.16 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.948 3.299 . . . . 0.0 117.253 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -20.93 59.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.268 1.827 . . . . 0.0 112.601 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -133.2 5.1 3.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.26 1.824 . . . . 0.0 112.894 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.293 46.6 mttm 49.8 13.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 129.404 3.081 . . . . 0.0 116.519 -168.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 m -47.51 158.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.974 2.51 . . . . 0.0 113.505 156.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.4 160.91 30.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 129.439 3.096 . . . . 0.0 111.383 168.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.5 m -145.62 124.32 12.57 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.291 -0.88 . . . . 0.0 110.896 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.85 100.67 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.857 0.837 . . . . 0.0 112.293 160.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.37 131.83 37.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.11 0.957 . . . . 0.0 110.123 157.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 112.449 161.901 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 118.547 -0.74 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.5 135.28 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 121.274 1.852 . . . . 0.0 111.953 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.21 118.1 9.97 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.504 1.922 . . . . 0.0 108.589 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.81 143.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.26 -170.11 41.37 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 23.5 t30 119.94 -13.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 131.646 3.978 . . . . 0.0 110.995 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.2 -27.43 63.89 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -165.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.68 -27.02 0.28 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.782 2.135 . . . . 0.0 117.662 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.46 -13.61 12.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.858 1.663 . . . . 0.0 112.793 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -169.77 -177.79 2.78 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.231 2.612 . . . . 0.0 109.059 -163.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.91 15.79 0.25 Allowed Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.978 -0.901 . . . . 0.0 114.819 164.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -49.38 163.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.36 3.064 . . . . 0.0 113.987 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -59.31 -35.88 74.62 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.403 -0.811 . . . . 0.0 112.662 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.7 m -92.15 -32.56 15.07 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.587 1.085 . . . . 0.0 113.87 -168.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.48 -31.73 69.61 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.432 -1.418 . . . . 0.0 111.728 165.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.85 -28.01 20.67 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.123 1.156 . . . . 0.0 114.123 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.56 -33.19 71.11 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.607 1.548 . . . . 0.0 109.154 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -82.3 -47.23 12.64 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.487 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.42 -28.46 65.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.161 0.891 . . . . 0.0 112.874 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.57 -37.58 8.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.743 0.817 . . . . 0.0 112.672 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.82 -36.91 3.81 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.263 1.887 . . . . 0.0 114.978 167.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -55.03 -45.65 75.19 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -75.06 -35.65 61.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.141 0.577 . . . . 0.0 110.401 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.56 178.45 40.75 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.507 1.051 . . . . 0.0 115.473 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.4 155.73 63.21 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.053 3.169 . . . . 0.0 114.822 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.56 148.26 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.746 2.418 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -103.55 -37.82 7.4 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.648 1.979 . . . . 0.0 112.759 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -161.38 157.81 25.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 p -167.6 131.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.46 1.104 . . . . 0.0 112.155 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -155.48 159.32 39.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.288 1.835 . . . . 0.0 111.317 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.91 157.67 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.223 -1.548 . . . . 0.0 113.431 -171.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 125.513 1.525 . . . . 0.0 113.665 -178.344 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.779 0 CA-C-O 118.363 -1.243 . . . . 0.0 115.201 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.72 132.62 21.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.671 1.236 . . . . 0.0 112.773 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.88 163.05 28.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.854 2.462 . . . . 0.0 113.379 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -135.61 138.71 43.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.01 1.724 . . . . 0.0 109.23 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.283 2.0 m -146.9 -177.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.234 -0.916 . . . . 0.0 112.404 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.09 117.31 10.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.733 2.013 . . . . 0.0 107.196 162.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.06 -174.87 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.002 1.321 . . . . 0.0 114.067 165.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -124.12 -8.54 7.67 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -149.58 123.37 4.56 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 120.562 1.528 . . . . 0.0 113.01 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.64 -24.32 48.19 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.271 2.648 . . . . 0.0 114.934 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -63.06 -55.08 28.55 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.765 1.166 . . . . 0.0 110.451 172.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.73 -34.06 76.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.014 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.09 92.26 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.32 80.59 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.549 -1.344 . . . . 0.0 110.27 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.94 -42.52 48.45 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -14.28 41.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.83 1.252 . . . . 0.0 114.084 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.17 -60.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.396 0.998 . . . . 0.0 109.705 155.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -19.92 62.29 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -160.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -98.34 1.64 47.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.276 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.05 -31.13 0.5 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -159.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.48 104.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.317 1.447 . . . . 0.0 110.671 156.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.12 24.15 25.44 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.42 -1.211 . . . . 0.0 114.76 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -116.59 164.18 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.583 1.691 . . . . 0.0 112.985 -168.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -95.4 128.35 42.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.513 1.525 . . . . 0.0 110.844 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.1 -12.79 11.89 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.153 1.381 . . . . 0.0 114.344 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.32 -65.31 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.985 0.914 . . . . 0.0 111.811 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -165.69 32.8 0.23 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.756 2.122 . . . . 0.0 111.059 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 3.7 m -142.77 -158.9 0.91 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.198 2.199 . . . . 0.0 109.192 -158.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -149.26 153.43 37.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.128 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -137.81 160.66 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -165.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.61 142.64 41.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.492 2.717 . . . . 0.0 109.55 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.37 125.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.565 -0.71 . . . . 0.0 110.907 -152.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 126.965 2.106 . . . . 0.0 106.96 168.841 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.015 0.435 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.15 106.6 9.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.49 99.82 4.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.177 0.991 . . . . 0.0 111.496 -163.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.09 95.64 10.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.335 1.054 . . . . 0.0 108.952 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.38 117.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.625 1.57 . . . . 0.0 108.912 160.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -93.22 129.63 39.19 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.655 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 69.8 m-80 -143.18 109.51 5.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.84 177.47 27.05 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 121.803 0.669 . . . . 0.0 114.617 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.952 1.301 . . . . 0.0 110.655 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.3 m -63.12 -55.87 21.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.634 2.373 . . . . 0.0 113.216 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -165.08 144.21 6.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.792 1.637 . . . . 0.0 109.687 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -131.73 150.24 52.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.885 1.274 . . . . 0.0 112.459 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.14 -134.64 4.51 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.957 1.742 . . . . 0.0 111.294 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.4 mt-10 -161.25 -166.6 1.58 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.22 2.608 . . . . 0.0 107.801 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -145.9 -39.68 0.23 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 161.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p 57.62 163.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -165.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -159.96 -169.36 2.5 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.592 2.357 . . . . 0.0 106.754 153.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -137.92 132.02 31.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.289 -1.507 . . . . 0.0 108.146 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.84 -178.72 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.147 0.979 . . . . 0.0 112.417 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -44.41 -57.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.677 1.991 . . . . 0.0 110.809 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -178.97 -164.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 129.521 3.128 . . . . 0.0 108.751 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 20.47 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.178 2.191 . . . . 0.0 115.189 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.24 5.13 5.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.442 1.097 . . . . 0.0 112.233 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -125.63 -14.62 6.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 111.713 161.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.46 7.34 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.453 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.25 -47.88 65.51 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -56.37 -19.43 14.69 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.6 -168.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.67 -34.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.712 1.605 . . . . 0.0 110.296 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -54.08 -44.67 71.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.701 1.2 . . . . 0.0 112.071 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -43.48 -56.49 3.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.326 1.85 . . . . 0.0 111.564 168.135 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -75.23 -31.51 60.87 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.034 0.834 . . . . 0.0 111.134 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -35.07 57.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.346 -0.846 . . . . 0.0 110.013 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -66.73 -31.09 71.52 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.003 0.819 . . . . 0.0 112.173 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.59 -38.31 80.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.016 1.326 . . . . 0.0 113.168 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.99 -33.15 74.94 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 121.682 -0.636 . . . . 0.0 112.525 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.28 27.12 2.28 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.894 1.711 . . . . 0.0 114.021 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.359 1.463 . . . . 0.0 111.88 -165.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.78 3.89 6.05 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 121.818 0.818 . . . . 0.0 112.243 152.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.71 -112.12 0.98 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.181 2.324 . . . . 0.0 118.396 150.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -147.33 37.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.972 2.509 . . . . 0.0 107.223 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 18.4 m95 -40.67 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.497 1.519 . . . . 0.0 114.152 -160.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 m -125.08 160.2 29.63 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.918 1.687 . . . . 0.0 110.012 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -148.15 154.03 39.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.598 1.559 . . . . 0.0 111.151 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 19.5 t70 -129.88 139.6 51.13 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 126.361 1.864 . . . . 0.0 109.18 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -108.38 -16.83 14.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.31 -26.42 61.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 111.856 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.3 p -122.28 -6.9 8.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.429 1.891 . . . . 0.0 112.953 167.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.421 45.1 mttm 66.13 12.63 8.64 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 126.992 2.117 . . . . 0.0 115.376 -173.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -59.67 155.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 127.229 2.211 . . . . 0.0 114.361 170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -123.91 166.33 15.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.925 2.49 . . . . 0.0 112.318 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -150.01 137.57 19.91 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.769 -1.207 . . . . 0.0 110.793 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.63 153.94 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.512 155.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -151.14 88.42 1.45 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.313 1.845 . . . . 0.0 113.957 -176.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 113.913 177.685 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -118.9 141.93 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.818 -1.176 . . . . 0.0 109.716 150.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -141.81 128.25 20.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.07 1.348 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.7 t -133.38 122.58 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.06 -171.09 12.2 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.998 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.42 41.33 24.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.416 0.686 . . . . 0.0 112.27 -158.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.34 -30.76 42.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.899 0.88 . . . . 0.0 111.75 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.14 -51.65 0.56 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 127.927 2.68 . . . . 0.0 117.404 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -124.1 -56.62 1.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.382 1.091 . . . . 0.0 113.795 -152.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.62 -27.84 28.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -165.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -7.03 82.83 0.0 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 128.943 3.163 . . . . 0.0 117.039 -165.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -118.21 -66.62 1.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 147.36 -46.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 131.386 3.874 . . . . 0.0 111.93 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -74.73 -27.16 60.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.57 0.623 . . . . 0.0 112.166 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.97 -38.4 50.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.742 0.817 . . . . 0.0 112.759 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.6 -34.97 18.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.665 1.586 . . . . 0.0 111.585 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -56.34 -35.5 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.544 0.738 . . . . 0.0 110.496 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -83.91 -53.46 5.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.801 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.03 47.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -115.88 -26.48 7.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.344 1.058 . . . . 0.0 112.424 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.04 -33.3 21.42 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.533 1.063 . . . . 0.0 114.145 165.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -55.23 -43.77 74.86 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.03 -34.18 44.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.511 0.324 . . . . 0.0 111.024 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.25 -171.04 44.0 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -168.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.13 126.06 8.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.217 3.278 . . . . 0.0 113.322 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -99.83 144.0 29.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 109.416 167.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.92 -5.23 1.15 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.764 1.626 . . . . 0.0 113.272 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -156.78 160.55 39.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.741 1.216 . . . . 0.0 110.638 154.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.4 t -159.91 136.19 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.774 2.03 . . . . 0.0 110.145 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -157.03 160.18 38.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.95 1.7 . . . . 0.0 111.444 161.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.13 148.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 120.705 -1.247 . . . . 0.0 112.823 171.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 126.293 1.837 . . . . 0.0 114.153 176.556 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 116.288 1.275 . . . . 0.0 116.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.8 139.32 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.79 1.295 . . . . 0.0 111.964 -168.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -133.98 154.58 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 129.077 2.951 . . . . 0.0 112.082 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.56 138.8 36.56 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.813 1.245 . . . . 0.0 109.462 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.278 2.0 m -141.6 -179.65 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.247 -0.908 . . . . 0.0 110.834 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -141.45 102.74 4.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.506 1.522 . . . . 0.0 108.314 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -64.61 175.92 1.28 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.447 0.699 . . . . 0.0 111.698 159.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -124.96 9.89 8.18 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.555 -1.34 . . . . 0.0 112.741 166.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.66 126.61 11.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.363 . . . . 0.0 110.991 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.08 -22.15 6.2 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.748 2.299 . . . . 0.0 113.914 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -70.82 -51.78 24.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.781 1.173 . . . . 0.0 110.358 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.85 -37.23 81.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.53 1.132 . . . . 0.0 110.589 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.64 67.19 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.133 1.373 . . . . 0.0 112.49 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.7 -30.88 67.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.724 -1.235 . . . . 0.0 111.033 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.88 -40.2 65.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.97 1.259 . . . . 0.0 113.483 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -17.34 36.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 0.0 113.898 166.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.33 -55.79 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.405 1.457 . . . . 0.0 110.131 159.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -54.96 -29.4 56.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.895 2.078 . . . . 0.0 114.068 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.36 -11.99 16.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.85 1.26 . . . . 0.0 112.075 -169.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.17 -20.54 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -154.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.18 136.82 48.28 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.756 0.822 . . . . 0.0 112.687 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.18 43.39 21.23 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.074 0.845 . . . . 0.0 112.622 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.12 -154.96 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.368 1.467 . . . . 0.0 111.671 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.2 m -129.46 -42.45 1.32 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.786 1.234 . . . . 0.0 110.744 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 tp 41.55 -99.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.771 2.828 . . . . 0.0 114.217 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.5 m -77.86 41.2 0.34 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.545 2.338 . . . . 0.0 113.475 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.87 75.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.745 1.164 . . . . 0.0 114.386 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.41 -119.22 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 111.489 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.72 32.27 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.597 0.713 . . . . 0.0 112.652 -153.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.13 140.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.232 2.213 . . . . 0.0 115.864 -156.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -134.32 113.76 12.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 129.385 3.074 . . . . 0.0 107.584 -170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.18 132.51 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.919 0.488 . . . . 0.0 112.077 -150.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 125.958 1.703 . . . . 0.0 109.938 171.306 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -130.55 95.67 3.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.06 102.27 7.16 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.159 -154.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.4 tp -88.71 93.58 9.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.16 1.384 . . . . 0.0 109.053 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 mt -58.22 118.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.65 1.98 . . . . 0.0 108.757 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.92 139.36 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.76 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -145.89 51.33 1.17 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.223 0.609 . . . . 0.0 109.879 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.56 -168.0 18.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 -165.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -41.11 -28.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.416 3.086 . . . . 0.0 116.014 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -134.44 -40.47 0.8 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.253 1.421 . . . . 0.0 111.871 -144.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.54 137.77 15.7 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.244 1.818 . . . . 0.0 107.82 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -127.93 124.43 37.32 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.907 1.283 . . . . 0.0 109.464 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.44 -134.89 4.47 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.287 1.423 . . . . 0.0 109.929 -152.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -164.05 -174.06 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.166 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -142.82 -29.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p 57.98 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.426 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -166.03 -179.38 5.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.84 2.856 . . . . 0.0 107.76 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -140.02 134.89 32.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.751 1.621 . . . . 0.0 108.403 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.28 -178.74 6.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.935 0.894 . . . . 0.0 112.131 -163.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -43.32 -57.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.564 1.945 . . . . 0.0 110.741 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -171.22 -163.39 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.93 2.892 . . . . 0.0 107.681 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.37 24.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.231 1.812 . . . . 0.0 114.249 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.0 -59.03 1.81 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.1 m -65.03 -21.97 66.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.13 -49.05 10.6 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 119.071 0.85 . . . . 0.0 111.67 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -62.51 -44.99 95.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.92 -20.38 51.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.94 -42.1 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.423 1.889 . . . . 0.0 111.282 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CZ ' HG22 ' A' ' 18' ' ' THR . 11.3 m-85 -54.9 -36.46 65.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 170.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.3 mmpt? -48.49 -50.09 33.08 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.494 1.918 . . . . 0.0 110.186 171.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -74.92 -37.71 61.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.839 1.655 . . . . 0.0 114.721 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -58.56 -39.4 80.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.463 1.029 . . . . 0.0 111.366 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -83.13 -32.22 26.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.449 -0.782 . . . . 0.0 110.858 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.03 -31.44 72.67 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.21 -41.9 80.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 113.084 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.27 -35.29 80.02 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.775 -0.578 . . . . 0.0 112.488 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.74 29.8 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.619 1.58 . . . . 0.0 113.798 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.99 127.17 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.938 1.295 . . . . 0.0 111.99 -165.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -122.75 -3.56 8.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.583 152.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 18.6 -78.68 0.0 OUTLIER Glycine 0 CA--C 1.528 0.892 1 C-N-CA 131.31 4.291 . . . . 0.0 119.256 170.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -134.61 2.33 3.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.391 1.877 . . . . 0.0 111.615 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.449 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 m95 -19.29 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.911 2.084 . . . . 0.0 115.518 -149.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 t -129.91 170.44 13.92 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.074 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -157.38 157.65 34.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.274 1.829 . . . . 0.0 111.679 -166.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -110.91 -48.98 3.07 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -164.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 58.44 -38.12 0.06 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 129.046 2.938 . . . . 0.0 117.624 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.02 61.96 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.969 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 p -122.26 -5.54 8.86 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.081 1.753 . . . . 0.0 113.091 165.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 48.5 mttm 60.2 6.31 0.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.46 2.304 . . . . 0.0 116.52 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.8 m -46.85 146.36 1.66 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.632 1.973 . . . . 0.0 114.054 156.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.52 163.07 15.89 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.632 2.773 . . . . 0.0 111.516 164.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -148.95 144.33 26.74 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.311 -1.493 . . . . 0.0 111.599 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.93 128.3 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.963 161.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -132.1 107.5 8.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 126.832 2.053 . . . . 0.0 109.802 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 115' ' ' VAL . 60.1 t -125.45 139.78 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 121.129 -0.982 . . . . 0.0 111.38 152.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -144.56 133.25 22.28 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.981 1.312 . . . . 0.0 109.556 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 142' ' ' VAL . 13.6 m -140.2 161.59 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.646 0.736 . . . . 0.0 112.469 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.55 -166.1 27.04 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 80.84 -1.28 1.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.155 2.582 . . . . 0.0 114.312 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' CD1' ' H ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -71.27 -172.59 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.778 1.231 . . . . 0.0 111.363 175.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 81' ' ' LEU . . . 168.47 -24.18 0.11 Allowed Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.546 1.07 . . . . 0.0 113.938 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.96 -30.65 71.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.464 1.506 . . . . 0.0 114.303 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -150.64 -18.03 0.23 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -172.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.61 115.28 6.92 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 120.131 1.332 . . . . 0.0 113.508 -150.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -131.2 -19.44 2.81 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 140.0 -52.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 131.164 3.786 . . . . 0.0 111.239 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -91.53 -23.45 19.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -158.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.75 -35.53 70.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.868 -1.77 . . . . 0.0 111.472 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.7 mt -89.73 -29.33 18.79 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.978 2.511 . . . . 0.0 111.157 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.85 -33.01 69.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.24 1.382 . . . . 0.0 110.605 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -84.04 -48.59 9.76 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.714 0.805 . . . . 0.0 112.432 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.28 67.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -96.9 -27.84 14.49 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -56.67 -35.16 66.14 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.577 1.56 . . . . 0.0 113.989 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -57.36 -31.54 65.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -96.97 17.84 16.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.194 0.997 . . . . 0.0 112.14 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 -160.99 14.12 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.865 -1.147 . . . . 0.0 115.603 163.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -49.79 117.41 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 125.409 4.072 . . . . 0.0 114.471 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -110.14 149.97 29.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.864 1.666 . . . . 0.0 109.514 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -124.7 -25.97 3.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.713 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -163.56 152.61 14.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.076 0.95 . . . . 0.0 109.621 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -151.46 127.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.85 1.66 . . . . 0.0 108.316 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -138.64 168.71 19.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.754 1.222 . . . . 0.0 111.512 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 113' ' ' ALA . 6.2 t -150.09 142.51 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.581 1.153 . . . . 0.0 111.093 -164.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 126.171 1.788 . . . . 0.0 113.391 173.229 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 115.368 0.907 . . . . 0.0 115.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -138.99 143.13 38.38 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.665 1.586 . . . . 0.0 109.451 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -139.7 153.1 47.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -141.32 120.94 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.924 0.89 . . . . 0.0 109.655 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.5 m -143.33 -177.39 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -161.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -145.47 110.2 5.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.562 1.945 . . . . 0.0 109.635 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -71.31 -175.71 1.31 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.121 0.968 . . . . 0.0 110.056 151.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -150.33 70.04 1.02 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.707 -1.246 . . . . 0.0 111.675 150.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.75 138.39 10.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.517 1.527 . . . . 0.0 110.393 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -73.5 -38.2 2.68 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.381 2.054 . . . . 0.0 115.435 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -60.38 1.67 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.64 1.109 . . . . 0.0 113.49 -154.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.4 -21.28 66.22 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.398 -0.814 . . . . 0.0 111.488 173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.64 -37.66 41.53 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.06 74.5 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 120.304 -1.498 . . . . 0.0 109.369 163.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.03 -36.75 84.09 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 3.5 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 168.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.47 -41.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 120.413 1.46 . . . . 0.0 113.112 144.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -62.83 -23.74 67.43 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.985 1.266 . . . . 0.0 113.213 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.74 -10.52 14.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.298 1.839 . . . . 0.0 110.883 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.58 -28.71 0.64 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -154.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.31 136.96 54.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.966 0.888 . . . . 0.0 111.728 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.12 13.15 52.51 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.377 0.989 . . . . 0.0 114.775 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 134' ' ' THR . 5.8 ttt180 -85.42 -159.5 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.451 1.5 . . . . 0.0 111.259 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 133' ' ' ARG . 55.3 m -147.64 134.6 20.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.418 2.287 . . . . 0.0 106.218 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.0 tp -133.44 -36.32 0.98 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -156.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 36.2 m -138.63 8.05 2.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.829 1.251 . . . . 0.0 114.191 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.31 26.69 3.37 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.79 -82.06 0.3 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.926 1.363 . . . . 0.0 110.401 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 175.13 165.05 0.28 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.019 3.327 . . . . 0.0 107.467 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.86 155.27 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.873 0.761 . . . . 0.0 111.574 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.5 127.14 17.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.783 2.433 . . . . 0.0 108.063 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 78' ' ' VAL . 76.9 t -141.37 134.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.532 0.605 . . . . 0.0 111.389 -152.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.061 1.744 . . . . 0.0 108.804 175.594 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -143.41 107.25 4.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.2 ttpt -117.9 132.69 56.39 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 112.623 -171.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.85 102.56 14.33 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.608 1.163 . . . . 0.0 109.283 165.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 mt -64.95 119.33 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 128.461 2.705 . . . . 0.0 109.854 158.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.0 128.92 42.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.766 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -140.37 48.51 1.75 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.565 1.946 . . . . 0.0 109.469 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.75 160.69 13.16 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 122.807 1.226 . . . . 0.0 114.565 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -53.78 -39.3 65.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.687 2.395 . . . . 0.0 112.781 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -59.65 -55.35 35.58 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.759 2.824 . . . . 0.0 112.862 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.0 139.74 8.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.054 1.342 . . . . 0.0 110.789 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.72 111.02 16.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.89 2.076 . . . . 0.0 109.001 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.29 0.05 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.117 0.865 . . . . 0.0 113.253 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.34 157.84 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.05 2.14 . . . . 0.0 115.914 161.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 33' ' ' TYR . 9.2 t -135.39 -22.09 1.53 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.4 p 62.49 161.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.501 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -170.55 -170.68 0.95 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.722 2.809 . . . . 0.0 109.116 168.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -143.57 141.22 30.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.658 2.383 . . . . 0.0 108.387 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.36 172.8 13.83 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -163.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.49 -44.14 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.042 2.137 . . . . 0.0 112.077 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -140.13 -64.17 0.48 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -152.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 130.2 2.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 131.309 3.844 . . . . 0.0 112.637 -160.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.41 -44.3 1.12 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.05 0.94 . . . . 0.0 110.119 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.2 m -63.5 -20.48 65.64 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.611 1.565 . . . . 0.0 113.887 164.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.49 10.65 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 118.804 0.729 . . . . 0.0 110.938 167.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.99 -45.77 93.45 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -64.06 -13.88 50.48 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.66 -40.43 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.197 2.199 . . . . 0.0 110.563 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.501 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -57.87 -39.99 79.16 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 13.9 mmtp -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.331 2.252 . . . . 0.0 111.014 166.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -75.95 -31.44 59.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 16' ' ' THR . 40.6 t80 -60.43 -43.28 96.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.687 1.13 . . . . 0.0 111.022 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.62 -34.97 58.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.513 -0.742 . . . . 0.0 109.962 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.06 -30.45 69.66 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.353 0.524 . . . . 0.0 112.101 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.92 -36.76 70.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.214 1.405 . . . . 0.0 113.402 170.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -64.62 -49.26 71.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.632 -0.667 . . . . 0.0 111.683 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.97 31.92 0.57 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.795 1.664 . . . . 0.0 114.181 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.67 146.36 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.4 1.88 . . . . 0.0 111.015 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -138.72 -6.79 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.204 1.002 . . . . 0.0 113.47 154.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.84 -129.06 6.47 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 126.155 1.836 . . . . 0.0 116.228 160.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.51 34.9 4.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.288 2.235 . . . . 0.0 108.428 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.451 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 13.9 m95 -19.66 97.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.762 2.825 . . . . 0.0 114.953 -169.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -118.11 162.4 18.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.454 1.501 . . . . 0.0 110.898 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -146.38 151.2 37.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.732 2.013 . . . . 0.0 111.114 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -107.07 -40.05 5.55 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -164.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 60.5 -33.43 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 119.185 3.031 . . . . 0.0 119.185 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.57 61.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.796 1.638 . . . . 0.0 112.266 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -135.24 13.17 3.55 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.49 1.916 . . . . 0.0 111.849 162.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.264 36.8 mttm 54.9 11.43 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 127.836 2.455 . . . . 0.0 116.581 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -44.57 156.14 0.09 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.574 1.949 . . . . 0.0 114.363 150.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.2 160.18 34.6 Favored 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.69 4.796 . . . . 0.0 110.107 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -147.82 134.69 20.14 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 112.073 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG13 ' CE3' ' A' ' 43' ' ' TRP . 1.6 m -108.94 96.58 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 122.215 1.007 . . . . 0.0 112.483 156.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -79.98 114.22 18.72 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.516 0.726 . . . . 0.0 109.855 160.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 125.397 1.479 . . . . 0.0 110.82 170.765 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' CG2' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -132.32 163.77 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 135.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -137.86 152.33 48.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.912 1.285 . . . . 0.0 111.284 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.6 t -141.2 152.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 111.242 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 -176.16 32.71 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.162 1.625 . . . . 0.0 117.162 161.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 91.53 1.85 0.12 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 130.805 3.642 . . . . 0.0 113.279 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.09 174.21 1.64 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.358 1.463 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.85 -37.76 0.18 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.564 1.078 . . . . 0.0 113.287 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -69.26 -57.57 5.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.733 0.813 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.5 -54.69 4.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.024 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.81 62.43 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 128.394 2.902 . . . . 0.0 117.004 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -132.66 -52.02 0.92 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.746 1.773 . . . . 0.0 115.67 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? 150.74 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 130.73 3.612 . . . . 0.0 112.625 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -87.63 -24.84 23.82 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.476 -0.765 . . . . 0.0 112.228 -164.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -55.43 -38.34 68.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.819 162.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.6 mt -82.67 -34.25 27.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.242 1.017 . . . . 0.0 112.569 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -54.68 -36.27 64.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.867 0.758 . . . . 0.0 111.102 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtm-85 -78.26 -57.05 3.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -20.67 41.9 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -113.91 -29.93 6.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.884 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.24 -35.19 26.71 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.765 1.174 . . . . 0.0 114.054 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -58.39 -41.72 85.47 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -78.44 -32.2 48.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.586 0.355 . . . . 0.0 111.235 -171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -177.68 44.67 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.036 0.826 . . . . 0.0 115.086 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.01 136.71 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.704 3.603 . . . . 0.0 114.509 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 152.38 23.87 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.27 1.828 . . . . 0.0 109.95 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -122.74 -22.36 5.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.556 1.542 . . . . 0.0 113.253 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -167.92 156.75 9.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.335 1.454 . . . . 0.0 109.655 173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -152.71 131.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.799 1.239 . . . . 0.0 110.843 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -147.28 153.9 40.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.305 1.442 . . . . 0.0 111.367 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.84 144.81 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.107 -0.996 . . . . 0.0 112.032 171.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.579 1.152 . . . . 0.0 111.386 175.369 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -142.52 139.38 31.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.521 1.661 . . . . 0.0 112.417 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -127.88 162.5 26.57 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.126 1.771 . . . . 0.0 113.448 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -149.28 136.91 20.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.728 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.483 HG22 ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -139.89 177.9 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -172.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -137.77 147.06 44.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.594 1.158 . . . . 0.0 110.065 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -177.72 3.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.177 2.591 . . . . 0.0 111.466 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.42 -22.15 6.59 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.54 106.11 54.41 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 120.557 1.526 . . . . 0.0 113.352 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 -20.79 36.27 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.416 2.744 . . . . 0.0 114.639 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -41.87 17.63 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.056 1.298 . . . . 0.0 111.308 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -67.33 -33.3 74.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.622 0.769 . . . . 0.0 112.257 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.508 0.723 . . . . 0.0 112.863 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.22 -34.73 70.73 Favored 'General case' 0 C--O 1.226 -0.165 0 O-C-N 121.002 -1.061 . . . . 0.0 110.142 168.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -38.2 76.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 172.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.9 -15.0 39.41 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.766 -1.209 . . . . 0.0 113.721 166.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.55 -54.34 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.462 -1.399 . . . . 0.0 109.594 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -58.32 -26.79 63.47 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 113.816 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.23 -10.64 17.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.245 1.418 . . . . 0.0 112.299 -170.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 -33.98 0.19 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -154.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -60.43 133.84 56.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.71 0.804 . . . . 0.0 112.492 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.88 13.63 83.21 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.231 -0.761 . . . . 0.0 114.305 160.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -113.19 -106.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.158 1.783 . . . . 0.0 109.736 -173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -156.64 136.89 12.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 109.038 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 tp -154.41 155.17 34.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.325 1.45 . . . . 0.0 109.375 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.1 m 51.76 25.57 3.01 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.41 73.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.11 1.338 . . . . 0.0 115.164 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.5 p -121.95 156.21 33.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.567 1.547 . . . . 0.0 111.579 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.21 53.04 0.78 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.05 1.74 . . . . 0.0 112.953 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -46.99 152.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.833 2.453 . . . . 0.0 115.957 -163.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -137.31 137.24 38.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.122 2.569 . . . . 0.0 108.687 167.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.54 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.477 0.58 . . . . 0.0 111.406 -163.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.477 0.916 0 O-C-N 119.624 -1.922 . . . . 0.0 110.207 167.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.68 109.37 5.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 37.5 ttpt -133.99 150.5 51.26 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 125.85 1.66 . . . . 0.0 113.018 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.9 tp -117.62 109.97 17.32 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.443 1.897 . . . . 0.0 110.211 161.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.25 120.33 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 129.739 3.216 . . . . 0.0 110.259 158.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.12 128.19 40.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.134 165.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -139.49 40.35 2.05 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.983 2.113 . . . . 0.0 110.226 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.99 171.65 42.94 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 120.25 -1.531 . . . . 0.0 116.169 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -66.0 -43.15 88.54 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 152.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.7 m -53.45 -57.12 11.78 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.482 3.113 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.3 tm? -162.33 141.23 9.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.0 110.008 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -126.92 110.45 13.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.614 1.566 . . . . 0.0 109.466 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.64 77.6 0.03 OUTLIER Glycine 0 N--CA 1.465 0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.004 -161.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.87 160.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.117 1.367 . . . . 0.0 114.222 162.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -124.28 -37.26 2.56 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.6 p 58.62 166.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -155.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.471 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -155.38 -25.15 0.11 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.35 136.39 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 127.17 2.188 . . . . 0.0 116.541 -162.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.77 -179.68 7.47 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.4 -1.438 . . . . 0.0 112.924 -166.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 4.8 t -63.81 -50.91 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.289 1.836 . . . . 0.0 111.876 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -167.93 167.93 12.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.568 1.547 . . . . 0.0 109.661 -152.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.04 15.81 0.5 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.43 -31.33 0.81 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.103 -0.998 . . . . 0.0 111.865 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.3 m -76.34 -21.29 56.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.0 111.837 163.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -50.42 15.46 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.617 -0.677 . . . . 0.0 110.123 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -48.26 58.09 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.084 1.354 . . . . 0.0 108.6 173.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -24.8 15.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.551 1.157 . . . . 0.0 114.068 -170.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.05 -38.77 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.607 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.1 m-85 -55.11 -41.83 72.15 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.046 0.938 . . . . 0.0 113.471 167.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE2' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -48.86 -55.06 12.78 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 110.051 169.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -68.87 -34.17 75.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -60.38 -40.91 92.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.286 0.948 . . . . 0.0 110.842 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -77.59 -35.84 52.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.21 -32.72 73.15 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.359 0.527 . . . . 0.0 111.857 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.81 -38.88 87.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.192 . . . . 0.0 113.186 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -67.1 -34.54 77.85 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.567 -0.708 . . . . 0.0 112.741 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.31 22.83 1.83 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.895 1.712 . . . . 0.0 114.684 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -122.88 134.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.58 1.552 . . . . 0.0 111.92 -161.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.23 10.44 3.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 149.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.08 -139.06 1.19 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 149.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -119.46 53.87 1.02 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.899 2.479 . . . . 0.0 106.276 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HE2' ' A' ' 31' ' ' LYS . 13.9 m95 -45.65 104.28 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.334 1.454 . . . . 0.0 112.631 -172.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.1 m -124.44 158.6 32.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.351 1.861 . . . . 0.0 108.672 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 38.9 t80 -137.91 144.04 41.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.83 1.252 . . . . 0.0 110.11 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -130.59 60.79 1.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 110.094 -156.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -47.0 -28.06 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.581 2.752 . . . . 0.0 116.128 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.7 -24.06 46.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.573 2.349 . . . . 0.0 112.852 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -132.9 7.8 4.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 112.854 165.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 51.0 mttm 45.78 25.16 0.26 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.555 2.742 . . . . 0.0 115.097 -164.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 m -63.43 168.98 4.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.235 1.814 . . . . 0.0 111.351 160.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 60.7 m-85 -135.73 156.41 48.87 Favored 'General case' 0 C--N 1.324 -0.509 1 C-N-CA 132.573 4.349 . . . . 0.0 108.903 175.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.8 m -143.35 129.72 19.96 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 m -103.51 93.21 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.21 1.005 . . . . 0.0 112.281 160.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.99 59.02 3.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.41 1.084 . . . . 0.0 112.457 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 . . . . . 0 N--CA 1.481 1.09 0 O-C-N 120.551 -1.343 . . . . 0.0 113.284 -176.465 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' CG1' HG22 ' A' ' 115' ' ' VAL . 37.8 t -113.56 141.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.19 -1.569 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -139.88 127.59 21.81 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.637 1.575 . . . . 0.0 109.116 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.22 146.91 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.41 -177.78 38.62 Favored Glycine 0 CA--C 1.518 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 115.249 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.65 16.66 9.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.316 1.446 . . . . 0.0 113.969 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 38.47 0.16 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 127.152 2.181 . . . . 0.0 111.714 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.49 -25.63 50.12 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.513 1.53 . . . . 0.0 115.762 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.74 -31.16 72.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.365 1.466 . . . . 0.0 113.223 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -134.02 -88.31 0.39 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.067 1.347 . . . . 0.0 110.192 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.22 56.33 2.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.817 1.199 . . . . 0.0 113.453 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -128.93 163.99 24.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.631 1.572 . . . . 0.0 111.555 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -72.56 -40.18 66.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.165 -0.959 . . . . 0.0 112.918 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.1 m -74.2 -34.62 63.78 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -168.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -54.38 -36.03 63.45 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.969 1.259 . . . . 0.0 111.64 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.98 -27.94 30.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.934 1.293 . . . . 0.0 112.826 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.92 -36.69 72.83 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.119 1.327 . . . . 0.0 109.94 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -103.18 -39.59 6.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.404 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.38 -30.88 68.74 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.547 0.612 . . . . 0.0 112.417 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -97.87 -30.16 12.91 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.22 -33.78 16.14 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.001 1.286 . . . . 0.0 114.439 167.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -58.94 -41.57 87.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -78.63 -24.75 45.13 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.971 0.509 . . . . 0.0 112.354 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.72 -177.49 41.48 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.031 0.824 . . . . 0.0 114.925 -171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.55 147.6 46.25 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.74 2.96 . . . . 0.0 113.149 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.97 164.25 18.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.676 2.391 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 116' ' ' GLU . 5.1 tmm_? -122.99 -36.88 2.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.434 1.494 . . . . 0.0 112.403 173.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -161.98 154.41 19.69 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.259 0.936 . . . . 0.0 111.068 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.5 t -153.02 123.56 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.233 1.413 . . . . 0.0 110.151 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -145.27 159.93 42.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.695 1.198 . . . . 0.0 111.671 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.76 153.3 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.397 -0.815 . . . . 0.0 111.897 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.148 1.379 . . . . 0.0 114.267 -177.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.324 0 N-CA-C 117.318 1.687 . . . . 0.0 117.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -133.54 130.28 38.25 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.254 1.527 . . . . 0.0 111.06 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.44 160.81 38.96 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.128 2.171 . . . . 0.0 114.489 -158.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -155.08 119.71 4.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.957 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG22 ' CG1' ' A' ' 76' ' ' VAL . 2.6 m -137.22 -171.03 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.832 0.853 . . . . 0.0 111.764 -168.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 101' ' ' ARG . 15.6 tt0 -153.75 115.88 4.32 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.427 1.091 . . . . 0.0 111.239 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -67.28 179.94 1.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.077 1.751 . . . . 0.0 112.457 165.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -115.08 -50.29 2.76 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.46 -0.775 . . . . 0.0 112.549 155.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -75.96 123.69 88.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 O-C-N 121.296 -0.877 . . . . 0.0 112.261 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -26.22 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.97 2.447 . . . . 0.0 114.724 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -27.54 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.302 1.41 . . . . 0.0 112.378 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.43 -37.46 83.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.801 0.84 . . . . 0.0 111.445 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.51 96.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.269 0.628 . . . . 0.0 112.132 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.39 91.53 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.151 -0.968 . . . . 0.0 110.516 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -40.33 81.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.85 0.75 . . . . 0.0 112.687 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.46 -20.14 58.92 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 168.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.9 t -77.84 -53.88 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 120.403 1.456 . . . . 0.0 109.383 160.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.28 -24.0 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.932 1.693 . . . . 0.0 113.972 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -111.68 -6.89 14.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.451 1.5 . . . . 0.0 111.814 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.49 -22.66 0.28 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -156.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -74.5 144.98 43.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.892 0.853 . . . . 0.0 111.831 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.95 34.11 71.0 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.033 -171.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -132.36 -140.53 0.2 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.038 1.335 . . . . 0.0 110.977 -171.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.4 m -154.05 144.21 22.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.208 2.203 . . . . 0.0 109.395 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mp -118.26 -37.56 3.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.483 1.113 . . . . 0.0 113.031 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.2 t -144.87 43.67 1.35 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.077 0.951 . . . . 0.0 112.811 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.65 4.81 88.08 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.322 0.963 . . . . 0.0 114.512 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.9 p -72.61 -176.29 1.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.544 1.537 . . . . 0.0 112.185 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.44 115.51 10.93 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.539 1.536 . . . . 0.0 106.939 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.36 162.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -143.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.43 125.58 20.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.17 1.788 . . . . 0.0 109.758 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.58 132.31 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -158.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -173.293 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.864 0.364 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.29 112.44 13.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.21 111.97 9.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -159.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.3 101.99 13.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.475 1.11 . . . . 0.0 110.136 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.42 117.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 128.535 2.734 . . . . 0.0 110.02 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -90.98 127.73 36.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.605 165.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -136.72 43.26 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.71 1.604 . . . . 0.0 110.554 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.98 171.54 22.67 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.493 -1.379 . . . . 0.0 116.418 -168.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -67.06 -37.04 83.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.627 1.171 . . . . 0.0 110.175 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -66.16 -53.82 32.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.072 1.349 . . . . 0.0 112.307 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -157.87 142.91 16.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.898 0.879 . . . . 0.0 111.552 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.24 111.43 16.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.937 2.095 . . . . 0.0 109.92 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.54 93.07 0.11 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.632 1.11 . . . . 0.0 113.496 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -31.81 166.24 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.891 2.477 . . . . 0.0 116.898 163.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -133.08 -38.98 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.2 p 55.7 164.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -152.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.9 t -152.65 -17.54 0.16 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.72 154.23 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.255 2.622 . . . . 0.0 117.476 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.12 175.89 9.78 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.805 -1.185 . . . . 0.0 112.949 -164.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.92 -45.06 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.106 0.955 . . . . 0.0 110.296 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -166.73 178.17 6.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.949 -158.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.37 -10.1 40.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.03 -1.89 18.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 120.549 1.522 . . . . 0.0 110.526 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -112.33 -20.25 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 128.219 2.608 . . . . 0.0 112.092 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.68 9.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.082 0.953 . . . . 0.0 110.387 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.95 -48.19 82.72 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.13 -18.53 48.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.586 -167.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.43 -45.92 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.021 1.728 . . . . 0.0 110.858 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 18' ' ' THR . 6.8 m-85 -54.13 -40.9 67.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 mmpt? -46.39 -39.61 10.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.941 1.696 . . . . 0.0 111.624 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -104.65 -20.57 13.6 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -55.76 -42.1 74.98 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.997 1.271 . . . . 0.0 109.507 159.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.97 -36.19 49.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.591 -0.693 . . . . 0.0 110.521 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -78.65 -22.83 46.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.474 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.17 -37.42 66.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.028 1.331 . . . . 0.0 113.134 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -59.88 -47.18 86.79 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.656 0.662 . . . . 0.0 110.777 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.61 10.28 6.01 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.361 1.934 . . . . 0.0 113.667 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.96 150.76 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.38 1.072 . . . . 0.0 110.597 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.74 128.11 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.222 1.011 . . . . 0.0 111.25 134.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.18 -154.0 7.13 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-O 123.701 1.723 . . . . 0.0 115.13 -158.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.04 53.09 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.648 2.379 . . . . 0.0 109.766 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.402 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 6.7 m95 -46.06 103.28 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.981 1.712 . . . . 0.0 112.836 -168.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.47 156.38 30.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.897 1.679 . . . . 0.0 111.72 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 52.7 t80 -149.69 142.19 24.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.073 1.349 . . . . 0.0 110.464 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.29 -36.58 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -162.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.08 -45.56 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 129.065 2.946 . . . . 0.0 117.96 -171.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.99 -25.05 64.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.206 1.803 . . . . 0.0 112.117 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.5 p -128.66 7.2 5.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 113.125 167.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.254 16.0 mttp 51.39 8.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -51.54 152.53 2.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.08 2.552 . . . . 0.0 113.338 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 28.7 m-85 -126.3 165.44 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 131.45 3.9 . . . . 0.0 110.235 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -145.75 150.55 36.44 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.885 0.85 . . . . 0.0 111.231 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.77 95.07 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 122.296 1.046 . . . . 0.0 113.249 158.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.46 101.56 10.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.179 0.992 . . . . 0.0 110.643 172.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 N--CA 1.48 1.053 0 O-C-N 120.929 -1.107 . . . . 0.0 113.006 173.595 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.5 168.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.629 2.013 . . . . 0.0 114.934 169.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -138.03 118.32 13.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.332 2.253 . . . . 0.0 108.848 168.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.2 t -126.7 141.75 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.538 . . . . 0.0 110.481 -174.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.86 -162.77 25.53 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 78.47 12.1 1.63 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.284 2.634 . . . . 0.0 113.971 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 33.16 5.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 -152.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.53 -26.31 44.95 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.119 1.342 . . . . 0.0 116.222 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.53 -30.13 68.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.725 1.21 . . . . 0.0 113.986 170.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.3 -119.35 0.3 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.28 55.25 27.02 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 121.112 1.778 . . . . 0.0 113.72 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.2 -60.79 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.323 1.449 . . . . 0.0 111.868 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 170.79 -60.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.954 2.502 . . . . 0.0 112.934 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -95.75 -26.98 15.47 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.327 0.967 . . . . 0.0 113.218 -162.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -57.57 -36.82 72.18 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.289 -0.882 . . . . 0.0 111.676 163.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.2 mt -74.05 -36.32 64.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.967 0.907 . . . . 0.0 112.36 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -57.28 -30.69 64.91 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.973 1.261 . . . . 0.0 112.216 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -84.22 -46.3 12.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.56 -28.18 63.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.523 0.729 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -98.21 -35.05 10.49 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.827 0.851 . . . . 0.0 112.649 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.85 -30.93 37.83 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.546 1.546 . . . . 0.0 115.463 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -58.23 -36.35 73.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.212 1.006 . . . . 0.0 113.603 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -78.52 -16.27 57.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.82 178.55 25.77 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.44 1.972 . . . . 0.0 112.213 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -58.58 151.29 63.61 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.523 2.816 . . . . 0.0 113.393 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.51 154.99 31.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.78 2.032 . . . . 0.0 109.877 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -120.74 -22.76 6.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.501 1.52 . . . . 0.0 113.441 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -168.99 155.16 6.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.844 1.258 . . . . 0.0 109.845 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -151.21 130.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.077 1.751 . . . . 0.0 108.939 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -141.91 149.3 40.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.363 1.865 . . . . 0.0 109.584 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.55 147.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.746 -1.222 . . . . 0.0 113.956 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 126.539 1.936 . . . . 0.0 110.861 175.88 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.097 0 N-CA-C 114.834 0.693 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -59.16 131.71 51.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.404 1.081 . . . . 0.0 111.801 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.53 155.9 31.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 112.274 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.18 131.21 36.47 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.951 1.3 . . . . 0.0 107.724 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.56 175.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.217 1.007 . . . . 0.0 110.86 -165.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -140.88 125.6 17.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.309 1.044 . . . . 0.0 109.588 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -86.85 173.01 9.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.413 1.885 . . . . 0.0 112.417 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.57 -68.63 0.74 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.96 155.96 74.89 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-N 120.965 1.711 . . . . 0.0 114.364 -170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.92 -42.82 62.98 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 116.008 -163.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -35.68 81.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.252 0.933 . . . . 0.0 112.375 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.54 -45.07 84.82 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.517 0.727 . . . . 0.0 110.535 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.13 -48.04 46.68 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.06 69.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.284 1.033 . . . . 0.0 111.252 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -74.09 -40.93 62.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.189 0.904 . . . . 0.0 112.286 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.9 -7.5 16.9 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 164.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.05 -55.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.566 1.53 . . . . 0.0 110.212 153.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -49.04 -36.54 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.783 2.033 . . . . 0.0 112.847 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -103.47 -13.17 16.71 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.164 0.986 . . . . 0.0 112.276 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mp -147.36 -8.46 0.44 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -152.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.557 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -63.08 -19.32 64.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -179.76 70.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.438 1.018 . . . . 0.0 111.621 -159.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -132.86 -132.9 0.18 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.594 1.558 . . . . 0.0 111.942 -163.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -151.22 -36.56 0.13 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.456 1.902 . . . . 0.0 110.682 -173.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.9 tp 62.17 -48.6 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 130.302 3.441 . . . . 0.0 118.869 156.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.21 29.02 1.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.846 1.658 . . . . 0.0 112.01 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.68 55.27 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.157 -0.965 . . . . 0.0 113.301 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 p -133.85 -129.89 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.588 1.955 . . . . 0.0 110.254 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -154.63 150.86 28.13 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 130.065 3.346 . . . . 0.0 106.813 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.69 151.88 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.151 0.98 . . . . 0.0 109.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -144.35 123.26 12.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 0.0 109.1 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 2.3 t -144.55 136.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.686 -161.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 125.986 1.714 . . . . 0.0 107.522 163.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.717 0.294 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -129.05 103.65 7.12 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.33 111.88 9.3 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 125.764 1.625 . . . . 0.0 111.28 -160.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.31 91.45 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.578 1.551 . . . . 0.0 110.076 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 mt -52.67 119.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.994 2.117 . . . . 0.0 109.207 159.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.58 134.04 40.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.429 1.092 . . . . 0.0 109.625 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -146.34 63.62 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.442 1.097 . . . . 0.0 108.767 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.72 178.54 16.35 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 122.045 0.803 . . . . 0.0 114.37 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -57.57 -43.56 84.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.33 1.052 . . . . 0.0 112.492 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -68.18 -50.67 52.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.283 2.233 . . . . 0.0 113.223 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -156.48 140.59 16.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.191 0.996 . . . . 0.0 110.397 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 131.11 47.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.798 1.639 . . . . 0.0 110.056 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.39 -134.74 4.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.347 1.451 . . . . 0.0 110.318 -158.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -161.71 -167.08 1.61 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.235 2.214 . . . . 0.0 108.892 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -144.82 -41.49 0.24 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 161.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p 56.12 166.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -156.47 -25.66 0.1 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 47.86 139.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.049 2.54 . . . . 0.0 117.049 -161.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.88 -178.0 7.03 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.576 -1.328 . . . . 0.0 112.118 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 21' ' ' VAL . 15.5 t -51.01 -51.1 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.368 1.867 . . . . 0.0 111.88 168.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -173.68 174.84 3.06 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.111 1.765 . . . . 0.0 110.903 -157.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.7 19.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.524 1.13 . . . . 0.0 113.697 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.31 11.36 6.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.096 0.959 . . . . 0.0 111.388 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -135.43 -24.49 1.38 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.499 1.92 . . . . 0.0 111.153 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.52 8.45 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.686 -0.633 . . . . 0.0 111.025 164.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -59.86 -46.35 89.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -49.3 -25.0 2.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.818 1.647 . . . . 0.0 114.267 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.2 -40.12 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.886 1.674 . . . . 0.0 110.339 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -53.7 -36.38 62.14 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.8 mtpp -49.74 -56.99 8.18 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.536 1.534 . . . . 0.0 109.832 172.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.48 -38.82 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.883 -0.58 . . . . 0.0 112.491 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -56.94 -36.25 70.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.044 0.838 . . . . 0.0 111.439 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.79 -37.29 24.73 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 121.662 -0.649 . . . . 0.0 110.512 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -67.02 -29.01 68.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.288 0.949 . . . . 0.0 112.469 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.11 -41.8 76.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.551 1.54 . . . . 0.0 113.181 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -63.53 -44.94 92.77 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.619 -0.676 . . . . 0.0 111.308 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.37 22.76 1.06 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.987 1.756 . . . . 0.0 113.212 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.17 129.94 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.271 1.828 . . . . 0.0 110.879 -164.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.84 3.1 16.21 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.894 150.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.97 -123.01 12.79 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.531 1.539 . . . . 0.0 113.256 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -132.05 48.85 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.077 2.151 . . . . 0.0 106.49 161.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 9.8 m95 -18.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.112 2.565 . . . . 0.0 115.607 -173.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.5 m -120.22 160.53 22.76 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.42 152.41 35.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.689 1.996 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.24 -39.93 5.09 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -166.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 t70 64.35 -33.45 0.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.07 64.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.694 1.598 . . . . 0.0 111.715 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -119.49 -7.64 10.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.277 2.231 . . . . 0.0 112.513 165.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.29 39.0 mttm 61.56 17.46 8.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.502 2.321 . . . . 0.0 115.37 -171.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -57.65 150.05 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.385 1.474 . . . . 0.0 112.713 162.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -118.35 164.68 14.86 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.569 2.747 . . . . 0.0 112.06 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -150.39 138.32 20.08 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.748 -1.22 . . . . 0.0 112.248 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.37 90.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.581 1.181 . . . . 0.0 113.468 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 84.17 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.228 1.811 . . . . 0.0 113.069 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 N--CA 1.477 0.895 0 O-C-N 120.83 -1.169 . . . . 0.0 110.529 163.556 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 115' ' ' VAL . 9.5 p -128.82 155.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.879 1.218 . . . . 0.0 110.482 158.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -134.51 147.77 50.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 t -136.88 147.18 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.053 1.341 . . . . 0.0 111.106 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.36 -157.2 15.26 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.113 -0.992 . . . . 0.0 114.559 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -16.51 0.17 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.64 2.376 . . . . 0.0 114.239 -166.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.63 153.3 20.32 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.863 -1.148 . . . . 0.0 112.036 164.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.04 29.78 0.53 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.956 1.265 . . . . 0.0 113.225 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.86 -56.55 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.46 1.904 . . . . 0.0 109.735 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 24.2 m-80 -104.36 -166.19 1.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 140.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 84' ' ' ASN . . . -63.61 168.83 21.47 Favored Glycine 0 CA--C 1.531 1.085 1 C-N-CA 131.011 4.148 . . . . 0.0 114.117 -9.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -137.86 -23.39 1.05 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.209 2.203 . . . . 0.0 110.784 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.251 2.4 pttp 131.7 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 1 C-N-CA 134.866 5.266 . . . . 0.0 110.822 163.723 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.6 m -74.93 -45.6 41.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.153 1.381 . . . . 0.0 111.329 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -42.32 93.67 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.246 1.018 . . . . 0.0 112.179 172.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.23 -32.76 64.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.761 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' A' ' 103' ' ' VAL . 18.8 mt-10 -51.92 -37.0 50.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.316 1.417 . . . . 0.0 110.579 170.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -102.87 -34.3 9.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.86 79.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.279 0.631 . . . . 0.0 111.952 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -83.75 -28.08 28.47 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.811 -0.556 . . . . 0.0 110.918 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.34 -32.64 37.68 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.911 1.72 . . . . 0.0 114.411 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -51.84 -40.72 61.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -78.69 -24.12 45.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.7 179.38 30.75 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.321 1.438 . . . . 0.0 113.068 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.2 118.76 5.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.335 2.69 . . . . 0.0 113.038 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.13 156.39 25.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.899 0.857 . . . . 0.0 110.856 162.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -124.34 -23.9 4.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.604 2.362 . . . . 0.0 112.251 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -165.8 153.95 10.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.558 1.943 . . . . 0.0 108.95 163.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.53 HG11 ' HG3' ' A' ' 91' ' ' GLU . 39.0 t -150.73 125.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.542 1.137 . . . . 0.0 109.387 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -141.64 167.91 21.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.31 1.052 . . . . 0.0 112.505 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 113' ' ' ALA . 7.5 t -144.34 141.84 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.624 1.57 . . . . 0.0 110.231 -170.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 C-N-CA 124.314 1.046 . . . . 0.0 113.361 176.56 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -84.3 149.89 25.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.262 1.425 . . . . 0.0 110.543 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -143.61 159.84 41.73 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.627 1.171 . . . . 0.0 113.917 -169.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.26 122.14 10.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.459 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 76' ' ' VAL . 2.0 m -138.85 -179.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.759 0.824 . . . . 0.0 111.845 -168.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.31 152.2 29.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.186 1.394 . . . . 0.0 110.863 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.63 167.21 12.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.678 2.391 . . . . 0.0 112.41 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -72.06 -20.79 61.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -143.0 133.54 12.34 Favored Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 121.001 -1.062 . . . . 0.0 112.429 -162.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.89 -27.99 9.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.756 2.304 . . . . 0.0 114.335 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.2 mtm105 -71.54 -49.36 41.59 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.432 1.015 . . . . 0.0 110.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.88 -37.36 84.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.856 0.862 . . . . 0.0 110.718 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.2 70.07 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.02 -26.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.219 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.58 -41.87 37.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.304 1.411 . . . . 0.0 113.866 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.66 -8.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.484 1.514 . . . . 0.0 114.087 163.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.5 t -96.7 -53.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.704 1.202 . . . . 0.0 111.109 160.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -53.36 -35.2 60.01 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.294 1.838 . . . . 0.0 113.102 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.36 -7.89 49.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.892 1.277 . . . . 0.0 112.103 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.51 -2.9 0.94 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -155.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -58.25 -24.28 58.82 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -170.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.91 75.77 0.11 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.31 1.91 . . . . 0.0 111.508 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 70.0 mmt-85 -132.51 -146.6 0.29 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.119 1.768 . . . . 0.0 111.238 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.4 m -151.19 139.33 20.16 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.392 2.277 . . . . 0.0 106.661 168.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 tp -142.27 -66.21 0.4 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -158.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.8 m -152.79 49.29 0.73 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.549 1.939 . . . . 0.0 109.97 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.79 26.74 0.34 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 130.635 3.969 . . . . 0.0 111.526 16.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.0 t -90.35 172.23 8.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.054 1.342 . . . . 0.0 110.027 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -43.64 132.95 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.247 1.019 . . . . 0.0 111.144 150.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.4 t -109.09 154.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.836 1.654 . . . . 0.0 110.012 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.0 135.7 27.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.762 1.225 . . . . 0.0 108.593 159.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.3 t -133.07 155.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.987 1.315 . . . . 0.0 110.244 -166.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 125.103 1.361 . . . . 0.0 110.482 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -134.61 110.37 9.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -123.89 108.54 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.312 1.445 . . . . 0.0 112.18 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.23 89.37 6.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.121 0.968 . . . . 0.0 109.231 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 mt -51.52 115.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.006 1.722 . . . . 0.0 108.576 159.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -92.87 128.04 38.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.379 174.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 86.2 m-20 -140.34 58.82 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.35 -179.12 15.62 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-N 120.809 1.641 . . . . 0.0 115.693 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -56.83 -23.83 46.7 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.6 1.96 . . . . 0.0 115.187 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -99.04 -42.86 6.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.494 1.917 . . . . 0.0 112.542 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -160.43 140.2 11.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.118 1.367 . . . . 0.0 109.43 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -130.51 130.64 44.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.267 1.427 . . . . 0.0 110.097 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -133.58 4.21 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.088 1.804 . . . . 0.0 111.295 -148.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 6.7 mt-10 -161.87 -167.77 1.76 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.774 2.43 . . . . 0.0 107.965 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -139.35 -39.24 0.48 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 158.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p 53.9 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -158.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -160.48 179.68 8.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.906 2.482 . . . . 0.0 107.557 166.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -139.42 136.18 34.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.873 1.269 . . . . 0.0 109.138 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.19 -177.7 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.776 0.83 . . . . 0.0 111.992 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -46.04 -57.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.071 1.748 . . . . 0.0 110.6 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -172.15 -163.67 0.25 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.964 3.306 . . . . 0.0 107.149 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.13 -14.8 11.32 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.41 4.88 53.26 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.695 1.589 . . . . 0.0 111.951 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -126.49 -14.54 5.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.941 166.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.76 -49.94 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.555 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -57.02 -46.98 81.96 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -53.64 -21.05 6.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.866 1.354 . . . . 0.0 113.93 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.5 -35.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.138 1.775 . . . . 0.0 110.19 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 18' ' ' THR . 13.7 m-85 -53.35 -41.17 65.52 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.473 1.033 . . . . 0.0 113.599 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.79 -52.33 11.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.096 1.758 . . . . 0.0 110.624 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -80.31 -34.04 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.568 1.547 . . . . 0.0 114.863 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.73 -39.4 88.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.041 1.291 . . . . 0.0 111.225 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.05 61.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.617 -0.677 . . . . 0.0 109.696 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -71.9 -23.51 61.5 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -77.09 -37.0 55.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.689 . . . . 0.0 112.931 170.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -58.69 -44.21 90.22 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.738 -0.601 . . . . 0.0 110.464 164.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.01 5.72 8.77 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.074 1.797 . . . . 0.0 113.459 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.53 146.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.437 1.095 . . . . 0.0 110.719 172.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.12 125.19 9.27 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.726 0.775 . . . . 0.0 110.836 135.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.07 -147.04 4.61 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-O 123.878 1.821 . . . . 0.0 115.456 -157.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HB3' ' H ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -62.22 -19.16 62.87 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.689 2.396 . . . . 0.0 114.181 -172.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CD2' ' CG1' ' A' ' 54' ' ' VAL 0.267 10.7 m95 36.58 52.79 1.0 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.541 2.736 . . . . 0.0 115.514 170.097 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 m -75.41 156.42 35.39 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.047 0.927 . . . . 0.0 111.638 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -144.36 146.11 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.592 1.557 . . . . 0.0 110.448 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -106.03 -40.03 5.8 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -163.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.04 -34.8 0.06 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.78 65.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.334 1.853 . . . . 0.0 111.466 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -125.88 -0.29 7.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.709 2.003 . . . . 0.0 112.809 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 42.2 mttm 56.13 7.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.204 2.602 . . . . 0.0 116.512 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -43.44 152.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.205 2.202 . . . . 0.0 113.972 150.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.88 173.54 8.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 130.557 3.543 . . . . 0.0 110.914 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -146.1 156.23 43.31 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.764 -1.21 . . . . 0.0 110.433 158.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -130.46 128.91 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 152.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 42' ' ' GLU . 5.7 m -125.34 117.57 24.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.057 1.408 . . . . 0.0 112.353 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.437 0 C-N-CA 130.744 3.618 . . . . 0.0 108.509 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 115' ' ' VAL . 75.5 t -117.71 121.52 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 140.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -144.36 141.56 29.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.514 -1.366 . . . . 0.0 111.273 -167.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.59 159.71 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.98 -163.91 12.97 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.822 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 65.77 20.97 11.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.983 1.713 . . . . 0.0 114.692 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -84.13 132.74 34.66 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.014 -1.054 . . . . 0.0 110.105 170.056 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.31 34.01 1.2 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.048 1.308 . . . . 0.0 112.099 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -143.29 -40.61 0.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 110.549 -162.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' H ' HD12 ' A' ' 81' ' ' LEU . 46.5 m-20 -124.15 -111.34 0.31 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.299 2.64 . . . . 0.0 108.125 173.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.04 61.92 0.56 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.902 1.715 . . . . 0.0 111.111 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.35 166.12 26.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.261 1.025 . . . . 0.0 112.243 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -30.08 65.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 m -75.89 -39.6 56.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.348 -0.845 . . . . 0.0 113.156 -169.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.29 -35.93 65.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.138 -0.976 . . . . 0.0 111.467 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 mt -83.86 -30.07 26.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.324 1.449 . . . . 0.0 111.859 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -56.79 -36.52 69.96 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.804 0.729 . . . . 0.0 109.797 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -91.24 -52.55 4.76 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.179 0.992 . . . . 0.0 111.584 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.77 54.09 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.372 1.069 . . . . 0.0 113.475 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.17 -26.53 9.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.22 -33.21 37.94 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 124.869 1.223 . . . . 0.0 114.502 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -57.01 -37.82 72.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -79.63 -20.99 45.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.387 0.675 . . . . 0.0 112.656 -170.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.49 175.91 26.19 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 125.553 1.549 . . . . 0.0 113.556 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.24 116.44 2.68 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.186 3.924 . . . . 0.0 115.173 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.39 161.26 29.4 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 110.502 159.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -126.93 -29.73 2.79 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.633 1.973 . . . . 0.0 112.585 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -154.54 164.08 39.23 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.709 0.686 . . . . 0.0 111.195 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.38 131.22 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.719 1.208 . . . . 0.0 111.766 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -158.32 165.6 34.37 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.39 1.476 . . . . 0.0 110.983 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . 0.263 1.3 m -142.76 143.97 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.965 -1.085 . . . . 0.0 112.808 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 126.334 1.854 . . . . 0.0 112.732 -178.127 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.185 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -139.64 134.28 31.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.487 1.515 . . . . 0.0 110.808 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.54 151.24 51.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.28 1.832 . . . . 0.0 113.743 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.42 129.38 31.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 76' ' ' VAL . 3.4 m -143.63 -178.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 110.764 -166.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -141.41 152.01 43.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.168 -0.957 . . . . 0.0 112.257 170.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.406 ' CD1' HG11 ' A' ' 76' ' ' VAL . 3.6 m-85 -117.45 169.01 9.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.018 2.527 . . . . 0.0 110.764 171.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.48 3.28 40.1 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -156.44 137.18 9.13 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.2 -38.42 33.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 125.221 3.947 . . . . 0.0 117.517 168.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.8 -59.33 5.39 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 120.42 1.464 . . . . 0.0 110.127 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.16 -41.91 76.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.989 1.716 . . . . 0.0 110.907 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.75 -52.71 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.029 1.732 . . . . 0.0 113.255 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.41 65.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.195 1.361 . . . . 0.0 111.503 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -47.92 82.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.894 . . . . 0.0 111.868 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.36 -9.7 58.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.703 1.601 . . . . 0.0 114.617 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.2 -46.62 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.288 -1.508 . . . . 0.0 108.953 157.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.72 -20.9 65.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -114.62 -12.5 12.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.64 1.176 . . . . 0.0 111.899 -173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.21 -10.22 0.57 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -156.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -71.92 141.79 49.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.966 0.803 . . . . 0.0 111.96 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.63 15.52 62.01 Favored Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.433 1.492 . . . . 0.0 114.958 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.3 179.04 6.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.337 1.455 . . . . 0.0 112.49 -168.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 99.8 m -136.16 89.67 2.5 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.101 1.36 . . . . 0.0 110.686 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.4 -32.47 42.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 112.777 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.5 m -145.75 17.07 1.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.858 1.263 . . . . 0.0 114.122 -165.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.94 -4.41 65.53 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 113.827 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.1 p -63.99 -179.51 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.545 1.938 . . . . 0.0 113.538 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -130.74 63.29 1.58 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.581 1.152 . . . . 0.0 108.75 155.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 p -50.53 141.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.269 1.828 . . . . 0.0 112.048 -169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.1 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.292 1.437 . . . . 0.0 109.346 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.8 t -144.25 129.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -148.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.479 0.988 0 O-C-N 120.706 -1.246 . . . . 0.0 111.335 167.998 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -130.87 130.82 44.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 133.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.03 112.91 12.77 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.974 -1.079 . . . . 0.0 113.527 -174.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.61 111.79 20.38 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.594 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 9.6 mt -77.2 117.23 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 129.189 2.995 . . . . 0.0 110.419 158.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.15 123.77 30.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.798 161.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.32 34.6 3.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.196 1.799 . . . . 0.0 110.911 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 150.37 20.98 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.033 -1.042 . . . . 0.0 114.422 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -49.16 -37.54 22.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 110.655 155.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 m -57.71 -55.17 38.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.815 2.846 . . . . 0.0 113.419 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 13' ' ' LYS . 1.8 tm? -165.26 140.16 5.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.99 1.716 . . . . 0.0 109.824 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' N ' HD13 ' A' ' 12' ' ' LEU . 7.3 mtpm? -128.7 119.52 24.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.901 1.28 . . . . 0.0 110.745 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.52 85.41 0.06 OUTLIER Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.163 0.887 . . . . 0.0 112.949 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -31.77 159.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 158.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 t -140.43 -27.7 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 7.1 p 61.86 162.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -171.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -158.96 -172.41 3.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.374 2.27 . . . . 0.0 107.733 159.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -138.16 146.72 43.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 120.189 -1.569 . . . . 0.0 111.531 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.41 -174.77 5.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 111.972 -163.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.8 -50.91 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.11 166.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -165.99 175.85 8.23 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.284 1.516 . . . . 0.0 112.045 -156.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.13 17.92 0.09 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.567 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.69 7.84 6.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.111 1.364 . . . . 0.0 111.545 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.8 p -135.42 -26.27 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.958 2.503 . . . . 0.0 112.29 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.5 -47.03 16.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.618 163.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.42 -47.5 75.87 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -21.31 6.76 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.982 1.313 . . . . 0.0 114.408 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.02 -34.57 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.032 1.733 . . . . 0.0 110.914 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.4 m-30 -54.39 -43.0 71.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.339 0.972 . . . . 0.0 113.549 165.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -37.25 -57.28 0.9 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.423 2.289 . . . . 0.0 110.452 166.175 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -80.39 -32.25 37.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.975 1.71 . . . . 0.0 114.729 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -59.0 -44.7 91.71 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.431 1.014 . . . . 0.0 111.087 168.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.66 58.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.46 -31.39 72.1 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.051 0.841 . . . . 0.0 112.272 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.9 -37.99 76.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.718 1.207 . . . . 0.0 113.219 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -66.05 -44.2 85.28 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.695 -0.628 . . . . 0.0 111.784 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.07 13.66 0.59 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.984 1.754 . . . . 0.0 114.052 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.87 144.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.957 1.703 . . . . 0.0 111.877 -166.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -132.56 8.22 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.957 0.903 . . . . 0.0 112.849 158.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 56' ' ' GLU . . . 45.12 -132.2 8.26 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 123.018 1.343 . . . . 0.0 114.193 166.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -136.16 42.22 2.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.191 1.796 . . . . 0.0 106.615 167.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 26.3 m95 -3.22 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 130.525 3.53 . . . . 0.0 115.939 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.0 m -83.89 157.97 21.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.109 0.956 . . . . 0.0 109.774 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -137.64 145.53 42.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.211 1.404 . . . . 0.0 110.112 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -133.2 56.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.447 1.499 . . . . 0.0 110.278 -155.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.88 -32.35 1.56 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.084 2.953 . . . . 0.0 116.822 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.82 -21.88 61.48 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.061 2.144 . . . . 0.0 112.624 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -131.78 7.91 4.45 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 112.846 167.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm 63.76 2.24 1.27 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.975 2.51 . . . . 0.0 114.61 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.5 m -52.52 161.98 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 129.741 3.216 . . . . 0.0 113.127 166.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -132.1 155.33 48.32 Favored 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 132.053 4.141 . . . . 0.0 110.039 171.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -144.92 121.22 10.9 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.999 0.428 . . . . 0.0 111.786 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.97 90.91 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 122.535 1.159 . . . . 0.0 112.53 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.56 39.23 0.82 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -163.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 9.7 tm-20 . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.441 0.639 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.04 144.28 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.711 0.804 . . . . 0.0 109.651 168.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -121.94 147.56 45.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.61 0.764 . . . . 0.0 111.61 -158.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.28 151.87 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.952 0.901 . . . . 0.0 110.56 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 -172.57 36.25 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 118.336 2.094 . . . . 0.0 118.336 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t30 53.28 36.22 22.17 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.378 1.871 . . . . 0.0 113.542 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.85 9.55 43.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.089 1.756 . . . . 0.0 113.238 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.94 -21.03 6.95 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.018 1.771 . . . . 0.0 117.034 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -54.52 -33.11 59.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 113.233 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -131.78 -45.74 0.96 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.104 1.762 . . . . 0.0 111.545 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.73 77.3 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 129.111 3.243 . . . . 0.0 115.661 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -139.75 167.53 21.88 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.557 1.143 . . . . 0.0 111.518 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -68.9 -37.43 78.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -79.86 -29.19 40.01 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.974 -1.079 . . . . 0.0 113.462 -163.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.95 -18.54 63.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.2 mt -96.67 -34.19 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.316 1.446 . . . . 0.0 111.666 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -54.12 -36.47 63.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.733 0.697 . . . . 0.0 110.893 168.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.88 -55.98 4.87 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.77 45.25 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -117.19 -30.29 5.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.863 1.265 . . . . 0.0 111.091 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.72 -35.58 17.21 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.033 1.301 . . . . 0.0 114.804 164.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -54.04 -41.95 68.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -78.43 -30.97 47.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.255 -171.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.59 40.74 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 -170.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.45 112.22 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.168 3.245 . . . . 0.0 112.072 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.13 156.69 37.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.737 0.78 . . . . 0.0 111.003 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -134.01 -21.89 1.85 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 112.878 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 m -163.74 166.52 22.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.006 1.322 . . . . 0.0 111.558 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.67 131.29 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.906 1.282 . . . . 0.0 110.519 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -150.05 144.11 25.57 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.25 1.42 . . . . 0.0 111.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.76 149.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.594 -1.316 . . . . 0.0 113.73 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 127.19 2.196 . . . . 0.0 110.45 174.729 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.89 142.97 49.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.704 1.202 . . . . 0.0 111.566 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.2 161.8 27.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.513 1.925 . . . . 0.0 113.227 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.5 137.13 30.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.911 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.02 168.55 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 109.506 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -139.42 149.74 44.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.86 178.13 5.66 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.315 2.246 . . . . 0.0 111.3 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -126.63 29.24 5.75 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.825 1.25 . . . . 0.0 112.543 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -160.24 119.37 1.6 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.132 1.373 . . . . 0.0 111.312 163.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.04 -43.29 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 125.168 3.912 . . . . 0.0 116.165 167.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -58.5 -38.74 78.31 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.013 1.725 . . . . 0.0 113.408 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.65 -37.38 19.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.32 92.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.741 0.701 . . . . 0.0 112.156 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.92 93.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.81 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.62 -40.39 66.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.433 1.015 . . . . 0.0 113.649 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.99 -10.57 10.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 114.333 169.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.75 -50.92 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.619 1.1 . . . . 0.0 110.571 158.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -54.19 -31.83 53.98 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.39 1.876 . . . . 0.0 113.688 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.65 -2.07 42.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.841 1.656 . . . . 0.0 112.937 -173.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.54 -24.45 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -153.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.88 109.76 0.23 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.098 1.759 . . . . 0.0 112.427 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.34 85.07 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -105.15 -122.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.814 1.307 . . . . 0.0 111.796 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -150.69 142.52 23.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.413 1.485 . . . . 0.0 109.317 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.88 -35.93 2.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.425 1.09 . . . . 0.0 113.465 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 89.8 m -146.61 23.7 1.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.535 1.934 . . . . 0.0 111.811 -163.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.31 -10.41 63.93 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.817 1.675 . . . . 0.0 114.412 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.0 p -70.11 -179.69 2.03 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.837 2.455 . . . . 0.0 113.223 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -126.5 135.39 51.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.678 1.591 . . . . 0.0 108.048 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.79 171.67 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.127 0.571 . . . . 0.0 112.252 -145.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -133.11 147.49 52.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.635 1.974 . . . . 0.0 109.525 159.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.88 130.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.939 0.896 . . . . 0.0 108.639 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 125.911 1.684 . . . . 0.0 112.507 -170.425 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.749 0.785 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -140.91 106.51 5.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.6 ttpt -123.32 128.45 49.94 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 124.307 1.043 . . . . 0.0 112.279 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 43' ' ' TRP . 30.0 tp -98.34 103.76 15.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.178 1.791 . . . . 0.0 108.878 162.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 10.9 mt -72.23 114.63 11.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 128.498 2.719 . . . . 0.0 110.135 160.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.99 125.1 34.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.33 166.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -134.96 48.41 2.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.125 1.77 . . . . 0.0 109.88 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -112.2 150.89 18.17 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.925 1.25 . . . . 0.0 113.331 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -59.97 -24.06 64.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.148 1.379 . . . . 0.0 111.075 162.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.6 m -57.47 -56.59 19.95 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.315 1.846 . . . . 0.0 111.91 162.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 13' ' ' LYS . 3.0 tm? -164.37 139.53 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.311 1.845 . . . . 0.0 111.126 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 9' ' ' GLY . 24.0 mtmt -122.49 110.12 15.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.311 1.844 . . . . 0.0 110.259 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.19 83.82 0.04 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.039 0.828 . . . . 0.0 112.825 -166.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -29.48 155.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.919 1.688 . . . . 0.0 115.513 155.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -134.38 -26.07 1.47 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.047 2.239 . . . . 0.0 117.047 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.0 p 57.46 167.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 -175.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.3 t -160.84 -171.48 3.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.02 2.528 . . . . 0.0 107.623 162.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -140.12 131.66 27.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.517 1.527 . . . . 0.0 108.464 170.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.74 176.53 8.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.384 1.088 . . . . 0.0 113.439 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 7.7 t -58.54 -50.74 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.362 1.865 . . . . 0.0 111.259 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.82 172.57 4.06 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.187 1.795 . . . . 0.0 109.824 -154.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.68 -3.28 11.48 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.8 -43.21 3.65 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 120.552 1.524 . . . . 0.0 108.503 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -63.66 -21.37 66.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.708 1.14 . . . . 0.0 112.818 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.35 8.19 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.796 0.725 . . . . 0.0 111.663 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -61.3 -46.22 91.2 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -58.58 -20.19 44.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 -41.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.479 1.911 . . . . 0.0 110.868 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 18' ' ' THR . 12.6 m-85 -54.73 -38.77 67.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -45.77 -52.8 10.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.178 1.791 . . . . 0.0 110.318 171.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -75.75 -34.05 60.26 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.118 1.767 . . . . 0.0 114.525 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -59.26 -42.24 90.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.797 1.181 . . . . 0.0 111.211 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.56 -34.17 47.23 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.254 -0.904 . . . . 0.0 110.488 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -70.45 -27.24 64.09 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.725 0.693 . . . . 0.0 112.542 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.95 -37.61 75.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.979 1.312 . . . . 0.0 112.863 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -66.36 -53.03 40.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.18 0.592 . . . . 0.0 111.318 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.22 20.2 0.3 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.734 1.635 . . . . 0.0 114.474 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.1 150.27 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 112.526 -167.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.56 -0.27 2.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.642 1.177 . . . . 0.0 112.746 161.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 41.45 -113.79 0.54 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-O 124.422 2.123 . . . . 0.0 113.739 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -2.45 7.11 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 131.318 3.847 . . . . 0.0 109.652 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 41.6 m95 27.25 72.47 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.912 2.885 . . . . 0.0 114.26 -153.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.3 m -71.31 157.11 38.66 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 110.452 170.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -146.17 156.14 43.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.915 1.686 . . . . 0.0 111.423 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -133.77 135.39 43.87 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 127.365 2.266 . . . . 0.0 109.858 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.24 -16.05 14.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.2 60.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.465 1.506 . . . . 0.0 112.106 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -125.2 -1.63 7.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.394 1.878 . . . . 0.0 112.52 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.384 55.2 mttm 60.07 19.47 8.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.427 1.891 . . . . 0.0 114.259 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -67.03 162.77 21.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.111 2.564 . . . . 0.0 113.957 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.98 158.72 41.98 Favored 'General case' 0 C--N 1.327 -0.404 1 C-N-CA 132.34 4.256 . . . . 0.0 110.514 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -145.19 144.56 30.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.757 -0.589 . . . . 0.0 111.292 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.2 94.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.087 1.355 . . . . 0.0 112.443 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -95.79 58.93 2.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.0 113.605 -169.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 O-C-N 120.921 -1.112 . . . . 0.0 113.298 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.334 9.8 ptpt . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 115' ' ' VAL . 14.8 t -130.88 143.37 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 119.785 1.175 . . . . 0.0 112.629 -160.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -135.67 132.87 37.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.613 1.965 . . . . 0.0 108.711 172.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.64 150.64 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.188 0.518 . . . . 0.0 109.854 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.37 -169.34 29.85 Favored Glycine 0 N--CA 1.465 0.631 0 O-C-N 121.337 -0.852 . . . . 0.0 114.402 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 60.87 4.86 0.85 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 85' ' ' GLY . 2.2 tm? -62.59 -49.61 74.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.471 1.032 . . . . 0.0 110.458 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.82 -60.11 0.34 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.536 2.017 . . . . 0.0 116.923 168.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -81.75 -13.74 57.38 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -159.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.89 -57.79 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 109.134 165.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.537 ' H ' HD12 ' A' ' 81' ' ' LEU . . . 38.26 62.67 1.05 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.794 2.14 . . . . 0.0 114.885 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -127.77 -42.61 1.59 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 pttp 139.75 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 1 C-N-CA 131.709 4.003 . . . . 0.0 112.171 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 m -79.57 -35.71 39.33 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.75 -0.594 . . . . 0.0 111.497 -167.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -40.76 76.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.118 -0.989 . . . . 0.0 111.519 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.0 mt -78.24 -31.3 49.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.617 0.767 . . . . 0.0 112.606 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.67 -37.96 68.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.943 1.247 . . . . 0.0 110.078 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -104.43 -42.44 5.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.386 -164.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.26 -34.55 66.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.138 0.575 . . . . 0.0 112.007 168.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -95.65 -29.83 14.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.73 -33.21 26.71 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.02 1.295 . . . . 0.0 114.205 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -57.52 -40.1 77.99 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -76.71 -27.61 55.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.07 -171.14 37.91 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 114.817 0.687 . . . . 0.0 114.817 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.09 135.02 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.828 3.019 . . . . 0.0 112.56 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.99 157.97 17.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.963 1.705 . . . . 0.0 110.043 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -127.67 -27.5 2.84 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.446 1.899 . . . . 0.0 112.669 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -168.32 155.84 8.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.808 1.243 . . . . 0.0 110.226 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -153.21 129.08 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.223 1.809 . . . . 0.0 108.902 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -148.85 160.38 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.923 0.889 . . . . 0.0 111.953 166.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.4 147.03 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.406 -0.809 . . . . 0.0 112.945 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 125.561 1.544 . . . . 0.0 111.319 169.579 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.064 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -127.31 139.49 52.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.924 1.69 . . . . 0.0 110.225 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.35 158.85 43.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.547 1.539 . . . . 0.0 114.685 -157.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.93 125.63 17.96 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.449 1.1 . . . . 0.0 108.869 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.7 m -138.26 -175.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -172.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -147.47 110.83 4.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.47 1.908 . . . . 0.0 109.547 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.02 173.02 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 111.224 158.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.13 37.37 2.12 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.883 0.849 . . . . 0.0 113.171 166.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.25 130.72 7.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 120.952 -1.092 . . . . 0.0 110.906 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 -37.76 4.85 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.133 2.555 . . . . 0.0 113.671 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -71.23 -44.65 64.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.396 1.078 . . . . 0.0 110.758 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.17 -34.86 78.43 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.382 0.673 . . . . 0.0 112.354 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.55 -46.98 68.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -31.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.991 -1.068 . . . . 0.0 110.959 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.13 -43.89 60.99 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 119.228 0.922 . . . . 0.0 112.508 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.65 -2.5 6.92 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.861 1.264 . . . . 0.0 113.964 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.49 -56.83 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 120.558 -1.339 . . . . 0.0 109.921 151.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -55.2 -29.75 58.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.522 1.529 . . . . 0.0 113.651 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -102.47 -12.04 18.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.725 1.61 . . . . 0.0 112.367 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.46 -5.48 0.65 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -154.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.6 p30 -57.91 -6.86 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 166.01 62.64 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.56 -0.712 . . . . 0.0 112.316 -151.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -135.68 -165.73 1.74 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.743 1.617 . . . . 0.0 111.719 -167.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.4 m -131.01 115.9 17.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.76 1.624 . . . . 0.0 109.288 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.37 -34.92 6.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.7 m -140.43 24.75 2.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.047 1.339 . . . . 0.0 112.739 -165.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.36 29.67 39.69 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 121.024 -1.047 . . . . 0.0 112.96 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.77 -165.98 1.55 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.77 2.428 . . . . 0.0 111.357 -167.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -139.64 55.56 1.66 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.842 0.857 . . . . 0.0 112.061 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.3 p -46.11 146.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 127.034 2.134 . . . . 0.0 114.091 -174.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.85 133.05 35.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.803 2.441 . . . . 0.0 109.441 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 46.7 t -143.42 136.42 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.785 0.434 . . . . 0.0 111.493 -158.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 127.504 2.322 . . . . 0.0 108.513 173.511 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.6 104.34 5.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 164.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.06 113.85 9.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.878 1.271 . . . . 0.0 112.836 -163.035 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.0 tp -99.84 101.85 13.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 110.434 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.03 124.09 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 128.343 2.657 . . . . 0.0 110.012 158.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.16 133.74 45.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.736 168.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -148.14 49.5 1.04 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.93 2.092 . . . . 0.0 109.723 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.58 157.48 21.32 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 120.539 -1.35 . . . . 0.0 112.924 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -55.49 -37.47 67.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.152 0.981 . . . . 0.0 110.179 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.492 HG21 ' HA3' ' A' ' 38' ' ' GLY . 85.0 m -56.78 -72.24 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.913 2.485 . . . . 0.0 112.967 164.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -140.59 132.71 27.97 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.441 1.096 . . . . 0.0 110.613 -161.667 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -132.28 123.23 26.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.244 1.818 . . . . 0.0 109.169 -175.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.84 99.11 0.81 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.469 1.033 . . . . 0.0 112.024 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -32.22 164.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.019 2.528 . . . . 0.0 116.941 165.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -129.06 -38.72 1.61 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.2 p 57.58 162.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -158.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -151.03 -6.94 0.26 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 28.17 99.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.806 3.242 . . . . 0.0 117.549 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.77 -159.6 0.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.447 1.499 . . . . 0.0 113.353 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.77 -17.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.537 1.935 . . . . 0.0 111.936 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -145.13 -11.1 0.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.58 -0.41 3.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.431 2.692 . . . . 0.0 115.445 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.51 -46.2 4.83 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 125.51 1.524 . . . . 0.0 107.956 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.64 -19.72 58.86 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.629 1.972 . . . . 0.0 113.455 162.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -54.2 6.61 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 119.402 1.001 . . . . 0.0 110.922 167.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.65 -43.95 91.97 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -60.77 -16.85 44.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.34 -41.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.427 2.291 . . . . 0.0 110.295 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.0 m-85 -53.63 -43.8 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.606 1.094 . . . . 0.0 113.701 168.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -58.15 1.44 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.944 2.097 . . . . 0.0 110.866 168.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.6 -30.89 46.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 114.918 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -59.5 -43.61 93.29 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.543 1.065 . . . . 0.0 110.928 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.95 -32.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.406 -0.809 . . . . 0.0 110.864 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.84 -26.74 67.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 118.335 0.516 . . . . 0.0 112.307 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.85 -48.39 59.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.837 1.655 . . . . 0.0 113.324 164.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.33 -38.61 87.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.595 0.634 . . . . 0.0 111.975 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' HA3' HG21 ' A' ' 11' ' ' THR . . . 128.62 28.37 0.82 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.524 1.535 . . . . 0.0 113.648 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.49 142.72 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.713 1.605 . . . . 0.0 111.176 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.86 113.71 5.41 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.376 1.084 . . . . 0.0 109.797 143.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -152.83 8.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-O 124.369 2.094 . . . . 0.0 115.387 -156.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.37 58.43 2.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 111.334 -2.433 . . . . 0.0 108.519 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 22.1 m95 -47.35 98.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.691 2.397 . . . . 0.0 112.019 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -121.98 159.28 27.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.341 1.856 . . . . 0.0 109.943 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.32 156.81 42.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.628 1.571 . . . . 0.0 111.127 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -135.29 113.1 10.95 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.729 2.012 . . . . 0.0 110.141 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.01 -18.6 53.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.61 -25.35 56.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.457 1.103 . . . . 0.0 111.863 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -120.69 -4.05 9.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.298 1.439 . . . . 0.0 112.949 167.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.385 37.8 mttm 56.42 24.66 8.71 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.86 2.064 . . . . 0.0 114.286 -171.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -73.12 155.06 40.07 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.553 1.941 . . . . 0.0 111.923 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.66 159.15 36.5 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 129.35 3.06 . . . . 0.0 111.37 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -143.8 136.76 27.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 2.3 m -111.89 96.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.514 1.15 . . . . 0.0 112.847 157.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 106.15 15.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.68 1.192 . . . . 0.0 109.324 165.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 . . . . . 0 CA--C 1.549 0.911 0 O-C-N 120.878 -1.139 . . . . 0.0 112.277 174.897 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -118.92 145.69 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.091 -1.006 . . . . 0.0 112.712 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -131.59 147.09 52.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.65 2.78 . . . . 0.0 108.808 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 5.3 t -138.01 150.42 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.442 1.097 . . . . 0.0 109.591 172.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.22 -168.73 20.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.36 -6.79 1.94 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.59 2.356 . . . . 0.0 114.646 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 51.76 2.31 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 122.747 1.261 . . . . 0.0 113.353 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.22 -20.34 69.14 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -67.89 -32.05 72.27 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.134 1.467 . . . . 0.0 113.213 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.94 -21.48 0.18 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -49.09 109.85 0.65 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 119.84 1.2 . . . . 0.0 115.081 -157.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -133.39 -25.58 1.72 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.678 1.991 . . . . 0.0 113.545 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 139.22 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 1 C-N-CA 132.787 4.435 . . . . 0.0 111.685 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -66.62 -44.11 82.93 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.814 0.734 . . . . 0.0 112.17 -163.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 1.5 pm0 -53.96 -34.82 60.77 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.8 mt -83.94 -37.74 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.469 1.107 . . . . 0.0 111.836 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -55.41 -36.5 66.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.941 1.297 . . . . 0.0 109.896 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.66 -54.79 5.33 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.04 -11.57 40.75 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -119.29 -30.66 4.87 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.369 1.068 . . . . 0.0 113.001 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.3 -31.5 50.34 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 119.509 1.049 . . . . 0.0 113.784 168.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -62.5 -41.02 98.54 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 172.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.87 -25.23 48.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.902 0.481 . . . . 0.0 111.955 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.62 -172.98 43.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.245 0.858 . . . . 0.0 115.245 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.69 131.03 17.86 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.643 2.895 . . . . 0.0 112.361 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.16 148.91 28.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.215 1.806 . . . . 0.0 109.478 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -123.83 -22.03 5.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.022 1.729 . . . . 0.0 113.188 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -164.29 153.15 13.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.034 1.334 . . . . 0.0 110.358 172.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.0 t -151.98 135.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.0 108.767 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -150.58 152.6 34.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.559 1.544 . . . . 0.0 111.137 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -146.54 146.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.991 -1.068 . . . . 0.0 111.472 172.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.994 . . . . 0.0 111.669 -177.399 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 119.649 -0.529 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.5 139.39 49.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.183 1.793 . . . . 0.0 110.798 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -130.82 166.19 21.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.725 2.01 . . . . 0.0 113.74 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.97 142.12 34.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.237 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.27 1.3 m -141.45 178.85 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.291 1.043 . . . . 0.0 112.296 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.05 104.63 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.767 2.027 . . . . 0.0 108.07 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.89 174.82 0.44 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.794 0.838 . . . . 0.0 112.584 155.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -115.72 -12.51 11.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.303 1.041 . . . . 0.0 112.71 164.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.91 140.76 21.38 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.052 1.341 . . . . 0.0 111.885 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.45 -37.59 0.94 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.694 2.93 . . . . 0.0 114.969 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -28.57 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.71 -1.244 . . . . 0.0 113.991 -159.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.23 -24.03 63.96 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.594 -0.691 . . . . 0.0 111.052 161.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 -47.16 66.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.807 1.243 . . . . 0.0 113.647 161.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.36 65.08 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 120.275 -1.516 . . . . 0.0 110.739 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -43.21 77.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 172.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.73 -8.62 2.16 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 166.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.48 -53.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.863 1.665 . . . . 0.0 110.743 157.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -59.86 -21.85 61.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.148 1.779 . . . . 0.0 112.882 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -107.51 -9.06 16.03 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.089 1.756 . . . . 0.0 111.537 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.12 -4.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -153.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -5.67 41.07 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.861 1.21 . . . . 0.0 113.763 168.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.75 46.89 0.53 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.418 1.485 . . . . 0.0 113.773 -159.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -132.19 177.97 7.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.155 0.982 . . . . 0.0 113.007 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.6 m -113.55 123.06 49.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.448 1.499 . . . . 0.0 109.129 168.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mp -129.52 145.59 51.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.007 2.523 . . . . 0.0 107.99 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.0 m 52.41 18.96 1.03 Allowed 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.96 60.18 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.277 1.418 . . . . 0.0 114.01 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.14 147.28 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.148 1.779 . . . . 0.0 111.226 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -52.58 148.07 7.58 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.99 152.01 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.316 . . . . 0.0 109.915 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 147.25 50.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.349 1.059 . . . . 0.0 108.342 167.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.48 158.15 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.308 0.643 . . . . 0.0 111.817 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 125.339 1.456 . . . . 0.0 107.584 165.665 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.781 0.324 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.51 109.68 8.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 160.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.3 ttmm -131.13 135.72 47.72 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 127.018 2.127 . . . . 0.0 109.18 -169.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -114.41 98.82 7.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.358 1.863 . . . . 0.0 108.554 162.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.36 124.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.903 1.681 . . . . 0.0 108.738 158.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.24 135.22 38.36 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.934 166.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -144.84 53.19 1.22 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.26 1.024 . . . . 0.0 109.078 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.83 175.8 21.74 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.739 1.188 . . . . 0.0 114.044 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -49.42 77.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 109.758 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -56.2 -52.1 65.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.931 1.692 . . . . 0.0 113.339 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.82 142.43 13.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.474 1.11 . . . . 0.0 110.649 -170.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.12 138.04 53.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.649 1.58 . . . . 0.0 110.256 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.52 -133.38 4.84 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.343 1.449 . . . . 0.0 110.138 -157.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -162.64 -169.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.146 1.778 . . . . 0.0 109.433 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -136.29 -45.26 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 158.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.8 p 55.94 164.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.281 1.432 . . . . 0.0 114.633 -159.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -155.46 -19.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.44 142.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 128.051 2.54 . . . . 0.0 116.062 -161.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.75 177.92 9.1 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.035 -1.666 . . . . 0.0 114.368 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.24 -39.28 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.258 1.823 . . . . 0.0 111.823 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -151.03 -8.06 0.25 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -146.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.39 27.09 15.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.287 1.835 . . . . 0.0 114.01 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.37 -38.31 0.61 Allowed 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 124.417 1.087 . . . . 0.0 111.039 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 95.1 m -64.53 -15.61 61.2 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.251 2.22 . . . . 0.0 112.453 155.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.95 7.21 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 110.8 165.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.35 -47.34 86.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 1.7 ptpp? -59.91 -15.75 24.11 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -171.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.5 -43.96 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.48 1.912 . . . . 0.0 111.034 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.7 -43.31 68.86 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.232 1.013 . . . . 0.0 112.753 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.4 mmpt? -40.97 -49.61 3.28 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.813 2.045 . . . . 0.0 112.111 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -94.92 -21.33 18.71 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.77 -37.75 74.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.051 0.841 . . . . 0.0 110.077 160.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.84 -39.16 27.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.524 -0.735 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.4 -23.18 61.06 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.245 -0.909 . . . . 0.0 111.539 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.06 -36.32 79.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.916 1.287 . . . . 0.0 113.374 164.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -69.33 -15.81 63.41 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.792 0.837 . . . . 0.0 112.73 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.35 25.54 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.638 1.59 . . . . 0.0 112.859 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -112.44 124.2 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 125.386 1.474 . . . . 0.0 112.225 -161.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.3 9.87 7.96 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.271 152.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 35.8 -134.98 0.56 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 128.189 2.804 . . . . 0.0 119.889 151.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -124.19 49.32 1.79 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.84 2.456 . . . . 0.0 106.673 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 20.7 m95 -42.75 104.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.285 1.834 . . . . 0.0 113.225 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 m -125.37 157.49 36.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 109.668 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -148.18 155.8 41.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.619 1.568 . . . . 0.0 111.335 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -134.73 130.46 36.26 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 126.106 1.762 . . . . 0.0 110.278 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -97.72 -18.16 18.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.461 1.104 . . . . 0.0 113.12 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.55 63.21 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.819 1.248 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -122.7 -2.79 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.574 1.549 . . . . 0.0 113.156 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.375 35.8 mttm 59.78 21.29 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.825 1.65 . . . . 0.0 114.321 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.4 m -73.69 160.06 32.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.746 2.418 . . . . 0.0 113.362 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -134.21 158.19 44.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 130.862 3.665 . . . . 0.0 110.705 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.3 m -146.88 133.73 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.187 0.595 . . . . 0.0 110.991 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.1 96.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 159.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.59 62.29 7.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.311 1.529 . . . . 0.0 112.612 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 124.058 0.943 . . . . 0.0 113.477 -176.525 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 116' ' ' GLU . 20.2 tttt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 116.039 -1.934 . . . . 0.0 107.402 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 115' ' ' VAL . 7.5 p -137.93 146.92 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 123.492 2.86 . . . . 0.0 116.714 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -140.57 156.97 46.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.922 2.089 . . . . 0.0 111.814 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -139.75 158.27 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 120.957 -1.09 . . . . 0.0 112.908 -176.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -170.31 -167.42 30.71 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 169.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.24 20.81 7.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.588 1.555 . . . . 0.0 115.036 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.55 51.42 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 111.716 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.41 -17.76 33.75 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.386 1.946 . . . . 0.0 115.895 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.47 -55.31 10.61 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.57 1.185 . . . . 0.0 111.467 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -131.94 -22.55 2.32 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 8.47 74.15 0.01 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.68 3.038 . . . . 0.0 117.839 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -135.27 162.79 31.56 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.415 1.107 . . . . 0.0 113.646 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -60.5 -43.84 96.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.596 1.558 . . . . 0.0 113.158 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -86.46 -29.77 22.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -163.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.81 -31.38 64.65 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.316 -1.49 . . . . 0.0 111.727 164.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.93 -22.25 22.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.044 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.13 -34.77 75.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.259 1.391 . . . . 0.0 109.359 167.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -80.2 -64.91 1.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.638 1.175 . . . . 0.0 111.206 174.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -4.28 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -123.6 -30.62 3.59 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.487 1.039 . . . . 0.0 112.18 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.98 -27.71 30.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.174 1.352 . . . . 0.0 115.189 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -55.03 -38.79 68.41 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.0 -16.97 54.06 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.18 -170.82 33.9 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.105 0.86 . . . . 0.0 114.741 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.27 101.91 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.13 3.22 . . . . 0.0 112.443 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.18 68.23 2.57 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.288 1.835 . . . . 0.0 111.808 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -12.43 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.076 2.15 . . . . 0.0 114.342 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.3 m -150.44 150.25 31.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.541 1.064 . . . . 0.0 110.819 161.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.14 116.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 110.143 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -146.43 147.11 30.91 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.34 1.856 . . . . 0.0 109.219 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.06 154.33 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.387 -0.821 . . . . 0.0 112.391 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 125.735 1.614 . . . . 0.0 111.902 173.904 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.539 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 61.2 m-85 -130.09 136.67 49.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.703 1.201 . . . . 0.0 111.213 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -132.44 156.59 46.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.62 1.2 . . . . 0.0 113.586 -167.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 136.88 54.29 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.444 1.498 . . . . 0.0 108.533 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -139.24 164.97 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.934 0.894 . . . . 0.0 111.373 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.437 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 44.7 mt-10 -144.34 142.33 30.31 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 109.526 170.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -119.2 140.57 49.98 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 156.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.4 29.16 0.3 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.259 -0.9 . . . . 0.0 112.94 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -152.79 137.83 11.15 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 126.083 1.753 . . . . 0.0 111.559 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.73 -51.35 9.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.553 3.502 . . . . 0.0 117.203 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.35 -14.61 22.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -160.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.31 -45.22 66.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.551 0.614 . . . . 0.0 110.536 165.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.74 77.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 111.935 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.97 78.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.44 -1.267 . . . . 0.0 110.849 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.55 -40.84 61.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.356 1.435 . . . . 0.0 113.172 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.02 -14.33 6.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.588 1.555 . . . . 0.0 114.03 166.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.6 -47.92 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 120.127 1.33 . . . . 0.0 111.699 161.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.84 -36.27 62.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.868 2.067 . . . . 0.0 112.987 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.19 -11.64 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.024 1.329 . . . . 0.0 112.516 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.09 -27.89 0.63 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -148.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -45.07 101.65 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.055 2.542 . . . . 0.0 112.114 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.4 27.01 73.31 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.075 -0.847 . . . . 0.0 114.568 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -97.16 -138.51 0.27 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.611 1.205 . . . . 0.0 111.452 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 138' ' ' CYS . 52.9 m -152.91 143.17 22.47 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.683 2.793 . . . . 0.0 108.346 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.53 -42.32 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 112.377 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 87.1 m -137.23 29.51 2.74 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.493 1.117 . . . . 0.0 112.744 -155.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.27 44.76 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.369 -0.832 . . . . 0.0 112.415 -170.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.421 ' H ' HG23 ' A' ' 134' ' ' THR . 31.6 p -129.4 -174.91 3.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.17 2.188 . . . . 0.0 112.314 -166.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 89.96 2.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 108.346 174.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.7 172.39 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.063 0.945 . . . . 0.0 112.756 -168.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.657 1.583 . . . . 0.0 108.932 151.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 t -136.7 134.66 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 C--O 1.235 0.334 0 C-N-CA 124.186 0.995 . . . . 0.0 109.55 -171.851 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.481 0.658 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.86 105.37 8.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.95 107.21 8.55 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.716 0.807 . . . . 0.0 112.116 -164.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 54' ' ' VAL . 42.9 tp -97.63 92.39 5.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.625 1.57 . . . . 0.0 109.84 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.25 105.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.602 2.361 . . . . 0.0 109.203 162.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.557 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 mp -82.53 132.01 35.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.5 ' HB3' HG23 ' A' ' 55' ' ' THR . 67.5 m-20 -137.08 44.73 2.28 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.938 2.095 . . . . 0.0 108.183 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.85 51.34 Favored Glycine 0 C--N 1.338 0.685 0 O-C-N 120.439 -1.413 . . . . 0.0 115.451 -161.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -56.23 -48.03 77.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.856 1.662 . . . . 0.0 109.857 160.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m -78.99 -62.48 1.69 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.449 2.3 . . . . 0.0 113.849 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.87 145.01 34.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.511 1.124 . . . . 0.0 110.409 -166.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 119.98 21.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.549 1.94 . . . . 0.0 110.144 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.62 23.1 0.09 OUTLIER Glycine 0 N--CA 1.477 1.407 0 N-CA-C 119.898 2.719 . . . . 0.0 119.898 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 57.34 -176.46 0.06 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -150.79 -32.49 0.17 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p 59.22 163.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.3 t -161.5 -163.51 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.358 2.663 . . . . 0.0 106.994 157.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.12 138.7 35.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 120.092 -1.63 . . . . 0.0 108.924 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.04 -171.13 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 123.508 1.623 . . . . 0.0 112.887 -165.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.31 -22.69 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 112.474 -2.148 . . . . 0.0 111.343 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -140.28 -57.69 0.54 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 129.89 -30.55 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 131.138 3.775 . . . . 0.0 112.243 -162.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.9 -36.01 25.67 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.723 1.209 . . . . 0.0 110.293 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -76.19 -20.97 57.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.444 3.098 . . . . 0.0 112.447 167.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.47 -52.83 8.44 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.457 -0.777 . . . . 0.0 109.968 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -47.05 47.21 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 125.685 1.594 . . . . 0.0 108.596 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -20.29 16.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -170.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.94 -40.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.386 1.474 . . . . 0.0 109.629 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.1 m-30 -51.51 -46.0 63.1 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.56 1.144 . . . . 0.0 112.922 166.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.7 mmpt? -42.0 -46.84 4.28 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.572 1.549 . . . . 0.0 112.277 170.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -100.21 -19.08 16.57 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.29 -39.07 74.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.023 0.829 . . . . 0.0 110.51 156.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -85.04 -33.28 22.53 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.537 -0.727 . . . . 0.0 110.705 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -75.3 -22.12 57.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.0 1.273 . . . . 0.0 112.047 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.2 1.0 . . . . 0.0 112.649 163.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -64.84 -31.47 72.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.71 -0.618 . . . . 0.0 111.94 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.17 5.41 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.337 1.923 . . . . 0.0 113.698 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.03 134.01 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.506 1.922 . . . . 0.0 111.746 -163.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.41 12.24 3.81 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 157.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 2.06 -93.02 0.0 OUTLIER Glycine 0 N--CA 1.473 1.149 0 C-N-CA 130.114 3.721 . . . . 0.0 117.639 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -6.64 1.32 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.8 1.64 . . . . 0.0 111.988 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.493 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 30.0 m95 23.05 67.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.257 3.423 . . . . 0.0 116.254 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 m -75.33 153.63 37.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.331 1.062 . . . . 0.0 110.858 170.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -145.8 146.08 31.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.334 1.453 . . . . 0.0 110.363 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -134.62 56.14 1.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.296 1.038 . . . . 0.0 112.026 -155.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -40.56 -27.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 130.392 3.477 . . . . 0.0 119.034 -173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.33 -20.54 66.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.583 1.953 . . . . 0.0 112.505 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -128.93 -15.95 4.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.125 2.17 . . . . 0.0 113.058 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.344 36.3 mttm 65.47 14.39 9.44 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.211 3.004 . . . . 0.0 115.144 -170.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.4 m -53.76 159.07 1.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.951 1.7 . . . . 0.0 112.624 157.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.14 170.01 14.06 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 130.109 3.364 . . . . 0.0 111.07 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.4 m -147.09 153.63 40.18 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.009 -1.057 . . . . 0.0 110.525 159.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.49 113.77 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.443 0.64 . . . . 0.0 111.666 153.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 8' ' ' ASN . 2.0 m -106.12 114.8 29.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.697 0.799 . . . . 0.0 110.253 172.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 124.708 1.203 . . . . 0.0 113.205 179.201 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . 0.282 4.5 p -122.74 146.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 125.071 3.578 . . . . 0.0 112.327 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -134.33 153.35 51.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.174 -167.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 11.2 t -135.9 153.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.408 1.083 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.98 26.87 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.272 0.939 . . . . 0.0 115.128 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 70.37 33.07 2.61 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.095 1.758 . . . . 0.0 113.549 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -112.8 160.86 17.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 114.039 -174.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.18 -30.54 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.857 1.694 . . . . 0.0 113.653 168.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -50.83 -36.48 37.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.733 2.413 . . . . 0.0 114.675 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.64 -50.66 0.24 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.114 2.166 . . . . 0.0 110.427 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.412 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -10.3 95.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.535 2.493 . . . . 0.0 116.316 -163.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -132.68 -29.91 1.48 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -168.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 pttp 135.26 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 1 C-N-CA 132.581 4.352 . . . . 0.0 110.578 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 m -69.46 -39.49 77.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.5 0.72 . . . . 0.0 111.525 -167.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -37.07 76.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.186 -0.947 . . . . 0.0 112.466 173.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.8 mt -79.96 -31.75 39.92 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.026 0.931 . . . . 0.0 111.856 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -57.93 -34.9 70.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.014 0.825 . . . . 0.0 110.016 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -91.75 -51.97 4.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.725 0.81 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.23 -28.28 66.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.959 0.904 . . . . 0.0 113.411 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.74 -25.98 13.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.535 0.734 . . . . 0.0 110.31 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.7 -34.14 20.58 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 126.547 2.023 . . . . 0.0 115.231 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -53.26 -37.82 62.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.041 0.921 . . . . 0.0 113.461 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -84.69 -12.01 54.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.009 0.923 . . . . 0.0 111.528 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.87 168.56 14.29 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.792 1.663 . . . . 0.0 113.042 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.68 117.02 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.96 2.44 . . . . 0.0 111.044 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.14 153.1 35.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.331 0.586 . . . . 0.0 110.602 168.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -124.31 1.33 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.737 1.615 . . . . 0.0 113.278 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -161.81 152.97 18.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.6 1.16 . . . . 0.0 109.913 147.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.5 t -153.56 124.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.449 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -152.0 149.1 28.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.956 0.902 . . . . 0.0 111.363 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -146.58 146.54 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -171.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 127.029 2.132 . . . . 0.0 111.454 170.098 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.159 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -142.96 149.35 38.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.494 1.118 . . . . 0.0 112.574 -155.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -129.67 164.37 24.09 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.435 1.894 . . . . 0.0 113.906 169.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.15 149.34 51.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.701 -1.59 . . . . 0.0 109.146 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.47 150.41 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 122.346 1.069 . . . . 0.0 111.769 -171.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -143.37 138.88 29.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.08 1.352 . . . . 0.0 110.466 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.77 -21.54 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.758 2.423 . . . . 0.0 112.78 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.272 8.9 tm-20 39.06 53.07 2.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 -153.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -150.95 137.15 11.08 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.514 1.525 . . . . 0.0 109.864 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.47 -45.06 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.913 1.742 . . . . 0.0 113.299 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.11 -54.61 10.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.898 1.279 . . . . 0.0 112.816 -165.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.86 -21.49 54.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.39 1.076 . . . . 0.0 113.406 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.55 -45.21 54.83 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.943 0.792 . . . . 0.0 112.387 169.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.98 74.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -45.46 72.74 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.65 -0.656 . . . . 0.0 112.054 173.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -6.82 3.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 114.4 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.92 -54.47 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.138 -0.977 . . . . 0.0 111.594 153.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -33.86 67.47 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.254 1.388 . . . . 0.0 114.23 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.55 1.73 23.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.051 1.741 . . . . 0.0 111.803 -163.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.45 -19.94 0.48 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.962 1.705 . . . . 0.0 113.594 -162.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -76.91 146.27 37.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.984 1.313 . . . . 0.0 113.236 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.01 37.8 81.51 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.183 0.897 . . . . 0.0 112.844 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.48 158.96 34.73 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.166 1.787 . . . . 0.0 111.702 -165.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 m -88.11 56.68 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 111.642 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.25 -28.86 65.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -160.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 70.1 m -142.48 22.5 2.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.047 1.339 . . . . 0.0 113.847 -162.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.04 11.32 70.03 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 120.341 -1.474 . . . . 0.0 113.217 -166.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 19.1 p -122.97 165.34 16.9 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.041 2.536 . . . . 0.0 107.806 164.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -89.36 102.0 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.77 163.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.981 1.313 . . . . 0.0 111.962 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -124.09 135.06 53.28 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.343 1.457 . . . . 0.0 107.357 162.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.42 138.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 108.585 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 124.002 0.921 . . . . 0.0 111.397 -166.956 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -132.7 124.6 28.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 136.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 34.2 ttmt -125.02 152.94 43.59 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 125.218 1.407 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.9 tp -129.21 100.77 5.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.806 2.843 . . . . 0.0 108.503 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.36 118.46 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 127.423 2.289 . . . . 0.0 109.054 158.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.3 mp -94.27 137.14 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -147.51 42.96 1.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.768 2.027 . . . . 0.0 109.282 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.01 -172.81 25.37 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.721 -1.237 . . . . 0.0 115.586 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -60.13 -45.13 94.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.041 0.924 . . . . 0.0 111.393 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -68.59 -60.49 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.833 2.053 . . . . 0.0 112.193 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.07 144.19 26.52 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.174 0.99 . . . . 0.0 110.355 -166.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -129.72 122.27 28.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.213 1.805 . . . . 0.0 108.649 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.07 23.92 0.12 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 119.006 2.363 . . . . 0.0 119.006 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.629 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER 59.65 -175.22 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.098 2.259 . . . . 0.0 117.098 175.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -145.22 -40.72 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 162.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 15.0 p 60.75 151.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 126.035 1.734 . . . . 0.0 115.405 -165.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.2 126.15 0.66 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.026 1.73 . . . . 0.0 106.747 163.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.69 148.65 33.03 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 121.848 -0.533 . . . . 0.0 110.692 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.82 176.35 11.14 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.07 -1.019 . . . . 0.0 112.814 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.79 -54.75 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.134 1.774 . . . . 0.0 111.428 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -165.18 174.53 10.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.045 1.738 . . . . 0.0 109.966 -158.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.73 -39.93 1.59 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.772 1.169 . . . . 0.0 110.699 -173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -71.32 -23.13 61.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.755 1.622 . . . . 0.0 112.129 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.36 -50.79 14.82 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 109.802 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -47.68 61.32 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.771 1.228 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -23.17 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -169.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.02 -36.97 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.22 1.408 . . . . 0.0 109.609 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -53.41 -45.52 69.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.444 1.098 . . . . 0.0 112.75 164.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.52 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.1 mmpt? -44.75 -53.97 6.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 111.224 168.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -72.21 -36.43 69.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.38 -41.58 94.07 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.655 1.116 . . . . 0.0 111.309 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -75.55 -38.38 59.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.0 -29.5 69.89 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.17 0.895 . . . . 0.0 112.235 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.08 -38.28 85.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 113.009 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -67.33 -12.96 61.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.667 0.787 . . . . 0.0 112.511 165.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.25 10.0 52.32 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.04 1.781 . . . . 0.0 112.756 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 57.7 t -100.08 128.04 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 125.93 1.692 . . . . 0.0 112.362 -161.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 68.18 1.31 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 125.074 2.369 . . . . 0.0 110.569 156.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.5 -153.14 0.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 109.696 -3.411 . . . . 0.0 115.15 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.99 52.66 0.72 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.768 2.827 . . . . 0.0 109.824 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.52 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 21.9 m95 -43.74 100.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.247 2.619 . . . . 0.0 112.916 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.3 m -125.95 162.2 25.76 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.38 1.872 . . . . 0.0 110.125 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -147.23 155.88 42.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.627 1.571 . . . . 0.0 111.536 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.42 129.76 35.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.715 2.006 . . . . 0.0 109.275 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.61 -18.11 23.5 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.13 61.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.079 0.951 . . . . 0.0 111.824 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -122.93 -2.15 8.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.242 1.817 . . . . 0.0 112.601 166.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.317 49.8 mttm 58.86 24.8 12.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.596 1.558 . . . . 0.0 113.372 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.2 m -79.22 157.22 27.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.523 2.329 . . . . 0.0 112.36 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.71 159.52 32.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.596 2.758 . . . . 0.0 109.658 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -145.15 132.79 20.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.09 -0.381 . . . . 0.0 111.274 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 3.1 m -112.87 100.52 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.983 0.897 . . . . 0.0 112.014 156.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 115.04 18.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 155.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 124.025 1.869 . . . . 0.0 109.335 170.958 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.418 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 115' ' ' VAL . 12.1 p -132.44 155.82 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 108.849 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -137.34 152.27 49.52 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.854 -1.154 . . . . 0.0 112.126 -162.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 t -138.98 149.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 110.207 -177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.62 38.11 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 3.2 t30 81.86 5.6 1.18 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.1 2.56 . . . . 0.0 113.918 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 61.51 5.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.389 1.476 . . . . 0.0 112.83 -167.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.23 63.95 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 114.649 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 114.234 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -136.16 -61.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.608 1.163 . . . . 0.0 111.076 -167.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.96 54.38 4.41 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.513 2.006 . . . . 0.0 114.556 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.09 -40.88 2.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -173.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 pttp 138.48 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 1 C-N-CA 132.461 4.305 . . . . 0.0 111.586 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.3 m -82.46 -26.12 32.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.13 0.877 . . . . 0.0 112.293 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -53.65 -35.14 60.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.78 -1.2 . . . . 0.0 112.321 159.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.71 -29.62 17.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.682 1.193 . . . . 0.0 113.129 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -60.08 -32.21 70.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.671 1.123 . . . . 0.0 109.301 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -85.23 -54.67 4.46 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.481 1.112 . . . . 0.0 112.51 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 -21.22 59.17 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.09 -29.47 8.53 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.013 0.925 . . . . 0.0 111.499 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -51.66 -36.47 40.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.632 1.111 . . . . 0.0 114.196 167.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -57.0 -36.02 69.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.51 -24.39 50.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.02 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.68 -169.54 34.54 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.69 106.54 2.13 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.881 3.054 . . . . 0.0 111.927 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.92 143.2 52.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.228 1.011 . . . . 0.0 111.22 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.1 ttp-105 -94.33 -35.19 12.51 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.172 1.389 . . . . 0.0 111.705 163.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -172.4 160.44 4.9 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.767 1.167 . . . . 0.0 111.011 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.8 t -151.31 134.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 107.846 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -146.06 148.45 32.67 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.297 1.839 . . . . 0.0 109.982 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.14 145.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 112.876 173.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.75 1.22 . . . . 0.0 114.044 -173.632 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 CA-C-O 119.37 -0.683 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.52 135.67 48.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 0.0 111.063 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.465 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -137.12 162.6 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.515 1.926 . . . . 0.0 113.707 -168.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.74 156.23 47.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.504 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -158.53 160.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.163 . . . . 0.0 110.488 -162.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.56 154.34 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.66 1.584 . . . . 0.0 110.764 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -132.64 151.55 51.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.972 2.109 . . . . 0.0 111.681 -173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -84.62 -2.23 57.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.811 -1.18 . . . . 0.0 113.821 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.88 129.03 23.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.486 1.114 . . . . 0.0 111.608 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.23 -27.85 13.2 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.381 2.721 . . . . 0.0 114.043 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.98 -34.0 12.53 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.252 1.021 . . . . 0.0 110.875 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -68.93 -29.5 67.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.609 1.095 . . . . 0.0 112.895 164.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.44 -45.28 91.61 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.84 1.2 . . . . 0.0 111.802 165.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.92 89.12 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.614 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.33 -42.98 61.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.87 -12.31 7.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.552 1.141 . . . . 0.0 113.536 168.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 87.6 t -89.89 -52.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 119.408 1.004 . . . . 0.0 112.312 159.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -59.31 -25.5 64.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.327 1.851 . . . . 0.0 113.156 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.54 -7.37 34.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 112.162 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.59 -15.82 0.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -153.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -48.11 -23.74 0.92 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.314 2.246 . . . . 0.0 115.645 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -161.4 40.14 0.41 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.684 1.135 . . . . 0.0 114.199 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.25 34.5 ttp180 -113.42 -123.37 0.29 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.353 1.077 . . . . 0.0 112.283 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.5 m -161.07 142.39 11.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.372 1.869 . . . . 0.0 107.621 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.9 tp -138.38 -36.93 0.57 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -163.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.8 m -140.47 21.42 2.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.158 1.383 . . . . 0.0 113.216 -171.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.89 47.47 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.499 -0.751 . . . . 0.0 113.397 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 11.9 t -137.15 152.61 50.15 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 108.327 157.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HE ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 tmm_? -35.5 134.67 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.477 1.511 . . . . 0.0 109.902 150.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.18 157.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.195 0.598 . . . . 0.0 110.259 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -128.21 159.37 35.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.104 159.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.1 t -149.24 148.59 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.975 1.31 . . . . 0.0 108.493 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.122 1.369 . . . . 0.0 110.815 -178.749 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 120.731 0.301 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.35 111.33 12.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -138.21 99.69 3.93 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.765 0.826 . . . . 0.0 112.096 -163.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 34' ' ' ALA . 14.4 tp -87.54 90.76 8.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 119.021 0.828 . . . . 0.0 109.486 173.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -53.8 120.39 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 126.431 1.892 . . . . 0.0 109.056 159.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.41 128.77 38.38 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.012 168.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -144.1 59.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 111.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.15 152.13 18.01 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.136 0.874 . . . . 0.0 113.366 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -52.24 -29.84 24.77 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.811 1.244 . . . . 0.0 110.11 156.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 m -59.43 -55.39 35.21 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.981 2.513 . . . . 0.0 113.596 167.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.4 tm? -167.35 141.5 3.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.258 1.823 . . . . 0.0 110.123 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' N ' HD13 ' A' ' 12' ' ' LEU . 6.0 mtpm? -132.59 140.79 48.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.087 1.355 . . . . 0.0 111.922 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.7 -136.07 5.87 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 125.702 1.62 . . . . 0.0 110.586 -163.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -161.57 -169.66 2.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.352 2.261 . . . . 0.0 109.076 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -138.33 -43.32 0.5 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 160.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p 62.06 164.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.428 2.011 . . . . 0.0 116.428 -168.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -161.68 -167.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.64 2.776 . . . . 0.0 105.864 156.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -134.97 140.13 45.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.147 -1.595 . . . . 0.0 108.948 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.79 10.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 0.0 112.329 -162.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -61.48 -49.19 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 110.191 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -164.04 178.99 7.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 123.507 1.623 . . . . 0.0 111.611 -160.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 16.85 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.844 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 p -61.28 -25.46 67.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.252 1.821 . . . . 0.0 115.885 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 -46.87 12.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.112 0.415 . . . . 0.0 111.221 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.37 -47.5 85.2 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -58.89 -22.43 59.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.62 -47.21 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.045 1.738 . . . . 0.0 110.946 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -52.26 -43.1 64.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.61 1.164 . . . . 0.0 113.136 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 5.6 mmmm -46.81 -50.58 18.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.967 2.107 . . . . 0.0 111.409 171.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.84 -38.83 70.06 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.69 -36.68 83.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.108 0.867 . . . . 0.0 111.786 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -82.54 -26.54 32.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.35 -0.844 . . . . 0.0 111.95 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.3 -37.95 81.15 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.051 0.841 . . . . 0.0 111.744 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.44 -40.01 89.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.374 1.47 . . . . 0.0 112.396 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -66.74 -38.44 86.65 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.001 -0.437 . . . . 0.0 111.635 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.07 22.03 9.09 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.173 1.844 . . . . 0.0 113.88 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.31 -65.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.645 1.212 . . . . 0.0 113.021 -163.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.265 23.0 m-20 22.79 64.76 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 130.816 3.646 . . . . 0.0 113.816 -168.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.8 -134.94 6.55 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 108.872 -3.785 . . . . 0.0 113.106 -165.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.43 59.08 0.58 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.353 1.461 . . . . 0.0 109.46 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.445 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 5.7 m95 -50.84 100.2 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.933 1.693 . . . . 0.0 112.617 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -136.86 162.86 32.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.542 1.137 . . . . 0.0 111.557 -170.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 55.8 t80 -143.75 153.06 42.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.139 1.776 . . . . 0.0 110.867 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.46 77.79 1.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.367 1.467 . . . . 0.0 112.27 -168.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -22.86 23.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.5 64.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.5 1.92 . . . . 0.0 112.697 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -130.58 -4.91 4.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.824 1.25 . . . . 0.0 113.147 167.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.374 36.2 mttm 57.28 18.09 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.462 3.105 . . . . 0.0 114.748 -167.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -60.85 157.91 14.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.328 1.851 . . . . 0.0 111.538 165.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 37.7 m-85 -122.91 167.81 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.863 2.465 . . . . 0.0 110.942 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -149.73 146.17 27.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.598 -1.314 . . . . 0.0 110.665 167.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.86 88.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.232 1.013 . . . . 0.0 112.678 161.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 58.11 4.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.949 1.3 . . . . 0.0 113.34 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.151 0 O-C-N 120.785 -1.197 . . . . 0.0 113.204 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 115' ' ' VAL . 66.5 t -117.42 138.6 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.846 1.657 . . . . 0.0 112.768 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -126.33 140.69 52.32 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.269 1.828 . . . . 0.0 108.632 158.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.94 135.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 108.915 175.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.27 -147.39 5.19 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.702 -0.623 . . . . 0.0 114.193 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.79 -6.12 0.45 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.918 1.687 . . . . 0.0 113.701 -152.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.1 mt -80.67 55.27 2.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.907 1.683 . . . . 0.0 112.264 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.37 42.15 0.4 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 127.788 2.613 . . . . 0.0 114.558 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -157.21 -50.3 0.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.11 2.564 . . . . 0.0 110.482 -167.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.09 -112.63 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.644 2.378 . . . . 0.0 108.182 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.21 69.08 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.486 1.993 . . . . 0.0 116.543 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.25 161.27 5.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.036 2.534 . . . . 0.0 113.639 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -34.82 52.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -71.46 -46.35 60.18 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.101 0.96 . . . . 0.0 112.939 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -33.05 75.03 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.886 -1.134 . . . . 0.0 111.406 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.8 mt -83.54 -36.08 24.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.114 0.965 . . . . 0.0 112.663 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -44.57 -42.87 7.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.456 1.103 . . . . 0.0 110.092 165.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -105.48 -39.57 6.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 118.32 -0.848 . . . . 0.0 112.645 -162.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.4 70.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.809 0.731 . . . . 0.0 112.092 168.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -95.12 -30.8 13.85 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.22 -35.44 6.72 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.996 1.284 . . . . 0.0 114.432 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -58.18 -37.15 74.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -81.27 -20.98 39.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 111.641 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.25 -173.49 33.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.65 0.643 . . . . 0.0 114.124 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.02 156.46 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.306 2.671 . . . . 0.0 112.457 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.51 143.49 50.86 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.089 2.556 . . . . 0.0 108.206 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -95.1 -32.75 12.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.905 1.282 . . . . 0.0 112.247 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 t -166.33 169.28 14.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.992 0.917 . . . . 0.0 111.954 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 t -159.89 127.0 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.279 3.032 . . . . 0.0 107.311 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -156.86 144.71 19.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.613 1.165 . . . . 0.0 111.943 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.14 139.86 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.682 -1.261 . . . . 0.0 113.004 -166.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 125.423 1.489 . . . . 0.0 109.569 167.592 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 CA-C-O 121.446 0.47 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -155.82 158.48 38.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.575 1.95 . . . . 0.0 109.139 -166.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.72 156.78 35.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.379 1.472 . . . . 0.0 113.497 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -131.83 148.05 52.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.872 165.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 76' ' ' VAL 0.252 0.7 OUTLIER -143.64 -179.47 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.033 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -141.42 106.72 5.01 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 107.731 166.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.94 169.36 0.53 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 165.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.08 25.48 5.88 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.051 0.929 . . . . 0.0 113.244 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.93 132.23 10.25 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.616 -1.303 . . . . 0.0 110.295 160.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.8 -34.01 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.638 2.226 . . . . 0.0 114.639 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.07 -31.77 20.31 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.061 1.3 . . . . 0.0 112.289 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.52 -24.04 60.09 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 167.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.52 -51.04 62.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.533 1.06 . . . . 0.0 111.875 163.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.81 -32.11 63.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.607 -1.308 . . . . 0.0 110.998 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -43.25 55.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.77 -10.65 9.43 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 113.618 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.78 -62.23 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.893 . . . . 0.0 110.732 153.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -49.48 -33.63 14.86 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.672 1.989 . . . . 0.0 114.309 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.7 -13.52 16.45 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 112.193 -164.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.63 -33.09 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.545 1.138 . . . . 0.0 114.025 -161.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -56.75 139.34 51.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.901 1.28 . . . . 0.0 113.125 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.76 4.62 54.45 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.523 1.058 . . . . 0.0 114.898 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -117.38 -109.72 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.292 1.437 . . . . 0.0 110.703 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 m -143.92 153.61 42.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.569 1.547 . . . . 0.0 109.573 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.69 -44.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.029 0.932 . . . . 0.0 112.956 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.5 t -149.66 68.09 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.551 1.54 . . . . 0.0 110.713 -170.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.63 93.34 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.432 1.015 . . . . 0.0 114.651 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.0 p -145.59 -174.57 4.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 113.05 -159.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.7 136.77 51.89 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 153.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.82 163.03 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.227 1.411 . . . . 0.0 112.104 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -135.46 138.01 42.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.947 2.099 . . . . 0.0 108.659 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -139.11 137.05 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.463 0.705 . . . . 0.0 111.121 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.475 0.796 0 O-C-N 120.711 -1.243 . . . . 0.0 109.302 164.827 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 120.554 0.216 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.83 112.05 18.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 166.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -128.32 108.14 10.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.451 1.1 . . . . 0.0 111.906 -168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 54' ' ' VAL . 47.4 tp -95.23 98.77 10.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.073 1.349 . . . . 0.0 109.371 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.81 115.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.167 2.187 . . . . 0.0 108.888 163.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.8 mp -89.17 136.06 33.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.959 168.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -142.64 51.03 1.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.662 1.185 . . . . 0.0 108.501 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.85 176.36 25.97 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 122.504 1.058 . . . . 0.0 114.4 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -60.28 -40.95 92.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.065 1.346 . . . . 0.0 111.494 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -71.12 -48.63 51.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.639 2.376 . . . . 0.0 113.533 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.42 139.73 14.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.273 1.029 . . . . 0.0 110.482 -169.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -126.45 132.31 51.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.923 1.689 . . . . 0.0 109.79 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.39 -137.78 5.76 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.404 1.478 . . . . 0.0 110.334 -153.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.8 mt-10 -159.46 -161.22 0.9 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.897 1.679 . . . . 0.0 109.467 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -143.88 -42.34 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 156.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.6 p 55.97 164.41 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -158.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -160.31 -164.36 1.25 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.76 2.424 . . . . 0.0 106.364 156.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -140.35 130.62 25.13 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.697 1.599 . . . . 0.0 107.778 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.48 23.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -157.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 21' ' ' VAL . 1.8 t -64.71 -42.14 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.128 1.771 . . . . 0.0 111.825 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -144.31 -58.86 0.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -161.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 134.49 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 131.679 3.991 . . . . 0.0 111.659 -162.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -36.95 10.9 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.592 1.157 . . . . 0.0 109.749 -170.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -74.88 -17.22 60.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.04 2.936 . . . . 0.0 112.457 164.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.7 -54.6 5.71 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.717 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.07 -46.07 44.0 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 125.25 1.42 . . . . 0.0 109.087 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -20.94 13.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -171.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.56 -38.81 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.473 1.509 . . . . 0.0 109.788 -169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -50.38 -46.72 56.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.019 1.328 . . . . 0.0 112.326 163.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.4 mmpt? -43.8 -55.46 4.46 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.949 1.699 . . . . 0.0 112.024 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.07 -35.21 64.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -60.74 -39.94 90.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.445 1.02 . . . . 0.0 111.302 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 -32.4 38.01 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.181 -0.949 . . . . 0.0 111.168 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.22 -26.29 61.97 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.872 0.76 . . . . 0.0 112.554 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.7 -39.26 77.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 166.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -67.18 -50.58 60.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.197 0.599 . . . . 0.0 111.576 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.8 33.14 0.39 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.269 1.414 . . . . 0.0 113.844 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.77 134.2 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.785 1.234 . . . . 0.0 112.001 -168.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.72 -4.28 5.25 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.54 158.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.45 -127.17 4.61 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.317 1.913 . . . . 0.0 116.365 161.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.89 -14.56 39.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 112.118 171.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.525 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 26.0 m95 8.32 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.271 1.829 . . . . 0.0 114.694 -130.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -73.17 151.09 41.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.629 1.204 . . . . 0.0 110.141 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -154.19 142.52 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 109.961 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -104.76 -37.6 6.99 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 56.61 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.447 3.099 . . . . 0.0 117.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.64 -28.5 69.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.434 1.893 . . . . 0.0 111.965 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.2 p -125.08 5.03 7.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.158 1.783 . . . . 0.0 113.274 166.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt 57.55 -5.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 128.177 2.591 . . . . 0.0 116.81 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -39.57 150.45 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.055 2.542 . . . . 0.0 114.473 156.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -131.99 162.9 29.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 131.252 3.821 . . . . 0.0 110.645 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.0 m -148.79 141.3 24.33 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 167.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 5' ' ' LEU . 1.1 m -131.45 111.46 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.54 171.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 m -119.94 96.5 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.565 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.914 1.286 . . . . 0.0 113.972 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.76 143.87 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 120.877 1.672 . . . . 0.0 107.34 156.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.39 146.29 25.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.409 1.083 . . . . 0.0 110.941 -168.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 113' ' ' ALA . 18.3 m -141.14 157.41 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.222 158.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -165.16 14.86 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 114.836 0.694 . . . . 0.0 114.836 170.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER 76.01 -5.47 2.17 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 127.205 2.202 . . . . 0.0 113.262 -172.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.2 OUTLIER -94.63 46.24 1.14 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.639 1.576 . . . . 0.0 113.316 -150.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.36 -29.7 75.32 Favored Glycine 0 CA--C 1.537 1.466 0 N-CA-C 118.418 2.127 . . . . 0.0 118.418 -160.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -70.87 -35.01 72.18 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.239 2.019 . . . . 0.0 113.682 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.431 HD21 ' CD1' ' A' ' 81' ' ' LEU . 1.6 p-10 -129.35 -16.69 3.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.95 108.17 0.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -157.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -138.66 169.04 18.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.833 2.053 . . . . 0.0 111.003 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.87 -47.91 70.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.2 m -76.14 -30.93 58.35 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -160.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -58.76 -34.71 71.73 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.034 -1.041 . . . . 0.0 112.411 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.46 -35.14 40.79 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 111.778 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 100' ' ' LEU . 49.7 mt-10 -58.07 -29.46 65.44 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.442 0.697 . . . . 0.0 111.595 171.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.47 -48.94 7.54 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.01 -23.6 54.82 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -117.54 -19.04 9.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 113.25 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.28 -38.16 18.99 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.644 1.116 . . . . 0.0 114.048 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -55.94 -36.95 68.35 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.84 1.42 55.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.186 1.394 . . . . 0.0 112.29 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.34 166.77 12.32 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.773 1.178 . . . . 0.0 114.779 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.87 116.15 4.61 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.334 2.689 . . . . 0.0 111.505 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 91' ' ' GLU . 10.5 mp -63.83 138.58 58.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.466 0.651 . . . . 0.0 110.528 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -14.31 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.136 2.174 . . . . 0.0 112.665 -167.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -151.92 150.04 29.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.265 1.826 . . . . 0.0 108.539 159.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 100' ' ' LEU . 91.5 t -155.58 128.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.27 1.028 . . . . 0.0 110.987 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -150.21 148.25 28.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.12 2.168 . . . . 0.0 110.19 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.69 155.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.156 -0.965 . . . . 0.0 112.296 168.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 125.74 1.616 . . . . 0.0 112.718 174.95 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -124.99 129.43 50.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.97 1.308 . . . . 0.0 109.025 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -123.32 160.85 25.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.41 1.484 . . . . 0.0 112.228 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -141.34 148.89 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.387 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.99 171.95 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 -165.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.97 141.95 36.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 109.311 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -151.76 157.39 41.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.202 1.401 . . . . 0.0 110.701 150.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.77 47.4 0.88 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.053 0.93 . . . . 0.0 113.016 -148.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.0 142.33 24.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.409 1.884 . . . . 0.0 110.602 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.65 -28.47 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.085 2.523 . . . . 0.0 114.836 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.67 -57.49 3.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.96 1.255 . . . . 0.0 113.09 -164.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.4 -27.18 65.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.585 1.154 . . . . 0.0 111.647 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.21 68.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.96 -31.42 70.98 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.662 -1.274 . . . . 0.0 110.562 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.36 -45.83 82.58 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.769 -0.582 . . . . 0.0 112.55 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -15.9 54.88 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.2 t -79.27 -52.89 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.768 -1.208 . . . . 0.0 109.673 159.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -25.29 65.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.033 1.733 . . . . 0.0 115.017 -175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -97.37 -19.64 18.35 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.339 1.856 . . . . 0.0 112.018 -174.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 -18.1 0.34 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -148.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.69 130.28 37.53 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.149 -0.969 . . . . 0.0 113.285 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.25 86.54 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.076 1.322 . . . . 0.0 115.05 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -78.63 -161.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 128.028 2.531 . . . . 0.0 112.678 -173.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.9 m -112.8 137.52 51.0 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.716 1.606 . . . . 0.0 107.969 155.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.75 133.4 35.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 110.398 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 8.6 t 58.52 -55.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.983 2.513 . . . . 0.0 115.151 -170.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.58 18.24 0.05 OUTLIER Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.509 1.528 . . . . 0.0 115.432 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.2 p -151.38 159.82 44.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.999 1.399 . . . . 0.0 112.659 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -58.04 144.35 40.18 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.494 1.117 . . . . 0.0 110.475 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 2.5 p -128.88 159.59 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.243 1.417 . . . . 0.0 112.793 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.53 135.96 40.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 164.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -143.92 138.86 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.337 0.971 . . . . 0.0 110.917 -162.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 N--CA 1.475 0.82 0 O-C-N 120.88 -1.137 . . . . 0.0 111.824 -178.369 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.355 0.597 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -131.76 112.85 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 157.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.2 ttmm -130.05 146.13 51.7 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 127.199 2.2 . . . . 0.0 108.885 -171.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 34' ' ' ALA . 24.6 tp -122.16 99.38 6.4 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.559 1.944 . . . . 0.0 109.305 162.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -62.12 130.31 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.759 1.624 . . . . 0.0 109.514 160.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.63 132.09 48.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.646 171.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -145.62 54.96 1.19 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.811 1.244 . . . . 0.0 111.296 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.52 179.89 17.78 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -73.67 15.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 128.499 2.72 . . . . 0.0 112.954 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -142.22 -57.34 0.45 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 127.533 2.333 . . . . 0.0 108.932 -144.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -156.6 146.77 21.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.869 2.068 . . . . 0.0 109.321 162.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -128.83 142.41 50.98 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.884 1.274 . . . . 0.0 111.828 167.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.66 -136.55 6.28 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 125.149 1.357 . . . . 0.0 109.985 -159.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -160.83 -158.92 0.63 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.483 1.513 . . . . 0.0 110.113 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -143.84 -47.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 154.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.9 p 57.09 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.774 1.63 . . . . 0.0 115.263 -158.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -157.93 -18.0 0.08 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.59 141.63 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.627 2.371 . . . . 0.0 116.942 -163.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.28 -164.24 1.97 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.354 1.461 . . . . 0.0 111.47 -174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.44 -15.76 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.407 1.883 . . . . 0.0 111.676 -163.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -145.22 -9.08 0.59 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.19 30.97 19.25 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.989 1.316 . . . . 0.0 113.337 -167.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.1 -37.52 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.765 1.626 . . . . 0.0 112.012 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.84 -24.61 66.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.51 2.724 . . . . 0.0 112.456 158.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.83 -53.82 9.38 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.85 -0.531 . . . . 0.0 109.813 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -49.96 -46.86 52.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 125.525 1.53 . . . . 0.0 109.229 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -54.88 -25.02 26.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.21 -40.32 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 109.146 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -50.72 -48.45 58.89 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.289 1.436 . . . . 0.0 112.431 165.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.6 mmpt? -43.8 -55.03 4.74 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.867 1.667 . . . . 0.0 112.089 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -73.52 -35.25 65.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -63.48 -41.23 98.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.863 0.756 . . . . 0.0 110.99 172.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -74.49 -36.4 63.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.314 -0.866 . . . . 0.0 109.926 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.33 -33.21 75.43 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.283 0.492 . . . . 0.0 111.543 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.78 -36.44 78.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.031 1.332 . . . . 0.0 113.603 169.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.59 -20.78 64.52 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.01 20.12 7.33 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.904 1.716 . . . . 0.0 113.385 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.3 t -120.59 123.03 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.942 1.297 . . . . 0.0 111.925 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.61 69.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 124.924 2.297 . . . . 0.0 108.897 155.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -149.98 0.24 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 109.413 -3.54 . . . . 0.0 114.046 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.88 24.38 0.4 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.371 1.868 . . . . 0.0 111.954 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 32.5 m95 -6.42 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.451 3.501 . . . . 0.0 115.368 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.9 m -103.4 158.68 16.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 109.298 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -137.14 143.76 42.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.591 1.556 . . . . 0.0 109.826 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.13 60.01 1.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.439 1.496 . . . . 0.0 110.012 -155.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.89 -25.71 0.83 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.608 3.163 . . . . 0.0 117.372 -172.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.88 -21.64 66.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.147 2.179 . . . . 0.0 112.559 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -131.27 -3.42 3.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.366 1.867 . . . . 0.0 112.86 168.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.299 35.6 mttm 54.94 20.03 2.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.415 2.686 . . . . 0.0 114.732 -169.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.7 m -60.34 165.04 3.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.754 1.621 . . . . 0.0 111.682 157.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -132.84 152.63 51.79 Favored 'General case' 0 C--N 1.324 -0.534 1 C-N-CA 132.327 4.251 . . . . 0.0 108.03 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -145.82 116.11 7.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.696 0.284 . . . . 0.0 110.247 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -96.98 88.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-O 122.144 0.973 . . . . 0.0 112.081 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -69.96 113.74 7.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.18 156.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.511 1.125 . . . . 0.0 112.289 173.878 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.511 ' CG1' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -95.91 150.65 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.098 -1.001 . . . . 0.0 111.357 -169.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -125.98 139.09 53.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.765 0.826 . . . . 0.0 110.098 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.64 136.29 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.413 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.94 31.96 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 121.524 -0.735 . . . . 0.0 114.672 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 63.63 17.6 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.474 1.11 . . . . 0.0 113.96 -170.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -33.91 76.89 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.163 -0.96 . . . . 0.0 111.622 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.79 -60.38 0.34 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.652 2.549 . . . . 0.0 116.215 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.57 -29.32 37.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.434 1.894 . . . . 0.0 112.957 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HB2' ' H ' ' A' ' 85' ' ' GLY . 1.1 p-10 -153.67 -153.65 0.48 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.703 2.401 . . . . 0.0 109.044 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 84' ' ' ASN . . . 131.18 -17.52 5.11 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 128.068 2.747 . . . . 0.0 112.58 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -37.37 74.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 132.421 4.288 . . . . 0.0 116.781 169.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' H ' HG11 ' A' ' 105' ' ' VAL . 55.2 tttm 52.11 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.626 3.171 . . . . 0.0 116.847 167.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.9 m -66.96 -26.86 67.04 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 121.07 1.759 . . . . 0.0 114.648 -158.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.73 -30.6 70.88 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.435 -1.416 . . . . 0.0 113.198 168.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.9 mt -90.83 -25.21 20.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.85 1.66 . . . . 0.0 111.998 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.41 -30.63 69.73 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.384 0.993 . . . . 0.0 109.81 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.87 -47.23 8.74 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.685 1.194 . . . . 0.0 113.085 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.76 -25.09 64.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.085 1.311 . . . . 0.0 113.373 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -105.24 -31.09 9.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.592 1.157 . . . . 0.0 110.943 174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.23 -32.92 44.7 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.345 1.45 . . . . 0.0 115.512 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -57.36 -39.49 76.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.329 1.064 . . . . 0.0 112.589 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -75.31 -25.9 58.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.865 0.466 . . . . 0.0 111.944 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.95 -176.5 40.71 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -174.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 147.6 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.851 3.034 . . . . 0.0 112.493 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mp -113.79 141.42 47.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.041 1.736 . . . . 0.0 110.671 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -114.94 -16.22 11.71 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.402 1.881 . . . . 0.0 114.434 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -159.68 150.96 19.72 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.065 1.346 . . . . 0.0 110.347 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.7 t -154.86 134.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 126.158 1.783 . . . . 0.0 109.81 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -153.79 158.55 41.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.493 1.517 . . . . 0.0 111.455 166.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -149.29 143.67 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 126.648 1.979 . . . . 0.0 111.059 166.338 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 112.101 -0.399 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -109.72 112.74 24.98 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.005 1.322 . . . . 0.0 109.961 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.02 158.06 16.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.554 1.169 . . . . 0.0 112.092 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -139.34 130.34 26.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.013 163.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.511 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.2 m -139.42 -178.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.689 0.795 . . . . 0.0 111.235 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -154.01 136.06 14.7 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.452 -1.405 . . . . 0.0 110.797 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.87 154.2 27.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.441 1.497 . . . . 0.0 112.548 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.88 -7.6 58.82 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.101 -0.999 . . . . 0.0 112.595 164.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.05 109.43 27.47 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.815 1.646 . . . . 0.0 110.805 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.75 -31.7 95.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.154 3.236 . . . . 0.0 115.718 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -73.66 -41.88 62.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 110.547 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.54 -30.28 71.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.802 0.728 . . . . 0.0 112.415 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.78 78.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.762 0.825 . . . . 0.0 112.189 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.25 74.12 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.496 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -49.97 48.17 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.68 -11.03 31.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.552 1.541 . . . . 0.0 114.465 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.28 -52.8 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 157.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -31.53 69.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.833 1.253 . . . . 0.0 114.089 -172.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.61 -0.8 20.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.634 1.574 . . . . 0.0 111.924 -163.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -23.64 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.577 1.551 . . . . 0.0 113.233 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.31 125.18 23.01 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.138 -0.977 . . . . 0.0 111.436 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.7 9.1 87.36 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -84.78 -176.23 6.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.319 1.448 . . . . 0.0 112.44 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.7 m -134.9 93.07 2.96 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.042 1.737 . . . . 0.0 108.806 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.59 -39.51 31.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.754 1.222 . . . . 0.0 112.686 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.402 ' CB ' HD21 ' A' ' 84' ' ' ASN . 76.3 m -144.49 46.1 1.4 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.822 1.249 . . . . 0.0 112.926 -162.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.31 72.58 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.139 -0.976 . . . . 0.0 113.119 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.5 p -112.04 -166.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.456 2.303 . . . . 0.0 111.862 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -147.03 53.07 1.08 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.2 1.0 . . . . 0.0 111.373 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.56 156.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 126.98 2.112 . . . . 0.0 113.936 -170.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.23 152.11 42.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.35 1.46 . . . . 0.0 110.183 158.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.2 t -144.51 128.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.891 0.876 . . . . 0.0 109.531 -162.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 126.026 1.73 . . . . 0.0 110.219 177.477 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -156.6 -62.95 0.1 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -167.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -80.17 94.36 6.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 97.22 4.35 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.385 -151.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -87.57 86.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.068 1.347 . . . . 0.0 109.903 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -56.33 101.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.351 2.261 . . . . 0.0 109.155 163.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.2 mp -78.99 136.09 37.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 165.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -145.33 54.8 1.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.721 2.008 . . . . 0.0 108.576 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.54 -177.91 21.82 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -171.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -51.11 -48.37 61.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.486 1.114 . . . . 0.0 110.608 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 m -74.79 -63.34 1.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.732 2.413 . . . . 0.0 113.679 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.57 141.69 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.252 1.021 . . . . 0.0 110.456 -168.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 96.6 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.752 2.021 . . . . 0.0 108.833 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.45 23.87 0.02 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 120.684 3.033 . . . . 0.0 120.684 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU 0.255 0.6 OUTLIER 54.61 -175.96 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.084 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -154.81 -32.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 164.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p 59.0 161.96 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.2 t -160.82 -162.07 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.331 2.252 . . . . 0.0 108.835 153.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -148.23 151.32 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 111.783 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.13 -177.67 6.06 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.355 1.862 . . . . 0.0 111.143 -167.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.37 -18.32 9.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 112.203 -2.271 . . . . 0.0 112.6 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -148.65 -9.01 0.36 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 23.13 13.49 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.111 1.765 . . . . 0.0 114.462 -168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.03 -38.47 1.1 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.309 1.844 . . . . 0.0 110.571 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.0 m -57.66 -21.21 38.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.356 1.862 . . . . 0.0 112.458 149.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.87 -47.65 16.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.264 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -48.03 80.42 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -68.22 -7.53 31.15 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -166.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.29 -38.22 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.76 2.424 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 18' ' ' THR . 18.1 m-30 -53.13 -43.01 66.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.679 1.127 . . . . 0.0 112.083 162.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -43.63 -56.18 3.89 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.061 2.144 . . . . 0.0 111.277 168.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.75 -34.69 67.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -57.94 -42.96 86.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.756 1.162 . . . . 0.0 110.952 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.95 -33.46 39.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.371 -0.83 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.3 -26.76 63.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.177 0.898 . . . . 0.0 112.528 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.48 -40.4 77.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.111 1.364 . . . . 0.0 112.638 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -64.62 -43.58 93.28 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.764 -0.585 . . . . 0.0 111.655 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 27.79 1.29 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.713 1.625 . . . . 0.0 114.095 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 139.86 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.276 1.83 . . . . 0.0 111.287 -168.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 6.28 4.03 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 157.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.9 -130.34 10.14 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.203 1.859 . . . . 0.0 116.55 159.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -92.86 -13.29 29.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.017 1.727 . . . . 0.0 111.759 167.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.497 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 47.3 m95 6.61 82.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.041 1.736 . . . . 0.0 115.68 -127.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 m -82.2 156.86 24.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.692 1.234 . . . . 0.0 110.642 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -148.31 151.48 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.191 1.797 . . . . 0.0 110.559 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 23.8 t70 -124.31 143.62 50.46 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.955 1.702 . . . . 0.0 109.065 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.24 -15.94 12.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.14 57.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.376 1.87 . . . . 0.0 111.638 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.0 p -120.12 -7.4 9.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.417 1.887 . . . . 0.0 112.65 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.378 35.6 mttm 65.27 12.69 8.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.519 1.528 . . . . 0.0 114.759 -174.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -54.56 153.84 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.36 2.264 . . . . 0.0 113.913 166.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -125.09 166.14 16.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.719 2.408 . . . . 0.0 112.318 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.5 m -151.75 139.16 19.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.421 -1.424 . . . . 0.0 112.086 167.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.0 89.06 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.055 1.342 . . . . 0.0 113.463 171.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -99.77 79.13 2.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.071 0.948 . . . . 0.0 112.643 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.66 -16.24 64.06 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.498 1.119 . . . . 0.0 114.001 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.21 -28.26 3.04 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.068 0.842 . . . . 0.0 114.754 160.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -66.72 2.44 1.37 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.673 1.989 . . . . 0.0 114.917 172.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -129.32 18.13 5.94 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.753 2.021 . . . . 0.0 110.963 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.98 -50.51 0.23 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.95 -1.094 . . . . 0.0 113.837 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -135.11 -7.28 2.32 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.322 1.449 . . . . 0.0 113.88 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.33 -172.71 2.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 140.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 155.35 46.76 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -157.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -163.52 168.44 20.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.242 1.417 . . . . 0.0 110.573 166.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.38 178.44 9.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.379 1.072 . . . . 0.0 110.353 162.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -129.89 62.91 1.54 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.127 2.171 . . . . 0.0 109.327 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -143.02 -49.62 0.34 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.692 2.797 . . . . 0.0 109.272 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -128.89 -101.68 0.33 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.984 1.713 . . . . 0.0 107.937 158.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.5 p -152.16 -5.24 0.24 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.967 1.307 . . . . 0.0 114.396 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 59.1 m -78.4 165.18 51.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.308 1.043 . . . . 0.0 111.303 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.19 -55.18 2.76 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.479 2.786 . . . . 0.0 113.036 167.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -154.38 -61.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.04 1.736 . . . . 0.0 107.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -162.9 171.19 16.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.401 2.281 . . . . 0.0 110.639 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.5 -8.74 20.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 127.932 2.493 . . . . 0.0 117.477 -150.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.73 179.74 0.12 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.328 2.651 . . . . 0.0 108.808 -161.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.0 137.21 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 163.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -137.53 143.79 41.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.156 1.783 . . . . 0.0 109.822 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 23.1 t -138.06 145.23 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.267 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.81 -178.98 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.133 0.852 . . . . 0.0 115.193 161.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 72.84 13.65 5.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 115.418 -171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.5 OUTLIER -76.09 28.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.358 1.863 . . . . 0.0 112.102 178.037 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.14 -18.42 27.52 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 117.28 1.672 . . . . 0.0 117.28 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -89.69 -9.1 50.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.595 1.158 . . . . 0.0 113.901 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' LEU . 2.6 p-10 -154.65 -21.46 0.12 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -164.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.34 109.54 0.7 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -149.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -138.17 164.11 29.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.235 1.414 . . . . 0.0 112.057 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -67.93 -37.0 81.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.9 m -66.48 -48.11 70.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.186 0.994 . . . . 0.0 112.556 -169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.24 -37.63 80.95 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.678 -0.639 . . . . 0.0 111.69 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.96 -37.17 29.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.495 1.118 . . . . 0.0 112.319 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -47.43 -39.17 14.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.845 1.258 . . . . 0.0 111.338 169.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -106.9 -26.98 10.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.335 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.3 93.7 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.688 0.677 . . . . 0.0 111.58 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -81.58 -35.24 30.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.819 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.06 -37.1 5.5 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.658 1.599 . . . . 0.0 114.863 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -59.45 -44.99 92.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.29 -23.68 40.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.525 0.73 . . . . 0.0 110.878 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.28 166.45 30.1 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.102 1.334 . . . . 0.0 113.869 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 153.16 56.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.34 2.693 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.64 122.12 46.07 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 109.176 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -74.75 -33.57 62.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.565 0.746 . . . . 0.0 111.454 166.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -142.67 157.5 44.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.303 0.502 . . . . 0.0 111.916 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.66 144.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.553 1.541 . . . . 0.0 110.825 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.11 151.24 17.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.919 1.688 . . . . 0.0 110.951 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.72 144.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 170.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.28 138.91 35.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.266 1.826 . . . . 0.0 112.181 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -25.28 47.5 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.767 -0.583 . . . . 0.0 112.5 163.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -140.18 115.29 7.74 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 126.267 1.827 . . . . 0.0 109.201 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.73 149.91 9.16 Favored 'Cis proline' 0 C--N 1.356 0.941 0 CA-C-N 121.616 1.613 . . . . 0.0 115.078 1.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.74 -19.31 3.45 Favored 'Trans proline' 0 C--N 1.352 0.719 1 C-N-CA 125.318 4.012 . . . . 0.0 118.853 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.78 63.6 0.12 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.392 0.996 . . . . 0.0 112.341 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.36 132.32 56.61 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.975 1.71 . . . . 0.0 109.385 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -128.57 163.87 24.06 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.592 1.557 . . . . 0.0 113.865 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -140.82 147.06 38.44 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.833 165.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.98 177.93 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 121.102 -0.999 . . . . 0.0 111.995 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.33 102.79 4.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.326 1.05 . . . . 0.0 110.701 172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -70.22 165.11 22.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 110.605 140.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.02 -36.95 11.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.583 -0.698 . . . . 0.0 112.796 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.04 131.47 83.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.113 0.965 . . . . 0.0 112.313 -172.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.79 -8.99 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.429 2.753 . . . . 0.0 115.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -112.62 -41.42 3.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.347 1.859 . . . . 0.0 110.851 -160.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 -29.96 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.534 0.606 . . . . 0.0 111.225 159.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.01 70.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.777 0.831 . . . . 0.0 112.399 168.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.04 -30.41 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.07 -1.019 . . . . 0.0 111.226 170.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.02 -35.46 69.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.524 1.057 . . . . 0.0 113.693 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.95 -27.71 69.32 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.181 -1.575 . . . . 0.0 112.824 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.43 -37.26 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 119.205 -2.184 . . . . 0.0 110.926 165.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -62.46 -34.36 76.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.725 -1.235 . . . . 0.0 112.998 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -128.82 -14.33 4.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -158.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -17.07 7.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.203 1.001 . . . . 0.0 113.604 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -82.91 159.86 22.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.092 1.314 . . . . 0.0 112.24 165.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.78 5.47 88.51 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.601 1.096 . . . . 0.0 115.175 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.98 -137.64 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.933 1.693 . . . . 0.0 112.134 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 m -141.41 123.8 15.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.721 2.409 . . . . 0.0 108.616 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.58 131.85 56.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.195 1.398 . . . . 0.0 108.88 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 9.0 t 59.44 -58.14 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.656 2.382 . . . . 0.0 115.906 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.45 35.58 0.08 OUTLIER Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.0 1.285 . . . . 0.0 114.362 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.5 p -129.66 -163.57 1.31 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.85 1.26 . . . . 0.0 113.941 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -130.98 63.82 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.34 1.856 . . . . 0.0 109.558 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.82 161.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 130.012 3.325 . . . . 0.0 117.657 -165.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.87 149.15 41.58 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.922 1.289 . . . . 0.0 110.21 140.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.48 145.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.678 1.191 . . . . 0.0 110.12 -167.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 134.99 20.34 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 109.62 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -146.12 128.42 15.82 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.915 1.688 . . . . 0.0 115.227 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.0 p -159.35 -111.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.568 128.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -152.88 4.67 0.35 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -171.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.89 -169.22 40.55 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.486 1.039 . . . . 0.0 115.623 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -154.48 -23.31 0.13 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 118.707 -2.643 . . . . 0.0 114.317 6.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -135.72 21.05 3.32 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -164.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 124.533 1.133 . . . . 0.0 112.789 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -141.51 175.83 9.36 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 131.658 3.983 . . . . 0.0 111.923 21.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -136.51 100.3 4.32 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.92 116.08 14.31 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -157.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.9 tp -101.62 95.02 6.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.683 1.193 . . . . 0.0 110.432 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -55.65 108.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 128.122 2.569 . . . . 0.0 109.37 159.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.565 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.9 mp -86.08 139.85 30.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 167.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -147.82 47.77 1.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.419 1.887 . . . . 0.0 108.496 172.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.68 -169.94 23.57 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 -162.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -43.71 -31.89 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.953 2.101 . . . . 0.0 114.308 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -126.26 -44.59 1.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.773 1.629 . . . . 0.0 112.589 -148.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -154.7 142.85 20.3 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.705 1.602 . . . . 0.0 108.22 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -136.91 127.18 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.709 1.604 . . . . 0.0 109.084 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.59 31.82 0.26 Allowed Glycine 0 N--CA 1.477 1.404 0 N-CA-C 117.896 1.918 . . . . 0.0 117.896 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER 56.59 -177.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -144.73 -27.53 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p 61.83 161.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.439 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -164.57 -175.06 3.68 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.32 2.248 . . . . 0.0 108.561 163.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -142.68 134.44 26.81 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.894 1.678 . . . . 0.0 108.416 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.7 6.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.133 0.968 . . . . 0.0 113.514 -161.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 21' ' ' VAL . 27.5 t -47.57 -59.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.742 2.017 . . . . 0.0 111.052 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -172.96 177.94 2.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.005 2.122 . . . . 0.0 108.997 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.89 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.774 2.03 . . . . 0.0 113.735 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 -58.74 2.05 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -67.13 -29.98 69.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.169 1.788 . . . . 0.0 113.165 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.76 -46.61 29.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.829 -0.544 . . . . 0.0 110.468 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.33 -44.16 83.98 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -54.08 -28.76 41.2 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.67 -38.28 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.088 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HG22 ' A' ' 18' ' ' THR . 10.9 m-85 -54.94 -42.38 72.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -39.74 -53.72 2.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.909 2.083 . . . . 0.0 110.54 167.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -82.32 -31.47 29.89 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.581 1.952 . . . . 0.0 114.737 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.42 -41.75 98.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.349 0.977 . . . . 0.0 111.212 168.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -76.79 -36.75 56.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.278 -0.889 . . . . 0.0 109.855 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.35 -28.41 67.94 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.235 0.925 . . . . 0.0 112.501 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.9 -39.96 75.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 113.093 168.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -63.95 -34.26 77.57 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 121.707 -0.621 . . . . 0.0 111.957 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.59 17.92 5.45 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.128 1.823 . . . . 0.0 113.656 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 1.3 t -107.3 140.3 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.749 1.62 . . . . 0.0 111.956 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.08 -9.2 3.01 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.623 1.169 . . . . 0.0 113.132 156.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.14 -99.03 0.01 OUTLIER Glycine 0 C--N 1.34 0.805 0 C-N-CA 129.699 3.523 . . . . 0.0 118.767 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.86 11.13 3.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.377 1.871 . . . . 0.0 110.298 -167.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.41 ' CE3' HG13 ' A' ' 54' ' ' VAL . 10.6 m95 -16.62 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.937 2.495 . . . . 0.0 115.502 -156.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -116.89 163.29 16.41 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.744 1.618 . . . . 0.0 110.944 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -145.63 157.69 43.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.964 2.106 . . . . 0.0 111.11 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -135.7 125.79 26.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.572 2.349 . . . . 0.0 110.479 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.24 -21.07 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.78 60.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.659 0.784 . . . . 0.0 112.23 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.1 p -136.71 -2.39 2.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.428 1.491 . . . . 0.0 113.033 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.355 34.6 mtpt 65.16 17.54 11.08 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.904 2.482 . . . . 0.0 113.787 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -66.96 159.44 28.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.994 2.918 . . . . 0.0 114.478 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -122.14 164.53 17.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 130.056 3.342 . . . . 0.0 112.779 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.4 m -150.14 143.89 25.34 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.64 -1.288 . . . . 0.0 112.527 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -127.51 128.65 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.216 1.006 . . . . 0.0 112.939 160.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -132.61 100.6 5.01 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.259 1.824 . . . . 0.0 110.748 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -105.44 -20.21 13.55 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.15 -161.46 12.93 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.82 1.191 . . . . 0.0 115.306 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.56 76.59 1.48 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.657 1.183 . . . . 0.0 112.195 -165.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -140.58 -39.38 0.43 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.353 3.061 . . . . 0.0 111.966 -0.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -145.2 165.67 27.69 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.275 1.43 . . . . 0.0 112.594 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -78.21 47.34 0.67 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.052 1.741 . . . . 0.0 114.984 -167.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -138.48 -53.81 0.61 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -59.01 -26.95 64.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -61.42 -15.54 37.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.5 ptp -135.45 21.69 3.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.654 1.582 . . . . 0.0 112.645 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 144.05 36.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.564 0.746 . . . . 0.0 111.946 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -159.55 -27.37 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.767 1.627 . . . . 0.0 113.104 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -0.05 -58.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 130.389 3.476 . . . . 0.0 118.08 157.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 m -146.78 155.11 42.12 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.531 1.132 . . . . 0.0 112.32 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.31 120.51 62.59 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.564 1.546 . . . . 0.0 113.353 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.12 -43.17 1.67 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.848 2.365 . . . . 0.0 111.984 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.02 -43.73 0.26 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.124 2.57 . . . . 0.0 106.569 156.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -174.68 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.744 1.218 . . . . 0.0 112.727 136.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 51.7 t -156.41 120.56 4.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.351 0.66 . . . . 0.0 112.113 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.05 -175.46 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.975 2.51 . . . . 0.0 113.757 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 115' ' ' VAL . 43.9 t -109.0 142.02 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 120.651 -1.281 . . . . 0.0 108.455 161.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.29 133.7 24.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.706 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 142' ' ' VAL . 50.9 t -137.69 148.58 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.419 0.688 . . . . 0.0 109.624 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.37 -166.9 20.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 60.99 14.65 5.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.917 1.687 . . . . 0.0 113.737 -157.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.66 46.37 1.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.01 1.724 . . . . 0.0 113.3 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.96 93.82 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.923 -1.11 . . . . 0.0 115.569 -166.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.82 -35.57 78.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -167.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -146.06 -28.31 0.42 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -163.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.68 111.89 1.06 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.599 0.618 . . . . 0.0 113.757 -155.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -129.05 -31.22 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 116.516 -1.707 . . . . 0.0 113.898 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.8 tttm 153.12 -60.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 129.374 3.07 . . . . 0.0 112.876 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.8 m -74.16 -26.14 60.13 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -161.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -26.65 65.77 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.873 -1.142 . . . . 0.0 113.682 167.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.8 mt -89.48 -34.55 16.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.966 1.306 . . . . 0.0 111.564 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -54.35 -35.39 62.7 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.747 -0.596 . . . . 0.0 112.321 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -88.06 -42.33 12.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.29 -30.24 64.55 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.037 1.29 . . . . 0.0 113.16 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -106.86 -22.91 12.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.968 0.907 . . . . 0.0 112.102 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.7 -35.11 7.36 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.039 1.78 . . . . 0.0 114.383 161.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -53.6 -42.58 67.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.641 1.176 . . . . 0.0 113.18 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -85.29 -24.52 27.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.878 0.871 . . . . 0.0 110.895 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 124.81 -74.13 0.41 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 153.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.5 43.98 1.6 Allowed 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.269 3.312 . . . . 0.0 114.831 -158.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.84 154.28 15.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.439 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -139.13 -20.9 0.96 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.047 1.739 . . . . 0.0 113.314 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -163.95 149.7 11.01 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.758 0.823 . . . . 0.0 110.812 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -151.1 121.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.091 1.756 . . . . 0.0 107.986 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -148.19 150.59 34.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.317 1.447 . . . . 0.0 110.304 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.51 157.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.718 -1.239 . . . . 0.0 113.582 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.82 170.18 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.487 1.915 . . . . 0.0 113.055 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -127.03 28.11 5.84 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.267 1.827 . . . . 0.0 110.509 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -156.17 72.42 5.1 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 126.077 1.751 . . . . 0.0 113.534 -162.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -68.25 153.24 88.48 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 120.613 1.255 . . . . 0.0 114.559 -0.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.33 71.49 5.8 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.554 3.502 . . . . 0.0 113.569 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.64 24.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.961 -1.466 . . . . 0.0 116.597 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.93 145.94 40.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.844 1.822 . . . . 0.0 114.048 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 161.9 35.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.451 3.1 . . . . 0.0 113.287 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.3 144.0 23.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.24 1.416 . . . . 0.0 110.731 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG13 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -152.36 174.51 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.137 -0.977 . . . . 0.0 110.93 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.34 120.44 13.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.085 1.354 . . . . 0.0 109.588 167.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.73 159.78 20.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.338 1.055 . . . . 0.0 110.046 153.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.82 -22.61 31.71 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.427 -1.421 . . . . 0.0 114.276 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.92 136.7 29.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.733 0.813 . . . . 0.0 112.678 -162.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.4 -33.67 17.46 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.934 2.423 . . . . 0.0 114.827 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -41.1 44.43 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.728 1.604 . . . . 0.0 113.444 -166.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.17 -26.82 60.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.701 0.682 . . . . 0.0 112.36 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.22 -45.13 67.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.368 0.667 . . . . 0.0 111.809 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.24 81.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 120.685 -1.26 . . . . 0.0 110.322 172.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -39.82 78.42 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.96 -17.99 58.85 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.904 -1.122 . . . . 0.0 113.914 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 -53.08 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.548 -1.345 . . . . 0.0 110.004 160.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -61.06 -24.47 66.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.168 1.787 . . . . 0.0 113.97 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.86 -8.21 15.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.158 1.383 . . . . 0.0 112.091 -168.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -152.07 -30.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -154.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -63.99 132.95 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.913 0.779 . . . . 0.0 111.772 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.35 79.15 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.749 0.69 . . . . 0.0 114.323 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -111.56 -117.43 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.325 1.45 . . . . 0.0 110.114 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -154.33 148.88 26.3 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.495 1.498 . . . . 0.0 110.257 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.83 -48.4 0.46 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.6 m -134.52 35.97 3.17 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.212 1.405 . . . . 0.0 112.163 -167.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.22 24.76 67.81 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.335 -0.853 . . . . 0.0 113.165 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.8 p -134.41 144.47 48.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.878 2.071 . . . . 0.0 110.755 -172.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -75.49 67.75 2.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.406 1.082 . . . . 0.0 111.133 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 p -54.67 151.54 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.844 2.057 . . . . 0.0 113.943 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.3 132.61 35.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.275 1.83 . . . . 0.0 109.434 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 144' ' ' LEU . 4.9 t -148.63 129.91 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 117.973 0.351 . . . . 0.0 111.209 -152.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -140.84 137.68 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 119.954 -1.716 . . . . 0.0 111.629 167.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.487 HD11 HG12 ' A' ' 142' ' ' VAL . 2.0 mp -140.03 124.75 18.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -152.35 -81.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.062 0.945 . . . . 0.0 112.945 140.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.3 p30 132.1 -176.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.293 3.037 . . . . 0.0 106.964 -135.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.84 -0.09 2.63 Favored Glycine 0 N--CA 1.474 1.225 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -21.39 23.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.42 1.11 . . . . 0.0 112.948 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 -173.74 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.391 2.276 . . . . 0.0 111.855 -165.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 125.059 1.344 . . . . 0.0 111.328 151.105 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -150.53 167.51 26.99 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.267 2.627 . . . . 0.0 111.138 -9.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.91 110.46 10.81 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.39 101.83 5.31 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.023 0.929 . . . . 0.0 111.488 -165.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.922 0.889 . . . . 0.0 109.851 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.6 mt -59.53 113.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.576 2.35 . . . . 0.0 109.37 160.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.04 136.6 32.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.744 164.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -144.02 42.84 1.44 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.84 2.056 . . . . 0.0 107.403 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.49 173.99 33.08 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 120.743 -1.223 . . . . 0.0 113.865 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -58.69 -42.15 87.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.619 0.723 . . . . 0.0 112.029 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -69.49 -62.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.641 2.376 . . . . 0.0 112.48 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -141.55 140.09 33.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.928 0.891 . . . . 0.0 110.801 -166.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 103.95 7.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.228 2.211 . . . . 0.0 107.884 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.3 95.95 0.16 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.619 1.581 . . . . 0.0 112.49 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -28.58 160.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.751 2.82 . . . . 0.0 118.024 166.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -135.47 -25.03 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 11.3 p 57.07 162.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.552 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.1 t -164.14 -171.94 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.31 3.044 . . . . 0.0 108.222 169.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.35 136.28 27.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 109.282 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.43 177.45 10.59 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.136 0.97 . . . . 0.0 113.453 -164.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.18 -56.56 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.503 1.921 . . . . 0.0 111.214 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -174.36 -174.85 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.196 2.998 . . . . 0.0 107.464 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.92 24.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.932 2.093 . . . . 0.0 114.941 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.01 4.18 7.98 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.39 1.076 . . . . 0.0 112.117 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.6 m -126.4 -22.22 4.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.245 1.818 . . . . 0.0 111.389 168.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.3 11.43 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 121.362 -0.837 . . . . 0.0 111.315 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.4 -45.63 90.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -51.53 -22.34 3.12 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.51 -39.02 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.724 1.61 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -55.57 -39.38 70.59 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 169.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -57.23 3.14 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.999 2.12 . . . . 0.0 110.074 168.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.91 -35.22 64.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -61.48 -40.31 94.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.362 0.983 . . . . 0.0 111.132 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -78.06 -37.03 47.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.58 -0.7 . . . . 0.0 109.85 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -69.92 -25.92 63.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.756 0.707 . . . . 0.0 112.258 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.96 -36.57 69.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.103 1.361 . . . . 0.0 112.809 168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -63.91 -31.18 72.27 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.707 -0.62 . . . . 0.0 111.566 164.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.59 -3.18 15.43 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.811 2.148 . . . . 0.0 113.038 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.6 t -81.01 127.9 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.251 1.82 . . . . 0.0 111.358 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -143.76 82.65 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 124.184 1.945 . . . . 0.0 108.305 152.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.95 -136.43 9.11 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 110.328 -3.124 . . . . 0.0 112.777 -155.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.78 39.75 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 127.865 2.466 . . . . 0.0 110.785 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CD2' HG13 ' A' ' 54' ' ' VAL . 32.6 m95 -37.8 98.2 0.01 OUTLIER 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.053 2.541 . . . . 0.0 112.902 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.6 m -116.61 157.93 24.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.25 1.82 . . . . 0.0 108.385 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -141.95 146.38 35.58 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.83 1.252 . . . . 0.0 109.952 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.42 54.36 1.96 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.855 1.262 . . . . 0.0 110.607 -156.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -41.56 -31.16 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.948 3.299 . . . . 0.0 117.253 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -20.93 59.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.268 1.827 . . . . 0.0 112.601 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -133.2 5.1 3.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.26 1.824 . . . . 0.0 112.894 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.293 46.6 mttm 49.8 13.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 129.404 3.081 . . . . 0.0 116.519 -168.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 m -47.51 158.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.974 2.51 . . . . 0.0 113.505 156.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.4 160.91 30.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 129.439 3.096 . . . . 0.0 111.383 168.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.5 m -145.62 124.32 12.57 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.291 -0.88 . . . . 0.0 110.896 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.85 100.67 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.857 0.837 . . . . 0.0 112.293 160.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.37 131.83 37.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.11 0.957 . . . . 0.0 110.123 157.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 20.1 tt0 -148.37 -42.95 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 112.449 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 -20.68 67.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.042 1.306 . . . . 0.0 113.12 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -131.69 44.7 2.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.462 166.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -43.08 147.74 0.32 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.379 1.472 . . . . 0.0 112.663 168.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -121.88 -21.87 5.92 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.382 1.073 . . . . 0.0 112.431 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -69.21 117.57 11.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.609 1.164 . . . . 0.0 109.522 160.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -65.2 145.68 55.94 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.371 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -151.31 169.78 21.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 111.053 -165.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -140.59 15.42 2.35 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -129.38 -24.43 2.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -159.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -130.26 35.56 4.07 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.896 1.278 . . . . 0.0 112.198 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.41 -47.89 0.64 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -171.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.67 173.12 15.92 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.349 0.977 . . . . 0.0 113.414 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.1 p -117.73 -36.29 3.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.416 1.886 . . . . 0.0 112.453 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 p -131.41 154.32 81.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 129.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 -43.77 5.12 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.319 1.346 . . . . 0.0 110.536 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 0.3 OUTLIER -162.98 -36.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.81 2.444 . . . . 0.0 108.64 155.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -139.33 -79.5 0.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.015 1.326 . . . . 0.0 110.57 164.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 30.4 p -163.34 -12.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.995 1.718 . . . . 0.0 115.528 159.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.9 -169.81 2.51 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 120.838 1.654 . . . . 0.0 111.082 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.5 135.28 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 121.274 1.852 . . . . 0.0 111.953 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.21 118.1 9.97 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.504 1.922 . . . . 0.0 108.589 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.81 143.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.26 -170.11 41.37 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 23.5 t30 119.94 -13.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 131.646 3.978 . . . . 0.0 110.995 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.2 -27.43 63.89 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -165.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.68 -27.02 0.28 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.782 2.135 . . . . 0.0 117.662 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.46 -13.61 12.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.858 1.663 . . . . 0.0 112.793 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -169.77 -177.79 2.78 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.231 2.612 . . . . 0.0 109.059 -163.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.91 15.79 0.25 Allowed Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.978 -0.901 . . . . 0.0 114.819 164.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -49.38 163.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.36 3.064 . . . . 0.0 113.987 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -59.31 -35.88 74.62 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.403 -0.811 . . . . 0.0 112.662 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.7 m -92.15 -32.56 15.07 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.587 1.085 . . . . 0.0 113.87 -168.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.48 -31.73 69.61 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.432 -1.418 . . . . 0.0 111.728 165.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.85 -28.01 20.67 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.123 1.156 . . . . 0.0 114.123 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.56 -33.19 71.11 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.607 1.548 . . . . 0.0 109.154 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -82.3 -47.23 12.64 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.487 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.42 -28.46 65.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.161 0.891 . . . . 0.0 112.874 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.57 -37.58 8.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.743 0.817 . . . . 0.0 112.672 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.82 -36.91 3.81 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.263 1.887 . . . . 0.0 114.978 167.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -55.03 -45.65 75.19 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -75.06 -35.65 61.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.141 0.577 . . . . 0.0 110.401 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.56 178.45 40.75 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.507 1.051 . . . . 0.0 115.473 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.4 155.73 63.21 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.053 3.169 . . . . 0.0 114.822 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.56 148.26 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.746 2.418 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -103.55 -37.82 7.4 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.648 1.979 . . . . 0.0 112.759 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -161.38 157.81 25.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 p -167.6 131.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.46 1.104 . . . . 0.0 112.155 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -155.48 159.32 39.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.288 1.835 . . . . 0.0 111.317 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.91 157.67 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.223 -1.548 . . . . 0.0 113.431 -171.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.93 -44.9 74.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.513 1.525 . . . . 0.0 113.665 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? 61.45 -37.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 129.55 3.14 . . . . 0.0 115.908 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.44 83.71 30.63 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 127.721 2.408 . . . . 0.0 110.571 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.04 160.98 91.68 Favored 'Cis proline' 0 CA--C 1.544 0.983 0 CA-C-N 119.57 0.882 . . . . 0.0 113.458 6.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.63 172.28 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.353 2.702 . . . . 0.0 113.1 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.37 -18.82 9.38 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.363 -1.243 . . . . 0.0 115.201 163.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.72 132.62 21.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.671 1.236 . . . . 0.0 112.773 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.88 163.05 28.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.854 2.462 . . . . 0.0 113.379 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -135.61 138.71 43.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.01 1.724 . . . . 0.0 109.23 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.283 2.0 m -146.9 -177.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.234 -0.916 . . . . 0.0 112.404 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.09 117.31 10.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.733 2.013 . . . . 0.0 107.196 162.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.06 -174.87 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.002 1.321 . . . . 0.0 114.067 165.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -124.12 -8.54 7.67 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -149.58 123.37 4.56 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 120.562 1.528 . . . . 0.0 113.01 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.64 -24.32 48.19 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.271 2.648 . . . . 0.0 114.934 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -63.06 -55.08 28.55 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.765 1.166 . . . . 0.0 110.451 172.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.73 -34.06 76.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.014 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.09 92.26 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.32 80.59 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.549 -1.344 . . . . 0.0 110.27 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.94 -42.52 48.45 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -14.28 41.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.83 1.252 . . . . 0.0 114.084 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.17 -60.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.396 0.998 . . . . 0.0 109.705 155.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -19.92 62.29 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -160.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -98.34 1.64 47.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.276 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.05 -31.13 0.5 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -159.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.48 104.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.317 1.447 . . . . 0.0 110.671 156.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.12 24.15 25.44 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.42 -1.211 . . . . 0.0 114.76 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -116.59 164.18 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.583 1.691 . . . . 0.0 112.985 -168.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -95.4 128.35 42.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.513 1.525 . . . . 0.0 110.844 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.1 -12.79 11.89 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.153 1.381 . . . . 0.0 114.344 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.32 -65.31 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.985 0.914 . . . . 0.0 111.811 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -165.69 32.8 0.23 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.756 2.122 . . . . 0.0 111.059 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 3.7 m -142.77 -158.9 0.91 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.198 2.199 . . . . 0.0 109.192 -158.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -149.26 153.43 37.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.128 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -137.81 160.66 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -165.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.61 142.64 41.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.492 2.717 . . . . 0.0 109.55 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.37 125.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.565 -0.71 . . . . 0.0 110.907 -152.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.42 120.44 33.96 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.965 2.106 . . . . 0.0 106.96 168.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.5 tt -153.85 112.25 3.62 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.933 1.242 . . . . 0.0 113.445 -161.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . 12.6 p -153.34 -161.72 1.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.418 1.887 . . . . 0.0 114.733 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.58 93.42 1.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.651 1.58 . . . . 0.0 112.554 -164.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.53 -145.03 9.74 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 123.596 1.664 . . . . 0.0 116.948 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.4 -179.49 6.69 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 129.409 3.083 . . . . 0.0 107.827 173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -131.13 85.77 2.3 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.06 -1.025 . . . . 0.0 113.107 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.467 1.507 . . . . 0.0 111.304 151.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 pmm? . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.0 tp60 -135.29 166.94 21.97 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.833 2.853 . . . . 0.0 110.943 1.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.15 106.6 9.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.49 99.82 4.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.177 0.991 . . . . 0.0 111.496 -163.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.09 95.64 10.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.335 1.054 . . . . 0.0 108.952 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.38 117.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.625 1.57 . . . . 0.0 108.912 160.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -93.22 129.63 39.19 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.655 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 69.8 m-80 -143.18 109.51 5.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.84 177.47 27.05 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 121.803 0.669 . . . . 0.0 114.617 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.952 1.301 . . . . 0.0 110.655 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.3 m -63.12 -55.87 21.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.634 2.373 . . . . 0.0 113.216 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -165.08 144.21 6.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.792 1.637 . . . . 0.0 109.687 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -131.73 150.24 52.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.885 1.274 . . . . 0.0 112.459 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.14 -134.64 4.51 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.957 1.742 . . . . 0.0 111.294 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.4 mt-10 -161.25 -166.6 1.58 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.22 2.608 . . . . 0.0 107.801 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -145.9 -39.68 0.23 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 161.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p 57.62 163.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -165.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -159.96 -169.36 2.5 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.592 2.357 . . . . 0.0 106.754 153.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -137.92 132.02 31.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.289 -1.507 . . . . 0.0 108.146 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.84 -178.72 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.147 0.979 . . . . 0.0 112.417 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -44.41 -57.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.677 1.991 . . . . 0.0 110.809 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -178.97 -164.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 129.521 3.128 . . . . 0.0 108.751 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 20.47 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.178 2.191 . . . . 0.0 115.189 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.24 5.13 5.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.442 1.097 . . . . 0.0 112.233 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -125.63 -14.62 6.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 111.713 161.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.46 7.34 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.453 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.25 -47.88 65.51 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -56.37 -19.43 14.69 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.6 -168.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.67 -34.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.712 1.605 . . . . 0.0 110.296 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -54.08 -44.67 71.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.701 1.2 . . . . 0.0 112.071 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -43.48 -56.49 3.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.326 1.85 . . . . 0.0 111.564 168.135 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -75.23 -31.51 60.87 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.034 0.834 . . . . 0.0 111.134 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -35.07 57.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.346 -0.846 . . . . 0.0 110.013 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -66.73 -31.09 71.52 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.003 0.819 . . . . 0.0 112.173 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.59 -38.31 80.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.016 1.326 . . . . 0.0 113.168 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.99 -33.15 74.94 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 121.682 -0.636 . . . . 0.0 112.525 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.28 27.12 2.28 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.894 1.711 . . . . 0.0 114.021 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.359 1.463 . . . . 0.0 111.88 -165.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.78 3.89 6.05 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 121.818 0.818 . . . . 0.0 112.243 152.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.71 -112.12 0.98 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.181 2.324 . . . . 0.0 118.396 150.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -147.33 37.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.972 2.509 . . . . 0.0 107.223 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 18.4 m95 -40.67 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.497 1.519 . . . . 0.0 114.152 -160.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 m -125.08 160.2 29.63 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.918 1.687 . . . . 0.0 110.012 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -148.15 154.03 39.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.598 1.559 . . . . 0.0 111.151 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 19.5 t70 -129.88 139.6 51.13 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 126.361 1.864 . . . . 0.0 109.18 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -108.38 -16.83 14.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.31 -26.42 61.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 111.856 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.3 p -122.28 -6.9 8.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.429 1.891 . . . . 0.0 112.953 167.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.421 45.1 mttm 66.13 12.63 8.64 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 126.992 2.117 . . . . 0.0 115.376 -173.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -59.67 155.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 127.229 2.211 . . . . 0.0 114.361 170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -123.91 166.33 15.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.925 2.49 . . . . 0.0 112.318 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -150.01 137.57 19.91 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.769 -1.207 . . . . 0.0 110.793 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.63 153.94 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.512 155.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -151.14 88.42 1.45 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.313 1.845 . . . . 0.0 113.957 -176.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -93.85 -1.08 55.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 113.913 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.0 168.16 34.99 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.519 -1.363 . . . . 0.0 113.365 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 p -46.13 115.74 1.07 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.602 1.961 . . . . 0.0 115.868 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 97.3 m-70 100.33 133.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 131.21 3.804 . . . . 0.0 113.087 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -90.17 -11.98 39.51 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -133.5 -2.76 3.03 Favored 'General case' 0 N--CA 1.474 0.727 3 C-N-CA 134.154 4.981 . . . . 0.0 113.44 2.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -66.03 -19.0 65.71 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.41 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 5.9 p80 -58.74 -13.42 5.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.357 1.463 . . . . 0.0 114.911 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -62.18 -12.32 19.31 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.696 1.598 . . . . 0.0 113.851 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 87.6 mtp -53.02 145.25 13.37 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.642 -1.286 . . . . 0.0 113.557 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -157.28 173.45 16.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.666 2.386 . . . . 0.0 109.622 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 -173.6 4.1 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -72.26 24.83 0.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.141 2.177 . . . . 0.0 115.696 -163.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 t -152.72 152.51 31.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.5 1.92 . . . . 0.0 110.531 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -64.64 138.25 97.4 Favored Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.559 -0.713 . . . . 0.0 110.404 161.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.39 -38.6 25.54 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.272 1.981 . . . . 0.0 112.888 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.34 -45.77 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.94 2.496 . . . . 0.0 108.156 170.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -146.21 -130.71 0.07 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.403 2.281 . . . . 0.0 108.286 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.4 m -135.49 -11.9 2.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.041 1.336 . . . . 0.0 114.238 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -149.95 -157.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.886 2.475 . . . . 0.0 108.892 -167.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 144' ' ' LEU . 70.1 t -118.9 141.93 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.818 -1.176 . . . . 0.0 109.716 150.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -141.81 128.25 20.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.07 1.348 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.7 t -133.38 122.58 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.06 -171.09 12.2 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.998 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.42 41.33 24.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.416 0.686 . . . . 0.0 112.27 -158.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.34 -30.76 42.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.899 0.88 . . . . 0.0 111.75 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.14 -51.65 0.56 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 127.927 2.68 . . . . 0.0 117.404 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -124.1 -56.62 1.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.382 1.091 . . . . 0.0 113.795 -152.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.62 -27.84 28.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -165.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -7.03 82.83 0.0 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 128.943 3.163 . . . . 0.0 117.039 -165.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -118.21 -66.62 1.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 147.36 -46.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 131.386 3.874 . . . . 0.0 111.93 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -74.73 -27.16 60.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.57 0.623 . . . . 0.0 112.166 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.97 -38.4 50.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.742 0.817 . . . . 0.0 112.759 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.6 -34.97 18.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.665 1.586 . . . . 0.0 111.585 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -56.34 -35.5 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.544 0.738 . . . . 0.0 110.496 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -83.91 -53.46 5.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.801 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.03 47.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -115.88 -26.48 7.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.344 1.058 . . . . 0.0 112.424 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.04 -33.3 21.42 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.533 1.063 . . . . 0.0 114.145 165.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -55.23 -43.77 74.86 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.03 -34.18 44.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.511 0.324 . . . . 0.0 111.024 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.25 -171.04 44.0 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -168.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.13 126.06 8.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.217 3.278 . . . . 0.0 113.322 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -99.83 144.0 29.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 109.416 167.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.92 -5.23 1.15 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.764 1.626 . . . . 0.0 113.272 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -156.78 160.55 39.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.741 1.216 . . . . 0.0 110.638 154.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.4 t -159.91 136.19 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.774 2.03 . . . . 0.0 110.145 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -157.03 160.18 38.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.95 1.7 . . . . 0.0 111.444 161.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.13 148.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 120.705 -1.247 . . . . 0.0 112.823 171.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.11 169.35 2.08 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.293 1.837 . . . . 0.0 114.153 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -145.63 31.44 1.07 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.801 2.04 . . . . 0.0 110.366 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -150.02 44.71 0.33 Allowed Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 127.139 2.175 . . . . 0.0 114.921 -161.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -78.83 171.0 67.75 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 CA-C-N 121.979 1.742 . . . . 0.0 114.451 0.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.63 21.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 1 C-N-CA 126.245 4.63 . . . . 0.0 117.011 170.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.86 -3.52 59.25 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.288 1.275 . . . . 0.0 116.288 -165.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.8 139.32 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.79 1.295 . . . . 0.0 111.964 -168.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -133.98 154.58 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 129.077 2.951 . . . . 0.0 112.082 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.56 138.8 36.56 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.813 1.245 . . . . 0.0 109.462 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.278 2.0 m -141.6 -179.65 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.247 -0.908 . . . . 0.0 110.834 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -141.45 102.74 4.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.506 1.522 . . . . 0.0 108.314 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -64.61 175.92 1.28 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.447 0.699 . . . . 0.0 111.698 159.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -124.96 9.89 8.18 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.555 -1.34 . . . . 0.0 112.741 166.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.66 126.61 11.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.363 . . . . 0.0 110.991 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.08 -22.15 6.2 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.748 2.299 . . . . 0.0 113.914 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -70.82 -51.78 24.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.781 1.173 . . . . 0.0 110.358 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.85 -37.23 81.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.53 1.132 . . . . 0.0 110.589 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.64 67.19 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.133 1.373 . . . . 0.0 112.49 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.7 -30.88 67.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.724 -1.235 . . . . 0.0 111.033 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.88 -40.2 65.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.97 1.259 . . . . 0.0 113.483 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -17.34 36.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 0.0 113.898 166.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.33 -55.79 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.405 1.457 . . . . 0.0 110.131 159.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -54.96 -29.4 56.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.895 2.078 . . . . 0.0 114.068 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.36 -11.99 16.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.85 1.26 . . . . 0.0 112.075 -169.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.17 -20.54 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -154.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.18 136.82 48.28 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.756 0.822 . . . . 0.0 112.687 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.18 43.39 21.23 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.074 0.845 . . . . 0.0 112.622 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.12 -154.96 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.368 1.467 . . . . 0.0 111.671 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.2 m -129.46 -42.45 1.32 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.786 1.234 . . . . 0.0 110.744 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 tp 41.55 -99.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.771 2.828 . . . . 0.0 114.217 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.5 m -77.86 41.2 0.34 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.545 2.338 . . . . 0.0 113.475 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.87 75.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.745 1.164 . . . . 0.0 114.386 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.41 -119.22 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 111.489 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.72 32.27 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.597 0.713 . . . . 0.0 112.652 -153.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.13 140.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.232 2.213 . . . . 0.0 115.864 -156.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -134.32 113.76 12.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 129.385 3.074 . . . . 0.0 107.584 -170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.18 132.51 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.919 0.488 . . . . 0.0 112.077 -150.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.48 132.7 29.81 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.958 1.703 . . . . 0.0 109.938 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.458 ' HG ' HG13 ' A' ' 76' ' ' VAL . 1.8 mp -144.11 137.94 27.87 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.958 -1.089 . . . . 0.0 112.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 p -172.18 -32.31 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 162.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.96 56.25 6.16 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.56 1.944 . . . . 0.0 115.45 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.48 62.93 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.87 123.43 11.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.691 1.746 . . . . 0.0 110.313 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -112.31 1.54 16.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 119.372 3.101 . . . . 0.0 119.372 -128.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 120.365 1.438 . . . . 0.0 113.748 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -147.07 165.65 29.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.873 2.869 . . . . 0.0 110.064 -8.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -130.55 95.67 3.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.06 102.27 7.16 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.159 -154.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.4 tp -88.71 93.58 9.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.16 1.384 . . . . 0.0 109.053 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 mt -58.22 118.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.65 1.98 . . . . 0.0 108.757 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.92 139.36 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.76 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -145.89 51.33 1.17 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.223 0.609 . . . . 0.0 109.879 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.56 -168.0 18.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 -165.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -41.11 -28.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.416 3.086 . . . . 0.0 116.014 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -134.44 -40.47 0.8 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.253 1.421 . . . . 0.0 111.871 -144.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.54 137.77 15.7 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.244 1.818 . . . . 0.0 107.82 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE3' ' NE2' ' A' ' 59' ' ' HIS . 25.4 mttt -127.93 124.43 37.32 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.907 1.283 . . . . 0.0 109.464 171.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.44 -134.89 4.47 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.287 1.423 . . . . 0.0 109.929 -152.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -164.05 -174.06 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.166 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -142.82 -29.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p 57.98 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.426 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -166.03 -179.38 5.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.84 2.856 . . . . 0.0 107.76 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -140.02 134.89 32.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.751 1.621 . . . . 0.0 108.403 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.28 -178.74 6.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.935 0.894 . . . . 0.0 112.131 -163.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -43.32 -57.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.564 1.945 . . . . 0.0 110.741 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -171.22 -163.39 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.93 2.892 . . . . 0.0 107.681 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.37 24.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.231 1.812 . . . . 0.0 114.249 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.0 -59.03 1.81 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.1 m -65.03 -21.97 66.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.13 -49.05 10.6 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 119.071 0.85 . . . . 0.0 111.67 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -62.51 -44.99 95.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.92 -20.38 51.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.94 -42.1 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.423 1.889 . . . . 0.0 111.282 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CZ ' HG22 ' A' ' 18' ' ' THR . 11.3 m-85 -54.9 -36.46 65.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 170.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.3 mmpt? -48.49 -50.09 33.08 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.494 1.918 . . . . 0.0 110.186 171.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -74.92 -37.71 61.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.839 1.655 . . . . 0.0 114.721 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -58.56 -39.4 80.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.463 1.029 . . . . 0.0 111.366 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -83.13 -32.22 26.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.449 -0.782 . . . . 0.0 110.858 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.03 -31.44 72.67 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.21 -41.9 80.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 113.084 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.27 -35.29 80.02 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.775 -0.578 . . . . 0.0 112.488 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.74 29.8 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.619 1.58 . . . . 0.0 113.798 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.99 127.17 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.938 1.295 . . . . 0.0 111.99 -165.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -122.75 -3.56 8.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.583 152.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 18.6 -78.68 0.0 OUTLIER Glycine 0 CA--C 1.528 0.892 1 C-N-CA 131.31 4.291 . . . . 0.0 119.256 170.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -134.61 2.33 3.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.391 1.877 . . . . 0.0 111.615 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.449 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 m95 -19.29 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.911 2.084 . . . . 0.0 115.518 -149.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 t -129.91 170.44 13.92 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.074 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -157.38 157.65 34.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.274 1.829 . . . . 0.0 111.679 -166.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -110.91 -48.98 3.07 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -164.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 58.44 -38.12 0.06 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 129.046 2.938 . . . . 0.0 117.624 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.02 61.96 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.969 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 p -122.26 -5.54 8.86 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.081 1.753 . . . . 0.0 113.091 165.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 48.5 mttm 60.2 6.31 0.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.46 2.304 . . . . 0.0 116.52 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.8 m -46.85 146.36 1.66 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.632 1.973 . . . . 0.0 114.054 156.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.52 163.07 15.89 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.632 2.773 . . . . 0.0 111.516 164.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -148.95 144.33 26.74 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.311 -1.493 . . . . 0.0 111.599 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.93 128.3 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.963 161.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -132.1 107.5 8.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.33 -138.66 0.31 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.832 2.053 . . . . 0.0 109.802 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.31 36.8 0.05 OUTLIER Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.231 -1.543 . . . . 0.0 115.702 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -75.27 61.72 1.21 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.423 1.612 . . . . 0.0 112.592 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' NE2' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -140.31 144.23 36.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.113 2.165 . . . . 0.0 110.298 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -135.93 51.07 2.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.256 1.022 . . . . 0.0 111.578 -165.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.03 21.23 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.524 2.329 . . . . 0.0 116.652 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.65 69.81 1.31 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.951 -1.718 . . . . 0.0 111.733 166.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -135.69 48.78 2.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.532 1.933 . . . . 0.0 110.866 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 57.09 -161.92 0.2 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.729 1.612 . . . . 0.0 113.418 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 ttp -77.82 57.04 1.62 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.739 1.616 . . . . 0.0 112.793 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -71.12 48.26 0.12 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.69 1.996 . . . . 0.0 113.737 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -125.89 155.99 40.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.143 1.377 . . . . 0.0 114.355 -159.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -58.71 -17.79 25.7 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.765 2.826 . . . . 0.0 115.35 167.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.2 p -150.45 166.63 29.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.938 1.295 . . . . 0.0 112.865 -170.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.9 p -148.34 157.85 41.7 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.697 1.599 . . . . 0.0 111.888 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.58 -43.12 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.539 2.826 . . . . 0.0 113.254 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -173.4 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.79 2.836 . . . . 0.0 107.469 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -137.24 -124.63 0.14 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.438 2.295 . . . . 0.0 108.007 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.9 t -162.27 -23.49 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.042 2.137 . . . . 0.0 113.072 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.88 -168.46 2.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 129.959 3.304 . . . . 0.0 108.638 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 115' ' ' VAL . 60.1 t -125.45 139.78 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 121.129 -0.982 . . . . 0.0 111.38 152.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -144.56 133.25 22.28 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.981 1.312 . . . . 0.0 109.556 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 142' ' ' VAL . 13.6 m -140.2 161.59 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.646 0.736 . . . . 0.0 112.469 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.55 -166.1 27.04 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 80.84 -1.28 1.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.155 2.582 . . . . 0.0 114.312 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.428 ' CD1' ' H ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -71.27 -172.59 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.778 1.231 . . . . 0.0 111.363 175.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 81' ' ' LEU . . . 168.47 -24.18 0.11 Allowed Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.546 1.07 . . . . 0.0 113.938 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.96 -30.65 71.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.464 1.506 . . . . 0.0 114.303 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -150.64 -18.03 0.23 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -172.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.61 115.28 6.92 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 120.131 1.332 . . . . 0.0 113.508 -150.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -131.2 -19.44 2.81 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 140.0 -52.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 131.164 3.786 . . . . 0.0 111.239 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -91.53 -23.45 19.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -158.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.75 -35.53 70.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.868 -1.77 . . . . 0.0 111.472 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.7 mt -89.73 -29.33 18.79 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.978 2.511 . . . . 0.0 111.157 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.85 -33.01 69.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.24 1.382 . . . . 0.0 110.605 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -84.04 -48.59 9.76 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.714 0.805 . . . . 0.0 112.432 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.28 67.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -96.9 -27.84 14.49 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -56.67 -35.16 66.14 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.577 1.56 . . . . 0.0 113.989 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -57.36 -31.54 65.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -96.97 17.84 16.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.194 0.997 . . . . 0.0 112.14 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 -160.99 14.12 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.865 -1.147 . . . . 0.0 115.603 163.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -49.79 117.41 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 125.409 4.072 . . . . 0.0 114.471 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -110.14 149.97 29.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.864 1.666 . . . . 0.0 109.514 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -124.7 -25.97 3.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.713 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -163.56 152.61 14.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.076 0.95 . . . . 0.0 109.621 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -151.46 127.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.85 1.66 . . . . 0.0 108.316 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -138.64 168.71 19.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.754 1.222 . . . . 0.0 111.512 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 113' ' ' ALA . 6.2 t -150.09 142.51 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.581 1.153 . . . . 0.0 111.093 -164.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.89 165.84 24.14 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.171 1.788 . . . . 0.0 113.391 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -126.38 16.56 7.69 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.496 1.518 . . . . 0.0 111.935 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -155.95 43.59 0.2 Allowed Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.535 1.534 . . . . 0.0 114.446 -152.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -86.95 174.4 30.38 Favored 'Cis proline' 0 CA--C 1.547 1.149 0 CA-C-N 121.725 1.652 . . . . 0.0 113.757 10.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.09 47.62 0.37 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 125.239 3.959 . . . . 0.0 112.436 165.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.25 4.59 5.26 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.028 1.775 . . . . 0.0 115.368 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -138.99 143.13 38.38 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.665 1.586 . . . . 0.0 109.451 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -139.7 153.1 47.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -141.32 120.94 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.924 0.89 . . . . 0.0 109.655 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.5 m -143.33 -177.39 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -161.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -145.47 110.2 5.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.562 1.945 . . . . 0.0 109.635 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -71.31 -175.71 1.31 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.121 0.968 . . . . 0.0 110.056 151.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -150.33 70.04 1.02 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.707 -1.246 . . . . 0.0 111.675 150.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.75 138.39 10.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.517 1.527 . . . . 0.0 110.393 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -73.5 -38.2 2.68 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.381 2.054 . . . . 0.0 115.435 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -60.38 1.67 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.64 1.109 . . . . 0.0 113.49 -154.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.4 -21.28 66.22 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.398 -0.814 . . . . 0.0 111.488 173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 145' ' ' SER . . . -78.64 -37.66 41.53 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.06 74.5 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 120.304 -1.498 . . . . 0.0 109.369 163.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.03 -36.75 84.09 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 3.5 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 168.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.47 -41.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 120.413 1.46 . . . . 0.0 113.112 144.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -62.83 -23.74 67.43 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.985 1.266 . . . . 0.0 113.213 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.74 -10.52 14.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.298 1.839 . . . . 0.0 110.883 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.58 -28.71 0.64 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -154.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.31 136.96 54.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.966 0.888 . . . . 0.0 111.728 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.12 13.15 52.51 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.377 0.989 . . . . 0.0 114.775 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 134' ' ' THR . 5.8 ttt180 -85.42 -159.5 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.451 1.5 . . . . 0.0 111.259 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 133' ' ' ARG . 55.3 m -147.64 134.6 20.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.418 2.287 . . . . 0.0 106.218 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.0 tp -133.44 -36.32 0.98 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -156.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 36.2 m -138.63 8.05 2.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.829 1.251 . . . . 0.0 114.191 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.31 26.69 3.37 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.79 -82.06 0.3 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.926 1.363 . . . . 0.0 110.401 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 175.13 165.05 0.28 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.019 3.327 . . . . 0.0 107.467 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.86 155.27 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.873 0.761 . . . . 0.0 111.574 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.5 127.14 17.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.783 2.433 . . . . 0.0 108.063 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 78' ' ' VAL . 76.9 t -141.37 134.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.532 0.605 . . . . 0.0 111.389 -152.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -132.93 99.2 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.061 1.744 . . . . 0.0 108.804 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 tt -147.41 120.56 8.88 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.107 -0.996 . . . . 0.0 112.63 -153.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HA ' ' HB1' ' A' ' 123' ' ' ALA . 12.7 m -165.87 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 144.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.3 t30 62.04 145.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.271 1.828 . . . . 0.0 114.592 -166.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.7 20.46 0.06 OUTLIER Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -9.03 26.12 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.585 2.193 . . . . 0.0 116.27 -166.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.306 0.0 OUTLIER 44.04 19.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 128.726 2.811 . . . . 0.0 117.516 -176.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? . . . . . 0 C--O 1.25 1.119 0 C-N-CA 129.962 3.305 . . . . 0.0 114.078 -164.262 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -160.46 155.56 24.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.775 1.23 . . . . 0.0 110.22 164.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -143.41 107.25 4.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.2 ttpt -117.9 132.69 56.39 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 112.623 -171.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.85 102.56 14.33 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.608 1.163 . . . . 0.0 109.283 165.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 mt -64.95 119.33 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 128.461 2.705 . . . . 0.0 109.854 158.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.0 128.92 42.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.766 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -140.37 48.51 1.75 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.565 1.946 . . . . 0.0 109.469 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.75 160.69 13.16 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 122.807 1.226 . . . . 0.0 114.565 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -53.78 -39.3 65.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.687 2.395 . . . . 0.0 112.781 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -59.65 -55.35 35.58 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.759 2.824 . . . . 0.0 112.862 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.0 139.74 8.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.054 1.342 . . . . 0.0 110.789 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.72 111.02 16.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.89 2.076 . . . . 0.0 109.001 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.29 0.05 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.117 0.865 . . . . 0.0 113.253 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.34 157.84 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.05 2.14 . . . . 0.0 115.914 161.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 33' ' ' TYR . 9.2 t -135.39 -22.09 1.53 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.4 p 62.49 161.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.501 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -170.55 -170.68 0.95 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.722 2.809 . . . . 0.0 109.116 168.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -143.57 141.22 30.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.658 2.383 . . . . 0.0 108.387 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.36 172.8 13.83 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -163.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.49 -44.14 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.042 2.137 . . . . 0.0 112.077 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -140.13 -64.17 0.48 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -152.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 130.2 2.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 131.309 3.844 . . . . 0.0 112.637 -160.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.41 -44.3 1.12 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.05 0.94 . . . . 0.0 110.119 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.2 m -63.5 -20.48 65.64 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.611 1.565 . . . . 0.0 113.887 164.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.49 10.65 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 118.804 0.729 . . . . 0.0 110.938 167.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.99 -45.77 93.45 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -64.06 -13.88 50.48 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.66 -40.43 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.197 2.199 . . . . 0.0 110.563 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.501 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -57.87 -39.99 79.16 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 13.9 mmtp -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.331 2.252 . . . . 0.0 111.014 166.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -75.95 -31.44 59.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 16' ' ' THR . 40.6 t80 -60.43 -43.28 96.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.687 1.13 . . . . 0.0 111.022 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.62 -34.97 58.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.513 -0.742 . . . . 0.0 109.962 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.06 -30.45 69.66 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.353 0.524 . . . . 0.0 112.101 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.92 -36.76 70.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.214 1.405 . . . . 0.0 113.402 170.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -64.62 -49.26 71.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.632 -0.667 . . . . 0.0 111.683 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.97 31.92 0.57 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.795 1.664 . . . . 0.0 114.181 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.67 146.36 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.4 1.88 . . . . 0.0 111.015 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -138.72 -6.79 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.204 1.002 . . . . 0.0 113.47 154.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.84 -129.06 6.47 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 126.155 1.836 . . . . 0.0 116.228 160.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.51 34.9 4.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.288 2.235 . . . . 0.0 108.428 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.451 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 13.9 m95 -19.66 97.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.762 2.825 . . . . 0.0 114.953 -169.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -118.11 162.4 18.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.454 1.501 . . . . 0.0 110.898 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -146.38 151.2 37.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.732 2.013 . . . . 0.0 111.114 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -107.07 -40.05 5.55 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -164.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 60.5 -33.43 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 119.185 3.031 . . . . 0.0 119.185 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.57 61.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.796 1.638 . . . . 0.0 112.266 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -135.24 13.17 3.55 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.49 1.916 . . . . 0.0 111.849 162.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.264 36.8 mttm 54.9 11.43 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 127.836 2.455 . . . . 0.0 116.581 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -44.57 156.14 0.09 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.574 1.949 . . . . 0.0 114.363 150.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.2 160.18 34.6 Favored 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.69 4.796 . . . . 0.0 110.107 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -147.82 134.69 20.14 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 112.073 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG13 ' CE3' ' A' ' 43' ' ' TRP . 1.6 m -108.94 96.58 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 122.215 1.007 . . . . 0.0 112.483 156.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -79.98 114.22 18.72 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.516 0.726 . . . . 0.0 109.855 160.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -126.78 57.83 1.43 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.397 1.479 . . . . 0.0 110.82 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.32 -167.94 14.24 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 129.449 3.404 . . . . 0.0 112.07 15.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -60.07 -27.94 67.4 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.389 -1.065 . . . . 0.0 111.997 161.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -63.65 -7.44 7.38 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.386 1.875 . . . . 0.0 113.912 169.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -127.9 10.98 6.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.267 1.427 . . . . 0.0 112.36 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 45.2 42.92 7.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.002 2.121 . . . . 0.0 113.9 -170.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -65.16 10.15 0.09 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 126.902 2.081 . . . . 0.0 114.48 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -161.45 170.72 19.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.662 3.185 . . . . 0.0 109.254 -170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.01 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 119.527 3.158 . . . . 0.0 119.527 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.7 tpp -162.18 171.19 17.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.315 1.87 . . . . 0.0 111.519 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -120.95 158.32 27.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.419 1.487 . . . . 0.0 112.626 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.5 0.86 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.605 2.362 . . . . 0.0 111.168 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -152.99 -58.14 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.489 1.516 . . . . 0.0 113.092 -165.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 m -165.79 -172.39 2.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.347 2.659 . . . . 0.0 108.916 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.3 p -53.03 138.78 45.21 Favored Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 121.1 -1.0 . . . . 0.0 112.218 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.92 -47.51 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.85 2.367 . . . . 0.0 113.633 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -160.05 -46.0 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.76 1.624 . . . . 0.0 110.264 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -148.84 -30.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.7 m 109.49 -11.07 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 131.668 3.987 . . . . 0.0 114.657 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 -137.41 0.15 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' CG2' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -132.32 163.77 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 135.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -137.86 152.33 48.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.912 1.285 . . . . 0.0 111.284 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.6 t -141.2 152.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 111.242 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 -176.16 32.71 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.162 1.625 . . . . 0.0 117.162 161.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 91.53 1.85 0.12 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 130.805 3.642 . . . . 0.0 113.279 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.09 174.21 1.64 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.358 1.463 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.85 -37.76 0.18 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.564 1.078 . . . . 0.0 113.287 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -69.26 -57.57 5.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.733 0.813 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.5 -54.69 4.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.024 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.81 62.43 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 128.394 2.902 . . . . 0.0 117.004 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -132.66 -52.02 0.92 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.746 1.773 . . . . 0.0 115.67 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? 150.74 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 130.73 3.612 . . . . 0.0 112.625 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -87.63 -24.84 23.82 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.476 -0.765 . . . . 0.0 112.228 -164.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -55.43 -38.34 68.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.819 162.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.6 mt -82.67 -34.25 27.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.242 1.017 . . . . 0.0 112.569 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -54.68 -36.27 64.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.867 0.758 . . . . 0.0 111.102 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtm-85 -78.26 -57.05 3.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -20.67 41.9 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -113.91 -29.93 6.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.884 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.24 -35.19 26.71 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.765 1.174 . . . . 0.0 114.054 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -58.39 -41.72 85.47 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -78.44 -32.2 48.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.586 0.355 . . . . 0.0 111.235 -171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -177.68 44.67 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.036 0.826 . . . . 0.0 115.086 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.01 136.71 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.704 3.603 . . . . 0.0 114.509 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 152.38 23.87 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.27 1.828 . . . . 0.0 109.95 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -122.74 -22.36 5.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.556 1.542 . . . . 0.0 113.253 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -167.92 156.75 9.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.335 1.454 . . . . 0.0 109.655 173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -152.71 131.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.799 1.239 . . . . 0.0 110.843 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -147.28 153.9 40.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.305 1.442 . . . . 0.0 111.367 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.84 144.81 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.107 -0.996 . . . . 0.0 112.032 171.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.47 130.32 39.4 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.579 1.152 . . . . 0.0 111.386 175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -93.69 -1.73 54.82 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 166.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -150.57 102.88 3.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.487 1.515 . . . . 0.0 111.247 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.52 146.79 66.75 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 CA-C-N 119.977 1.028 . . . . 0.0 111.433 -5.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.95 15.07 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.421 3.414 . . . . 0.0 116.039 -167.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.75 16.21 5.88 Favored Glycine 0 N--CA 1.466 0.678 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -142.52 139.38 31.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.521 1.661 . . . . 0.0 112.417 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -127.88 162.5 26.57 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.126 1.771 . . . . 0.0 113.448 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -149.28 136.91 20.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.728 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.483 HG22 ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -139.89 177.9 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -172.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -137.77 147.06 44.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.594 1.158 . . . . 0.0 110.065 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -177.72 3.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.177 2.591 . . . . 0.0 111.466 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.42 -22.15 6.59 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.54 106.11 54.41 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 120.557 1.526 . . . . 0.0 113.352 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 -20.79 36.27 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.416 2.744 . . . . 0.0 114.639 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -41.87 17.63 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.056 1.298 . . . . 0.0 111.308 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -67.33 -33.3 74.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.622 0.769 . . . . 0.0 112.257 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.508 0.723 . . . . 0.0 112.863 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.22 -34.73 70.73 Favored 'General case' 0 C--O 1.226 -0.165 0 O-C-N 121.002 -1.061 . . . . 0.0 110.142 168.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -38.2 76.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 172.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.9 -15.0 39.41 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.766 -1.209 . . . . 0.0 113.721 166.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.55 -54.34 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.462 -1.399 . . . . 0.0 109.594 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -58.32 -26.79 63.47 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 113.816 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.23 -10.64 17.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.245 1.418 . . . . 0.0 112.299 -170.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 -33.98 0.19 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -154.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -60.43 133.84 56.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.71 0.804 . . . . 0.0 112.492 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.88 13.63 83.21 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.231 -0.761 . . . . 0.0 114.305 160.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -113.19 -106.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.158 1.783 . . . . 0.0 109.736 -173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -156.64 136.89 12.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 109.038 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 tp -154.41 155.17 34.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.325 1.45 . . . . 0.0 109.375 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.1 m 51.76 25.57 3.01 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.41 73.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.11 1.338 . . . . 0.0 115.164 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.5 p -121.95 156.21 33.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.567 1.547 . . . . 0.0 111.579 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.21 53.04 0.78 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.05 1.74 . . . . 0.0 112.953 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -46.99 152.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.833 2.453 . . . . 0.0 115.957 -163.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -137.31 137.24 38.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.122 2.569 . . . . 0.0 108.687 167.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.54 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.477 0.58 . . . . 0.0 111.406 -163.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.45 131.84 14.66 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 119.624 -1.922 . . . . 0.0 110.207 167.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.19 145.63 32.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.126 0.876 . . . . 0.0 113.023 -173.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 p -154.25 -92.05 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.726 1.211 . . . . 0.0 114.083 167.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.5 t30 118.25 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 131.18 3.792 . . . . 0.0 108.532 -160.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.58 37.92 0.62 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.089 0.852 . . . . 0.0 113.658 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.77 -12.63 60.76 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -74.33 151.33 39.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.115 1.366 . . . . 0.0 110.638 164.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.231 1.812 . . . . 0.0 111.133 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -155.76 161.31 40.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 129.427 3.091 . . . . 0.0 109.576 -15.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.68 109.37 5.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 37.5 ttpt -133.99 150.5 51.26 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 125.85 1.66 . . . . 0.0 113.018 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.9 tp -117.62 109.97 17.32 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.443 1.897 . . . . 0.0 110.211 161.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.25 120.33 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 129.739 3.216 . . . . 0.0 110.259 158.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.12 128.19 40.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.134 165.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -139.49 40.35 2.05 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.983 2.113 . . . . 0.0 110.226 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.99 171.65 42.94 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 120.25 -1.531 . . . . 0.0 116.169 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -66.0 -43.15 88.54 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 152.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.7 m -53.45 -57.12 11.78 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.482 3.113 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.3 tm? -162.33 141.23 9.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.0 110.008 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -126.92 110.45 13.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.614 1.566 . . . . 0.0 109.466 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.64 77.6 0.03 OUTLIER Glycine 0 N--CA 1.465 0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.004 -161.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.87 160.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.117 1.367 . . . . 0.0 114.222 162.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -124.28 -37.26 2.56 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.6 p 58.62 166.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -155.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.471 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -155.38 -25.15 0.11 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.35 136.39 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 127.17 2.188 . . . . 0.0 116.541 -162.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.77 -179.68 7.47 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.4 -1.438 . . . . 0.0 112.924 -166.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 4.8 t -63.81 -50.91 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.289 1.836 . . . . 0.0 111.876 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -167.93 167.93 12.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.568 1.547 . . . . 0.0 109.661 -152.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.04 15.81 0.5 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.43 -31.33 0.81 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.103 -0.998 . . . . 0.0 111.865 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.3 m -76.34 -21.29 56.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.0 111.837 163.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -50.42 15.46 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.617 -0.677 . . . . 0.0 110.123 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -48.26 58.09 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.084 1.354 . . . . 0.0 108.6 173.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -24.8 15.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.551 1.157 . . . . 0.0 114.068 -170.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.05 -38.77 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.607 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.1 m-85 -55.11 -41.83 72.15 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.046 0.938 . . . . 0.0 113.471 167.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE2' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -48.86 -55.06 12.78 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 110.051 169.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -68.87 -34.17 75.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -60.38 -40.91 92.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.286 0.948 . . . . 0.0 110.842 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -77.59 -35.84 52.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.21 -32.72 73.15 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.359 0.527 . . . . 0.0 111.857 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.81 -38.88 87.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.192 . . . . 0.0 113.186 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -67.1 -34.54 77.85 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.567 -0.708 . . . . 0.0 112.741 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.31 22.83 1.83 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.895 1.712 . . . . 0.0 114.684 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -122.88 134.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.58 1.552 . . . . 0.0 111.92 -161.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.23 10.44 3.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 149.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.08 -139.06 1.19 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 149.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -119.46 53.87 1.02 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.899 2.479 . . . . 0.0 106.276 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HE2' ' A' ' 31' ' ' LYS . 13.9 m95 -45.65 104.28 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.334 1.454 . . . . 0.0 112.631 -172.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.1 m -124.44 158.6 32.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.351 1.861 . . . . 0.0 108.672 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 38.9 t80 -137.91 144.04 41.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.83 1.252 . . . . 0.0 110.11 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -130.59 60.79 1.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 110.094 -156.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -47.0 -28.06 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.581 2.752 . . . . 0.0 116.128 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.7 -24.06 46.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.573 2.349 . . . . 0.0 112.852 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -132.9 7.8 4.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 112.854 165.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 51.0 mttm 45.78 25.16 0.26 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.555 2.742 . . . . 0.0 115.097 -164.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 m -63.43 168.98 4.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.235 1.814 . . . . 0.0 111.351 160.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 60.7 m-85 -135.73 156.41 48.87 Favored 'General case' 0 C--N 1.324 -0.509 1 C-N-CA 132.573 4.349 . . . . 0.0 108.903 175.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.8 m -143.35 129.72 19.96 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 m -103.51 93.21 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.21 1.005 . . . . 0.0 112.281 160.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.99 59.02 3.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.41 1.084 . . . . 0.0 112.457 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -65.67 -16.15 63.47 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.551 -1.343 . . . . 0.0 113.284 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.44 -1.3 55.57 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.08 1.324 . . . . 0.0 114.482 168.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.8 t 48.14 -53.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 131.433 3.893 . . . . 0.0 118.298 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -129.01 -5.64 5.0 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.477 1.911 . . . . 0.0 112.636 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -64.82 -11.7 39.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.383 1.873 . . . . 0.0 113.97 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -139.99 171.95 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.205 1.402 . . . . 0.0 111.586 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.94 134.82 43.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.715 1.206 . . . . 0.0 111.409 -169.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -66.08 -17.82 64.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -93.12 -4.46 52.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.527 1.131 . . . . 0.0 113.395 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -56.02 132.94 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.204 0.911 . . . . 0.0 111.084 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -93.64 133.59 36.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.965 0.906 . . . . 0.0 113.251 -165.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 9.82 3.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.009 1.724 . . . . 0.0 112.651 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -105.17 -4.15 22.13 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -149.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.1 p 160.79 -86.89 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 129.947 3.299 . . . . 0.0 111.15 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -148.97 148.41 27.13 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.277 1.431 . . . . 0.0 112.236 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.05 -49.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.176 2.584 . . . . 0.0 113.664 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 179.47 -46.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 129.676 3.191 . . . . 0.0 108.043 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.28 -91.3 0.09 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.692 2.797 . . . . 0.0 111.041 164.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.15 -31.72 0.08 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -148.39 -165.21 2.21 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.796 1.638 . . . . 0.0 110.097 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' CG1' HG22 ' A' ' 115' ' ' VAL . 37.8 t -113.56 141.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.19 -1.569 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -139.88 127.59 21.81 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.637 1.575 . . . . 0.0 109.116 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.22 146.91 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.41 -177.78 38.62 Favored Glycine 0 CA--C 1.518 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 115.249 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.65 16.66 9.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.316 1.446 . . . . 0.0 113.969 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 38.47 0.16 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 127.152 2.181 . . . . 0.0 111.714 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.49 -25.63 50.12 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.513 1.53 . . . . 0.0 115.762 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.74 -31.16 72.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.365 1.466 . . . . 0.0 113.223 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -134.02 -88.31 0.39 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.067 1.347 . . . . 0.0 110.192 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.22 56.33 2.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.817 1.199 . . . . 0.0 113.453 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -128.93 163.99 24.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.631 1.572 . . . . 0.0 111.555 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -72.56 -40.18 66.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.165 -0.959 . . . . 0.0 112.918 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.1 m -74.2 -34.62 63.78 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -168.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -54.38 -36.03 63.45 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.969 1.259 . . . . 0.0 111.64 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.98 -27.94 30.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.934 1.293 . . . . 0.0 112.826 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.92 -36.69 72.83 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.119 1.327 . . . . 0.0 109.94 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -103.18 -39.59 6.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.404 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.38 -30.88 68.74 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.547 0.612 . . . . 0.0 112.417 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -97.87 -30.16 12.91 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.22 -33.78 16.14 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.001 1.286 . . . . 0.0 114.439 167.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -58.94 -41.57 87.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -78.63 -24.75 45.13 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.971 0.509 . . . . 0.0 112.354 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.72 -177.49 41.48 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.031 0.824 . . . . 0.0 114.925 -171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.55 147.6 46.25 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.74 2.96 . . . . 0.0 113.149 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.97 164.25 18.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.676 2.391 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 116' ' ' GLU . 5.1 tmm_? -122.99 -36.88 2.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.434 1.494 . . . . 0.0 112.403 173.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -161.98 154.41 19.69 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.259 0.936 . . . . 0.0 111.068 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.5 t -153.02 123.56 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.233 1.413 . . . . 0.0 110.151 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -145.27 159.93 42.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.695 1.198 . . . . 0.0 111.671 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.76 153.3 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.397 -0.815 . . . . 0.0 111.897 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.68 66.6 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.148 1.379 . . . . 0.0 114.267 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 42.23 38.21 1.09 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.024 2.53 . . . . 0.0 115.197 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -137.33 -42.98 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.495 1.518 . . . . 0.0 113.901 -174.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 108' ' ' ASN . 53.8 Cg_exo -50.78 -37.48 54.79 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.651 2.234 . . . . 0.0 115.274 169.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -74.51 170.48 71.19 Favored 'Cis proline' 0 CA--C 1.544 1.003 0 CA-C-N 121.275 1.491 . . . . 0.0 111.412 -27.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.83 19.12 2.53 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 117.318 1.687 . . . . 0.0 117.318 168.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -133.54 130.28 38.25 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.254 1.527 . . . . 0.0 111.06 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.44 160.81 38.96 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.128 2.171 . . . . 0.0 114.489 -158.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -155.08 119.71 4.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.957 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG22 ' CG1' ' A' ' 76' ' ' VAL . 2.6 m -137.22 -171.03 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.832 0.853 . . . . 0.0 111.764 -168.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 101' ' ' ARG . 15.6 tt0 -153.75 115.88 4.32 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.427 1.091 . . . . 0.0 111.239 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -67.28 179.94 1.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.077 1.751 . . . . 0.0 112.457 165.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -115.08 -50.29 2.76 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.46 -0.775 . . . . 0.0 112.549 155.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -75.96 123.69 88.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 O-C-N 121.296 -0.877 . . . . 0.0 112.261 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -26.22 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.97 2.447 . . . . 0.0 114.724 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -27.54 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.302 1.41 . . . . 0.0 112.378 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.43 -37.46 83.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.801 0.84 . . . . 0.0 111.445 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.51 96.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.269 0.628 . . . . 0.0 112.132 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.39 91.53 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.151 -0.968 . . . . 0.0 110.516 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -40.33 81.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.85 0.75 . . . . 0.0 112.687 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.46 -20.14 58.92 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 168.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.9 t -77.84 -53.88 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 120.403 1.456 . . . . 0.0 109.383 160.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.28 -24.0 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.932 1.693 . . . . 0.0 113.972 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -111.68 -6.89 14.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.451 1.5 . . . . 0.0 111.814 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.49 -22.66 0.28 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -156.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -74.5 144.98 43.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.892 0.853 . . . . 0.0 111.831 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.95 34.11 71.0 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.033 -171.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -132.36 -140.53 0.2 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.038 1.335 . . . . 0.0 110.977 -171.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.4 m -154.05 144.21 22.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.208 2.203 . . . . 0.0 109.395 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mp -118.26 -37.56 3.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.483 1.113 . . . . 0.0 113.031 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.2 t -144.87 43.67 1.35 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.077 0.951 . . . . 0.0 112.811 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.65 4.81 88.08 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.322 0.963 . . . . 0.0 114.512 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.9 p -72.61 -176.29 1.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.544 1.537 . . . . 0.0 112.185 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.44 115.51 10.93 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.539 1.536 . . . . 0.0 106.939 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.36 162.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -143.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.43 125.58 20.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.17 1.788 . . . . 0.0 109.758 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 144' ' ' LEU . 2.8 t -147.58 132.31 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -158.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -144.37 119.25 9.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.477 HD11 ' CG1' ' A' ' 142' ' ' VAL . 1.6 mp -137.09 131.62 32.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.089 1.768 . . . . 0.0 115.257 -169.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.4 m -147.47 176.27 10.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.178 2.191 . . . . 0.0 114.973 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -150.55 104.34 3.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.865 2.466 . . . . 0.0 109.549 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.29 -15.15 0.04 OUTLIER Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 -170.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.24 133.9 30.3 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.341 1.57 . . . . 0.0 110.6 165.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -116.58 90.25 3.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.961 1.304 . . . . 0.0 110.983 -151.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.45 ' C ' HH22 ' A' ' 101' ' ' ARG . 55.6 mmt-85 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.875 2.47 . . . . 0.0 109.003 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -150.46 158.9 44.67 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.717 2.807 . . . . 0.0 111.312 -3.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.29 112.44 13.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.21 111.97 9.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -159.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.3 101.99 13.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.475 1.11 . . . . 0.0 110.136 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.42 117.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 128.535 2.734 . . . . 0.0 110.02 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -90.98 127.73 36.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.605 165.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -136.72 43.26 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.71 1.604 . . . . 0.0 110.554 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.98 171.54 22.67 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.493 -1.379 . . . . 0.0 116.418 -168.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -67.06 -37.04 83.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.627 1.171 . . . . 0.0 110.175 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -66.16 -53.82 32.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.072 1.349 . . . . 0.0 112.307 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -157.87 142.91 16.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.898 0.879 . . . . 0.0 111.552 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.24 111.43 16.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.937 2.095 . . . . 0.0 109.92 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.54 93.07 0.11 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.632 1.11 . . . . 0.0 113.496 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -31.81 166.24 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.891 2.477 . . . . 0.0 116.898 163.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -133.08 -38.98 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.2 p 55.7 164.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -152.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.9 t -152.65 -17.54 0.16 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.72 154.23 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.255 2.622 . . . . 0.0 117.476 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.12 175.89 9.78 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.805 -1.185 . . . . 0.0 112.949 -164.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.92 -45.06 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.106 0.955 . . . . 0.0 110.296 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -166.73 178.17 6.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.949 -158.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.37 -10.1 40.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.03 -1.89 18.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 120.549 1.522 . . . . 0.0 110.526 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -112.33 -20.25 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 128.219 2.608 . . . . 0.0 112.092 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.68 9.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.082 0.953 . . . . 0.0 110.387 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.95 -48.19 82.72 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.13 -18.53 48.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.586 -167.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.43 -45.92 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.021 1.728 . . . . 0.0 110.858 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 18' ' ' THR . 6.8 m-85 -54.13 -40.9 67.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 mmpt? -46.39 -39.61 10.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.941 1.696 . . . . 0.0 111.624 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -104.65 -20.57 13.6 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -55.76 -42.1 74.98 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.997 1.271 . . . . 0.0 109.507 159.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.97 -36.19 49.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.591 -0.693 . . . . 0.0 110.521 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -78.65 -22.83 46.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.474 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.17 -37.42 66.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.028 1.331 . . . . 0.0 113.134 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -59.88 -47.18 86.79 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.656 0.662 . . . . 0.0 110.777 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.61 10.28 6.01 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.361 1.934 . . . . 0.0 113.667 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.96 150.76 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.38 1.072 . . . . 0.0 110.597 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.74 128.11 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.222 1.011 . . . . 0.0 111.25 134.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.18 -154.0 7.13 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-O 123.701 1.723 . . . . 0.0 115.13 -158.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.04 53.09 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.648 2.379 . . . . 0.0 109.766 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.402 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 6.7 m95 -46.06 103.28 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.981 1.712 . . . . 0.0 112.836 -168.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.47 156.38 30.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.897 1.679 . . . . 0.0 111.72 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 52.7 t80 -149.69 142.19 24.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.073 1.349 . . . . 0.0 110.464 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.29 -36.58 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -162.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.08 -45.56 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 129.065 2.946 . . . . 0.0 117.96 -171.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.99 -25.05 64.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.206 1.803 . . . . 0.0 112.117 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.5 p -128.66 7.2 5.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 113.125 167.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.254 16.0 mttp 51.39 8.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -51.54 152.53 2.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.08 2.552 . . . . 0.0 113.338 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 28.7 m-85 -126.3 165.44 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 131.45 3.9 . . . . 0.0 110.235 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -145.75 150.55 36.44 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.885 0.85 . . . . 0.0 111.231 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.77 95.07 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 122.296 1.046 . . . . 0.0 113.249 158.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.46 101.56 10.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.179 0.992 . . . . 0.0 110.643 172.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -112.98 -19.95 11.73 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.929 -1.107 . . . . 0.0 113.006 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.34 58.01 0.06 OUTLIER Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.704 -1.247 . . . . 0.0 114.778 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.0 m -47.77 -21.41 0.39 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.88 -57.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.571 1.078 . . . . 0.0 110.896 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -60.83 150.74 31.87 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -171.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 140.19 166.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 133.902 4.881 . . . . 0.0 108.556 -177.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -76.79 59.99 1.66 Allowed 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -161.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -66.37 -11.6 52.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.504 2.322 . . . . 0.0 114.477 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.0 t60 67.52 -8.1 0.51 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.55 2.34 . . . . 0.0 116.757 170.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 tpt -51.66 -34.33 37.68 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.525 1.53 . . . . 0.0 113.853 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.3 117.26 17.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.802 159.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 41.77 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 131.159 3.783 . . . . 0.0 118.09 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.19 -65.65 0.12 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.533 1.933 . . . . 0.0 109.579 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.1 p -155.81 74.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.383 1.073 . . . . 0.0 112.973 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.13 146.54 52.33 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.91 0.884 . . . . 0.0 111.472 166.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.94 -47.16 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.514 2.143 . . . . 0.0 113.812 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -156.88 -45.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.431 1.892 . . . . 0.0 109.09 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.468 ' H ' ' CB ' ' A' ' 145' ' ' SER 0.261 3.7 p30 -145.57 -98.06 0.1 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.112 1.765 . . . . 0.0 110.14 162.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.4 t -153.99 -23.49 0.14 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 120.728 1.604 . . . . 0.0 114.918 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -162.62 -155.15 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 129.701 3.2 . . . . 0.0 104.052 -170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 145' ' ' SER . 1.0 OUTLIER -126.5 168.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.629 2.013 . . . . 0.0 114.934 169.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -138.03 118.32 13.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.332 2.253 . . . . 0.0 108.848 168.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.2 t -126.7 141.75 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.538 . . . . 0.0 110.481 -174.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.86 -162.77 25.53 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 78.47 12.1 1.63 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.284 2.634 . . . . 0.0 113.971 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 33.16 5.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 -152.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.53 -26.31 44.95 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.119 1.342 . . . . 0.0 116.222 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.53 -30.13 68.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.725 1.21 . . . . 0.0 113.986 170.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.3 -119.35 0.3 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.28 55.25 27.02 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 121.112 1.778 . . . . 0.0 113.72 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.2 -60.79 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.323 1.449 . . . . 0.0 111.868 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 170.79 -60.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.954 2.502 . . . . 0.0 112.934 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -95.75 -26.98 15.47 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.327 0.967 . . . . 0.0 113.218 -162.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -57.57 -36.82 72.18 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.289 -0.882 . . . . 0.0 111.676 163.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.2 mt -74.05 -36.32 64.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.967 0.907 . . . . 0.0 112.36 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -57.28 -30.69 64.91 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.973 1.261 . . . . 0.0 112.216 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -84.22 -46.3 12.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.56 -28.18 63.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.523 0.729 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -98.21 -35.05 10.49 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.827 0.851 . . . . 0.0 112.649 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.85 -30.93 37.83 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.546 1.546 . . . . 0.0 115.463 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -58.23 -36.35 73.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.212 1.006 . . . . 0.0 113.603 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -78.52 -16.27 57.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.82 178.55 25.77 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.44 1.972 . . . . 0.0 112.213 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -58.58 151.29 63.61 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.523 2.816 . . . . 0.0 113.393 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.51 154.99 31.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.78 2.032 . . . . 0.0 109.877 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -120.74 -22.76 6.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.501 1.52 . . . . 0.0 113.441 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -168.99 155.16 6.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.844 1.258 . . . . 0.0 109.845 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -151.21 130.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.077 1.751 . . . . 0.0 108.939 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -141.91 149.3 40.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.363 1.865 . . . . 0.0 109.584 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.55 147.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.746 -1.222 . . . . 0.0 113.956 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.25 101.04 13.77 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.539 1.936 . . . . 0.0 110.861 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -67.89 -29.44 68.55 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.647 1.579 . . . . 0.0 113.685 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . 0.287 9.0 p30 -90.61 -29.02 0.33 Allowed Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -61.44 178.49 0.62 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.508 2.805 . . . . 0.0 113.185 152.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.24 43.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.461 1 C-N-CA 126.559 4.839 . . . . 0.0 117.809 168.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.17 79.6 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.189 -1.569 . . . . 0.0 114.834 169.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -59.16 131.71 51.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.404 1.081 . . . . 0.0 111.801 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.53 155.9 31.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 112.274 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.18 131.21 36.47 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.951 1.3 . . . . 0.0 107.724 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.56 175.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.217 1.007 . . . . 0.0 110.86 -165.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -140.88 125.6 17.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.309 1.044 . . . . 0.0 109.588 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 144' ' ' LEU . 2.1 m-85 -86.85 173.01 9.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.413 1.885 . . . . 0.0 112.417 174.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.57 -68.63 0.74 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.96 155.96 74.89 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-N 120.965 1.711 . . . . 0.0 114.364 -170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.92 -42.82 62.98 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 116.008 -163.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -35.68 81.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.252 0.933 . . . . 0.0 112.375 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.54 -45.07 84.82 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.517 0.727 . . . . 0.0 110.535 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.13 -48.04 46.68 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.06 69.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.284 1.033 . . . . 0.0 111.252 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -74.09 -40.93 62.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.189 0.904 . . . . 0.0 112.286 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.9 -7.5 16.9 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 164.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.05 -55.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.566 1.53 . . . . 0.0 110.212 153.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -49.04 -36.54 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.783 2.033 . . . . 0.0 112.847 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -103.47 -13.17 16.71 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.164 0.986 . . . . 0.0 112.276 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mp -147.36 -8.46 0.44 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -152.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.557 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -63.08 -19.32 64.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -179.76 70.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.438 1.018 . . . . 0.0 111.621 -159.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -132.86 -132.9 0.18 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.594 1.558 . . . . 0.0 111.942 -163.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -151.22 -36.56 0.13 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.456 1.902 . . . . 0.0 110.682 -173.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.9 tp 62.17 -48.6 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 130.302 3.441 . . . . 0.0 118.869 156.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.21 29.02 1.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.846 1.658 . . . . 0.0 112.01 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.68 55.27 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.157 -0.965 . . . . 0.0 113.301 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 p -133.85 -129.89 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.588 1.955 . . . . 0.0 110.254 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -154.63 150.86 28.13 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 130.065 3.346 . . . . 0.0 106.813 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.69 151.88 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.151 0.98 . . . . 0.0 109.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -144.35 123.26 12.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 0.0 109.1 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 2.3 t -144.55 136.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.686 -161.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.89 48.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.986 1.714 . . . . 0.0 107.522 163.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -148.28 108.14 4.03 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.383 -0.823 . . . . 0.0 111.62 -150.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.468 ' CB ' ' H ' ' A' ' 73' ' ' ASP . 3.7 t -148.23 -173.65 4.37 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.617 1.967 . . . . 0.0 114.805 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -159.94 17.72 0.15 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.232 1.813 . . . . 0.0 114.217 -158.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.75 45.13 0.39 Allowed Glycine 0 N--CA 1.482 1.709 0 C-N-CA 127.123 2.297 . . . . 0.0 116.689 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -141.01 50.31 1.64 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.693 2.797 . . . . 0.0 109.147 -166.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -73.68 35.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.421 1.888 . . . . 0.0 115.466 -168.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 C-N-CA 127.25 2.22 . . . . 0.0 109.624 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -151.26 164.98 35.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.242 2.617 . . . . 0.0 110.305 -6.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -129.05 103.65 7.12 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.33 111.88 9.3 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 125.764 1.625 . . . . 0.0 111.28 -160.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.31 91.45 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.578 1.551 . . . . 0.0 110.076 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 mt -52.67 119.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.994 2.117 . . . . 0.0 109.207 159.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.58 134.04 40.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.429 1.092 . . . . 0.0 109.625 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -146.34 63.62 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.442 1.097 . . . . 0.0 108.767 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.72 178.54 16.35 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 122.045 0.803 . . . . 0.0 114.37 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -57.57 -43.56 84.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.33 1.052 . . . . 0.0 112.492 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -68.18 -50.67 52.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.283 2.233 . . . . 0.0 113.223 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -156.48 140.59 16.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.191 0.996 . . . . 0.0 110.397 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 131.11 47.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.798 1.639 . . . . 0.0 110.056 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.39 -134.74 4.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.347 1.451 . . . . 0.0 110.318 -158.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -161.71 -167.08 1.61 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.235 2.214 . . . . 0.0 108.892 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -144.82 -41.49 0.24 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 161.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p 56.12 166.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -156.47 -25.66 0.1 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 47.86 139.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.049 2.54 . . . . 0.0 117.049 -161.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.88 -178.0 7.03 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.576 -1.328 . . . . 0.0 112.118 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 21' ' ' VAL . 15.5 t -51.01 -51.1 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.368 1.867 . . . . 0.0 111.88 168.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -173.68 174.84 3.06 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.111 1.765 . . . . 0.0 110.903 -157.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.7 19.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.524 1.13 . . . . 0.0 113.697 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.31 11.36 6.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.096 0.959 . . . . 0.0 111.388 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -135.43 -24.49 1.38 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.499 1.92 . . . . 0.0 111.153 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.52 8.45 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.686 -0.633 . . . . 0.0 111.025 164.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -59.86 -46.35 89.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -49.3 -25.0 2.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.818 1.647 . . . . 0.0 114.267 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.2 -40.12 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.886 1.674 . . . . 0.0 110.339 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -53.7 -36.38 62.14 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.8 mtpp -49.74 -56.99 8.18 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.536 1.534 . . . . 0.0 109.832 172.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.48 -38.82 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.883 -0.58 . . . . 0.0 112.491 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -56.94 -36.25 70.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.044 0.838 . . . . 0.0 111.439 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.79 -37.29 24.73 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 121.662 -0.649 . . . . 0.0 110.512 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -67.02 -29.01 68.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.288 0.949 . . . . 0.0 112.469 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.11 -41.8 76.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.551 1.54 . . . . 0.0 113.181 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -63.53 -44.94 92.77 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.619 -0.676 . . . . 0.0 111.308 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.37 22.76 1.06 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.987 1.756 . . . . 0.0 113.212 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.17 129.94 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.271 1.828 . . . . 0.0 110.879 -164.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.84 3.1 16.21 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.894 150.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.97 -123.01 12.79 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.531 1.539 . . . . 0.0 113.256 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -132.05 48.85 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.077 2.151 . . . . 0.0 106.49 161.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 9.8 m95 -18.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.112 2.565 . . . . 0.0 115.607 -173.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.5 m -120.22 160.53 22.76 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.42 152.41 35.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.689 1.996 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.24 -39.93 5.09 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -166.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 t70 64.35 -33.45 0.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.07 64.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.694 1.598 . . . . 0.0 111.715 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -119.49 -7.64 10.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.277 2.231 . . . . 0.0 112.513 165.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.29 39.0 mttm 61.56 17.46 8.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.502 2.321 . . . . 0.0 115.37 -171.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -57.65 150.05 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.385 1.474 . . . . 0.0 112.713 162.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -118.35 164.68 14.86 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.569 2.747 . . . . 0.0 112.06 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -150.39 138.32 20.08 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.748 -1.22 . . . . 0.0 112.248 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.37 90.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.581 1.181 . . . . 0.0 113.468 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 84.17 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.228 1.811 . . . . 0.0 113.069 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -70.87 -31.86 68.67 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.83 -1.169 . . . . 0.0 110.529 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.58 67.22 1.29 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.873 1.225 . . . . 0.0 111.089 152.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -40.09 128.19 2.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.293 2.237 . . . . 0.0 113.992 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 119.38 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 1 C-N-CA 132.51 4.324 . . . . 0.0 112.139 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 153.7 10.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 121.015 -1.053 . . . . 0.0 112.312 167.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -145.62 148.62 33.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 -174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 57.76 -11.99 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 129.423 3.089 . . . . 0.0 118.047 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -123.03 40.11 3.79 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.182 -1.574 . . . . 0.0 111.278 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -146.21 151.38 37.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.562 1.945 . . . . 0.0 111.307 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.7 tpp -148.17 38.57 0.89 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.124 1.769 . . . . 0.0 110.945 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -74.82 39.75 0.14 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.162 1.785 . . . . 0.0 114.676 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 67' ' ' ARG . 24.0 ttp85 46.79 57.1 5.87 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.404 1.882 . . . . 0.0 111.565 -162.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -9.22 9.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.699 2.399 . . . . 0.0 115.237 -166.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -67.05 52.82 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.806 2.842 . . . . 0.0 113.77 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 m 62.58 147.35 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 129.555 3.142 . . . . 0.0 113.808 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -79.97 -95.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.089 2.526 . . . . 0.0 111.821 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -135.97 -56.36 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.972 2.109 . . . . 0.0 107.546 163.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -138.77 -119.82 0.13 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.762 2.025 . . . . 0.0 107.804 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 13.2 m -150.18 14.51 0.8 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.327 2.651 . . . . 0.0 111.956 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 173.25 2.82 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.198 1.399 . . . . 0.0 109.978 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 145' ' ' SER . 9.5 p -128.82 155.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.879 1.218 . . . . 0.0 110.482 158.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -134.51 147.77 50.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 t -136.88 147.18 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.053 1.341 . . . . 0.0 111.106 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.36 -157.2 15.26 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.113 -0.992 . . . . 0.0 114.559 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -16.51 0.17 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.64 2.376 . . . . 0.0 114.239 -166.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.63 153.3 20.32 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.863 -1.148 . . . . 0.0 112.036 164.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.04 29.78 0.53 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.956 1.265 . . . . 0.0 113.225 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.86 -56.55 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.46 1.904 . . . . 0.0 109.735 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 24.2 m-80 -104.36 -166.19 1.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 140.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 84' ' ' ASN . . . -63.61 168.83 21.47 Favored Glycine 0 CA--C 1.531 1.085 1 C-N-CA 131.011 4.148 . . . . 0.0 114.117 -9.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -137.86 -23.39 1.05 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.209 2.203 . . . . 0.0 110.784 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.251 2.4 pttp 131.7 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 1 C-N-CA 134.866 5.266 . . . . 0.0 110.822 163.723 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.6 m -74.93 -45.6 41.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.153 1.381 . . . . 0.0 111.329 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -42.32 93.67 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.246 1.018 . . . . 0.0 112.179 172.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.23 -32.76 64.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.761 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' A' ' 103' ' ' VAL . 18.8 mt-10 -51.92 -37.0 50.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.316 1.417 . . . . 0.0 110.579 170.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -102.87 -34.3 9.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.86 79.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.279 0.631 . . . . 0.0 111.952 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -83.75 -28.08 28.47 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.811 -0.556 . . . . 0.0 110.918 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.34 -32.64 37.68 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.911 1.72 . . . . 0.0 114.411 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -51.84 -40.72 61.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -78.69 -24.12 45.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.7 179.38 30.75 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.321 1.438 . . . . 0.0 113.068 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.2 118.76 5.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.335 2.69 . . . . 0.0 113.038 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.13 156.39 25.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.899 0.857 . . . . 0.0 110.856 162.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -124.34 -23.9 4.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.604 2.362 . . . . 0.0 112.251 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -165.8 153.95 10.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.558 1.943 . . . . 0.0 108.95 163.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.53 HG11 ' HG3' ' A' ' 91' ' ' GLU . 39.0 t -150.73 125.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.542 1.137 . . . . 0.0 109.387 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -141.64 167.91 21.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.31 1.052 . . . . 0.0 112.505 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 113' ' ' ALA . 7.5 t -144.34 141.84 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.624 1.57 . . . . 0.0 110.231 -170.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.94 -30.1 31.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.314 1.046 . . . . 0.0 113.361 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? 59.85 -25.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 129.817 3.247 . . . . 0.0 116.815 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -109.39 -42.38 0.11 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.959 1.704 . . . . 0.0 112.007 -167.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -52.28 104.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 129.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 4.01 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.152 2.568 . . . . 0.0 117.425 -129.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.89 14.33 0.04 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.224 1.869 . . . . 0.0 114.609 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -84.3 149.89 25.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.262 1.425 . . . . 0.0 110.543 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -143.61 159.84 41.73 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.627 1.171 . . . . 0.0 113.917 -169.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.26 122.14 10.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.459 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 76' ' ' VAL . 2.0 m -138.85 -179.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.759 0.824 . . . . 0.0 111.845 -168.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.31 152.2 29.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.186 1.394 . . . . 0.0 110.863 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.63 167.21 12.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.678 2.391 . . . . 0.0 112.41 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -72.06 -20.79 61.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -143.0 133.54 12.34 Favored Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 121.001 -1.062 . . . . 0.0 112.429 -162.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.89 -27.99 9.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.756 2.304 . . . . 0.0 114.335 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.2 mtm105 -71.54 -49.36 41.59 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.432 1.015 . . . . 0.0 110.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.88 -37.36 84.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.856 0.862 . . . . 0.0 110.718 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.2 70.07 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.02 -26.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.219 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.58 -41.87 37.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.304 1.411 . . . . 0.0 113.866 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.66 -8.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.484 1.514 . . . . 0.0 114.087 163.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.5 t -96.7 -53.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.704 1.202 . . . . 0.0 111.109 160.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -53.36 -35.2 60.01 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.294 1.838 . . . . 0.0 113.102 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.36 -7.89 49.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.892 1.277 . . . . 0.0 112.103 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.51 -2.9 0.94 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -155.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -58.25 -24.28 58.82 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -170.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.91 75.77 0.11 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.31 1.91 . . . . 0.0 111.508 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 70.0 mmt-85 -132.51 -146.6 0.29 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.119 1.768 . . . . 0.0 111.238 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.4 m -151.19 139.33 20.16 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.392 2.277 . . . . 0.0 106.661 168.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 tp -142.27 -66.21 0.4 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -158.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.8 m -152.79 49.29 0.73 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.549 1.939 . . . . 0.0 109.97 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.79 26.74 0.34 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 130.635 3.969 . . . . 0.0 111.526 16.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.0 t -90.35 172.23 8.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.054 1.342 . . . . 0.0 110.027 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -43.64 132.95 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.247 1.019 . . . . 0.0 111.144 150.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.4 t -109.09 154.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.836 1.654 . . . . 0.0 110.012 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.0 135.7 27.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.762 1.225 . . . . 0.0 108.593 159.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.3 t -133.07 155.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.987 1.315 . . . . 0.0 110.244 -166.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.51 159.26 43.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.103 1.361 . . . . 0.0 110.482 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 161.74 15.01 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -152.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 t -155.77 -23.42 0.11 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.558 2.743 . . . . 0.0 117.303 -24.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -175.98 144.86 0.62 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 122.738 2.517 . . . . 0.0 110.961 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 166.71 111.9 0.25 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.207 0.908 . . . . 0.0 113.455 157.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -141.2 134.75 29.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 109.906 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.425 ' H ' ' HD3' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -87.3 1.62 52.68 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -159.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 127.115 2.166 . . . . 0.0 114.064 174.503 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -145.77 165.75 27.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 129.934 3.293 . . . . 0.0 111.06 -0.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -134.61 110.37 9.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -123.89 108.54 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.312 1.445 . . . . 0.0 112.18 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.23 89.37 6.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.121 0.968 . . . . 0.0 109.231 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 mt -51.52 115.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.006 1.722 . . . . 0.0 108.576 159.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -92.87 128.04 38.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.379 174.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 86.2 m-20 -140.34 58.82 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.35 -179.12 15.62 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-N 120.809 1.641 . . . . 0.0 115.693 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -56.83 -23.83 46.7 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.6 1.96 . . . . 0.0 115.187 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -99.04 -42.86 6.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.494 1.917 . . . . 0.0 112.542 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -160.43 140.2 11.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.118 1.367 . . . . 0.0 109.43 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -130.51 130.64 44.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.267 1.427 . . . . 0.0 110.097 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -133.58 4.21 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.088 1.804 . . . . 0.0 111.295 -148.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 6.7 mt-10 -161.87 -167.77 1.76 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.774 2.43 . . . . 0.0 107.965 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -139.35 -39.24 0.48 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 158.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p 53.9 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -158.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -160.48 179.68 8.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.906 2.482 . . . . 0.0 107.557 166.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -139.42 136.18 34.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.873 1.269 . . . . 0.0 109.138 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.19 -177.7 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.776 0.83 . . . . 0.0 111.992 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -46.04 -57.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.071 1.748 . . . . 0.0 110.6 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -172.15 -163.67 0.25 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.964 3.306 . . . . 0.0 107.149 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.13 -14.8 11.32 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.41 4.88 53.26 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.695 1.589 . . . . 0.0 111.951 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -126.49 -14.54 5.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.941 166.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.76 -49.94 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.555 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -57.02 -46.98 81.96 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -53.64 -21.05 6.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.866 1.354 . . . . 0.0 113.93 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.5 -35.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.138 1.775 . . . . 0.0 110.19 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 18' ' ' THR . 13.7 m-85 -53.35 -41.17 65.52 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.473 1.033 . . . . 0.0 113.599 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.79 -52.33 11.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.096 1.758 . . . . 0.0 110.624 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -80.31 -34.04 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.568 1.547 . . . . 0.0 114.863 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.73 -39.4 88.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.041 1.291 . . . . 0.0 111.225 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.05 61.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.617 -0.677 . . . . 0.0 109.696 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -71.9 -23.51 61.5 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -77.09 -37.0 55.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.689 . . . . 0.0 112.931 170.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -58.69 -44.21 90.22 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.738 -0.601 . . . . 0.0 110.464 164.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.01 5.72 8.77 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.074 1.797 . . . . 0.0 113.459 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.53 146.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.437 1.095 . . . . 0.0 110.719 172.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.12 125.19 9.27 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.726 0.775 . . . . 0.0 110.836 135.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.07 -147.04 4.61 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-O 123.878 1.821 . . . . 0.0 115.456 -157.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HB3' ' H ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -62.22 -19.16 62.87 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.689 2.396 . . . . 0.0 114.181 -172.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CD2' ' CG1' ' A' ' 54' ' ' VAL 0.267 10.7 m95 36.58 52.79 1.0 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.541 2.736 . . . . 0.0 115.514 170.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 m -75.41 156.42 35.39 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.047 0.927 . . . . 0.0 111.638 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -144.36 146.11 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.592 1.557 . . . . 0.0 110.448 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -106.03 -40.03 5.8 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -163.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.04 -34.8 0.06 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.78 65.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.334 1.853 . . . . 0.0 111.466 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -125.88 -0.29 7.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.709 2.003 . . . . 0.0 112.809 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 42.2 mttm 56.13 7.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.204 2.602 . . . . 0.0 116.512 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -43.44 152.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.205 2.202 . . . . 0.0 113.972 150.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.88 173.54 8.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 130.557 3.543 . . . . 0.0 110.914 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -146.1 156.23 43.31 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.764 -1.21 . . . . 0.0 110.433 158.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -130.46 128.91 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 152.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 42' ' ' GLU . 5.7 m -125.34 117.57 24.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.057 1.408 . . . . 0.0 112.353 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -149.9 -164.47 2.03 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 130.744 3.618 . . . . 0.0 108.509 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.541 ' H ' ' HG2' ' A' ' 56' ' ' GLU . . . 73.17 121.9 0.08 OUTLIER Glycine 0 CA--C 1.539 1.586 0 O-C-N 119.737 -1.852 . . . . 0.0 115.436 171.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.0 p -165.89 165.08 18.46 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 130.419 3.488 . . . . 0.0 110.167 -7.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -55.21 -43.79 74.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.218 1.007 . . . . 0.0 112.494 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -160.27 160.39 32.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.808 1.243 . . . . 0.0 111.868 144.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -97.79 170.53 8.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.083 1.353 . . . . 0.0 113.037 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -62.37 -12.45 21.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.726 2.01 . . . . 0.0 115.073 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -163.98 -173.31 3.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.115 2.566 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -68.47 33.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.141 2.274 . . . . 0.0 117.141 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.57 81.7 0.06 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.373 -1.455 . . . . 0.0 111.627 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -51.23 -35.29 36.14 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.315 1.046 . . . . 0.0 112.497 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -52.54 -27.95 18.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.31 2.244 . . . . 0.0 115.627 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -39.38 76.68 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -126.86 -0.51 6.65 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 93.8 m -123.98 -92.77 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 115.202 -2.332 . . . . 0.0 109.789 171.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -76.78 -33.52 3.9 Favored 'Cis proline' 0 C--N 1.362 1.265 0 CA-C-N 124.582 2.672 . . . . 0.0 115.725 -0.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -170.04 -51.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.897 2.479 . . . . 0.0 107.19 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -163.77 163.92 23.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.39 2.276 . . . . 0.0 109.316 -165.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.3 m -108.48 29.68 7.16 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.369 2.668 . . . . 0.0 111.898 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -155.03 -178.22 7.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.212 1.805 . . . . 0.0 109.755 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.714 HG13 HD22 ' A' ' 144' ' ' LEU . 75.5 t -117.71 121.52 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 140.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' H ' HD23 ' A' ' 144' ' ' LEU . 40.4 t80 -144.36 141.56 29.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.514 -1.366 . . . . 0.0 111.273 -167.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.59 159.71 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.98 -163.91 12.97 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.822 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 65.77 20.97 11.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.983 1.713 . . . . 0.0 114.692 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -84.13 132.74 34.66 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.014 -1.054 . . . . 0.0 110.105 170.056 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.31 34.01 1.2 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.048 1.308 . . . . 0.0 112.099 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -143.29 -40.61 0.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 110.549 -162.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' H ' HD12 ' A' ' 81' ' ' LEU . 46.5 m-20 -124.15 -111.34 0.31 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.299 2.64 . . . . 0.0 108.125 173.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.04 61.92 0.56 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.902 1.715 . . . . 0.0 111.111 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.35 166.12 26.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.261 1.025 . . . . 0.0 112.243 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -30.08 65.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 m -75.89 -39.6 56.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.348 -0.845 . . . . 0.0 113.156 -169.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.29 -35.93 65.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.138 -0.976 . . . . 0.0 111.467 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 mt -83.86 -30.07 26.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.324 1.449 . . . . 0.0 111.859 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -56.79 -36.52 69.96 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.804 0.729 . . . . 0.0 109.797 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -91.24 -52.55 4.76 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.179 0.992 . . . . 0.0 111.584 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.77 54.09 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.372 1.069 . . . . 0.0 113.475 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.17 -26.53 9.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.22 -33.21 37.94 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 124.869 1.223 . . . . 0.0 114.502 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -57.01 -37.82 72.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -79.63 -20.99 45.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.387 0.675 . . . . 0.0 112.656 -170.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.49 175.91 26.19 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 125.553 1.549 . . . . 0.0 113.556 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.24 116.44 2.68 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.186 3.924 . . . . 0.0 115.173 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.39 161.26 29.4 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 110.502 159.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -126.93 -29.73 2.79 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.633 1.973 . . . . 0.0 112.585 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -154.54 164.08 39.23 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.709 0.686 . . . . 0.0 111.195 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.38 131.22 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.719 1.208 . . . . 0.0 111.766 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -158.32 165.6 34.37 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.39 1.476 . . . . 0.0 110.983 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . 0.263 1.3 m -142.76 143.97 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.965 -1.085 . . . . 0.0 112.808 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.79 161.98 11.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.334 1.854 . . . . 0.0 112.732 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -122.41 19.27 10.53 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 127.1 2.16 . . . . 0.0 110.928 171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -155.54 50.67 0.51 Allowed Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -153.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -76.01 166.48 82.81 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 CA-C-N 122.231 1.833 . . . . 0.0 114.164 0.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.93 -6.76 18.5 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.432 2.755 . . . . 0.0 115.611 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.55 18.39 49.9 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.877 1.227 . . . . 0.0 116.166 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -139.64 134.28 31.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.487 1.515 . . . . 0.0 110.808 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.54 151.24 51.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.28 1.832 . . . . 0.0 113.743 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.42 129.38 31.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 76' ' ' VAL . 3.4 m -143.63 -178.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 110.764 -166.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -141.41 152.01 43.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.168 -0.957 . . . . 0.0 112.257 170.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.406 ' CD1' HG11 ' A' ' 76' ' ' VAL . 3.6 m-85 -117.45 169.01 9.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.018 2.527 . . . . 0.0 110.764 171.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.48 3.28 40.1 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -156.44 137.18 9.13 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.2 -38.42 33.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 125.221 3.947 . . . . 0.0 117.517 168.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.8 -59.33 5.39 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 120.42 1.464 . . . . 0.0 110.127 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.16 -41.91 76.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.989 1.716 . . . . 0.0 110.907 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 145' ' ' SER . . . -69.75 -52.71 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.029 1.732 . . . . 0.0 113.255 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.41 65.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.195 1.361 . . . . 0.0 111.503 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -47.92 82.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.894 . . . . 0.0 111.868 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.36 -9.7 58.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.703 1.601 . . . . 0.0 114.617 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.2 -46.62 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.288 -1.508 . . . . 0.0 108.953 157.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.72 -20.9 65.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -114.62 -12.5 12.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.64 1.176 . . . . 0.0 111.899 -173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.21 -10.22 0.57 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -156.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -71.92 141.79 49.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.966 0.803 . . . . 0.0 111.96 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.63 15.52 62.01 Favored Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.433 1.492 . . . . 0.0 114.958 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.3 179.04 6.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.337 1.455 . . . . 0.0 112.49 -168.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 99.8 m -136.16 89.67 2.5 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.101 1.36 . . . . 0.0 110.686 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.4 -32.47 42.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 112.777 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.5 m -145.75 17.07 1.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.858 1.263 . . . . 0.0 114.122 -165.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.94 -4.41 65.53 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 113.827 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.1 p -63.99 -179.51 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.545 1.938 . . . . 0.0 113.538 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -130.74 63.29 1.58 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.581 1.152 . . . . 0.0 108.75 155.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 p -50.53 141.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.269 1.828 . . . . 0.0 112.048 -169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.1 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.292 1.437 . . . . 0.0 109.346 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.8 t -144.25 129.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -148.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.19 130.6 21.06 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.706 -1.246 . . . . 0.0 111.335 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.714 HD22 HG13 ' A' ' 76' ' ' VAL . 10.6 mt -147.99 127.15 12.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.307 1.043 . . . . 0.0 110.245 -159.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.412 ' HA ' ' CB ' ' A' ' 123' ' ' ALA . 3.5 m -173.81 -12.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 155.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.28 56.87 3.63 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.776 1.171 . . . . 0.0 112.622 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.11 -4.1 2.21 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 -170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 148' ' ' GLU . 10.9 mp0 -67.96 -21.65 65.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.412 2.285 . . . . 0.0 112.098 174.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.35 148.77 35.08 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.81 1.644 . . . . 0.0 109.31 165.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 . . . . . 0 C--O 1.244 0.798 0 C-N-CA 125.94 1.696 . . . . 0.0 111.198 -173.127 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.448 0.166 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -65.32 -179.02 0.55 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.666 1.986 . . . . 0.0 112.928 -11.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -130.87 130.82 44.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 133.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.03 112.91 12.77 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.974 -1.079 . . . . 0.0 113.527 -174.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.61 111.79 20.38 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.594 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 9.6 mt -77.2 117.23 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 129.189 2.995 . . . . 0.0 110.419 158.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.15 123.77 30.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.798 161.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.32 34.6 3.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.196 1.799 . . . . 0.0 110.911 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 150.37 20.98 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.033 -1.042 . . . . 0.0 114.422 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -49.16 -37.54 22.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 110.655 155.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 m -57.71 -55.17 38.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.815 2.846 . . . . 0.0 113.419 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 13' ' ' LYS . 1.8 tm? -165.26 140.16 5.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.99 1.716 . . . . 0.0 109.824 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' N ' HD13 ' A' ' 12' ' ' LEU . 7.3 mtpm? -128.7 119.52 24.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.901 1.28 . . . . 0.0 110.745 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.52 85.41 0.06 OUTLIER Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.163 0.887 . . . . 0.0 112.949 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -31.77 159.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 158.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 t -140.43 -27.7 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 7.1 p 61.86 162.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -171.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -158.96 -172.41 3.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.374 2.27 . . . . 0.0 107.733 159.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -138.16 146.72 43.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 120.189 -1.569 . . . . 0.0 111.531 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.41 -174.77 5.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 111.972 -163.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.8 -50.91 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.11 166.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -165.99 175.85 8.23 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.284 1.516 . . . . 0.0 112.045 -156.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.13 17.92 0.09 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.567 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.69 7.84 6.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.111 1.364 . . . . 0.0 111.545 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.8 p -135.42 -26.27 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.958 2.503 . . . . 0.0 112.29 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.5 -47.03 16.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.618 163.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.42 -47.5 75.87 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -21.31 6.76 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.982 1.313 . . . . 0.0 114.408 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.02 -34.57 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.032 1.733 . . . . 0.0 110.914 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.4 m-30 -54.39 -43.0 71.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.339 0.972 . . . . 0.0 113.549 165.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -37.25 -57.28 0.9 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.423 2.289 . . . . 0.0 110.452 166.175 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -80.39 -32.25 37.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.975 1.71 . . . . 0.0 114.729 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -59.0 -44.7 91.71 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.431 1.014 . . . . 0.0 111.087 168.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.66 58.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.46 -31.39 72.1 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.051 0.841 . . . . 0.0 112.272 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.9 -37.99 76.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.718 1.207 . . . . 0.0 113.219 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -66.05 -44.2 85.28 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.695 -0.628 . . . . 0.0 111.784 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.07 13.66 0.59 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.984 1.754 . . . . 0.0 114.052 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.87 144.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.957 1.703 . . . . 0.0 111.877 -166.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -132.56 8.22 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.957 0.903 . . . . 0.0 112.849 158.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 56' ' ' GLU . . . 45.12 -132.2 8.26 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 123.018 1.343 . . . . 0.0 114.193 166.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -136.16 42.22 2.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.191 1.796 . . . . 0.0 106.615 167.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 26.3 m95 -3.22 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 130.525 3.53 . . . . 0.0 115.939 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.0 m -83.89 157.97 21.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.109 0.956 . . . . 0.0 109.774 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -137.64 145.53 42.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.211 1.404 . . . . 0.0 110.112 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -133.2 56.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.447 1.499 . . . . 0.0 110.278 -155.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.88 -32.35 1.56 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.084 2.953 . . . . 0.0 116.822 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.82 -21.88 61.48 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.061 2.144 . . . . 0.0 112.624 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -131.78 7.91 4.45 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 112.846 167.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm 63.76 2.24 1.27 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.975 2.51 . . . . 0.0 114.61 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.5 m -52.52 161.98 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 129.741 3.216 . . . . 0.0 113.127 166.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -132.1 155.33 48.32 Favored 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 132.053 4.141 . . . . 0.0 110.039 171.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -144.92 121.22 10.9 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.999 0.428 . . . . 0.0 111.786 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.97 90.91 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 122.535 1.159 . . . . 0.0 112.53 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.56 39.23 0.82 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -163.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 9.7 tm-20 -62.11 -14.53 37.67 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -170.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.0 5.01 45.81 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.974 1.75 . . . . 0.0 114.949 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -142.14 -15.41 0.78 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.01 1.405 . . . . 0.0 114.436 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -128.44 100.47 5.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.651 1.581 . . . . 0.0 107.254 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -135.21 117.93 16.07 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.959 0.904 . . . . 0.0 112.696 -159.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -155.52 132.79 10.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.703 2.801 . . . . 0.0 109.001 -14.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -5.32 1.1 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . 0.272 0.0 OUTLIER 57.05 -9.74 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.624 2.77 . . . . 0.0 116.87 -176.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.71 -19.6 59.16 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.533 1.933 . . . . 0.0 113.889 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.0 ptm 55.91 -26.27 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 130.447 3.499 . . . . 0.0 119.588 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -160.02 166.86 29.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.094 2.158 . . . . 0.0 110.264 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.5 24.13 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 173.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p30 21.56 -100.27 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 128.601 2.76 . . . . 0.0 116.194 164.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 m -164.43 -43.98 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.936 2.494 . . . . 0.0 109.755 163.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.8 p -143.26 136.27 13.83 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.852 2.061 . . . . 0.0 107.937 156.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.99 -30.07 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 114.88 1.069 . . . . 0.0 114.88 -158.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 mp 50.17 -65.5 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 127.128 2.171 . . . . 0.0 114.404 -149.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -66.73 -7.12 18.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -120.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.4 m -109.21 46.88 0.95 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.436 1.895 . . . . 0.0 111.357 163.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.636 ' H ' ' H ' ' A' ' 146' ' ' ASN . 2.9 mptp? -148.42 178.68 8.39 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.47 -0.769 . . . . 0.0 110.505 57.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.04 144.28 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.711 0.804 . . . . 0.0 109.651 168.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -121.94 147.56 45.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.61 0.764 . . . . 0.0 111.61 -158.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.28 151.87 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.952 0.901 . . . . 0.0 110.56 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 -172.57 36.25 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 118.336 2.094 . . . . 0.0 118.336 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t30 53.28 36.22 22.17 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.378 1.871 . . . . 0.0 113.542 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.85 9.55 43.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.089 1.756 . . . . 0.0 113.238 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.94 -21.03 6.95 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.018 1.771 . . . . 0.0 117.034 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -54.52 -33.11 59.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 113.233 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -131.78 -45.74 0.96 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.104 1.762 . . . . 0.0 111.545 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.73 77.3 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 129.111 3.243 . . . . 0.0 115.661 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -139.75 167.53 21.88 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.557 1.143 . . . . 0.0 111.518 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -68.9 -37.43 78.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -79.86 -29.19 40.01 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.974 -1.079 . . . . 0.0 113.462 -163.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.95 -18.54 63.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.2 mt -96.67 -34.19 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.316 1.446 . . . . 0.0 111.666 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -54.12 -36.47 63.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.733 0.697 . . . . 0.0 110.893 168.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.88 -55.98 4.87 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.77 45.25 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -117.19 -30.29 5.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.863 1.265 . . . . 0.0 111.091 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.72 -35.58 17.21 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.033 1.301 . . . . 0.0 114.804 164.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -54.04 -41.95 68.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -78.43 -30.97 47.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.255 -171.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.59 40.74 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 -170.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.45 112.22 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.168 3.245 . . . . 0.0 112.072 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.13 156.69 37.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.737 0.78 . . . . 0.0 111.003 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -134.01 -21.89 1.85 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 112.878 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 m -163.74 166.52 22.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.006 1.322 . . . . 0.0 111.558 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.67 131.29 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.906 1.282 . . . . 0.0 110.519 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -150.05 144.11 25.57 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.25 1.42 . . . . 0.0 111.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.76 149.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.594 -1.316 . . . . 0.0 113.73 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.15 124.5 49.64 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.19 2.196 . . . . 0.0 110.45 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -153.94 162.07 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -154.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.61 -42.61 14.61 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 126.36 1.864 . . . . 0.0 112.089 -17.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.66 143.8 82.15 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.558 2.172 . . . . 0.0 110.906 149.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.24 -15.96 24.11 Favored 'Cis proline' 0 CA--C 1.543 0.959 0 CA-C-N 120.314 1.148 . . . . 0.0 113.427 -7.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.35 42.02 3.55 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 124.391 0.996 . . . . 0.0 112.731 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.89 142.97 49.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.704 1.202 . . . . 0.0 111.566 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.2 161.8 27.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.513 1.925 . . . . 0.0 113.227 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.5 137.13 30.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.911 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.02 168.55 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 109.506 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -139.42 149.74 44.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.86 178.13 5.66 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.315 2.246 . . . . 0.0 111.3 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.442 ' HA ' HH22 ' A' ' 150' ' ' ARG . 5.2 tp10 -126.63 29.24 5.75 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.825 1.25 . . . . 0.0 112.543 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -160.24 119.37 1.6 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.132 1.373 . . . . 0.0 111.312 163.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.04 -43.29 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 125.168 3.912 . . . . 0.0 116.165 167.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -58.5 -38.74 78.31 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.013 1.725 . . . . 0.0 113.408 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.65 -37.38 19.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.32 92.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.741 0.701 . . . . 0.0 112.156 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.92 93.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.81 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.62 -40.39 66.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.433 1.015 . . . . 0.0 113.649 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.99 -10.57 10.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 114.333 169.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.75 -50.92 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.619 1.1 . . . . 0.0 110.571 158.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -54.19 -31.83 53.98 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.39 1.876 . . . . 0.0 113.688 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.65 -2.07 42.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.841 1.656 . . . . 0.0 112.937 -173.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.54 -24.45 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -153.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.88 109.76 0.23 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.098 1.759 . . . . 0.0 112.427 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.34 85.07 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -105.15 -122.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.814 1.307 . . . . 0.0 111.796 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -150.69 142.52 23.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.413 1.485 . . . . 0.0 109.317 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.88 -35.93 2.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.425 1.09 . . . . 0.0 113.465 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 89.8 m -146.61 23.7 1.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.535 1.934 . . . . 0.0 111.811 -163.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.31 -10.41 63.93 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.817 1.675 . . . . 0.0 114.412 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.0 p -70.11 -179.69 2.03 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.837 2.455 . . . . 0.0 113.223 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -126.5 135.39 51.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.678 1.591 . . . . 0.0 108.048 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.79 171.67 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.127 0.571 . . . . 0.0 112.252 -145.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -133.11 147.49 52.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.635 1.974 . . . . 0.0 109.525 159.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.88 130.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.939 0.896 . . . . 0.0 108.639 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -139.26 -179.53 5.93 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.911 1.684 . . . . 0.0 112.507 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -98.39 169.46 9.53 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.856 2.062 . . . . 0.0 114.901 -175.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 m -142.03 -122.4 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.704 1.201 . . . . 0.0 111.995 154.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.636 ' H ' ' H ' ' A' ' 75' ' ' LYS . 79.9 m-20 -125.8 -26.66 3.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -137.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.36 171.51 6.5 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 120.095 1.316 . . . . 0.0 112.56 -158.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -35.34 5.97 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.005 -1.291 . . . . 0.0 113.043 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.13 -31.96 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.015 2.526 . . . . 0.0 113.421 168.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.442 HH22 ' HA ' ' A' ' 118' ' ' GLU . 27.5 mmt180 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 129.665 3.186 . . . . 0.0 115.807 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -149.71 172.79 14.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.378 2.671 . . . . 0.0 110.966 -8.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -140.91 106.51 5.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.6 ttpt -123.32 128.45 49.94 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 124.307 1.043 . . . . 0.0 112.279 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 43' ' ' TRP . 30.0 tp -98.34 103.76 15.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.178 1.791 . . . . 0.0 108.878 162.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 10.9 mt -72.23 114.63 11.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 128.498 2.719 . . . . 0.0 110.135 160.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.99 125.1 34.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.33 166.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -134.96 48.41 2.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.125 1.77 . . . . 0.0 109.88 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -112.2 150.89 18.17 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.925 1.25 . . . . 0.0 113.331 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -59.97 -24.06 64.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.148 1.379 . . . . 0.0 111.075 162.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.6 m -57.47 -56.59 19.95 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.315 1.846 . . . . 0.0 111.91 162.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 13' ' ' LYS . 3.0 tm? -164.37 139.53 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.311 1.845 . . . . 0.0 111.126 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 9' ' ' GLY . 24.0 mtmt -122.49 110.12 15.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.311 1.844 . . . . 0.0 110.259 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.19 83.82 0.04 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.039 0.828 . . . . 0.0 112.825 -166.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -29.48 155.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.919 1.688 . . . . 0.0 115.513 155.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -134.38 -26.07 1.47 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.047 2.239 . . . . 0.0 117.047 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.0 p 57.46 167.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 -175.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.3 t -160.84 -171.48 3.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.02 2.528 . . . . 0.0 107.623 162.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -140.12 131.66 27.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.517 1.527 . . . . 0.0 108.464 170.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.74 176.53 8.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.384 1.088 . . . . 0.0 113.439 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 7.7 t -58.54 -50.74 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.362 1.865 . . . . 0.0 111.259 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.82 172.57 4.06 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.187 1.795 . . . . 0.0 109.824 -154.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.68 -3.28 11.48 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.8 -43.21 3.65 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 120.552 1.524 . . . . 0.0 108.503 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -63.66 -21.37 66.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.708 1.14 . . . . 0.0 112.818 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.35 8.19 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.796 0.725 . . . . 0.0 111.663 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -61.3 -46.22 91.2 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -58.58 -20.19 44.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 -41.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.479 1.911 . . . . 0.0 110.868 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 18' ' ' THR . 12.6 m-85 -54.73 -38.77 67.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -45.77 -52.8 10.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.178 1.791 . . . . 0.0 110.318 171.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -75.75 -34.05 60.26 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.118 1.767 . . . . 0.0 114.525 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -59.26 -42.24 90.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.797 1.181 . . . . 0.0 111.211 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.56 -34.17 47.23 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.254 -0.904 . . . . 0.0 110.488 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -70.45 -27.24 64.09 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.725 0.693 . . . . 0.0 112.542 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.95 -37.61 75.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.979 1.312 . . . . 0.0 112.863 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -66.36 -53.03 40.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.18 0.592 . . . . 0.0 111.318 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.22 20.2 0.3 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.734 1.635 . . . . 0.0 114.474 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.1 150.27 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 112.526 -167.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.56 -0.27 2.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.642 1.177 . . . . 0.0 112.746 161.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 41.45 -113.79 0.54 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-O 124.422 2.123 . . . . 0.0 113.739 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -2.45 7.11 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 131.318 3.847 . . . . 0.0 109.652 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 41.6 m95 27.25 72.47 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.912 2.885 . . . . 0.0 114.26 -153.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.3 m -71.31 157.11 38.66 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 110.452 170.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -146.17 156.14 43.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.915 1.686 . . . . 0.0 111.423 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -133.77 135.39 43.87 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 127.365 2.266 . . . . 0.0 109.858 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.24 -16.05 14.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.2 60.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.465 1.506 . . . . 0.0 112.106 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -125.2 -1.63 7.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.394 1.878 . . . . 0.0 112.52 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.384 55.2 mttm 60.07 19.47 8.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.427 1.891 . . . . 0.0 114.259 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -67.03 162.77 21.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.111 2.564 . . . . 0.0 113.957 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.98 158.72 41.98 Favored 'General case' 0 C--N 1.327 -0.404 1 C-N-CA 132.34 4.256 . . . . 0.0 110.514 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -145.19 144.56 30.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.757 -0.589 . . . . 0.0 111.292 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.2 94.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.087 1.355 . . . . 0.0 112.443 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -95.79 58.93 2.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.0 113.605 -169.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.97 65.96 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.921 -1.112 . . . . 0.0 113.298 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.56 -7.07 45.46 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.312 1.91 . . . . 0.0 114.933 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.8 p -64.24 -18.23 64.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.902 1.351 . . . . 0.0 113.93 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.02 72.27 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.416 1.486 . . . . 0.0 112.661 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 63.5 -20.63 0.06 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.519 3.128 . . . . 0.0 118.533 164.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -141.46 141.93 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.099 1.318 . . . . 0.0 110.353 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -138.93 -14.45 1.19 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -156.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -153.61 14.98 0.5 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.797 2.039 . . . . 0.0 111.731 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -153.85 151.5 29.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.596 1.558 . . . . 0.0 111.513 -166.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.1 tpt -155.02 158.37 39.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.035 2.134 . . . . 0.0 108.655 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.932 0.787 . . . . 0.0 112.839 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.49 -178.84 4.14 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 128.328 2.651 . . . . 0.0 110.178 159.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.98 -48.88 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.701 1.6 . . . . 0.0 113.584 -165.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m 134.23 -21.36 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 1 C-N-CA 132.954 4.502 . . . . 0.0 113.013 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 53.7 m -154.58 166.74 15.33 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.991 1.716 . . . . 0.0 112.091 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.25 -30.04 0.34 Allowed 'Cis proline' 0 C--N 1.352 0.721 0 N-CA-C 114.271 0.835 . . . . 0.0 114.271 -8.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -156.43 -53.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.087 2.555 . . . . 0.0 106.607 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -172.2 -89.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.344 1.857 . . . . 0.0 112.052 150.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.2 t -144.24 116.54 8.49 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.582 1.553 . . . . 0.0 112.161 -172.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.334 9.8 ptpt 43.08 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 128.635 2.774 . . . . 0.0 114.472 -175.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 115' ' ' VAL . 14.8 t -130.88 143.37 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 119.785 1.175 . . . . 0.0 112.629 -160.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -135.67 132.87 37.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.613 1.965 . . . . 0.0 108.711 172.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.64 150.64 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.188 0.518 . . . . 0.0 109.854 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.37 -169.34 29.85 Favored Glycine 0 N--CA 1.465 0.631 0 O-C-N 121.337 -0.852 . . . . 0.0 114.402 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 60.87 4.86 0.85 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 85' ' ' GLY . 2.2 tm? -62.59 -49.61 74.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.471 1.032 . . . . 0.0 110.458 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.82 -60.11 0.34 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.536 2.017 . . . . 0.0 116.923 168.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -81.75 -13.74 57.38 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -159.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.89 -57.79 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 109.134 165.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.537 ' H ' HD12 ' A' ' 81' ' ' LEU . . . 38.26 62.67 1.05 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.794 2.14 . . . . 0.0 114.885 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -127.77 -42.61 1.59 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 pttp 139.75 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 1 C-N-CA 131.709 4.003 . . . . 0.0 112.171 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 m -79.57 -35.71 39.33 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.75 -0.594 . . . . 0.0 111.497 -167.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -40.76 76.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.118 -0.989 . . . . 0.0 111.519 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.0 mt -78.24 -31.3 49.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.617 0.767 . . . . 0.0 112.606 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.67 -37.96 68.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.943 1.247 . . . . 0.0 110.078 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -104.43 -42.44 5.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.386 -164.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.26 -34.55 66.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.138 0.575 . . . . 0.0 112.007 168.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -95.65 -29.83 14.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.73 -33.21 26.71 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.02 1.295 . . . . 0.0 114.205 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -57.52 -40.1 77.99 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -76.71 -27.61 55.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.07 -171.14 37.91 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 114.817 0.687 . . . . 0.0 114.817 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.09 135.02 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.828 3.019 . . . . 0.0 112.56 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.99 157.97 17.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.963 1.705 . . . . 0.0 110.043 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -127.67 -27.5 2.84 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.446 1.899 . . . . 0.0 112.669 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -168.32 155.84 8.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.808 1.243 . . . . 0.0 110.226 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -153.21 129.08 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.223 1.809 . . . . 0.0 108.902 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -148.85 160.38 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.923 0.889 . . . . 0.0 111.953 166.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.4 147.03 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.406 -0.809 . . . . 0.0 112.945 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.95 129.87 34.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.561 1.544 . . . . 0.0 111.319 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -68.22 -19.46 64.76 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.88 1.272 . . . . 0.0 112.895 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.95 113.37 5.36 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 127.234 2.213 . . . . 0.0 110.163 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.58 156.27 6.53 Favored 'Cis proline' 0 C--N 1.358 1.066 0 CA-C-N 121.734 1.655 . . . . 0.0 115.393 -1.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -53.65 2.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 1 C-N-CA 126.277 4.651 . . . . 0.0 121.818 -153.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.61 61.13 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 120.954 1.707 . . . . 0.0 111.822 -174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -127.31 139.49 52.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.924 1.69 . . . . 0.0 110.225 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.35 158.85 43.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.547 1.539 . . . . 0.0 114.685 -157.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.93 125.63 17.96 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.449 1.1 . . . . 0.0 108.869 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.7 m -138.26 -175.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -172.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -147.47 110.83 4.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.47 1.908 . . . . 0.0 109.547 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 144' ' ' LEU . 4.4 m-85 -75.02 173.02 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 111.224 158.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.13 37.37 2.12 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.883 0.849 . . . . 0.0 113.171 166.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.25 130.72 7.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 120.952 -1.092 . . . . 0.0 110.906 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 -37.76 4.85 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.133 2.555 . . . . 0.0 113.671 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -71.23 -44.65 64.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.396 1.078 . . . . 0.0 110.758 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.17 -34.86 78.43 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.382 0.673 . . . . 0.0 112.354 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.55 -46.98 68.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -31.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.991 -1.068 . . . . 0.0 110.959 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.13 -43.89 60.99 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 119.228 0.922 . . . . 0.0 112.508 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.65 -2.5 6.92 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.861 1.264 . . . . 0.0 113.964 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.49 -56.83 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 120.558 -1.339 . . . . 0.0 109.921 151.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -55.2 -29.75 58.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.522 1.529 . . . . 0.0 113.651 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -102.47 -12.04 18.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.725 1.61 . . . . 0.0 112.367 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.46 -5.48 0.65 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -154.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.6 p30 -57.91 -6.86 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 166.01 62.64 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.56 -0.712 . . . . 0.0 112.316 -151.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -135.68 -165.73 1.74 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.743 1.617 . . . . 0.0 111.719 -167.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.4 m -131.01 115.9 17.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.76 1.624 . . . . 0.0 109.288 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.37 -34.92 6.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.7 m -140.43 24.75 2.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.047 1.339 . . . . 0.0 112.739 -165.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.36 29.67 39.69 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 121.024 -1.047 . . . . 0.0 112.96 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.77 -165.98 1.55 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.77 2.428 . . . . 0.0 111.357 -167.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -139.64 55.56 1.66 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.842 0.857 . . . . 0.0 112.061 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.3 p -46.11 146.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 127.034 2.134 . . . . 0.0 114.091 -174.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.85 133.05 35.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.803 2.441 . . . . 0.0 109.441 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 46.7 t -143.42 136.42 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.785 0.434 . . . . 0.0 111.493 -158.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -134.05 112.13 10.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.504 2.322 . . . . 0.0 108.513 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD11 ' CE1' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -145.57 115.63 7.42 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.981 -1.074 . . . . 0.0 112.672 -152.102 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -149.74 -172.17 4.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.042 1.737 . . . . 0.0 113.951 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -140.21 10.28 2.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.185 1.794 . . . . 0.0 113.038 167.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.46 31.79 4.39 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 120.702 -1.249 . . . . 0.0 116.088 -160.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.65 -11.7 3.37 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.916 1.358 . . . . 0.0 114.214 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -64.93 -11.18 35.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.785 2.434 . . . . 0.0 115.583 -160.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.874 0 C-N-CA 126.231 1.812 . . . . 0.0 110.797 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -149.37 161.57 41.8 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.943 2.497 . . . . 0.0 111.38 -1.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.6 104.34 5.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 164.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.06 113.85 9.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.878 1.271 . . . . 0.0 112.836 -163.035 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.0 tp -99.84 101.85 13.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 110.434 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.03 124.09 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 128.343 2.657 . . . . 0.0 110.012 158.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.16 133.74 45.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.736 168.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -148.14 49.5 1.04 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.93 2.092 . . . . 0.0 109.723 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.58 157.48 21.32 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 120.539 -1.35 . . . . 0.0 112.924 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -55.49 -37.47 67.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.152 0.981 . . . . 0.0 110.179 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.492 HG21 ' HA3' ' A' ' 38' ' ' GLY . 85.0 m -56.78 -72.24 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.913 2.485 . . . . 0.0 112.967 164.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -140.59 132.71 27.97 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.441 1.096 . . . . 0.0 110.613 -161.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -132.28 123.23 26.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.244 1.818 . . . . 0.0 109.169 -175.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.84 99.11 0.81 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.469 1.033 . . . . 0.0 112.024 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -32.22 164.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.019 2.528 . . . . 0.0 116.941 165.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -129.06 -38.72 1.61 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.2 p 57.58 162.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -158.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -151.03 -6.94 0.26 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 28.17 99.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.806 3.242 . . . . 0.0 117.549 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.77 -159.6 0.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.447 1.499 . . . . 0.0 113.353 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.77 -17.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.537 1.935 . . . . 0.0 111.936 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -145.13 -11.1 0.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.58 -0.41 3.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.431 2.692 . . . . 0.0 115.445 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.51 -46.2 4.83 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 125.51 1.524 . . . . 0.0 107.956 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.64 -19.72 58.86 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.629 1.972 . . . . 0.0 113.455 162.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -54.2 6.61 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 119.402 1.001 . . . . 0.0 110.922 167.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.65 -43.95 91.97 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -60.77 -16.85 44.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.34 -41.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.427 2.291 . . . . 0.0 110.295 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.0 m-85 -53.63 -43.8 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.606 1.094 . . . . 0.0 113.701 168.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -58.15 1.44 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.944 2.097 . . . . 0.0 110.866 168.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.6 -30.89 46.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 114.918 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -59.5 -43.61 93.29 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.543 1.065 . . . . 0.0 110.928 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.95 -32.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.406 -0.809 . . . . 0.0 110.864 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.84 -26.74 67.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 118.335 0.516 . . . . 0.0 112.307 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.85 -48.39 59.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.837 1.655 . . . . 0.0 113.324 164.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.33 -38.61 87.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.595 0.634 . . . . 0.0 111.975 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' HA3' HG21 ' A' ' 11' ' ' THR . . . 128.62 28.37 0.82 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.524 1.535 . . . . 0.0 113.648 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.49 142.72 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.713 1.605 . . . . 0.0 111.176 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.86 113.71 5.41 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.376 1.084 . . . . 0.0 109.797 143.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -152.83 8.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-O 124.369 2.094 . . . . 0.0 115.387 -156.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.37 58.43 2.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 111.334 -2.433 . . . . 0.0 108.519 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 22.1 m95 -47.35 98.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.691 2.397 . . . . 0.0 112.019 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -121.98 159.28 27.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.341 1.856 . . . . 0.0 109.943 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.32 156.81 42.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.628 1.571 . . . . 0.0 111.127 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -135.29 113.1 10.95 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.729 2.012 . . . . 0.0 110.141 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.01 -18.6 53.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.61 -25.35 56.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.457 1.103 . . . . 0.0 111.863 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -120.69 -4.05 9.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.298 1.439 . . . . 0.0 112.949 167.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.385 37.8 mttm 56.42 24.66 8.71 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.86 2.064 . . . . 0.0 114.286 -171.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -73.12 155.06 40.07 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.553 1.941 . . . . 0.0 111.923 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.66 159.15 36.5 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 129.35 3.06 . . . . 0.0 111.37 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -143.8 136.76 27.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 2.3 m -111.89 96.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.514 1.15 . . . . 0.0 112.847 157.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 106.15 15.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.68 1.192 . . . . 0.0 109.324 165.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -118.67 -6.89 10.62 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.878 -1.139 . . . . 0.0 112.277 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.63 42.65 1.9 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 127.244 2.354 . . . . 0.0 112.311 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -156.11 169.63 24.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.113 2.165 . . . . 0.0 111.315 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -121.43 -162.68 0.99 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.186 1.794 . . . . 0.0 109.876 171.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -54.31 -25.29 22.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -164.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -50.79 -18.34 0.72 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.127 1.771 . . . . 0.0 115.353 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.0 t60 49.47 -127.26 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.39 1.476 . . . . 0.0 109.249 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -116.19 167.54 10.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 139.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -64.75 14.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 62.2 mtt -87.63 -9.55 53.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.575 2.35 . . . . 0.0 113.029 168.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -53.99 139.13 35.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.515 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HB3' HH12 ' A' ' 150' ' ' ARG . 0.2 OUTLIER -165.77 158.43 15.18 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.482 1.113 . . . . 0.0 112.683 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.52 135.19 36.56 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.368 2.267 . . . . 0.0 109.758 -24.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -140.48 169.37 17.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.493 1.117 . . . . 0.0 113.938 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.2 p -158.91 99.21 1.64 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.0 110.09 158.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.05 -31.26 6.29 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.221 1.947 . . . . 0.0 115.144 -169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -163.87 -51.41 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.999 2.12 . . . . 0.0 107.652 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.49 -124.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.42 2.288 . . . . 0.0 107.325 169.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.8 p -155.81 15.79 0.36 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 -179.19 4.85 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 128.004 2.522 . . . . 0.0 110.509 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -118.92 145.69 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.091 -1.006 . . . . 0.0 112.712 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -131.59 147.09 52.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.65 2.78 . . . . 0.0 108.808 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 5.3 t -138.01 150.42 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.442 1.097 . . . . 0.0 109.591 172.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.22 -168.73 20.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.36 -6.79 1.94 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.59 2.356 . . . . 0.0 114.646 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 51.76 2.31 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 122.747 1.261 . . . . 0.0 113.353 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.22 -20.34 69.14 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -67.89 -32.05 72.27 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.134 1.467 . . . . 0.0 113.213 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.94 -21.48 0.18 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -49.09 109.85 0.65 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 119.84 1.2 . . . . 0.0 115.081 -157.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -133.39 -25.58 1.72 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.678 1.991 . . . . 0.0 113.545 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 139.22 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 1 C-N-CA 132.787 4.435 . . . . 0.0 111.685 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -66.62 -44.11 82.93 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.814 0.734 . . . . 0.0 112.17 -163.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 1.5 pm0 -53.96 -34.82 60.77 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.8 mt -83.94 -37.74 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.469 1.107 . . . . 0.0 111.836 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -55.41 -36.5 66.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.941 1.297 . . . . 0.0 109.896 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.66 -54.79 5.33 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.04 -11.57 40.75 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -119.29 -30.66 4.87 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.369 1.068 . . . . 0.0 113.001 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.3 -31.5 50.34 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 119.509 1.049 . . . . 0.0 113.784 168.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -62.5 -41.02 98.54 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 172.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.87 -25.23 48.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.902 0.481 . . . . 0.0 111.955 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.62 -172.98 43.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.245 0.858 . . . . 0.0 115.245 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.69 131.03 17.86 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.643 2.895 . . . . 0.0 112.361 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.16 148.91 28.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.215 1.806 . . . . 0.0 109.478 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -123.83 -22.03 5.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.022 1.729 . . . . 0.0 113.188 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -164.29 153.15 13.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.034 1.334 . . . . 0.0 110.358 172.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.0 t -151.98 135.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.0 108.767 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -150.58 152.6 34.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.559 1.544 . . . . 0.0 111.137 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -146.54 146.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.991 -1.068 . . . . 0.0 111.472 172.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -66.42 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.994 . . . . 0.0 111.669 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.53 -178.87 0.22 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 130.315 3.446 . . . . 0.0 109.079 164.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -64.77 -28.17 2.72 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 79.5 Cg_endo -83.76 120.04 2.67 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 122.826 2.35 . . . . 0.0 110.345 143.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 109' ' ' PRO . 33.3 Cg_endo -87.39 -1.37 64.87 Favored 'Cis proline' 0 CA--C 1.55 1.281 0 CA-C-N 120.841 1.336 . . . . 0.0 114.462 -4.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.54 30.69 9.52 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.533 1.063 . . . . 0.0 113.271 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.5 139.39 49.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.183 1.793 . . . . 0.0 110.798 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -130.82 166.19 21.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.725 2.01 . . . . 0.0 113.74 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.97 142.12 34.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.237 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.27 1.3 m -141.45 178.85 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.291 1.043 . . . . 0.0 112.296 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.05 104.63 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.767 2.027 . . . . 0.0 108.07 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.417 ' CE1' HD21 ' A' ' 144' ' ' LEU . 5.7 m-85 -59.89 174.82 0.44 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.794 0.838 . . . . 0.0 112.584 155.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -115.72 -12.51 11.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.303 1.041 . . . . 0.0 112.71 164.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.91 140.76 21.38 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.052 1.341 . . . . 0.0 111.885 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.45 -37.59 0.94 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.694 2.93 . . . . 0.0 114.969 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -28.57 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.71 -1.244 . . . . 0.0 113.991 -159.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.23 -24.03 63.96 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.594 -0.691 . . . . 0.0 111.052 161.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 -47.16 66.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.807 1.243 . . . . 0.0 113.647 161.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.36 65.08 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 120.275 -1.516 . . . . 0.0 110.739 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -43.21 77.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 172.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.73 -8.62 2.16 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 166.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.48 -53.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.863 1.665 . . . . 0.0 110.743 157.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -59.86 -21.85 61.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.148 1.779 . . . . 0.0 112.882 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -107.51 -9.06 16.03 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.089 1.756 . . . . 0.0 111.537 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.12 -4.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -153.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -5.67 41.07 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.861 1.21 . . . . 0.0 113.763 168.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.75 46.89 0.53 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.418 1.485 . . . . 0.0 113.773 -159.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -132.19 177.97 7.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.155 0.982 . . . . 0.0 113.007 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.6 m -113.55 123.06 49.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.448 1.499 . . . . 0.0 109.129 168.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mp -129.52 145.59 51.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.007 2.523 . . . . 0.0 107.99 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.0 m 52.41 18.96 1.03 Allowed 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.96 60.18 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.277 1.418 . . . . 0.0 114.01 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.14 147.28 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.148 1.779 . . . . 0.0 111.226 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -52.58 148.07 7.58 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.99 152.01 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.316 . . . . 0.0 109.915 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 147.25 50.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.349 1.059 . . . . 0.0 108.342 167.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.48 158.15 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.308 0.643 . . . . 0.0 111.817 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -148.19 104.91 3.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.339 1.456 . . . . 0.0 107.584 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.417 HD21 ' CE1' ' A' ' 117' ' ' PHE . 5.0 tt -142.74 94.91 2.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.843 -0.536 . . . . 0.0 111.646 -151.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.8 t -166.76 140.55 3.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.549 0.69 . . . . 0.0 112.852 143.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -61.15 157.1 16.73 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 130.279 3.432 . . . . 0.0 111.148 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.67 -160.67 28.21 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.019 0.819 . . . . 0.0 111.486 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -162.9 165.42 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.316 1.046 . . . . 0.0 111.752 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.53 82.17 0.67 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.513 1.125 . . . . 0.0 111.2 153.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.407 HH12 ' HB3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 125.406 1.482 . . . . 0.0 110.41 168.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -155.65 162.07 40.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.632 2.773 . . . . 0.0 110.447 -8.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.51 109.68 8.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 160.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.3 ttmm -131.13 135.72 47.72 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 127.018 2.127 . . . . 0.0 109.18 -169.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -114.41 98.82 7.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.358 1.863 . . . . 0.0 108.554 162.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.36 124.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.903 1.681 . . . . 0.0 108.738 158.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.24 135.22 38.36 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.934 166.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -144.84 53.19 1.22 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.26 1.024 . . . . 0.0 109.078 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.83 175.8 21.74 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.739 1.188 . . . . 0.0 114.044 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -49.42 77.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 109.758 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -56.2 -52.1 65.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.931 1.692 . . . . 0.0 113.339 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.82 142.43 13.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.474 1.11 . . . . 0.0 110.649 -170.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.12 138.04 53.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.649 1.58 . . . . 0.0 110.256 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.52 -133.38 4.84 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.343 1.449 . . . . 0.0 110.138 -157.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -162.64 -169.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.146 1.778 . . . . 0.0 109.433 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -136.29 -45.26 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 158.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.8 p 55.94 164.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.281 1.432 . . . . 0.0 114.633 -159.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -155.46 -19.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.44 142.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 128.051 2.54 . . . . 0.0 116.062 -161.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.75 177.92 9.1 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.035 -1.666 . . . . 0.0 114.368 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.24 -39.28 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.258 1.823 . . . . 0.0 111.823 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -151.03 -8.06 0.25 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -146.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.39 27.09 15.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.287 1.835 . . . . 0.0 114.01 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.37 -38.31 0.61 Allowed 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 124.417 1.087 . . . . 0.0 111.039 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 95.1 m -64.53 -15.61 61.2 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.251 2.22 . . . . 0.0 112.453 155.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.95 7.21 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 110.8 165.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.35 -47.34 86.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 1.7 ptpp? -59.91 -15.75 24.11 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -171.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.5 -43.96 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.48 1.912 . . . . 0.0 111.034 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.7 -43.31 68.86 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.232 1.013 . . . . 0.0 112.753 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.4 mmpt? -40.97 -49.61 3.28 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.813 2.045 . . . . 0.0 112.111 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -94.92 -21.33 18.71 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.77 -37.75 74.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.051 0.841 . . . . 0.0 110.077 160.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.84 -39.16 27.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.524 -0.735 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.4 -23.18 61.06 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.245 -0.909 . . . . 0.0 111.539 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.06 -36.32 79.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.916 1.287 . . . . 0.0 113.374 164.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -69.33 -15.81 63.41 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.792 0.837 . . . . 0.0 112.73 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.35 25.54 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.638 1.59 . . . . 0.0 112.859 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -112.44 124.2 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 125.386 1.474 . . . . 0.0 112.225 -161.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.3 9.87 7.96 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.271 152.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 35.8 -134.98 0.56 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 128.189 2.804 . . . . 0.0 119.889 151.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -124.19 49.32 1.79 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.84 2.456 . . . . 0.0 106.673 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 20.7 m95 -42.75 104.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.285 1.834 . . . . 0.0 113.225 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 m -125.37 157.49 36.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 109.668 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -148.18 155.8 41.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.619 1.568 . . . . 0.0 111.335 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -134.73 130.46 36.26 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 126.106 1.762 . . . . 0.0 110.278 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -97.72 -18.16 18.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.461 1.104 . . . . 0.0 113.12 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.55 63.21 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.819 1.248 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -122.7 -2.79 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.574 1.549 . . . . 0.0 113.156 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.375 35.8 mttm 59.78 21.29 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.825 1.65 . . . . 0.0 114.321 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.4 m -73.69 160.06 32.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.746 2.418 . . . . 0.0 113.362 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -134.21 158.19 44.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 130.862 3.665 . . . . 0.0 110.705 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.3 m -146.88 133.73 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.187 0.595 . . . . 0.0 110.991 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.1 96.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 159.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.59 62.29 7.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.311 1.529 . . . . 0.0 112.612 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -69.19 -20.49 63.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.058 0.943 . . . . 0.0 113.477 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.62 88.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.322 0.963 . . . . 0.0 113.798 166.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -80.5 -38.55 29.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.633 1.173 . . . . 0.0 112.865 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 63.08 1.99 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 123.3 1.524 . . . . 0.0 113.273 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -60.16 -15.25 22.37 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.171 2.588 . . . . 0.0 115.193 170.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -47.99 121.39 4.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 111.073 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.31 107.13 2.71 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -156.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -146.83 -178.25 6.08 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.029 1.732 . . . . 0.0 112.328 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -51.31 -21.14 1.99 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -26.11 41.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 172.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -58.73 -47.42 84.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.5 mmp_? -121.58 84.34 2.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.509 1.124 . . . . 0.0 111.869 -164.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -140.38 153.89 46.52 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.069 2.947 . . . . 0.0 112.396 2.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.8 p -152.11 -45.02 0.11 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.777 1.631 . . . . 0.0 111.613 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.1 m -110.43 163.0 18.24 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.142 1.777 . . . . 0.0 109.674 154.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.9 -79.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.162 2.575 . . . . 0.0 114.877 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.32 33.18 0.29 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 120.411 1.46 . . . . 0.0 111.905 -175.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 60.08 -18.44 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.54 1.936 . . . . 0.0 114.471 -153.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 68.7 m -129.34 -80.55 0.56 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.553 1.941 . . . . 0.0 110.52 153.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 116' ' ' GLU . 20.2 tttt 177.09 -143.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 129.022 2.929 . . . . 0.0 107.402 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 115' ' ' VAL . 7.5 p -137.93 146.92 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 123.492 2.86 . . . . 0.0 116.714 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -140.57 156.97 46.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.922 2.089 . . . . 0.0 111.814 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -139.75 158.27 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 120.957 -1.09 . . . . 0.0 112.908 -176.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -170.31 -167.42 30.71 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 169.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.24 20.81 7.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.588 1.555 . . . . 0.0 115.036 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.55 51.42 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 111.716 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.41 -17.76 33.75 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.386 1.946 . . . . 0.0 115.895 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.47 -55.31 10.61 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.57 1.185 . . . . 0.0 111.467 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -131.94 -22.55 2.32 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 8.47 74.15 0.01 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.68 3.038 . . . . 0.0 117.839 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -135.27 162.79 31.56 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.415 1.107 . . . . 0.0 113.646 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -60.5 -43.84 96.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.596 1.558 . . . . 0.0 113.158 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -86.46 -29.77 22.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -163.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.81 -31.38 64.65 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.316 -1.49 . . . . 0.0 111.727 164.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.93 -22.25 22.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.044 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.13 -34.77 75.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.259 1.391 . . . . 0.0 109.359 167.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -80.2 -64.91 1.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.638 1.175 . . . . 0.0 111.206 174.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -4.28 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -123.6 -30.62 3.59 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.487 1.039 . . . . 0.0 112.18 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.98 -27.71 30.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.174 1.352 . . . . 0.0 115.189 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -55.03 -38.79 68.41 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.0 -16.97 54.06 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.18 -170.82 33.9 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.105 0.86 . . . . 0.0 114.741 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.27 101.91 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.13 3.22 . . . . 0.0 112.443 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.18 68.23 2.57 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.288 1.835 . . . . 0.0 111.808 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -12.43 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.076 2.15 . . . . 0.0 114.342 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.3 m -150.44 150.25 31.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.541 1.064 . . . . 0.0 110.819 161.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.14 116.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 110.143 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -146.43 147.11 30.91 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.34 1.856 . . . . 0.0 109.219 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.06 154.33 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.387 -0.821 . . . . 0.0 112.391 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.94 154.77 30.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.735 1.614 . . . . 0.0 111.902 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -112.09 25.1 11.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.782 1.233 . . . . 0.0 111.815 163.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 90.93 7.26 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 128.054 2.542 . . . . 0.0 107.513 164.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.32 159.33 85.15 Favored 'Cis proline' 0 CA--C 1.55 1.317 0 CA-C-N 120.244 1.123 . . . . 0.0 113.765 5.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -53.02 6.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.256 2 C-N-CA 127.119 5.213 . . . . 0.0 122.626 -159.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.43 58.78 0.02 OUTLIER Glycine 0 N--CA 1.474 1.18 0 CA-C-N 121.756 2.071 . . . . 0.0 113.539 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 61.2 m-85 -130.09 136.67 49.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.703 1.201 . . . . 0.0 111.213 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -132.44 156.59 46.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.62 1.2 . . . . 0.0 113.586 -167.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 136.88 54.29 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.444 1.498 . . . . 0.0 108.533 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -139.24 164.97 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.934 0.894 . . . . 0.0 111.373 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.437 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 44.7 mt-10 -144.34 142.33 30.31 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 109.526 170.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -119.2 140.57 49.98 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 156.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.4 29.16 0.3 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.259 -0.9 . . . . 0.0 112.94 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -152.79 137.83 11.15 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 126.083 1.753 . . . . 0.0 111.559 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.73 -51.35 9.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.553 3.502 . . . . 0.0 117.203 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.35 -14.61 22.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -160.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.31 -45.22 66.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.551 0.614 . . . . 0.0 110.536 165.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.74 77.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 111.935 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.97 78.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.44 -1.267 . . . . 0.0 110.849 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.55 -40.84 61.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.356 1.435 . . . . 0.0 113.172 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.02 -14.33 6.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.588 1.555 . . . . 0.0 114.03 166.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.6 -47.92 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 120.127 1.33 . . . . 0.0 111.699 161.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.84 -36.27 62.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.868 2.067 . . . . 0.0 112.987 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.19 -11.64 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.024 1.329 . . . . 0.0 112.516 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.09 -27.89 0.63 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -148.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -45.07 101.65 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.055 2.542 . . . . 0.0 112.114 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.4 27.01 73.31 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.075 -0.847 . . . . 0.0 114.568 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -97.16 -138.51 0.27 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.611 1.205 . . . . 0.0 111.452 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 138' ' ' CYS . 52.9 m -152.91 143.17 22.47 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.683 2.793 . . . . 0.0 108.346 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.53 -42.32 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 112.377 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 87.1 m -137.23 29.51 2.74 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.493 1.117 . . . . 0.0 112.744 -155.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.27 44.76 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.369 -0.832 . . . . 0.0 112.415 -170.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.421 ' H ' HG23 ' A' ' 134' ' ' THR . 31.6 p -129.4 -174.91 3.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.17 2.188 . . . . 0.0 112.314 -166.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 89.96 2.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 108.346 174.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.7 172.39 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.063 0.945 . . . . 0.0 112.756 -168.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.657 1.583 . . . . 0.0 108.932 151.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 t -136.7 134.66 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -130.37 149.24 52.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.186 0.995 . . . . 0.0 109.55 -171.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.93 148.64 49.05 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.004 -1.06 . . . . 0.0 111.14 152.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . 0.294 11.8 t 126.93 101.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.32 2.648 . . . . 0.0 114.734 144.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -149.02 6.48 0.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.464 1.505 . . . . 0.0 114.532 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -97.79 13.48 63.78 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.05 1.786 . . . . 0.0 112.104 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 -52.87 2.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 110.471 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.3 3.93 8.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.592 1.957 . . . . 0.0 113.431 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.492 0.187 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -152.21 169.24 22.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.144 2.578 . . . . 0.0 110.951 -7.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.86 105.37 8.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.95 107.21 8.55 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.716 0.807 . . . . 0.0 112.116 -164.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 54' ' ' VAL . 42.9 tp -97.63 92.39 5.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.625 1.57 . . . . 0.0 109.84 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.25 105.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.602 2.361 . . . . 0.0 109.203 162.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.557 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 mp -82.53 132.01 35.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.5 ' HB3' HG23 ' A' ' 55' ' ' THR . 67.5 m-20 -137.08 44.73 2.28 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.938 2.095 . . . . 0.0 108.183 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.85 51.34 Favored Glycine 0 C--N 1.338 0.685 0 O-C-N 120.439 -1.413 . . . . 0.0 115.451 -161.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -56.23 -48.03 77.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.856 1.662 . . . . 0.0 109.857 160.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m -78.99 -62.48 1.69 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.449 2.3 . . . . 0.0 113.849 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.87 145.01 34.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.511 1.124 . . . . 0.0 110.409 -166.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 119.98 21.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.549 1.94 . . . . 0.0 110.144 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.62 23.1 0.09 OUTLIER Glycine 0 N--CA 1.477 1.407 0 N-CA-C 119.898 2.719 . . . . 0.0 119.898 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 57.34 -176.46 0.06 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -150.79 -32.49 0.17 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p 59.22 163.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.3 t -161.5 -163.51 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.358 2.663 . . . . 0.0 106.994 157.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.12 138.7 35.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 120.092 -1.63 . . . . 0.0 108.924 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.04 -171.13 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 123.508 1.623 . . . . 0.0 112.887 -165.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.31 -22.69 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 112.474 -2.148 . . . . 0.0 111.343 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -140.28 -57.69 0.54 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 129.89 -30.55 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 131.138 3.775 . . . . 0.0 112.243 -162.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.9 -36.01 25.67 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.723 1.209 . . . . 0.0 110.293 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -76.19 -20.97 57.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.444 3.098 . . . . 0.0 112.447 167.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.47 -52.83 8.44 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.457 -0.777 . . . . 0.0 109.968 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -47.05 47.21 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 125.685 1.594 . . . . 0.0 108.596 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -20.29 16.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -170.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.94 -40.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.386 1.474 . . . . 0.0 109.629 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.1 m-30 -51.51 -46.0 63.1 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.56 1.144 . . . . 0.0 112.922 166.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.7 mmpt? -42.0 -46.84 4.28 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.572 1.549 . . . . 0.0 112.277 170.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -100.21 -19.08 16.57 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.29 -39.07 74.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.023 0.829 . . . . 0.0 110.51 156.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -85.04 -33.28 22.53 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.537 -0.727 . . . . 0.0 110.705 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -75.3 -22.12 57.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.0 1.273 . . . . 0.0 112.047 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.2 1.0 . . . . 0.0 112.649 163.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -64.84 -31.47 72.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.71 -0.618 . . . . 0.0 111.94 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.17 5.41 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.337 1.923 . . . . 0.0 113.698 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.03 134.01 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.506 1.922 . . . . 0.0 111.746 -163.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.41 12.24 3.81 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 157.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 2.06 -93.02 0.0 OUTLIER Glycine 0 N--CA 1.473 1.149 0 C-N-CA 130.114 3.721 . . . . 0.0 117.639 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -6.64 1.32 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.8 1.64 . . . . 0.0 111.988 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.493 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 30.0 m95 23.05 67.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.257 3.423 . . . . 0.0 116.254 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 m -75.33 153.63 37.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.331 1.062 . . . . 0.0 110.858 170.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -145.8 146.08 31.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.334 1.453 . . . . 0.0 110.363 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -134.62 56.14 1.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.296 1.038 . . . . 0.0 112.026 -155.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -40.56 -27.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 130.392 3.477 . . . . 0.0 119.034 -173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.33 -20.54 66.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.583 1.953 . . . . 0.0 112.505 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -128.93 -15.95 4.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.125 2.17 . . . . 0.0 113.058 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.344 36.3 mttm 65.47 14.39 9.44 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.211 3.004 . . . . 0.0 115.144 -170.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.4 m -53.76 159.07 1.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.951 1.7 . . . . 0.0 112.624 157.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.14 170.01 14.06 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 130.109 3.364 . . . . 0.0 111.07 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.4 m -147.09 153.63 40.18 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.009 -1.057 . . . . 0.0 110.525 159.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.49 113.77 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.443 0.64 . . . . 0.0 111.666 153.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 8' ' ' ASN . 2.0 m -106.12 114.8 29.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.697 0.799 . . . . 0.0 110.253 172.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -124.03 -22.32 4.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.708 1.203 . . . . 0.0 113.205 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.21 -45.58 0.04 OUTLIER Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.51 -0.744 . . . . 0.0 114.117 -174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 p 55.08 -18.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.204 2.601 . . . . 0.0 117.682 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -61.18 130.64 47.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.525 1.93 . . . . 0.0 113.068 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -106.74 55.6 0.66 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.764 3.626 . . . . 0.0 111.007 0.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -136.39 22.25 3.19 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.726 2.01 . . . . 0.0 111.728 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -67.2 -11.34 57.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -166.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -131.95 161.22 33.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.536 1.535 . . . . 0.0 111.594 169.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.9 m170 63.59 -51.15 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 129.155 2.982 . . . . 0.0 115.305 -172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . 0.302 3.1 ppp? 49.21 -14.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 130.188 3.395 . . . . 0.0 119.062 -172.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -116.42 -17.44 10.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.218 1.807 . . . . 0.0 113.447 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.4 tpt85 -140.75 55.32 1.58 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.892 2.077 . . . . 0.0 110.138 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.33 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 1 C-N-CA 132.174 4.19 . . . . 0.0 109.112 1.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -141.21 146.01 36.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 128.858 2.863 . . . . 0.0 108.1 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.18 176.3 0.86 Allowed Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.26 0.624 . . . . 0.0 110.484 156.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -61.86 -133.38 0.03 OUTLIER 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-O 118.111 -0.87 . . . . 0.0 112.759 -29.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 7.9 tt -37.5 -22.06 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 131.069 3.748 . . . . 0.0 117.216 -173.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.6 t0 112.47 -22.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 1 C-N-CA 133.659 4.784 . . . . 0.0 106.573 -155.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.9 m -128.71 -119.88 0.24 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 128.415 2.686 . . . . 0.0 107.661 160.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -144.63 179.64 7.16 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 131.256 3.822 . . . . 0.0 104.196 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . 0.282 4.5 p -122.74 146.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 125.071 3.578 . . . . 0.0 112.327 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -134.33 153.35 51.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.174 -167.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 11.2 t -135.9 153.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.408 1.083 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.98 26.87 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.272 0.939 . . . . 0.0 115.128 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 70.37 33.07 2.61 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.095 1.758 . . . . 0.0 113.549 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -112.8 160.86 17.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 114.039 -174.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.18 -30.54 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.857 1.694 . . . . 0.0 113.653 168.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -50.83 -36.48 37.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.733 2.413 . . . . 0.0 114.675 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.64 -50.66 0.24 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.114 2.166 . . . . 0.0 110.427 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.412 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -10.3 95.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.535 2.493 . . . . 0.0 116.316 -163.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -132.68 -29.91 1.48 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -168.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 pttp 135.26 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 1 C-N-CA 132.581 4.352 . . . . 0.0 110.578 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 m -69.46 -39.49 77.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.5 0.72 . . . . 0.0 111.525 -167.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -37.07 76.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.186 -0.947 . . . . 0.0 112.466 173.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.8 mt -79.96 -31.75 39.92 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.026 0.931 . . . . 0.0 111.856 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -57.93 -34.9 70.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.014 0.825 . . . . 0.0 110.016 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -91.75 -51.97 4.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.725 0.81 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.23 -28.28 66.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.959 0.904 . . . . 0.0 113.411 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.74 -25.98 13.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.535 0.734 . . . . 0.0 110.31 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.7 -34.14 20.58 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 126.547 2.023 . . . . 0.0 115.231 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -53.26 -37.82 62.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.041 0.921 . . . . 0.0 113.461 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -84.69 -12.01 54.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.009 0.923 . . . . 0.0 111.528 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.87 168.56 14.29 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.792 1.663 . . . . 0.0 113.042 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.68 117.02 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.96 2.44 . . . . 0.0 111.044 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.14 153.1 35.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.331 0.586 . . . . 0.0 110.602 168.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -124.31 1.33 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.737 1.615 . . . . 0.0 113.278 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -161.81 152.97 18.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.6 1.16 . . . . 0.0 109.913 147.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.5 t -153.56 124.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.449 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -152.0 149.1 28.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.956 0.902 . . . . 0.0 111.363 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -146.58 146.54 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -171.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.18 83.12 0.23 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.029 2.132 . . . . 0.0 111.454 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 25.68 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.586 2.754 . . . . 0.0 114.669 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.12 67.09 26.27 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 127.704 2.401 . . . . 0.0 109.936 -166.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.04 143.1 42.06 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.349 3.366 . . . . 0.0 115.7 -161.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.65 145.98 85.33 Favored 'Cis proline' 0 CA--C 1.548 1.222 0 CA-C-N 118.842 0.622 . . . . 0.0 112.052 -2.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.21 36.56 0.02 OUTLIER Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.408 2.432 . . . . 0.0 113.423 -2.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -142.96 149.35 38.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.494 1.118 . . . . 0.0 112.574 -155.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -129.67 164.37 24.09 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.435 1.894 . . . . 0.0 113.906 169.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.15 149.34 51.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.701 -1.59 . . . . 0.0 109.146 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.47 150.41 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 122.346 1.069 . . . . 0.0 111.769 -171.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -143.37 138.88 29.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.08 1.352 . . . . 0.0 110.466 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.77 -21.54 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.758 2.423 . . . . 0.0 112.78 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.272 8.9 tm-20 39.06 53.07 2.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 -153.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -150.95 137.15 11.08 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.514 1.525 . . . . 0.0 109.864 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.47 -45.06 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.913 1.742 . . . . 0.0 113.299 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.11 -54.61 10.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.898 1.279 . . . . 0.0 112.816 -165.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.86 -21.49 54.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.39 1.076 . . . . 0.0 113.406 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.55 -45.21 54.83 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.943 0.792 . . . . 0.0 112.387 169.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.98 74.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -45.46 72.74 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.65 -0.656 . . . . 0.0 112.054 173.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -6.82 3.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 114.4 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.92 -54.47 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.138 -0.977 . . . . 0.0 111.594 153.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -33.86 67.47 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.254 1.388 . . . . 0.0 114.23 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.55 1.73 23.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.051 1.741 . . . . 0.0 111.803 -163.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.45 -19.94 0.48 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.962 1.705 . . . . 0.0 113.594 -162.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -76.91 146.27 37.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.984 1.313 . . . . 0.0 113.236 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.01 37.8 81.51 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.183 0.897 . . . . 0.0 112.844 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.48 158.96 34.73 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.166 1.787 . . . . 0.0 111.702 -165.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 m -88.11 56.68 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 111.642 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.25 -28.86 65.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -160.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 70.1 m -142.48 22.5 2.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.047 1.339 . . . . 0.0 113.847 -162.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.04 11.32 70.03 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 120.341 -1.474 . . . . 0.0 113.217 -166.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 19.1 p -122.97 165.34 16.9 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.041 2.536 . . . . 0.0 107.806 164.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -89.36 102.0 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.77 163.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.981 1.313 . . . . 0.0 111.962 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -124.09 135.06 53.28 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.343 1.457 . . . . 0.0 107.357 162.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.42 138.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 108.585 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -139.82 172.11 13.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.002 0.921 . . . . 0.0 111.397 -166.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 165.7 24.16 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.713 -0.617 . . . . 0.0 112.353 156.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -130.32 -73.87 0.55 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -148.7 -78.38 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.808 1.185 . . . . 0.0 112.941 -170.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.07 120.23 0.03 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.876 2.655 . . . . 0.0 113.408 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -62.91 -7.04 4.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.82 -4.42 57.62 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.071 1.748 . . . . 0.0 115.288 173.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . 0.303 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 130.346 3.458 . . . . 0.0 118.471 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 tpp . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.494 0.188 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -156.59 170.18 22.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.862 2.865 . . . . 0.0 110.355 -11.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -132.7 124.6 28.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 136.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 34.2 ttmt -125.02 152.94 43.59 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 125.218 1.407 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.9 tp -129.21 100.77 5.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.806 2.843 . . . . 0.0 108.503 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.36 118.46 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 127.423 2.289 . . . . 0.0 109.054 158.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.3 mp -94.27 137.14 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -147.51 42.96 1.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.768 2.027 . . . . 0.0 109.282 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.01 -172.81 25.37 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.721 -1.237 . . . . 0.0 115.586 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -60.13 -45.13 94.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.041 0.924 . . . . 0.0 111.393 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -68.59 -60.49 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.833 2.053 . . . . 0.0 112.193 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.07 144.19 26.52 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.174 0.99 . . . . 0.0 110.355 -166.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -129.72 122.27 28.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.213 1.805 . . . . 0.0 108.649 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.07 23.92 0.12 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 119.006 2.363 . . . . 0.0 119.006 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.629 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER 59.65 -175.22 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.098 2.259 . . . . 0.0 117.098 175.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -145.22 -40.72 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 162.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 15.0 p 60.75 151.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 126.035 1.734 . . . . 0.0 115.405 -165.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.2 126.15 0.66 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.026 1.73 . . . . 0.0 106.747 163.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.69 148.65 33.03 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 121.848 -0.533 . . . . 0.0 110.692 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.82 176.35 11.14 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.07 -1.019 . . . . 0.0 112.814 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.79 -54.75 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.134 1.774 . . . . 0.0 111.428 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -165.18 174.53 10.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.045 1.738 . . . . 0.0 109.966 -158.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.73 -39.93 1.59 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.772 1.169 . . . . 0.0 110.699 -173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -71.32 -23.13 61.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.755 1.622 . . . . 0.0 112.129 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.36 -50.79 14.82 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 109.802 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -47.68 61.32 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.771 1.228 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -23.17 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -169.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.02 -36.97 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.22 1.408 . . . . 0.0 109.609 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -53.41 -45.52 69.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.444 1.098 . . . . 0.0 112.75 164.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.52 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.1 mmpt? -44.75 -53.97 6.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 111.224 168.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -72.21 -36.43 69.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.38 -41.58 94.07 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.655 1.116 . . . . 0.0 111.309 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -75.55 -38.38 59.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.0 -29.5 69.89 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.17 0.895 . . . . 0.0 112.235 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.08 -38.28 85.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 113.009 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -67.33 -12.96 61.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.667 0.787 . . . . 0.0 112.511 165.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.25 10.0 52.32 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.04 1.781 . . . . 0.0 112.756 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 57.7 t -100.08 128.04 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 125.93 1.692 . . . . 0.0 112.362 -161.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 68.18 1.31 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 125.074 2.369 . . . . 0.0 110.569 156.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.5 -153.14 0.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 109.696 -3.411 . . . . 0.0 115.15 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.99 52.66 0.72 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.768 2.827 . . . . 0.0 109.824 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.52 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 21.9 m95 -43.74 100.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.247 2.619 . . . . 0.0 112.916 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.3 m -125.95 162.2 25.76 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.38 1.872 . . . . 0.0 110.125 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -147.23 155.88 42.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.627 1.571 . . . . 0.0 111.536 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.42 129.76 35.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.715 2.006 . . . . 0.0 109.275 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.61 -18.11 23.5 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.13 61.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.079 0.951 . . . . 0.0 111.824 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -122.93 -2.15 8.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.242 1.817 . . . . 0.0 112.601 166.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.317 49.8 mttm 58.86 24.8 12.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.596 1.558 . . . . 0.0 113.372 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.2 m -79.22 157.22 27.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.523 2.329 . . . . 0.0 112.36 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.71 159.52 32.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.596 2.758 . . . . 0.0 109.658 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -145.15 132.79 20.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.09 -0.381 . . . . 0.0 111.274 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 3.1 m -112.87 100.52 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.983 0.897 . . . . 0.0 112.014 156.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 115.04 18.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 155.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.21 45.57 2.16 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 124.025 1.869 . . . . 0.0 109.335 170.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.84 59.75 0.06 OUTLIER Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.534 2.969 . . . . 0.0 108.168 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -23.04 89.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.994 3.318 . . . . 0.0 116.267 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t60 57.56 22.35 8.07 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.892 1.677 . . . . 0.0 115.361 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -137.66 156.27 48.22 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.656 -1.278 . . . . 0.0 114.064 -172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -96.93 49.12 1.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.22 2.608 . . . . 0.0 111.164 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -37.11 134.77 0.53 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.86 2.064 . . . . 0.0 115.509 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.06 -43.46 3.39 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.001 1.72 . . . . 0.0 113.253 -174.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -59.05 132.65 54.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -164.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.7 mtm 51.74 33.83 11.85 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.614 2.366 . . . . 0.0 113.925 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -158.97 -49.36 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -141.54 29.61 1.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.766 2.026 . . . . 0.0 111.6 -170.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.11 11.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 129.26 3.024 . . . . 0.0 117.689 -167.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.4 p -58.47 125.92 25.38 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.278 -1.514 . . . . 0.0 111.8 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 p -54.68 113.09 4.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.326 0.65 . . . . 0.0 111.568 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' HA3' ' A' ' 147' ' ' GLY . 4.3 Cg_endo -103.37 -10.67 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 121.687 1.591 . . . . 0.0 114.883 -158.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tt 60.68 -49.74 0.1 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.514 1.926 . . . . 0.0 114.581 -158.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.61 -26.38 21.66 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -148.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . 0.304 5.0 t -79.93 14.58 1.74 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' H ' ' H ' ' A' ' 146' ' ' ASN . 0.1 OUTLIER -166.25 149.68 7.39 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 117.202 -1.799 . . . . 0.0 112.005 117.376 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 115' ' ' VAL . 12.1 p -132.44 155.82 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 108.849 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -137.34 152.27 49.52 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.854 -1.154 . . . . 0.0 112.126 -162.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 t -138.98 149.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 110.207 -177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.62 38.11 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 3.2 t30 81.86 5.6 1.18 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.1 2.56 . . . . 0.0 113.918 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 61.51 5.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.389 1.476 . . . . 0.0 112.83 -167.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.23 63.95 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 114.649 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 114.234 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -136.16 -61.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.608 1.163 . . . . 0.0 111.076 -167.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.96 54.38 4.41 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.513 2.006 . . . . 0.0 114.556 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.09 -40.88 2.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -173.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 pttp 138.48 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 1 C-N-CA 132.461 4.305 . . . . 0.0 111.586 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.3 m -82.46 -26.12 32.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.13 0.877 . . . . 0.0 112.293 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -53.65 -35.14 60.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.78 -1.2 . . . . 0.0 112.321 159.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.71 -29.62 17.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.682 1.193 . . . . 0.0 113.129 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -60.08 -32.21 70.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.671 1.123 . . . . 0.0 109.301 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -85.23 -54.67 4.46 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.481 1.112 . . . . 0.0 112.51 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 -21.22 59.17 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.09 -29.47 8.53 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.013 0.925 . . . . 0.0 111.499 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -51.66 -36.47 40.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.632 1.111 . . . . 0.0 114.196 167.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -57.0 -36.02 69.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.51 -24.39 50.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.02 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.68 -169.54 34.54 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.69 106.54 2.13 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.881 3.054 . . . . 0.0 111.927 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.92 143.2 52.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.228 1.011 . . . . 0.0 111.22 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.1 ttp-105 -94.33 -35.19 12.51 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.172 1.389 . . . . 0.0 111.705 163.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -172.4 160.44 4.9 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.767 1.167 . . . . 0.0 111.011 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.8 t -151.31 134.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 107.846 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -146.06 148.45 32.67 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.297 1.839 . . . . 0.0 109.982 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.14 145.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 112.876 173.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 108' ' ' ASN . . . -80.48 -37.58 31.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.75 1.22 . . . . 0.0 114.044 -173.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 50.58 -1.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.074 2.549 . . . . 0.0 116.659 -165.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -140.52 99.52 7.0 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 127.673 2.389 . . . . 0.0 108.133 166.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.35 159.05 70.26 Favored 'Cis proline' 0 CA--C 1.549 1.252 0 CA-C-N 120.372 1.168 . . . . 0.0 114.47 9.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -53.44 6.59 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 1 C-N-CA 126.969 5.112 . . . . 0.0 121.865 -157.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.74 54.32 0.03 OUTLIER Glycine 0 N--CA 1.47 0.908 0 CA-C-N 122.162 2.256 . . . . 0.0 113.746 -172.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.52 135.67 48.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 0.0 111.063 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.465 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -137.12 162.6 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.515 1.926 . . . . 0.0 113.707 -168.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.74 156.23 47.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.504 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -158.53 160.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.163 . . . . 0.0 110.488 -162.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.56 154.34 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.66 1.584 . . . . 0.0 110.764 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -132.64 151.55 51.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.972 2.109 . . . . 0.0 111.681 -173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -84.62 -2.23 57.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.811 -1.18 . . . . 0.0 113.821 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.88 129.03 23.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.486 1.114 . . . . 0.0 111.608 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.23 -27.85 13.2 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.381 2.721 . . . . 0.0 114.043 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.98 -34.0 12.53 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.252 1.021 . . . . 0.0 110.875 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -68.93 -29.5 67.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.609 1.095 . . . . 0.0 112.895 164.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.44 -45.28 91.61 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.84 1.2 . . . . 0.0 111.802 165.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.92 89.12 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.614 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.33 -42.98 61.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.87 -12.31 7.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.552 1.141 . . . . 0.0 113.536 168.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 87.6 t -89.89 -52.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 119.408 1.004 . . . . 0.0 112.312 159.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -59.31 -25.5 64.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.327 1.851 . . . . 0.0 113.156 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.54 -7.37 34.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 112.162 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.59 -15.82 0.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -153.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -48.11 -23.74 0.92 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.314 2.246 . . . . 0.0 115.645 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -161.4 40.14 0.41 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.684 1.135 . . . . 0.0 114.199 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.25 34.5 ttp180 -113.42 -123.37 0.29 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.353 1.077 . . . . 0.0 112.283 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.5 m -161.07 142.39 11.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.372 1.869 . . . . 0.0 107.621 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.9 tp -138.38 -36.93 0.57 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -163.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.8 m -140.47 21.42 2.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.158 1.383 . . . . 0.0 113.216 -171.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.89 47.47 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.499 -0.751 . . . . 0.0 113.397 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 11.9 t -137.15 152.61 50.15 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 108.327 157.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HE ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 tmm_? -35.5 134.67 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.477 1.511 . . . . 0.0 109.902 150.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.18 157.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.195 0.598 . . . . 0.0 110.259 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -128.21 159.37 35.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.104 159.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.1 t -149.24 148.59 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.975 1.31 . . . . 0.0 108.493 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -138.53 175.8 9.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.122 1.369 . . . . 0.0 110.815 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.62 150.04 35.63 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -157.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t 92.22 123.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 130.333 3.453 . . . . 0.0 116.031 151.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.483 ' H ' ' H ' ' A' ' 75' ' ' LYS . 15.6 t-20 -134.6 -59.93 0.8 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.674 134.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.408 ' HA3' ' CG ' ' A' ' 71' ' ' PRO . . . 78.87 -4.38 61.53 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 118.95 2.34 . . . . 0.0 118.95 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -138.38 157.16 46.77 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.378 2.089 . . . . 0.0 113.224 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -95.88 131.1 42.56 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.24 2.616 . . . . 0.0 111.72 0.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 125.776 1.63 . . . . 0.0 111.513 164.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -143.46 162.29 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.177 2.591 . . . . 0.0 110.678 -3.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.35 111.33 12.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -138.21 99.69 3.93 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.765 0.826 . . . . 0.0 112.096 -163.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 34' ' ' ALA . 14.4 tp -87.54 90.76 8.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 119.021 0.828 . . . . 0.0 109.486 173.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -53.8 120.39 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 126.431 1.892 . . . . 0.0 109.056 159.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.41 128.77 38.38 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.012 168.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -144.1 59.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 111.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.15 152.13 18.01 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.136 0.874 . . . . 0.0 113.366 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -52.24 -29.84 24.77 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.811 1.244 . . . . 0.0 110.11 156.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 m -59.43 -55.39 35.21 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.981 2.513 . . . . 0.0 113.596 167.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.4 tm? -167.35 141.5 3.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.258 1.823 . . . . 0.0 110.123 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' N ' HD13 ' A' ' 12' ' ' LEU . 6.0 mtpm? -132.59 140.79 48.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.087 1.355 . . . . 0.0 111.922 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.7 -136.07 5.87 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 125.702 1.62 . . . . 0.0 110.586 -163.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -161.57 -169.66 2.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.352 2.261 . . . . 0.0 109.076 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -138.33 -43.32 0.5 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 160.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p 62.06 164.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.428 2.011 . . . . 0.0 116.428 -168.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -161.68 -167.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.64 2.776 . . . . 0.0 105.864 156.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -134.97 140.13 45.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.147 -1.595 . . . . 0.0 108.948 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.79 10.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 0.0 112.329 -162.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -61.48 -49.19 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 110.191 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -164.04 178.99 7.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 123.507 1.623 . . . . 0.0 111.611 -160.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 16.85 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.844 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 p -61.28 -25.46 67.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.252 1.821 . . . . 0.0 115.885 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 -46.87 12.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.112 0.415 . . . . 0.0 111.221 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.37 -47.5 85.2 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -58.89 -22.43 59.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.62 -47.21 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.045 1.738 . . . . 0.0 110.946 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -52.26 -43.1 64.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.61 1.164 . . . . 0.0 113.136 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 5.6 mmmm -46.81 -50.58 18.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.967 2.107 . . . . 0.0 111.409 171.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.84 -38.83 70.06 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.69 -36.68 83.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.108 0.867 . . . . 0.0 111.786 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -82.54 -26.54 32.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.35 -0.844 . . . . 0.0 111.95 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.3 -37.95 81.15 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.051 0.841 . . . . 0.0 111.744 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.44 -40.01 89.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.374 1.47 . . . . 0.0 112.396 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -66.74 -38.44 86.65 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.001 -0.437 . . . . 0.0 111.635 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.07 22.03 9.09 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.173 1.844 . . . . 0.0 113.88 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.31 -65.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.645 1.212 . . . . 0.0 113.021 -163.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.265 23.0 m-20 22.79 64.76 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 130.816 3.646 . . . . 0.0 113.816 -168.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.8 -134.94 6.55 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 108.872 -3.785 . . . . 0.0 113.106 -165.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.43 59.08 0.58 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.353 1.461 . . . . 0.0 109.46 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.445 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 5.7 m95 -50.84 100.2 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.933 1.693 . . . . 0.0 112.617 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.459 HG21 ' CG ' ' A' ' 62' ' ' HIS . 11.2 m -136.86 162.86 32.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.542 1.137 . . . . 0.0 111.557 -170.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 55.8 t80 -143.75 153.06 42.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.139 1.776 . . . . 0.0 110.867 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.46 77.79 1.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.367 1.467 . . . . 0.0 112.27 -168.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -22.86 23.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.5 64.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.5 1.92 . . . . 0.0 112.697 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -130.58 -4.91 4.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.824 1.25 . . . . 0.0 113.147 167.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.374 36.2 mttm 57.28 18.09 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.462 3.105 . . . . 0.0 114.748 -167.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -60.85 157.91 14.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.328 1.851 . . . . 0.0 111.538 165.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 37.7 m-85 -122.91 167.81 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.863 2.465 . . . . 0.0 110.942 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -149.73 146.17 27.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.598 -1.314 . . . . 0.0 110.665 167.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.86 88.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.232 1.013 . . . . 0.0 112.678 161.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 58.11 4.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.949 1.3 . . . . 0.0 113.34 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -29.37 59.5 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.785 -1.197 . . . . 0.0 113.204 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.2 -4.7 71.11 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.567 1.556 . . . . 0.0 115.109 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p 51.83 -172.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.966 1.706 . . . . 0.0 113.623 -164.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m80 56.9 19.54 4.61 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.97 54.0 1.22 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 128.47 2.708 . . . . 0.0 107.538 161.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.15 160.12 31.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 113.835 -165.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.459 ' CG ' HG21 ' A' ' 44' ' ' THR . 32.3 p-80 -49.9 157.46 0.61 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.377 2.271 . . . . 0.0 114.865 169.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 t60 42.92 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.508 2.323 . . . . 0.0 114.889 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -64.76 170.16 4.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.477 1.511 . . . . 0.0 112.888 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.461 ' HG2' ' HB1' ' A' ' 124' ' ' ALA . 10.9 tpt -77.36 65.32 2.9 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.455 1.102 . . . . 0.0 112.011 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -60.99 -9.82 4.89 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -167.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -153.79 153.89 32.99 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.981 1.264 . . . . 0.0 113.79 -169.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -154.61 -49.36 0.09 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 129.715 3.206 . . . . 0.0 112.743 -21.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.6 m -104.12 -12.83 16.51 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -158.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.3 p -155.21 152.34 24.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.988 1.715 . . . . 0.0 110.133 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.38 -61.71 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.875 1.717 . . . . 0.0 111.65 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -171.6 -57.4 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.887 1.675 . . . . 0.0 108.001 -171.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -143.28 -108.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.934 2.094 . . . . 0.0 108.651 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 18.7 p -141.65 -6.45 1.01 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.14 -175.92 5.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.193 1.397 . . . . 0.0 111.351 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 115' ' ' VAL . 66.5 t -117.42 138.6 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.846 1.657 . . . . 0.0 112.768 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -126.33 140.69 52.32 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.269 1.828 . . . . 0.0 108.632 158.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.94 135.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 108.915 175.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.27 -147.39 5.19 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.702 -0.623 . . . . 0.0 114.193 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.79 -6.12 0.45 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.918 1.687 . . . . 0.0 113.701 -152.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.1 mt -80.67 55.27 2.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.907 1.683 . . . . 0.0 112.264 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.37 42.15 0.4 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 127.788 2.613 . . . . 0.0 114.558 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -157.21 -50.3 0.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.11 2.564 . . . . 0.0 110.482 -167.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.09 -112.63 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.644 2.378 . . . . 0.0 108.182 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.21 69.08 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.486 1.993 . . . . 0.0 116.543 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.25 161.27 5.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.036 2.534 . . . . 0.0 113.639 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -34.82 52.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -71.46 -46.35 60.18 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.101 0.96 . . . . 0.0 112.939 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -33.05 75.03 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.886 -1.134 . . . . 0.0 111.406 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.8 mt -83.54 -36.08 24.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.114 0.965 . . . . 0.0 112.663 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -44.57 -42.87 7.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.456 1.103 . . . . 0.0 110.092 165.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -105.48 -39.57 6.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 118.32 -0.848 . . . . 0.0 112.645 -162.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.4 70.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.809 0.731 . . . . 0.0 112.092 168.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -95.12 -30.8 13.85 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.22 -35.44 6.72 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.996 1.284 . . . . 0.0 114.432 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -58.18 -37.15 74.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -81.27 -20.98 39.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 111.641 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.25 -173.49 33.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.65 0.643 . . . . 0.0 114.124 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.02 156.46 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.306 2.671 . . . . 0.0 112.457 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.51 143.49 50.86 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.089 2.556 . . . . 0.0 108.206 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -95.1 -32.75 12.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.905 1.282 . . . . 0.0 112.247 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 t -166.33 169.28 14.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.992 0.917 . . . . 0.0 111.954 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 t -159.89 127.0 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.279 3.032 . . . . 0.0 107.311 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -156.86 144.71 19.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.613 1.165 . . . . 0.0 111.943 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.14 139.86 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.682 -1.261 . . . . 0.0 113.004 -166.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.59 118.64 20.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.423 1.489 . . . . 0.0 109.569 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 2.67 29.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.76 151.58 92.23 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.2 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.31 143.6 75.46 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.373 2.715 . . . . 0.0 114.627 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.77 -44.78 0.35 Allowed 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.232 0.761 . . . . 0.0 112.37 -18.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.69 140.64 7.9 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.292 1.901 . . . . 0.0 112.937 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -155.82 158.48 38.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.575 1.95 . . . . 0.0 109.139 -166.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.72 156.78 35.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.379 1.472 . . . . 0.0 113.497 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -131.83 148.05 52.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.872 165.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 76' ' ' VAL 0.252 0.7 OUTLIER -143.64 -179.47 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.033 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -141.42 106.72 5.01 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 107.731 166.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.94 169.36 0.53 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 165.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.08 25.48 5.88 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.051 0.929 . . . . 0.0 113.244 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.93 132.23 10.25 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.616 -1.303 . . . . 0.0 110.295 160.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.8 -34.01 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.638 2.226 . . . . 0.0 114.639 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.07 -31.77 20.31 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.061 1.3 . . . . 0.0 112.289 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.52 -24.04 60.09 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 167.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.52 -51.04 62.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.533 1.06 . . . . 0.0 111.875 163.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 65' ' ' MET . . . -55.81 -32.11 63.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.607 -1.308 . . . . 0.0 110.998 173.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -43.25 55.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.77 -10.65 9.43 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 113.618 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.78 -62.23 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.893 . . . . 0.0 110.732 153.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -49.48 -33.63 14.86 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.672 1.989 . . . . 0.0 114.309 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.7 -13.52 16.45 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 112.193 -164.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.63 -33.09 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.545 1.138 . . . . 0.0 114.025 -161.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -56.75 139.34 51.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.901 1.28 . . . . 0.0 113.125 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.76 4.62 54.45 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.523 1.058 . . . . 0.0 114.898 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -117.38 -109.72 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.292 1.437 . . . . 0.0 110.703 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 m -143.92 153.61 42.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.569 1.547 . . . . 0.0 109.573 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.69 -44.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.029 0.932 . . . . 0.0 112.956 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.5 t -149.66 68.09 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.551 1.54 . . . . 0.0 110.713 -170.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.63 93.34 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.432 1.015 . . . . 0.0 114.651 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.0 p -145.59 -174.57 4.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 113.05 -159.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.7 136.77 51.89 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 153.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.82 163.03 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.227 1.411 . . . . 0.0 112.104 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -135.46 138.01 42.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.947 2.099 . . . . 0.0 108.659 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -139.11 137.05 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.463 0.705 . . . . 0.0 111.121 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -141.2 105.75 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.711 -1.243 . . . . 0.0 109.302 164.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tt -141.77 116.01 9.45 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.961 0.886 . . . . 0.0 110.926 -147.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.7 177.03 9.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.603 2.361 . . . . 0.0 113.407 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -153.41 104.95 2.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.349 2.66 . . . . 0.0 107.54 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.57 38.61 0.32 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.284 0.468 . . . . 0.0 112.53 -167.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.88 1.74 0.25 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.771 1.629 . . . . 0.0 115.214 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.256 8.2 tptp -130.86 50.04 2.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.164 1.386 . . . . 0.0 112.878 165.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 O-C-N 121.234 -0.916 . . . . 0.0 111.109 130.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -151.06 164.19 37.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 129.021 2.929 . . . . 0.0 110.886 -4.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.83 112.05 18.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 166.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -128.32 108.14 10.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.451 1.1 . . . . 0.0 111.906 -168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 54' ' ' VAL . 47.4 tp -95.23 98.77 10.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.073 1.349 . . . . 0.0 109.371 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.81 115.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.167 2.187 . . . . 0.0 108.888 163.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.8 mp -89.17 136.06 33.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.959 168.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -142.64 51.03 1.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.662 1.185 . . . . 0.0 108.501 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.85 176.36 25.97 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 122.504 1.058 . . . . 0.0 114.4 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -60.28 -40.95 92.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.065 1.346 . . . . 0.0 111.494 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -71.12 -48.63 51.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.639 2.376 . . . . 0.0 113.533 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.42 139.73 14.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.273 1.029 . . . . 0.0 110.482 -169.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -126.45 132.31 51.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.923 1.689 . . . . 0.0 109.79 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.39 -137.78 5.76 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.404 1.478 . . . . 0.0 110.334 -153.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.8 mt-10 -159.46 -161.22 0.9 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.897 1.679 . . . . 0.0 109.467 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -143.88 -42.34 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 156.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.6 p 55.97 164.41 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -158.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -160.31 -164.36 1.25 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.76 2.424 . . . . 0.0 106.364 156.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -140.35 130.62 25.13 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.697 1.599 . . . . 0.0 107.778 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.48 23.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -157.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 21' ' ' VAL . 1.8 t -64.71 -42.14 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.128 1.771 . . . . 0.0 111.825 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -144.31 -58.86 0.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -161.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 134.49 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 131.679 3.991 . . . . 0.0 111.659 -162.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -36.95 10.9 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.592 1.157 . . . . 0.0 109.749 -170.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -74.88 -17.22 60.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.04 2.936 . . . . 0.0 112.457 164.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.7 -54.6 5.71 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.717 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.07 -46.07 44.0 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 125.25 1.42 . . . . 0.0 109.087 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -20.94 13.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -171.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.56 -38.81 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.473 1.509 . . . . 0.0 109.788 -169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -50.38 -46.72 56.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.019 1.328 . . . . 0.0 112.326 163.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.4 mmpt? -43.8 -55.46 4.46 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.949 1.699 . . . . 0.0 112.024 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.07 -35.21 64.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -60.74 -39.94 90.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.445 1.02 . . . . 0.0 111.302 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 -32.4 38.01 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.181 -0.949 . . . . 0.0 111.168 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.22 -26.29 61.97 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.872 0.76 . . . . 0.0 112.554 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.7 -39.26 77.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 166.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -67.18 -50.58 60.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.197 0.599 . . . . 0.0 111.576 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.8 33.14 0.39 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.269 1.414 . . . . 0.0 113.844 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.77 134.2 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.785 1.234 . . . . 0.0 112.001 -168.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.72 -4.28 5.25 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.54 158.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.45 -127.17 4.61 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.317 1.913 . . . . 0.0 116.365 161.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.89 -14.56 39.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 112.118 171.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.525 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 26.0 m95 8.32 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.271 1.829 . . . . 0.0 114.694 -130.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -73.17 151.09 41.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.629 1.204 . . . . 0.0 110.141 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -154.19 142.52 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 109.961 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -104.76 -37.6 6.99 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 56.61 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.447 3.099 . . . . 0.0 117.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.64 -28.5 69.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.434 1.893 . . . . 0.0 111.965 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.2 p -125.08 5.03 7.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.158 1.783 . . . . 0.0 113.274 166.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt 57.55 -5.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 128.177 2.591 . . . . 0.0 116.81 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -39.57 150.45 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.055 2.542 . . . . 0.0 114.473 156.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -131.99 162.9 29.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 131.252 3.821 . . . . 0.0 110.645 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.0 m -148.79 141.3 24.33 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 167.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 5' ' ' LEU . 1.1 m -131.45 111.46 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.54 171.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 m -119.94 96.5 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.565 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.71 14.6 5.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.914 1.286 . . . . 0.0 113.972 172.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.36 38.06 0.57 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.479 1.99 . . . . 0.0 114.065 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 m -65.06 2.16 0.82 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.71 3.204 . . . . 0.0 115.579 -170.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -59.76 -22.73 62.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.328 1.051 . . . . 0.0 113.419 170.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 52.63 -10.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -140.84 7.13 2.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.909 1.684 . . . . 0.0 113.364 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.11 153.97 40.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.241 1.016 . . . . 0.0 112.905 174.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -82.56 46.68 1.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.858 1.663 . . . . 0.0 114.799 -166.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -69.56 33.91 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 O-C-N 120.688 -1.257 . . . . 0.0 114.235 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 tpp -77.81 53.43 1.14 Allowed 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.202 -2.186 . . . . 0.0 109.61 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -132.12 6.41 4.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.677 1.591 . . . . 0.0 113.311 -167.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.77 139.07 22.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.216 1.006 . . . . 0.0 111.591 168.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.72 -79.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.113 2.165 . . . . 0.0 113.201 -2.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 p -146.5 -59.66 0.3 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 65.7 m 57.06 -171.62 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 124.89 1.276 . . . . 0.0 112.447 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -130.0 -99.39 0.0 OUTLIER 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 122.089 1.782 . . . . 0.0 112.619 -6.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -128.72 -45.29 1.31 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.755 2.022 . . . . 0.0 109.557 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -149.78 -71.76 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 150.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.8 t -159.22 -18.12 0.07 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -157.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -179.18 7.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.845 2.058 . . . . 0.0 110.573 -172.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.76 143.87 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 120.877 1.672 . . . . 0.0 107.34 156.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.39 146.29 25.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.409 1.083 . . . . 0.0 110.941 -168.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 113' ' ' ALA . 18.3 m -141.14 157.41 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.222 158.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -165.16 14.86 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 114.836 0.694 . . . . 0.0 114.836 170.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER 76.01 -5.47 2.17 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 127.205 2.202 . . . . 0.0 113.262 -172.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.2 OUTLIER -94.63 46.24 1.14 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.639 1.576 . . . . 0.0 113.316 -150.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.36 -29.7 75.32 Favored Glycine 0 CA--C 1.537 1.466 0 N-CA-C 118.418 2.127 . . . . 0.0 118.418 -160.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -70.87 -35.01 72.18 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.239 2.019 . . . . 0.0 113.682 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.431 HD21 ' CD1' ' A' ' 81' ' ' LEU . 1.6 p-10 -129.35 -16.69 3.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.95 108.17 0.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -157.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -138.66 169.04 18.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.833 2.053 . . . . 0.0 111.003 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.87 -47.91 70.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.2 m -76.14 -30.93 58.35 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -160.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -58.76 -34.71 71.73 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.034 -1.041 . . . . 0.0 112.411 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.46 -35.14 40.79 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 111.778 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 100' ' ' LEU . 49.7 mt-10 -58.07 -29.46 65.44 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.442 0.697 . . . . 0.0 111.595 171.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.47 -48.94 7.54 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.01 -23.6 54.82 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -117.54 -19.04 9.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 113.25 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.28 -38.16 18.99 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.644 1.116 . . . . 0.0 114.048 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -55.94 -36.95 68.35 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.84 1.42 55.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.186 1.394 . . . . 0.0 112.29 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.34 166.77 12.32 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.773 1.178 . . . . 0.0 114.779 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.87 116.15 4.61 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.334 2.689 . . . . 0.0 111.505 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 91' ' ' GLU . 10.5 mp -63.83 138.58 58.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.466 0.651 . . . . 0.0 110.528 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -14.31 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.136 2.174 . . . . 0.0 112.665 -167.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -151.92 150.04 29.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.265 1.826 . . . . 0.0 108.539 159.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 100' ' ' LEU . 91.5 t -155.58 128.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.27 1.028 . . . . 0.0 110.987 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -150.21 148.25 28.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.12 2.168 . . . . 0.0 110.19 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.69 155.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.156 -0.965 . . . . 0.0 112.296 168.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -130.41 161.5 31.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.74 1.616 . . . . 0.0 112.718 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -111.38 12.34 21.56 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.033 1.333 . . . . 0.0 113.279 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -142.03 104.74 5.68 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.683 1.593 . . . . 0.0 108.568 157.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.74 153.05 16.41 Favored 'Cis proline' 0 CA--C 1.546 1.119 0 CA-C-N 120.792 1.318 . . . . 0.0 115.336 -1.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.55 84.32 0.99 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.469 3.446 . . . . 0.0 113.947 -166.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.07 53.73 1.85 Allowed Glycine 0 N--CA 1.466 0.685 0 C-N-CA 123.885 0.755 . . . . 0.0 112.585 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -124.99 129.43 50.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.97 1.308 . . . . 0.0 109.025 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -123.32 160.85 25.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.41 1.484 . . . . 0.0 112.228 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -141.34 148.89 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.387 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.99 171.95 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 -165.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.97 141.95 36.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 109.311 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -151.76 157.39 41.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.202 1.401 . . . . 0.0 110.701 150.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.77 47.4 0.88 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.053 0.93 . . . . 0.0 113.016 -148.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.0 142.33 24.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.409 1.884 . . . . 0.0 110.602 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.65 -28.47 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.085 2.523 . . . . 0.0 114.836 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.67 -57.49 3.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.96 1.255 . . . . 0.0 113.09 -164.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.4 -27.18 65.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.585 1.154 . . . . 0.0 111.647 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.21 68.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.96 -31.42 70.98 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.662 -1.274 . . . . 0.0 110.562 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.36 -45.83 82.58 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.769 -0.582 . . . . 0.0 112.55 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -15.9 54.88 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.2 t -79.27 -52.89 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.768 -1.208 . . . . 0.0 109.673 159.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -25.29 65.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.033 1.733 . . . . 0.0 115.017 -175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -97.37 -19.64 18.35 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.339 1.856 . . . . 0.0 112.018 -174.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 -18.1 0.34 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -148.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.69 130.28 37.53 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.149 -0.969 . . . . 0.0 113.285 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.25 86.54 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.076 1.322 . . . . 0.0 115.05 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -78.63 -161.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 128.028 2.531 . . . . 0.0 112.678 -173.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.9 m -112.8 137.52 51.0 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.716 1.606 . . . . 0.0 107.969 155.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.75 133.4 35.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 110.398 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 8.6 t 58.52 -55.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.983 2.513 . . . . 0.0 115.151 -170.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.58 18.24 0.05 OUTLIER Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.509 1.528 . . . . 0.0 115.432 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.2 p -151.38 159.82 44.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.999 1.399 . . . . 0.0 112.659 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -58.04 144.35 40.18 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.494 1.117 . . . . 0.0 110.475 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 2.5 p -128.88 159.59 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.243 1.417 . . . . 0.0 112.793 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.53 135.96 40.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 164.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -143.92 138.86 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.337 0.971 . . . . 0.0 110.917 -162.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -153.54 126.12 8.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.88 -1.137 . . . . 0.0 111.824 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -135.16 109.06 8.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 m 131.44 134.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 129.439 3.096 . . . . 0.0 114.693 134.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.518 ' H ' ' CA ' ' A' ' 147' ' ' GLY . 17.7 p-10 -154.38 -23.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.082 2.953 . . . . 0.0 115.36 -12.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.518 ' CA ' ' H ' ' A' ' 146' ' ' ASN . . . -158.78 -65.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 130.021 3.676 . . . . 0.0 112.109 -19.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -88.75 54.5 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.455 -1.027 . . . . 0.0 112.607 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 19.89 6.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.574 1.949 . . . . 0.0 113.203 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.323 0 C-N-CA 127.636 2.374 . . . . 0.0 112.517 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -152.42 162.56 41.02 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.15 2.58 . . . . 0.0 111.357 -6.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -131.76 112.85 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 157.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.2 ttmm -130.05 146.13 51.7 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 127.199 2.2 . . . . 0.0 108.885 -171.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 34' ' ' ALA . 24.6 tp -122.16 99.38 6.4 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.559 1.944 . . . . 0.0 109.305 162.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -62.12 130.31 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.759 1.624 . . . . 0.0 109.514 160.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.63 132.09 48.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.646 171.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -145.62 54.96 1.19 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.811 1.244 . . . . 0.0 111.296 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.52 179.89 17.78 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -73.67 15.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 128.499 2.72 . . . . 0.0 112.954 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -142.22 -57.34 0.45 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 127.533 2.333 . . . . 0.0 108.932 -144.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -156.6 146.77 21.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.869 2.068 . . . . 0.0 109.321 162.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -128.83 142.41 50.98 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.884 1.274 . . . . 0.0 111.828 167.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.66 -136.55 6.28 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 125.149 1.357 . . . . 0.0 109.985 -159.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -160.83 -158.92 0.63 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.483 1.513 . . . . 0.0 110.113 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -143.84 -47.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 154.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.9 p 57.09 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.774 1.63 . . . . 0.0 115.263 -158.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -157.93 -18.0 0.08 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.59 141.63 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.627 2.371 . . . . 0.0 116.942 -163.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.28 -164.24 1.97 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.354 1.461 . . . . 0.0 111.47 -174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.44 -15.76 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.407 1.883 . . . . 0.0 111.676 -163.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -145.22 -9.08 0.59 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.19 30.97 19.25 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.989 1.316 . . . . 0.0 113.337 -167.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.1 -37.52 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.765 1.626 . . . . 0.0 112.012 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.84 -24.61 66.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.51 2.724 . . . . 0.0 112.456 158.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.83 -53.82 9.38 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.85 -0.531 . . . . 0.0 109.813 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -49.96 -46.86 52.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 125.525 1.53 . . . . 0.0 109.229 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -54.88 -25.02 26.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.21 -40.32 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 109.146 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -50.72 -48.45 58.89 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.289 1.436 . . . . 0.0 112.431 165.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.6 mmpt? -43.8 -55.03 4.74 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.867 1.667 . . . . 0.0 112.089 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -73.52 -35.25 65.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -63.48 -41.23 98.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.863 0.756 . . . . 0.0 110.99 172.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -74.49 -36.4 63.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.314 -0.866 . . . . 0.0 109.926 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.33 -33.21 75.43 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.283 0.492 . . . . 0.0 111.543 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.78 -36.44 78.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.031 1.332 . . . . 0.0 113.603 169.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.59 -20.78 64.52 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.01 20.12 7.33 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.904 1.716 . . . . 0.0 113.385 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.3 t -120.59 123.03 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.942 1.297 . . . . 0.0 111.925 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.61 69.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 124.924 2.297 . . . . 0.0 108.897 155.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -149.98 0.24 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 109.413 -3.54 . . . . 0.0 114.046 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.88 24.38 0.4 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.371 1.868 . . . . 0.0 111.954 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 32.5 m95 -6.42 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.451 3.501 . . . . 0.0 115.368 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.9 m -103.4 158.68 16.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 109.298 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -137.14 143.76 42.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.591 1.556 . . . . 0.0 109.826 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.13 60.01 1.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.439 1.496 . . . . 0.0 110.012 -155.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.89 -25.71 0.83 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.608 3.163 . . . . 0.0 117.372 -172.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.88 -21.64 66.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.147 2.179 . . . . 0.0 112.559 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -131.27 -3.42 3.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.366 1.867 . . . . 0.0 112.86 168.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.299 35.6 mttm 54.94 20.03 2.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.415 2.686 . . . . 0.0 114.732 -169.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.7 m -60.34 165.04 3.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.754 1.621 . . . . 0.0 111.682 157.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -132.84 152.63 51.79 Favored 'General case' 0 C--N 1.324 -0.534 1 C-N-CA 132.327 4.251 . . . . 0.0 108.03 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -145.82 116.11 7.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.696 0.284 . . . . 0.0 110.247 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -96.98 88.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-O 122.144 0.973 . . . . 0.0 112.081 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -69.96 113.74 7.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.18 156.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -116.78 -20.27 9.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.511 1.125 . . . . 0.0 112.289 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.58 -3.83 62.53 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 121.212 -0.93 . . . . 0.0 115.224 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.3 p -33.23 -37.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 129.477 3.111 . . . . 0.0 118.041 -167.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -19.14 61.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.408 2.283 . . . . 0.0 114.122 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -159.19 -44.67 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.683 1.193 . . . . 0.0 112.55 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.29 62.12 0.93 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.169 1.787 . . . . 0.0 110.03 159.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -53.99 169.07 0.18 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.424 1.49 . . . . 0.0 114.741 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -66.38 -33.8 76.53 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.616 -1.303 . . . . 0.0 111.375 164.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.43 174.75 3.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.929 1.292 . . . . 0.0 111.917 164.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 58.6 mtp -56.27 133.47 52.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.987 -1.071 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -67.1 150.03 49.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.41 -0.806 . . . . 0.0 112.319 -166.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -0.21 50.94 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -121.63 -5.59 9.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.929 1.691 . . . . 0.0 114.773 -169.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -145.99 152.41 39.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.676 1.191 . . . . 0.0 112.243 -167.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.12 154.93 80.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.533 1.533 . . . . 0.0 108.241 160.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.71 -42.9 42.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.609 1.539 . . . . 0.0 111.164 168.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 145' ' ' SER . 8.8 tt -158.49 -50.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.501 2.32 . . . . 0.0 109.385 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.26 19.3 t70 135.92 136.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 1 C-N-CA 133.6 4.76 . . . . 0.0 111.464 161.384 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . 0.313 1.5 t 61.81 21.13 12.0 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 121.479 3.881 . . . . 0.0 121.479 154.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp 75.98 159.86 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 120.256 1.389 . . . . 0.0 109.176 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.511 ' CG1' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -95.91 150.65 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.098 -1.001 . . . . 0.0 111.357 -169.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -125.98 139.09 53.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.765 0.826 . . . . 0.0 110.098 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.64 136.29 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.413 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.94 31.96 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 121.524 -0.735 . . . . 0.0 114.672 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 63.63 17.6 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.474 1.11 . . . . 0.0 113.96 -170.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -33.91 76.89 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.163 -0.96 . . . . 0.0 111.622 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.79 -60.38 0.34 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.652 2.549 . . . . 0.0 116.215 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.57 -29.32 37.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.434 1.894 . . . . 0.0 112.957 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HB2' ' H ' ' A' ' 85' ' ' GLY . 1.1 p-10 -153.67 -153.65 0.48 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.703 2.401 . . . . 0.0 109.044 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 84' ' ' ASN . . . 131.18 -17.52 5.11 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 128.068 2.747 . . . . 0.0 112.58 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -37.37 74.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 132.421 4.288 . . . . 0.0 116.781 169.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' H ' HG11 ' A' ' 105' ' ' VAL . 55.2 tttm 52.11 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.626 3.171 . . . . 0.0 116.847 167.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.9 m -66.96 -26.86 67.04 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 121.07 1.759 . . . . 0.0 114.648 -158.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.73 -30.6 70.88 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.435 -1.416 . . . . 0.0 113.198 168.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.9 mt -90.83 -25.21 20.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.85 1.66 . . . . 0.0 111.998 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.41 -30.63 69.73 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.384 0.993 . . . . 0.0 109.81 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.87 -47.23 8.74 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.685 1.194 . . . . 0.0 113.085 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.76 -25.09 64.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.085 1.311 . . . . 0.0 113.373 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -105.24 -31.09 9.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.592 1.157 . . . . 0.0 110.943 174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.23 -32.92 44.7 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.345 1.45 . . . . 0.0 115.512 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -57.36 -39.49 76.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.329 1.064 . . . . 0.0 112.589 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -75.31 -25.9 58.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.865 0.466 . . . . 0.0 111.944 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.95 -176.5 40.71 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -174.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 147.6 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.851 3.034 . . . . 0.0 112.493 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mp -113.79 141.42 47.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.041 1.736 . . . . 0.0 110.671 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -114.94 -16.22 11.71 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.402 1.881 . . . . 0.0 114.434 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -159.68 150.96 19.72 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.065 1.346 . . . . 0.0 110.347 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.7 t -154.86 134.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 126.158 1.783 . . . . 0.0 109.81 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -153.79 158.55 41.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.493 1.517 . . . . 0.0 111.455 166.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -149.29 143.67 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.15 130.72 38.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.648 1.979 . . . . 0.0 111.059 166.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 -1.69 5.71 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.22 -46.68 85.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.333 158.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.81 173.85 13.29 Favored 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.071 2.514 . . . . 0.0 111.571 162.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -57.22 35.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.554 1.491 1 C-N-CA 126.663 4.909 . . . . 0.0 119.677 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.47 63.43 1.56 Allowed Glycine 0 N--CA 1.47 0.939 0 O-C-N 119.686 -1.884 . . . . 0.0 112.101 168.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -109.72 112.74 24.98 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.005 1.322 . . . . 0.0 109.961 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.02 158.06 16.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.554 1.169 . . . . 0.0 112.092 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -139.34 130.34 26.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.013 163.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.511 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.2 m -139.42 -178.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.689 0.795 . . . . 0.0 111.235 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -154.01 136.06 14.7 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.452 -1.405 . . . . 0.0 110.797 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.87 154.2 27.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.441 1.497 . . . . 0.0 112.548 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.88 -7.6 58.82 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.101 -0.999 . . . . 0.0 112.595 164.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.05 109.43 27.47 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.815 1.646 . . . . 0.0 110.805 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.75 -31.7 95.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.154 3.236 . . . . 0.0 115.718 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -73.66 -41.88 62.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 110.547 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.54 -30.28 71.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.802 0.728 . . . . 0.0 112.415 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.78 78.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.762 0.825 . . . . 0.0 112.189 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.25 74.12 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.496 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -49.97 48.17 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.68 -11.03 31.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.552 1.541 . . . . 0.0 114.465 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.28 -52.8 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 157.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -31.53 69.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.833 1.253 . . . . 0.0 114.089 -172.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.61 -0.8 20.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.634 1.574 . . . . 0.0 111.924 -163.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -23.64 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.577 1.551 . . . . 0.0 113.233 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.31 125.18 23.01 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.138 -0.977 . . . . 0.0 111.436 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.7 9.1 87.36 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -84.78 -176.23 6.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.319 1.448 . . . . 0.0 112.44 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.7 m -134.9 93.07 2.96 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.042 1.737 . . . . 0.0 108.806 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.59 -39.51 31.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.754 1.222 . . . . 0.0 112.686 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.402 ' CB ' HD21 ' A' ' 84' ' ' ASN . 76.3 m -144.49 46.1 1.4 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.822 1.249 . . . . 0.0 112.926 -162.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.31 72.58 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.139 -0.976 . . . . 0.0 113.119 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.5 p -112.04 -166.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.456 2.303 . . . . 0.0 111.862 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -147.03 53.07 1.08 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.2 1.0 . . . . 0.0 111.373 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.56 156.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 126.98 2.112 . . . . 0.0 113.936 -170.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.23 152.11 42.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.35 1.46 . . . . 0.0 110.183 158.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.2 t -144.51 128.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.891 0.876 . . . . 0.0 109.531 -162.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.7 170.51 8.72 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.026 1.73 . . . . 0.0 110.219 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -130.56 140.78 50.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.218 -1.552 . . . . 0.0 112.481 -145.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -174.67 -28.59 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 1 C-N-CA 132.068 4.147 . . . . 0.0 115.315 -7.254 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.19 129.98 4.55 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 119.694 -1.879 . . . . 0.0 113.064 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.62 102.46 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.043 0.83 . . . . 0.0 112.525 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.02 54.17 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.622 1.569 . . . . 0.0 110.934 162.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -105.26 149.6 25.86 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.189 1.796 . . . . 0.0 113.879 -161.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.254 1.339 0 C-N-CA 128.236 2.614 . . . . 0.0 110.565 162.488 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -80.17 94.36 6.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 97.22 4.35 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.385 -151.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -87.57 86.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.068 1.347 . . . . 0.0 109.903 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -56.33 101.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.351 2.261 . . . . 0.0 109.155 163.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.2 mp -78.99 136.09 37.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 165.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -145.33 54.8 1.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.721 2.008 . . . . 0.0 108.576 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.54 -177.91 21.82 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -171.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -51.11 -48.37 61.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.486 1.114 . . . . 0.0 110.608 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 m -74.79 -63.34 1.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.732 2.413 . . . . 0.0 113.679 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.57 141.69 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.252 1.021 . . . . 0.0 110.456 -168.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 96.6 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.752 2.021 . . . . 0.0 108.833 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.45 23.87 0.02 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 120.684 3.033 . . . . 0.0 120.684 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU 0.255 0.6 OUTLIER 54.61 -175.96 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.084 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -154.81 -32.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 164.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p 59.0 161.96 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.2 t -160.82 -162.07 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.331 2.252 . . . . 0.0 108.835 153.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -148.23 151.32 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 111.783 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.13 -177.67 6.06 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.355 1.862 . . . . 0.0 111.143 -167.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.37 -18.32 9.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 112.203 -2.271 . . . . 0.0 112.6 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -148.65 -9.01 0.36 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 23.13 13.49 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.111 1.765 . . . . 0.0 114.462 -168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.03 -38.47 1.1 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.309 1.844 . . . . 0.0 110.571 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.0 m -57.66 -21.21 38.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.356 1.862 . . . . 0.0 112.458 149.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.87 -47.65 16.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.264 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -48.03 80.42 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -68.22 -7.53 31.15 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -166.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.29 -38.22 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.76 2.424 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 18' ' ' THR . 18.1 m-30 -53.13 -43.01 66.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.679 1.127 . . . . 0.0 112.083 162.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -43.63 -56.18 3.89 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.061 2.144 . . . . 0.0 111.277 168.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.75 -34.69 67.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -57.94 -42.96 86.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.756 1.162 . . . . 0.0 110.952 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.95 -33.46 39.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.371 -0.83 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.3 -26.76 63.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.177 0.898 . . . . 0.0 112.528 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.48 -40.4 77.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.111 1.364 . . . . 0.0 112.638 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -64.62 -43.58 93.28 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.764 -0.585 . . . . 0.0 111.655 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 27.79 1.29 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.713 1.625 . . . . 0.0 114.095 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 139.86 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.276 1.83 . . . . 0.0 111.287 -168.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 6.28 4.03 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 157.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.9 -130.34 10.14 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.203 1.859 . . . . 0.0 116.55 159.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -92.86 -13.29 29.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.017 1.727 . . . . 0.0 111.759 167.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.497 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 47.3 m95 6.61 82.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.041 1.736 . . . . 0.0 115.68 -127.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 m -82.2 156.86 24.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.692 1.234 . . . . 0.0 110.642 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -148.31 151.48 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.191 1.797 . . . . 0.0 110.559 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 23.8 t70 -124.31 143.62 50.46 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.955 1.702 . . . . 0.0 109.065 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.24 -15.94 12.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.14 57.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.376 1.87 . . . . 0.0 111.638 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.0 p -120.12 -7.4 9.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.417 1.887 . . . . 0.0 112.65 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.378 35.6 mttm 65.27 12.69 8.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.519 1.528 . . . . 0.0 114.759 -174.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -54.56 153.84 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.36 2.264 . . . . 0.0 113.913 166.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -125.09 166.14 16.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.719 2.408 . . . . 0.0 112.318 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.5 m -151.75 139.16 19.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.421 -1.424 . . . . 0.0 112.086 167.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.0 89.06 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.055 1.342 . . . . 0.0 113.463 171.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -99.77 79.13 2.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.071 0.948 . . . . 0.0 112.643 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 124.498 1.119 . . . . 0.0 114.001 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.0 137.21 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 163.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -137.53 143.79 41.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.156 1.783 . . . . 0.0 109.822 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 23.1 t -138.06 145.23 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.267 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.81 -178.98 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.133 0.852 . . . . 0.0 115.193 161.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 72.84 13.65 5.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 115.418 -171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.5 OUTLIER -76.09 28.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.358 1.863 . . . . 0.0 112.102 178.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.14 -18.42 27.52 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 117.28 1.672 . . . . 0.0 117.28 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -89.69 -9.1 50.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.595 1.158 . . . . 0.0 113.901 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' LEU . 2.6 p-10 -154.65 -21.46 0.12 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -164.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.34 109.54 0.7 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -149.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -138.17 164.11 29.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.235 1.414 . . . . 0.0 112.057 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -67.93 -37.0 81.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.9 m -66.48 -48.11 70.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.186 0.994 . . . . 0.0 112.556 -169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.24 -37.63 80.95 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.678 -0.639 . . . . 0.0 111.69 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.96 -37.17 29.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.495 1.118 . . . . 0.0 112.319 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -47.43 -39.17 14.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.845 1.258 . . . . 0.0 111.338 169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -106.9 -26.98 10.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.335 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.3 93.7 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.688 0.677 . . . . 0.0 111.58 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -81.58 -35.24 30.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.819 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.06 -37.1 5.5 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.658 1.599 . . . . 0.0 114.863 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -59.45 -44.99 92.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.29 -23.68 40.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.525 0.73 . . . . 0.0 110.878 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.28 166.45 30.1 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.102 1.334 . . . . 0.0 113.869 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 153.16 56.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.34 2.693 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.64 122.12 46.07 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 109.176 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -74.75 -33.57 62.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.565 0.746 . . . . 0.0 111.454 166.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -142.67 157.5 44.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.303 0.502 . . . . 0.0 111.916 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.66 144.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.553 1.541 . . . . 0.0 110.825 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.11 151.24 17.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.919 1.688 . . . . 0.0 110.951 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.72 144.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 170.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 126.266 1.826 . . . . 0.0 112.181 175.714 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.36 132.32 56.61 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.975 1.71 . . . . 0.0 109.385 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -128.57 163.87 24.06 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.592 1.557 . . . . 0.0 113.865 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -140.82 147.06 38.44 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.833 165.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.98 177.93 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 121.102 -0.999 . . . . 0.0 111.995 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.33 102.79 4.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.326 1.05 . . . . 0.0 110.701 172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -70.22 165.11 22.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 110.605 140.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.02 -36.95 11.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.583 -0.698 . . . . 0.0 112.796 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.04 131.47 83.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.113 0.965 . . . . 0.0 112.313 -172.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.79 -8.99 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.429 2.753 . . . . 0.0 115.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -112.62 -41.42 3.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.347 1.859 . . . . 0.0 110.851 -160.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 -29.96 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.534 0.606 . . . . 0.0 111.225 159.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.01 70.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.777 0.831 . . . . 0.0 112.399 168.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.04 -30.41 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.07 -1.019 . . . . 0.0 111.226 170.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.02 -35.46 69.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.524 1.057 . . . . 0.0 113.693 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.95 -27.71 69.32 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.181 -1.575 . . . . 0.0 112.824 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.43 -37.26 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 119.205 -2.184 . . . . 0.0 110.926 165.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -62.46 -34.36 76.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.725 -1.235 . . . . 0.0 112.998 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -128.82 -14.33 4.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -158.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -17.07 7.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.203 1.001 . . . . 0.0 113.604 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -82.91 159.86 22.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.092 1.314 . . . . 0.0 112.24 165.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.78 5.47 88.51 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.601 1.096 . . . . 0.0 115.175 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.98 -137.64 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.933 1.693 . . . . 0.0 112.134 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 m -141.41 123.8 15.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.721 2.409 . . . . 0.0 108.616 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.58 131.85 56.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.195 1.398 . . . . 0.0 108.88 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 9.0 t 59.44 -58.14 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.656 2.382 . . . . 0.0 115.906 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.45 35.58 0.08 OUTLIER Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.0 1.285 . . . . 0.0 114.362 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.5 p -129.66 -163.57 1.31 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.85 1.26 . . . . 0.0 113.941 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -130.98 63.82 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.34 1.856 . . . . 0.0 109.558 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.82 161.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 130.012 3.325 . . . . 0.0 117.657 -165.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.87 149.15 41.58 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.922 1.289 . . . . 0.0 110.21 140.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.48 145.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.678 1.191 . . . . 0.0 110.12 -167.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 109.62 -179.39 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.385 0.612 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -136.51 100.3 4.32 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.92 116.08 14.31 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -157.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.9 tp -101.62 95.02 6.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.683 1.193 . . . . 0.0 110.432 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -55.65 108.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 128.122 2.569 . . . . 0.0 109.37 159.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.565 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.9 mp -86.08 139.85 30.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 167.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -147.82 47.77 1.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.419 1.887 . . . . 0.0 108.496 172.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.68 -169.94 23.57 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 -162.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -43.71 -31.89 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.953 2.101 . . . . 0.0 114.308 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -126.26 -44.59 1.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.773 1.629 . . . . 0.0 112.589 -148.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -154.7 142.85 20.3 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.705 1.602 . . . . 0.0 108.22 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -136.91 127.18 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.709 1.604 . . . . 0.0 109.084 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.59 31.82 0.26 Allowed Glycine 0 N--CA 1.477 1.404 0 N-CA-C 117.896 1.918 . . . . 0.0 117.896 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER 56.59 -177.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -144.73 -27.53 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p 61.83 161.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.439 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -164.57 -175.06 3.68 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.32 2.248 . . . . 0.0 108.561 163.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -142.68 134.44 26.81 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.894 1.678 . . . . 0.0 108.416 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.7 6.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.133 0.968 . . . . 0.0 113.514 -161.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 21' ' ' VAL . 27.5 t -47.57 -59.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.742 2.017 . . . . 0.0 111.052 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -172.96 177.94 2.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.005 2.122 . . . . 0.0 108.997 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.89 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.774 2.03 . . . . 0.0 113.735 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 -58.74 2.05 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -67.13 -29.98 69.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.169 1.788 . . . . 0.0 113.165 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.76 -46.61 29.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.829 -0.544 . . . . 0.0 110.468 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.33 -44.16 83.98 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -54.08 -28.76 41.2 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.67 -38.28 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.088 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HG22 ' A' ' 18' ' ' THR . 10.9 m-85 -54.94 -42.38 72.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -39.74 -53.72 2.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.909 2.083 . . . . 0.0 110.54 167.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -82.32 -31.47 29.89 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.581 1.952 . . . . 0.0 114.737 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.42 -41.75 98.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.349 0.977 . . . . 0.0 111.212 168.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -76.79 -36.75 56.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.278 -0.889 . . . . 0.0 109.855 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.35 -28.41 67.94 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.235 0.925 . . . . 0.0 112.501 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.9 -39.96 75.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 113.093 168.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -63.95 -34.26 77.57 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 121.707 -0.621 . . . . 0.0 111.957 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.59 17.92 5.45 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.128 1.823 . . . . 0.0 113.656 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 1.3 t -107.3 140.3 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.749 1.62 . . . . 0.0 111.956 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.08 -9.2 3.01 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.623 1.169 . . . . 0.0 113.132 156.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.14 -99.03 0.01 OUTLIER Glycine 0 C--N 1.34 0.805 0 C-N-CA 129.699 3.523 . . . . 0.0 118.767 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.86 11.13 3.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.377 1.871 . . . . 0.0 110.298 -167.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.41 ' CE3' HG13 ' A' ' 54' ' ' VAL . 10.6 m95 -16.62 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.937 2.495 . . . . 0.0 115.502 -156.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -116.89 163.29 16.41 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.744 1.618 . . . . 0.0 110.944 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -145.63 157.69 43.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.964 2.106 . . . . 0.0 111.11 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -135.7 125.79 26.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.572 2.349 . . . . 0.0 110.479 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.24 -21.07 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.78 60.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.659 0.784 . . . . 0.0 112.23 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.1 p -136.71 -2.39 2.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.428 1.491 . . . . 0.0 113.033 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.355 34.6 mtpt 65.16 17.54 11.08 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.904 2.482 . . . . 0.0 113.787 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -66.96 159.44 28.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.994 2.918 . . . . 0.0 114.478 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -122.14 164.53 17.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 130.056 3.342 . . . . 0.0 112.779 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.4 m -150.14 143.89 25.34 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.64 -1.288 . . . . 0.0 112.527 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -127.51 128.65 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.216 1.006 . . . . 0.0 112.939 160.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -132.61 100.6 5.01 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.259 1.824 . . . . 0.0 110.748 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -174.347 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 115' ' ' VAL . 43.9 t -109.0 142.02 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 120.651 -1.281 . . . . 0.0 108.455 161.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.29 133.7 24.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.706 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 142' ' ' VAL . 50.9 t -137.69 148.58 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.419 0.688 . . . . 0.0 109.624 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.37 -166.9 20.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 60.99 14.65 5.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.917 1.687 . . . . 0.0 113.737 -157.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.66 46.37 1.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.01 1.724 . . . . 0.0 113.3 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.96 93.82 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.923 -1.11 . . . . 0.0 115.569 -166.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.82 -35.57 78.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -167.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -146.06 -28.31 0.42 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -163.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.68 111.89 1.06 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.599 0.618 . . . . 0.0 113.757 -155.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -129.05 -31.22 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 116.516 -1.707 . . . . 0.0 113.898 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.8 tttm 153.12 -60.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 129.374 3.07 . . . . 0.0 112.876 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.8 m -74.16 -26.14 60.13 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -161.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -26.65 65.77 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.873 -1.142 . . . . 0.0 113.682 167.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.8 mt -89.48 -34.55 16.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.966 1.306 . . . . 0.0 111.564 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -54.35 -35.39 62.7 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.747 -0.596 . . . . 0.0 112.321 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -88.06 -42.33 12.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.29 -30.24 64.55 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.037 1.29 . . . . 0.0 113.16 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -106.86 -22.91 12.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.968 0.907 . . . . 0.0 112.102 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.7 -35.11 7.36 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.039 1.78 . . . . 0.0 114.383 161.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -53.6 -42.58 67.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.641 1.176 . . . . 0.0 113.18 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -85.29 -24.52 27.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.878 0.871 . . . . 0.0 110.895 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 124.81 -74.13 0.41 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 153.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.5 43.98 1.6 Allowed 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.269 3.312 . . . . 0.0 114.831 -158.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.84 154.28 15.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.439 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -139.13 -20.9 0.96 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.047 1.739 . . . . 0.0 113.314 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -163.95 149.7 11.01 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.758 0.823 . . . . 0.0 110.812 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -151.1 121.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.091 1.756 . . . . 0.0 107.986 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -148.19 150.59 34.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.317 1.447 . . . . 0.0 110.304 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.51 157.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.718 -1.239 . . . . 0.0 113.582 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 126.487 1.915 . . . . 0.0 113.055 -173.6 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 CA-C-O 117.961 -1.466 . . . . 0.0 116.597 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.93 145.94 40.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.844 1.822 . . . . 0.0 114.048 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 161.9 35.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.451 3.1 . . . . 0.0 113.287 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.3 144.0 23.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.24 1.416 . . . . 0.0 110.731 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG13 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -152.36 174.51 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.137 -0.977 . . . . 0.0 110.93 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.34 120.44 13.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.085 1.354 . . . . 0.0 109.588 167.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.73 159.78 20.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.338 1.055 . . . . 0.0 110.046 153.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.82 -22.61 31.71 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.427 -1.421 . . . . 0.0 114.276 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.92 136.7 29.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.733 0.813 . . . . 0.0 112.678 -162.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.4 -33.67 17.46 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.934 2.423 . . . . 0.0 114.827 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -41.1 44.43 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.728 1.604 . . . . 0.0 113.444 -166.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.17 -26.82 60.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.701 0.682 . . . . 0.0 112.36 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.22 -45.13 67.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.368 0.667 . . . . 0.0 111.809 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.24 81.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 120.685 -1.26 . . . . 0.0 110.322 172.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -39.82 78.42 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.96 -17.99 58.85 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.904 -1.122 . . . . 0.0 113.914 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 -53.08 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.548 -1.345 . . . . 0.0 110.004 160.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -61.06 -24.47 66.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.168 1.787 . . . . 0.0 113.97 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.86 -8.21 15.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.158 1.383 . . . . 0.0 112.091 -168.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -152.07 -30.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -154.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -63.99 132.95 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.913 0.779 . . . . 0.0 111.772 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.35 79.15 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.749 0.69 . . . . 0.0 114.323 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -111.56 -117.43 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.325 1.45 . . . . 0.0 110.114 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -154.33 148.88 26.3 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.495 1.498 . . . . 0.0 110.257 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.83 -48.4 0.46 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.6 m -134.52 35.97 3.17 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.212 1.405 . . . . 0.0 112.163 -167.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.22 24.76 67.81 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.335 -0.853 . . . . 0.0 113.165 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.8 p -134.41 144.47 48.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.878 2.071 . . . . 0.0 110.755 -172.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -75.49 67.75 2.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.406 1.082 . . . . 0.0 111.133 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 p -54.67 151.54 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.844 2.057 . . . . 0.0 113.943 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.3 132.61 35.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.275 1.83 . . . . 0.0 109.434 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 78' ' ' VAL . 4.9 t -148.63 129.91 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 117.973 0.351 . . . . 0.0 111.209 -152.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.477 0.904 0 O-C-N 119.954 -1.716 . . . . 0.0 111.629 167.388 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.91 110.46 10.81 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.39 101.83 5.31 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.023 0.929 . . . . 0.0 111.488 -165.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.922 0.889 . . . . 0.0 109.851 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.6 mt -59.53 113.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.576 2.35 . . . . 0.0 109.37 160.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.04 136.6 32.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.744 164.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -144.02 42.84 1.44 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.84 2.056 . . . . 0.0 107.403 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.49 173.99 33.08 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 120.743 -1.223 . . . . 0.0 113.865 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -58.69 -42.15 87.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.619 0.723 . . . . 0.0 112.029 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -69.49 -62.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.641 2.376 . . . . 0.0 112.48 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -141.55 140.09 33.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.928 0.891 . . . . 0.0 110.801 -166.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 103.95 7.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.228 2.211 . . . . 0.0 107.884 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.3 95.95 0.16 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.619 1.581 . . . . 0.0 112.49 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -28.58 160.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.751 2.82 . . . . 0.0 118.024 166.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -135.47 -25.03 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 11.3 p 57.07 162.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.552 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.1 t -164.14 -171.94 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.31 3.044 . . . . 0.0 108.222 169.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.35 136.28 27.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 109.282 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.43 177.45 10.59 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.136 0.97 . . . . 0.0 113.453 -164.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.18 -56.56 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.503 1.921 . . . . 0.0 111.214 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -174.36 -174.85 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.196 2.998 . . . . 0.0 107.464 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.92 24.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.932 2.093 . . . . 0.0 114.941 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.01 4.18 7.98 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.39 1.076 . . . . 0.0 112.117 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.6 m -126.4 -22.22 4.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.245 1.818 . . . . 0.0 111.389 168.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.3 11.43 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 121.362 -0.837 . . . . 0.0 111.315 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.4 -45.63 90.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -51.53 -22.34 3.12 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.51 -39.02 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.724 1.61 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -55.57 -39.38 70.59 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 169.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -57.23 3.14 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.999 2.12 . . . . 0.0 110.074 168.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.91 -35.22 64.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -61.48 -40.31 94.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.362 0.983 . . . . 0.0 111.132 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -78.06 -37.03 47.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.58 -0.7 . . . . 0.0 109.85 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -69.92 -25.92 63.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.756 0.707 . . . . 0.0 112.258 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.96 -36.57 69.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.103 1.361 . . . . 0.0 112.809 168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -63.91 -31.18 72.27 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.707 -0.62 . . . . 0.0 111.566 164.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.59 -3.18 15.43 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.811 2.148 . . . . 0.0 113.038 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.6 t -81.01 127.9 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.251 1.82 . . . . 0.0 111.358 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -143.76 82.65 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 124.184 1.945 . . . . 0.0 108.305 152.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.95 -136.43 9.11 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 110.328 -3.124 . . . . 0.0 112.777 -155.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.78 39.75 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 127.865 2.466 . . . . 0.0 110.785 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CD2' HG13 ' A' ' 54' ' ' VAL . 32.6 m95 -37.8 98.2 0.01 OUTLIER 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.053 2.541 . . . . 0.0 112.902 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.6 m -116.61 157.93 24.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.25 1.82 . . . . 0.0 108.385 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -141.95 146.38 35.58 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.83 1.252 . . . . 0.0 109.952 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.42 54.36 1.96 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.855 1.262 . . . . 0.0 110.607 -156.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -41.56 -31.16 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.948 3.299 . . . . 0.0 117.253 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -20.93 59.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.268 1.827 . . . . 0.0 112.601 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -133.2 5.1 3.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.26 1.824 . . . . 0.0 112.894 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.293 46.6 mttm 49.8 13.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 129.404 3.081 . . . . 0.0 116.519 -168.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 m -47.51 158.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.974 2.51 . . . . 0.0 113.505 156.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.4 160.91 30.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 129.439 3.096 . . . . 0.0 111.383 168.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.5 m -145.62 124.32 12.57 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.291 -0.88 . . . . 0.0 110.896 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.85 100.67 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.857 0.837 . . . . 0.0 112.293 160.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.37 131.83 37.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.11 0.957 . . . . 0.0 110.123 157.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 112.449 161.901 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 118.547 -0.74 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.5 135.28 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 121.274 1.852 . . . . 0.0 111.953 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.21 118.1 9.97 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.504 1.922 . . . . 0.0 108.589 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.81 143.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.26 -170.11 41.37 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 23.5 t30 119.94 -13.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 131.646 3.978 . . . . 0.0 110.995 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.2 -27.43 63.89 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -165.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.68 -27.02 0.28 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.782 2.135 . . . . 0.0 117.662 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.46 -13.61 12.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.858 1.663 . . . . 0.0 112.793 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -169.77 -177.79 2.78 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.231 2.612 . . . . 0.0 109.059 -163.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.91 15.79 0.25 Allowed Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.978 -0.901 . . . . 0.0 114.819 164.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -49.38 163.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.36 3.064 . . . . 0.0 113.987 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -59.31 -35.88 74.62 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.403 -0.811 . . . . 0.0 112.662 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.7 m -92.15 -32.56 15.07 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.587 1.085 . . . . 0.0 113.87 -168.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.48 -31.73 69.61 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.432 -1.418 . . . . 0.0 111.728 165.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.85 -28.01 20.67 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.123 1.156 . . . . 0.0 114.123 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.56 -33.19 71.11 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.607 1.548 . . . . 0.0 109.154 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -82.3 -47.23 12.64 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.487 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.42 -28.46 65.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.161 0.891 . . . . 0.0 112.874 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.57 -37.58 8.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.743 0.817 . . . . 0.0 112.672 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.82 -36.91 3.81 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.263 1.887 . . . . 0.0 114.978 167.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -55.03 -45.65 75.19 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -75.06 -35.65 61.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.141 0.577 . . . . 0.0 110.401 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.56 178.45 40.75 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.507 1.051 . . . . 0.0 115.473 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.4 155.73 63.21 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.053 3.169 . . . . 0.0 114.822 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.56 148.26 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.746 2.418 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -103.55 -37.82 7.4 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.648 1.979 . . . . 0.0 112.759 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -161.38 157.81 25.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 p -167.6 131.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.46 1.104 . . . . 0.0 112.155 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -155.48 159.32 39.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.288 1.835 . . . . 0.0 111.317 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.91 157.67 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.223 -1.548 . . . . 0.0 113.431 -171.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 125.513 1.525 . . . . 0.0 113.665 -178.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.779 0 CA-C-O 118.363 -1.243 . . . . 0.0 115.201 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.72 132.62 21.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.671 1.236 . . . . 0.0 112.773 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.88 163.05 28.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.854 2.462 . . . . 0.0 113.379 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -135.61 138.71 43.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.01 1.724 . . . . 0.0 109.23 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.283 2.0 m -146.9 -177.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.234 -0.916 . . . . 0.0 112.404 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.09 117.31 10.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.733 2.013 . . . . 0.0 107.196 162.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.06 -174.87 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.002 1.321 . . . . 0.0 114.067 165.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -124.12 -8.54 7.67 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -149.58 123.37 4.56 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 120.562 1.528 . . . . 0.0 113.01 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.64 -24.32 48.19 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.271 2.648 . . . . 0.0 114.934 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -63.06 -55.08 28.55 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.765 1.166 . . . . 0.0 110.451 172.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.73 -34.06 76.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.014 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.09 92.26 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.32 80.59 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.549 -1.344 . . . . 0.0 110.27 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.94 -42.52 48.45 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -14.28 41.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.83 1.252 . . . . 0.0 114.084 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.17 -60.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.396 0.998 . . . . 0.0 109.705 155.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -19.92 62.29 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -160.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -98.34 1.64 47.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.276 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.05 -31.13 0.5 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -159.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.48 104.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.317 1.447 . . . . 0.0 110.671 156.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.12 24.15 25.44 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.42 -1.211 . . . . 0.0 114.76 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -116.59 164.18 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.583 1.691 . . . . 0.0 112.985 -168.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -95.4 128.35 42.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.513 1.525 . . . . 0.0 110.844 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.1 -12.79 11.89 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.153 1.381 . . . . 0.0 114.344 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.32 -65.31 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.985 0.914 . . . . 0.0 111.811 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -165.69 32.8 0.23 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.756 2.122 . . . . 0.0 111.059 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 3.7 m -142.77 -158.9 0.91 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.198 2.199 . . . . 0.0 109.192 -158.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -149.26 153.43 37.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.128 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -137.81 160.66 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -165.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.61 142.64 41.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.492 2.717 . . . . 0.0 109.55 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.37 125.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.565 -0.71 . . . . 0.0 110.907 -152.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 126.965 2.106 . . . . 0.0 106.96 168.841 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.015 0.435 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.15 106.6 9.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.49 99.82 4.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.177 0.991 . . . . 0.0 111.496 -163.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.09 95.64 10.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.335 1.054 . . . . 0.0 108.952 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.38 117.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.625 1.57 . . . . 0.0 108.912 160.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -93.22 129.63 39.19 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.655 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 69.8 m-80 -143.18 109.51 5.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.84 177.47 27.05 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 121.803 0.669 . . . . 0.0 114.617 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.952 1.301 . . . . 0.0 110.655 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.3 m -63.12 -55.87 21.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.634 2.373 . . . . 0.0 113.216 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -165.08 144.21 6.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.792 1.637 . . . . 0.0 109.687 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -131.73 150.24 52.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.885 1.274 . . . . 0.0 112.459 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.14 -134.64 4.51 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.957 1.742 . . . . 0.0 111.294 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.4 mt-10 -161.25 -166.6 1.58 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.22 2.608 . . . . 0.0 107.801 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -145.9 -39.68 0.23 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 161.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p 57.62 163.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -165.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -159.96 -169.36 2.5 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.592 2.357 . . . . 0.0 106.754 153.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -137.92 132.02 31.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.289 -1.507 . . . . 0.0 108.146 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.84 -178.72 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.147 0.979 . . . . 0.0 112.417 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -44.41 -57.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.677 1.991 . . . . 0.0 110.809 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -178.97 -164.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 129.521 3.128 . . . . 0.0 108.751 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 20.47 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.178 2.191 . . . . 0.0 115.189 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.24 5.13 5.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.442 1.097 . . . . 0.0 112.233 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -125.63 -14.62 6.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 111.713 161.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.46 7.34 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.453 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.25 -47.88 65.51 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -56.37 -19.43 14.69 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.6 -168.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.67 -34.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.712 1.605 . . . . 0.0 110.296 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -54.08 -44.67 71.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.701 1.2 . . . . 0.0 112.071 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -43.48 -56.49 3.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.326 1.85 . . . . 0.0 111.564 168.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -75.23 -31.51 60.87 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.034 0.834 . . . . 0.0 111.134 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -35.07 57.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.346 -0.846 . . . . 0.0 110.013 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -66.73 -31.09 71.52 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.003 0.819 . . . . 0.0 112.173 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.59 -38.31 80.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.016 1.326 . . . . 0.0 113.168 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.99 -33.15 74.94 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 121.682 -0.636 . . . . 0.0 112.525 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.28 27.12 2.28 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.894 1.711 . . . . 0.0 114.021 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.359 1.463 . . . . 0.0 111.88 -165.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.78 3.89 6.05 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 121.818 0.818 . . . . 0.0 112.243 152.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.71 -112.12 0.98 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.181 2.324 . . . . 0.0 118.396 150.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -147.33 37.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.972 2.509 . . . . 0.0 107.223 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 18.4 m95 -40.67 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.497 1.519 . . . . 0.0 114.152 -160.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 m -125.08 160.2 29.63 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.918 1.687 . . . . 0.0 110.012 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -148.15 154.03 39.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.598 1.559 . . . . 0.0 111.151 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 19.5 t70 -129.88 139.6 51.13 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 126.361 1.864 . . . . 0.0 109.18 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -108.38 -16.83 14.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.31 -26.42 61.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 111.856 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.3 p -122.28 -6.9 8.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.429 1.891 . . . . 0.0 112.953 167.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.421 45.1 mttm 66.13 12.63 8.64 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 126.992 2.117 . . . . 0.0 115.376 -173.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -59.67 155.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 127.229 2.211 . . . . 0.0 114.361 170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -123.91 166.33 15.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.925 2.49 . . . . 0.0 112.318 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -150.01 137.57 19.91 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.769 -1.207 . . . . 0.0 110.793 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.63 153.94 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.512 155.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -151.14 88.42 1.45 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.313 1.845 . . . . 0.0 113.957 -176.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 113.913 177.685 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.1 t -118.9 141.93 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.818 -1.176 . . . . 0.0 109.716 150.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -141.81 128.25 20.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.07 1.348 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.7 t -133.38 122.58 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.06 -171.09 12.2 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.998 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.42 41.33 24.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.416 0.686 . . . . 0.0 112.27 -158.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.34 -30.76 42.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.899 0.88 . . . . 0.0 111.75 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.14 -51.65 0.56 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 127.927 2.68 . . . . 0.0 117.404 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -124.1 -56.62 1.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.382 1.091 . . . . 0.0 113.795 -152.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.62 -27.84 28.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -165.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -7.03 82.83 0.0 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 128.943 3.163 . . . . 0.0 117.039 -165.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -118.21 -66.62 1.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 147.36 -46.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 131.386 3.874 . . . . 0.0 111.93 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -74.73 -27.16 60.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.57 0.623 . . . . 0.0 112.166 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.97 -38.4 50.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.742 0.817 . . . . 0.0 112.759 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.6 -34.97 18.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.665 1.586 . . . . 0.0 111.585 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -56.34 -35.5 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.544 0.738 . . . . 0.0 110.496 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -83.91 -53.46 5.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.801 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.03 47.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -115.88 -26.48 7.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.344 1.058 . . . . 0.0 112.424 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.04 -33.3 21.42 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.533 1.063 . . . . 0.0 114.145 165.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -55.23 -43.77 74.86 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.03 -34.18 44.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.511 0.324 . . . . 0.0 111.024 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.25 -171.04 44.0 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -168.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.13 126.06 8.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.217 3.278 . . . . 0.0 113.322 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -99.83 144.0 29.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 109.416 167.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.92 -5.23 1.15 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.764 1.626 . . . . 0.0 113.272 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -156.78 160.55 39.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.741 1.216 . . . . 0.0 110.638 154.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.4 t -159.91 136.19 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.774 2.03 . . . . 0.0 110.145 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -157.03 160.18 38.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.95 1.7 . . . . 0.0 111.444 161.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.13 148.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 120.705 -1.247 . . . . 0.0 112.823 171.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 126.293 1.837 . . . . 0.0 114.153 176.556 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 N-CA-C 116.288 1.275 . . . . 0.0 116.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.8 139.32 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.79 1.295 . . . . 0.0 111.964 -168.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -133.98 154.58 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 129.077 2.951 . . . . 0.0 112.082 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.56 138.8 36.56 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.813 1.245 . . . . 0.0 109.462 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.278 2.0 m -141.6 -179.65 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.247 -0.908 . . . . 0.0 110.834 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -141.45 102.74 4.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.506 1.522 . . . . 0.0 108.314 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -64.61 175.92 1.28 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.447 0.699 . . . . 0.0 111.698 159.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -124.96 9.89 8.18 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.555 -1.34 . . . . 0.0 112.741 166.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.66 126.61 11.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.363 . . . . 0.0 110.991 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.08 -22.15 6.2 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.748 2.299 . . . . 0.0 113.914 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -70.82 -51.78 24.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.781 1.173 . . . . 0.0 110.358 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.85 -37.23 81.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.53 1.132 . . . . 0.0 110.589 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.64 67.19 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.133 1.373 . . . . 0.0 112.49 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.7 -30.88 67.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.724 -1.235 . . . . 0.0 111.033 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.88 -40.2 65.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.97 1.259 . . . . 0.0 113.483 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -17.34 36.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 0.0 113.898 166.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.33 -55.79 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.405 1.457 . . . . 0.0 110.131 159.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -54.96 -29.4 56.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.895 2.078 . . . . 0.0 114.068 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.36 -11.99 16.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.85 1.26 . . . . 0.0 112.075 -169.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.17 -20.54 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -154.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.18 136.82 48.28 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.756 0.822 . . . . 0.0 112.687 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.18 43.39 21.23 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.074 0.845 . . . . 0.0 112.622 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.12 -154.96 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.368 1.467 . . . . 0.0 111.671 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.2 m -129.46 -42.45 1.32 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.786 1.234 . . . . 0.0 110.744 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 tp 41.55 -99.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.771 2.828 . . . . 0.0 114.217 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.5 m -77.86 41.2 0.34 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.545 2.338 . . . . 0.0 113.475 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.87 75.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.745 1.164 . . . . 0.0 114.386 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.41 -119.22 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 111.489 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.72 32.27 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.597 0.713 . . . . 0.0 112.652 -153.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.13 140.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.232 2.213 . . . . 0.0 115.864 -156.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -134.32 113.76 12.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 129.385 3.074 . . . . 0.0 107.584 -170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.18 132.51 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.919 0.488 . . . . 0.0 112.077 -150.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 125.958 1.703 . . . . 0.0 109.938 171.306 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -130.55 95.67 3.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.06 102.27 7.16 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.159 -154.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.4 tp -88.71 93.58 9.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.16 1.384 . . . . 0.0 109.053 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 mt -58.22 118.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.65 1.98 . . . . 0.0 108.757 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.92 139.36 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.76 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -145.89 51.33 1.17 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.223 0.609 . . . . 0.0 109.879 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.56 -168.0 18.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 -165.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -41.11 -28.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.416 3.086 . . . . 0.0 116.014 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -134.44 -40.47 0.8 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.253 1.421 . . . . 0.0 111.871 -144.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.54 137.77 15.7 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.244 1.818 . . . . 0.0 107.82 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -127.93 124.43 37.32 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.907 1.283 . . . . 0.0 109.464 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.44 -134.89 4.47 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.287 1.423 . . . . 0.0 109.929 -152.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -164.05 -174.06 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.166 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -142.82 -29.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p 57.98 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.426 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -166.03 -179.38 5.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.84 2.856 . . . . 0.0 107.76 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -140.02 134.89 32.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.751 1.621 . . . . 0.0 108.403 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.28 -178.74 6.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.935 0.894 . . . . 0.0 112.131 -163.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -43.32 -57.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.564 1.945 . . . . 0.0 110.741 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -171.22 -163.39 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.93 2.892 . . . . 0.0 107.681 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.37 24.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.231 1.812 . . . . 0.0 114.249 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.0 -59.03 1.81 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.1 m -65.03 -21.97 66.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.13 -49.05 10.6 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 119.071 0.85 . . . . 0.0 111.67 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -62.51 -44.99 95.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.92 -20.38 51.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.94 -42.1 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.423 1.889 . . . . 0.0 111.282 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CZ ' HG22 ' A' ' 18' ' ' THR . 11.3 m-85 -54.9 -36.46 65.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 170.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.3 mmpt? -48.49 -50.09 33.08 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.494 1.918 . . . . 0.0 110.186 171.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -74.92 -37.71 61.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.839 1.655 . . . . 0.0 114.721 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -58.56 -39.4 80.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.463 1.029 . . . . 0.0 111.366 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -83.13 -32.22 26.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.449 -0.782 . . . . 0.0 110.858 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.03 -31.44 72.67 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.21 -41.9 80.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 113.084 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.27 -35.29 80.02 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.775 -0.578 . . . . 0.0 112.488 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.74 29.8 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.619 1.58 . . . . 0.0 113.798 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.99 127.17 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.938 1.295 . . . . 0.0 111.99 -165.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -122.75 -3.56 8.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.583 152.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 18.6 -78.68 0.0 OUTLIER Glycine 0 CA--C 1.528 0.892 1 C-N-CA 131.31 4.291 . . . . 0.0 119.256 170.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -134.61 2.33 3.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.391 1.877 . . . . 0.0 111.615 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.449 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 m95 -19.29 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.911 2.084 . . . . 0.0 115.518 -149.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 t -129.91 170.44 13.92 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.074 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -157.38 157.65 34.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.274 1.829 . . . . 0.0 111.679 -166.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -110.91 -48.98 3.07 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -164.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 58.44 -38.12 0.06 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 129.046 2.938 . . . . 0.0 117.624 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.02 61.96 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.969 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 p -122.26 -5.54 8.86 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.081 1.753 . . . . 0.0 113.091 165.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 48.5 mttm 60.2 6.31 0.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.46 2.304 . . . . 0.0 116.52 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.8 m -46.85 146.36 1.66 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.632 1.973 . . . . 0.0 114.054 156.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.52 163.07 15.89 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.632 2.773 . . . . 0.0 111.516 164.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -148.95 144.33 26.74 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.311 -1.493 . . . . 0.0 111.599 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.93 128.3 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.963 161.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -132.1 107.5 8.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 126.832 2.053 . . . . 0.0 109.802 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 115' ' ' VAL . 60.1 t -125.45 139.78 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 121.129 -0.982 . . . . 0.0 111.38 152.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -144.56 133.25 22.28 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.981 1.312 . . . . 0.0 109.556 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 142' ' ' VAL . 13.6 m -140.2 161.59 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.646 0.736 . . . . 0.0 112.469 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.55 -166.1 27.04 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 80.84 -1.28 1.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.155 2.582 . . . . 0.0 114.312 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' CD1' ' H ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -71.27 -172.59 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.778 1.231 . . . . 0.0 111.363 175.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 81' ' ' LEU . . . 168.47 -24.18 0.11 Allowed Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.546 1.07 . . . . 0.0 113.938 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.96 -30.65 71.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.464 1.506 . . . . 0.0 114.303 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -150.64 -18.03 0.23 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -172.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.61 115.28 6.92 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 120.131 1.332 . . . . 0.0 113.508 -150.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -131.2 -19.44 2.81 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 140.0 -52.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 131.164 3.786 . . . . 0.0 111.239 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -91.53 -23.45 19.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -158.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.75 -35.53 70.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.868 -1.77 . . . . 0.0 111.472 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.7 mt -89.73 -29.33 18.79 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.978 2.511 . . . . 0.0 111.157 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.85 -33.01 69.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.24 1.382 . . . . 0.0 110.605 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -84.04 -48.59 9.76 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.714 0.805 . . . . 0.0 112.432 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.28 67.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -96.9 -27.84 14.49 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -56.67 -35.16 66.14 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.577 1.56 . . . . 0.0 113.989 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -57.36 -31.54 65.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -96.97 17.84 16.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.194 0.997 . . . . 0.0 112.14 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 -160.99 14.12 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.865 -1.147 . . . . 0.0 115.603 163.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -49.79 117.41 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 125.409 4.072 . . . . 0.0 114.471 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -110.14 149.97 29.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.864 1.666 . . . . 0.0 109.514 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -124.7 -25.97 3.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.713 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -163.56 152.61 14.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.076 0.95 . . . . 0.0 109.621 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -151.46 127.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.85 1.66 . . . . 0.0 108.316 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -138.64 168.71 19.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.754 1.222 . . . . 0.0 111.512 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 113' ' ' ALA . 6.2 t -150.09 142.51 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.581 1.153 . . . . 0.0 111.093 -164.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 126.171 1.788 . . . . 0.0 113.391 173.229 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 115.368 0.907 . . . . 0.0 115.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -138.99 143.13 38.38 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.665 1.586 . . . . 0.0 109.451 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -139.7 153.1 47.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -141.32 120.94 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.924 0.89 . . . . 0.0 109.655 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.5 m -143.33 -177.39 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -161.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -145.47 110.2 5.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.562 1.945 . . . . 0.0 109.635 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -71.31 -175.71 1.31 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.121 0.968 . . . . 0.0 110.056 151.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -150.33 70.04 1.02 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.707 -1.246 . . . . 0.0 111.675 150.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.75 138.39 10.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.517 1.527 . . . . 0.0 110.393 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -73.5 -38.2 2.68 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.381 2.054 . . . . 0.0 115.435 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -60.38 1.67 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.64 1.109 . . . . 0.0 113.49 -154.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.4 -21.28 66.22 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.398 -0.814 . . . . 0.0 111.488 173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.64 -37.66 41.53 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.06 74.5 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 120.304 -1.498 . . . . 0.0 109.369 163.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.03 -36.75 84.09 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 3.5 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 168.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.47 -41.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 120.413 1.46 . . . . 0.0 113.112 144.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -62.83 -23.74 67.43 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.985 1.266 . . . . 0.0 113.213 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.74 -10.52 14.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.298 1.839 . . . . 0.0 110.883 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.58 -28.71 0.64 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -154.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.31 136.96 54.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.966 0.888 . . . . 0.0 111.728 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.12 13.15 52.51 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.377 0.989 . . . . 0.0 114.775 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 134' ' ' THR . 5.8 ttt180 -85.42 -159.5 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.451 1.5 . . . . 0.0 111.259 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 133' ' ' ARG . 55.3 m -147.64 134.6 20.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.418 2.287 . . . . 0.0 106.218 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.0 tp -133.44 -36.32 0.98 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -156.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 36.2 m -138.63 8.05 2.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.829 1.251 . . . . 0.0 114.191 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.31 26.69 3.37 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.79 -82.06 0.3 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.926 1.363 . . . . 0.0 110.401 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 175.13 165.05 0.28 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.019 3.327 . . . . 0.0 107.467 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.86 155.27 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.873 0.761 . . . . 0.0 111.574 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.5 127.14 17.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.783 2.433 . . . . 0.0 108.063 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 78' ' ' VAL . 76.9 t -141.37 134.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.532 0.605 . . . . 0.0 111.389 -152.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 126.061 1.744 . . . . 0.0 108.804 175.594 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -143.41 107.25 4.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.2 ttpt -117.9 132.69 56.39 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 112.623 -171.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.85 102.56 14.33 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.608 1.163 . . . . 0.0 109.283 165.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 mt -64.95 119.33 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 128.461 2.705 . . . . 0.0 109.854 158.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.0 128.92 42.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.766 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -140.37 48.51 1.75 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.565 1.946 . . . . 0.0 109.469 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.75 160.69 13.16 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 122.807 1.226 . . . . 0.0 114.565 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -53.78 -39.3 65.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.687 2.395 . . . . 0.0 112.781 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -59.65 -55.35 35.58 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.759 2.824 . . . . 0.0 112.862 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.0 139.74 8.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.054 1.342 . . . . 0.0 110.789 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.72 111.02 16.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.89 2.076 . . . . 0.0 109.001 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.29 0.05 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.117 0.865 . . . . 0.0 113.253 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.34 157.84 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.05 2.14 . . . . 0.0 115.914 161.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 33' ' ' TYR . 9.2 t -135.39 -22.09 1.53 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.4 p 62.49 161.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.501 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -170.55 -170.68 0.95 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.722 2.809 . . . . 0.0 109.116 168.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -143.57 141.22 30.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.658 2.383 . . . . 0.0 108.387 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.36 172.8 13.83 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -163.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.49 -44.14 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.042 2.137 . . . . 0.0 112.077 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -140.13 -64.17 0.48 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -152.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 130.2 2.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 131.309 3.844 . . . . 0.0 112.637 -160.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.41 -44.3 1.12 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.05 0.94 . . . . 0.0 110.119 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.2 m -63.5 -20.48 65.64 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.611 1.565 . . . . 0.0 113.887 164.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.49 10.65 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 118.804 0.729 . . . . 0.0 110.938 167.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.99 -45.77 93.45 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -64.06 -13.88 50.48 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.66 -40.43 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.197 2.199 . . . . 0.0 110.563 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.501 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -57.87 -39.99 79.16 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 13.9 mmtp -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.331 2.252 . . . . 0.0 111.014 166.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -75.95 -31.44 59.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 16' ' ' THR . 40.6 t80 -60.43 -43.28 96.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.687 1.13 . . . . 0.0 111.022 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.62 -34.97 58.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.513 -0.742 . . . . 0.0 109.962 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.06 -30.45 69.66 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.353 0.524 . . . . 0.0 112.101 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.92 -36.76 70.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.214 1.405 . . . . 0.0 113.402 170.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -64.62 -49.26 71.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.632 -0.667 . . . . 0.0 111.683 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.97 31.92 0.57 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.795 1.664 . . . . 0.0 114.181 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.67 146.36 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.4 1.88 . . . . 0.0 111.015 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -138.72 -6.79 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.204 1.002 . . . . 0.0 113.47 154.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.84 -129.06 6.47 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 126.155 1.836 . . . . 0.0 116.228 160.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.51 34.9 4.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.288 2.235 . . . . 0.0 108.428 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.451 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 13.9 m95 -19.66 97.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.762 2.825 . . . . 0.0 114.953 -169.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -118.11 162.4 18.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.454 1.501 . . . . 0.0 110.898 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -146.38 151.2 37.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.732 2.013 . . . . 0.0 111.114 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -107.07 -40.05 5.55 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -164.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 60.5 -33.43 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 119.185 3.031 . . . . 0.0 119.185 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.57 61.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.796 1.638 . . . . 0.0 112.266 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -135.24 13.17 3.55 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.49 1.916 . . . . 0.0 111.849 162.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.264 36.8 mttm 54.9 11.43 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 127.836 2.455 . . . . 0.0 116.581 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -44.57 156.14 0.09 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.574 1.949 . . . . 0.0 114.363 150.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.2 160.18 34.6 Favored 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.69 4.796 . . . . 0.0 110.107 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -147.82 134.69 20.14 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 112.073 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG13 ' CE3' ' A' ' 43' ' ' TRP . 1.6 m -108.94 96.58 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 122.215 1.007 . . . . 0.0 112.483 156.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -79.98 114.22 18.72 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.516 0.726 . . . . 0.0 109.855 160.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 125.397 1.479 . . . . 0.0 110.82 170.765 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' CG2' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -132.32 163.77 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 135.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -137.86 152.33 48.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.912 1.285 . . . . 0.0 111.284 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.6 t -141.2 152.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 111.242 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 -176.16 32.71 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.162 1.625 . . . . 0.0 117.162 161.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 91.53 1.85 0.12 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 130.805 3.642 . . . . 0.0 113.279 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.09 174.21 1.64 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.358 1.463 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.85 -37.76 0.18 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.564 1.078 . . . . 0.0 113.287 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -69.26 -57.57 5.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.733 0.813 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.5 -54.69 4.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.024 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.81 62.43 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 128.394 2.902 . . . . 0.0 117.004 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -132.66 -52.02 0.92 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.746 1.773 . . . . 0.0 115.67 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? 150.74 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 130.73 3.612 . . . . 0.0 112.625 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -87.63 -24.84 23.82 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.476 -0.765 . . . . 0.0 112.228 -164.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -55.43 -38.34 68.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.819 162.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.6 mt -82.67 -34.25 27.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.242 1.017 . . . . 0.0 112.569 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -54.68 -36.27 64.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.867 0.758 . . . . 0.0 111.102 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtm-85 -78.26 -57.05 3.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -20.67 41.9 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -113.91 -29.93 6.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.884 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.24 -35.19 26.71 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.765 1.174 . . . . 0.0 114.054 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -58.39 -41.72 85.47 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -78.44 -32.2 48.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.586 0.355 . . . . 0.0 111.235 -171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -177.68 44.67 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.036 0.826 . . . . 0.0 115.086 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.01 136.71 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.704 3.603 . . . . 0.0 114.509 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 152.38 23.87 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.27 1.828 . . . . 0.0 109.95 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -122.74 -22.36 5.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.556 1.542 . . . . 0.0 113.253 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -167.92 156.75 9.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.335 1.454 . . . . 0.0 109.655 173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -152.71 131.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.799 1.239 . . . . 0.0 110.843 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -147.28 153.9 40.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.305 1.442 . . . . 0.0 111.367 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.84 144.81 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.107 -0.996 . . . . 0.0 112.032 171.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.579 1.152 . . . . 0.0 111.386 175.369 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -142.52 139.38 31.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.521 1.661 . . . . 0.0 112.417 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -127.88 162.5 26.57 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.126 1.771 . . . . 0.0 113.448 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -149.28 136.91 20.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.728 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.483 HG22 ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -139.89 177.9 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -172.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -137.77 147.06 44.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.594 1.158 . . . . 0.0 110.065 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -177.72 3.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.177 2.591 . . . . 0.0 111.466 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.42 -22.15 6.59 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.54 106.11 54.41 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 120.557 1.526 . . . . 0.0 113.352 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 -20.79 36.27 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.416 2.744 . . . . 0.0 114.639 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -41.87 17.63 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.056 1.298 . . . . 0.0 111.308 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -67.33 -33.3 74.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.622 0.769 . . . . 0.0 112.257 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.508 0.723 . . . . 0.0 112.863 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.22 -34.73 70.73 Favored 'General case' 0 C--O 1.226 -0.165 0 O-C-N 121.002 -1.061 . . . . 0.0 110.142 168.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -38.2 76.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 172.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.9 -15.0 39.41 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.766 -1.209 . . . . 0.0 113.721 166.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.55 -54.34 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.462 -1.399 . . . . 0.0 109.594 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -58.32 -26.79 63.47 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 113.816 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.23 -10.64 17.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.245 1.418 . . . . 0.0 112.299 -170.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 -33.98 0.19 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -154.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -60.43 133.84 56.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.71 0.804 . . . . 0.0 112.492 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.88 13.63 83.21 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.231 -0.761 . . . . 0.0 114.305 160.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -113.19 -106.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.158 1.783 . . . . 0.0 109.736 -173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -156.64 136.89 12.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 109.038 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 tp -154.41 155.17 34.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.325 1.45 . . . . 0.0 109.375 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.1 m 51.76 25.57 3.01 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.41 73.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.11 1.338 . . . . 0.0 115.164 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.5 p -121.95 156.21 33.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.567 1.547 . . . . 0.0 111.579 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.21 53.04 0.78 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.05 1.74 . . . . 0.0 112.953 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -46.99 152.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.833 2.453 . . . . 0.0 115.957 -163.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -137.31 137.24 38.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.122 2.569 . . . . 0.0 108.687 167.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.54 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.477 0.58 . . . . 0.0 111.406 -163.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.477 0.916 0 O-C-N 119.624 -1.922 . . . . 0.0 110.207 167.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.68 109.37 5.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 37.5 ttpt -133.99 150.5 51.26 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 125.85 1.66 . . . . 0.0 113.018 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.9 tp -117.62 109.97 17.32 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.443 1.897 . . . . 0.0 110.211 161.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.25 120.33 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 129.739 3.216 . . . . 0.0 110.259 158.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.12 128.19 40.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.134 165.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -139.49 40.35 2.05 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.983 2.113 . . . . 0.0 110.226 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.99 171.65 42.94 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 120.25 -1.531 . . . . 0.0 116.169 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -66.0 -43.15 88.54 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 152.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.7 m -53.45 -57.12 11.78 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.482 3.113 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.3 tm? -162.33 141.23 9.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.0 110.008 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -126.92 110.45 13.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.614 1.566 . . . . 0.0 109.466 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.64 77.6 0.03 OUTLIER Glycine 0 N--CA 1.465 0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.004 -161.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.87 160.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.117 1.367 . . . . 0.0 114.222 162.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -124.28 -37.26 2.56 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.6 p 58.62 166.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -155.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.471 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -155.38 -25.15 0.11 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.35 136.39 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 127.17 2.188 . . . . 0.0 116.541 -162.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.77 -179.68 7.47 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.4 -1.438 . . . . 0.0 112.924 -166.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 4.8 t -63.81 -50.91 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.289 1.836 . . . . 0.0 111.876 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -167.93 167.93 12.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.568 1.547 . . . . 0.0 109.661 -152.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.04 15.81 0.5 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.43 -31.33 0.81 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.103 -0.998 . . . . 0.0 111.865 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.3 m -76.34 -21.29 56.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.0 111.837 163.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -50.42 15.46 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.617 -0.677 . . . . 0.0 110.123 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -48.26 58.09 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.084 1.354 . . . . 0.0 108.6 173.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -24.8 15.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.551 1.157 . . . . 0.0 114.068 -170.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.05 -38.77 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.607 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.1 m-85 -55.11 -41.83 72.15 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.046 0.938 . . . . 0.0 113.471 167.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE2' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -48.86 -55.06 12.78 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 110.051 169.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -68.87 -34.17 75.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -60.38 -40.91 92.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.286 0.948 . . . . 0.0 110.842 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -77.59 -35.84 52.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.21 -32.72 73.15 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.359 0.527 . . . . 0.0 111.857 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.81 -38.88 87.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.192 . . . . 0.0 113.186 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -67.1 -34.54 77.85 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.567 -0.708 . . . . 0.0 112.741 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.31 22.83 1.83 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.895 1.712 . . . . 0.0 114.684 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -122.88 134.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.58 1.552 . . . . 0.0 111.92 -161.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.23 10.44 3.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 149.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.08 -139.06 1.19 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 149.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -119.46 53.87 1.02 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.899 2.479 . . . . 0.0 106.276 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HE2' ' A' ' 31' ' ' LYS . 13.9 m95 -45.65 104.28 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.334 1.454 . . . . 0.0 112.631 -172.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.1 m -124.44 158.6 32.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.351 1.861 . . . . 0.0 108.672 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 38.9 t80 -137.91 144.04 41.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.83 1.252 . . . . 0.0 110.11 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -130.59 60.79 1.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 110.094 -156.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -47.0 -28.06 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.581 2.752 . . . . 0.0 116.128 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.7 -24.06 46.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.573 2.349 . . . . 0.0 112.852 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -132.9 7.8 4.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 112.854 165.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 51.0 mttm 45.78 25.16 0.26 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.555 2.742 . . . . 0.0 115.097 -164.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 m -63.43 168.98 4.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.235 1.814 . . . . 0.0 111.351 160.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 60.7 m-85 -135.73 156.41 48.87 Favored 'General case' 0 C--N 1.324 -0.509 1 C-N-CA 132.573 4.349 . . . . 0.0 108.903 175.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.8 m -143.35 129.72 19.96 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 m -103.51 93.21 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.21 1.005 . . . . 0.0 112.281 160.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.99 59.02 3.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.41 1.084 . . . . 0.0 112.457 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 . . . . . 0 N--CA 1.481 1.09 0 O-C-N 120.551 -1.343 . . . . 0.0 113.284 -176.465 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' CG1' HG22 ' A' ' 115' ' ' VAL . 37.8 t -113.56 141.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.19 -1.569 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -139.88 127.59 21.81 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.637 1.575 . . . . 0.0 109.116 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.22 146.91 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.41 -177.78 38.62 Favored Glycine 0 CA--C 1.518 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 115.249 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.65 16.66 9.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.316 1.446 . . . . 0.0 113.969 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 38.47 0.16 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 127.152 2.181 . . . . 0.0 111.714 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.49 -25.63 50.12 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.513 1.53 . . . . 0.0 115.762 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.74 -31.16 72.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.365 1.466 . . . . 0.0 113.223 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -134.02 -88.31 0.39 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.067 1.347 . . . . 0.0 110.192 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.22 56.33 2.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.817 1.199 . . . . 0.0 113.453 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -128.93 163.99 24.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.631 1.572 . . . . 0.0 111.555 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -72.56 -40.18 66.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.165 -0.959 . . . . 0.0 112.918 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.1 m -74.2 -34.62 63.78 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -168.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -54.38 -36.03 63.45 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.969 1.259 . . . . 0.0 111.64 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.98 -27.94 30.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.934 1.293 . . . . 0.0 112.826 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.92 -36.69 72.83 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.119 1.327 . . . . 0.0 109.94 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -103.18 -39.59 6.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.404 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.38 -30.88 68.74 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.547 0.612 . . . . 0.0 112.417 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -97.87 -30.16 12.91 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.22 -33.78 16.14 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.001 1.286 . . . . 0.0 114.439 167.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -58.94 -41.57 87.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -78.63 -24.75 45.13 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.971 0.509 . . . . 0.0 112.354 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.72 -177.49 41.48 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.031 0.824 . . . . 0.0 114.925 -171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.55 147.6 46.25 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.74 2.96 . . . . 0.0 113.149 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.97 164.25 18.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.676 2.391 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 116' ' ' GLU . 5.1 tmm_? -122.99 -36.88 2.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.434 1.494 . . . . 0.0 112.403 173.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -161.98 154.41 19.69 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.259 0.936 . . . . 0.0 111.068 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.5 t -153.02 123.56 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.233 1.413 . . . . 0.0 110.151 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -145.27 159.93 42.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.695 1.198 . . . . 0.0 111.671 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.76 153.3 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.397 -0.815 . . . . 0.0 111.897 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.148 1.379 . . . . 0.0 114.267 -177.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.324 0 N-CA-C 117.318 1.687 . . . . 0.0 117.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -133.54 130.28 38.25 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.254 1.527 . . . . 0.0 111.06 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.44 160.81 38.96 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.128 2.171 . . . . 0.0 114.489 -158.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -155.08 119.71 4.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.957 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG22 ' CG1' ' A' ' 76' ' ' VAL . 2.6 m -137.22 -171.03 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.832 0.853 . . . . 0.0 111.764 -168.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 101' ' ' ARG . 15.6 tt0 -153.75 115.88 4.32 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.427 1.091 . . . . 0.0 111.239 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -67.28 179.94 1.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.077 1.751 . . . . 0.0 112.457 165.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -115.08 -50.29 2.76 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.46 -0.775 . . . . 0.0 112.549 155.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -75.96 123.69 88.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 O-C-N 121.296 -0.877 . . . . 0.0 112.261 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -26.22 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.97 2.447 . . . . 0.0 114.724 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -27.54 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.302 1.41 . . . . 0.0 112.378 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.43 -37.46 83.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.801 0.84 . . . . 0.0 111.445 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.51 96.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.269 0.628 . . . . 0.0 112.132 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.39 91.53 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.151 -0.968 . . . . 0.0 110.516 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -40.33 81.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.85 0.75 . . . . 0.0 112.687 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.46 -20.14 58.92 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 168.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.9 t -77.84 -53.88 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 120.403 1.456 . . . . 0.0 109.383 160.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.28 -24.0 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.932 1.693 . . . . 0.0 113.972 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -111.68 -6.89 14.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.451 1.5 . . . . 0.0 111.814 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.49 -22.66 0.28 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -156.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -74.5 144.98 43.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.892 0.853 . . . . 0.0 111.831 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.95 34.11 71.0 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.033 -171.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -132.36 -140.53 0.2 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.038 1.335 . . . . 0.0 110.977 -171.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.4 m -154.05 144.21 22.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.208 2.203 . . . . 0.0 109.395 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mp -118.26 -37.56 3.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.483 1.113 . . . . 0.0 113.031 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.2 t -144.87 43.67 1.35 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.077 0.951 . . . . 0.0 112.811 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.65 4.81 88.08 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.322 0.963 . . . . 0.0 114.512 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.9 p -72.61 -176.29 1.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.544 1.537 . . . . 0.0 112.185 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.44 115.51 10.93 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.539 1.536 . . . . 0.0 106.939 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.36 162.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -143.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.43 125.58 20.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.17 1.788 . . . . 0.0 109.758 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.58 132.31 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -158.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -173.293 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.864 0.364 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.29 112.44 13.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.21 111.97 9.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -159.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.3 101.99 13.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.475 1.11 . . . . 0.0 110.136 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.42 117.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 128.535 2.734 . . . . 0.0 110.02 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -90.98 127.73 36.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.605 165.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -136.72 43.26 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.71 1.604 . . . . 0.0 110.554 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.98 171.54 22.67 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.493 -1.379 . . . . 0.0 116.418 -168.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -67.06 -37.04 83.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.627 1.171 . . . . 0.0 110.175 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -66.16 -53.82 32.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.072 1.349 . . . . 0.0 112.307 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -157.87 142.91 16.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.898 0.879 . . . . 0.0 111.552 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.24 111.43 16.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.937 2.095 . . . . 0.0 109.92 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.54 93.07 0.11 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.632 1.11 . . . . 0.0 113.496 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -31.81 166.24 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.891 2.477 . . . . 0.0 116.898 163.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -133.08 -38.98 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.2 p 55.7 164.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -152.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.9 t -152.65 -17.54 0.16 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.72 154.23 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.255 2.622 . . . . 0.0 117.476 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.12 175.89 9.78 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.805 -1.185 . . . . 0.0 112.949 -164.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.92 -45.06 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.106 0.955 . . . . 0.0 110.296 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -166.73 178.17 6.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.949 -158.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.37 -10.1 40.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.03 -1.89 18.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 120.549 1.522 . . . . 0.0 110.526 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -112.33 -20.25 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 128.219 2.608 . . . . 0.0 112.092 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.68 9.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.082 0.953 . . . . 0.0 110.387 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.95 -48.19 82.72 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.13 -18.53 48.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.586 -167.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.43 -45.92 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.021 1.728 . . . . 0.0 110.858 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 18' ' ' THR . 6.8 m-85 -54.13 -40.9 67.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 mmpt? -46.39 -39.61 10.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.941 1.696 . . . . 0.0 111.624 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -104.65 -20.57 13.6 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -55.76 -42.1 74.98 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.997 1.271 . . . . 0.0 109.507 159.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.97 -36.19 49.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.591 -0.693 . . . . 0.0 110.521 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -78.65 -22.83 46.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.474 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.17 -37.42 66.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.028 1.331 . . . . 0.0 113.134 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -59.88 -47.18 86.79 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.656 0.662 . . . . 0.0 110.777 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.61 10.28 6.01 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.361 1.934 . . . . 0.0 113.667 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.96 150.76 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.38 1.072 . . . . 0.0 110.597 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.74 128.11 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.222 1.011 . . . . 0.0 111.25 134.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.18 -154.0 7.13 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-O 123.701 1.723 . . . . 0.0 115.13 -158.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.04 53.09 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.648 2.379 . . . . 0.0 109.766 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.402 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 6.7 m95 -46.06 103.28 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.981 1.712 . . . . 0.0 112.836 -168.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.47 156.38 30.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.897 1.679 . . . . 0.0 111.72 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 52.7 t80 -149.69 142.19 24.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.073 1.349 . . . . 0.0 110.464 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.29 -36.58 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -162.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.08 -45.56 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 129.065 2.946 . . . . 0.0 117.96 -171.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.99 -25.05 64.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.206 1.803 . . . . 0.0 112.117 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.5 p -128.66 7.2 5.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 113.125 167.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.254 16.0 mttp 51.39 8.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -51.54 152.53 2.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.08 2.552 . . . . 0.0 113.338 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 28.7 m-85 -126.3 165.44 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 131.45 3.9 . . . . 0.0 110.235 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -145.75 150.55 36.44 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.885 0.85 . . . . 0.0 111.231 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.77 95.07 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 122.296 1.046 . . . . 0.0 113.249 158.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.46 101.56 10.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.179 0.992 . . . . 0.0 110.643 172.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 . . . . . 0 N--CA 1.48 1.053 0 O-C-N 120.929 -1.107 . . . . 0.0 113.006 173.595 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.5 168.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.629 2.013 . . . . 0.0 114.934 169.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -138.03 118.32 13.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.332 2.253 . . . . 0.0 108.848 168.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.2 t -126.7 141.75 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.538 . . . . 0.0 110.481 -174.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.86 -162.77 25.53 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 78.47 12.1 1.63 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.284 2.634 . . . . 0.0 113.971 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 33.16 5.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 -152.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.53 -26.31 44.95 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.119 1.342 . . . . 0.0 116.222 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.53 -30.13 68.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.725 1.21 . . . . 0.0 113.986 170.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.3 -119.35 0.3 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.28 55.25 27.02 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 121.112 1.778 . . . . 0.0 113.72 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.2 -60.79 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.323 1.449 . . . . 0.0 111.868 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 170.79 -60.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.954 2.502 . . . . 0.0 112.934 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -95.75 -26.98 15.47 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.327 0.967 . . . . 0.0 113.218 -162.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -57.57 -36.82 72.18 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.289 -0.882 . . . . 0.0 111.676 163.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.2 mt -74.05 -36.32 64.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.967 0.907 . . . . 0.0 112.36 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -57.28 -30.69 64.91 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.973 1.261 . . . . 0.0 112.216 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -84.22 -46.3 12.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.56 -28.18 63.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.523 0.729 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -98.21 -35.05 10.49 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.827 0.851 . . . . 0.0 112.649 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.85 -30.93 37.83 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.546 1.546 . . . . 0.0 115.463 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -58.23 -36.35 73.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.212 1.006 . . . . 0.0 113.603 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -78.52 -16.27 57.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.82 178.55 25.77 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.44 1.972 . . . . 0.0 112.213 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -58.58 151.29 63.61 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.523 2.816 . . . . 0.0 113.393 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.51 154.99 31.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.78 2.032 . . . . 0.0 109.877 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -120.74 -22.76 6.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.501 1.52 . . . . 0.0 113.441 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -168.99 155.16 6.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.844 1.258 . . . . 0.0 109.845 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -151.21 130.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.077 1.751 . . . . 0.0 108.939 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -141.91 149.3 40.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.363 1.865 . . . . 0.0 109.584 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.55 147.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.746 -1.222 . . . . 0.0 113.956 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 126.539 1.936 . . . . 0.0 110.861 175.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.097 0 N-CA-C 114.834 0.693 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -59.16 131.71 51.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.404 1.081 . . . . 0.0 111.801 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.53 155.9 31.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 112.274 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.18 131.21 36.47 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.951 1.3 . . . . 0.0 107.724 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.56 175.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.217 1.007 . . . . 0.0 110.86 -165.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -140.88 125.6 17.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.309 1.044 . . . . 0.0 109.588 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -86.85 173.01 9.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.413 1.885 . . . . 0.0 112.417 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.57 -68.63 0.74 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.96 155.96 74.89 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-N 120.965 1.711 . . . . 0.0 114.364 -170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.92 -42.82 62.98 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 116.008 -163.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -35.68 81.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.252 0.933 . . . . 0.0 112.375 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.54 -45.07 84.82 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.517 0.727 . . . . 0.0 110.535 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.13 -48.04 46.68 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.06 69.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.284 1.033 . . . . 0.0 111.252 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -74.09 -40.93 62.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.189 0.904 . . . . 0.0 112.286 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.9 -7.5 16.9 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 164.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.05 -55.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.566 1.53 . . . . 0.0 110.212 153.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -49.04 -36.54 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.783 2.033 . . . . 0.0 112.847 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -103.47 -13.17 16.71 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.164 0.986 . . . . 0.0 112.276 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mp -147.36 -8.46 0.44 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -152.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.557 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -63.08 -19.32 64.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -179.76 70.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.438 1.018 . . . . 0.0 111.621 -159.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -132.86 -132.9 0.18 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.594 1.558 . . . . 0.0 111.942 -163.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -151.22 -36.56 0.13 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.456 1.902 . . . . 0.0 110.682 -173.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.9 tp 62.17 -48.6 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 130.302 3.441 . . . . 0.0 118.869 156.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.21 29.02 1.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.846 1.658 . . . . 0.0 112.01 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.68 55.27 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.157 -0.965 . . . . 0.0 113.301 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 p -133.85 -129.89 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.588 1.955 . . . . 0.0 110.254 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -154.63 150.86 28.13 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 130.065 3.346 . . . . 0.0 106.813 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.69 151.88 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.151 0.98 . . . . 0.0 109.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -144.35 123.26 12.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 0.0 109.1 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 2.3 t -144.55 136.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.686 -161.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 125.986 1.714 . . . . 0.0 107.522 163.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.717 0.294 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -129.05 103.65 7.12 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.33 111.88 9.3 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 125.764 1.625 . . . . 0.0 111.28 -160.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.31 91.45 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.578 1.551 . . . . 0.0 110.076 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 mt -52.67 119.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.994 2.117 . . . . 0.0 109.207 159.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.58 134.04 40.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.429 1.092 . . . . 0.0 109.625 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -146.34 63.62 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.442 1.097 . . . . 0.0 108.767 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.72 178.54 16.35 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 122.045 0.803 . . . . 0.0 114.37 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -57.57 -43.56 84.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.33 1.052 . . . . 0.0 112.492 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -68.18 -50.67 52.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.283 2.233 . . . . 0.0 113.223 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -156.48 140.59 16.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.191 0.996 . . . . 0.0 110.397 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 131.11 47.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.798 1.639 . . . . 0.0 110.056 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.39 -134.74 4.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.347 1.451 . . . . 0.0 110.318 -158.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -161.71 -167.08 1.61 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.235 2.214 . . . . 0.0 108.892 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -144.82 -41.49 0.24 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 161.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p 56.12 166.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -156.47 -25.66 0.1 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 47.86 139.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.049 2.54 . . . . 0.0 117.049 -161.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.88 -178.0 7.03 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.576 -1.328 . . . . 0.0 112.118 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 21' ' ' VAL . 15.5 t -51.01 -51.1 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.368 1.867 . . . . 0.0 111.88 168.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -173.68 174.84 3.06 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.111 1.765 . . . . 0.0 110.903 -157.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.7 19.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.524 1.13 . . . . 0.0 113.697 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.31 11.36 6.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.096 0.959 . . . . 0.0 111.388 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -135.43 -24.49 1.38 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.499 1.92 . . . . 0.0 111.153 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.52 8.45 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.686 -0.633 . . . . 0.0 111.025 164.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -59.86 -46.35 89.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -49.3 -25.0 2.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.818 1.647 . . . . 0.0 114.267 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.2 -40.12 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.886 1.674 . . . . 0.0 110.339 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -53.7 -36.38 62.14 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.8 mtpp -49.74 -56.99 8.18 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.536 1.534 . . . . 0.0 109.832 172.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.48 -38.82 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.883 -0.58 . . . . 0.0 112.491 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -56.94 -36.25 70.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.044 0.838 . . . . 0.0 111.439 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.79 -37.29 24.73 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 121.662 -0.649 . . . . 0.0 110.512 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -67.02 -29.01 68.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.288 0.949 . . . . 0.0 112.469 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.11 -41.8 76.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.551 1.54 . . . . 0.0 113.181 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -63.53 -44.94 92.77 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.619 -0.676 . . . . 0.0 111.308 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.37 22.76 1.06 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.987 1.756 . . . . 0.0 113.212 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.17 129.94 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.271 1.828 . . . . 0.0 110.879 -164.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.84 3.1 16.21 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.894 150.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.97 -123.01 12.79 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.531 1.539 . . . . 0.0 113.256 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -132.05 48.85 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.077 2.151 . . . . 0.0 106.49 161.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 9.8 m95 -18.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.112 2.565 . . . . 0.0 115.607 -173.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.5 m -120.22 160.53 22.76 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.42 152.41 35.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.689 1.996 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.24 -39.93 5.09 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -166.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 t70 64.35 -33.45 0.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.07 64.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.694 1.598 . . . . 0.0 111.715 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -119.49 -7.64 10.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.277 2.231 . . . . 0.0 112.513 165.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.29 39.0 mttm 61.56 17.46 8.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.502 2.321 . . . . 0.0 115.37 -171.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -57.65 150.05 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.385 1.474 . . . . 0.0 112.713 162.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -118.35 164.68 14.86 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.569 2.747 . . . . 0.0 112.06 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -150.39 138.32 20.08 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.748 -1.22 . . . . 0.0 112.248 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.37 90.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.581 1.181 . . . . 0.0 113.468 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 84.17 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.228 1.811 . . . . 0.0 113.069 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 N--CA 1.477 0.895 0 O-C-N 120.83 -1.169 . . . . 0.0 110.529 163.556 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 117.408 -1.282 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 115' ' ' VAL . 9.5 p -128.82 155.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.879 1.218 . . . . 0.0 110.482 158.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -134.51 147.77 50.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 t -136.88 147.18 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.053 1.341 . . . . 0.0 111.106 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.36 -157.2 15.26 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.113 -0.992 . . . . 0.0 114.559 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -16.51 0.17 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.64 2.376 . . . . 0.0 114.239 -166.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.63 153.3 20.32 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.863 -1.148 . . . . 0.0 112.036 164.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.04 29.78 0.53 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.956 1.265 . . . . 0.0 113.225 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.86 -56.55 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.46 1.904 . . . . 0.0 109.735 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 24.2 m-80 -104.36 -166.19 1.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 140.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 84' ' ' ASN . . . -63.61 168.83 21.47 Favored Glycine 0 CA--C 1.531 1.085 1 C-N-CA 131.011 4.148 . . . . 0.0 114.117 -9.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -137.86 -23.39 1.05 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.209 2.203 . . . . 0.0 110.784 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.251 2.4 pttp 131.7 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 1 C-N-CA 134.866 5.266 . . . . 0.0 110.822 163.723 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.6 m -74.93 -45.6 41.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.153 1.381 . . . . 0.0 111.329 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -42.32 93.67 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.246 1.018 . . . . 0.0 112.179 172.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.23 -32.76 64.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.761 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' A' ' 103' ' ' VAL . 18.8 mt-10 -51.92 -37.0 50.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.316 1.417 . . . . 0.0 110.579 170.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -102.87 -34.3 9.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.86 79.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.279 0.631 . . . . 0.0 111.952 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -83.75 -28.08 28.47 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.811 -0.556 . . . . 0.0 110.918 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.34 -32.64 37.68 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.911 1.72 . . . . 0.0 114.411 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -51.84 -40.72 61.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -78.69 -24.12 45.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.7 179.38 30.75 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.321 1.438 . . . . 0.0 113.068 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.2 118.76 5.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.335 2.69 . . . . 0.0 113.038 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.13 156.39 25.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.899 0.857 . . . . 0.0 110.856 162.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -124.34 -23.9 4.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.604 2.362 . . . . 0.0 112.251 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -165.8 153.95 10.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.558 1.943 . . . . 0.0 108.95 163.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.53 HG11 ' HG3' ' A' ' 91' ' ' GLU . 39.0 t -150.73 125.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.542 1.137 . . . . 0.0 109.387 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -141.64 167.91 21.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.31 1.052 . . . . 0.0 112.505 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 113' ' ' ALA . 7.5 t -144.34 141.84 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.624 1.57 . . . . 0.0 110.231 -170.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 C-N-CA 124.314 1.046 . . . . 0.0 113.361 176.56 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 114.609 0.604 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -84.3 149.89 25.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.262 1.425 . . . . 0.0 110.543 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -143.61 159.84 41.73 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.627 1.171 . . . . 0.0 113.917 -169.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.26 122.14 10.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.459 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 76' ' ' VAL . 2.0 m -138.85 -179.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.759 0.824 . . . . 0.0 111.845 -168.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.31 152.2 29.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.186 1.394 . . . . 0.0 110.863 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.63 167.21 12.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.678 2.391 . . . . 0.0 112.41 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -72.06 -20.79 61.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -143.0 133.54 12.34 Favored Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 121.001 -1.062 . . . . 0.0 112.429 -162.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.89 -27.99 9.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.756 2.304 . . . . 0.0 114.335 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.2 mtm105 -71.54 -49.36 41.59 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.432 1.015 . . . . 0.0 110.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.88 -37.36 84.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.856 0.862 . . . . 0.0 110.718 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.2 70.07 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.02 -26.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.219 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.58 -41.87 37.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.304 1.411 . . . . 0.0 113.866 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.66 -8.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.484 1.514 . . . . 0.0 114.087 163.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.5 t -96.7 -53.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.704 1.202 . . . . 0.0 111.109 160.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -53.36 -35.2 60.01 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.294 1.838 . . . . 0.0 113.102 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.36 -7.89 49.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.892 1.277 . . . . 0.0 112.103 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.51 -2.9 0.94 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -155.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -58.25 -24.28 58.82 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -170.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.91 75.77 0.11 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.31 1.91 . . . . 0.0 111.508 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 70.0 mmt-85 -132.51 -146.6 0.29 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.119 1.768 . . . . 0.0 111.238 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.4 m -151.19 139.33 20.16 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.392 2.277 . . . . 0.0 106.661 168.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 tp -142.27 -66.21 0.4 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -158.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.8 m -152.79 49.29 0.73 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.549 1.939 . . . . 0.0 109.97 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.79 26.74 0.34 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 130.635 3.969 . . . . 0.0 111.526 16.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.0 t -90.35 172.23 8.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.054 1.342 . . . . 0.0 110.027 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -43.64 132.95 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.247 1.019 . . . . 0.0 111.144 150.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.4 t -109.09 154.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.836 1.654 . . . . 0.0 110.012 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.0 135.7 27.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.762 1.225 . . . . 0.0 108.593 159.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.3 t -133.07 155.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.987 1.315 . . . . 0.0 110.244 -166.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 125.103 1.361 . . . . 0.0 110.482 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -134.61 110.37 9.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -123.89 108.54 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.312 1.445 . . . . 0.0 112.18 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.23 89.37 6.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.121 0.968 . . . . 0.0 109.231 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 mt -51.52 115.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.006 1.722 . . . . 0.0 108.576 159.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -92.87 128.04 38.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.379 174.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 86.2 m-20 -140.34 58.82 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.35 -179.12 15.62 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-N 120.809 1.641 . . . . 0.0 115.693 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -56.83 -23.83 46.7 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.6 1.96 . . . . 0.0 115.187 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -99.04 -42.86 6.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.494 1.917 . . . . 0.0 112.542 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -160.43 140.2 11.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.118 1.367 . . . . 0.0 109.43 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -130.51 130.64 44.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.267 1.427 . . . . 0.0 110.097 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -133.58 4.21 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.088 1.804 . . . . 0.0 111.295 -148.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 6.7 mt-10 -161.87 -167.77 1.76 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.774 2.43 . . . . 0.0 107.965 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -139.35 -39.24 0.48 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 158.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p 53.9 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -158.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -160.48 179.68 8.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.906 2.482 . . . . 0.0 107.557 166.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -139.42 136.18 34.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.873 1.269 . . . . 0.0 109.138 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.19 -177.7 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.776 0.83 . . . . 0.0 111.992 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -46.04 -57.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.071 1.748 . . . . 0.0 110.6 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -172.15 -163.67 0.25 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.964 3.306 . . . . 0.0 107.149 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.13 -14.8 11.32 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.41 4.88 53.26 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.695 1.589 . . . . 0.0 111.951 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -126.49 -14.54 5.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.941 166.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.76 -49.94 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.555 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -57.02 -46.98 81.96 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -53.64 -21.05 6.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.866 1.354 . . . . 0.0 113.93 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.5 -35.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.138 1.775 . . . . 0.0 110.19 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 18' ' ' THR . 13.7 m-85 -53.35 -41.17 65.52 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.473 1.033 . . . . 0.0 113.599 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.79 -52.33 11.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.096 1.758 . . . . 0.0 110.624 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -80.31 -34.04 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.568 1.547 . . . . 0.0 114.863 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.73 -39.4 88.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.041 1.291 . . . . 0.0 111.225 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.05 61.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.617 -0.677 . . . . 0.0 109.696 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -71.9 -23.51 61.5 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -77.09 -37.0 55.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.689 . . . . 0.0 112.931 170.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -58.69 -44.21 90.22 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.738 -0.601 . . . . 0.0 110.464 164.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.01 5.72 8.77 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.074 1.797 . . . . 0.0 113.459 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.53 146.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.437 1.095 . . . . 0.0 110.719 172.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.12 125.19 9.27 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.726 0.775 . . . . 0.0 110.836 135.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.07 -147.04 4.61 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-O 123.878 1.821 . . . . 0.0 115.456 -157.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HB3' ' H ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -62.22 -19.16 62.87 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.689 2.396 . . . . 0.0 114.181 -172.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CD2' ' CG1' ' A' ' 54' ' ' VAL 0.267 10.7 m95 36.58 52.79 1.0 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.541 2.736 . . . . 0.0 115.514 170.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 m -75.41 156.42 35.39 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.047 0.927 . . . . 0.0 111.638 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -144.36 146.11 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.592 1.557 . . . . 0.0 110.448 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -106.03 -40.03 5.8 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -163.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.04 -34.8 0.06 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.78 65.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.334 1.853 . . . . 0.0 111.466 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -125.88 -0.29 7.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.709 2.003 . . . . 0.0 112.809 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 42.2 mttm 56.13 7.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.204 2.602 . . . . 0.0 116.512 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -43.44 152.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.205 2.202 . . . . 0.0 113.972 150.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.88 173.54 8.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 130.557 3.543 . . . . 0.0 110.914 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -146.1 156.23 43.31 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.764 -1.21 . . . . 0.0 110.433 158.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -130.46 128.91 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 152.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 42' ' ' GLU . 5.7 m -125.34 117.57 24.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.057 1.408 . . . . 0.0 112.353 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.437 0 C-N-CA 130.744 3.618 . . . . 0.0 108.509 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 115' ' ' VAL . 75.5 t -117.71 121.52 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 140.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -144.36 141.56 29.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.514 -1.366 . . . . 0.0 111.273 -167.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.59 159.71 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.98 -163.91 12.97 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.822 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 65.77 20.97 11.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.983 1.713 . . . . 0.0 114.692 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -84.13 132.74 34.66 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.014 -1.054 . . . . 0.0 110.105 170.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.31 34.01 1.2 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.048 1.308 . . . . 0.0 112.099 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -143.29 -40.61 0.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 110.549 -162.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' H ' HD12 ' A' ' 81' ' ' LEU . 46.5 m-20 -124.15 -111.34 0.31 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.299 2.64 . . . . 0.0 108.125 173.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.04 61.92 0.56 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.902 1.715 . . . . 0.0 111.111 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.35 166.12 26.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.261 1.025 . . . . 0.0 112.243 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -30.08 65.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 m -75.89 -39.6 56.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.348 -0.845 . . . . 0.0 113.156 -169.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.29 -35.93 65.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.138 -0.976 . . . . 0.0 111.467 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 mt -83.86 -30.07 26.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.324 1.449 . . . . 0.0 111.859 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -56.79 -36.52 69.96 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.804 0.729 . . . . 0.0 109.797 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -91.24 -52.55 4.76 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.179 0.992 . . . . 0.0 111.584 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.77 54.09 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.372 1.069 . . . . 0.0 113.475 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.17 -26.53 9.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.22 -33.21 37.94 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 124.869 1.223 . . . . 0.0 114.502 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -57.01 -37.82 72.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -79.63 -20.99 45.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.387 0.675 . . . . 0.0 112.656 -170.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.49 175.91 26.19 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 125.553 1.549 . . . . 0.0 113.556 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.24 116.44 2.68 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.186 3.924 . . . . 0.0 115.173 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.39 161.26 29.4 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 110.502 159.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -126.93 -29.73 2.79 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.633 1.973 . . . . 0.0 112.585 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -154.54 164.08 39.23 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.709 0.686 . . . . 0.0 111.195 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.38 131.22 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.719 1.208 . . . . 0.0 111.766 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -158.32 165.6 34.37 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.39 1.476 . . . . 0.0 110.983 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . 0.263 1.3 m -142.76 143.97 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.965 -1.085 . . . . 0.0 112.808 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 126.334 1.854 . . . . 0.0 112.732 -178.127 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.185 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -139.64 134.28 31.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.487 1.515 . . . . 0.0 110.808 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.54 151.24 51.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.28 1.832 . . . . 0.0 113.743 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.42 129.38 31.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 76' ' ' VAL . 3.4 m -143.63 -178.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 110.764 -166.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -141.41 152.01 43.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.168 -0.957 . . . . 0.0 112.257 170.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.406 ' CD1' HG11 ' A' ' 76' ' ' VAL . 3.6 m-85 -117.45 169.01 9.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.018 2.527 . . . . 0.0 110.764 171.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.48 3.28 40.1 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -156.44 137.18 9.13 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.2 -38.42 33.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 125.221 3.947 . . . . 0.0 117.517 168.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.8 -59.33 5.39 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 120.42 1.464 . . . . 0.0 110.127 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.16 -41.91 76.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.989 1.716 . . . . 0.0 110.907 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.75 -52.71 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.029 1.732 . . . . 0.0 113.255 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.41 65.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.195 1.361 . . . . 0.0 111.503 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -47.92 82.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.894 . . . . 0.0 111.868 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.36 -9.7 58.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.703 1.601 . . . . 0.0 114.617 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.2 -46.62 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.288 -1.508 . . . . 0.0 108.953 157.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.72 -20.9 65.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -114.62 -12.5 12.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.64 1.176 . . . . 0.0 111.899 -173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.21 -10.22 0.57 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -156.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -71.92 141.79 49.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.966 0.803 . . . . 0.0 111.96 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.63 15.52 62.01 Favored Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.433 1.492 . . . . 0.0 114.958 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.3 179.04 6.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.337 1.455 . . . . 0.0 112.49 -168.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 99.8 m -136.16 89.67 2.5 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.101 1.36 . . . . 0.0 110.686 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.4 -32.47 42.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 112.777 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.5 m -145.75 17.07 1.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.858 1.263 . . . . 0.0 114.122 -165.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.94 -4.41 65.53 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 113.827 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.1 p -63.99 -179.51 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.545 1.938 . . . . 0.0 113.538 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -130.74 63.29 1.58 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.581 1.152 . . . . 0.0 108.75 155.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 p -50.53 141.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.269 1.828 . . . . 0.0 112.048 -169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.1 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.292 1.437 . . . . 0.0 109.346 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.8 t -144.25 129.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -148.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.479 0.988 0 O-C-N 120.706 -1.246 . . . . 0.0 111.335 167.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -130.87 130.82 44.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 133.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.03 112.91 12.77 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.974 -1.079 . . . . 0.0 113.527 -174.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.61 111.79 20.38 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.594 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 9.6 mt -77.2 117.23 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 129.189 2.995 . . . . 0.0 110.419 158.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.15 123.77 30.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.798 161.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.32 34.6 3.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.196 1.799 . . . . 0.0 110.911 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 150.37 20.98 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.033 -1.042 . . . . 0.0 114.422 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -49.16 -37.54 22.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 110.655 155.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 m -57.71 -55.17 38.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.815 2.846 . . . . 0.0 113.419 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 13' ' ' LYS . 1.8 tm? -165.26 140.16 5.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.99 1.716 . . . . 0.0 109.824 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' N ' HD13 ' A' ' 12' ' ' LEU . 7.3 mtpm? -128.7 119.52 24.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.901 1.28 . . . . 0.0 110.745 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.52 85.41 0.06 OUTLIER Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.163 0.887 . . . . 0.0 112.949 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -31.77 159.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 158.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 t -140.43 -27.7 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 7.1 p 61.86 162.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -171.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -158.96 -172.41 3.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.374 2.27 . . . . 0.0 107.733 159.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -138.16 146.72 43.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 120.189 -1.569 . . . . 0.0 111.531 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.41 -174.77 5.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 111.972 -163.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.8 -50.91 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.11 166.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -165.99 175.85 8.23 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.284 1.516 . . . . 0.0 112.045 -156.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.13 17.92 0.09 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.567 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.69 7.84 6.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.111 1.364 . . . . 0.0 111.545 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.8 p -135.42 -26.27 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.958 2.503 . . . . 0.0 112.29 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.5 -47.03 16.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.618 163.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.42 -47.5 75.87 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -21.31 6.76 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.982 1.313 . . . . 0.0 114.408 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.02 -34.57 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.032 1.733 . . . . 0.0 110.914 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.4 m-30 -54.39 -43.0 71.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.339 0.972 . . . . 0.0 113.549 165.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -37.25 -57.28 0.9 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.423 2.289 . . . . 0.0 110.452 166.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -80.39 -32.25 37.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.975 1.71 . . . . 0.0 114.729 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -59.0 -44.7 91.71 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.431 1.014 . . . . 0.0 111.087 168.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.66 58.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.46 -31.39 72.1 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.051 0.841 . . . . 0.0 112.272 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.9 -37.99 76.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.718 1.207 . . . . 0.0 113.219 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -66.05 -44.2 85.28 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.695 -0.628 . . . . 0.0 111.784 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.07 13.66 0.59 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.984 1.754 . . . . 0.0 114.052 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.87 144.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.957 1.703 . . . . 0.0 111.877 -166.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -132.56 8.22 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.957 0.903 . . . . 0.0 112.849 158.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 56' ' ' GLU . . . 45.12 -132.2 8.26 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 123.018 1.343 . . . . 0.0 114.193 166.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -136.16 42.22 2.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.191 1.796 . . . . 0.0 106.615 167.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 26.3 m95 -3.22 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 130.525 3.53 . . . . 0.0 115.939 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.0 m -83.89 157.97 21.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.109 0.956 . . . . 0.0 109.774 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -137.64 145.53 42.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.211 1.404 . . . . 0.0 110.112 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -133.2 56.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.447 1.499 . . . . 0.0 110.278 -155.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.88 -32.35 1.56 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.084 2.953 . . . . 0.0 116.822 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.82 -21.88 61.48 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.061 2.144 . . . . 0.0 112.624 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -131.78 7.91 4.45 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 112.846 167.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm 63.76 2.24 1.27 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.975 2.51 . . . . 0.0 114.61 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.5 m -52.52 161.98 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 129.741 3.216 . . . . 0.0 113.127 166.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -132.1 155.33 48.32 Favored 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 132.053 4.141 . . . . 0.0 110.039 171.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -144.92 121.22 10.9 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.999 0.428 . . . . 0.0 111.786 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.97 90.91 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 122.535 1.159 . . . . 0.0 112.53 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.56 39.23 0.82 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -163.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 9.7 tm-20 . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -170.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.441 0.639 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.04 144.28 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.711 0.804 . . . . 0.0 109.651 168.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -121.94 147.56 45.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.61 0.764 . . . . 0.0 111.61 -158.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.28 151.87 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.952 0.901 . . . . 0.0 110.56 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 -172.57 36.25 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 118.336 2.094 . . . . 0.0 118.336 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t30 53.28 36.22 22.17 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.378 1.871 . . . . 0.0 113.542 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.85 9.55 43.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.089 1.756 . . . . 0.0 113.238 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.94 -21.03 6.95 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.018 1.771 . . . . 0.0 117.034 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -54.52 -33.11 59.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 113.233 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -131.78 -45.74 0.96 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.104 1.762 . . . . 0.0 111.545 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.73 77.3 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 129.111 3.243 . . . . 0.0 115.661 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -139.75 167.53 21.88 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.557 1.143 . . . . 0.0 111.518 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -68.9 -37.43 78.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -79.86 -29.19 40.01 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.974 -1.079 . . . . 0.0 113.462 -163.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.95 -18.54 63.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.2 mt -96.67 -34.19 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.316 1.446 . . . . 0.0 111.666 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -54.12 -36.47 63.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.733 0.697 . . . . 0.0 110.893 168.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.88 -55.98 4.87 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.77 45.25 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -117.19 -30.29 5.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.863 1.265 . . . . 0.0 111.091 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.72 -35.58 17.21 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.033 1.301 . . . . 0.0 114.804 164.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -54.04 -41.95 68.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -78.43 -30.97 47.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.255 -171.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.59 40.74 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 -170.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.45 112.22 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.168 3.245 . . . . 0.0 112.072 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.13 156.69 37.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.737 0.78 . . . . 0.0 111.003 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -134.01 -21.89 1.85 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 112.878 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 m -163.74 166.52 22.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.006 1.322 . . . . 0.0 111.558 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.67 131.29 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.906 1.282 . . . . 0.0 110.519 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -150.05 144.11 25.57 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.25 1.42 . . . . 0.0 111.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.76 149.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.594 -1.316 . . . . 0.0 113.73 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 127.19 2.196 . . . . 0.0 110.45 174.729 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 CA-C-O 119.921 -0.377 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.89 142.97 49.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.704 1.202 . . . . 0.0 111.566 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.2 161.8 27.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.513 1.925 . . . . 0.0 113.227 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.5 137.13 30.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.911 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.02 168.55 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 109.506 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -139.42 149.74 44.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.86 178.13 5.66 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.315 2.246 . . . . 0.0 111.3 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -126.63 29.24 5.75 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.825 1.25 . . . . 0.0 112.543 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -160.24 119.37 1.6 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.132 1.373 . . . . 0.0 111.312 163.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.04 -43.29 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 125.168 3.912 . . . . 0.0 116.165 167.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -58.5 -38.74 78.31 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.013 1.725 . . . . 0.0 113.408 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.65 -37.38 19.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.32 92.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.741 0.701 . . . . 0.0 112.156 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.92 93.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.81 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.62 -40.39 66.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.433 1.015 . . . . 0.0 113.649 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.99 -10.57 10.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 114.333 169.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.75 -50.92 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.619 1.1 . . . . 0.0 110.571 158.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -54.19 -31.83 53.98 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.39 1.876 . . . . 0.0 113.688 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.65 -2.07 42.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.841 1.656 . . . . 0.0 112.937 -173.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.54 -24.45 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -153.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.88 109.76 0.23 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.098 1.759 . . . . 0.0 112.427 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.34 85.07 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -105.15 -122.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.814 1.307 . . . . 0.0 111.796 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -150.69 142.52 23.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.413 1.485 . . . . 0.0 109.317 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.88 -35.93 2.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.425 1.09 . . . . 0.0 113.465 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 89.8 m -146.61 23.7 1.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.535 1.934 . . . . 0.0 111.811 -163.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.31 -10.41 63.93 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.817 1.675 . . . . 0.0 114.412 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.0 p -70.11 -179.69 2.03 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.837 2.455 . . . . 0.0 113.223 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -126.5 135.39 51.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.678 1.591 . . . . 0.0 108.048 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.79 171.67 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.127 0.571 . . . . 0.0 112.252 -145.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -133.11 147.49 52.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.635 1.974 . . . . 0.0 109.525 159.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.88 130.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.939 0.896 . . . . 0.0 108.639 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 125.911 1.684 . . . . 0.0 112.507 -170.425 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.749 0.785 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -140.91 106.51 5.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.6 ttpt -123.32 128.45 49.94 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 124.307 1.043 . . . . 0.0 112.279 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 43' ' ' TRP . 30.0 tp -98.34 103.76 15.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.178 1.791 . . . . 0.0 108.878 162.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 10.9 mt -72.23 114.63 11.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 128.498 2.719 . . . . 0.0 110.135 160.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.99 125.1 34.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.33 166.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -134.96 48.41 2.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.125 1.77 . . . . 0.0 109.88 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -112.2 150.89 18.17 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.925 1.25 . . . . 0.0 113.331 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -59.97 -24.06 64.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.148 1.379 . . . . 0.0 111.075 162.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.6 m -57.47 -56.59 19.95 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.315 1.846 . . . . 0.0 111.91 162.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 13' ' ' LYS . 3.0 tm? -164.37 139.53 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.311 1.845 . . . . 0.0 111.126 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 9' ' ' GLY . 24.0 mtmt -122.49 110.12 15.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.311 1.844 . . . . 0.0 110.259 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.19 83.82 0.04 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.039 0.828 . . . . 0.0 112.825 -166.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -29.48 155.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.919 1.688 . . . . 0.0 115.513 155.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -134.38 -26.07 1.47 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.047 2.239 . . . . 0.0 117.047 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.0 p 57.46 167.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 -175.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.3 t -160.84 -171.48 3.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.02 2.528 . . . . 0.0 107.623 162.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -140.12 131.66 27.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.517 1.527 . . . . 0.0 108.464 170.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.74 176.53 8.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.384 1.088 . . . . 0.0 113.439 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 7.7 t -58.54 -50.74 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.362 1.865 . . . . 0.0 111.259 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.82 172.57 4.06 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.187 1.795 . . . . 0.0 109.824 -154.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.68 -3.28 11.48 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.8 -43.21 3.65 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 120.552 1.524 . . . . 0.0 108.503 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -63.66 -21.37 66.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.708 1.14 . . . . 0.0 112.818 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.35 8.19 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.796 0.725 . . . . 0.0 111.663 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -61.3 -46.22 91.2 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -58.58 -20.19 44.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 -41.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.479 1.911 . . . . 0.0 110.868 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 18' ' ' THR . 12.6 m-85 -54.73 -38.77 67.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -45.77 -52.8 10.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.178 1.791 . . . . 0.0 110.318 171.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -75.75 -34.05 60.26 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.118 1.767 . . . . 0.0 114.525 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -59.26 -42.24 90.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.797 1.181 . . . . 0.0 111.211 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.56 -34.17 47.23 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.254 -0.904 . . . . 0.0 110.488 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -70.45 -27.24 64.09 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.725 0.693 . . . . 0.0 112.542 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.95 -37.61 75.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.979 1.312 . . . . 0.0 112.863 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -66.36 -53.03 40.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.18 0.592 . . . . 0.0 111.318 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.22 20.2 0.3 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.734 1.635 . . . . 0.0 114.474 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.1 150.27 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 112.526 -167.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.56 -0.27 2.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.642 1.177 . . . . 0.0 112.746 161.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 41.45 -113.79 0.54 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-O 124.422 2.123 . . . . 0.0 113.739 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -2.45 7.11 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 131.318 3.847 . . . . 0.0 109.652 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 41.6 m95 27.25 72.47 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.912 2.885 . . . . 0.0 114.26 -153.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.3 m -71.31 157.11 38.66 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 110.452 170.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -146.17 156.14 43.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.915 1.686 . . . . 0.0 111.423 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -133.77 135.39 43.87 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 127.365 2.266 . . . . 0.0 109.858 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.24 -16.05 14.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.2 60.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.465 1.506 . . . . 0.0 112.106 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -125.2 -1.63 7.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.394 1.878 . . . . 0.0 112.52 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.384 55.2 mttm 60.07 19.47 8.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.427 1.891 . . . . 0.0 114.259 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -67.03 162.77 21.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.111 2.564 . . . . 0.0 113.957 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.98 158.72 41.98 Favored 'General case' 0 C--N 1.327 -0.404 1 C-N-CA 132.34 4.256 . . . . 0.0 110.514 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -145.19 144.56 30.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.757 -0.589 . . . . 0.0 111.292 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.2 94.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.087 1.355 . . . . 0.0 112.443 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -95.79 58.93 2.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.0 113.605 -169.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 O-C-N 120.921 -1.112 . . . . 0.0 113.298 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.334 9.8 ptpt . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 115' ' ' VAL . 14.8 t -130.88 143.37 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 119.785 1.175 . . . . 0.0 112.629 -160.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -135.67 132.87 37.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.613 1.965 . . . . 0.0 108.711 172.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.64 150.64 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.188 0.518 . . . . 0.0 109.854 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.37 -169.34 29.85 Favored Glycine 0 N--CA 1.465 0.631 0 O-C-N 121.337 -0.852 . . . . 0.0 114.402 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 60.87 4.86 0.85 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 85' ' ' GLY . 2.2 tm? -62.59 -49.61 74.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.471 1.032 . . . . 0.0 110.458 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.82 -60.11 0.34 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.536 2.017 . . . . 0.0 116.923 168.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -81.75 -13.74 57.38 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -159.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.89 -57.79 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 109.134 165.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.537 ' H ' HD12 ' A' ' 81' ' ' LEU . . . 38.26 62.67 1.05 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.794 2.14 . . . . 0.0 114.885 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -127.77 -42.61 1.59 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 pttp 139.75 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 1 C-N-CA 131.709 4.003 . . . . 0.0 112.171 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 m -79.57 -35.71 39.33 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.75 -0.594 . . . . 0.0 111.497 -167.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -40.76 76.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.118 -0.989 . . . . 0.0 111.519 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.0 mt -78.24 -31.3 49.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.617 0.767 . . . . 0.0 112.606 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.67 -37.96 68.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.943 1.247 . . . . 0.0 110.078 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -104.43 -42.44 5.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.386 -164.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.26 -34.55 66.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.138 0.575 . . . . 0.0 112.007 168.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -95.65 -29.83 14.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.73 -33.21 26.71 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.02 1.295 . . . . 0.0 114.205 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -57.52 -40.1 77.99 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -76.71 -27.61 55.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.07 -171.14 37.91 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 114.817 0.687 . . . . 0.0 114.817 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.09 135.02 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.828 3.019 . . . . 0.0 112.56 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.99 157.97 17.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.963 1.705 . . . . 0.0 110.043 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -127.67 -27.5 2.84 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.446 1.899 . . . . 0.0 112.669 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -168.32 155.84 8.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.808 1.243 . . . . 0.0 110.226 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -153.21 129.08 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.223 1.809 . . . . 0.0 108.902 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -148.85 160.38 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.923 0.889 . . . . 0.0 111.953 166.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.4 147.03 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.406 -0.809 . . . . 0.0 112.945 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 125.561 1.544 . . . . 0.0 111.319 169.579 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.064 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -127.31 139.49 52.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.924 1.69 . . . . 0.0 110.225 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.35 158.85 43.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.547 1.539 . . . . 0.0 114.685 -157.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.93 125.63 17.96 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.449 1.1 . . . . 0.0 108.869 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.7 m -138.26 -175.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -172.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -147.47 110.83 4.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.47 1.908 . . . . 0.0 109.547 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -75.02 173.02 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 111.224 158.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.13 37.37 2.12 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.883 0.849 . . . . 0.0 113.171 166.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.25 130.72 7.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 120.952 -1.092 . . . . 0.0 110.906 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 -37.76 4.85 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.133 2.555 . . . . 0.0 113.671 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -71.23 -44.65 64.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.396 1.078 . . . . 0.0 110.758 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.17 -34.86 78.43 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.382 0.673 . . . . 0.0 112.354 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.55 -46.98 68.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -31.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.991 -1.068 . . . . 0.0 110.959 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.13 -43.89 60.99 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 119.228 0.922 . . . . 0.0 112.508 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.65 -2.5 6.92 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.861 1.264 . . . . 0.0 113.964 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.49 -56.83 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 120.558 -1.339 . . . . 0.0 109.921 151.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -55.2 -29.75 58.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.522 1.529 . . . . 0.0 113.651 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -102.47 -12.04 18.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.725 1.61 . . . . 0.0 112.367 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.46 -5.48 0.65 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -154.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.6 p30 -57.91 -6.86 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 166.01 62.64 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.56 -0.712 . . . . 0.0 112.316 -151.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -135.68 -165.73 1.74 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.743 1.617 . . . . 0.0 111.719 -167.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.4 m -131.01 115.9 17.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.76 1.624 . . . . 0.0 109.288 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.37 -34.92 6.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.7 m -140.43 24.75 2.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.047 1.339 . . . . 0.0 112.739 -165.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.36 29.67 39.69 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 121.024 -1.047 . . . . 0.0 112.96 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.77 -165.98 1.55 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.77 2.428 . . . . 0.0 111.357 -167.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -139.64 55.56 1.66 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.842 0.857 . . . . 0.0 112.061 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.3 p -46.11 146.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 127.034 2.134 . . . . 0.0 114.091 -174.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.85 133.05 35.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.803 2.441 . . . . 0.0 109.441 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 46.7 t -143.42 136.42 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.785 0.434 . . . . 0.0 111.493 -158.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 127.504 2.322 . . . . 0.0 108.513 173.511 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.916 0.389 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.6 104.34 5.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 164.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.06 113.85 9.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.878 1.271 . . . . 0.0 112.836 -163.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.0 tp -99.84 101.85 13.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 110.434 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.03 124.09 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 128.343 2.657 . . . . 0.0 110.012 158.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.16 133.74 45.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.736 168.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -148.14 49.5 1.04 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.93 2.092 . . . . 0.0 109.723 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.58 157.48 21.32 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 120.539 -1.35 . . . . 0.0 112.924 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -55.49 -37.47 67.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.152 0.981 . . . . 0.0 110.179 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.492 HG21 ' HA3' ' A' ' 38' ' ' GLY . 85.0 m -56.78 -72.24 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.913 2.485 . . . . 0.0 112.967 164.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -140.59 132.71 27.97 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.441 1.096 . . . . 0.0 110.613 -161.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -132.28 123.23 26.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.244 1.818 . . . . 0.0 109.169 -175.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.84 99.11 0.81 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.469 1.033 . . . . 0.0 112.024 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -32.22 164.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.019 2.528 . . . . 0.0 116.941 165.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -129.06 -38.72 1.61 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.2 p 57.58 162.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -158.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -151.03 -6.94 0.26 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 28.17 99.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.806 3.242 . . . . 0.0 117.549 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.77 -159.6 0.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.447 1.499 . . . . 0.0 113.353 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.77 -17.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.537 1.935 . . . . 0.0 111.936 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -145.13 -11.1 0.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.58 -0.41 3.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.431 2.692 . . . . 0.0 115.445 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.51 -46.2 4.83 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 125.51 1.524 . . . . 0.0 107.956 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.64 -19.72 58.86 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.629 1.972 . . . . 0.0 113.455 162.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -54.2 6.61 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 119.402 1.001 . . . . 0.0 110.922 167.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.65 -43.95 91.97 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -60.77 -16.85 44.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.34 -41.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.427 2.291 . . . . 0.0 110.295 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.0 m-85 -53.63 -43.8 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.606 1.094 . . . . 0.0 113.701 168.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -58.15 1.44 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.944 2.097 . . . . 0.0 110.866 168.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.6 -30.89 46.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 114.918 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -59.5 -43.61 93.29 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.543 1.065 . . . . 0.0 110.928 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.95 -32.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.406 -0.809 . . . . 0.0 110.864 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.84 -26.74 67.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 118.335 0.516 . . . . 0.0 112.307 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.85 -48.39 59.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.837 1.655 . . . . 0.0 113.324 164.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.33 -38.61 87.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.595 0.634 . . . . 0.0 111.975 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' HA3' HG21 ' A' ' 11' ' ' THR . . . 128.62 28.37 0.82 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.524 1.535 . . . . 0.0 113.648 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.49 142.72 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.713 1.605 . . . . 0.0 111.176 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.86 113.71 5.41 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.376 1.084 . . . . 0.0 109.797 143.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -152.83 8.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-O 124.369 2.094 . . . . 0.0 115.387 -156.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.37 58.43 2.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 111.334 -2.433 . . . . 0.0 108.519 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 22.1 m95 -47.35 98.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.691 2.397 . . . . 0.0 112.019 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -121.98 159.28 27.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.341 1.856 . . . . 0.0 109.943 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.32 156.81 42.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.628 1.571 . . . . 0.0 111.127 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -135.29 113.1 10.95 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.729 2.012 . . . . 0.0 110.141 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.01 -18.6 53.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.61 -25.35 56.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.457 1.103 . . . . 0.0 111.863 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -120.69 -4.05 9.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.298 1.439 . . . . 0.0 112.949 167.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.385 37.8 mttm 56.42 24.66 8.71 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.86 2.064 . . . . 0.0 114.286 -171.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -73.12 155.06 40.07 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.553 1.941 . . . . 0.0 111.923 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.66 159.15 36.5 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 129.35 3.06 . . . . 0.0 111.37 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -143.8 136.76 27.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 2.3 m -111.89 96.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.514 1.15 . . . . 0.0 112.847 157.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 106.15 15.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.68 1.192 . . . . 0.0 109.324 165.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 . . . . . 0 CA--C 1.549 0.911 0 O-C-N 120.878 -1.139 . . . . 0.0 112.277 174.897 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -118.92 145.69 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.091 -1.006 . . . . 0.0 112.712 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -131.59 147.09 52.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.65 2.78 . . . . 0.0 108.808 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 5.3 t -138.01 150.42 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.442 1.097 . . . . 0.0 109.591 172.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.22 -168.73 20.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.36 -6.79 1.94 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.59 2.356 . . . . 0.0 114.646 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 51.76 2.31 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 122.747 1.261 . . . . 0.0 113.353 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.22 -20.34 69.14 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -67.89 -32.05 72.27 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.134 1.467 . . . . 0.0 113.213 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.94 -21.48 0.18 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -49.09 109.85 0.65 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 119.84 1.2 . . . . 0.0 115.081 -157.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -133.39 -25.58 1.72 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.678 1.991 . . . . 0.0 113.545 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 139.22 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 1 C-N-CA 132.787 4.435 . . . . 0.0 111.685 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -66.62 -44.11 82.93 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.814 0.734 . . . . 0.0 112.17 -163.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 1.5 pm0 -53.96 -34.82 60.77 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.8 mt -83.94 -37.74 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.469 1.107 . . . . 0.0 111.836 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -55.41 -36.5 66.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.941 1.297 . . . . 0.0 109.896 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.66 -54.79 5.33 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.04 -11.57 40.75 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -119.29 -30.66 4.87 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.369 1.068 . . . . 0.0 113.001 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.3 -31.5 50.34 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 119.509 1.049 . . . . 0.0 113.784 168.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -62.5 -41.02 98.54 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 172.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.87 -25.23 48.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.902 0.481 . . . . 0.0 111.955 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.62 -172.98 43.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.245 0.858 . . . . 0.0 115.245 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.69 131.03 17.86 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.643 2.895 . . . . 0.0 112.361 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.16 148.91 28.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.215 1.806 . . . . 0.0 109.478 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -123.83 -22.03 5.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.022 1.729 . . . . 0.0 113.188 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -164.29 153.15 13.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.034 1.334 . . . . 0.0 110.358 172.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.0 t -151.98 135.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.0 108.767 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -150.58 152.6 34.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.559 1.544 . . . . 0.0 111.137 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -146.54 146.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.991 -1.068 . . . . 0.0 111.472 172.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.994 . . . . 0.0 111.669 -177.399 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 119.649 -0.529 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.5 139.39 49.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.183 1.793 . . . . 0.0 110.798 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -130.82 166.19 21.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.725 2.01 . . . . 0.0 113.74 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.97 142.12 34.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.237 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.27 1.3 m -141.45 178.85 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.291 1.043 . . . . 0.0 112.296 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.05 104.63 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.767 2.027 . . . . 0.0 108.07 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.89 174.82 0.44 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.794 0.838 . . . . 0.0 112.584 155.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -115.72 -12.51 11.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.303 1.041 . . . . 0.0 112.71 164.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.91 140.76 21.38 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.052 1.341 . . . . 0.0 111.885 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.45 -37.59 0.94 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.694 2.93 . . . . 0.0 114.969 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -28.57 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.71 -1.244 . . . . 0.0 113.991 -159.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.23 -24.03 63.96 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.594 -0.691 . . . . 0.0 111.052 161.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 -47.16 66.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.807 1.243 . . . . 0.0 113.647 161.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.36 65.08 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 120.275 -1.516 . . . . 0.0 110.739 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -43.21 77.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 172.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.73 -8.62 2.16 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 166.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.48 -53.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.863 1.665 . . . . 0.0 110.743 157.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -59.86 -21.85 61.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.148 1.779 . . . . 0.0 112.882 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -107.51 -9.06 16.03 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.089 1.756 . . . . 0.0 111.537 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.12 -4.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -153.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -5.67 41.07 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.861 1.21 . . . . 0.0 113.763 168.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.75 46.89 0.53 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.418 1.485 . . . . 0.0 113.773 -159.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -132.19 177.97 7.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.155 0.982 . . . . 0.0 113.007 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.6 m -113.55 123.06 49.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.448 1.499 . . . . 0.0 109.129 168.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mp -129.52 145.59 51.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.007 2.523 . . . . 0.0 107.99 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.0 m 52.41 18.96 1.03 Allowed 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.96 60.18 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.277 1.418 . . . . 0.0 114.01 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.14 147.28 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.148 1.779 . . . . 0.0 111.226 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -52.58 148.07 7.58 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.99 152.01 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.316 . . . . 0.0 109.915 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 147.25 50.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.349 1.059 . . . . 0.0 108.342 167.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.48 158.15 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.308 0.643 . . . . 0.0 111.817 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 125.339 1.456 . . . . 0.0 107.584 165.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.781 0.324 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.51 109.68 8.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 160.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.3 ttmm -131.13 135.72 47.72 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 127.018 2.127 . . . . 0.0 109.18 -169.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -114.41 98.82 7.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.358 1.863 . . . . 0.0 108.554 162.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.36 124.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.903 1.681 . . . . 0.0 108.738 158.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.24 135.22 38.36 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.934 166.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -144.84 53.19 1.22 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.26 1.024 . . . . 0.0 109.078 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.83 175.8 21.74 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.739 1.188 . . . . 0.0 114.044 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -49.42 77.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 109.758 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -56.2 -52.1 65.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.931 1.692 . . . . 0.0 113.339 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.82 142.43 13.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.474 1.11 . . . . 0.0 110.649 -170.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.12 138.04 53.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.649 1.58 . . . . 0.0 110.256 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.52 -133.38 4.84 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.343 1.449 . . . . 0.0 110.138 -157.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -162.64 -169.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.146 1.778 . . . . 0.0 109.433 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -136.29 -45.26 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 158.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.8 p 55.94 164.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.281 1.432 . . . . 0.0 114.633 -159.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -155.46 -19.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.44 142.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 128.051 2.54 . . . . 0.0 116.062 -161.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.75 177.92 9.1 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.035 -1.666 . . . . 0.0 114.368 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.24 -39.28 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.258 1.823 . . . . 0.0 111.823 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -151.03 -8.06 0.25 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -146.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.39 27.09 15.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.287 1.835 . . . . 0.0 114.01 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.37 -38.31 0.61 Allowed 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 124.417 1.087 . . . . 0.0 111.039 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 95.1 m -64.53 -15.61 61.2 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.251 2.22 . . . . 0.0 112.453 155.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.95 7.21 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 110.8 165.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.35 -47.34 86.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 1.7 ptpp? -59.91 -15.75 24.11 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -171.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.5 -43.96 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.48 1.912 . . . . 0.0 111.034 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.7 -43.31 68.86 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.232 1.013 . . . . 0.0 112.753 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.4 mmpt? -40.97 -49.61 3.28 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.813 2.045 . . . . 0.0 112.111 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -94.92 -21.33 18.71 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.77 -37.75 74.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.051 0.841 . . . . 0.0 110.077 160.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.84 -39.16 27.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.524 -0.735 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.4 -23.18 61.06 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.245 -0.909 . . . . 0.0 111.539 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.06 -36.32 79.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.916 1.287 . . . . 0.0 113.374 164.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -69.33 -15.81 63.41 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.792 0.837 . . . . 0.0 112.73 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.35 25.54 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.638 1.59 . . . . 0.0 112.859 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -112.44 124.2 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 125.386 1.474 . . . . 0.0 112.225 -161.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.3 9.87 7.96 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.271 152.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 35.8 -134.98 0.56 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 128.189 2.804 . . . . 0.0 119.889 151.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -124.19 49.32 1.79 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.84 2.456 . . . . 0.0 106.673 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 20.7 m95 -42.75 104.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.285 1.834 . . . . 0.0 113.225 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 m -125.37 157.49 36.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 109.668 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -148.18 155.8 41.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.619 1.568 . . . . 0.0 111.335 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -134.73 130.46 36.26 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 126.106 1.762 . . . . 0.0 110.278 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -97.72 -18.16 18.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.461 1.104 . . . . 0.0 113.12 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.55 63.21 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.819 1.248 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -122.7 -2.79 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.574 1.549 . . . . 0.0 113.156 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.375 35.8 mttm 59.78 21.29 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.825 1.65 . . . . 0.0 114.321 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.4 m -73.69 160.06 32.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.746 2.418 . . . . 0.0 113.362 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -134.21 158.19 44.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 130.862 3.665 . . . . 0.0 110.705 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.3 m -146.88 133.73 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.187 0.595 . . . . 0.0 110.991 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.1 96.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 159.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.59 62.29 7.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.311 1.529 . . . . 0.0 112.612 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 124.058 0.943 . . . . 0.0 113.477 -176.525 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 116' ' ' GLU . 20.2 tttt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 116.039 -1.934 . . . . 0.0 107.402 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 115' ' ' VAL . 7.5 p -137.93 146.92 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 123.492 2.86 . . . . 0.0 116.714 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -140.57 156.97 46.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.922 2.089 . . . . 0.0 111.814 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -139.75 158.27 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 120.957 -1.09 . . . . 0.0 112.908 -176.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -170.31 -167.42 30.71 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 169.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.24 20.81 7.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.588 1.555 . . . . 0.0 115.036 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.55 51.42 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 111.716 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.41 -17.76 33.75 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.386 1.946 . . . . 0.0 115.895 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.47 -55.31 10.61 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.57 1.185 . . . . 0.0 111.467 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -131.94 -22.55 2.32 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 8.47 74.15 0.01 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.68 3.038 . . . . 0.0 117.839 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -135.27 162.79 31.56 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.415 1.107 . . . . 0.0 113.646 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -60.5 -43.84 96.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.596 1.558 . . . . 0.0 113.158 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -86.46 -29.77 22.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -163.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.81 -31.38 64.65 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.316 -1.49 . . . . 0.0 111.727 164.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.93 -22.25 22.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.044 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.13 -34.77 75.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.259 1.391 . . . . 0.0 109.359 167.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -80.2 -64.91 1.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.638 1.175 . . . . 0.0 111.206 174.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -4.28 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -123.6 -30.62 3.59 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.487 1.039 . . . . 0.0 112.18 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.98 -27.71 30.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.174 1.352 . . . . 0.0 115.189 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -55.03 -38.79 68.41 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.0 -16.97 54.06 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.18 -170.82 33.9 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.105 0.86 . . . . 0.0 114.741 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.27 101.91 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.13 3.22 . . . . 0.0 112.443 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.18 68.23 2.57 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.288 1.835 . . . . 0.0 111.808 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -12.43 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.076 2.15 . . . . 0.0 114.342 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.3 m -150.44 150.25 31.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.541 1.064 . . . . 0.0 110.819 161.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.14 116.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 110.143 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -146.43 147.11 30.91 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.34 1.856 . . . . 0.0 109.219 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.06 154.33 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.387 -0.821 . . . . 0.0 112.391 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 125.735 1.614 . . . . 0.0 111.902 173.904 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.539 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 61.2 m-85 -130.09 136.67 49.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.703 1.201 . . . . 0.0 111.213 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -132.44 156.59 46.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.62 1.2 . . . . 0.0 113.586 -167.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 136.88 54.29 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.444 1.498 . . . . 0.0 108.533 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -139.24 164.97 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.934 0.894 . . . . 0.0 111.373 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.437 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 44.7 mt-10 -144.34 142.33 30.31 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 109.526 170.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -119.2 140.57 49.98 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 156.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.4 29.16 0.3 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.259 -0.9 . . . . 0.0 112.94 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -152.79 137.83 11.15 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 126.083 1.753 . . . . 0.0 111.559 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.73 -51.35 9.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.553 3.502 . . . . 0.0 117.203 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.35 -14.61 22.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -160.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.31 -45.22 66.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.551 0.614 . . . . 0.0 110.536 165.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.74 77.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 111.935 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.97 78.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.44 -1.267 . . . . 0.0 110.849 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.55 -40.84 61.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.356 1.435 . . . . 0.0 113.172 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.02 -14.33 6.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.588 1.555 . . . . 0.0 114.03 166.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.6 -47.92 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 120.127 1.33 . . . . 0.0 111.699 161.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.84 -36.27 62.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.868 2.067 . . . . 0.0 112.987 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.19 -11.64 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.024 1.329 . . . . 0.0 112.516 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.09 -27.89 0.63 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -148.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -45.07 101.65 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.055 2.542 . . . . 0.0 112.114 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.4 27.01 73.31 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.075 -0.847 . . . . 0.0 114.568 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -97.16 -138.51 0.27 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.611 1.205 . . . . 0.0 111.452 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 138' ' ' CYS . 52.9 m -152.91 143.17 22.47 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.683 2.793 . . . . 0.0 108.346 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.53 -42.32 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 112.377 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 87.1 m -137.23 29.51 2.74 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.493 1.117 . . . . 0.0 112.744 -155.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.27 44.76 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.369 -0.832 . . . . 0.0 112.415 -170.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.421 ' H ' HG23 ' A' ' 134' ' ' THR . 31.6 p -129.4 -174.91 3.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.17 2.188 . . . . 0.0 112.314 -166.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 89.96 2.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 108.346 174.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.7 172.39 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.063 0.945 . . . . 0.0 112.756 -168.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.657 1.583 . . . . 0.0 108.932 151.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 t -136.7 134.66 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 C--O 1.235 0.334 0 C-N-CA 124.186 0.995 . . . . 0.0 109.55 -171.851 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.481 0.658 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.86 105.37 8.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.95 107.21 8.55 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.716 0.807 . . . . 0.0 112.116 -164.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 54' ' ' VAL . 42.9 tp -97.63 92.39 5.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.625 1.57 . . . . 0.0 109.84 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.25 105.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.602 2.361 . . . . 0.0 109.203 162.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.557 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 mp -82.53 132.01 35.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.5 ' HB3' HG23 ' A' ' 55' ' ' THR . 67.5 m-20 -137.08 44.73 2.28 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.938 2.095 . . . . 0.0 108.183 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.85 51.34 Favored Glycine 0 C--N 1.338 0.685 0 O-C-N 120.439 -1.413 . . . . 0.0 115.451 -161.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -56.23 -48.03 77.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.856 1.662 . . . . 0.0 109.857 160.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m -78.99 -62.48 1.69 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.449 2.3 . . . . 0.0 113.849 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.87 145.01 34.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.511 1.124 . . . . 0.0 110.409 -166.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 119.98 21.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.549 1.94 . . . . 0.0 110.144 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.62 23.1 0.09 OUTLIER Glycine 0 N--CA 1.477 1.407 0 N-CA-C 119.898 2.719 . . . . 0.0 119.898 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 57.34 -176.46 0.06 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -150.79 -32.49 0.17 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p 59.22 163.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.3 t -161.5 -163.51 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.358 2.663 . . . . 0.0 106.994 157.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.12 138.7 35.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 120.092 -1.63 . . . . 0.0 108.924 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.04 -171.13 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 123.508 1.623 . . . . 0.0 112.887 -165.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.31 -22.69 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 112.474 -2.148 . . . . 0.0 111.343 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -140.28 -57.69 0.54 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 129.89 -30.55 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 131.138 3.775 . . . . 0.0 112.243 -162.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.9 -36.01 25.67 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.723 1.209 . . . . 0.0 110.293 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -76.19 -20.97 57.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.444 3.098 . . . . 0.0 112.447 167.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.47 -52.83 8.44 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.457 -0.777 . . . . 0.0 109.968 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -47.05 47.21 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 125.685 1.594 . . . . 0.0 108.596 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -20.29 16.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -170.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.94 -40.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.386 1.474 . . . . 0.0 109.629 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.1 m-30 -51.51 -46.0 63.1 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.56 1.144 . . . . 0.0 112.922 166.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.7 mmpt? -42.0 -46.84 4.28 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.572 1.549 . . . . 0.0 112.277 170.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -100.21 -19.08 16.57 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.29 -39.07 74.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.023 0.829 . . . . 0.0 110.51 156.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -85.04 -33.28 22.53 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.537 -0.727 . . . . 0.0 110.705 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -75.3 -22.12 57.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.0 1.273 . . . . 0.0 112.047 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.2 1.0 . . . . 0.0 112.649 163.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -64.84 -31.47 72.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.71 -0.618 . . . . 0.0 111.94 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.17 5.41 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.337 1.923 . . . . 0.0 113.698 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.03 134.01 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.506 1.922 . . . . 0.0 111.746 -163.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.41 12.24 3.81 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 157.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 2.06 -93.02 0.0 OUTLIER Glycine 0 N--CA 1.473 1.149 0 C-N-CA 130.114 3.721 . . . . 0.0 117.639 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -6.64 1.32 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.8 1.64 . . . . 0.0 111.988 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.493 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 30.0 m95 23.05 67.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.257 3.423 . . . . 0.0 116.254 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 m -75.33 153.63 37.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.331 1.062 . . . . 0.0 110.858 170.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -145.8 146.08 31.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.334 1.453 . . . . 0.0 110.363 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -134.62 56.14 1.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.296 1.038 . . . . 0.0 112.026 -155.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -40.56 -27.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 130.392 3.477 . . . . 0.0 119.034 -173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.33 -20.54 66.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.583 1.953 . . . . 0.0 112.505 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -128.93 -15.95 4.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.125 2.17 . . . . 0.0 113.058 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.344 36.3 mttm 65.47 14.39 9.44 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.211 3.004 . . . . 0.0 115.144 -170.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.4 m -53.76 159.07 1.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.951 1.7 . . . . 0.0 112.624 157.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.14 170.01 14.06 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 130.109 3.364 . . . . 0.0 111.07 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.4 m -147.09 153.63 40.18 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.009 -1.057 . . . . 0.0 110.525 159.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.49 113.77 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.443 0.64 . . . . 0.0 111.666 153.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 8' ' ' ASN . 2.0 m -106.12 114.8 29.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.697 0.799 . . . . 0.0 110.253 172.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 124.708 1.203 . . . . 0.0 113.205 179.201 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . 0.282 4.5 p -122.74 146.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 125.071 3.578 . . . . 0.0 112.327 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -134.33 153.35 51.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.174 -167.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 11.2 t -135.9 153.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.408 1.083 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.98 26.87 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.272 0.939 . . . . 0.0 115.128 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 70.37 33.07 2.61 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.095 1.758 . . . . 0.0 113.549 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -112.8 160.86 17.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 114.039 -174.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.18 -30.54 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.857 1.694 . . . . 0.0 113.653 168.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -50.83 -36.48 37.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.733 2.413 . . . . 0.0 114.675 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.64 -50.66 0.24 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.114 2.166 . . . . 0.0 110.427 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.412 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -10.3 95.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.535 2.493 . . . . 0.0 116.316 -163.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -132.68 -29.91 1.48 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -168.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 pttp 135.26 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 1 C-N-CA 132.581 4.352 . . . . 0.0 110.578 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 m -69.46 -39.49 77.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.5 0.72 . . . . 0.0 111.525 -167.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -37.07 76.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.186 -0.947 . . . . 0.0 112.466 173.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.8 mt -79.96 -31.75 39.92 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.026 0.931 . . . . 0.0 111.856 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -57.93 -34.9 70.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.014 0.825 . . . . 0.0 110.016 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -91.75 -51.97 4.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.725 0.81 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.23 -28.28 66.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.959 0.904 . . . . 0.0 113.411 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.74 -25.98 13.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.535 0.734 . . . . 0.0 110.31 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.7 -34.14 20.58 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 126.547 2.023 . . . . 0.0 115.231 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -53.26 -37.82 62.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.041 0.921 . . . . 0.0 113.461 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -84.69 -12.01 54.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.009 0.923 . . . . 0.0 111.528 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.87 168.56 14.29 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.792 1.663 . . . . 0.0 113.042 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.68 117.02 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.96 2.44 . . . . 0.0 111.044 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.14 153.1 35.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.331 0.586 . . . . 0.0 110.602 168.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -124.31 1.33 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.737 1.615 . . . . 0.0 113.278 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -161.81 152.97 18.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.6 1.16 . . . . 0.0 109.913 147.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.5 t -153.56 124.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.449 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -152.0 149.1 28.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.956 0.902 . . . . 0.0 111.363 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -146.58 146.54 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -171.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 127.029 2.132 . . . . 0.0 111.454 170.098 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.159 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -142.96 149.35 38.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.494 1.118 . . . . 0.0 112.574 -155.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -129.67 164.37 24.09 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.435 1.894 . . . . 0.0 113.906 169.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.15 149.34 51.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.701 -1.59 . . . . 0.0 109.146 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.47 150.41 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 122.346 1.069 . . . . 0.0 111.769 -171.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -143.37 138.88 29.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.08 1.352 . . . . 0.0 110.466 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.77 -21.54 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.758 2.423 . . . . 0.0 112.78 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.272 8.9 tm-20 39.06 53.07 2.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 -153.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -150.95 137.15 11.08 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.514 1.525 . . . . 0.0 109.864 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.47 -45.06 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.913 1.742 . . . . 0.0 113.299 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.11 -54.61 10.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.898 1.279 . . . . 0.0 112.816 -165.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.86 -21.49 54.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.39 1.076 . . . . 0.0 113.406 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.55 -45.21 54.83 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.943 0.792 . . . . 0.0 112.387 169.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.98 74.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -45.46 72.74 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.65 -0.656 . . . . 0.0 112.054 173.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -6.82 3.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 114.4 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.92 -54.47 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.138 -0.977 . . . . 0.0 111.594 153.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -33.86 67.47 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.254 1.388 . . . . 0.0 114.23 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.55 1.73 23.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.051 1.741 . . . . 0.0 111.803 -163.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.45 -19.94 0.48 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.962 1.705 . . . . 0.0 113.594 -162.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -76.91 146.27 37.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.984 1.313 . . . . 0.0 113.236 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.01 37.8 81.51 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.183 0.897 . . . . 0.0 112.844 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.48 158.96 34.73 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.166 1.787 . . . . 0.0 111.702 -165.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 m -88.11 56.68 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 111.642 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.25 -28.86 65.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -160.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 70.1 m -142.48 22.5 2.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.047 1.339 . . . . 0.0 113.847 -162.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.04 11.32 70.03 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 120.341 -1.474 . . . . 0.0 113.217 -166.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 19.1 p -122.97 165.34 16.9 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.041 2.536 . . . . 0.0 107.806 164.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -89.36 102.0 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.77 163.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.981 1.313 . . . . 0.0 111.962 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -124.09 135.06 53.28 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.343 1.457 . . . . 0.0 107.357 162.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.42 138.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 108.585 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 124.002 0.921 . . . . 0.0 111.397 -166.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -132.7 124.6 28.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 136.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 34.2 ttmt -125.02 152.94 43.59 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 125.218 1.407 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.9 tp -129.21 100.77 5.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.806 2.843 . . . . 0.0 108.503 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.36 118.46 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 127.423 2.289 . . . . 0.0 109.054 158.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.629 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.3 mp -94.27 137.14 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -147.51 42.96 1.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.768 2.027 . . . . 0.0 109.282 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.01 -172.81 25.37 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.721 -1.237 . . . . 0.0 115.586 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -60.13 -45.13 94.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.041 0.924 . . . . 0.0 111.393 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -68.59 -60.49 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.833 2.053 . . . . 0.0 112.193 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.07 144.19 26.52 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.174 0.99 . . . . 0.0 110.355 -166.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -129.72 122.27 28.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.213 1.805 . . . . 0.0 108.649 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.07 23.92 0.12 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 119.006 2.363 . . . . 0.0 119.006 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.629 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER 59.65 -175.22 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.098 2.259 . . . . 0.0 117.098 175.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -145.22 -40.72 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 162.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 15.0 p 60.75 151.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 126.035 1.734 . . . . 0.0 115.405 -165.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.2 126.15 0.66 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.026 1.73 . . . . 0.0 106.747 163.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.69 148.65 33.03 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 121.848 -0.533 . . . . 0.0 110.692 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.82 176.35 11.14 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.07 -1.019 . . . . 0.0 112.814 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.79 -54.75 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.134 1.774 . . . . 0.0 111.428 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -165.18 174.53 10.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.045 1.738 . . . . 0.0 109.966 -158.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.73 -39.93 1.59 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.772 1.169 . . . . 0.0 110.699 -173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -71.32 -23.13 61.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.755 1.622 . . . . 0.0 112.129 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.36 -50.79 14.82 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 109.802 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -47.68 61.32 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.771 1.228 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -23.17 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -169.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.02 -36.97 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.22 1.408 . . . . 0.0 109.609 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -53.41 -45.52 69.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.444 1.098 . . . . 0.0 112.75 164.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.52 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.1 mmpt? -44.75 -53.97 6.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 111.224 168.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -72.21 -36.43 69.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.38 -41.58 94.07 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.655 1.116 . . . . 0.0 111.309 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -75.55 -38.38 59.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.0 -29.5 69.89 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.17 0.895 . . . . 0.0 112.235 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.08 -38.28 85.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 113.009 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -67.33 -12.96 61.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.667 0.787 . . . . 0.0 112.511 165.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.25 10.0 52.32 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.04 1.781 . . . . 0.0 112.756 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 57.7 t -100.08 128.04 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 125.93 1.692 . . . . 0.0 112.362 -161.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 68.18 1.31 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 125.074 2.369 . . . . 0.0 110.569 156.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.5 -153.14 0.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 109.696 -3.411 . . . . 0.0 115.15 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.99 52.66 0.72 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.768 2.827 . . . . 0.0 109.824 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.52 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 21.9 m95 -43.74 100.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.247 2.619 . . . . 0.0 112.916 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.3 m -125.95 162.2 25.76 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.38 1.872 . . . . 0.0 110.125 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -147.23 155.88 42.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.627 1.571 . . . . 0.0 111.536 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.42 129.76 35.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.715 2.006 . . . . 0.0 109.275 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.61 -18.11 23.5 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.13 61.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.079 0.951 . . . . 0.0 111.824 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -122.93 -2.15 8.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.242 1.817 . . . . 0.0 112.601 166.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.317 49.8 mttm 58.86 24.8 12.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.596 1.558 . . . . 0.0 113.372 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.2 m -79.22 157.22 27.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.523 2.329 . . . . 0.0 112.36 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.71 159.52 32.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.596 2.758 . . . . 0.0 109.658 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -145.15 132.79 20.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.09 -0.381 . . . . 0.0 111.274 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 3.1 m -112.87 100.52 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.983 0.897 . . . . 0.0 112.014 156.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 115.04 18.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 155.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 124.025 1.869 . . . . 0.0 109.335 170.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.418 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 115' ' ' VAL . 12.1 p -132.44 155.82 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 108.849 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -137.34 152.27 49.52 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.854 -1.154 . . . . 0.0 112.126 -162.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 t -138.98 149.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 110.207 -177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.62 38.11 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 3.2 t30 81.86 5.6 1.18 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.1 2.56 . . . . 0.0 113.918 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 61.51 5.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.389 1.476 . . . . 0.0 112.83 -167.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.23 63.95 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 114.649 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 114.234 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -136.16 -61.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.608 1.163 . . . . 0.0 111.076 -167.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.96 54.38 4.41 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.513 2.006 . . . . 0.0 114.556 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.09 -40.88 2.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -173.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 pttp 138.48 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 1 C-N-CA 132.461 4.305 . . . . 0.0 111.586 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.3 m -82.46 -26.12 32.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.13 0.877 . . . . 0.0 112.293 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -53.65 -35.14 60.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.78 -1.2 . . . . 0.0 112.321 159.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.71 -29.62 17.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.682 1.193 . . . . 0.0 113.129 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -60.08 -32.21 70.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.671 1.123 . . . . 0.0 109.301 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -85.23 -54.67 4.46 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.481 1.112 . . . . 0.0 112.51 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 -21.22 59.17 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.09 -29.47 8.53 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.013 0.925 . . . . 0.0 111.499 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -51.66 -36.47 40.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.632 1.111 . . . . 0.0 114.196 167.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -57.0 -36.02 69.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.51 -24.39 50.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.02 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.68 -169.54 34.54 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.69 106.54 2.13 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.881 3.054 . . . . 0.0 111.927 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.92 143.2 52.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.228 1.011 . . . . 0.0 111.22 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.1 ttp-105 -94.33 -35.19 12.51 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.172 1.389 . . . . 0.0 111.705 163.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -172.4 160.44 4.9 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.767 1.167 . . . . 0.0 111.011 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.8 t -151.31 134.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 107.846 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -146.06 148.45 32.67 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.297 1.839 . . . . 0.0 109.982 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.14 145.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 112.876 173.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.75 1.22 . . . . 0.0 114.044 -173.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 CA-C-O 119.37 -0.683 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.52 135.67 48.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 0.0 111.063 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.465 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -137.12 162.6 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.515 1.926 . . . . 0.0 113.707 -168.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.74 156.23 47.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.504 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -158.53 160.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.163 . . . . 0.0 110.488 -162.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.56 154.34 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.66 1.584 . . . . 0.0 110.764 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -132.64 151.55 51.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.972 2.109 . . . . 0.0 111.681 -173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -84.62 -2.23 57.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.811 -1.18 . . . . 0.0 113.821 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.88 129.03 23.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.486 1.114 . . . . 0.0 111.608 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.23 -27.85 13.2 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.381 2.721 . . . . 0.0 114.043 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.98 -34.0 12.53 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.252 1.021 . . . . 0.0 110.875 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -68.93 -29.5 67.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.609 1.095 . . . . 0.0 112.895 164.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.44 -45.28 91.61 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.84 1.2 . . . . 0.0 111.802 165.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.92 89.12 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.614 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.33 -42.98 61.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.87 -12.31 7.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.552 1.141 . . . . 0.0 113.536 168.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 87.6 t -89.89 -52.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 119.408 1.004 . . . . 0.0 112.312 159.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -59.31 -25.5 64.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.327 1.851 . . . . 0.0 113.156 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.54 -7.37 34.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 112.162 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.59 -15.82 0.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -153.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -48.11 -23.74 0.92 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.314 2.246 . . . . 0.0 115.645 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -161.4 40.14 0.41 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.684 1.135 . . . . 0.0 114.199 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.25 34.5 ttp180 -113.42 -123.37 0.29 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.353 1.077 . . . . 0.0 112.283 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.5 m -161.07 142.39 11.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.372 1.869 . . . . 0.0 107.621 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.9 tp -138.38 -36.93 0.57 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -163.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.8 m -140.47 21.42 2.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.158 1.383 . . . . 0.0 113.216 -171.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.89 47.47 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.499 -0.751 . . . . 0.0 113.397 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 11.9 t -137.15 152.61 50.15 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 108.327 157.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HE ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 tmm_? -35.5 134.67 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.477 1.511 . . . . 0.0 109.902 150.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.18 157.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.195 0.598 . . . . 0.0 110.259 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -128.21 159.37 35.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.104 159.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.1 t -149.24 148.59 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.975 1.31 . . . . 0.0 108.493 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.122 1.369 . . . . 0.0 110.815 -178.749 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 120.731 0.301 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.35 111.33 12.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -138.21 99.69 3.93 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.765 0.826 . . . . 0.0 112.096 -163.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 34' ' ' ALA . 14.4 tp -87.54 90.76 8.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 119.021 0.828 . . . . 0.0 109.486 173.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -53.8 120.39 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 126.431 1.892 . . . . 0.0 109.056 159.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.41 128.77 38.38 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.012 168.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -144.1 59.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 111.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.15 152.13 18.01 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.136 0.874 . . . . 0.0 113.366 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -52.24 -29.84 24.77 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.811 1.244 . . . . 0.0 110.11 156.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 m -59.43 -55.39 35.21 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.981 2.513 . . . . 0.0 113.596 167.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.4 tm? -167.35 141.5 3.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.258 1.823 . . . . 0.0 110.123 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' N ' HD13 ' A' ' 12' ' ' LEU . 6.0 mtpm? -132.59 140.79 48.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.087 1.355 . . . . 0.0 111.922 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.7 -136.07 5.87 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 125.702 1.62 . . . . 0.0 110.586 -163.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -161.57 -169.66 2.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.352 2.261 . . . . 0.0 109.076 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -138.33 -43.32 0.5 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 160.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p 62.06 164.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.428 2.011 . . . . 0.0 116.428 -168.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -161.68 -167.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.64 2.776 . . . . 0.0 105.864 156.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -134.97 140.13 45.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.147 -1.595 . . . . 0.0 108.948 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.79 10.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 0.0 112.329 -162.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -61.48 -49.19 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 110.191 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -164.04 178.99 7.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 123.507 1.623 . . . . 0.0 111.611 -160.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 16.85 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.844 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 p -61.28 -25.46 67.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.252 1.821 . . . . 0.0 115.885 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 -46.87 12.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.112 0.415 . . . . 0.0 111.221 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.37 -47.5 85.2 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -58.89 -22.43 59.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.62 -47.21 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.045 1.738 . . . . 0.0 110.946 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -52.26 -43.1 64.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.61 1.164 . . . . 0.0 113.136 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 5.6 mmmm -46.81 -50.58 18.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.967 2.107 . . . . 0.0 111.409 171.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.84 -38.83 70.06 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.69 -36.68 83.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.108 0.867 . . . . 0.0 111.786 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -82.54 -26.54 32.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.35 -0.844 . . . . 0.0 111.95 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.3 -37.95 81.15 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.051 0.841 . . . . 0.0 111.744 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.44 -40.01 89.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.374 1.47 . . . . 0.0 112.396 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -66.74 -38.44 86.65 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.001 -0.437 . . . . 0.0 111.635 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.07 22.03 9.09 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.173 1.844 . . . . 0.0 113.88 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.31 -65.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.645 1.212 . . . . 0.0 113.021 -163.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.265 23.0 m-20 22.79 64.76 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 130.816 3.646 . . . . 0.0 113.816 -168.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.8 -134.94 6.55 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 108.872 -3.785 . . . . 0.0 113.106 -165.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.43 59.08 0.58 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.353 1.461 . . . . 0.0 109.46 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.445 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 5.7 m95 -50.84 100.2 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.933 1.693 . . . . 0.0 112.617 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -136.86 162.86 32.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.542 1.137 . . . . 0.0 111.557 -170.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 55.8 t80 -143.75 153.06 42.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.139 1.776 . . . . 0.0 110.867 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.46 77.79 1.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.367 1.467 . . . . 0.0 112.27 -168.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -22.86 23.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.5 64.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.5 1.92 . . . . 0.0 112.697 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -130.58 -4.91 4.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.824 1.25 . . . . 0.0 113.147 167.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.374 36.2 mttm 57.28 18.09 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.462 3.105 . . . . 0.0 114.748 -167.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -60.85 157.91 14.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.328 1.851 . . . . 0.0 111.538 165.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 37.7 m-85 -122.91 167.81 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.863 2.465 . . . . 0.0 110.942 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -149.73 146.17 27.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.598 -1.314 . . . . 0.0 110.665 167.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.86 88.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.232 1.013 . . . . 0.0 112.678 161.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 58.11 4.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.949 1.3 . . . . 0.0 113.34 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.151 0 O-C-N 120.785 -1.197 . . . . 0.0 113.204 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.781 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 115' ' ' VAL . 66.5 t -117.42 138.6 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.846 1.657 . . . . 0.0 112.768 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -126.33 140.69 52.32 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.269 1.828 . . . . 0.0 108.632 158.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.94 135.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 108.915 175.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.27 -147.39 5.19 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.702 -0.623 . . . . 0.0 114.193 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.79 -6.12 0.45 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.918 1.687 . . . . 0.0 113.701 -152.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.1 mt -80.67 55.27 2.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.907 1.683 . . . . 0.0 112.264 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.37 42.15 0.4 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 127.788 2.613 . . . . 0.0 114.558 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -157.21 -50.3 0.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.11 2.564 . . . . 0.0 110.482 -167.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.09 -112.63 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.644 2.378 . . . . 0.0 108.182 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.21 69.08 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.486 1.993 . . . . 0.0 116.543 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.25 161.27 5.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.036 2.534 . . . . 0.0 113.639 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -34.82 52.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -71.46 -46.35 60.18 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.101 0.96 . . . . 0.0 112.939 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -33.05 75.03 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.886 -1.134 . . . . 0.0 111.406 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.8 mt -83.54 -36.08 24.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.114 0.965 . . . . 0.0 112.663 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -44.57 -42.87 7.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.456 1.103 . . . . 0.0 110.092 165.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -105.48 -39.57 6.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 118.32 -0.848 . . . . 0.0 112.645 -162.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.4 70.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.809 0.731 . . . . 0.0 112.092 168.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -95.12 -30.8 13.85 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.22 -35.44 6.72 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.996 1.284 . . . . 0.0 114.432 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -58.18 -37.15 74.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -81.27 -20.98 39.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 111.641 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.25 -173.49 33.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.65 0.643 . . . . 0.0 114.124 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.02 156.46 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.306 2.671 . . . . 0.0 112.457 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.51 143.49 50.86 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.089 2.556 . . . . 0.0 108.206 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -95.1 -32.75 12.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.905 1.282 . . . . 0.0 112.247 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 t -166.33 169.28 14.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.992 0.917 . . . . 0.0 111.954 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 t -159.89 127.0 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.279 3.032 . . . . 0.0 107.311 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -156.86 144.71 19.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.613 1.165 . . . . 0.0 111.943 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.14 139.86 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.682 -1.261 . . . . 0.0 113.004 -166.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 125.423 1.489 . . . . 0.0 109.569 167.592 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 CA-C-O 121.446 0.47 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -155.82 158.48 38.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.575 1.95 . . . . 0.0 109.139 -166.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.72 156.78 35.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.379 1.472 . . . . 0.0 113.497 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -131.83 148.05 52.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.872 165.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 76' ' ' VAL 0.252 0.7 OUTLIER -143.64 -179.47 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.033 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -141.42 106.72 5.01 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 107.731 166.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.94 169.36 0.53 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 165.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.08 25.48 5.88 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.051 0.929 . . . . 0.0 113.244 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.93 132.23 10.25 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.616 -1.303 . . . . 0.0 110.295 160.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.8 -34.01 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.638 2.226 . . . . 0.0 114.639 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.07 -31.77 20.31 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.061 1.3 . . . . 0.0 112.289 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.52 -24.04 60.09 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 167.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.52 -51.04 62.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.533 1.06 . . . . 0.0 111.875 163.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.81 -32.11 63.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.607 -1.308 . . . . 0.0 110.998 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -43.25 55.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.77 -10.65 9.43 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 113.618 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.78 -62.23 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.893 . . . . 0.0 110.732 153.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -49.48 -33.63 14.86 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.672 1.989 . . . . 0.0 114.309 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.7 -13.52 16.45 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 112.193 -164.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.63 -33.09 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.545 1.138 . . . . 0.0 114.025 -161.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -56.75 139.34 51.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.901 1.28 . . . . 0.0 113.125 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.76 4.62 54.45 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.523 1.058 . . . . 0.0 114.898 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -117.38 -109.72 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.292 1.437 . . . . 0.0 110.703 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 m -143.92 153.61 42.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.569 1.547 . . . . 0.0 109.573 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.69 -44.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.029 0.932 . . . . 0.0 112.956 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.5 t -149.66 68.09 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.551 1.54 . . . . 0.0 110.713 -170.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.63 93.34 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.432 1.015 . . . . 0.0 114.651 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.0 p -145.59 -174.57 4.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 113.05 -159.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.7 136.77 51.89 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 153.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.82 163.03 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.227 1.411 . . . . 0.0 112.104 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -135.46 138.01 42.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.947 2.099 . . . . 0.0 108.659 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -139.11 137.05 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.463 0.705 . . . . 0.0 111.121 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.475 0.796 0 O-C-N 120.711 -1.243 . . . . 0.0 109.302 164.827 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 120.554 0.216 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.83 112.05 18.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 166.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -128.32 108.14 10.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.451 1.1 . . . . 0.0 111.906 -168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 54' ' ' VAL . 47.4 tp -95.23 98.77 10.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.073 1.349 . . . . 0.0 109.371 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.81 115.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.167 2.187 . . . . 0.0 108.888 163.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.8 mp -89.17 136.06 33.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.959 168.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -142.64 51.03 1.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.662 1.185 . . . . 0.0 108.501 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.85 176.36 25.97 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 122.504 1.058 . . . . 0.0 114.4 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -60.28 -40.95 92.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.065 1.346 . . . . 0.0 111.494 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -71.12 -48.63 51.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.639 2.376 . . . . 0.0 113.533 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.42 139.73 14.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.273 1.029 . . . . 0.0 110.482 -169.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -126.45 132.31 51.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.923 1.689 . . . . 0.0 109.79 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.39 -137.78 5.76 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.404 1.478 . . . . 0.0 110.334 -153.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.8 mt-10 -159.46 -161.22 0.9 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.897 1.679 . . . . 0.0 109.467 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -143.88 -42.34 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 156.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.6 p 55.97 164.41 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -158.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -160.31 -164.36 1.25 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.76 2.424 . . . . 0.0 106.364 156.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -140.35 130.62 25.13 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.697 1.599 . . . . 0.0 107.778 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.48 23.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -157.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 21' ' ' VAL . 1.8 t -64.71 -42.14 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.128 1.771 . . . . 0.0 111.825 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -144.31 -58.86 0.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -161.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 134.49 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 131.679 3.991 . . . . 0.0 111.659 -162.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -36.95 10.9 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.592 1.157 . . . . 0.0 109.749 -170.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -74.88 -17.22 60.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.04 2.936 . . . . 0.0 112.457 164.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.7 -54.6 5.71 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.717 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.07 -46.07 44.0 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 125.25 1.42 . . . . 0.0 109.087 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -20.94 13.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -171.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.56 -38.81 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.473 1.509 . . . . 0.0 109.788 -169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -50.38 -46.72 56.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.019 1.328 . . . . 0.0 112.326 163.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.4 mmpt? -43.8 -55.46 4.46 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.949 1.699 . . . . 0.0 112.024 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.07 -35.21 64.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -60.74 -39.94 90.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.445 1.02 . . . . 0.0 111.302 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 -32.4 38.01 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.181 -0.949 . . . . 0.0 111.168 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.22 -26.29 61.97 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.872 0.76 . . . . 0.0 112.554 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.7 -39.26 77.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 166.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -67.18 -50.58 60.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.197 0.599 . . . . 0.0 111.576 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.8 33.14 0.39 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.269 1.414 . . . . 0.0 113.844 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.77 134.2 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.785 1.234 . . . . 0.0 112.001 -168.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.72 -4.28 5.25 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.54 158.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.45 -127.17 4.61 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.317 1.913 . . . . 0.0 116.365 161.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.89 -14.56 39.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 112.118 171.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.525 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 26.0 m95 8.32 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.271 1.829 . . . . 0.0 114.694 -130.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -73.17 151.09 41.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.629 1.204 . . . . 0.0 110.141 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -154.19 142.52 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 109.961 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -104.76 -37.6 6.99 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 56.61 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.447 3.099 . . . . 0.0 117.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.64 -28.5 69.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.434 1.893 . . . . 0.0 111.965 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.2 p -125.08 5.03 7.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.158 1.783 . . . . 0.0 113.274 166.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt 57.55 -5.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 128.177 2.591 . . . . 0.0 116.81 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -39.57 150.45 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.055 2.542 . . . . 0.0 114.473 156.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -131.99 162.9 29.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 131.252 3.821 . . . . 0.0 110.645 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.0 m -148.79 141.3 24.33 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 167.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 5' ' ' LEU . 1.1 m -131.45 111.46 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.54 171.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 m -119.94 96.5 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.565 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.914 1.286 . . . . 0.0 113.972 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.76 143.87 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 120.877 1.672 . . . . 0.0 107.34 156.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.39 146.29 25.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.409 1.083 . . . . 0.0 110.941 -168.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 113' ' ' ALA . 18.3 m -141.14 157.41 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.222 158.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -165.16 14.86 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 114.836 0.694 . . . . 0.0 114.836 170.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER 76.01 -5.47 2.17 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 127.205 2.202 . . . . 0.0 113.262 -172.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.2 OUTLIER -94.63 46.24 1.14 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.639 1.576 . . . . 0.0 113.316 -150.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.36 -29.7 75.32 Favored Glycine 0 CA--C 1.537 1.466 0 N-CA-C 118.418 2.127 . . . . 0.0 118.418 -160.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -70.87 -35.01 72.18 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.239 2.019 . . . . 0.0 113.682 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.431 HD21 ' CD1' ' A' ' 81' ' ' LEU . 1.6 p-10 -129.35 -16.69 3.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.95 108.17 0.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -157.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -138.66 169.04 18.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.833 2.053 . . . . 0.0 111.003 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.87 -47.91 70.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.2 m -76.14 -30.93 58.35 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -160.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -58.76 -34.71 71.73 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.034 -1.041 . . . . 0.0 112.411 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.46 -35.14 40.79 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 111.778 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 100' ' ' LEU . 49.7 mt-10 -58.07 -29.46 65.44 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.442 0.697 . . . . 0.0 111.595 171.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.47 -48.94 7.54 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.01 -23.6 54.82 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -117.54 -19.04 9.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 113.25 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.28 -38.16 18.99 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.644 1.116 . . . . 0.0 114.048 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -55.94 -36.95 68.35 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.84 1.42 55.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.186 1.394 . . . . 0.0 112.29 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.34 166.77 12.32 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.773 1.178 . . . . 0.0 114.779 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.87 116.15 4.61 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.334 2.689 . . . . 0.0 111.505 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 91' ' ' GLU . 10.5 mp -63.83 138.58 58.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.466 0.651 . . . . 0.0 110.528 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -14.31 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.136 2.174 . . . . 0.0 112.665 -167.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -151.92 150.04 29.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.265 1.826 . . . . 0.0 108.539 159.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 100' ' ' LEU . 91.5 t -155.58 128.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.27 1.028 . . . . 0.0 110.987 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -150.21 148.25 28.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.12 2.168 . . . . 0.0 110.19 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.69 155.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.156 -0.965 . . . . 0.0 112.296 168.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 125.74 1.616 . . . . 0.0 112.718 174.95 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -124.99 129.43 50.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.97 1.308 . . . . 0.0 109.025 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -123.32 160.85 25.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.41 1.484 . . . . 0.0 112.228 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -141.34 148.89 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.387 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.99 171.95 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 -165.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.97 141.95 36.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 109.311 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -151.76 157.39 41.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.202 1.401 . . . . 0.0 110.701 150.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.77 47.4 0.88 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.053 0.93 . . . . 0.0 113.016 -148.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.0 142.33 24.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.409 1.884 . . . . 0.0 110.602 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.65 -28.47 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.085 2.523 . . . . 0.0 114.836 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.67 -57.49 3.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.96 1.255 . . . . 0.0 113.09 -164.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.4 -27.18 65.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.585 1.154 . . . . 0.0 111.647 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.21 68.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.96 -31.42 70.98 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.662 -1.274 . . . . 0.0 110.562 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.36 -45.83 82.58 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.769 -0.582 . . . . 0.0 112.55 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -15.9 54.88 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.2 t -79.27 -52.89 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.768 -1.208 . . . . 0.0 109.673 159.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -25.29 65.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.033 1.733 . . . . 0.0 115.017 -175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -97.37 -19.64 18.35 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.339 1.856 . . . . 0.0 112.018 -174.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 -18.1 0.34 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -148.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.69 130.28 37.53 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.149 -0.969 . . . . 0.0 113.285 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.25 86.54 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.076 1.322 . . . . 0.0 115.05 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -78.63 -161.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 128.028 2.531 . . . . 0.0 112.678 -173.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.9 m -112.8 137.52 51.0 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.716 1.606 . . . . 0.0 107.969 155.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.75 133.4 35.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 110.398 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 8.6 t 58.52 -55.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.983 2.513 . . . . 0.0 115.151 -170.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.58 18.24 0.05 OUTLIER Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.509 1.528 . . . . 0.0 115.432 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.2 p -151.38 159.82 44.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.999 1.399 . . . . 0.0 112.659 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -58.04 144.35 40.18 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.494 1.117 . . . . 0.0 110.475 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 2.5 p -128.88 159.59 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.243 1.417 . . . . 0.0 112.793 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.53 135.96 40.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 164.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -143.92 138.86 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.337 0.971 . . . . 0.0 110.917 -162.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 N--CA 1.475 0.82 0 O-C-N 120.88 -1.137 . . . . 0.0 111.824 -178.369 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.355 0.597 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -131.76 112.85 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 157.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.2 ttmm -130.05 146.13 51.7 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 127.199 2.2 . . . . 0.0 108.885 -171.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 34' ' ' ALA . 24.6 tp -122.16 99.38 6.4 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.559 1.944 . . . . 0.0 109.305 162.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -62.12 130.31 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.759 1.624 . . . . 0.0 109.514 160.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.63 132.09 48.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.646 171.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -145.62 54.96 1.19 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.811 1.244 . . . . 0.0 111.296 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.52 179.89 17.78 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -73.67 15.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 128.499 2.72 . . . . 0.0 112.954 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -142.22 -57.34 0.45 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 127.533 2.333 . . . . 0.0 108.932 -144.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -156.6 146.77 21.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.869 2.068 . . . . 0.0 109.321 162.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -128.83 142.41 50.98 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.884 1.274 . . . . 0.0 111.828 167.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.66 -136.55 6.28 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 125.149 1.357 . . . . 0.0 109.985 -159.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -160.83 -158.92 0.63 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.483 1.513 . . . . 0.0 110.113 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -143.84 -47.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 154.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.9 p 57.09 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.774 1.63 . . . . 0.0 115.263 -158.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -157.93 -18.0 0.08 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.59 141.63 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.627 2.371 . . . . 0.0 116.942 -163.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.28 -164.24 1.97 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.354 1.461 . . . . 0.0 111.47 -174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.44 -15.76 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.407 1.883 . . . . 0.0 111.676 -163.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -145.22 -9.08 0.59 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.19 30.97 19.25 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.989 1.316 . . . . 0.0 113.337 -167.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.1 -37.52 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.765 1.626 . . . . 0.0 112.012 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.84 -24.61 66.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.51 2.724 . . . . 0.0 112.456 158.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.83 -53.82 9.38 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.85 -0.531 . . . . 0.0 109.813 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -49.96 -46.86 52.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 125.525 1.53 . . . . 0.0 109.229 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -54.88 -25.02 26.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.21 -40.32 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 109.146 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -50.72 -48.45 58.89 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.289 1.436 . . . . 0.0 112.431 165.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.6 mmpt? -43.8 -55.03 4.74 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.867 1.667 . . . . 0.0 112.089 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -73.52 -35.25 65.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -63.48 -41.23 98.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.863 0.756 . . . . 0.0 110.99 172.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -74.49 -36.4 63.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.314 -0.866 . . . . 0.0 109.926 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.33 -33.21 75.43 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.283 0.492 . . . . 0.0 111.543 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.78 -36.44 78.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.031 1.332 . . . . 0.0 113.603 169.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.59 -20.78 64.52 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.01 20.12 7.33 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.904 1.716 . . . . 0.0 113.385 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.3 t -120.59 123.03 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.942 1.297 . . . . 0.0 111.925 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.61 69.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 124.924 2.297 . . . . 0.0 108.897 155.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -149.98 0.24 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 109.413 -3.54 . . . . 0.0 114.046 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.88 24.38 0.4 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.371 1.868 . . . . 0.0 111.954 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.536 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 32.5 m95 -6.42 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.451 3.501 . . . . 0.0 115.368 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.9 m -103.4 158.68 16.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 109.298 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -137.14 143.76 42.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.591 1.556 . . . . 0.0 109.826 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.13 60.01 1.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.439 1.496 . . . . 0.0 110.012 -155.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.89 -25.71 0.83 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.608 3.163 . . . . 0.0 117.372 -172.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.88 -21.64 66.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.147 2.179 . . . . 0.0 112.559 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -131.27 -3.42 3.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.366 1.867 . . . . 0.0 112.86 168.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.299 35.6 mttm 54.94 20.03 2.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.415 2.686 . . . . 0.0 114.732 -169.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.7 m -60.34 165.04 3.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.754 1.621 . . . . 0.0 111.682 157.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -132.84 152.63 51.79 Favored 'General case' 0 C--N 1.324 -0.534 1 C-N-CA 132.327 4.251 . . . . 0.0 108.03 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -145.82 116.11 7.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.696 0.284 . . . . 0.0 110.247 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -96.98 88.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-O 122.144 0.973 . . . . 0.0 112.081 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -69.96 113.74 7.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.18 156.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.511 1.125 . . . . 0.0 112.289 173.878 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.511 ' CG1' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -95.91 150.65 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.098 -1.001 . . . . 0.0 111.357 -169.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -125.98 139.09 53.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.765 0.826 . . . . 0.0 110.098 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.64 136.29 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.413 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.94 31.96 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 121.524 -0.735 . . . . 0.0 114.672 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 63.63 17.6 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.474 1.11 . . . . 0.0 113.96 -170.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -33.91 76.89 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.163 -0.96 . . . . 0.0 111.622 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.79 -60.38 0.34 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.652 2.549 . . . . 0.0 116.215 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.57 -29.32 37.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.434 1.894 . . . . 0.0 112.957 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HB2' ' H ' ' A' ' 85' ' ' GLY . 1.1 p-10 -153.67 -153.65 0.48 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.703 2.401 . . . . 0.0 109.044 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 84' ' ' ASN . . . 131.18 -17.52 5.11 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 128.068 2.747 . . . . 0.0 112.58 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -37.37 74.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 132.421 4.288 . . . . 0.0 116.781 169.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' H ' HG11 ' A' ' 105' ' ' VAL . 55.2 tttm 52.11 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.626 3.171 . . . . 0.0 116.847 167.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.9 m -66.96 -26.86 67.04 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 121.07 1.759 . . . . 0.0 114.648 -158.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.73 -30.6 70.88 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.435 -1.416 . . . . 0.0 113.198 168.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.9 mt -90.83 -25.21 20.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.85 1.66 . . . . 0.0 111.998 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.41 -30.63 69.73 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.384 0.993 . . . . 0.0 109.81 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.87 -47.23 8.74 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.685 1.194 . . . . 0.0 113.085 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.76 -25.09 64.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.085 1.311 . . . . 0.0 113.373 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -105.24 -31.09 9.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.592 1.157 . . . . 0.0 110.943 174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.23 -32.92 44.7 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.345 1.45 . . . . 0.0 115.512 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -57.36 -39.49 76.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.329 1.064 . . . . 0.0 112.589 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -75.31 -25.9 58.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.865 0.466 . . . . 0.0 111.944 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.95 -176.5 40.71 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -174.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 147.6 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.851 3.034 . . . . 0.0 112.493 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mp -113.79 141.42 47.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.041 1.736 . . . . 0.0 110.671 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -114.94 -16.22 11.71 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.402 1.881 . . . . 0.0 114.434 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -159.68 150.96 19.72 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.065 1.346 . . . . 0.0 110.347 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.7 t -154.86 134.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 126.158 1.783 . . . . 0.0 109.81 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -153.79 158.55 41.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.493 1.517 . . . . 0.0 111.455 166.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -149.29 143.67 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 126.648 1.979 . . . . 0.0 111.059 166.338 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 112.101 -0.399 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -109.72 112.74 24.98 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.005 1.322 . . . . 0.0 109.961 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.02 158.06 16.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.554 1.169 . . . . 0.0 112.092 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -139.34 130.34 26.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.013 163.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.511 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.2 m -139.42 -178.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.689 0.795 . . . . 0.0 111.235 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -154.01 136.06 14.7 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.452 -1.405 . . . . 0.0 110.797 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.87 154.2 27.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.441 1.497 . . . . 0.0 112.548 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.88 -7.6 58.82 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.101 -0.999 . . . . 0.0 112.595 164.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.05 109.43 27.47 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.815 1.646 . . . . 0.0 110.805 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.75 -31.7 95.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.154 3.236 . . . . 0.0 115.718 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -73.66 -41.88 62.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 110.547 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.54 -30.28 71.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.802 0.728 . . . . 0.0 112.415 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.78 78.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.762 0.825 . . . . 0.0 112.189 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.25 74.12 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.496 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -49.97 48.17 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.68 -11.03 31.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.552 1.541 . . . . 0.0 114.465 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.28 -52.8 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 157.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -31.53 69.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.833 1.253 . . . . 0.0 114.089 -172.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.61 -0.8 20.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.634 1.574 . . . . 0.0 111.924 -163.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -23.64 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.577 1.551 . . . . 0.0 113.233 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.31 125.18 23.01 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.138 -0.977 . . . . 0.0 111.436 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.7 9.1 87.36 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -84.78 -176.23 6.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.319 1.448 . . . . 0.0 112.44 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.7 m -134.9 93.07 2.96 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.042 1.737 . . . . 0.0 108.806 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.59 -39.51 31.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.754 1.222 . . . . 0.0 112.686 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.402 ' CB ' HD21 ' A' ' 84' ' ' ASN . 76.3 m -144.49 46.1 1.4 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.822 1.249 . . . . 0.0 112.926 -162.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.31 72.58 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.139 -0.976 . . . . 0.0 113.119 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.5 p -112.04 -166.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.456 2.303 . . . . 0.0 111.862 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -147.03 53.07 1.08 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.2 1.0 . . . . 0.0 111.373 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.56 156.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 126.98 2.112 . . . . 0.0 113.936 -170.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.23 152.11 42.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.35 1.46 . . . . 0.0 110.183 158.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.2 t -144.51 128.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.891 0.876 . . . . 0.0 109.531 -162.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 126.026 1.73 . . . . 0.0 110.219 177.477 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -156.6 -62.95 0.1 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -167.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -80.17 94.36 6.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 97.22 4.35 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.385 -151.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -87.57 86.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.068 1.347 . . . . 0.0 109.903 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 mt -56.33 101.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.351 2.261 . . . . 0.0 109.155 163.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.2 mp -78.99 136.09 37.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 165.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -145.33 54.8 1.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.721 2.008 . . . . 0.0 108.576 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.54 -177.91 21.82 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 -171.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -51.11 -48.37 61.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.486 1.114 . . . . 0.0 110.608 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 m -74.79 -63.34 1.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.732 2.413 . . . . 0.0 113.679 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.57 141.69 41.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.252 1.021 . . . . 0.0 110.456 -168.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 96.6 3.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.752 2.021 . . . . 0.0 108.833 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.45 23.87 0.02 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 120.684 3.033 . . . . 0.0 120.684 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU 0.255 0.6 OUTLIER 54.61 -175.96 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.084 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -154.81 -32.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 164.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p 59.0 161.96 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 118.143 2.646 . . . . 0.0 118.143 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.2 t -160.82 -162.07 0.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.331 2.252 . . . . 0.0 108.835 153.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -148.23 151.32 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 111.783 162.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.13 -177.67 6.06 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 126.355 1.862 . . . . 0.0 111.143 -167.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.37 -18.32 9.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 112.203 -2.271 . . . . 0.0 112.6 -169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -148.65 -9.01 0.36 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 23.13 13.49 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.111 1.765 . . . . 0.0 114.462 -168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.03 -38.47 1.1 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.309 1.844 . . . . 0.0 110.571 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.0 m -57.66 -21.21 38.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.356 1.862 . . . . 0.0 112.458 149.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.87 -47.65 16.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.264 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -48.03 80.42 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -68.22 -7.53 31.15 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -166.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.29 -38.22 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.76 2.424 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 18' ' ' THR . 18.1 m-30 -53.13 -43.01 66.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.679 1.127 . . . . 0.0 112.083 162.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -43.63 -56.18 3.89 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.061 2.144 . . . . 0.0 111.277 168.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.75 -34.69 67.18 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -57.94 -42.96 86.0 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.756 1.162 . . . . 0.0 110.952 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.95 -33.46 39.57 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.371 -0.83 . . . . 0.0 110.367 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -71.3 -26.76 63.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.177 0.898 . . . . 0.0 112.528 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.48 -40.4 77.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.111 1.364 . . . . 0.0 112.638 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -64.62 -43.58 93.28 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.764 -0.585 . . . . 0.0 111.655 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.34 27.79 1.29 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.713 1.625 . . . . 0.0 114.095 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.42 139.86 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.276 1.83 . . . . 0.0 111.287 -168.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.67 6.28 4.03 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 157.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.9 -130.34 10.14 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.203 1.859 . . . . 0.0 116.55 159.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -92.86 -13.29 29.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.017 1.727 . . . . 0.0 111.759 167.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.497 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 47.3 m95 6.61 82.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.041 1.736 . . . . 0.0 115.68 -127.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.6 m -82.2 156.86 24.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.692 1.234 . . . . 0.0 110.642 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -148.31 151.48 35.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.191 1.797 . . . . 0.0 110.559 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 23.8 t70 -124.31 143.62 50.46 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 125.955 1.702 . . . . 0.0 109.065 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -114.24 -15.94 12.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.99 -28.14 57.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.376 1.87 . . . . 0.0 111.638 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.0 p -120.12 -7.4 9.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.417 1.887 . . . . 0.0 112.65 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.378 35.6 mttm 65.27 12.69 8.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.519 1.528 . . . . 0.0 114.759 -174.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.9 m -54.56 153.84 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.36 2.264 . . . . 0.0 113.913 166.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -125.09 166.14 16.94 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.719 2.408 . . . . 0.0 112.318 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.5 m -151.75 139.16 19.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.421 -1.424 . . . . 0.0 112.086 167.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.4 m -124.0 89.06 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.055 1.342 . . . . 0.0 113.463 171.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -99.77 79.13 2.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.071 0.948 . . . . 0.0 112.643 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.66 -16.24 64.06 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.498 1.119 . . . . 0.0 114.001 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.21 -28.26 3.04 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.068 0.842 . . . . 0.0 114.754 160.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -66.72 2.44 1.37 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.673 1.989 . . . . 0.0 114.917 172.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -129.32 18.13 5.94 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.753 2.021 . . . . 0.0 110.963 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -145.98 -50.51 0.23 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.95 -1.094 . . . . 0.0 113.837 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -135.11 -7.28 2.32 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.322 1.449 . . . . 0.0 113.88 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.33 -172.71 2.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 140.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 155.35 46.76 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -157.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -163.52 168.44 20.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.242 1.417 . . . . 0.0 110.573 166.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.38 178.44 9.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.379 1.072 . . . . 0.0 110.353 162.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -129.89 62.91 1.54 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.127 2.171 . . . . 0.0 109.327 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -143.02 -49.62 0.34 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.692 2.797 . . . . 0.0 109.272 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -128.89 -101.68 0.33 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.984 1.713 . . . . 0.0 107.937 158.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.5 p -152.16 -5.24 0.24 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.967 1.307 . . . . 0.0 114.396 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 59.1 m -78.4 165.18 51.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.308 1.043 . . . . 0.0 111.303 166.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.19 -55.18 2.76 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.479 2.786 . . . . 0.0 113.036 167.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -154.38 -61.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.04 1.736 . . . . 0.0 107.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -162.9 171.19 16.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.401 2.281 . . . . 0.0 110.639 176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.5 -8.74 20.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 127.932 2.493 . . . . 0.0 117.477 -150.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.73 179.74 0.12 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 128.328 2.651 . . . . 0.0 108.808 -161.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.0 137.21 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 163.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -137.53 143.79 41.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.156 1.783 . . . . 0.0 109.822 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 23.1 t -138.06 145.23 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.267 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.81 -178.98 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.133 0.852 . . . . 0.0 115.193 161.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 72.84 13.65 5.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 115.418 -171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.5 OUTLIER -76.09 28.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.358 1.863 . . . . 0.0 112.102 178.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.14 -18.42 27.52 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 117.28 1.672 . . . . 0.0 117.28 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -89.69 -9.1 50.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.595 1.158 . . . . 0.0 113.901 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' LEU . 2.6 p-10 -154.65 -21.46 0.12 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -164.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -50.34 109.54 0.7 Allowed Glycine 0 CA--C 1.53 0.988 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -149.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -138.17 164.11 29.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.235 1.414 . . . . 0.0 112.057 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -67.93 -37.0 81.09 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.9 m -66.48 -48.11 70.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.186 0.994 . . . . 0.0 112.556 -169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.24 -37.63 80.95 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.678 -0.639 . . . . 0.0 111.69 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.96 -37.17 29.82 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.495 1.118 . . . . 0.0 112.319 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -47.43 -39.17 14.96 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.845 1.258 . . . . 0.0 111.338 169.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -106.9 -26.98 10.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.335 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.3 93.7 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.688 0.677 . . . . 0.0 111.58 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -81.58 -35.24 30.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 118.82 -0.609 . . . . 0.0 111.819 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -45.06 -37.1 5.5 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.658 1.599 . . . . 0.0 114.863 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -59.45 -44.99 92.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -80.29 -23.68 40.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.525 0.73 . . . . 0.0 110.878 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.28 166.45 30.1 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.102 1.334 . . . . 0.0 113.869 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.31 153.16 56.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.34 2.693 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.64 122.12 46.07 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.669 1.188 . . . . 0.0 109.176 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.8 ttp85 -74.75 -33.57 62.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.565 0.746 . . . . 0.0 111.454 166.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.3 m -142.67 157.5 44.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.303 0.502 . . . . 0.0 111.916 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 p -158.66 144.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.553 1.541 . . . . 0.0 110.825 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.11 151.24 17.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.919 1.688 . . . . 0.0 110.951 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.72 144.28 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.153 -0.967 . . . . 0.0 112.864 170.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.28 138.91 35.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.266 1.826 . . . . 0.0 112.181 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -25.28 47.5 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.767 -0.583 . . . . 0.0 112.5 163.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -140.18 115.29 7.74 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 126.267 1.827 . . . . 0.0 109.201 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.73 149.91 9.16 Favored 'Cis proline' 0 C--N 1.356 0.941 0 CA-C-N 121.616 1.613 . . . . 0.0 115.078 1.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -49.74 -19.31 3.45 Favored 'Trans proline' 0 C--N 1.352 0.719 1 C-N-CA 125.318 4.012 . . . . 0.0 118.853 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.78 63.6 0.12 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.392 0.996 . . . . 0.0 112.341 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.36 132.32 56.61 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.975 1.71 . . . . 0.0 109.385 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -128.57 163.87 24.06 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 125.592 1.557 . . . . 0.0 113.865 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -140.82 147.06 38.44 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.833 165.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.98 177.93 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 121.102 -0.999 . . . . 0.0 111.995 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -137.33 102.79 4.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.326 1.05 . . . . 0.0 110.701 172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -70.22 165.11 22.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 110.605 140.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.02 -36.95 11.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.583 -0.698 . . . . 0.0 112.796 158.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.04 131.47 83.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.113 0.965 . . . . 0.0 112.313 -172.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -85.79 -8.99 7.94 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.429 2.753 . . . . 0.0 115.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -112.62 -41.42 3.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.347 1.859 . . . . 0.0 110.851 -160.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 -29.96 70.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.534 0.606 . . . . 0.0 111.225 159.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.01 70.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.777 0.831 . . . . 0.0 112.399 168.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.04 -30.41 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.07 -1.019 . . . . 0.0 111.226 170.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.02 -35.46 69.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.524 1.057 . . . . 0.0 113.693 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.95 -27.71 69.32 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.181 -1.575 . . . . 0.0 112.824 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.43 -37.26 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 119.205 -2.184 . . . . 0.0 110.926 165.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -62.46 -34.36 76.66 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.725 -1.235 . . . . 0.0 112.998 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -128.82 -14.33 4.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -158.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -17.07 7.25 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.203 1.001 . . . . 0.0 113.604 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -82.91 159.86 22.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.092 1.314 . . . . 0.0 112.24 165.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.78 5.47 88.51 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.601 1.096 . . . . 0.0 115.175 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -131.98 -137.64 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.933 1.693 . . . . 0.0 112.134 -165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 m -141.41 123.8 15.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.721 2.409 . . . . 0.0 108.616 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.58 131.85 56.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.195 1.398 . . . . 0.0 108.88 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 9.0 t 59.44 -58.14 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.656 2.382 . . . . 0.0 115.906 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.45 35.58 0.08 OUTLIER Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.0 1.285 . . . . 0.0 114.362 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 13.5 p -129.66 -163.57 1.31 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.85 1.26 . . . . 0.0 113.941 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -130.98 63.82 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.34 1.856 . . . . 0.0 109.558 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -43.82 161.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 130.012 3.325 . . . . 0.0 117.657 -165.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.87 149.15 41.58 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.922 1.289 . . . . 0.0 110.21 140.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -148.48 145.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.678 1.191 . . . . 0.0 110.12 -167.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 134.99 20.34 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 109.62 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -146.12 128.42 15.82 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.915 1.688 . . . . 0.0 115.227 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.0 p -159.35 -111.81 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.568 128.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -152.88 4.67 0.35 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -171.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.89 -169.22 40.55 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.486 1.039 . . . . 0.0 115.623 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -154.48 -23.31 0.13 Allowed 'General case' 0 N--CA 1.478 0.927 0 O-C-N 118.707 -2.643 . . . . 0.0 114.317 6.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -135.72 21.05 3.32 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -164.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 124.533 1.133 . . . . 0.0 112.789 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -141.51 175.83 9.36 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 131.658 3.983 . . . . 0.0 111.923 21.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -136.51 100.3 4.32 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.92 116.08 14.31 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -157.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.9 tp -101.62 95.02 6.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.683 1.193 . . . . 0.0 110.432 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -55.65 108.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 128.122 2.569 . . . . 0.0 109.37 159.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.565 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.9 mp -86.08 139.85 30.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 167.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -147.82 47.77 1.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.419 1.887 . . . . 0.0 108.496 172.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.68 -169.94 23.57 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 116.806 1.482 . . . . 0.0 116.806 -162.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -43.71 -31.89 0.89 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.953 2.101 . . . . 0.0 114.308 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -126.26 -44.59 1.72 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.773 1.629 . . . . 0.0 112.589 -148.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -154.7 142.85 20.3 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.705 1.602 . . . . 0.0 108.22 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -136.91 127.18 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.709 1.604 . . . . 0.0 109.084 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.59 31.82 0.26 Allowed Glycine 0 N--CA 1.477 1.404 0 N-CA-C 117.896 1.918 . . . . 0.0 117.896 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER 56.59 -177.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -144.73 -27.53 0.49 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p 61.83 161.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.439 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -164.57 -175.06 3.68 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.32 2.248 . . . . 0.0 108.561 163.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -142.68 134.44 26.81 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.894 1.678 . . . . 0.0 108.416 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.7 6.54 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.133 0.968 . . . . 0.0 113.514 -161.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 21' ' ' VAL . 27.5 t -47.57 -59.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.742 2.017 . . . . 0.0 111.052 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -172.96 177.94 2.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.005 2.122 . . . . 0.0 108.997 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.89 24.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.774 2.03 . . . . 0.0 113.735 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 -58.74 2.05 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -67.13 -29.98 69.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.169 1.788 . . . . 0.0 113.165 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.76 -46.61 29.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.829 -0.544 . . . . 0.0 110.468 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.33 -44.16 83.98 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -54.08 -28.76 41.2 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.67 -38.28 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.088 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CZ ' HG22 ' A' ' 18' ' ' THR . 10.9 m-85 -54.94 -42.38 72.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 167.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -39.74 -53.72 2.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.909 2.083 . . . . 0.0 110.54 167.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -82.32 -31.47 29.89 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.581 1.952 . . . . 0.0 114.737 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.42 -41.75 98.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.349 0.977 . . . . 0.0 111.212 168.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -76.79 -36.75 56.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.278 -0.889 . . . . 0.0 109.855 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -67.35 -28.41 67.94 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.235 0.925 . . . . 0.0 112.501 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.9 -39.96 75.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 113.093 168.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -63.95 -34.26 77.57 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 121.707 -0.621 . . . . 0.0 111.957 169.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.59 17.92 5.45 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.128 1.823 . . . . 0.0 113.656 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 1.3 t -107.3 140.3 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.749 1.62 . . . . 0.0 111.956 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.08 -9.2 3.01 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.623 1.169 . . . . 0.0 113.132 156.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.14 -99.03 0.01 OUTLIER Glycine 0 C--N 1.34 0.805 0 C-N-CA 129.699 3.523 . . . . 0.0 118.767 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.86 11.13 3.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.377 1.871 . . . . 0.0 110.298 -167.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.41 ' CE3' HG13 ' A' ' 54' ' ' VAL . 10.6 m95 -16.62 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.937 2.495 . . . . 0.0 115.502 -156.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -116.89 163.29 16.41 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.744 1.618 . . . . 0.0 110.944 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -145.63 157.69 43.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.964 2.106 . . . . 0.0 111.11 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -135.7 125.79 26.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.572 2.349 . . . . 0.0 110.479 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.24 -21.07 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.78 60.85 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.659 0.784 . . . . 0.0 112.23 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.1 p -136.71 -2.39 2.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.428 1.491 . . . . 0.0 113.033 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.355 34.6 mtpt 65.16 17.54 11.08 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.904 2.482 . . . . 0.0 113.787 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -66.96 159.44 28.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.994 2.918 . . . . 0.0 114.478 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -122.14 164.53 17.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 130.056 3.342 . . . . 0.0 112.779 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.4 m -150.14 143.89 25.34 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.64 -1.288 . . . . 0.0 112.527 167.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -127.51 128.65 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.216 1.006 . . . . 0.0 112.939 160.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -132.61 100.6 5.01 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.259 1.824 . . . . 0.0 110.748 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -105.44 -20.21 13.55 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.15 -161.46 12.93 Favored Glycine 0 N--CA 1.475 1.294 0 CA-C-N 119.82 1.191 . . . . 0.0 115.306 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -145.56 76.59 1.48 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.657 1.183 . . . . 0.0 112.195 -165.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -140.58 -39.38 0.43 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.353 3.061 . . . . 0.0 111.966 -0.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -145.2 165.67 27.69 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.275 1.43 . . . . 0.0 112.594 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -78.21 47.34 0.67 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.052 1.741 . . . . 0.0 114.984 -167.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -138.48 -53.81 0.61 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -59.01 -26.95 64.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -61.42 -15.54 37.96 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.5 ptp -135.45 21.69 3.39 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.654 1.582 . . . . 0.0 112.645 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 144.05 36.33 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.564 0.746 . . . . 0.0 111.946 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -159.55 -27.37 0.07 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.767 1.627 . . . . 0.0 113.104 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -0.05 -58.04 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 130.389 3.476 . . . . 0.0 118.08 157.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 m -146.78 155.11 42.12 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.531 1.132 . . . . 0.0 112.32 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.4 p -63.31 120.51 62.59 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.564 1.546 . . . . 0.0 113.353 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.12 -43.17 1.67 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.848 2.365 . . . . 0.0 111.984 170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.02 -43.73 0.26 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.124 2.57 . . . . 0.0 106.569 156.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -174.68 -51.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.744 1.218 . . . . 0.0 112.727 136.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 51.7 t -156.41 120.56 4.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.351 0.66 . . . . 0.0 112.113 -168.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.05 -175.46 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.975 2.51 . . . . 0.0 113.757 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.401 HG12 HG13 ' A' ' 115' ' ' VAL . 43.9 t -109.0 142.02 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 O-C-N 120.651 -1.281 . . . . 0.0 108.455 161.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.29 133.7 24.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.706 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG13 ' A' ' 142' ' ' VAL . 50.9 t -137.69 148.58 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.419 0.688 . . . . 0.0 109.624 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.37 -166.9 20.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 60.99 14.65 5.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.917 1.687 . . . . 0.0 113.737 -157.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.66 46.37 1.07 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.01 1.724 . . . . 0.0 113.3 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -43.96 93.82 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.923 -1.11 . . . . 0.0 115.569 -166.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.82 -35.57 78.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -167.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -146.06 -28.31 0.42 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -163.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.68 111.89 1.06 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 123.599 0.618 . . . . 0.0 113.757 -155.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -129.05 -31.22 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 116.516 -1.707 . . . . 0.0 113.898 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.8 tttm 153.12 -60.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 129.374 3.07 . . . . 0.0 112.876 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.8 m -74.16 -26.14 60.13 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -161.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -26.65 65.77 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.873 -1.142 . . . . 0.0 113.682 167.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.8 mt -89.48 -34.55 16.38 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.966 1.306 . . . . 0.0 111.564 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -54.35 -35.39 62.7 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.747 -0.596 . . . . 0.0 112.321 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -88.06 -42.33 12.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.29 -30.24 64.55 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 120.037 1.29 . . . . 0.0 113.16 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -106.86 -22.91 12.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.968 0.907 . . . . 0.0 112.102 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.7 -35.11 7.36 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.039 1.78 . . . . 0.0 114.383 161.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -53.6 -42.58 67.8 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.641 1.176 . . . . 0.0 113.18 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -85.29 -24.52 27.68 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.878 0.871 . . . . 0.0 110.895 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 124.81 -74.13 0.41 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 153.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.5 43.98 1.6 Allowed 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.269 3.312 . . . . 0.0 114.831 -158.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.84 154.28 15.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.965 -1.085 . . . . 0.0 112.439 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -139.13 -20.9 0.96 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.047 1.739 . . . . 0.0 113.314 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -163.95 149.7 11.01 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.758 0.823 . . . . 0.0 110.812 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -151.1 121.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.091 1.756 . . . . 0.0 107.986 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -148.19 150.59 34.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.317 1.447 . . . . 0.0 110.304 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.51 157.66 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.718 -1.239 . . . . 0.0 113.582 -172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.82 170.18 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.487 1.915 . . . . 0.0 113.055 -173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -127.03 28.11 5.84 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.267 1.827 . . . . 0.0 110.509 166.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -156.17 72.42 5.1 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 126.077 1.751 . . . . 0.0 113.534 -162.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -68.25 153.24 88.48 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 120.613 1.255 . . . . 0.0 114.559 -0.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.33 71.49 5.8 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.554 3.502 . . . . 0.0 113.569 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.64 24.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-O 117.961 -1.466 . . . . 0.0 116.597 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.93 145.94 40.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.844 1.822 . . . . 0.0 114.048 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -138.15 161.9 35.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.451 3.1 . . . . 0.0 113.287 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -152.3 144.0 23.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.24 1.416 . . . . 0.0 110.731 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG13 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -152.36 174.51 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.137 -0.977 . . . . 0.0 110.93 -161.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.34 120.44 13.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.085 1.354 . . . . 0.0 109.588 167.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.73 159.78 20.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.338 1.055 . . . . 0.0 110.046 153.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.82 -22.61 31.71 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.427 -1.421 . . . . 0.0 114.276 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.92 136.7 29.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.733 0.813 . . . . 0.0 112.678 -162.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.4 -33.67 17.46 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.934 2.423 . . . . 0.0 114.827 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -41.1 44.43 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.728 1.604 . . . . 0.0 113.444 -166.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.17 -26.82 60.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.701 0.682 . . . . 0.0 112.36 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.22 -45.13 67.17 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.368 0.667 . . . . 0.0 111.809 171.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.24 81.29 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 120.685 -1.26 . . . . 0.0 110.322 172.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -39.82 78.42 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.96 -17.99 58.85 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.904 -1.122 . . . . 0.0 113.914 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 -53.08 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.548 -1.345 . . . . 0.0 110.004 160.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -61.06 -24.47 66.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.168 1.787 . . . . 0.0 113.97 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -108.86 -8.21 15.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.158 1.383 . . . . 0.0 112.091 -168.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -152.07 -30.35 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -154.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -63.99 132.95 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.913 0.779 . . . . 0.0 111.772 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.35 79.15 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.749 0.69 . . . . 0.0 114.323 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -111.56 -117.43 0.3 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.325 1.45 . . . . 0.0 110.114 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -154.33 148.88 26.3 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.495 1.498 . . . . 0.0 110.257 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 tp -139.83 -48.4 0.46 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.6 m -134.52 35.97 3.17 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.212 1.405 . . . . 0.0 112.163 -167.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.22 24.76 67.81 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.335 -0.853 . . . . 0.0 113.165 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.8 p -134.41 144.47 48.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.878 2.071 . . . . 0.0 110.755 -172.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -75.49 67.75 2.05 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.406 1.082 . . . . 0.0 111.133 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 p -54.67 151.54 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.844 2.057 . . . . 0.0 113.943 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.3 132.61 35.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.275 1.83 . . . . 0.0 109.434 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 144' ' ' LEU . 4.9 t -148.63 129.91 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 117.973 0.351 . . . . 0.0 111.209 -152.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -140.84 137.68 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 119.954 -1.716 . . . . 0.0 111.629 167.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.487 HD11 HG12 ' A' ' 142' ' ' VAL . 2.0 mp -140.03 124.75 18.26 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -152.35 -81.4 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.062 0.945 . . . . 0.0 112.945 140.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.3 p30 132.1 -176.47 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.293 3.037 . . . . 0.0 106.964 -135.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.84 -0.09 2.63 Favored Glycine 0 N--CA 1.474 1.225 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -21.39 23.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.42 1.11 . . . . 0.0 112.948 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 -173.74 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.391 2.276 . . . . 0.0 111.855 -165.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 125.059 1.344 . . . . 0.0 111.328 151.105 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -150.53 167.51 26.99 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.267 2.627 . . . . 0.0 111.138 -9.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -131.91 110.46 10.81 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.39 101.83 5.31 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.023 0.929 . . . . 0.0 111.488 -165.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.3 98.26 11.49 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.922 0.889 . . . . 0.0 109.851 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.6 mt -59.53 113.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.576 2.35 . . . . 0.0 109.37 160.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.04 136.6 32.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.744 164.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -144.02 42.84 1.44 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.84 2.056 . . . . 0.0 107.403 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.49 173.99 33.08 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 120.743 -1.223 . . . . 0.0 113.865 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -58.69 -42.15 87.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.619 0.723 . . . . 0.0 112.029 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -69.49 -62.99 1.16 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.641 2.376 . . . . 0.0 112.48 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -141.55 140.09 33.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.928 0.891 . . . . 0.0 110.801 -166.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 103.95 7.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.228 2.211 . . . . 0.0 107.884 -174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.3 95.95 0.16 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.619 1.581 . . . . 0.0 112.49 -162.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -28.58 160.4 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.751 2.82 . . . . 0.0 118.024 166.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -135.47 -25.03 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 11.3 p 57.07 162.57 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.978 2.955 . . . . 0.0 118.978 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.552 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.1 t -164.14 -171.94 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.31 3.044 . . . . 0.0 108.222 169.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.35 136.28 27.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.867 1.667 . . . . 0.0 109.282 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.43 177.45 10.59 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.136 0.97 . . . . 0.0 113.453 -164.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -56.18 -56.56 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.503 1.921 . . . . 0.0 111.214 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -174.36 -174.85 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.196 2.998 . . . . 0.0 107.464 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.92 24.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.932 2.093 . . . . 0.0 114.941 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.01 4.18 7.98 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.39 1.076 . . . . 0.0 112.117 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.6 m -126.4 -22.22 4.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.245 1.818 . . . . 0.0 111.389 168.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.65 -49.3 11.43 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 121.362 -0.837 . . . . 0.0 111.315 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.4 -45.63 90.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -51.53 -22.34 3.12 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.51 -39.02 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.724 1.61 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -55.57 -39.38 70.59 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 169.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -57.23 3.14 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.999 2.12 . . . . 0.0 110.074 168.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.91 -35.22 64.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -61.48 -40.31 94.07 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.362 0.983 . . . . 0.0 111.132 172.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -78.06 -37.03 47.62 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.58 -0.7 . . . . 0.0 109.85 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -69.92 -25.92 63.9 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.756 0.707 . . . . 0.0 112.258 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.96 -36.57 69.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.103 1.361 . . . . 0.0 112.809 168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -63.91 -31.18 72.27 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.707 -0.62 . . . . 0.0 111.566 164.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.59 -3.18 15.43 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.811 2.148 . . . . 0.0 113.038 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.6 t -81.01 127.9 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.251 1.82 . . . . 0.0 111.358 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -143.76 82.65 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 124.184 1.945 . . . . 0.0 108.305 152.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.95 -136.43 9.11 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 110.328 -3.124 . . . . 0.0 112.777 -155.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.78 39.75 0.5 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 127.865 2.466 . . . . 0.0 110.785 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.427 ' CD2' HG13 ' A' ' 54' ' ' VAL . 32.6 m95 -37.8 98.2 0.01 OUTLIER 'General case' 0 C--O 1.235 0.321 0 C-N-CA 128.053 2.541 . . . . 0.0 112.902 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.6 m -116.61 157.93 24.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.25 1.82 . . . . 0.0 108.385 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -141.95 146.38 35.58 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.83 1.252 . . . . 0.0 109.952 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.42 54.36 1.96 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.855 1.262 . . . . 0.0 110.607 -156.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -41.56 -31.16 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 129.948 3.299 . . . . 0.0 117.253 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -20.93 59.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.268 1.827 . . . . 0.0 112.601 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -133.2 5.1 3.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.26 1.824 . . . . 0.0 112.894 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.293 46.6 mttm 49.8 13.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 129.404 3.081 . . . . 0.0 116.519 -168.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.8 m -47.51 158.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.974 2.51 . . . . 0.0 113.505 156.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -128.4 160.91 30.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 129.439 3.096 . . . . 0.0 111.383 168.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.5 m -145.62 124.32 12.57 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.291 -0.88 . . . . 0.0 110.896 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.85 100.67 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 121.857 0.837 . . . . 0.0 112.293 160.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.37 131.83 37.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.11 0.957 . . . . 0.0 110.123 157.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 20.1 tt0 -148.37 -42.95 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 112.449 161.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 -20.68 67.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.042 1.306 . . . . 0.0 113.12 171.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.7 p -131.69 44.7 2.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.462 166.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -43.08 147.74 0.32 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.379 1.472 . . . . 0.0 112.663 168.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -121.88 -21.87 5.92 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.382 1.073 . . . . 0.0 112.431 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -69.21 117.57 11.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.609 1.164 . . . . 0.0 109.522 160.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -65.2 145.68 55.94 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.371 173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -151.31 169.78 21.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 111.053 -165.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -140.59 15.42 2.35 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -162.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -129.38 -24.43 2.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -159.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -130.26 35.56 4.07 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.896 1.278 . . . . 0.0 112.198 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.41 -47.89 0.64 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -171.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -160.67 173.12 15.92 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.349 0.977 . . . . 0.0 113.414 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.1 p -117.73 -36.29 3.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.416 1.886 . . . . 0.0 112.453 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 p -131.41 154.32 81.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 129.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 -43.77 5.12 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.319 1.346 . . . . 0.0 110.536 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 0.3 OUTLIER -162.98 -36.92 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.81 2.444 . . . . 0.0 108.64 155.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -139.33 -79.5 0.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.015 1.326 . . . . 0.0 110.57 164.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 30.4 p -163.34 -12.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.995 1.718 . . . . 0.0 115.528 159.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.9 -169.81 2.51 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 120.838 1.654 . . . . 0.0 111.082 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.5 135.28 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 121.274 1.852 . . . . 0.0 111.953 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.21 118.1 9.97 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.504 1.922 . . . . 0.0 108.589 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.81 143.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.26 -170.11 41.37 Favored Glycine 0 C--O 1.224 -0.493 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 23.5 t30 119.94 -13.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 131.646 3.978 . . . . 0.0 110.995 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.3 mt -58.2 -27.43 63.89 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -165.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.68 -27.02 0.28 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 126.782 2.135 . . . . 0.0 117.662 170.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.46 -13.61 12.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.858 1.663 . . . . 0.0 112.793 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -169.77 -177.79 2.78 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.231 2.612 . . . . 0.0 109.059 -163.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 143.91 15.79 0.25 Allowed Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.978 -0.901 . . . . 0.0 114.819 164.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -49.38 163.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 129.36 3.064 . . . . 0.0 113.987 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -59.31 -35.88 74.62 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.403 -0.811 . . . . 0.0 112.662 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.7 m -92.15 -32.56 15.07 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.587 1.085 . . . . 0.0 113.87 -168.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.48 -31.73 69.61 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.432 -1.418 . . . . 0.0 111.728 165.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.85 -28.01 20.67 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.123 1.156 . . . . 0.0 114.123 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.56 -33.19 71.11 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.607 1.548 . . . . 0.0 109.154 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -82.3 -47.23 12.64 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.487 175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.42 -28.46 65.27 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.161 0.891 . . . . 0.0 112.874 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.57 -37.58 8.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.743 0.817 . . . . 0.0 112.672 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -43.82 -36.91 3.81 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.263 1.887 . . . . 0.0 114.978 167.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -55.03 -45.65 75.19 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 172.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -75.06 -35.65 61.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.141 0.577 . . . . 0.0 110.401 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.56 178.45 40.75 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.507 1.051 . . . . 0.0 115.473 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.4 155.73 63.21 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.053 3.169 . . . . 0.0 114.822 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.56 148.26 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.746 2.418 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -103.55 -37.82 7.4 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.648 1.979 . . . . 0.0 112.759 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -161.38 157.81 25.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 p -167.6 131.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.46 1.104 . . . . 0.0 112.155 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -155.48 159.32 39.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.288 1.835 . . . . 0.0 111.317 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.91 157.67 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.223 -1.548 . . . . 0.0 113.431 -171.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.93 -44.9 74.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.513 1.525 . . . . 0.0 113.665 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? 61.45 -37.58 0.11 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 129.55 3.14 . . . . 0.0 115.908 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.44 83.71 30.63 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 127.721 2.408 . . . . 0.0 110.571 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.04 160.98 91.68 Favored 'Cis proline' 0 CA--C 1.544 0.983 0 CA-C-N 119.57 0.882 . . . . 0.0 113.458 6.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.63 172.28 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.353 2.702 . . . . 0.0 113.1 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.37 -18.82 9.38 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.363 -1.243 . . . . 0.0 115.201 163.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.72 132.62 21.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.671 1.236 . . . . 0.0 112.773 -169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.88 163.05 28.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.854 2.462 . . . . 0.0 113.379 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -135.61 138.71 43.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.01 1.724 . . . . 0.0 109.23 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.283 2.0 m -146.9 -177.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.234 -0.916 . . . . 0.0 112.404 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.09 117.31 10.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.733 2.013 . . . . 0.0 107.196 162.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.06 -174.87 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.002 1.321 . . . . 0.0 114.067 165.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -124.12 -8.54 7.67 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -149.58 123.37 4.56 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 120.562 1.528 . . . . 0.0 113.01 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.64 -24.32 48.19 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.271 2.648 . . . . 0.0 114.934 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.6 ttp-105 -63.06 -55.08 28.55 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.765 1.166 . . . . 0.0 110.451 172.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.73 -34.06 76.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.014 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.09 92.26 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.57 -35.32 80.59 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.549 -1.344 . . . . 0.0 110.27 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.94 -42.52 48.45 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.63 -14.28 41.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.83 1.252 . . . . 0.0 114.084 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.17 -60.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.396 0.998 . . . . 0.0 109.705 155.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.27 -19.92 62.29 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -160.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -98.34 1.64 47.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.276 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.05 -31.13 0.5 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -159.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.48 104.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.317 1.447 . . . . 0.0 110.671 156.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.12 24.15 25.44 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 118.42 -1.211 . . . . 0.0 114.76 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -116.59 164.18 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.583 1.691 . . . . 0.0 112.985 -168.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 22.4 m -95.4 128.35 42.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.513 1.525 . . . . 0.0 110.844 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.1 -12.79 11.89 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.153 1.381 . . . . 0.0 114.344 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.32 -65.31 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.985 0.914 . . . . 0.0 111.811 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -165.69 32.8 0.23 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.756 2.122 . . . . 0.0 111.059 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 3.7 m -142.77 -158.9 0.91 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.198 2.199 . . . . 0.0 109.192 -158.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -149.26 153.43 37.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.806 1.242 . . . . 0.0 110.128 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -137.81 160.66 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -165.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.61 142.64 41.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.492 2.717 . . . . 0.0 109.55 172.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.37 125.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.565 -0.71 . . . . 0.0 110.907 -152.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -122.42 120.44 33.96 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.965 2.106 . . . . 0.0 106.96 168.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.5 tt -153.85 112.25 3.62 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.933 1.242 . . . . 0.0 113.445 -161.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . 12.6 p -153.34 -161.72 1.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.418 1.887 . . . . 0.0 114.733 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.58 93.42 1.29 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.651 1.58 . . . . 0.0 112.554 -164.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.53 -145.03 9.74 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 123.596 1.664 . . . . 0.0 116.948 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.4 -179.49 6.69 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 129.409 3.083 . . . . 0.0 107.827 173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -131.13 85.77 2.3 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.06 -1.025 . . . . 0.0 113.107 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.467 1.507 . . . . 0.0 111.304 151.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 pmm? . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.0 tp60 -135.29 166.94 21.97 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.833 2.853 . . . . 0.0 110.943 1.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -127.15 106.6 9.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.49 99.82 4.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.177 0.991 . . . . 0.0 111.496 -163.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 tp -89.09 95.64 10.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.335 1.054 . . . . 0.0 108.952 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.38 117.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.625 1.57 . . . . 0.0 108.912 160.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.404 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -93.22 129.63 39.19 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.655 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 69.8 m-80 -143.18 109.51 5.35 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.84 177.47 27.05 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 121.803 0.669 . . . . 0.0 114.617 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -61.59 -33.14 73.38 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.952 1.301 . . . . 0.0 110.655 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.3 m -63.12 -55.87 21.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.634 2.373 . . . . 0.0 113.216 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -165.08 144.21 6.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.792 1.637 . . . . 0.0 109.687 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -131.73 150.24 52.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.885 1.274 . . . . 0.0 112.459 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.14 -134.64 4.51 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 125.957 1.742 . . . . 0.0 111.294 -165.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.4 mt-10 -161.25 -166.6 1.58 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.22 2.608 . . . . 0.0 107.801 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 t -145.9 -39.68 0.23 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 161.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 p 57.62 163.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -165.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 t -159.96 -169.36 2.5 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.592 2.357 . . . . 0.0 106.754 153.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -137.92 132.02 31.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.289 -1.507 . . . . 0.0 108.146 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -141.84 -178.72 5.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.147 0.979 . . . . 0.0 112.417 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -44.41 -57.72 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.677 1.991 . . . . 0.0 110.809 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -178.97 -164.47 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 129.521 3.128 . . . . 0.0 108.751 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.34 20.47 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.178 2.191 . . . . 0.0 115.189 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.24 5.13 5.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.442 1.097 . . . . 0.0 112.233 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -125.63 -14.62 6.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 111.713 161.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.47 -51.46 7.34 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.453 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.25 -47.88 65.51 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -56.37 -19.43 14.69 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.6 -168.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.67 -34.05 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.712 1.605 . . . . 0.0 110.296 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -54.08 -44.67 71.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.701 1.2 . . . . 0.0 112.071 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -43.48 -56.49 3.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.326 1.85 . . . . 0.0 111.564 168.135 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -75.23 -31.51 60.87 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.034 0.834 . . . . 0.0 111.134 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.03 -35.07 57.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.346 -0.846 . . . . 0.0 110.013 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -66.73 -31.09 71.52 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.003 0.819 . . . . 0.0 112.173 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.59 -38.31 80.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.016 1.326 . . . . 0.0 113.168 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.99 -33.15 74.94 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 121.682 -0.636 . . . . 0.0 112.525 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.28 27.12 2.28 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.894 1.711 . . . . 0.0 114.021 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.75 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.359 1.463 . . . . 0.0 111.88 -165.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.78 3.89 6.05 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 121.818 0.818 . . . . 0.0 112.243 152.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.71 -112.12 0.98 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.181 2.324 . . . . 0.0 118.396 150.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -147.33 37.24 0.92 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.972 2.509 . . . . 0.0 107.223 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 18.4 m95 -40.67 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.497 1.519 . . . . 0.0 114.152 -160.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 m -125.08 160.2 29.63 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.918 1.687 . . . . 0.0 110.012 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -148.15 154.03 39.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.598 1.559 . . . . 0.0 111.151 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 19.5 t70 -129.88 139.6 51.13 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 126.361 1.864 . . . . 0.0 109.18 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -108.38 -16.83 14.14 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.31 -26.42 61.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 111.856 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.3 p -122.28 -6.9 8.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.429 1.891 . . . . 0.0 112.953 167.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' ASP 0.421 45.1 mttm 66.13 12.63 8.64 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 126.992 2.117 . . . . 0.0 115.376 -173.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -59.67 155.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 127.229 2.211 . . . . 0.0 114.361 170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -123.91 166.33 15.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.925 2.49 . . . . 0.0 112.318 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -150.01 137.57 19.91 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.769 -1.207 . . . . 0.0 110.793 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.63 153.94 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 118.54 -0.743 . . . . 0.0 110.512 155.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -151.14 88.42 1.45 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.313 1.845 . . . . 0.0 113.957 -176.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -93.85 -1.08 55.36 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 113.913 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.0 168.16 34.99 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.519 -1.363 . . . . 0.0 113.365 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.6 p -46.13 115.74 1.07 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.602 1.961 . . . . 0.0 115.868 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 97.3 m-70 100.33 133.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 131.21 3.804 . . . . 0.0 113.087 174.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -90.17 -11.98 39.51 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -133.5 -2.76 3.03 Favored 'General case' 0 N--CA 1.474 0.727 3 C-N-CA 134.154 4.981 . . . . 0.0 113.44 2.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -66.03 -19.0 65.71 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.41 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 5.9 p80 -58.74 -13.42 5.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.357 1.463 . . . . 0.0 114.911 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -62.18 -12.32 19.31 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.696 1.598 . . . . 0.0 113.851 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 87.6 mtp -53.02 145.25 13.37 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.642 -1.286 . . . . 0.0 113.557 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -157.28 173.45 16.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.666 2.386 . . . . 0.0 109.622 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.67 -173.6 4.1 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -72.26 24.83 0.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.141 2.177 . . . . 0.0 115.696 -163.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 t -152.72 152.51 31.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.5 1.92 . . . . 0.0 110.531 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -64.64 138.25 97.4 Favored Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.559 -0.713 . . . . 0.0 110.404 161.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.39 -38.6 25.54 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.272 1.981 . . . . 0.0 112.888 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -155.34 -45.77 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.94 2.496 . . . . 0.0 108.156 170.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -146.21 -130.71 0.07 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.403 2.281 . . . . 0.0 108.286 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.4 m -135.49 -11.9 2.1 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.041 1.336 . . . . 0.0 114.238 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -149.95 -157.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.886 2.475 . . . . 0.0 108.892 -167.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 144' ' ' LEU . 70.1 t -118.9 141.93 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.818 -1.176 . . . . 0.0 109.716 150.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -141.81 128.25 20.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.07 1.348 . . . . 0.0 109.772 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.7 t -133.38 122.58 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.06 -171.09 12.2 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 119.997 -0.335 . . . . 0.0 112.998 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.42 41.33 24.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.416 0.686 . . . . 0.0 112.27 -158.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.34 -30.76 42.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.899 0.88 . . . . 0.0 111.75 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.14 -51.65 0.56 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 127.927 2.68 . . . . 0.0 117.404 171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -124.1 -56.62 1.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.382 1.091 . . . . 0.0 113.795 -152.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.62 -27.84 28.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -165.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -7.03 82.83 0.0 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 128.943 3.163 . . . . 0.0 117.039 -165.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -118.21 -66.62 1.06 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 147.36 -46.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 131.386 3.874 . . . . 0.0 111.93 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -74.73 -27.16 60.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.57 0.623 . . . . 0.0 112.166 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.97 -38.4 50.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.742 0.817 . . . . 0.0 112.759 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.6 -34.97 18.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.665 1.586 . . . . 0.0 111.585 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -56.34 -35.5 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.544 0.738 . . . . 0.0 110.496 172.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -83.91 -53.46 5.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.801 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.02 -22.03 47.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -115.88 -26.48 7.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.344 1.058 . . . . 0.0 112.424 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.04 -33.3 21.42 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.533 1.063 . . . . 0.0 114.145 165.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -55.23 -43.77 74.86 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 172.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.03 -34.18 44.11 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.511 0.324 . . . . 0.0 111.024 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.25 -171.04 44.0 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -168.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.13 126.06 8.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.217 3.278 . . . . 0.0 113.322 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -99.83 144.0 29.4 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 109.416 167.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.92 -5.23 1.15 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.764 1.626 . . . . 0.0 113.272 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -156.78 160.55 39.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.741 1.216 . . . . 0.0 110.638 154.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.4 t -159.91 136.19 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.774 2.03 . . . . 0.0 110.145 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -157.03 160.18 38.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.95 1.7 . . . . 0.0 111.444 161.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.13 148.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 120.705 -1.247 . . . . 0.0 112.823 171.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.11 169.35 2.08 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.293 1.837 . . . . 0.0 114.153 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -145.63 31.44 1.07 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.801 2.04 . . . . 0.0 110.366 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -150.02 44.71 0.33 Allowed Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 127.139 2.175 . . . . 0.0 114.921 -161.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -78.83 171.0 67.75 Favored 'Cis proline' 0 CA--C 1.548 1.189 0 CA-C-N 121.979 1.742 . . . . 0.0 114.451 0.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.63 21.91 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.325 1 C-N-CA 126.245 4.63 . . . . 0.0 117.011 170.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.86 -3.52 59.25 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 116.288 1.275 . . . . 0.0 116.288 -165.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.8 139.32 32.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.79 1.295 . . . . 0.0 111.964 -168.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -133.98 154.58 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 129.077 2.951 . . . . 0.0 112.082 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.56 138.8 36.56 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.813 1.245 . . . . 0.0 109.462 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.278 2.0 m -141.6 -179.65 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.247 -0.908 . . . . 0.0 110.834 -177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -141.45 102.74 4.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.506 1.522 . . . . 0.0 108.314 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -64.61 175.92 1.28 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.447 0.699 . . . . 0.0 111.698 159.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -124.96 9.89 8.18 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.555 -1.34 . . . . 0.0 112.741 166.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.66 126.61 11.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.363 . . . . 0.0 110.991 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -81.08 -22.15 6.2 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.748 2.299 . . . . 0.0 113.914 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -70.82 -51.78 24.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.781 1.173 . . . . 0.0 110.358 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -67.85 -37.23 81.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.53 1.132 . . . . 0.0 110.589 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.64 67.19 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.133 1.373 . . . . 0.0 112.49 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.7 -30.88 67.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.724 -1.235 . . . . 0.0 111.033 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.88 -40.2 65.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.97 1.259 . . . . 0.0 113.483 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -17.34 36.21 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 0.0 113.898 166.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.9 t -79.33 -55.79 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.405 1.457 . . . . 0.0 110.131 159.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -54.96 -29.4 56.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.895 2.078 . . . . 0.0 114.068 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.36 -11.99 16.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.85 1.26 . . . . 0.0 112.075 -169.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.17 -20.54 0.44 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -154.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -71.18 136.82 48.28 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.756 0.822 . . . . 0.0 112.687 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.18 43.39 21.23 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.074 0.845 . . . . 0.0 112.622 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.12 -154.96 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.368 1.467 . . . . 0.0 111.671 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 89.2 m -129.46 -42.45 1.32 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.786 1.234 . . . . 0.0 110.744 -169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 tp 41.55 -99.53 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.771 2.828 . . . . 0.0 114.217 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.5 m -77.86 41.2 0.34 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.545 2.338 . . . . 0.0 113.475 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.81 23.87 75.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.745 1.164 . . . . 0.0 114.386 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.41 -119.22 0.23 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 111.489 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.72 32.27 0.1 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.597 0.713 . . . . 0.0 112.652 -153.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.7 p -51.13 140.81 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 127.232 2.213 . . . . 0.0 115.864 -156.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -134.32 113.76 12.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 129.385 3.074 . . . . 0.0 107.584 -170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.18 132.51 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.919 0.488 . . . . 0.0 112.077 -150.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.48 132.7 29.81 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.958 1.703 . . . . 0.0 109.938 171.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.458 ' HG ' HG13 ' A' ' 76' ' ' VAL . 1.8 mp -144.11 137.94 27.87 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.958 -1.089 . . . . 0.0 112.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 p -172.18 -32.31 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 162.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.96 56.25 6.16 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.56 1.944 . . . . 0.0 115.45 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.48 62.93 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.87 123.43 11.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.691 1.746 . . . . 0.0 110.313 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -112.31 1.54 16.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 119.372 3.101 . . . . 0.0 119.372 -128.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 120.365 1.438 . . . . 0.0 113.748 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -147.07 165.65 29.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.873 2.869 . . . . 0.0 110.064 -8.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -130.55 95.67 3.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.06 102.27 7.16 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.159 -154.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.4 tp -88.71 93.58 9.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.16 1.384 . . . . 0.0 109.053 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 mt -58.22 118.11 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 126.65 1.98 . . . . 0.0 108.757 159.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.92 139.36 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.76 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -145.89 51.33 1.17 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.223 0.609 . . . . 0.0 109.879 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.56 -168.0 18.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 -165.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -41.11 -28.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 129.416 3.086 . . . . 0.0 116.014 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -134.44 -40.47 0.8 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.253 1.421 . . . . 0.0 111.871 -144.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.54 137.77 15.7 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.244 1.818 . . . . 0.0 107.82 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE3' ' NE2' ' A' ' 59' ' ' HIS . 25.4 mttt -127.93 124.43 37.32 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.907 1.283 . . . . 0.0 109.464 171.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.44 -134.89 4.47 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 125.287 1.423 . . . . 0.0 109.929 -152.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -164.05 -174.06 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.166 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -142.82 -29.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p 57.98 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.426 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -166.03 -179.38 5.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.84 2.856 . . . . 0.0 107.76 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -140.02 134.89 32.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.751 1.621 . . . . 0.0 108.403 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.28 -178.74 6.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.935 0.894 . . . . 0.0 112.131 -163.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -43.32 -57.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.564 1.945 . . . . 0.0 110.741 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -171.22 -163.39 0.29 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.93 2.892 . . . . 0.0 107.681 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.37 24.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.231 1.812 . . . . 0.0 114.249 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.0 -59.03 1.81 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.1 m -65.03 -21.97 66.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.13 -49.05 10.6 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 119.071 0.85 . . . . 0.0 111.67 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -62.51 -44.99 95.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.92 -20.38 51.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.94 -42.1 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.423 1.889 . . . . 0.0 111.282 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CZ ' HG22 ' A' ' 18' ' ' THR . 11.3 m-85 -54.9 -36.46 65.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 170.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.3 mmpt? -48.49 -50.09 33.08 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.494 1.918 . . . . 0.0 110.186 171.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -74.92 -37.71 61.98 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.839 1.655 . . . . 0.0 114.721 175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -58.56 -39.4 80.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.463 1.029 . . . . 0.0 111.366 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -83.13 -32.22 26.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.449 -0.782 . . . . 0.0 110.858 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.03 -31.44 72.67 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.21 -41.9 80.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 113.084 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -66.27 -35.29 80.02 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.775 -0.578 . . . . 0.0 112.488 172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.74 29.8 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.619 1.58 . . . . 0.0 113.798 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.99 127.17 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.938 1.295 . . . . 0.0 111.99 -165.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -122.75 -3.56 8.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.583 152.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 18.6 -78.68 0.0 OUTLIER Glycine 0 CA--C 1.528 0.892 1 C-N-CA 131.31 4.291 . . . . 0.0 119.256 170.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -134.61 2.33 3.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.391 1.877 . . . . 0.0 111.615 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.449 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 m95 -19.29 94.24 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.911 2.084 . . . . 0.0 115.518 -149.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 t -129.91 170.44 13.92 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.074 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -157.38 157.65 34.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.274 1.829 . . . . 0.0 111.679 -166.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -110.91 -48.98 3.07 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -164.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 58.44 -38.12 0.06 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 129.046 2.938 . . . . 0.0 117.624 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.12 -26.02 61.96 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.969 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.2 p -122.26 -5.54 8.86 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.081 1.753 . . . . 0.0 113.091 165.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 48.5 mttm 60.2 6.31 0.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.46 2.304 . . . . 0.0 116.52 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.8 m -46.85 146.36 1.66 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.632 1.973 . . . . 0.0 114.054 156.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -114.52 163.07 15.89 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.632 2.773 . . . . 0.0 111.516 164.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -148.95 144.33 26.74 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.311 -1.493 . . . . 0.0 111.599 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.93 128.3 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.963 161.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -132.1 107.5 8.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.903 1.281 . . . . 0.0 111.898 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.33 -138.66 0.31 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.832 2.053 . . . . 0.0 109.802 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.31 36.8 0.05 OUTLIER Glycine 0 CA--C 1.538 1.491 0 O-C-N 120.231 -1.543 . . . . 0.0 115.702 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 m -75.27 61.72 1.21 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.423 1.612 . . . . 0.0 112.592 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' NE2' ' HE3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -140.31 144.23 36.25 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.113 2.165 . . . . 0.0 110.298 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -135.93 51.07 2.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.256 1.022 . . . . 0.0 111.578 -165.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.03 21.23 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.524 2.329 . . . . 0.0 116.652 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.65 69.81 1.31 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.951 -1.718 . . . . 0.0 111.733 166.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -135.69 48.78 2.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.532 1.933 . . . . 0.0 110.866 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 57.09 -161.92 0.2 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.729 1.612 . . . . 0.0 113.418 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 36.8 ttp -77.82 57.04 1.62 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.739 1.616 . . . . 0.0 112.793 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -71.12 48.26 0.12 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.69 1.996 . . . . 0.0 113.737 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 -125.89 155.99 40.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.143 1.377 . . . . 0.0 114.355 -159.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -58.71 -17.79 25.7 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.765 2.826 . . . . 0.0 115.35 167.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.2 p -150.45 166.63 29.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.938 1.295 . . . . 0.0 112.865 -170.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.9 p -148.34 157.85 41.7 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.697 1.599 . . . . 0.0 111.888 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.58 -43.12 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.539 2.826 . . . . 0.0 113.254 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -173.4 -48.61 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.79 2.836 . . . . 0.0 107.469 -175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -137.24 -124.63 0.14 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.438 2.295 . . . . 0.0 108.007 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.9 t -162.27 -23.49 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.042 2.137 . . . . 0.0 113.072 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.88 -168.46 2.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 129.959 3.304 . . . . 0.0 108.638 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 115' ' ' VAL . 60.1 t -125.45 139.78 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 121.129 -0.982 . . . . 0.0 111.38 152.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -144.56 133.25 22.28 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.981 1.312 . . . . 0.0 109.556 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 142' ' ' VAL . 13.6 m -140.2 161.59 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.646 0.736 . . . . 0.0 112.469 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.55 -166.1 27.04 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 80.84 -1.28 1.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 128.155 2.582 . . . . 0.0 114.312 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.428 ' CD1' ' H ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -71.27 -172.59 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.778 1.231 . . . . 0.0 111.363 175.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 81' ' ' LEU . . . 168.47 -24.18 0.11 Allowed Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.546 1.07 . . . . 0.0 113.938 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.96 -30.65 71.74 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.464 1.506 . . . . 0.0 114.303 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 p30 -150.64 -18.03 0.23 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -172.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.61 115.28 6.92 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 120.131 1.332 . . . . 0.0 113.508 -150.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -131.2 -19.44 2.81 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 140.0 -52.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 131.164 3.786 . . . . 0.0 111.239 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -91.53 -23.45 19.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -158.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.75 -35.53 70.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.868 -1.77 . . . . 0.0 111.472 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.7 mt -89.73 -29.33 18.79 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.978 2.511 . . . . 0.0 111.157 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -58.85 -33.01 69.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.24 1.382 . . . . 0.0 110.605 163.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -84.04 -48.59 9.76 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.714 0.805 . . . . 0.0 112.432 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -31.28 67.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -96.9 -27.84 14.49 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -56.67 -35.16 66.14 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.577 1.56 . . . . 0.0 113.989 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -57.36 -31.54 65.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -96.97 17.84 16.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.194 0.997 . . . . 0.0 112.14 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.34 -160.99 14.12 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.865 -1.147 . . . . 0.0 115.603 163.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -49.79 117.41 3.01 Favored 'Trans proline' 0 CA--C 1.539 0.751 1 C-N-CA 125.409 4.072 . . . . 0.0 114.471 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -110.14 149.97 29.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.864 1.666 . . . . 0.0 109.514 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -124.7 -25.97 3.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.713 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 m -163.56 152.61 14.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.076 0.95 . . . . 0.0 109.621 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -151.46 127.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.85 1.66 . . . . 0.0 108.316 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -138.64 168.71 19.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.754 1.222 . . . . 0.0 111.512 171.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 113' ' ' ALA . 6.2 t -150.09 142.51 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.581 1.153 . . . . 0.0 111.093 -164.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.89 165.84 24.14 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.171 1.788 . . . . 0.0 113.391 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -126.38 16.56 7.69 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.496 1.518 . . . . 0.0 111.935 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -155.95 43.59 0.2 Allowed Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.535 1.534 . . . . 0.0 114.446 -152.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -86.95 174.4 30.38 Favored 'Cis proline' 0 CA--C 1.547 1.149 0 CA-C-N 121.725 1.652 . . . . 0.0 113.757 10.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.09 47.62 0.37 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 125.239 3.959 . . . . 0.0 112.436 165.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.25 4.59 5.26 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.028 1.775 . . . . 0.0 115.368 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -138.99 143.13 38.38 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.665 1.586 . . . . 0.0 109.451 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -139.7 153.1 47.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -141.32 120.94 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.924 0.89 . . . . 0.0 109.655 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.523 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.5 m -143.33 -177.39 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -161.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -145.47 110.2 5.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.562 1.945 . . . . 0.0 109.635 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -71.31 -175.71 1.31 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.121 0.968 . . . . 0.0 110.056 151.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -150.33 70.04 1.02 Allowed 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.707 -1.246 . . . . 0.0 111.675 150.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.75 138.39 10.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.517 1.527 . . . . 0.0 110.393 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -73.5 -38.2 2.68 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.381 2.054 . . . . 0.0 115.435 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -60.38 1.67 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 119.64 1.109 . . . . 0.0 113.49 -154.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.4 -21.28 66.22 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.398 -0.814 . . . . 0.0 111.488 173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 145' ' ' SER . . . -78.64 -37.66 41.53 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.06 74.5 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 120.304 -1.498 . . . . 0.0 109.369 163.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.03 -36.75 84.09 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 3.5 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 168.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.47 -41.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 120.413 1.46 . . . . 0.0 113.112 144.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -62.83 -23.74 67.43 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.985 1.266 . . . . 0.0 113.213 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.74 -10.52 14.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.298 1.839 . . . . 0.0 110.883 -173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tp -141.58 -28.71 0.64 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -154.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.31 136.96 54.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.966 0.888 . . . . 0.0 111.728 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.12 13.15 52.51 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.377 0.989 . . . . 0.0 114.775 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 134' ' ' THR . 5.8 ttt180 -85.42 -159.5 0.45 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.451 1.5 . . . . 0.0 111.259 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 133' ' ' ARG . 55.3 m -147.64 134.6 20.25 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.418 2.287 . . . . 0.0 106.218 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.0 tp -133.44 -36.32 0.98 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -156.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 36.2 m -138.63 8.05 2.58 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.829 1.251 . . . . 0.0 114.191 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.31 26.69 3.37 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.5 t -138.79 -82.06 0.3 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.926 1.363 . . . . 0.0 110.401 171.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 175.13 165.05 0.28 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.019 3.327 . . . . 0.0 107.467 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.86 155.27 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.873 0.761 . . . . 0.0 111.574 170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.5 127.14 17.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.783 2.433 . . . . 0.0 108.063 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 78' ' ' VAL . 76.9 t -141.37 134.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.532 0.605 . . . . 0.0 111.389 -152.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -132.93 99.2 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.061 1.744 . . . . 0.0 108.804 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 tt -147.41 120.56 8.88 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.107 -0.996 . . . . 0.0 112.63 -153.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HA ' ' HB1' ' A' ' 123' ' ' ALA . 12.7 m -165.87 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 144.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.3 t30 62.04 145.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.271 1.828 . . . . 0.0 114.592 -166.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.7 20.46 0.06 OUTLIER Glycine 0 CA--C 1.536 1.349 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.28 -9.03 26.12 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.585 2.193 . . . . 0.0 116.27 -166.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.306 0.0 OUTLIER 44.04 19.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 128.726 2.811 . . . . 0.0 117.516 -176.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? . . . . . 0 C--O 1.25 1.119 0 C-N-CA 129.962 3.305 . . . . 0.0 114.078 -164.262 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -160.46 155.56 24.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.775 1.23 . . . . 0.0 110.22 164.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -143.41 107.25 4.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.2 ttpt -117.9 132.69 56.39 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.343 1.057 . . . . 0.0 112.623 -171.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.85 102.56 14.33 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.608 1.163 . . . . 0.0 109.283 165.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 mt -64.95 119.33 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 128.461 2.705 . . . . 0.0 109.854 158.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.0 128.92 42.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.766 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -140.37 48.51 1.75 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.565 1.946 . . . . 0.0 109.469 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.75 160.69 13.16 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 122.807 1.226 . . . . 0.0 114.565 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pptp? -53.78 -39.3 65.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.687 2.395 . . . . 0.0 112.781 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -59.65 -55.35 35.58 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.759 2.824 . . . . 0.0 112.862 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.0 139.74 8.75 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.054 1.342 . . . . 0.0 110.789 -173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.72 111.02 16.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.89 2.076 . . . . 0.0 109.001 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.29 0.05 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.117 0.865 . . . . 0.0 113.253 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.34 157.84 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.05 2.14 . . . . 0.0 115.914 161.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 33' ' ' TYR . 9.2 t -135.39 -22.09 1.53 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 -175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.4 p 62.49 161.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.501 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -170.55 -170.68 0.95 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.722 2.809 . . . . 0.0 109.116 168.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -143.57 141.22 30.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.658 2.383 . . . . 0.0 108.387 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.36 172.8 13.83 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -163.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.49 -44.14 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.042 2.137 . . . . 0.0 112.077 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -140.13 -64.17 0.48 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -152.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 130.2 2.6 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 131.309 3.844 . . . . 0.0 112.637 -160.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.41 -44.3 1.12 Allowed 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.05 0.94 . . . . 0.0 110.119 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.2 m -63.5 -20.48 65.64 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.611 1.565 . . . . 0.0 113.887 164.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.53 -50.49 10.65 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 118.804 0.729 . . . . 0.0 110.938 167.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -60.99 -45.77 93.45 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -64.06 -13.88 50.48 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -106.66 -40.43 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.197 2.199 . . . . 0.0 110.563 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.501 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.3 m-85 -57.87 -39.99 79.16 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 13.9 mmtp -43.63 -53.9 5.38 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.331 2.252 . . . . 0.0 111.014 166.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -75.95 -31.44 59.06 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE1' HG21 ' A' ' 16' ' ' THR . 40.6 t80 -60.43 -43.28 96.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.687 1.13 . . . . 0.0 111.022 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.62 -34.97 58.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.513 -0.742 . . . . 0.0 109.962 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -68.06 -30.45 69.66 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.353 0.524 . . . . 0.0 112.101 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.92 -36.76 70.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.214 1.405 . . . . 0.0 113.402 170.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -64.62 -49.26 71.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.632 -0.667 . . . . 0.0 111.683 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.97 31.92 0.57 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.795 1.664 . . . . 0.0 114.181 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.67 146.36 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.4 1.88 . . . . 0.0 111.015 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -138.72 -6.79 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.204 1.002 . . . . 0.0 113.47 154.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.84 -129.06 6.47 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 126.155 1.836 . . . . 0.0 116.228 160.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.51 34.9 4.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.288 2.235 . . . . 0.0 108.428 -172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.451 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 13.9 m95 -19.66 97.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.762 2.825 . . . . 0.0 114.953 -169.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.5 m -118.11 162.4 18.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.454 1.501 . . . . 0.0 110.898 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -146.38 151.2 37.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.732 2.013 . . . . 0.0 111.114 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -107.07 -40.05 5.55 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -164.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 t70 60.5 -33.43 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 119.185 3.031 . . . . 0.0 119.185 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.57 61.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.796 1.638 . . . . 0.0 112.266 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -135.24 13.17 3.55 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.49 1.916 . . . . 0.0 111.849 162.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.264 36.8 mttm 54.9 11.43 0.48 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 127.836 2.455 . . . . 0.0 116.581 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -44.57 156.14 0.09 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.574 1.949 . . . . 0.0 114.363 150.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.2 160.18 34.6 Favored 'General case' 0 C--N 1.324 -0.517 1 C-N-CA 133.69 4.796 . . . . 0.0 110.107 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -147.82 134.69 20.14 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.223 -0.923 . . . . 0.0 112.073 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG13 ' CE3' ' A' ' 43' ' ' TRP . 1.6 m -108.94 96.58 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 122.215 1.007 . . . . 0.0 112.483 156.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 p -79.98 114.22 18.72 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.516 0.726 . . . . 0.0 109.855 160.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -126.78 57.83 1.43 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.397 1.479 . . . . 0.0 110.82 170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.32 -167.94 14.24 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 129.449 3.404 . . . . 0.0 112.07 15.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -60.07 -27.94 67.4 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.389 -1.065 . . . . 0.0 111.997 161.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -63.65 -7.44 7.38 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.386 1.875 . . . . 0.0 113.912 169.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -127.9 10.98 6.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.267 1.427 . . . . 0.0 112.36 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 45.2 42.92 7.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.002 2.121 . . . . 0.0 113.9 -170.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -65.16 10.15 0.09 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 126.902 2.081 . . . . 0.0 114.48 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -161.45 170.72 19.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.662 3.185 . . . . 0.0 109.254 -170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.01 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 119.527 3.158 . . . . 0.0 119.527 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.7 tpp -162.18 171.19 17.79 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.315 1.87 . . . . 0.0 111.519 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -120.95 158.32 27.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.419 1.487 . . . . 0.0 112.626 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 40.5 0.86 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.605 2.362 . . . . 0.0 111.168 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -152.99 -58.14 0.13 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.489 1.516 . . . . 0.0 113.092 -165.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 m -165.79 -172.39 2.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.347 2.659 . . . . 0.0 108.916 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.3 p -53.03 138.78 45.21 Favored Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 121.1 -1.0 . . . . 0.0 112.218 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.92 -47.51 1.19 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.85 2.367 . . . . 0.0 113.633 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -160.05 -46.0 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.76 1.624 . . . . 0.0 110.264 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -148.84 -30.62 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.7 m 109.49 -11.07 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 131.668 3.987 . . . . 0.0 114.657 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 -137.41 0.15 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' CG2' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -132.32 163.77 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 O-C-N 121.868 -0.52 . . . . 0.0 110.192 135.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -137.86 152.33 48.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.912 1.285 . . . . 0.0 111.284 167.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.6 t -141.2 152.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.415 1.086 . . . . 0.0 111.242 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 -176.16 32.71 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 117.162 1.625 . . . . 0.0 117.162 161.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 91.53 1.85 0.12 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 130.805 3.642 . . . . 0.0 113.279 -172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.09 174.21 1.64 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.358 1.463 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.85 -37.76 0.18 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.564 1.078 . . . . 0.0 113.287 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -69.26 -57.57 5.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.733 0.813 . . . . 0.0 111.112 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.5 -54.69 4.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.024 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.81 62.43 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 128.394 2.902 . . . . 0.0 117.004 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -132.66 -52.02 0.92 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.746 1.773 . . . . 0.0 115.67 -173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? 150.74 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 130.73 3.612 . . . . 0.0 112.625 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -87.63 -24.84 23.82 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.476 -0.765 . . . . 0.0 112.228 -164.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -55.43 -38.34 68.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.819 162.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.6 mt -82.67 -34.25 27.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.242 1.017 . . . . 0.0 112.569 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -54.68 -36.27 64.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.867 0.758 . . . . 0.0 111.102 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtm-85 -78.26 -57.05 3.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 171.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.11 -20.67 41.9 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -113.91 -29.93 6.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.884 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.24 -35.19 26.71 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.765 1.174 . . . . 0.0 114.054 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -58.39 -41.72 85.47 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -78.44 -32.2 48.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.586 0.355 . . . . 0.0 111.235 -171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 -177.68 44.67 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.036 0.826 . . . . 0.0 115.086 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.01 136.71 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.704 3.603 . . . . 0.0 114.509 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 152.38 23.87 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.27 1.828 . . . . 0.0 109.95 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -122.74 -22.36 5.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.556 1.542 . . . . 0.0 113.253 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 m -167.92 156.75 9.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.335 1.454 . . . . 0.0 109.655 173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -152.71 131.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.799 1.239 . . . . 0.0 110.843 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -147.28 153.9 40.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.305 1.442 . . . . 0.0 111.367 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.84 144.81 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.107 -0.996 . . . . 0.0 112.032 171.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.47 130.32 39.4 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.579 1.152 . . . . 0.0 111.386 175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -93.69 -1.73 54.82 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 166.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -150.57 102.88 3.08 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 125.487 1.515 . . . . 0.0 111.247 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.52 146.79 66.75 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 CA-C-N 119.977 1.028 . . . . 0.0 111.433 -5.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.95 15.07 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.421 3.414 . . . . 0.0 116.039 -167.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -128.75 16.21 5.88 Favored Glycine 0 N--CA 1.466 0.678 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 -158.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -142.52 139.38 31.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.521 1.661 . . . . 0.0 112.417 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -127.88 162.5 26.57 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.126 1.771 . . . . 0.0 113.448 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -149.28 136.91 20.29 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.728 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.483 HG22 ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -139.89 177.9 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -172.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -137.77 147.06 44.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.594 1.158 . . . . 0.0 110.065 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.99 -177.72 3.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.177 2.591 . . . . 0.0 111.466 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.42 -22.15 6.59 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 161.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.54 106.11 54.41 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 120.557 1.526 . . . . 0.0 113.352 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 -20.79 36.27 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.416 2.744 . . . . 0.0 114.639 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -41.87 17.63 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.056 1.298 . . . . 0.0 111.308 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -67.33 -33.3 74.96 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.622 0.769 . . . . 0.0 112.257 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.508 0.723 . . . . 0.0 112.863 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.22 -34.73 70.73 Favored 'General case' 0 C--O 1.226 -0.165 0 O-C-N 121.002 -1.061 . . . . 0.0 110.142 168.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -38.2 76.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 172.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.9 -15.0 39.41 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.766 -1.209 . . . . 0.0 113.721 166.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.55 -54.34 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.462 -1.399 . . . . 0.0 109.594 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -58.32 -26.79 63.47 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 113.816 -173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.23 -10.64 17.74 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.245 1.418 . . . . 0.0 112.299 -170.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 -33.98 0.19 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -154.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -60.43 133.84 56.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.71 0.804 . . . . 0.0 112.492 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.88 13.63 83.21 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.231 -0.761 . . . . 0.0 114.305 160.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -113.19 -106.05 0.38 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.158 1.783 . . . . 0.0 109.736 -173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.4 m -156.64 136.89 12.87 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 109.038 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.7 tp -154.41 155.17 34.5 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.325 1.45 . . . . 0.0 109.375 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.1 m 51.76 25.57 3.01 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.41 73.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.11 1.338 . . . . 0.0 115.164 -173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.5 p -121.95 156.21 33.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.567 1.547 . . . . 0.0 111.579 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.21 53.04 0.78 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.05 1.74 . . . . 0.0 112.953 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -46.99 152.71 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.833 2.453 . . . . 0.0 115.957 -163.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -137.31 137.24 38.75 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.122 2.569 . . . . 0.0 108.687 167.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -150.54 146.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.477 0.58 . . . . 0.0 111.406 -163.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.45 131.84 14.66 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 119.624 -1.922 . . . . 0.0 110.207 167.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.19 145.63 32.97 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.126 0.876 . . . . 0.0 113.023 -173.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.4 p -154.25 -92.05 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.726 1.211 . . . . 0.0 114.083 167.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.5 t30 118.25 99.72 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 131.18 3.792 . . . . 0.0 108.532 -160.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.58 37.92 0.62 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.089 0.852 . . . . 0.0 113.658 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.77 -12.63 60.76 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -74.33 151.33 39.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.115 1.366 . . . . 0.0 110.638 164.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.231 1.812 . . . . 0.0 111.133 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 tpt . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -155.76 161.31 40.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 129.427 3.091 . . . . 0.0 109.576 -15.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -140.68 109.37 5.97 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 166.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 37.5 ttpt -133.99 150.5 51.26 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 125.85 1.66 . . . . 0.0 113.018 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.9 tp -117.62 109.97 17.32 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.443 1.897 . . . . 0.0 110.211 161.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 mt -66.25 120.33 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 129.739 3.216 . . . . 0.0 110.259 158.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 mp -94.12 128.19 40.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.134 165.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -139.49 40.35 2.05 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.983 2.113 . . . . 0.0 110.226 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.99 171.65 42.94 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 120.25 -1.531 . . . . 0.0 116.169 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -66.0 -43.15 88.54 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 152.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.7 m -53.45 -57.12 11.78 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.482 3.113 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.3 tm? -162.33 141.23 9.17 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.887 1.275 . . . . 0.0 110.008 -170.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -126.92 110.45 13.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.614 1.566 . . . . 0.0 109.466 176.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.64 77.6 0.03 OUTLIER Glycine 0 N--CA 1.465 0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.004 -161.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.87 160.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.117 1.367 . . . . 0.0 114.222 162.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -124.28 -37.26 2.56 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 1.6 p 58.62 166.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -155.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.471 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.3 t -155.38 -25.15 0.11 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.35 136.39 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 127.17 2.188 . . . . 0.0 116.541 -162.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.77 -179.68 7.47 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.4 -1.438 . . . . 0.0 112.924 -166.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 4.8 t -63.81 -50.91 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.289 1.836 . . . . 0.0 111.876 172.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -167.93 167.93 12.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.568 1.547 . . . . 0.0 109.661 -152.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.04 15.81 0.5 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.43 -31.33 0.81 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.103 -0.998 . . . . 0.0 111.865 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.3 m -76.34 -21.29 56.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.0 111.837 163.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -50.42 15.46 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 121.617 -0.677 . . . . 0.0 110.123 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.62 -48.26 58.09 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.084 1.354 . . . . 0.0 108.6 173.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -24.8 15.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.551 1.157 . . . . 0.0 114.068 -170.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.05 -38.77 3.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.607 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 18' ' ' THR . 9.1 m-85 -55.11 -41.83 72.15 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.046 0.938 . . . . 0.0 113.471 167.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' HE2' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -48.86 -55.06 12.78 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.641 1.176 . . . . 0.0 110.051 169.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -68.87 -34.17 75.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -60.38 -40.91 92.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.286 0.948 . . . . 0.0 110.842 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -77.59 -35.84 52.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 110.358 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -68.21 -32.72 73.15 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.359 0.527 . . . . 0.0 111.857 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.81 -38.88 87.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.192 . . . . 0.0 113.186 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -67.1 -34.54 77.85 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.567 -0.708 . . . . 0.0 112.741 171.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.31 22.83 1.83 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.895 1.712 . . . . 0.0 114.684 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -122.88 134.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.58 1.552 . . . . 0.0 111.92 -161.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.23 10.44 3.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 149.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.08 -139.06 1.19 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 120.755 3.062 . . . . 0.0 120.755 149.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -119.46 53.87 1.02 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.899 2.479 . . . . 0.0 106.276 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.477 ' CE2' ' HE2' ' A' ' 31' ' ' LYS . 13.9 m95 -45.65 104.28 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.334 1.454 . . . . 0.0 112.631 -172.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.1 m -124.44 158.6 32.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.351 1.861 . . . . 0.0 108.672 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 38.9 t80 -137.91 144.04 41.11 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.83 1.252 . . . . 0.0 110.11 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -130.59 60.79 1.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.584 1.554 . . . . 0.0 110.094 -156.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -47.0 -28.06 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 128.581 2.752 . . . . 0.0 116.128 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.7 -24.06 46.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.573 2.349 . . . . 0.0 112.852 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -132.9 7.8 4.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 112.854 165.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.266 51.0 mttm 45.78 25.16 0.26 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.555 2.742 . . . . 0.0 115.097 -164.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 m -63.43 168.98 4.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.235 1.814 . . . . 0.0 111.351 160.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 60.7 m-85 -135.73 156.41 48.87 Favored 'General case' 0 C--N 1.324 -0.509 1 C-N-CA 132.573 4.349 . . . . 0.0 108.903 175.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.8 m -143.35 129.72 19.96 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 m -103.51 93.21 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.21 1.005 . . . . 0.0 112.281 160.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.99 59.02 3.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.41 1.084 . . . . 0.0 112.457 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -65.67 -16.15 63.47 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.551 -1.343 . . . . 0.0 113.284 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.44 -1.3 55.57 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.08 1.324 . . . . 0.0 114.482 168.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.8 t 48.14 -53.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 131.433 3.893 . . . . 0.0 118.298 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -129.01 -5.64 5.0 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.477 1.911 . . . . 0.0 112.636 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -64.82 -11.7 39.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.383 1.873 . . . . 0.0 113.97 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -139.99 171.95 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.205 1.402 . . . . 0.0 111.586 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.94 134.82 43.04 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.715 1.206 . . . . 0.0 111.409 -169.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -66.08 -17.82 64.94 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -93.12 -4.46 52.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.527 1.131 . . . . 0.0 113.395 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -56.02 132.94 51.33 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.204 0.911 . . . . 0.0 111.084 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -93.64 133.59 36.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.965 0.906 . . . . 0.0 113.251 -165.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 9.82 3.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.009 1.724 . . . . 0.0 112.651 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -105.17 -4.15 22.13 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -149.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.1 p 160.79 -86.89 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 129.947 3.299 . . . . 0.0 111.15 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -148.97 148.41 27.13 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.277 1.431 . . . . 0.0 112.236 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.05 -49.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.176 2.584 . . . . 0.0 113.664 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 tm? 179.47 -46.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 129.676 3.191 . . . . 0.0 108.043 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.28 -91.3 0.09 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.692 2.797 . . . . 0.0 111.041 164.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.9 p -157.15 -31.72 0.08 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -148.39 -165.21 2.21 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.796 1.638 . . . . 0.0 110.097 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' CG1' HG22 ' A' ' 115' ' ' VAL . 37.8 t -113.56 141.92 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.19 -1.569 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -139.88 127.59 21.81 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.637 1.575 . . . . 0.0 109.116 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.22 146.91 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.41 -177.78 38.62 Favored Glycine 0 CA--C 1.518 0.28 0 O-C-N 121.232 -0.918 . . . . 0.0 115.249 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.65 16.66 9.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.316 1.446 . . . . 0.0 113.969 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.74 38.47 0.16 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 127.152 2.181 . . . . 0.0 111.714 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.49 -25.63 50.12 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.513 1.53 . . . . 0.0 115.762 -168.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.74 -31.16 72.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.365 1.466 . . . . 0.0 113.223 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -134.02 -88.31 0.39 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.067 1.347 . . . . 0.0 110.192 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.22 56.33 2.31 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.817 1.199 . . . . 0.0 113.453 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -128.93 163.99 24.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.631 1.572 . . . . 0.0 111.555 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -72.56 -40.18 66.86 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.165 -0.959 . . . . 0.0 112.918 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.1 m -74.2 -34.62 63.78 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -168.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -54.38 -36.03 63.45 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.969 1.259 . . . . 0.0 111.64 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.98 -27.94 30.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.934 1.293 . . . . 0.0 112.826 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.92 -36.69 72.83 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.119 1.327 . . . . 0.0 109.94 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -103.18 -39.59 6.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.404 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.38 -30.88 68.74 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.547 0.612 . . . . 0.0 112.417 169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -97.87 -30.16 12.91 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.22 -33.78 16.14 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.001 1.286 . . . . 0.0 114.439 167.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -58.94 -41.57 87.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -78.63 -24.75 45.13 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.971 0.509 . . . . 0.0 112.354 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.72 -177.49 41.48 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.031 0.824 . . . . 0.0 114.925 -171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.55 147.6 46.25 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.74 2.96 . . . . 0.0 113.149 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.97 164.25 18.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.676 2.391 . . . . 0.0 110.377 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 116' ' ' GLU . 5.1 tmm_? -122.99 -36.88 2.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.434 1.494 . . . . 0.0 112.403 173.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -161.98 154.41 19.69 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.259 0.936 . . . . 0.0 111.068 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 29.5 t -153.02 123.56 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.233 1.413 . . . . 0.0 110.151 -171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -145.27 159.93 42.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.695 1.198 . . . . 0.0 111.671 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.76 153.3 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 121.397 -0.815 . . . . 0.0 111.897 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.68 66.6 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.148 1.379 . . . . 0.0 114.267 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 42.23 38.21 1.09 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.024 2.53 . . . . 0.0 115.197 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -137.33 -42.98 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.495 1.518 . . . . 0.0 113.901 -174.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 108' ' ' ASN . 53.8 Cg_exo -50.78 -37.48 54.79 Favored 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 122.651 2.234 . . . . 0.0 115.274 169.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -74.51 170.48 71.19 Favored 'Cis proline' 0 CA--C 1.544 1.003 0 CA-C-N 121.275 1.491 . . . . 0.0 111.412 -27.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.83 19.12 2.53 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 117.318 1.687 . . . . 0.0 117.318 168.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -133.54 130.28 38.25 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.254 1.527 . . . . 0.0 111.06 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -139.44 160.81 38.96 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.128 2.171 . . . . 0.0 114.489 -158.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -155.08 119.71 4.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.957 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG22 ' CG1' ' A' ' 76' ' ' VAL . 2.6 m -137.22 -171.03 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.832 0.853 . . . . 0.0 111.764 -168.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 101' ' ' ARG . 15.6 tt0 -153.75 115.88 4.32 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.427 1.091 . . . . 0.0 111.239 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -67.28 179.94 1.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.077 1.751 . . . . 0.0 112.457 165.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -115.08 -50.29 2.76 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.46 -0.775 . . . . 0.0 112.549 155.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -75.96 123.69 88.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 O-C-N 121.296 -0.877 . . . . 0.0 112.261 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 -26.22 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.97 2.447 . . . . 0.0 114.724 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -27.54 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.302 1.41 . . . . 0.0 112.378 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.43 -37.46 83.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.801 0.84 . . . . 0.0 111.445 164.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.51 96.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.269 0.628 . . . . 0.0 112.132 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.39 91.53 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.151 -0.968 . . . . 0.0 110.516 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -40.33 81.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.85 0.75 . . . . 0.0 112.687 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.46 -20.14 58.92 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 168.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.9 t -77.84 -53.88 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 120.403 1.456 . . . . 0.0 109.383 160.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.28 -24.0 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.932 1.693 . . . . 0.0 113.972 -170.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -111.68 -6.89 14.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.451 1.5 . . . . 0.0 111.814 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.49 -22.66 0.28 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -156.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -74.5 144.98 43.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.892 0.853 . . . . 0.0 111.831 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.95 34.11 71.0 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.033 -171.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -132.36 -140.53 0.2 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.038 1.335 . . . . 0.0 110.977 -171.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 60.4 m -154.05 144.21 22.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.208 2.203 . . . . 0.0 109.395 -170.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 mp -118.26 -37.56 3.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.483 1.113 . . . . 0.0 113.031 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.2 t -144.87 43.67 1.35 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.077 0.951 . . . . 0.0 112.811 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.65 4.81 88.08 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.322 0.963 . . . . 0.0 114.512 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.9 p -72.61 -176.29 1.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.544 1.537 . . . . 0.0 112.185 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.44 115.51 10.93 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.539 1.536 . . . . 0.0 106.939 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.36 162.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -143.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.43 125.58 20.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.17 1.788 . . . . 0.0 109.758 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 144' ' ' LEU . 2.8 t -147.58 132.31 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.958 0.903 . . . . 0.0 110.431 -158.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -144.37 119.25 9.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.157 1.383 . . . . 0.0 109.183 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.477 HD11 ' CG1' ' A' ' 142' ' ' VAL . 1.6 mp -137.09 131.62 32.94 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.089 1.768 . . . . 0.0 115.257 -169.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.4 m -147.47 176.27 10.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.178 2.191 . . . . 0.0 114.973 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -150.55 104.34 3.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.865 2.466 . . . . 0.0 109.549 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.29 -15.15 0.04 OUTLIER Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.744 1.057 . . . . 0.0 115.744 -170.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.24 133.9 30.3 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.341 1.57 . . . . 0.0 110.6 165.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -116.58 90.25 3.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.961 1.304 . . . . 0.0 110.983 -151.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.45 ' C ' HH22 ' A' ' 101' ' ' ARG . 55.6 mmt-85 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.875 2.47 . . . . 0.0 109.003 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -150.46 158.9 44.67 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.717 2.807 . . . . 0.0 111.312 -3.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.29 112.44 13.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.21 111.97 9.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -159.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.3 101.99 13.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.475 1.11 . . . . 0.0 110.136 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.42 117.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 128.535 2.734 . . . . 0.0 110.02 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -90.98 127.73 36.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.605 165.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -136.72 43.26 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.71 1.604 . . . . 0.0 110.554 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.98 171.54 22.67 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.493 -1.379 . . . . 0.0 116.418 -168.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -67.06 -37.04 83.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.627 1.171 . . . . 0.0 110.175 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -66.16 -53.82 32.94 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.072 1.349 . . . . 0.0 112.307 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -157.87 142.91 16.69 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.898 0.879 . . . . 0.0 111.552 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.24 111.43 16.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.937 2.095 . . . . 0.0 109.92 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.54 93.07 0.11 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.632 1.11 . . . . 0.0 113.496 -169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -31.81 166.24 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.891 2.477 . . . . 0.0 116.898 163.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -133.08 -38.98 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 5.2 p 55.7 164.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -152.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.412 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.9 t -152.65 -17.54 0.16 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.72 154.23 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.255 2.622 . . . . 0.0 117.476 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.12 175.89 9.78 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.805 -1.185 . . . . 0.0 112.949 -164.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.92 -45.06 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 122.106 0.955 . . . . 0.0 110.296 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -166.73 178.17 6.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.949 -158.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.37 -10.1 40.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -109.03 -1.89 18.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 120.549 1.522 . . . . 0.0 110.526 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -112.33 -20.25 11.9 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 128.219 2.608 . . . . 0.0 112.092 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.68 9.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.082 0.953 . . . . 0.0 110.387 168.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.95 -48.19 82.72 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.13 -18.53 48.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 119.211 -0.996 . . . . 0.0 113.586 -167.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.43 -45.92 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.021 1.728 . . . . 0.0 110.858 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 18' ' ' THR . 6.8 m-85 -54.13 -40.9 67.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 2.1 mmpt? -46.39 -39.61 10.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.941 1.696 . . . . 0.0 111.624 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -104.65 -20.57 13.6 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -55.76 -42.1 74.98 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.997 1.271 . . . . 0.0 109.507 159.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.97 -36.19 49.3 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.591 -0.693 . . . . 0.0 110.521 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -78.65 -22.83 46.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 120.182 -0.607 . . . . 0.0 112.474 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.17 -37.42 66.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.028 1.331 . . . . 0.0 113.134 166.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -59.88 -47.18 86.79 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.656 0.662 . . . . 0.0 110.777 167.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.61 10.28 6.01 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.361 1.934 . . . . 0.0 113.667 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.96 150.76 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.38 1.072 . . . . 0.0 110.597 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.74 128.11 10.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.222 1.011 . . . . 0.0 111.25 134.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.18 -154.0 7.13 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-O 123.701 1.723 . . . . 0.0 115.13 -158.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.04 53.09 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.648 2.379 . . . . 0.0 109.766 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.402 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 6.7 m95 -46.06 103.28 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.981 1.712 . . . . 0.0 112.836 -168.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.47 156.38 30.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.897 1.679 . . . . 0.0 111.72 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 52.7 t80 -149.69 142.19 24.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.073 1.349 . . . . 0.0 110.464 175.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.29 -36.58 7.57 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -162.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.08 -45.56 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 129.065 2.946 . . . . 0.0 117.96 -171.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.99 -25.05 64.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.206 1.803 . . . . 0.0 112.117 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.5 p -128.66 7.2 5.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 113.125 167.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.254 16.0 mttp 51.39 8.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -173.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.1 m -51.54 152.53 2.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.08 2.552 . . . . 0.0 113.338 159.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 28.7 m-85 -126.3 165.44 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 131.45 3.9 . . . . 0.0 110.235 169.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -145.75 150.55 36.44 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.885 0.85 . . . . 0.0 111.231 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.77 95.07 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 122.296 1.046 . . . . 0.0 113.249 158.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.46 101.56 10.76 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.179 0.992 . . . . 0.0 110.643 172.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -112.98 -19.95 11.73 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.929 -1.107 . . . . 0.0 113.006 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.34 58.01 0.06 OUTLIER Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.704 -1.247 . . . . 0.0 114.778 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.0 m -47.77 -21.41 0.39 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.88 -57.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.571 1.078 . . . . 0.0 110.896 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -60.83 150.74 31.87 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -171.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 140.19 166.35 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.859 1 C-N-CA 133.902 4.881 . . . . 0.0 108.556 -177.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -76.79 59.99 1.66 Allowed 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -161.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -66.37 -11.6 52.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.504 2.322 . . . . 0.0 114.477 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.0 t60 67.52 -8.1 0.51 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.55 2.34 . . . . 0.0 116.757 170.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 tpt -51.66 -34.33 37.68 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.525 1.53 . . . . 0.0 113.853 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.3 117.26 17.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.802 159.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 41.77 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 131.159 3.783 . . . . 0.0 118.09 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.19 -65.65 0.12 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.533 1.933 . . . . 0.0 109.579 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.1 p -155.81 74.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.383 1.073 . . . . 0.0 112.973 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.13 146.54 52.33 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.91 0.884 . . . . 0.0 111.472 166.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.94 -47.16 1.95 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.514 2.143 . . . . 0.0 113.812 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -156.88 -45.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.431 1.892 . . . . 0.0 109.09 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.468 ' H ' ' CB ' ' A' ' 145' ' ' SER 0.261 3.7 p30 -145.57 -98.06 0.1 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.112 1.765 . . . . 0.0 110.14 162.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.4 t -153.99 -23.49 0.14 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 120.728 1.604 . . . . 0.0 114.918 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -162.62 -155.15 0.34 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 129.701 3.2 . . . . 0.0 104.052 -170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 145' ' ' SER . 1.0 OUTLIER -126.5 168.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.629 2.013 . . . . 0.0 114.934 169.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -138.03 118.32 13.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.332 2.253 . . . . 0.0 108.848 168.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.2 t -126.7 141.75 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.538 . . . . 0.0 110.481 -174.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.86 -162.77 25.53 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 78.47 12.1 1.63 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.284 2.634 . . . . 0.0 113.971 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 33.16 5.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 -152.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -55.53 -26.31 44.95 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.119 1.342 . . . . 0.0 116.222 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.53 -30.13 68.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.725 1.21 . . . . 0.0 113.986 170.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.3 -119.35 0.3 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.28 55.25 27.02 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 121.112 1.778 . . . . 0.0 113.72 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -109.2 -60.79 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.323 1.449 . . . . 0.0 111.868 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 tptp 170.79 -60.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.954 2.502 . . . . 0.0 112.934 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 97.3 m -95.75 -26.98 15.47 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.327 0.967 . . . . 0.0 113.218 -162.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -57.57 -36.82 72.18 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.289 -0.882 . . . . 0.0 111.676 163.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.2 mt -74.05 -36.32 64.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.967 0.907 . . . . 0.0 112.36 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -57.28 -30.69 64.91 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.973 1.261 . . . . 0.0 112.216 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -84.22 -46.3 12.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.56 -28.18 63.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.523 0.729 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -98.21 -35.05 10.49 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.827 0.851 . . . . 0.0 112.649 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.85 -30.93 37.83 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.546 1.546 . . . . 0.0 115.463 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -58.23 -36.35 73.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.212 1.006 . . . . 0.0 113.603 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -78.52 -16.27 57.67 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.82 178.55 25.77 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 126.44 1.972 . . . . 0.0 112.213 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -58.58 151.29 63.61 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.523 2.816 . . . . 0.0 113.393 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.51 154.99 31.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.78 2.032 . . . . 0.0 109.877 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.1 mtp85 -120.74 -22.76 6.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.501 1.52 . . . . 0.0 113.441 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 m -168.99 155.16 6.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.844 1.258 . . . . 0.0 109.845 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -151.21 130.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.077 1.751 . . . . 0.0 108.939 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -141.91 149.3 40.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.363 1.865 . . . . 0.0 109.584 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.55 147.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 120.746 -1.222 . . . . 0.0 113.956 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.25 101.04 13.77 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.539 1.936 . . . . 0.0 110.861 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -67.89 -29.44 68.55 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.647 1.579 . . . . 0.0 113.685 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . 0.287 9.0 p30 -90.61 -29.02 0.33 Allowed Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -61.44 178.49 0.62 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 123.508 2.805 . . . . 0.0 113.185 152.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.24 43.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.461 1 C-N-CA 126.559 4.839 . . . . 0.0 117.809 168.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.17 79.6 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.189 -1.569 . . . . 0.0 114.834 169.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -59.16 131.71 51.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.404 1.081 . . . . 0.0 111.801 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -119.53 155.9 31.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.171 1.388 . . . . 0.0 112.274 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.18 131.21 36.47 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.951 1.3 . . . . 0.0 107.724 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.56 175.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.217 1.007 . . . . 0.0 110.86 -165.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -140.88 125.6 17.98 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.309 1.044 . . . . 0.0 109.588 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 144' ' ' LEU . 2.1 m-85 -86.85 173.01 9.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.413 1.885 . . . . 0.0 112.417 174.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -87.57 -68.63 0.74 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.96 155.96 74.89 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-N 120.965 1.711 . . . . 0.0 114.364 -170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.92 -42.82 62.98 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 116.008 -163.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -35.68 81.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.252 0.933 . . . . 0.0 112.375 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -65.54 -45.07 84.82 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.517 0.727 . . . . 0.0 110.535 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.13 -48.04 46.68 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.06 69.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.284 1.033 . . . . 0.0 111.252 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -74.09 -40.93 62.4 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.189 0.904 . . . . 0.0 112.286 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.9 -7.5 16.9 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 164.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.05 -55.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.566 1.53 . . . . 0.0 110.212 153.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -49.04 -36.54 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.783 2.033 . . . . 0.0 112.847 -174.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -103.47 -13.17 16.71 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.164 0.986 . . . . 0.0 112.276 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mp -147.36 -8.46 0.44 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -152.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.557 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -63.08 -19.32 64.3 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -179.76 70.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.438 1.018 . . . . 0.0 111.621 -159.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -132.86 -132.9 0.18 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.594 1.558 . . . . 0.0 111.942 -163.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.7 m -151.22 -36.56 0.13 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.456 1.902 . . . . 0.0 110.682 -173.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 15.9 tp 62.17 -48.6 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 130.302 3.441 . . . . 0.0 118.869 156.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.21 29.02 1.65 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.846 1.658 . . . . 0.0 112.01 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.68 55.27 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 121.157 -0.965 . . . . 0.0 113.301 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 6.5 p -133.85 -129.89 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.588 1.955 . . . . 0.0 110.254 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -154.63 150.86 28.13 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 130.065 3.346 . . . . 0.0 106.813 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.69 151.88 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.151 0.98 . . . . 0.0 109.706 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -144.35 123.26 12.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 0.0 109.1 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 2.3 t -144.55 136.19 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.686 -161.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.89 48.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.986 1.714 . . . . 0.0 107.522 163.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -148.28 108.14 4.03 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.383 -0.823 . . . . 0.0 111.62 -150.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.468 ' CB ' ' H ' ' A' ' 73' ' ' ASP . 3.7 t -148.23 -173.65 4.37 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.617 1.967 . . . . 0.0 114.805 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -159.94 17.72 0.15 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.232 1.813 . . . . 0.0 114.217 -158.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.75 45.13 0.39 Allowed Glycine 0 N--CA 1.482 1.709 0 C-N-CA 127.123 2.297 . . . . 0.0 116.689 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -141.01 50.31 1.64 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.693 2.797 . . . . 0.0 109.147 -166.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -73.68 35.24 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.421 1.888 . . . . 0.0 115.466 -168.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 C-N-CA 127.25 2.22 . . . . 0.0 109.624 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -151.26 164.98 35.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.242 2.617 . . . . 0.0 110.305 -6.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -129.05 103.65 7.12 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.33 111.88 9.3 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 125.764 1.625 . . . . 0.0 111.28 -160.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.31 91.45 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.578 1.551 . . . . 0.0 110.076 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.2 mt -52.67 119.66 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.994 2.117 . . . . 0.0 109.207 159.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.58 134.04 40.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.429 1.092 . . . . 0.0 109.625 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -146.34 63.62 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.442 1.097 . . . . 0.0 108.767 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.72 178.54 16.35 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 122.045 0.803 . . . . 0.0 114.37 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -57.57 -43.56 84.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.33 1.052 . . . . 0.0 112.492 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -68.18 -50.67 52.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.283 2.233 . . . . 0.0 113.223 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -156.48 140.59 16.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.191 0.996 . . . . 0.0 110.397 -169.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 131.11 47.66 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.798 1.639 . . . . 0.0 110.056 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.39 -134.74 4.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.347 1.451 . . . . 0.0 110.318 -158.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -161.71 -167.08 1.61 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.235 2.214 . . . . 0.0 108.892 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 t -144.82 -41.49 0.24 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 161.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p 56.12 166.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -159.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -156.47 -25.66 0.1 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 47.86 139.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.049 2.54 . . . . 0.0 117.049 -161.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.88 -178.0 7.03 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.576 -1.328 . . . . 0.0 112.118 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 21' ' ' VAL . 15.5 t -51.01 -51.1 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.368 1.867 . . . . 0.0 111.88 168.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -173.68 174.84 3.06 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.111 1.765 . . . . 0.0 110.903 -157.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.7 19.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.524 1.13 . . . . 0.0 113.697 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.31 11.36 6.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.096 0.959 . . . . 0.0 111.388 172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -135.43 -24.49 1.38 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.499 1.92 . . . . 0.0 111.153 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -51.52 8.45 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.686 -0.633 . . . . 0.0 111.025 164.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -59.86 -46.35 89.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -49.3 -25.0 2.09 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.818 1.647 . . . . 0.0 114.267 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.2 -40.12 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.886 1.674 . . . . 0.0 110.339 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -53.7 -36.38 62.14 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 1.8 mtpp -49.74 -56.99 8.18 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.536 1.534 . . . . 0.0 109.832 172.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.48 -38.82 81.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.883 -0.58 . . . . 0.0 112.491 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -56.94 -36.25 70.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.044 0.838 . . . . 0.0 111.439 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.79 -37.29 24.73 Favored 'General case' 0 C--O 1.225 -0.193 0 O-C-N 121.662 -0.649 . . . . 0.0 110.512 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -67.02 -29.01 68.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.288 0.949 . . . . 0.0 112.469 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.11 -41.8 76.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.551 1.54 . . . . 0.0 113.181 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -63.53 -44.94 92.77 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.619 -0.676 . . . . 0.0 111.308 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.37 22.76 1.06 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.987 1.756 . . . . 0.0 113.212 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.17 129.94 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.271 1.828 . . . . 0.0 110.879 -164.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.84 3.1 16.21 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.894 150.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.97 -123.01 12.79 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.531 1.539 . . . . 0.0 113.256 167.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -132.05 48.85 2.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.077 2.151 . . . . 0.0 106.49 161.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 9.8 m95 -18.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.112 2.565 . . . . 0.0 115.607 -173.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.5 m -120.22 160.53 22.76 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.475 1.11 . . . . 0.0 111.06 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.42 152.41 35.67 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.689 1.996 . . . . 0.0 110.239 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.24 -39.93 5.09 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -166.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.9 t70 64.35 -33.45 0.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.07 64.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.694 1.598 . . . . 0.0 111.715 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -119.49 -7.64 10.12 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.277 2.231 . . . . 0.0 112.513 165.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.29 39.0 mttm 61.56 17.46 8.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.502 2.321 . . . . 0.0 115.37 -171.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.0 m -57.65 150.05 20.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.385 1.474 . . . . 0.0 112.713 162.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -118.35 164.68 14.86 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.569 2.747 . . . . 0.0 112.06 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.6 m -150.39 138.32 20.08 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.748 -1.22 . . . . 0.0 112.248 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.37 90.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.581 1.181 . . . . 0.0 113.468 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 84.17 4.93 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.228 1.811 . . . . 0.0 113.069 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -70.87 -31.86 68.67 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.83 -1.169 . . . . 0.0 110.529 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.58 67.22 1.29 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.873 1.225 . . . . 0.0 111.089 152.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -40.09 128.19 2.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.293 2.237 . . . . 0.0 113.992 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 119.38 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 1 C-N-CA 132.51 4.324 . . . . 0.0 112.139 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 153.7 10.04 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 121.015 -1.053 . . . . 0.0 112.312 167.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -145.62 148.62 33.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 -174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 57.76 -11.99 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 129.423 3.089 . . . . 0.0 118.047 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -123.03 40.11 3.79 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.182 -1.574 . . . . 0.0 111.278 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -146.21 151.38 37.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.562 1.945 . . . . 0.0 111.307 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.7 tpp -148.17 38.57 0.89 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.124 1.769 . . . . 0.0 110.945 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -74.82 39.75 0.14 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.162 1.785 . . . . 0.0 114.676 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 67' ' ' ARG . 24.0 ttp85 46.79 57.1 5.87 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.404 1.882 . . . . 0.0 111.565 -162.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.03 -9.22 9.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.699 2.399 . . . . 0.0 115.237 -166.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -67.05 52.82 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.806 2.842 . . . . 0.0 113.77 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.5 m 62.58 147.35 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 129.555 3.142 . . . . 0.0 113.808 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -79.97 -95.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.089 2.526 . . . . 0.0 111.821 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -135.97 -56.36 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.972 2.109 . . . . 0.0 107.546 163.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -138.77 -119.82 0.13 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.762 2.025 . . . . 0.0 107.804 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 13.2 m -150.18 14.51 0.8 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.327 2.651 . . . . 0.0 111.956 172.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 173.25 2.82 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.198 1.399 . . . . 0.0 109.978 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 145' ' ' SER . 9.5 p -128.82 155.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.879 1.218 . . . . 0.0 110.482 158.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -134.51 147.77 50.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.8 t -136.88 147.18 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.053 1.341 . . . . 0.0 111.106 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.36 -157.2 15.26 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.113 -0.992 . . . . 0.0 114.559 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.81 -16.51 0.17 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.64 2.376 . . . . 0.0 114.239 -166.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.63 153.3 20.32 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.863 -1.148 . . . . 0.0 112.036 164.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.04 29.78 0.53 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.956 1.265 . . . . 0.0 113.225 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -149.86 -56.55 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.46 1.904 . . . . 0.0 109.735 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 24.2 m-80 -104.36 -166.19 1.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 140.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 84' ' ' ASN . . . -63.61 168.83 21.47 Favored Glycine 0 CA--C 1.531 1.085 1 C-N-CA 131.011 4.148 . . . . 0.0 114.117 -9.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -137.86 -23.39 1.05 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.209 2.203 . . . . 0.0 110.784 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.251 2.4 pttp 131.7 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.964 1 C-N-CA 134.866 5.266 . . . . 0.0 110.822 163.723 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.6 m -74.93 -45.6 41.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.153 1.381 . . . . 0.0 111.329 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -42.32 93.67 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.246 1.018 . . . . 0.0 112.179 172.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.23 -32.76 64.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.761 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' A' ' 103' ' ' VAL . 18.8 mt-10 -51.92 -37.0 50.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.316 1.417 . . . . 0.0 110.579 170.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -102.87 -34.3 9.03 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.86 79.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.279 0.631 . . . . 0.0 111.952 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -83.75 -28.08 28.47 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.811 -0.556 . . . . 0.0 110.918 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.34 -32.64 37.68 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.911 1.72 . . . . 0.0 114.411 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -51.84 -40.72 61.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -78.69 -24.12 45.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.7 179.38 30.75 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.321 1.438 . . . . 0.0 113.068 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.2 118.76 5.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.335 2.69 . . . . 0.0 113.038 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.13 156.39 25.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.899 0.857 . . . . 0.0 110.856 162.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -124.34 -23.9 4.39 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.604 2.362 . . . . 0.0 112.251 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.9 m -165.8 153.95 10.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.558 1.943 . . . . 0.0 108.95 163.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.53 HG11 ' HG3' ' A' ' 91' ' ' GLU . 39.0 t -150.73 125.3 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.542 1.137 . . . . 0.0 109.387 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -141.64 167.91 21.03 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.31 1.052 . . . . 0.0 112.505 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 113' ' ' ALA . 7.5 t -144.34 141.84 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.624 1.57 . . . . 0.0 110.231 -170.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.94 -30.1 31.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.314 1.046 . . . . 0.0 113.361 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? 59.85 -25.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 129.817 3.247 . . . . 0.0 116.815 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -109.39 -42.38 0.11 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.959 1.704 . . . . 0.0 112.007 -167.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -52.28 104.64 0.1 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 129.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.07 4.01 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.152 2.568 . . . . 0.0 117.425 -129.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.89 14.33 0.04 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.224 1.869 . . . . 0.0 114.609 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -84.3 149.89 25.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.262 1.425 . . . . 0.0 110.543 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 105' ' ' VAL . . . -143.61 159.84 41.73 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.627 1.171 . . . . 0.0 113.917 -169.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.26 122.14 10.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.459 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 76' ' ' VAL . 2.0 m -138.85 -179.62 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.759 0.824 . . . . 0.0 111.845 -168.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -154.31 152.2 29.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.186 1.394 . . . . 0.0 110.863 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.63 167.21 12.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.678 2.391 . . . . 0.0 112.41 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -72.06 -20.79 61.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -143.0 133.54 12.34 Favored Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 121.001 -1.062 . . . . 0.0 112.429 -162.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.89 -27.99 9.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.756 2.304 . . . . 0.0 114.335 -175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.2 mtm105 -71.54 -49.36 41.59 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.432 1.015 . . . . 0.0 110.07 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.88 -37.36 84.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.856 0.862 . . . . 0.0 110.718 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.2 70.07 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.02 -26.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.219 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -77.58 -41.87 37.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.304 1.411 . . . . 0.0 113.866 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.66 -8.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.484 1.514 . . . . 0.0 114.087 163.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.5 t -96.7 -53.58 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.704 1.202 . . . . 0.0 111.109 160.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -53.36 -35.2 60.01 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.294 1.838 . . . . 0.0 113.102 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -91.36 -7.89 49.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.892 1.277 . . . . 0.0 112.103 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.51 -2.9 0.94 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -155.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -58.25 -24.28 58.82 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -170.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.91 75.77 0.11 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.31 1.91 . . . . 0.0 111.508 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 70.0 mmt-85 -132.51 -146.6 0.29 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.119 1.768 . . . . 0.0 111.238 -170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.4 m -151.19 139.33 20.16 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.392 2.277 . . . . 0.0 106.661 168.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 tp -142.27 -66.21 0.4 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -158.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.8 m -152.79 49.29 0.73 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.549 1.939 . . . . 0.0 109.97 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.79 26.74 0.34 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 130.635 3.969 . . . . 0.0 111.526 16.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.0 t -90.35 172.23 8.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.054 1.342 . . . . 0.0 110.027 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -43.64 132.95 4.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.247 1.019 . . . . 0.0 111.144 150.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.4 t -109.09 154.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.836 1.654 . . . . 0.0 110.012 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.0 135.7 27.71 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.762 1.225 . . . . 0.0 108.593 159.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.3 t -133.07 155.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.987 1.315 . . . . 0.0 110.244 -166.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.51 159.26 43.64 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.103 1.361 . . . . 0.0 110.482 -177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 161.74 15.01 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 -152.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 t -155.77 -23.42 0.11 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.558 2.743 . . . . 0.0 117.303 -24.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -175.98 144.86 0.62 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 122.738 2.517 . . . . 0.0 110.961 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 166.71 111.9 0.25 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.207 0.908 . . . . 0.0 113.455 157.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -141.2 134.75 29.96 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 109.906 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.425 ' H ' ' HD3' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -87.3 1.62 52.68 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -159.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 127.115 2.166 . . . . 0.0 114.064 174.503 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -145.77 165.75 27.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 129.934 3.293 . . . . 0.0 111.06 -0.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -134.61 110.37 9.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -123.89 108.54 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.312 1.445 . . . . 0.0 112.18 -169.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.23 89.37 6.84 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.121 0.968 . . . . 0.0 109.231 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 mt -51.52 115.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.006 1.722 . . . . 0.0 108.576 159.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.501 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -92.87 128.04 38.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.379 174.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' HB2' ' HA ' ' A' ' 55' ' ' THR . 86.2 m-20 -140.34 58.82 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.35 -179.12 15.62 Favored Glycine 0 N--CA 1.473 1.14 0 CA-C-N 120.809 1.641 . . . . 0.0 115.693 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -56.83 -23.83 46.7 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.6 1.96 . . . . 0.0 115.187 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -99.04 -42.86 6.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.494 1.917 . . . . 0.0 112.542 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -160.43 140.2 11.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.118 1.367 . . . . 0.0 109.43 -168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -130.51 130.64 44.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.267 1.427 . . . . 0.0 110.097 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.02 -133.58 4.21 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.088 1.804 . . . . 0.0 111.295 -148.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 6.7 mt-10 -161.87 -167.77 1.76 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.774 2.43 . . . . 0.0 107.965 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 t -139.35 -39.24 0.48 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 158.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p 53.9 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -158.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -160.48 179.68 8.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.906 2.482 . . . . 0.0 107.557 166.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -139.42 136.18 34.39 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.873 1.269 . . . . 0.0 109.138 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.19 -177.7 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.776 0.83 . . . . 0.0 111.992 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -46.04 -57.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.071 1.748 . . . . 0.0 110.6 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -172.15 -163.67 0.25 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.964 3.306 . . . . 0.0 107.149 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.13 -14.8 11.32 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.41 4.88 53.26 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.695 1.589 . . . . 0.0 111.951 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -126.49 -14.54 5.79 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.941 166.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.76 -49.94 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.555 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -57.02 -46.98 81.96 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -53.64 -21.05 6.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.866 1.354 . . . . 0.0 113.93 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.5 -35.64 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.138 1.775 . . . . 0.0 110.19 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 18' ' ' THR . 13.7 m-85 -53.35 -41.17 65.52 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.473 1.033 . . . . 0.0 113.599 165.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.79 -52.33 11.34 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.096 1.758 . . . . 0.0 110.624 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -80.31 -34.04 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.568 1.547 . . . . 0.0 114.863 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.73 -39.4 88.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.041 1.291 . . . . 0.0 111.225 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.05 61.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.617 -0.677 . . . . 0.0 109.696 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -71.9 -23.51 61.5 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -77.09 -37.0 55.3 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.921 1.689 . . . . 0.0 112.931 170.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -58.69 -44.21 90.22 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.738 -0.601 . . . . 0.0 110.464 164.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.01 5.72 8.77 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 126.074 1.797 . . . . 0.0 113.459 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 t -69.53 146.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.437 1.095 . . . . 0.0 110.719 172.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -151.12 125.19 9.27 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.726 0.775 . . . . 0.0 110.836 135.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.07 -147.04 4.61 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-O 123.878 1.821 . . . . 0.0 115.456 -157.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' HB3' ' H ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -62.22 -19.16 62.87 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.689 2.396 . . . . 0.0 114.181 -172.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CD2' ' CG1' ' A' ' 54' ' ' VAL 0.267 10.7 m95 36.58 52.79 1.0 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.541 2.736 . . . . 0.0 115.514 170.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 m -75.41 156.42 35.39 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.047 0.927 . . . . 0.0 111.638 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -144.36 146.11 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.592 1.557 . . . . 0.0 110.448 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -106.03 -40.03 5.8 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -163.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.04 -34.8 0.06 Allowed 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.78 65.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.334 1.853 . . . . 0.0 111.466 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -125.88 -0.29 7.29 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.709 2.003 . . . . 0.0 112.809 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 42.2 mttm 56.13 7.14 0.29 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 128.204 2.602 . . . . 0.0 116.512 -176.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -43.44 152.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.205 2.202 . . . . 0.0 113.972 150.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -123.88 173.54 8.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 130.557 3.543 . . . . 0.0 110.914 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -146.1 156.23 43.31 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.764 -1.21 . . . . 0.0 110.433 158.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -130.46 128.91 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 152.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB3' ' A' ' 42' ' ' GLU . 5.7 m -125.34 117.57 24.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.057 1.408 . . . . 0.0 112.353 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.541 ' HG2' ' H ' ' A' ' 57' ' ' GLY . 0.2 OUTLIER -149.9 -164.47 2.03 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 130.744 3.618 . . . . 0.0 108.509 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.541 ' H ' ' HG2' ' A' ' 56' ' ' GLU . . . 73.17 121.9 0.08 OUTLIER Glycine 0 CA--C 1.539 1.586 0 O-C-N 119.737 -1.852 . . . . 0.0 115.436 171.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.0 p -165.89 165.08 18.46 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 130.419 3.488 . . . . 0.0 110.167 -7.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -55.21 -43.79 74.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.218 1.007 . . . . 0.0 112.494 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -160.27 160.39 32.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.808 1.243 . . . . 0.0 111.868 144.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -97.79 170.53 8.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.083 1.353 . . . . 0.0 113.037 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -62.37 -12.45 21.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.726 2.01 . . . . 0.0 115.073 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -163.98 -173.31 3.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 128.115 2.566 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -68.47 33.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.141 2.274 . . . . 0.0 117.141 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.57 81.7 0.06 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.373 -1.455 . . . . 0.0 111.627 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -51.23 -35.29 36.14 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.315 1.046 . . . . 0.0 112.497 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -52.54 -27.95 18.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.31 2.244 . . . . 0.0 115.627 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -39.38 76.68 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -126.86 -0.51 6.65 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 93.8 m -123.98 -92.77 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 115.202 -2.332 . . . . 0.0 109.789 171.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -76.78 -33.52 3.9 Favored 'Cis proline' 0 C--N 1.362 1.265 0 CA-C-N 124.582 2.672 . . . . 0.0 115.725 -0.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -170.04 -51.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 127.897 2.479 . . . . 0.0 107.19 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -163.77 163.92 23.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.39 2.276 . . . . 0.0 109.316 -165.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.3 m -108.48 29.68 7.16 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.369 2.668 . . . . 0.0 111.898 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -155.03 -178.22 7.09 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.212 1.805 . . . . 0.0 109.755 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.714 HG13 HD22 ' A' ' 144' ' ' LEU . 75.5 t -117.71 121.52 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 140.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' H ' HD23 ' A' ' 144' ' ' LEU . 40.4 t80 -144.36 141.56 29.79 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.514 -1.366 . . . . 0.0 111.273 -167.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.59 159.71 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.98 -163.91 12.97 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.822 171.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 65.77 20.97 11.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.983 1.713 . . . . 0.0 114.692 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' H ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -84.13 132.74 34.66 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.014 -1.054 . . . . 0.0 110.105 170.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.31 34.01 1.2 Allowed Glycine 0 N--CA 1.477 1.392 0 C-N-CA 125.048 1.308 . . . . 0.0 112.099 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -143.29 -40.61 0.31 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 110.549 -162.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' H ' HD12 ' A' ' 81' ' ' LEU . 46.5 m-20 -124.15 -111.34 0.31 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.299 2.64 . . . . 0.0 108.125 173.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.04 61.92 0.56 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.902 1.715 . . . . 0.0 111.111 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.35 166.12 26.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.261 1.025 . . . . 0.0 112.243 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -30.08 65.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 m -75.89 -39.6 56.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.348 -0.845 . . . . 0.0 113.156 -169.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.29 -35.93 65.61 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.138 -0.976 . . . . 0.0 111.467 173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 mt -83.86 -30.07 26.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.324 1.449 . . . . 0.0 111.859 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -56.79 -36.52 69.96 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.804 0.729 . . . . 0.0 109.797 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -91.24 -52.55 4.76 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.179 0.992 . . . . 0.0 111.584 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.29 -22.77 54.09 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.372 1.069 . . . . 0.0 113.475 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.17 -26.53 9.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.22 -33.21 37.94 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 124.869 1.223 . . . . 0.0 114.502 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -57.01 -37.82 72.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -79.63 -20.99 45.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.387 0.675 . . . . 0.0 112.656 -170.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.49 175.91 26.19 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 125.553 1.549 . . . . 0.0 113.556 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.24 116.44 2.68 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.186 3.924 . . . . 0.0 115.173 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.39 161.26 29.4 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 110.502 159.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -126.93 -29.73 2.79 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.633 1.973 . . . . 0.0 112.585 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -154.54 164.08 39.23 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.709 0.686 . . . . 0.0 111.195 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.8 p -162.38 131.22 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.719 1.208 . . . . 0.0 111.766 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -158.32 165.6 34.37 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.39 1.476 . . . . 0.0 110.983 165.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . 0.263 1.3 m -142.76 143.97 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.965 -1.085 . . . . 0.0 112.808 175.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.79 161.98 11.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.334 1.854 . . . . 0.0 112.732 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -122.41 19.27 10.53 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 127.1 2.16 . . . . 0.0 110.928 171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -155.54 50.67 0.51 Allowed Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -153.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -76.01 166.48 82.81 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 CA-C-N 122.231 1.833 . . . . 0.0 114.164 0.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.93 -6.76 18.5 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.432 2.755 . . . . 0.0 115.611 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -90.55 18.39 49.9 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.877 1.227 . . . . 0.0 116.166 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -139.64 134.28 31.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.487 1.515 . . . . 0.0 110.808 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -130.54 151.24 51.23 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.28 1.832 . . . . 0.0 113.743 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -136.42 129.38 31.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' HG12 ' A' ' 76' ' ' VAL . 3.4 m -143.63 -178.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.639 1.176 . . . . 0.0 110.764 -166.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -141.41 152.01 43.94 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.168 -0.957 . . . . 0.0 112.257 170.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.406 ' CD1' HG11 ' A' ' 76' ' ' VAL . 3.6 m-85 -117.45 169.01 9.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.018 2.527 . . . . 0.0 110.764 171.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.48 3.28 40.1 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -156.44 137.18 9.13 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.2 -38.42 33.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 125.221 3.947 . . . . 0.0 117.517 168.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -57.8 -59.33 5.39 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 120.42 1.464 . . . . 0.0 110.127 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -56.16 -41.91 76.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.989 1.716 . . . . 0.0 110.907 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 145' ' ' SER . . . -69.75 -52.71 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.029 1.732 . . . . 0.0 113.255 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.41 65.69 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.195 1.361 . . . . 0.0 111.503 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -47.92 82.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.894 . . . . 0.0 111.868 174.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.36 -9.7 58.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.703 1.601 . . . . 0.0 114.617 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.2 -46.62 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.288 -1.508 . . . . 0.0 108.953 157.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.72 -20.9 65.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -114.62 -12.5 12.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.64 1.176 . . . . 0.0 111.899 -173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.21 -10.22 0.57 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -156.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -71.92 141.79 49.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.966 0.803 . . . . 0.0 111.96 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.63 15.52 62.01 Favored Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.433 1.492 . . . . 0.0 114.958 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.3 179.04 6.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.337 1.455 . . . . 0.0 112.49 -168.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.433 ' H ' ' HG3' ' A' ' 133' ' ' ARG . 99.8 m -136.16 89.67 2.5 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.101 1.36 . . . . 0.0 110.686 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.4 -32.47 42.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 112.777 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 3.5 m -145.75 17.07 1.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.858 1.263 . . . . 0.0 114.122 -165.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.94 -4.41 65.53 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.188 1.375 . . . . 0.0 113.827 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 15.1 p -63.99 -179.51 0.42 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.545 1.938 . . . . 0.0 113.538 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -130.74 63.29 1.58 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.581 1.152 . . . . 0.0 108.75 155.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 p -50.53 141.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.269 1.828 . . . . 0.0 112.048 -169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.1 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.292 1.437 . . . . 0.0 109.346 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.8 t -144.25 129.13 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -148.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.19 130.6 21.06 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 120.706 -1.246 . . . . 0.0 111.335 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.714 HD22 HG13 ' A' ' 76' ' ' VAL . 10.6 mt -147.99 127.15 12.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.307 1.043 . . . . 0.0 110.245 -159.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.412 ' HA ' ' CB ' ' A' ' 123' ' ' ALA . 3.5 m -173.81 -12.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 155.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.28 56.87 3.63 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.776 1.171 . . . . 0.0 112.622 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.11 -4.1 2.21 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 -170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 148' ' ' GLU . 10.9 mp0 -67.96 -21.65 65.07 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.412 2.285 . . . . 0.0 112.098 174.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.35 148.77 35.08 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.81 1.644 . . . . 0.0 109.31 165.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 . . . . . 0 C--O 1.244 0.798 0 C-N-CA 125.94 1.696 . . . . 0.0 111.198 -173.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.448 0.166 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -65.32 -179.02 0.55 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.666 1.986 . . . . 0.0 112.928 -11.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -130.87 130.82 44.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 133.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.03 112.91 12.77 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.974 -1.079 . . . . 0.0 113.527 -174.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.61 111.79 20.38 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.594 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 9.6 mt -77.2 117.23 21.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 129.189 2.995 . . . . 0.0 110.419 158.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.15 123.77 30.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.798 161.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.32 34.6 3.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.196 1.799 . . . . 0.0 110.911 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 150.37 20.98 Favored Glycine 0 CA--C 1.523 0.561 0 O-C-N 121.033 -1.042 . . . . 0.0 114.422 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -49.16 -37.54 22.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.138 1.375 . . . . 0.0 110.655 155.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 m -57.71 -55.17 38.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.815 2.846 . . . . 0.0 113.419 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 13' ' ' LYS . 1.8 tm? -165.26 140.16 5.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.99 1.716 . . . . 0.0 109.824 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' N ' HD13 ' A' ' 12' ' ' LEU . 7.3 mtpm? -128.7 119.52 24.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.901 1.28 . . . . 0.0 110.745 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.52 85.41 0.06 OUTLIER Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.163 0.887 . . . . 0.0 112.949 -168.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -31.77 159.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 158.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 t -140.43 -27.7 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 7.1 p 61.86 162.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -171.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.7 t -158.96 -172.41 3.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.374 2.27 . . . . 0.0 107.733 159.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -138.16 146.72 43.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 120.189 -1.569 . . . . 0.0 111.531 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.41 -174.77 5.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.288 1.035 . . . . 0.0 111.972 -163.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.8 -50.91 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.11 166.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -165.99 175.85 8.23 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.284 1.516 . . . . 0.0 112.045 -156.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.13 17.92 0.09 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.567 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.69 7.84 6.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.111 1.364 . . . . 0.0 111.545 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.8 p -135.42 -26.27 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.958 2.503 . . . . 0.0 112.29 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.5 -47.03 16.29 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.618 163.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.42 -47.5 75.87 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -21.31 6.76 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.982 1.313 . . . . 0.0 114.408 -171.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.02 -34.57 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.032 1.733 . . . . 0.0 110.914 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 18' ' ' THR . 16.4 m-30 -54.39 -43.0 71.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.339 0.972 . . . . 0.0 113.549 165.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -37.25 -57.28 0.9 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 127.423 2.289 . . . . 0.0 110.452 166.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -80.39 -32.25 37.61 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.975 1.71 . . . . 0.0 114.729 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -59.0 -44.7 91.71 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.431 1.014 . . . . 0.0 111.087 168.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.66 58.69 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.46 -31.39 72.1 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.051 0.841 . . . . 0.0 112.272 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.9 -37.99 76.16 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.718 1.207 . . . . 0.0 113.219 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -66.05 -44.2 85.28 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.695 -0.628 . . . . 0.0 111.784 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.07 13.66 0.59 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.984 1.754 . . . . 0.0 114.052 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.87 144.98 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.957 1.703 . . . . 0.0 111.877 -166.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -132.56 8.22 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.957 0.903 . . . . 0.0 112.849 158.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 56' ' ' GLU . . . 45.12 -132.2 8.26 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 123.018 1.343 . . . . 0.0 114.193 166.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -136.16 42.22 2.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.191 1.796 . . . . 0.0 106.615 167.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 26.3 m95 -3.22 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 130.525 3.53 . . . . 0.0 115.939 -168.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.0 m -83.89 157.97 21.78 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.109 0.956 . . . . 0.0 109.774 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -137.64 145.53 42.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.211 1.404 . . . . 0.0 110.112 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -133.2 56.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.447 1.499 . . . . 0.0 110.278 -155.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -44.88 -32.35 1.56 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.084 2.953 . . . . 0.0 116.822 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.82 -21.88 61.48 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.061 2.144 . . . . 0.0 112.624 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -131.78 7.91 4.45 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.527 1.531 . . . . 0.0 112.846 167.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm 63.76 2.24 1.27 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.975 2.51 . . . . 0.0 114.61 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.5 m -52.52 161.98 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 129.741 3.216 . . . . 0.0 113.127 166.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -132.1 155.33 48.32 Favored 'General case' 0 C--N 1.327 -0.399 1 C-N-CA 132.053 4.141 . . . . 0.0 110.039 171.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -144.92 121.22 10.9 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.999 0.428 . . . . 0.0 111.786 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.97 90.91 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 122.535 1.159 . . . . 0.0 112.53 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.56 39.23 0.82 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -163.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 9.7 tm-20 -62.11 -14.53 37.67 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -170.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.0 5.01 45.81 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.974 1.75 . . . . 0.0 114.949 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -142.14 -15.41 0.78 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.01 1.405 . . . . 0.0 114.436 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -128.44 100.47 5.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.651 1.581 . . . . 0.0 107.254 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -135.21 117.93 16.07 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.959 0.904 . . . . 0.0 112.696 -159.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -155.52 132.79 10.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.703 2.801 . . . . 0.0 109.001 -14.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -5.32 1.1 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . 0.272 0.0 OUTLIER 57.05 -9.74 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.624 2.77 . . . . 0.0 116.87 -176.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.71 -19.6 59.16 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.533 1.933 . . . . 0.0 113.889 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.0 ptm 55.91 -26.27 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 130.447 3.499 . . . . 0.0 119.588 171.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -160.02 166.86 29.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.094 2.158 . . . . 0.0 110.264 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.5 24.13 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 173.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p30 21.56 -100.27 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 128.601 2.76 . . . . 0.0 116.194 164.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 m -164.43 -43.98 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.936 2.494 . . . . 0.0 109.755 163.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.8 p -143.26 136.27 13.83 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.852 2.061 . . . . 0.0 107.937 156.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.99 -30.07 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 114.88 1.069 . . . . 0.0 114.88 -158.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 mp 50.17 -65.5 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 127.128 2.171 . . . . 0.0 114.404 -149.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -66.73 -7.12 18.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -120.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.4 m -109.21 46.88 0.95 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.436 1.895 . . . . 0.0 111.357 163.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.636 ' H ' ' H ' ' A' ' 146' ' ' ASN . 2.9 mptp? -148.42 178.68 8.39 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.47 -0.769 . . . . 0.0 110.505 57.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.04 144.28 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.711 0.804 . . . . 0.0 109.651 168.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -121.94 147.56 45.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.61 0.764 . . . . 0.0 111.61 -158.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.28 151.87 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.952 0.901 . . . . 0.0 110.56 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 -172.57 36.25 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 118.336 2.094 . . . . 0.0 118.336 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t30 53.28 36.22 22.17 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.378 1.871 . . . . 0.0 113.542 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.85 9.55 43.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.089 1.756 . . . . 0.0 113.238 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -51.94 -21.03 6.95 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.018 1.771 . . . . 0.0 117.034 -169.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -54.52 -33.11 59.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 113.233 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -131.78 -45.74 0.96 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.104 1.762 . . . . 0.0 111.545 -177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.73 77.3 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 129.111 3.243 . . . . 0.0 115.661 -174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -139.75 167.53 21.88 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.557 1.143 . . . . 0.0 111.518 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -68.9 -37.43 78.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -79.86 -29.19 40.01 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.974 -1.079 . . . . 0.0 113.462 -163.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.95 -18.54 63.28 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.2 mt -96.67 -34.19 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.316 1.446 . . . . 0.0 111.666 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -54.12 -36.47 63.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.733 0.697 . . . . 0.0 110.893 168.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.88 -55.98 4.87 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.77 45.25 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -117.19 -30.29 5.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.863 1.265 . . . . 0.0 111.091 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.72 -35.58 17.21 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 125.033 1.301 . . . . 0.0 114.804 164.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -54.04 -41.95 68.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -78.43 -30.97 47.88 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.255 -171.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.71 -168.59 40.74 Favored Glycine 0 CA--C 1.539 1.587 0 N-CA-C 116.089 1.196 . . . . 0.0 116.089 -170.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.45 112.22 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.168 3.245 . . . . 0.0 112.072 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.13 156.69 37.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.737 0.78 . . . . 0.0 111.003 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -134.01 -21.89 1.85 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 112.878 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.0 m -163.74 166.52 22.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.006 1.322 . . . . 0.0 111.558 166.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.67 131.29 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.906 1.282 . . . . 0.0 110.519 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -150.05 144.11 25.57 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.25 1.42 . . . . 0.0 111.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.76 149.14 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.594 -1.316 . . . . 0.0 113.73 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.15 124.5 49.64 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.19 2.196 . . . . 0.0 110.45 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -153.94 162.07 41.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -154.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.61 -42.61 14.61 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 126.36 1.864 . . . . 0.0 112.089 -17.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -64.66 143.8 82.15 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.558 2.172 . . . . 0.0 110.906 149.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.24 -15.96 24.11 Favored 'Cis proline' 0 CA--C 1.543 0.959 0 CA-C-N 120.314 1.148 . . . . 0.0 113.427 -7.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.35 42.02 3.55 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 124.391 0.996 . . . . 0.0 112.731 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.89 142.97 49.2 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.704 1.202 . . . . 0.0 111.566 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -127.2 161.8 27.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.513 1.925 . . . . 0.0 113.227 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.5 137.13 30.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.911 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.02 168.55 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 109.506 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -139.42 149.74 44.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.313 -0.867 . . . . 0.0 110.195 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.86 178.13 5.66 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.315 2.246 . . . . 0.0 111.3 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.442 ' HA ' HH22 ' A' ' 150' ' ' ARG . 5.2 tp10 -126.63 29.24 5.75 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.825 1.25 . . . . 0.0 112.543 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -160.24 119.37 1.6 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.132 1.373 . . . . 0.0 111.312 163.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.04 -43.29 2.31 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 125.168 3.912 . . . . 0.0 116.165 167.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -58.5 -38.74 78.31 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.013 1.725 . . . . 0.0 113.408 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.65 -37.38 19.54 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.32 92.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.741 0.701 . . . . 0.0 112.156 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.92 93.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.81 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.62 -40.39 66.52 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.433 1.015 . . . . 0.0 113.649 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.99 -10.57 10.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 114.333 169.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.75 -50.92 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.619 1.1 . . . . 0.0 110.571 158.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -54.19 -31.83 53.98 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.39 1.876 . . . . 0.0 113.688 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.65 -2.07 42.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.841 1.656 . . . . 0.0 112.937 -173.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.54 -24.45 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -153.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.88 109.76 0.23 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.098 1.759 . . . . 0.0 112.427 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.34 85.07 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.488 1.355 . . . . 0.0 116.488 172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -105.15 -122.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.814 1.307 . . . . 0.0 111.796 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.5 m -150.69 142.52 23.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.413 1.485 . . . . 0.0 109.317 -172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.88 -35.93 2.04 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.425 1.09 . . . . 0.0 113.465 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 89.8 m -146.61 23.7 1.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.535 1.934 . . . . 0.0 111.811 -163.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 85.31 -10.41 63.93 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.817 1.675 . . . . 0.0 114.412 -169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 12.0 p -70.11 -179.69 2.03 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.837 2.455 . . . . 0.0 113.223 172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -126.5 135.39 51.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.678 1.591 . . . . 0.0 108.048 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.79 171.67 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.127 0.571 . . . . 0.0 112.252 -145.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -133.11 147.49 52.13 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.635 1.974 . . . . 0.0 109.525 159.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 t -144.88 130.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.939 0.896 . . . . 0.0 108.639 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -139.26 -179.53 5.93 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.911 1.684 . . . . 0.0 112.507 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -98.39 169.46 9.53 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.856 2.062 . . . . 0.0 114.901 -175.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 m -142.03 -122.4 0.1 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.704 1.201 . . . . 0.0 111.995 154.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.636 ' H ' ' H ' ' A' ' 75' ' ' LYS . 79.9 m-20 -125.8 -26.66 3.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -137.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.36 171.51 6.5 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 120.095 1.316 . . . . 0.0 112.56 -158.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 -35.34 5.97 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.005 -1.291 . . . . 0.0 113.043 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.13 -31.96 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.015 2.526 . . . . 0.0 113.421 168.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.442 HH22 ' HA ' ' A' ' 118' ' ' GLU . 27.5 mmt180 . . . . . 0 N--CA 1.485 1.277 0 C-N-CA 129.665 3.186 . . . . 0.0 115.807 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -149.71 172.79 14.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 128.378 2.671 . . . . 0.0 110.966 -8.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -140.91 106.51 5.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 30.6 ttpt -123.32 128.45 49.94 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 124.307 1.043 . . . . 0.0 112.279 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 43' ' ' TRP . 30.0 tp -98.34 103.76 15.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.178 1.791 . . . . 0.0 108.878 162.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 10.9 mt -72.23 114.63 11.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 128.498 2.719 . . . . 0.0 110.135 160.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.99 125.1 34.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.33 166.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -134.96 48.41 2.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.125 1.77 . . . . 0.0 109.88 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 13' ' ' LYS . . . -112.2 150.89 18.17 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.925 1.25 . . . . 0.0 113.331 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -59.97 -24.06 64.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.148 1.379 . . . . 0.0 111.075 162.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.6 m -57.47 -56.59 19.95 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.315 1.846 . . . . 0.0 111.91 162.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 13' ' ' LYS . 3.0 tm? -164.37 139.53 5.78 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.311 1.845 . . . . 0.0 111.126 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 9' ' ' GLY . 24.0 mtmt -122.49 110.12 15.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.311 1.844 . . . . 0.0 110.259 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.19 83.82 0.04 OUTLIER Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.039 0.828 . . . . 0.0 112.825 -166.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -29.48 155.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.919 1.688 . . . . 0.0 115.513 155.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -134.38 -26.07 1.47 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.047 2.239 . . . . 0.0 117.047 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.0 p 57.46 167.25 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 -175.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 2.3 t -160.84 -171.48 3.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.02 2.528 . . . . 0.0 107.623 162.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -140.12 131.66 27.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.517 1.527 . . . . 0.0 108.464 170.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.74 176.53 8.98 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.384 1.088 . . . . 0.0 113.439 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 21' ' ' VAL . 7.7 t -58.54 -50.74 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.362 1.865 . . . . 0.0 111.259 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.82 172.57 4.06 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.187 1.795 . . . . 0.0 109.824 -154.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.68 -3.28 11.48 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.8 -43.21 3.65 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 120.552 1.524 . . . . 0.0 108.503 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 m -63.66 -21.37 66.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.708 1.14 . . . . 0.0 112.818 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.35 8.19 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.796 0.725 . . . . 0.0 111.663 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -61.3 -46.22 91.2 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -58.58 -20.19 44.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.02 -41.62 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 126.479 1.911 . . . . 0.0 110.868 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 18' ' ' THR . 12.6 m-85 -54.73 -38.77 67.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -45.77 -52.8 10.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.178 1.791 . . . . 0.0 110.318 171.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -75.75 -34.05 60.26 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.118 1.767 . . . . 0.0 114.525 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -59.26 -42.24 90.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.797 1.181 . . . . 0.0 111.211 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.56 -34.17 47.23 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.254 -0.904 . . . . 0.0 110.488 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -70.45 -27.24 64.09 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.725 0.693 . . . . 0.0 112.542 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.95 -37.61 75.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.979 1.312 . . . . 0.0 112.863 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -66.36 -53.03 40.84 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.18 0.592 . . . . 0.0 111.318 171.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.22 20.2 0.3 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.734 1.635 . . . . 0.0 114.474 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.1 150.27 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.595 1.558 . . . . 0.0 112.526 -167.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.56 -0.27 2.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.642 1.177 . . . . 0.0 112.746 161.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 41.45 -113.79 0.54 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-O 124.422 2.123 . . . . 0.0 113.739 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -2.45 7.11 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 131.318 3.847 . . . . 0.0 109.652 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 41.6 m95 27.25 72.47 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 128.912 2.885 . . . . 0.0 114.26 -153.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.3 m -71.31 157.11 38.66 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 110.452 170.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -146.17 156.14 43.21 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.915 1.686 . . . . 0.0 111.423 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -133.77 135.39 43.87 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 127.365 2.266 . . . . 0.0 109.858 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.24 -16.05 14.88 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.08 -25.2 60.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.465 1.506 . . . . 0.0 112.106 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.9 p -125.2 -1.63 7.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.394 1.878 . . . . 0.0 112.52 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.384 55.2 mttm 60.07 19.47 8.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.427 1.891 . . . . 0.0 114.259 -175.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.5 m -67.03 162.77 21.4 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.111 2.564 . . . . 0.0 113.957 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -132.98 158.72 41.98 Favored 'General case' 0 C--N 1.327 -0.404 1 C-N-CA 132.34 4.256 . . . . 0.0 110.514 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -145.19 144.56 30.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.757 -0.589 . . . . 0.0 111.292 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.2 94.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.087 1.355 . . . . 0.0 112.443 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.8 m -95.79 58.93 2.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.0 113.605 -169.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.97 65.96 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.921 -1.112 . . . . 0.0 113.298 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.56 -7.07 45.46 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.312 1.91 . . . . 0.0 114.933 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.8 p -64.24 -18.23 64.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.902 1.351 . . . . 0.0 113.93 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -73.02 72.27 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.416 1.486 . . . . 0.0 112.661 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 63.5 -20.63 0.06 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.519 3.128 . . . . 0.0 118.533 164.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -141.46 141.93 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.099 1.318 . . . . 0.0 110.353 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -138.93 -14.45 1.19 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -156.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -153.61 14.98 0.5 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.797 2.039 . . . . 0.0 111.731 175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -153.85 151.5 29.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.596 1.558 . . . . 0.0 111.513 -166.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.1 tpt -155.02 158.37 39.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.035 2.134 . . . . 0.0 108.655 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.932 0.787 . . . . 0.0 112.839 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.49 -178.84 4.14 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 128.328 2.651 . . . . 0.0 110.178 159.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.98 -48.88 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.701 1.6 . . . . 0.0 113.584 -165.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m 134.23 -21.36 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.267 1 C-N-CA 132.954 4.502 . . . . 0.0 113.013 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 53.7 m -154.58 166.74 15.33 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.991 1.716 . . . . 0.0 112.091 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.25 -30.04 0.34 Allowed 'Cis proline' 0 C--N 1.352 0.721 0 N-CA-C 114.271 0.835 . . . . 0.0 114.271 -8.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -156.43 -53.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.087 2.555 . . . . 0.0 106.607 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -172.2 -89.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.344 1.857 . . . . 0.0 112.052 150.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.2 t -144.24 116.54 8.49 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.582 1.553 . . . . 0.0 112.161 -172.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.334 9.8 ptpt 43.08 -156.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 128.635 2.774 . . . . 0.0 114.472 -175.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 115' ' ' VAL . 14.8 t -130.88 143.37 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 119.785 1.175 . . . . 0.0 112.629 -160.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -135.67 132.87 37.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.613 1.965 . . . . 0.0 108.711 172.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.64 150.64 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.188 0.518 . . . . 0.0 109.854 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.37 -169.34 29.85 Favored Glycine 0 N--CA 1.465 0.631 0 O-C-N 121.337 -0.852 . . . . 0.0 114.402 172.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 60.87 4.86 0.85 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 85' ' ' GLY . 2.2 tm? -62.59 -49.61 74.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.471 1.032 . . . . 0.0 110.458 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.82 -60.11 0.34 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.536 2.017 . . . . 0.0 116.923 168.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -81.75 -13.74 57.38 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -159.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.89 -57.79 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 109.134 165.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.537 ' H ' HD12 ' A' ' 81' ' ' LEU . . . 38.26 62.67 1.05 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.794 2.14 . . . . 0.0 114.885 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -127.77 -42.61 1.59 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 pttp 139.75 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 1 C-N-CA 131.709 4.003 . . . . 0.0 112.171 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 m -79.57 -35.71 39.33 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.75 -0.594 . . . . 0.0 111.497 -167.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -40.76 76.33 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.118 -0.989 . . . . 0.0 111.519 169.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.0 mt -78.24 -31.3 49.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.617 0.767 . . . . 0.0 112.606 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -55.67 -37.96 68.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.943 1.247 . . . . 0.0 110.078 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -104.43 -42.44 5.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.386 -164.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.26 -34.55 66.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.138 0.575 . . . . 0.0 112.007 168.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -95.65 -29.83 14.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -50.73 -33.21 26.71 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.02 1.295 . . . . 0.0 114.205 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -57.52 -40.1 77.99 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -76.71 -27.61 55.54 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.07 -171.14 37.91 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 114.817 0.687 . . . . 0.0 114.817 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.09 135.02 24.32 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.828 3.019 . . . . 0.0 112.56 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.99 157.97 17.39 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.963 1.705 . . . . 0.0 110.043 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -127.67 -27.5 2.84 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.446 1.899 . . . . 0.0 112.669 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -168.32 155.84 8.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.808 1.243 . . . . 0.0 110.226 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -153.21 129.08 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.223 1.809 . . . . 0.0 108.902 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -148.85 160.38 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.923 0.889 . . . . 0.0 111.953 166.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.4 147.03 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.406 -0.809 . . . . 0.0 112.945 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.95 129.87 34.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.561 1.544 . . . . 0.0 111.319 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -68.22 -19.46 64.76 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.88 1.272 . . . . 0.0 112.895 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.95 113.37 5.36 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 127.234 2.213 . . . . 0.0 110.163 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.58 156.27 6.53 Favored 'Cis proline' 0 C--N 1.358 1.066 0 CA-C-N 121.734 1.655 . . . . 0.0 115.393 -1.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -53.65 2.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 1 C-N-CA 126.277 4.651 . . . . 0.0 121.818 -153.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.61 61.13 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 CA-C-N 120.954 1.707 . . . . 0.0 111.822 -174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -127.31 139.49 52.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.924 1.69 . . . . 0.0 110.225 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -137.35 158.85 43.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.547 1.539 . . . . 0.0 114.685 -157.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.93 125.63 17.96 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.449 1.1 . . . . 0.0 108.869 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.7 m -138.26 -175.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -172.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -147.47 110.83 4.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.47 1.908 . . . . 0.0 109.547 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 144' ' ' LEU . 4.4 m-85 -75.02 173.02 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.948 0.899 . . . . 0.0 111.224 158.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -139.13 37.37 2.12 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.883 0.849 . . . . 0.0 113.171 166.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.25 130.72 7.76 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 120.952 -1.092 . . . . 0.0 110.906 166.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.79 -37.76 4.85 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.133 2.555 . . . . 0.0 113.671 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -71.23 -44.65 64.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.396 1.078 . . . . 0.0 110.758 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -67.17 -34.86 78.43 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.382 0.673 . . . . 0.0 112.354 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.55 -46.98 68.05 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -31.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.991 -1.068 . . . . 0.0 110.959 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.13 -43.89 60.99 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 119.228 0.922 . . . . 0.0 112.508 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.65 -2.5 6.92 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.861 1.264 . . . . 0.0 113.964 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.49 -56.83 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 120.558 -1.339 . . . . 0.0 109.921 151.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -55.2 -29.75 58.53 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.522 1.529 . . . . 0.0 113.651 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -102.47 -12.04 18.13 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.725 1.61 . . . . 0.0 112.367 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.46 -5.48 0.65 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -154.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.6 p30 -57.91 -6.86 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 166.01 62.64 0.03 OUTLIER Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.56 -0.712 . . . . 0.0 112.316 -151.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -135.68 -165.73 1.74 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.743 1.617 . . . . 0.0 111.719 -167.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.4 m -131.01 115.9 17.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.76 1.624 . . . . 0.0 109.288 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 mp -109.37 -34.92 6.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.111 1.365 . . . . 0.0 113.354 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 82.7 m -140.43 24.75 2.26 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.047 1.339 . . . . 0.0 112.739 -165.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.36 29.67 39.69 Favored Glycine 0 N--CA 1.478 1.441 0 O-C-N 121.024 -1.047 . . . . 0.0 112.96 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.77 -165.98 1.55 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.77 2.428 . . . . 0.0 111.357 -167.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -139.64 55.56 1.66 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.842 0.857 . . . . 0.0 112.061 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.3 p -46.11 146.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 127.034 2.134 . . . . 0.0 114.091 -174.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.85 133.05 35.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.803 2.441 . . . . 0.0 109.441 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 46.7 t -143.42 136.42 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.785 0.434 . . . . 0.0 111.493 -158.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -134.05 112.13 10.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.504 2.322 . . . . 0.0 108.513 173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD11 ' CE1' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -145.57 115.63 7.42 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.981 -1.074 . . . . 0.0 112.672 -152.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -149.74 -172.17 4.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.042 1.737 . . . . 0.0 113.951 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -140.21 10.28 2.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.185 1.794 . . . . 0.0 113.038 167.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.46 31.79 4.39 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 120.702 -1.249 . . . . 0.0 116.088 -160.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.65 -11.7 3.37 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.916 1.358 . . . . 0.0 114.214 175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -64.93 -11.18 35.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.785 2.434 . . . . 0.0 115.583 -160.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.874 0 C-N-CA 126.231 1.812 . . . . 0.0 110.797 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -149.37 161.57 41.8 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.943 2.497 . . . . 0.0 111.38 -1.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.6 104.34 5.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 164.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.06 113.85 9.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.878 1.271 . . . . 0.0 112.836 -163.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.0 tp -99.84 101.85 13.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 124.72 1.208 . . . . 0.0 110.434 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.03 124.09 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 128.343 2.657 . . . . 0.0 110.012 158.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.16 133.74 45.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.736 168.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -148.14 49.5 1.04 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.93 2.092 . . . . 0.0 109.723 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.58 157.48 21.32 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 120.539 -1.35 . . . . 0.0 112.924 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -55.49 -37.47 67.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.152 0.981 . . . . 0.0 110.179 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.492 HG21 ' HA3' ' A' ' 38' ' ' GLY . 85.0 m -56.78 -72.24 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.913 2.485 . . . . 0.0 112.967 164.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 11' ' ' THR . 1.0 OUTLIER -140.59 132.71 27.97 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.441 1.096 . . . . 0.0 110.613 -161.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -132.28 123.23 26.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.244 1.818 . . . . 0.0 109.169 -175.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.84 99.11 0.81 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.469 1.033 . . . . 0.0 112.024 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -32.22 164.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.019 2.528 . . . . 0.0 116.941 165.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -129.06 -38.72 1.61 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 4.2 p 57.58 162.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -158.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 1.4 t -151.03 -6.94 0.26 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 28.17 99.02 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.806 3.242 . . . . 0.0 117.549 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.77 -159.6 0.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.447 1.499 . . . . 0.0 113.353 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.77 -17.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.537 1.935 . . . . 0.0 111.936 -160.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -145.13 -11.1 0.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.58 -0.41 3.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.431 2.692 . . . . 0.0 115.445 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.51 -46.2 4.83 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 125.51 1.524 . . . . 0.0 107.956 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.64 -19.72 58.86 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.629 1.972 . . . . 0.0 113.455 162.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -54.2 6.61 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 119.402 1.001 . . . . 0.0 110.922 167.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.65 -43.95 91.97 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -60.77 -16.85 44.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.34 -41.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.427 2.291 . . . . 0.0 110.295 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.0 m-85 -53.63 -43.8 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.606 1.094 . . . . 0.0 113.701 168.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -58.15 1.44 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.944 2.097 . . . . 0.0 110.866 168.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.6 -30.89 46.84 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.945 1.698 . . . . 0.0 114.918 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -59.5 -43.61 93.29 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.543 1.065 . . . . 0.0 110.928 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.95 -32.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.406 -0.809 . . . . 0.0 110.864 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.84 -26.74 67.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 118.335 0.516 . . . . 0.0 112.307 172.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.85 -48.39 59.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.837 1.655 . . . . 0.0 113.324 164.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -61.33 -38.61 87.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.595 0.634 . . . . 0.0 111.975 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' HA3' HG21 ' A' ' 11' ' ' THR . . . 128.62 28.37 0.82 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.524 1.535 . . . . 0.0 113.648 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.49 142.72 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.713 1.605 . . . . 0.0 111.176 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -148.86 113.71 5.41 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.376 1.084 . . . . 0.0 109.797 143.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -152.83 8.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-O 124.369 2.094 . . . . 0.0 115.387 -156.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.37 58.43 2.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 111.334 -2.433 . . . . 0.0 108.519 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.428 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 22.1 m95 -47.35 98.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.691 2.397 . . . . 0.0 112.019 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -121.98 159.28 27.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.341 1.856 . . . . 0.0 109.943 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.32 156.81 42.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.628 1.571 . . . . 0.0 111.127 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -135.29 113.1 10.95 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.729 2.012 . . . . 0.0 110.141 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.01 -18.6 53.34 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.61 -25.35 56.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.457 1.103 . . . . 0.0 111.863 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -120.69 -4.05 9.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.298 1.439 . . . . 0.0 112.949 167.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.385 37.8 mttm 56.42 24.66 8.71 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.86 2.064 . . . . 0.0 114.286 -171.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.1 m -73.12 155.06 40.07 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.553 1.941 . . . . 0.0 111.923 168.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.66 159.15 36.5 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 129.35 3.06 . . . . 0.0 111.37 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -143.8 136.76 27.47 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.161 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 2.3 m -111.89 96.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 122.514 1.15 . . . . 0.0 112.847 157.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.74 106.15 15.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.68 1.192 . . . . 0.0 109.324 165.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -118.67 -6.89 10.62 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.878 -1.139 . . . . 0.0 112.277 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.63 42.65 1.9 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 127.244 2.354 . . . . 0.0 112.311 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -156.11 169.63 24.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.113 2.165 . . . . 0.0 111.315 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -121.43 -162.68 0.99 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.186 1.794 . . . . 0.0 109.876 171.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -54.31 -25.29 22.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -164.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -50.79 -18.34 0.72 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.127 1.771 . . . . 0.0 115.353 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.0 t60 49.47 -127.26 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.39 1.476 . . . . 0.0 109.249 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -116.19 167.54 10.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 139.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -64.75 14.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 62.2 mtt -87.63 -9.55 53.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.575 2.35 . . . . 0.0 113.029 168.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -53.99 139.13 35.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.515 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HB3' HH12 ' A' ' 150' ' ' ARG . 0.2 OUTLIER -165.77 158.43 15.18 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.482 1.113 . . . . 0.0 112.683 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -79.52 135.19 36.56 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.368 2.267 . . . . 0.0 109.758 -24.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -140.48 169.37 17.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.493 1.117 . . . . 0.0 113.938 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.2 p -158.91 99.21 1.64 Allowed Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.0 110.09 158.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.05 -31.26 6.29 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.221 1.947 . . . . 0.0 115.144 -169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -163.87 -51.41 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.999 2.12 . . . . 0.0 107.652 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.49 -124.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.42 2.288 . . . . 0.0 107.325 169.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 31.8 p -155.81 15.79 0.36 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.4 -179.19 4.85 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 128.004 2.522 . . . . 0.0 110.509 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.3 t -118.92 145.69 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.091 -1.006 . . . . 0.0 112.712 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -131.59 147.09 52.5 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 128.65 2.78 . . . . 0.0 108.808 169.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 5.3 t -138.01 150.42 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.442 1.097 . . . . 0.0 109.591 172.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.22 -168.73 20.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.36 -6.79 1.94 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.59 2.356 . . . . 0.0 114.646 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 51.76 2.31 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 122.747 1.261 . . . . 0.0 113.353 -163.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.22 -20.34 69.14 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 -167.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -67.89 -32.05 72.27 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.134 1.467 . . . . 0.0 113.213 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.94 -21.48 0.18 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -49.09 109.85 0.65 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 119.84 1.2 . . . . 0.0 115.081 -157.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -133.39 -25.58 1.72 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.678 1.991 . . . . 0.0 113.545 -169.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.3 pttp 139.22 -38.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 1 C-N-CA 132.787 4.435 . . . . 0.0 111.685 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -66.62 -44.11 82.93 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.814 0.734 . . . . 0.0 112.17 -163.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 1.5 pm0 -53.96 -34.82 60.77 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.8 mt -83.94 -37.74 21.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.469 1.107 . . . . 0.0 111.836 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -55.41 -36.5 66.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.941 1.297 . . . . 0.0 109.896 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -80.66 -54.79 5.33 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.04 -11.57 40.75 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -119.29 -30.66 4.87 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.369 1.068 . . . . 0.0 113.001 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.3 -31.5 50.34 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 119.509 1.049 . . . . 0.0 113.784 168.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -62.5 -41.02 98.54 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 172.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.87 -25.23 48.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.902 0.481 . . . . 0.0 111.955 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.62 -172.98 43.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.245 0.858 . . . . 0.0 115.245 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.69 131.03 17.86 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.643 2.895 . . . . 0.0 112.361 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.16 148.91 28.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.215 1.806 . . . . 0.0 109.478 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -123.83 -22.03 5.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.022 1.729 . . . . 0.0 113.188 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -164.29 153.15 13.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.034 1.334 . . . . 0.0 110.358 172.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.0 t -151.98 135.11 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.0 108.767 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -150.58 152.6 34.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.559 1.544 . . . . 0.0 111.137 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -146.54 146.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 120.991 -1.068 . . . . 0.0 111.472 172.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.63 -66.42 0.5 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.186 0.994 . . . . 0.0 111.669 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.53 -178.87 0.22 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 130.315 3.446 . . . . 0.0 109.079 164.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -64.77 -28.17 2.72 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 79.5 Cg_endo -83.76 120.04 2.67 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 122.826 2.35 . . . . 0.0 110.345 143.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 109' ' ' PRO . 33.3 Cg_endo -87.39 -1.37 64.87 Favored 'Cis proline' 0 CA--C 1.55 1.281 0 CA-C-N 120.841 1.336 . . . . 0.0 114.462 -4.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.54 30.69 9.52 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.533 1.063 . . . . 0.0 113.271 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.5 139.39 49.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.183 1.793 . . . . 0.0 110.798 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -130.82 166.19 21.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.725 2.01 . . . . 0.0 113.74 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -140.97 142.12 34.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.237 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.27 1.3 m -141.45 178.85 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.291 1.043 . . . . 0.0 112.296 -177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -141.05 104.63 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.767 2.027 . . . . 0.0 108.07 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.417 ' CE1' HD21 ' A' ' 144' ' ' LEU . 5.7 m-85 -59.89 174.82 0.44 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.794 0.838 . . . . 0.0 112.584 155.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -115.72 -12.51 11.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.303 1.041 . . . . 0.0 112.71 164.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.91 140.76 21.38 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.052 1.341 . . . . 0.0 111.885 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.45 -37.59 0.94 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.694 2.93 . . . . 0.0 114.969 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -28.57 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.71 -1.244 . . . . 0.0 113.991 -159.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.23 -24.03 63.96 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.594 -0.691 . . . . 0.0 111.052 161.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 -47.16 66.56 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.807 1.243 . . . . 0.0 113.647 161.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.36 65.08 Favored 'General case' 0 C--N 1.343 0.29 0 O-C-N 120.275 -1.516 . . . . 0.0 110.739 171.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -43.21 77.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 172.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.73 -8.62 2.16 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 166.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.48 -53.48 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.863 1.665 . . . . 0.0 110.743 157.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -59.86 -21.85 61.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.148 1.779 . . . . 0.0 112.882 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -107.51 -9.06 16.03 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.089 1.756 . . . . 0.0 111.537 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.12 -4.91 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -153.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -5.67 41.07 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.861 1.21 . . . . 0.0 113.763 168.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.75 46.89 0.53 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.418 1.485 . . . . 0.0 113.773 -159.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -132.19 177.97 7.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.155 0.982 . . . . 0.0 113.007 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.6 m -113.55 123.06 49.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.448 1.499 . . . . 0.0 109.129 168.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mp -129.52 145.59 51.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.007 2.523 . . . . 0.0 107.99 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 42.0 m 52.41 18.96 1.03 Allowed 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.96 60.18 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.277 1.418 . . . . 0.0 114.01 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.14 147.28 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.148 1.779 . . . . 0.0 111.226 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -52.58 148.07 7.58 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.99 152.01 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.316 . . . . 0.0 109.915 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 147.25 50.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.349 1.059 . . . . 0.0 108.342 167.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.48 158.15 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.308 0.643 . . . . 0.0 111.817 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -148.19 104.91 3.58 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.339 1.456 . . . . 0.0 107.584 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.417 HD21 ' CE1' ' A' ' 117' ' ' PHE . 5.0 tt -142.74 94.91 2.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.843 -0.536 . . . . 0.0 111.646 -151.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.8 t -166.76 140.55 3.9 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.549 0.69 . . . . 0.0 112.852 143.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -61.15 157.1 16.73 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 130.279 3.432 . . . . 0.0 111.148 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.67 -160.67 28.21 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.019 0.819 . . . . 0.0 111.486 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -162.9 165.42 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.316 1.046 . . . . 0.0 111.752 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.53 82.17 0.67 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.513 1.125 . . . . 0.0 111.2 153.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.407 HH12 ' HB3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 125.406 1.482 . . . . 0.0 110.41 168.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -155.65 162.07 40.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.632 2.773 . . . . 0.0 110.447 -8.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -135.51 109.68 8.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 160.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.3 ttmm -131.13 135.72 47.72 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 127.018 2.127 . . . . 0.0 109.18 -169.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.0 tp -114.41 98.82 7.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.358 1.863 . . . . 0.0 108.554 162.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -58.36 124.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 125.903 1.681 . . . . 0.0 108.738 158.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.24 135.22 38.36 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.934 166.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -144.84 53.19 1.22 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.26 1.024 . . . . 0.0 109.078 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.83 175.8 21.74 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.739 1.188 . . . . 0.0 114.044 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -49.42 77.88 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.089 1.356 . . . . 0.0 109.758 175.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m -56.2 -52.1 65.65 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.931 1.692 . . . . 0.0 113.339 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.82 142.43 13.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.474 1.11 . . . . 0.0 110.649 -170.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.12 138.04 53.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.649 1.58 . . . . 0.0 110.256 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.52 -133.38 4.84 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.343 1.449 . . . . 0.0 110.138 -157.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -162.64 -169.0 1.96 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.146 1.778 . . . . 0.0 109.433 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -136.29 -45.26 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 158.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 6.8 p 55.94 164.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.281 1.432 . . . . 0.0 114.633 -159.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -155.46 -19.23 0.11 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 171.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.44 142.97 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 128.051 2.54 . . . . 0.0 116.062 -161.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.75 177.92 9.1 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.035 -1.666 . . . . 0.0 114.368 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.24 -39.28 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.258 1.823 . . . . 0.0 111.823 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -151.03 -8.06 0.25 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -146.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.39 27.09 15.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.287 1.835 . . . . 0.0 114.01 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.37 -38.31 0.61 Allowed 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 124.417 1.087 . . . . 0.0 111.039 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 95.1 m -64.53 -15.61 61.2 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.251 2.22 . . . . 0.0 112.453 155.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.95 7.21 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 110.8 165.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.35 -47.34 86.31 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 1.7 ptpp? -59.91 -15.75 24.11 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -171.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.5 -43.96 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.48 1.912 . . . . 0.0 111.034 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.7 -43.31 68.86 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.232 1.013 . . . . 0.0 112.753 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.4 mmpt? -40.97 -49.61 3.28 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.813 2.045 . . . . 0.0 112.111 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -94.92 -21.33 18.71 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.77 -37.75 74.23 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.051 0.841 . . . . 0.0 110.077 160.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.84 -39.16 27.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.524 -0.735 . . . . 0.0 110.3 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.4 -23.18 61.06 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.245 -0.909 . . . . 0.0 111.539 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.06 -36.32 79.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.916 1.287 . . . . 0.0 113.374 164.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -69.33 -15.81 63.41 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.792 0.837 . . . . 0.0 112.73 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.35 25.54 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.638 1.59 . . . . 0.0 112.859 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.5 t -112.44 124.2 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 125.386 1.474 . . . . 0.0 112.225 -161.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.3 9.87 7.96 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.271 152.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 35.8 -134.98 0.56 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 128.189 2.804 . . . . 0.0 119.889 151.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -124.19 49.32 1.79 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.84 2.456 . . . . 0.0 106.673 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.481 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 20.7 m95 -42.75 104.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.285 1.834 . . . . 0.0 113.225 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 m -125.37 157.49 36.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 109.668 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -148.18 155.8 41.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.619 1.568 . . . . 0.0 111.335 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -134.73 130.46 36.26 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 126.106 1.762 . . . . 0.0 110.278 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -97.72 -18.16 18.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.461 1.104 . . . . 0.0 113.12 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.59 -27.55 63.21 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.819 1.248 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.7 p -122.7 -2.79 8.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.574 1.549 . . . . 0.0 113.156 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.375 35.8 mttm 59.78 21.29 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.825 1.65 . . . . 0.0 114.321 -175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.4 m -73.69 160.06 32.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.746 2.418 . . . . 0.0 113.362 169.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -134.21 158.19 44.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 130.862 3.665 . . . . 0.0 110.705 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.3 m -146.88 133.73 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.187 0.595 . . . . 0.0 110.991 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.1 96.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 159.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.59 62.29 7.22 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 123.311 1.529 . . . . 0.0 112.612 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -69.19 -20.49 63.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.058 0.943 . . . . 0.0 113.477 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.62 88.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.322 0.963 . . . . 0.0 113.798 166.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.9 t -80.5 -38.55 29.62 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.633 1.173 . . . . 0.0 112.865 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 63.08 1.99 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 123.3 1.524 . . . . 0.0 113.273 175.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -60.16 -15.25 22.37 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.171 2.588 . . . . 0.0 115.193 170.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -47.99 121.39 4.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 111.073 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.31 107.13 2.71 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -156.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -146.83 -178.25 6.08 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.029 1.732 . . . . 0.0 112.328 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -51.31 -21.14 1.99 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -26.11 41.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 172.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -58.73 -47.42 84.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.5 mmp_? -121.58 84.34 2.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.509 1.124 . . . . 0.0 111.869 -164.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -140.38 153.89 46.52 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.069 2.947 . . . . 0.0 112.396 2.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.8 p -152.11 -45.02 0.11 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.777 1.631 . . . . 0.0 111.613 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.1 m -110.43 163.0 18.24 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.142 1.777 . . . . 0.0 109.674 154.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.9 -79.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.162 2.575 . . . . 0.0 114.877 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.32 33.18 0.29 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 120.411 1.46 . . . . 0.0 111.905 -175.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 60.08 -18.44 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.54 1.936 . . . . 0.0 114.471 -153.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 68.7 m -129.34 -80.55 0.56 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.553 1.941 . . . . 0.0 110.52 153.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 116' ' ' GLU . 20.2 tttt 177.09 -143.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 129.022 2.929 . . . . 0.0 107.402 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 115' ' ' VAL . 7.5 p -137.93 146.92 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 123.492 2.86 . . . . 0.0 116.714 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -140.57 156.97 46.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.922 2.089 . . . . 0.0 111.814 -175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -139.75 158.27 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 120.957 -1.09 . . . . 0.0 112.908 -176.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -170.31 -167.42 30.71 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 116.762 1.465 . . . . 0.0 116.762 169.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.24 20.81 7.5 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.588 1.555 . . . . 0.0 115.036 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.55 51.42 1.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 111.716 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.41 -17.76 33.75 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.386 1.946 . . . . 0.0 115.895 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.47 -55.31 10.61 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.57 1.185 . . . . 0.0 111.467 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -131.94 -22.55 2.32 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 8.47 74.15 0.01 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.68 3.038 . . . . 0.0 117.839 -169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -135.27 162.79 31.56 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.415 1.107 . . . . 0.0 113.646 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -60.5 -43.84 96.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.596 1.558 . . . . 0.0 113.158 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 m -86.46 -29.77 22.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -163.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.81 -31.38 64.65 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.316 -1.49 . . . . 0.0 111.727 164.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.93 -22.25 22.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.044 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -61.13 -34.77 75.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.259 1.391 . . . . 0.0 109.359 167.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -80.2 -64.91 1.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.638 1.175 . . . . 0.0 111.206 174.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -4.28 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -123.6 -30.62 3.59 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.487 1.039 . . . . 0.0 112.18 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -52.98 -27.71 30.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.174 1.352 . . . . 0.0 115.189 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -55.03 -38.79 68.41 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.0 -16.97 54.06 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.18 -170.82 33.9 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.105 0.86 . . . . 0.0 114.741 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.27 101.91 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.13 3.22 . . . . 0.0 112.443 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.18 68.23 2.57 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.288 1.835 . . . . 0.0 111.808 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -12.43 1.31 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.076 2.15 . . . . 0.0 114.342 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.3 m -150.44 150.25 31.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.541 1.064 . . . . 0.0 110.819 161.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.7 p -159.14 116.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 110.143 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -146.43 147.11 30.91 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.34 1.856 . . . . 0.0 109.219 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.06 154.33 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.387 -0.821 . . . . 0.0 112.391 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.94 154.77 30.28 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.735 1.614 . . . . 0.0 111.902 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -112.09 25.1 11.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.782 1.233 . . . . 0.0 111.815 163.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 90.93 7.26 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 128.054 2.542 . . . . 0.0 107.513 164.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.32 159.33 85.15 Favored 'Cis proline' 0 CA--C 1.55 1.317 0 CA-C-N 120.244 1.123 . . . . 0.0 113.765 5.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -53.02 6.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.256 2 C-N-CA 127.119 5.213 . . . . 0.0 122.626 -159.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.43 58.78 0.02 OUTLIER Glycine 0 N--CA 1.474 1.18 0 CA-C-N 121.756 2.071 . . . . 0.0 113.539 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 61.2 m-85 -130.09 136.67 49.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.703 1.201 . . . . 0.0 111.213 -171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -132.44 156.59 46.44 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.62 1.2 . . . . 0.0 113.586 -167.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 136.88 54.29 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.444 1.498 . . . . 0.0 108.533 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -139.24 164.97 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.934 0.894 . . . . 0.0 111.373 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.437 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 44.7 mt-10 -144.34 142.33 30.31 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.834 0.854 . . . . 0.0 109.526 170.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -119.2 140.57 49.98 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 156.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.4 29.16 0.3 Allowed 'General case' 0 CA--C 1.553 1.076 0 O-C-N 121.259 -0.9 . . . . 0.0 112.94 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -152.79 137.83 11.15 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 126.083 1.753 . . . . 0.0 111.559 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.73 -51.35 9.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.553 3.502 . . . . 0.0 117.203 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.35 -14.61 22.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -160.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.31 -45.22 66.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.551 0.614 . . . . 0.0 110.536 165.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.74 77.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 111.935 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.19 -37.97 78.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.44 -1.267 . . . . 0.0 110.849 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -74.55 -40.84 61.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.356 1.435 . . . . 0.0 113.172 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.02 -14.33 6.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.588 1.555 . . . . 0.0 114.03 166.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.6 -47.92 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 120.127 1.33 . . . . 0.0 111.699 161.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -53.84 -36.27 62.37 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.868 2.067 . . . . 0.0 112.987 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.19 -11.64 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.024 1.329 . . . . 0.0 112.516 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.09 -27.89 0.63 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -148.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -45.07 101.65 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.055 2.542 . . . . 0.0 112.114 170.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.4 27.01 73.31 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.075 -0.847 . . . . 0.0 114.568 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -97.16 -138.51 0.27 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.611 1.205 . . . . 0.0 111.452 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 138' ' ' CYS . 52.9 m -152.91 143.17 22.47 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.683 2.793 . . . . 0.0 108.346 -174.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.53 -42.32 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 112.377 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 87.1 m -137.23 29.51 2.74 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.493 1.117 . . . . 0.0 112.744 -155.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.27 44.76 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.369 -0.832 . . . . 0.0 112.415 -170.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.421 ' H ' HG23 ' A' ' 134' ' ' THR . 31.6 p -129.4 -174.91 3.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.17 2.188 . . . . 0.0 112.314 -166.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 89.96 2.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.401 1.48 . . . . 0.0 108.346 174.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.7 172.39 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.063 0.945 . . . . 0.0 112.756 -168.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -129.08 141.86 51.08 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.657 1.583 . . . . 0.0 108.932 151.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 t -136.7 134.66 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -130.37 149.24 52.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.186 0.995 . . . . 0.0 109.55 -171.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.93 148.64 49.05 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.004 -1.06 . . . . 0.0 111.14 152.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . 0.294 11.8 t 126.93 101.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.32 2.648 . . . . 0.0 114.734 144.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -149.02 6.48 0.69 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.464 1.505 . . . . 0.0 114.532 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -97.79 13.48 63.78 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.05 1.786 . . . . 0.0 112.104 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 -52.87 2.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 110.471 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.3 3.93 8.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.16 0 C-N-CA 126.592 1.957 . . . . 0.0 113.431 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.492 0.187 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -152.21 169.24 22.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.144 2.578 . . . . 0.0 110.951 -7.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -127.86 105.37 8.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 168.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.95 107.21 8.55 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.716 0.807 . . . . 0.0 112.116 -164.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD11 HG22 ' A' ' 54' ' ' VAL . 42.9 tp -97.63 92.39 5.88 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.625 1.57 . . . . 0.0 109.84 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.25 105.66 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.602 2.361 . . . . 0.0 109.203 162.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.557 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 mp -82.53 132.01 35.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 163.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.5 ' HB3' HG23 ' A' ' 55' ' ' THR . 67.5 m-20 -137.08 44.73 2.28 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.938 2.095 . . . . 0.0 108.183 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 -177.85 51.34 Favored Glycine 0 C--N 1.338 0.685 0 O-C-N 120.439 -1.413 . . . . 0.0 115.451 -161.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -56.23 -48.03 77.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.856 1.662 . . . . 0.0 109.857 160.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 m -78.99 -62.48 1.69 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.449 2.3 . . . . 0.0 113.849 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.87 145.01 34.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.511 1.124 . . . . 0.0 110.409 -166.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 119.98 21.21 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.549 1.94 . . . . 0.0 110.144 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.62 23.1 0.09 OUTLIER Glycine 0 N--CA 1.477 1.407 0 N-CA-C 119.898 2.719 . . . . 0.0 119.898 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER 57.34 -176.46 0.06 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -150.79 -32.49 0.17 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p 59.22 163.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 -173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 30' ' ' PHE . 4.3 t -161.5 -163.51 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.358 2.663 . . . . 0.0 106.994 157.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -140.12 138.7 35.48 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 120.092 -1.63 . . . . 0.0 108.924 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.04 -171.13 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 123.508 1.623 . . . . 0.0 112.887 -165.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.31 -22.69 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 112.474 -2.148 . . . . 0.0 111.343 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -140.28 -57.69 0.54 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 129.89 -30.55 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 131.138 3.775 . . . . 0.0 112.243 -162.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.9 -36.01 25.67 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.723 1.209 . . . . 0.0 110.293 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -76.19 -20.97 57.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.444 3.098 . . . . 0.0 112.447 167.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.47 -52.83 8.44 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.457 -0.777 . . . . 0.0 109.968 170.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.29 -47.05 47.21 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 125.685 1.594 . . . . 0.0 108.596 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -20.29 16.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -170.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.94 -40.37 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.386 1.474 . . . . 0.0 109.629 -171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 18' ' ' THR . 8.1 m-30 -51.51 -46.0 63.1 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.56 1.144 . . . . 0.0 112.922 166.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 2.7 mmpt? -42.0 -46.84 4.28 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.572 1.549 . . . . 0.0 112.277 170.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -100.21 -19.08 16.57 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.29 -39.07 74.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.023 0.829 . . . . 0.0 110.51 156.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 43' ' ' TRP . . . -85.04 -33.28 22.53 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.537 -0.727 . . . . 0.0 110.705 -178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -75.3 -22.12 57.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.0 1.273 . . . . 0.0 112.047 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.2 1.0 . . . . 0.0 112.649 163.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -64.84 -31.47 72.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.71 -0.618 . . . . 0.0 111.94 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.17 5.41 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.337 1.923 . . . . 0.0 113.698 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.03 134.01 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.506 1.922 . . . . 0.0 111.746 -163.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.41 12.24 3.81 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 157.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 2.06 -93.02 0.0 OUTLIER Glycine 0 N--CA 1.473 1.149 0 C-N-CA 130.114 3.721 . . . . 0.0 117.639 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 -6.64 1.32 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.8 1.64 . . . . 0.0 111.988 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.493 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 30.0 m95 23.05 67.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.257 3.423 . . . . 0.0 116.254 -177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.3 m -75.33 153.63 37.74 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.331 1.062 . . . . 0.0 110.858 170.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -145.8 146.08 31.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.334 1.453 . . . . 0.0 110.363 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -134.62 56.14 1.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.296 1.038 . . . . 0.0 112.026 -155.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -40.56 -27.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 130.392 3.477 . . . . 0.0 119.034 -173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.33 -20.54 66.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.583 1.953 . . . . 0.0 112.505 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 p -128.93 -15.95 4.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.125 2.17 . . . . 0.0 113.058 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.344 36.3 mttm 65.47 14.39 9.44 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 129.211 3.004 . . . . 0.0 115.144 -170.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.4 m -53.76 159.07 1.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.951 1.7 . . . . 0.0 112.624 157.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.14 170.01 14.06 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 130.109 3.364 . . . . 0.0 111.07 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.4 m -147.09 153.63 40.18 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.009 -1.057 . . . . 0.0 110.525 159.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -132.49 113.77 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.443 0.64 . . . . 0.0 111.666 153.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 8' ' ' ASN . 2.0 m -106.12 114.8 29.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.697 0.799 . . . . 0.0 110.253 172.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -124.03 -22.32 4.85 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.708 1.203 . . . . 0.0 113.205 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.21 -45.58 0.04 OUTLIER Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.51 -0.744 . . . . 0.0 114.117 -174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 p 55.08 -18.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 128.204 2.601 . . . . 0.0 117.682 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -61.18 130.64 47.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.525 1.93 . . . . 0.0 113.068 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -106.74 55.6 0.66 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.764 3.626 . . . . 0.0 111.007 0.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -136.39 22.25 3.19 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.726 2.01 . . . . 0.0 111.728 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -67.2 -11.34 57.11 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -166.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -131.95 161.22 33.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.536 1.535 . . . . 0.0 111.594 169.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.9 m170 63.59 -51.15 0.24 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 129.155 2.982 . . . . 0.0 115.305 -172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . 0.302 3.1 ppp? 49.21 -14.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 130.188 3.395 . . . . 0.0 119.062 -172.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -116.42 -17.44 10.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.218 1.807 . . . . 0.0 113.447 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.4 tpt85 -140.75 55.32 1.58 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.892 2.077 . . . . 0.0 110.138 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.33 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 1 C-N-CA 132.174 4.19 . . . . 0.0 109.112 1.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -141.21 146.01 36.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 128.858 2.863 . . . . 0.0 108.1 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.18 176.3 0.86 Allowed Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.26 0.624 . . . . 0.0 110.484 156.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -61.86 -133.38 0.03 OUTLIER 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-O 118.111 -0.87 . . . . 0.0 112.759 -29.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 7.9 tt -37.5 -22.06 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 131.069 3.748 . . . . 0.0 117.216 -173.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.6 t0 112.47 -22.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 1 C-N-CA 133.659 4.784 . . . . 0.0 106.573 -155.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 73.9 m -128.71 -119.88 0.24 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 128.415 2.686 . . . . 0.0 107.661 160.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -144.63 179.64 7.16 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 131.256 3.822 . . . . 0.0 104.196 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . 0.282 4.5 p -122.74 146.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 125.071 3.578 . . . . 0.0 112.327 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -134.33 153.35 51.93 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.174 -167.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 11.2 t -135.9 153.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.408 1.083 . . . . 0.0 111.304 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.43 -167.98 26.87 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.272 0.939 . . . . 0.0 115.128 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 t30 70.37 33.07 2.61 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.095 1.758 . . . . 0.0 113.549 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -112.8 160.86 17.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.82 1.248 . . . . 0.0 114.039 -174.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.18 -30.54 0.03 OUTLIER Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.857 1.694 . . . . 0.0 113.653 168.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -50.83 -36.48 37.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.733 2.413 . . . . 0.0 114.675 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.64 -50.66 0.24 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.114 2.166 . . . . 0.0 110.427 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.412 ' H ' HD12 ' A' ' 81' ' ' LEU . . . -10.3 95.45 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.535 2.493 . . . . 0.0 116.316 -163.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -132.68 -29.91 1.48 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -168.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.4 pttp 135.26 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 1 C-N-CA 132.581 4.352 . . . . 0.0 110.578 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 m -69.46 -39.49 77.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.5 0.72 . . . . 0.0 111.525 -167.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -37.07 76.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.186 -0.947 . . . . 0.0 112.466 173.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 61.8 mt -79.96 -31.75 39.92 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.026 0.931 . . . . 0.0 111.856 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -57.93 -34.9 70.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.014 0.825 . . . . 0.0 110.016 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -91.75 -51.97 4.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.725 0.81 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.23 -28.28 66.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.959 0.904 . . . . 0.0 113.411 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -100.74 -25.98 13.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.535 0.734 . . . . 0.0 110.31 175.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.7 -34.14 20.58 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 126.547 2.023 . . . . 0.0 115.231 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -53.26 -37.82 62.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.041 0.921 . . . . 0.0 113.461 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -84.69 -12.01 54.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.009 0.923 . . . . 0.0 111.528 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.87 168.56 14.29 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.792 1.663 . . . . 0.0 113.042 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.68 117.02 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.96 2.44 . . . . 0.0 111.044 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.14 153.1 35.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.331 0.586 . . . . 0.0 110.602 168.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -124.31 1.33 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.737 1.615 . . . . 0.0 113.278 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -161.81 152.97 18.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.6 1.16 . . . . 0.0 109.913 147.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.5 t -153.56 124.12 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.449 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 14.8 p90 -152.0 149.1 28.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.956 0.902 . . . . 0.0 111.363 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -146.58 146.54 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -171.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.18 83.12 0.23 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.029 2.132 . . . . 0.0 111.454 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 25.68 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.586 2.754 . . . . 0.0 114.669 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.12 67.09 26.27 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 127.704 2.401 . . . . 0.0 109.936 -166.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.04 143.1 42.06 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.349 3.366 . . . . 0.0 115.7 -161.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.65 145.98 85.33 Favored 'Cis proline' 0 CA--C 1.548 1.222 0 CA-C-N 118.842 0.622 . . . . 0.0 112.052 -2.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.21 36.56 0.02 OUTLIER Glycine 0 CA--C 1.533 1.159 0 C-N-CA 127.408 2.432 . . . . 0.0 113.423 -2.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -142.96 149.35 38.26 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.494 1.118 . . . . 0.0 112.574 -155.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -129.67 164.37 24.09 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.435 1.894 . . . . 0.0 113.906 169.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.15 149.34 51.9 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.701 -1.59 . . . . 0.0 109.146 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.47 150.41 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 122.346 1.069 . . . . 0.0 111.769 -171.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -143.37 138.88 29.74 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.08 1.352 . . . . 0.0 110.466 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -117.77 -21.54 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.758 2.423 . . . . 0.0 112.78 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.272 8.9 tm-20 39.06 53.07 2.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 -153.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -150.95 137.15 11.08 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.514 1.525 . . . . 0.0 109.864 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.47 -45.06 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.913 1.742 . . . . 0.0 113.299 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.11 -54.61 10.48 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.898 1.279 . . . . 0.0 112.816 -165.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.86 -21.49 54.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.39 1.076 . . . . 0.0 113.406 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.55 -45.21 54.83 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.943 0.792 . . . . 0.0 112.387 169.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.2 -33.98 74.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -45.46 72.74 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.65 -0.656 . . . . 0.0 112.054 173.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -6.82 3.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.184 1.394 . . . . 0.0 114.4 168.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.3 t -87.92 -54.47 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.138 -0.977 . . . . 0.0 111.594 153.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.96 -33.86 67.47 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.254 1.388 . . . . 0.0 114.23 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.55 1.73 23.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.051 1.741 . . . . 0.0 111.803 -163.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.45 -19.94 0.48 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.962 1.705 . . . . 0.0 113.594 -162.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -76.91 146.27 37.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.984 1.313 . . . . 0.0 113.236 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 57.01 37.8 81.51 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.183 0.897 . . . . 0.0 112.844 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.48 158.96 34.73 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.166 1.787 . . . . 0.0 111.702 -165.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.1 m -88.11 56.68 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 111.642 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.25 -28.86 65.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 -160.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 70.1 m -142.48 22.5 2.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.047 1.339 . . . . 0.0 113.847 -162.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.04 11.32 70.03 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 120.341 -1.474 . . . . 0.0 113.217 -166.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 19.1 p -122.97 165.34 16.9 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.041 2.536 . . . . 0.0 107.806 164.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -89.36 102.0 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 163.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.77 163.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.981 1.313 . . . . 0.0 111.962 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -124.09 135.06 53.28 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.343 1.457 . . . . 0.0 107.357 162.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -136.42 138.41 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.075 0.95 . . . . 0.0 108.585 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -139.82 172.11 13.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.002 0.921 . . . . 0.0 111.397 -166.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 165.7 24.16 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.713 -0.617 . . . . 0.0 112.353 156.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -130.32 -73.87 0.55 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -167.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -148.7 -78.38 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.808 1.185 . . . . 0.0 112.941 -170.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.07 120.23 0.03 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.876 2.655 . . . . 0.0 113.408 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -62.91 -7.04 4.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.82 -4.42 57.62 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.071 1.748 . . . . 0.0 115.288 173.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . 0.303 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 130.346 3.458 . . . . 0.0 118.471 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 tpp . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.494 0.188 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -156.59 170.18 22.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.862 2.865 . . . . 0.0 110.355 -11.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -132.7 124.6 28.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 136.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 34.2 ttmt -125.02 152.94 43.59 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 125.218 1.407 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.9 tp -129.21 100.77 5.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.806 2.843 . . . . 0.0 108.503 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.36 118.46 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 127.423 2.289 . . . . 0.0 109.054 158.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 2.3 mp -94.27 137.14 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -147.51 42.96 1.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.768 2.027 . . . . 0.0 109.282 173.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.01 -172.81 25.37 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 120.721 -1.237 . . . . 0.0 115.586 -168.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -60.13 -45.13 94.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.041 0.924 . . . . 0.0 111.393 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -68.59 -60.49 2.38 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.833 2.053 . . . . 0.0 112.193 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -149.07 144.19 26.52 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.174 0.99 . . . . 0.0 110.355 -166.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -129.72 122.27 28.58 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.213 1.805 . . . . 0.0 108.649 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.07 23.92 0.12 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 119.006 2.363 . . . . 0.0 119.006 -174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.629 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER 59.65 -175.22 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.098 2.259 . . . . 0.0 117.098 175.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -145.22 -40.72 0.24 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 162.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 15.0 p 60.75 151.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 126.035 1.734 . . . . 0.0 115.405 -165.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.2 126.15 0.66 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.026 1.73 . . . . 0.0 106.747 163.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.69 148.65 33.03 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 121.848 -0.533 . . . . 0.0 110.692 -178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.82 176.35 11.14 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.07 -1.019 . . . . 0.0 112.814 -162.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.79 -54.75 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.134 1.774 . . . . 0.0 111.428 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -165.18 174.53 10.19 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.045 1.738 . . . . 0.0 109.966 -158.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.73 -39.93 1.59 Allowed 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.772 1.169 . . . . 0.0 110.699 -173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 m -71.32 -23.13 61.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.755 1.622 . . . . 0.0 112.129 164.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.36 -50.79 14.82 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 109.802 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -47.68 61.32 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 124.771 1.228 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -23.17 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -169.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.02 -36.97 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.22 1.408 . . . . 0.0 109.609 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -53.41 -45.52 69.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.444 1.098 . . . . 0.0 112.75 164.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.52 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.1 mmpt? -44.75 -53.97 6.8 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 111.224 168.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -72.21 -36.43 69.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.38 -41.58 94.07 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.655 1.116 . . . . 0.0 111.309 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -75.55 -38.38 59.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.0 -29.5 69.89 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.17 0.895 . . . . 0.0 112.235 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.08 -38.28 85.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.372 1.469 . . . . 0.0 113.009 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -67.33 -12.96 61.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.667 0.787 . . . . 0.0 112.511 165.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.25 10.0 52.32 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.04 1.781 . . . . 0.0 112.756 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 57.7 t -100.08 128.04 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 125.93 1.692 . . . . 0.0 112.362 -161.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 68.18 1.31 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 125.074 2.369 . . . . 0.0 110.569 156.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.5 -153.14 0.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 109.696 -3.411 . . . . 0.0 115.15 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.99 52.66 0.72 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.768 2.827 . . . . 0.0 109.824 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.52 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 21.9 m95 -43.74 100.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.247 2.619 . . . . 0.0 112.916 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.3 m -125.95 162.2 25.76 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.38 1.872 . . . . 0.0 110.125 -172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -147.23 155.88 42.47 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.627 1.571 . . . . 0.0 111.536 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.42 129.76 35.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.715 2.006 . . . . 0.0 109.275 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.61 -18.11 23.5 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.13 61.64 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.079 0.951 . . . . 0.0 111.824 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -122.93 -2.15 8.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.242 1.817 . . . . 0.0 112.601 166.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.317 49.8 mttm 58.86 24.8 12.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.596 1.558 . . . . 0.0 113.372 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.2 m -79.22 157.22 27.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.523 2.329 . . . . 0.0 112.36 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.71 159.52 32.07 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.596 2.758 . . . . 0.0 109.658 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -145.15 132.79 20.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.09 -0.381 . . . . 0.0 111.274 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 43' ' ' TRP . 3.1 m -112.87 100.52 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.983 0.897 . . . . 0.0 112.014 156.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 115.04 18.89 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 155.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.21 45.57 2.16 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 124.025 1.869 . . . . 0.0 109.335 170.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 176.84 59.75 0.06 OUTLIER Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.534 2.969 . . . . 0.0 108.168 -172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 m -23.04 89.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.994 3.318 . . . . 0.0 116.267 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t60 57.56 22.35 8.07 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.892 1.677 . . . . 0.0 115.361 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -137.66 156.27 48.22 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.656 -1.278 . . . . 0.0 114.064 -172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -96.93 49.12 1.07 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.22 2.608 . . . . 0.0 111.164 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -37.11 134.77 0.53 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.86 2.064 . . . . 0.0 115.509 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.06 -43.46 3.39 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.001 1.72 . . . . 0.0 113.253 -174.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -59.05 132.65 54.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -164.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.7 mtm 51.74 33.83 11.85 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.614 2.366 . . . . 0.0 113.925 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -158.97 -49.36 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -141.54 29.61 1.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.766 2.026 . . . . 0.0 111.6 -170.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.11 11.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 129.26 3.024 . . . . 0.0 117.689 -167.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.4 p -58.47 125.92 25.38 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.278 -1.514 . . . . 0.0 111.8 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.3 p -54.68 113.09 4.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 123.326 0.65 . . . . 0.0 111.568 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' HA3' ' A' ' 147' ' ' GLY . 4.3 Cg_endo -103.37 -10.67 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 121.687 1.591 . . . . 0.0 114.883 -158.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tt 60.68 -49.74 0.1 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.514 1.926 . . . . 0.0 114.581 -158.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.61 -26.38 21.66 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -148.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . 0.304 5.0 t -79.93 14.58 1.74 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 175.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' H ' ' H ' ' A' ' 146' ' ' ASN . 0.1 OUTLIER -166.25 149.68 7.39 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 117.202 -1.799 . . . . 0.0 112.005 117.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 115' ' ' VAL . 12.1 p -132.44 155.82 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 108.849 170.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -137.34 152.27 49.52 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.854 -1.154 . . . . 0.0 112.126 -162.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 113' ' ' ALA . 2.5 t -138.98 149.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 110.207 -177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.62 38.11 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.531 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 3.2 t30 81.86 5.6 1.18 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.1 2.56 . . . . 0.0 113.918 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 61.51 5.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.389 1.476 . . . . 0.0 112.83 -167.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -27.23 63.95 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 114.649 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.707 1.203 . . . . 0.0 114.234 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -136.16 -61.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.608 1.163 . . . . 0.0 111.076 -167.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.96 54.38 4.41 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.513 2.006 . . . . 0.0 114.556 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.09 -40.88 2.12 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -173.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 pttp 138.48 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.154 1 C-N-CA 132.461 4.305 . . . . 0.0 111.586 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.3 m -82.46 -26.12 32.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.13 0.877 . . . . 0.0 112.293 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -53.65 -35.14 60.68 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.78 -1.2 . . . . 0.0 112.321 159.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.71 -29.62 17.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.682 1.193 . . . . 0.0 113.129 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -60.08 -32.21 70.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.671 1.123 . . . . 0.0 109.301 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -85.23 -54.67 4.46 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.481 1.112 . . . . 0.0 112.51 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.22 -21.22 59.17 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.09 -29.47 8.53 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.013 0.925 . . . . 0.0 111.499 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -51.66 -36.47 40.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.632 1.111 . . . . 0.0 114.196 167.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -57.0 -36.02 69.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -77.51 -24.39 50.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.02 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.68 -169.54 34.54 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.108 1.203 . . . . 0.0 116.108 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.69 106.54 2.13 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.881 3.054 . . . . 0.0 111.927 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.92 143.2 52.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.228 1.011 . . . . 0.0 111.22 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.1 ttp-105 -94.33 -35.19 12.51 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.172 1.389 . . . . 0.0 111.705 163.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 m -172.4 160.44 4.9 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.767 1.167 . . . . 0.0 111.011 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 50.8 t -151.31 134.11 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 107.846 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -146.06 148.45 32.67 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.297 1.839 . . . . 0.0 109.982 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.14 145.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 112.876 173.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 108' ' ' ASN . . . -80.48 -37.58 31.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.75 1.22 . . . . 0.0 114.044 -173.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 50.58 -1.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.074 2.549 . . . . 0.0 116.659 -165.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -140.52 99.52 7.0 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 127.673 2.389 . . . . 0.0 108.133 166.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.35 159.05 70.26 Favored 'Cis proline' 0 CA--C 1.549 1.252 0 CA-C-N 120.372 1.168 . . . . 0.0 114.47 9.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -53.44 6.59 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 1 C-N-CA 126.969 5.112 . . . . 0.0 121.865 -157.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.74 54.32 0.03 OUTLIER Glycine 0 N--CA 1.47 0.908 0 CA-C-N 122.162 2.256 . . . . 0.0 113.746 -172.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.52 135.67 48.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 0.0 111.063 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.465 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . . . -137.12 162.6 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.515 1.926 . . . . 0.0 113.707 -168.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.74 156.23 47.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.504 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -158.53 160.29 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.163 . . . . 0.0 110.488 -162.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -142.56 154.34 44.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.66 1.584 . . . . 0.0 110.764 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -132.64 151.55 51.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.972 2.109 . . . . 0.0 111.681 -173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -84.62 -2.23 57.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.811 -1.18 . . . . 0.0 113.821 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.88 129.03 23.78 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.486 1.114 . . . . 0.0 111.608 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.23 -27.85 13.2 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.381 2.721 . . . . 0.0 114.043 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.98 -34.0 12.53 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.252 1.021 . . . . 0.0 110.875 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -68.93 -29.5 67.76 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.609 1.095 . . . . 0.0 112.895 164.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.44 -45.28 91.61 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.84 1.2 . . . . 0.0 111.802 165.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.92 89.12 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 110.614 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.33 -42.98 61.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.87 -12.31 7.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.552 1.141 . . . . 0.0 113.536 168.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 87.6 t -89.89 -52.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 119.408 1.004 . . . . 0.0 112.312 159.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -59.31 -25.5 64.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.327 1.851 . . . . 0.0 113.156 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.54 -7.37 34.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 112.162 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.59 -15.82 0.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 -153.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.515 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -48.11 -23.74 0.92 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 127.314 2.246 . . . . 0.0 115.645 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -161.4 40.14 0.41 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.684 1.135 . . . . 0.0 114.199 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . 0.25 34.5 ttp180 -113.42 -123.37 0.29 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.353 1.077 . . . . 0.0 112.283 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.5 m -161.07 142.39 11.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.372 1.869 . . . . 0.0 107.621 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 10.9 tp -138.38 -36.93 0.57 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -163.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.8 m -140.47 21.42 2.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.158 1.383 . . . . 0.0 113.216 -171.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.89 47.47 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 121.499 -0.751 . . . . 0.0 113.397 -169.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 11.9 t -137.15 152.61 50.15 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.763 1.225 . . . . 0.0 108.327 157.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HE ' ' ND2' ' A' ' 80' ' ' ASN . 6.5 tmm_? -35.5 134.67 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.477 1.511 . . . . 0.0 109.902 150.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.18 157.7 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.195 0.598 . . . . 0.0 110.259 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -128.21 159.37 35.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.104 159.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 131' ' ' ASP . 1.1 t -149.24 148.59 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 124.975 1.31 . . . . 0.0 108.493 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -138.53 175.8 9.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.122 1.369 . . . . 0.0 110.815 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.62 150.04 35.63 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -157.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t 92.22 123.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 130.333 3.453 . . . . 0.0 116.031 151.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.483 ' H ' ' H ' ' A' ' 75' ' ' LYS . 15.6 t-20 -134.6 -59.93 0.8 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.674 134.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.408 ' HA3' ' CG ' ' A' ' 71' ' ' PRO . . . 78.87 -4.38 61.53 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 118.95 2.34 . . . . 0.0 118.95 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -138.38 157.16 46.77 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.378 2.089 . . . . 0.0 113.224 -171.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -95.88 131.1 42.56 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.24 2.616 . . . . 0.0 111.72 0.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 125.776 1.63 . . . . 0.0 111.513 164.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -143.46 162.29 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.177 2.591 . . . . 0.0 110.678 -3.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.35 111.33 12.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -138.21 99.69 3.93 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.765 0.826 . . . . 0.0 112.096 -163.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 34' ' ' ALA . 14.4 tp -87.54 90.76 8.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 119.021 0.828 . . . . 0.0 109.486 173.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.8 mt -53.8 120.39 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 126.431 1.892 . . . . 0.0 109.056 159.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.41 128.77 38.38 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.012 168.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -144.1 59.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 111.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.15 152.13 18.01 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.136 0.874 . . . . 0.0 113.366 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -52.24 -29.84 24.77 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.811 1.244 . . . . 0.0 110.11 156.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 m -59.43 -55.39 35.21 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.981 2.513 . . . . 0.0 113.596 167.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.4 tm? -167.35 141.5 3.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.258 1.823 . . . . 0.0 110.123 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' N ' HD13 ' A' ' 12' ' ' LEU . 6.0 mtpm? -132.59 140.79 48.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.087 1.355 . . . . 0.0 111.922 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 147.7 -136.07 5.87 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 125.702 1.62 . . . . 0.0 110.586 -163.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -161.57 -169.66 2.34 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.352 2.261 . . . . 0.0 109.076 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -138.33 -43.32 0.5 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 160.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 p 62.06 164.26 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.428 2.011 . . . . 0.0 116.428 -168.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -161.68 -167.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.64 2.776 . . . . 0.0 105.864 156.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -134.97 140.13 45.45 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.147 -1.595 . . . . 0.0 108.948 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.79 10.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.161 0.981 . . . . 0.0 112.329 -162.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.2 t -61.48 -49.19 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.474 1.109 . . . . 0.0 110.191 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -164.04 178.99 7.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 123.507 1.623 . . . . 0.0 111.611 -160.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.66 16.85 0.24 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.844 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.9 p -61.28 -25.46 67.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.252 1.821 . . . . 0.0 115.885 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.13 -46.87 12.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.112 0.415 . . . . 0.0 111.221 169.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.37 -47.5 85.2 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -58.89 -22.43 59.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.62 -47.21 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.045 1.738 . . . . 0.0 110.946 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -52.26 -43.1 64.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.61 1.164 . . . . 0.0 113.136 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 43' ' ' TRP . 5.6 mmmm -46.81 -50.58 18.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.967 2.107 . . . . 0.0 111.409 171.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.84 -38.83 70.06 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -62.69 -36.68 83.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.108 0.867 . . . . 0.0 111.786 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HB2' HD21 ' A' ' 5' ' ' LEU . . . -82.54 -26.54 32.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.35 -0.844 . . . . 0.0 111.95 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.3 -37.95 81.15 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.051 0.841 . . . . 0.0 111.744 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.44 -40.01 89.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.374 1.47 . . . . 0.0 112.396 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -66.74 -38.44 86.65 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.001 -0.437 . . . . 0.0 111.635 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.07 22.03 9.09 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 126.173 1.844 . . . . 0.0 113.88 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.31 -65.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.645 1.212 . . . . 0.0 113.021 -163.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . 0.265 23.0 m-20 22.79 64.76 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 130.816 3.646 . . . . 0.0 113.816 -168.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.8 -134.94 6.55 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 108.872 -3.785 . . . . 0.0 113.106 -165.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -73.43 59.08 0.58 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.353 1.461 . . . . 0.0 109.46 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.445 ' CZ2' ' HA ' ' A' ' 31' ' ' LYS . 5.7 m95 -50.84 100.2 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.933 1.693 . . . . 0.0 112.617 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.459 HG21 ' CG ' ' A' ' 62' ' ' HIS . 11.2 m -136.86 162.86 32.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.542 1.137 . . . . 0.0 111.557 -170.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' PHE . 55.8 t80 -143.75 153.06 42.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.139 1.776 . . . . 0.0 110.867 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -135.46 77.79 1.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.367 1.467 . . . . 0.0 112.27 -168.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -22.86 23.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -20.5 64.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.5 1.92 . . . . 0.0 112.697 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.2 p -130.58 -4.91 4.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.824 1.25 . . . . 0.0 113.147 167.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.374 36.2 mttm 57.28 18.09 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.462 3.105 . . . . 0.0 114.748 -167.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 m -60.85 157.91 14.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.328 1.851 . . . . 0.0 111.538 165.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 37.7 m-85 -122.91 167.81 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.863 2.465 . . . . 0.0 110.942 166.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -149.73 146.17 27.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.598 -1.314 . . . . 0.0 110.665 167.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.86 88.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.232 1.013 . . . . 0.0 112.678 161.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 58.11 4.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.949 1.3 . . . . 0.0 113.34 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -29.37 59.5 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.785 -1.197 . . . . 0.0 113.204 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.2 -4.7 71.11 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.567 1.556 . . . . 0.0 115.109 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.9 p 51.83 -172.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.966 1.706 . . . . 0.0 113.623 -164.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.5 m80 56.9 19.54 4.61 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.97 54.0 1.22 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 128.47 2.708 . . . . 0.0 107.538 161.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.15 160.12 31.7 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.058 1.343 . . . . 0.0 113.835 -165.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.459 ' CG ' HG21 ' A' ' 44' ' ' THR . 32.3 p-80 -49.9 157.46 0.61 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.377 2.271 . . . . 0.0 114.865 169.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 t60 42.92 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.508 2.323 . . . . 0.0 114.889 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -64.76 170.16 4.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.477 1.511 . . . . 0.0 112.888 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.461 ' HG2' ' HB1' ' A' ' 124' ' ' ALA . 10.9 tpt -77.36 65.32 2.9 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.455 1.102 . . . . 0.0 112.011 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -60.99 -9.82 4.89 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -167.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -153.79 153.89 32.99 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.981 1.264 . . . . 0.0 113.79 -169.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -154.61 -49.36 0.09 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 129.715 3.206 . . . . 0.0 112.743 -21.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.6 m -104.12 -12.83 16.51 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -158.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.3 p -155.21 152.34 24.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.988 1.715 . . . . 0.0 110.133 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.38 -61.71 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.875 1.717 . . . . 0.0 111.65 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -171.6 -57.4 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.887 1.675 . . . . 0.0 108.001 -171.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -143.28 -108.54 0.12 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.934 2.094 . . . . 0.0 108.651 168.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 18.7 p -141.65 -6.45 1.01 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.14 -175.92 5.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.193 1.397 . . . . 0.0 111.351 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG21 HG22 ' A' ' 115' ' ' VAL . 66.5 t -117.42 138.6 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.846 1.657 . . . . 0.0 112.768 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -126.33 140.69 52.32 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.269 1.828 . . . . 0.0 108.632 158.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.94 135.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.273 1.029 . . . . 0.0 108.915 175.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.27 -147.39 5.19 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.702 -0.623 . . . . 0.0 114.193 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 65.79 -6.12 0.45 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.918 1.687 . . . . 0.0 113.701 -152.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.1 mt -80.67 55.27 2.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.907 1.683 . . . . 0.0 112.264 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.37 42.15 0.4 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 127.788 2.613 . . . . 0.0 114.558 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -157.21 -50.3 0.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.11 2.564 . . . . 0.0 110.482 -167.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.09 -112.63 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.644 2.378 . . . . 0.0 108.182 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.75 7.21 69.08 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 126.486 1.993 . . . . 0.0 116.543 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.25 161.27 5.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.036 2.534 . . . . 0.0 113.639 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -34.82 52.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -71.46 -46.35 60.18 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.101 0.96 . . . . 0.0 112.939 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -33.05 75.03 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.886 -1.134 . . . . 0.0 111.406 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.8 mt -83.54 -36.08 24.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.114 0.965 . . . . 0.0 112.663 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -44.57 -42.87 7.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.456 1.103 . . . . 0.0 110.092 165.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -105.48 -39.57 6.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 118.32 -0.848 . . . . 0.0 112.645 -162.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.4 70.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.809 0.731 . . . . 0.0 112.092 168.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -95.12 -30.8 13.85 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -46.22 -35.44 6.72 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.996 1.284 . . . . 0.0 114.432 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -58.18 -37.15 74.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -81.27 -20.98 39.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.887 0.475 . . . . 0.0 111.641 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.25 -173.49 33.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.65 0.643 . . . . 0.0 114.124 -173.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.02 156.46 56.0 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.306 2.671 . . . . 0.0 112.457 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.51 143.49 50.86 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.089 2.556 . . . . 0.0 108.206 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -95.1 -32.75 12.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.905 1.282 . . . . 0.0 112.247 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.6 t -166.33 169.28 14.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.992 0.917 . . . . 0.0 111.954 172.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 t -159.89 127.0 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 129.279 3.032 . . . . 0.0 107.311 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -156.86 144.71 19.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.613 1.165 . . . . 0.0 111.943 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.14 139.86 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 120.682 -1.261 . . . . 0.0 113.004 -166.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.59 118.64 20.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.423 1.489 . . . . 0.0 109.569 167.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 2.67 29.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.76 151.58 92.23 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.2 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.31 143.6 75.46 Favored 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.373 2.715 . . . . 0.0 114.627 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.77 -44.78 0.35 Allowed 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.232 0.761 . . . . 0.0 112.37 -18.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.69 140.64 7.9 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.292 1.901 . . . . 0.0 112.937 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -155.82 158.48 38.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.575 1.95 . . . . 0.0 109.139 -166.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -123.72 156.78 35.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.379 1.472 . . . . 0.0 113.497 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -131.83 148.05 52.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.872 165.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 76' ' ' VAL 0.252 0.7 OUTLIER -143.64 -179.47 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.033 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -141.42 106.72 5.01 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 107.731 166.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.94 169.36 0.53 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 165.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -128.08 25.48 5.88 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 122.051 0.929 . . . . 0.0 113.244 167.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -144.93 132.23 10.25 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.616 -1.303 . . . . 0.0 110.295 160.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.8 -34.01 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.638 2.226 . . . . 0.0 114.639 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.07 -31.77 20.31 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.061 1.3 . . . . 0.0 112.289 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -73.52 -24.04 60.09 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 167.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.52 -51.04 62.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.533 1.06 . . . . 0.0 111.875 163.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 65' ' ' MET . . . -55.81 -32.11 63.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.607 -1.308 . . . . 0.0 110.998 173.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -43.25 55.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.77 -10.65 9.43 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 113.618 169.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.78 -62.23 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.272 -0.893 . . . . 0.0 110.732 153.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -49.48 -33.63 14.86 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.672 1.989 . . . . 0.0 114.309 -171.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.7 -13.52 16.45 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 112.193 -164.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.63 -33.09 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.545 1.138 . . . . 0.0 114.025 -161.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -56.75 139.34 51.05 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.901 1.28 . . . . 0.0 113.125 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.76 4.62 54.45 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.523 1.058 . . . . 0.0 114.898 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -117.38 -109.72 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.292 1.437 . . . . 0.0 110.703 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 m -143.92 153.61 42.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.569 1.547 . . . . 0.0 109.573 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.69 -44.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.029 0.932 . . . . 0.0 112.956 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.5 t -149.66 68.09 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.551 1.54 . . . . 0.0 110.713 -170.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.63 93.34 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.432 1.015 . . . . 0.0 114.651 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.0 p -145.59 -174.57 4.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 113.05 -159.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.7 136.77 51.89 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 153.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.82 163.03 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.227 1.411 . . . . 0.0 112.104 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -135.46 138.01 42.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.947 2.099 . . . . 0.0 108.659 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -139.11 137.05 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.463 0.705 . . . . 0.0 111.121 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -141.2 105.75 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.711 -1.243 . . . . 0.0 109.302 164.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tt -141.77 116.01 9.45 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.961 0.886 . . . . 0.0 110.926 -147.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.7 177.03 9.86 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.603 2.361 . . . . 0.0 113.407 -173.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -153.41 104.95 2.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.349 2.66 . . . . 0.0 107.54 171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.57 38.61 0.32 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.284 0.468 . . . . 0.0 112.53 -167.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.88 1.74 0.25 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.771 1.629 . . . . 0.0 115.214 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . 0.256 8.2 tptp -130.86 50.04 2.26 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.164 1.386 . . . . 0.0 112.878 165.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 O-C-N 121.234 -0.916 . . . . 0.0 111.109 130.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -151.06 164.19 37.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 129.021 2.929 . . . . 0.0 110.886 -4.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -120.83 112.05 18.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 166.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -128.32 108.14 10.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.451 1.1 . . . . 0.0 111.906 -168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 54' ' ' VAL . 47.4 tp -95.23 98.77 10.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.073 1.349 . . . . 0.0 109.371 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.81 115.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 127.167 2.187 . . . . 0.0 108.888 163.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.405 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 3.8 mp -89.17 136.06 33.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.959 168.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -142.64 51.03 1.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.662 1.185 . . . . 0.0 108.501 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.85 176.36 25.97 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 122.504 1.058 . . . . 0.0 114.4 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -60.28 -40.95 92.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.065 1.346 . . . . 0.0 111.494 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -71.12 -48.63 51.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.639 2.376 . . . . 0.0 113.533 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.42 139.73 14.58 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.273 1.029 . . . . 0.0 110.482 -169.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -126.45 132.31 51.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.923 1.689 . . . . 0.0 109.79 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.39 -137.78 5.76 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.404 1.478 . . . . 0.0 110.334 -153.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HA ' ' H ' ' A' ' 7' ' ' LEU . 11.8 mt-10 -159.46 -161.22 0.9 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.897 1.679 . . . . 0.0 109.467 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -143.88 -42.34 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 156.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.6 p 55.97 164.41 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -158.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -160.31 -164.36 1.25 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.76 2.424 . . . . 0.0 106.364 156.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -140.35 130.62 25.13 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.697 1.599 . . . . 0.0 107.778 173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.48 23.25 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -157.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 21' ' ' VAL . 1.8 t -64.71 -42.14 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.128 1.771 . . . . 0.0 111.825 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -144.31 -58.86 0.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -161.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 134.49 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 131.679 3.991 . . . . 0.0 111.659 -162.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -36.95 10.9 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.592 1.157 . . . . 0.0 109.749 -170.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.8 m -74.88 -17.22 60.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 129.04 2.936 . . . . 0.0 112.457 164.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.7 -54.6 5.71 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.717 170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.07 -46.07 44.0 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 125.25 1.42 . . . . 0.0 109.087 170.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -20.94 13.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -171.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.56 -38.81 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.473 1.509 . . . . 0.0 109.788 -169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -50.38 -46.72 56.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.019 1.328 . . . . 0.0 112.326 163.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.4 mmpt? -43.8 -55.46 4.46 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.949 1.699 . . . . 0.0 112.024 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.07 -35.21 64.22 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -60.74 -39.94 90.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.445 1.02 . . . . 0.0 111.302 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 -32.4 38.01 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.181 -0.949 . . . . 0.0 111.168 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.22 -26.29 61.97 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.872 0.76 . . . . 0.0 112.554 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.7 -39.26 77.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.87 1.268 . . . . 0.0 112.758 166.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -67.18 -50.58 60.53 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.197 0.599 . . . . 0.0 111.576 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.8 33.14 0.39 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.269 1.414 . . . . 0.0 113.844 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.77 134.2 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.785 1.234 . . . . 0.0 112.001 -168.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.72 -4.28 5.25 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.54 158.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.45 -127.17 4.61 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.317 1.913 . . . . 0.0 116.365 161.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.89 -14.56 39.04 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 112.118 171.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.525 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 26.0 m95 8.32 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.271 1.829 . . . . 0.0 114.694 -130.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.8 m -73.17 151.09 41.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.629 1.204 . . . . 0.0 110.141 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -154.19 142.52 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 109.961 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -104.76 -37.6 6.99 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -161.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 t70 56.61 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.447 3.099 . . . . 0.0 117.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.64 -28.5 69.42 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.434 1.893 . . . . 0.0 111.965 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.2 p -125.08 5.03 7.9 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.158 1.783 . . . . 0.0 113.274 166.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt 57.55 -5.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 128.177 2.591 . . . . 0.0 116.81 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -39.57 150.45 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.055 2.542 . . . . 0.0 114.473 156.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -131.99 162.9 29.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 131.252 3.821 . . . . 0.0 110.645 174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.0 m -148.79 141.3 24.33 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.034 -1.041 . . . . 0.0 111.185 167.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 HD11 ' A' ' 5' ' ' LEU . 1.1 m -131.45 111.46 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.54 171.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 m -119.94 96.5 5.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.565 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.71 14.6 5.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.914 1.286 . . . . 0.0 113.972 172.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.36 38.06 0.57 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.479 1.99 . . . . 0.0 114.065 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 m -65.06 2.16 0.82 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.71 3.204 . . . . 0.0 115.579 -170.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -59.76 -22.73 62.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.328 1.051 . . . . 0.0 113.419 170.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 52.63 -10.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 168.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -140.84 7.13 2.05 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.909 1.684 . . . . 0.0 113.364 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.11 153.97 40.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.241 1.016 . . . . 0.0 112.905 174.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -82.56 46.68 1.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.858 1.663 . . . . 0.0 114.799 -166.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -69.56 33.91 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 O-C-N 120.688 -1.257 . . . . 0.0 114.235 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 tpp -77.81 53.43 1.14 Allowed 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.202 -2.186 . . . . 0.0 109.61 160.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -132.12 6.41 4.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.677 1.591 . . . . 0.0 113.311 -167.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.77 139.07 22.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.216 1.006 . . . . 0.0 111.591 168.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -90.72 -79.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.113 2.165 . . . . 0.0 113.201 -2.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.6 p -146.5 -59.66 0.3 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 65.7 m 57.06 -171.62 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 124.89 1.276 . . . . 0.0 112.447 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -130.0 -99.39 0.0 OUTLIER 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 122.089 1.782 . . . . 0.0 112.619 -6.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -128.72 -45.29 1.31 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.755 2.022 . . . . 0.0 109.557 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -149.78 -71.76 0.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 150.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 5.8 t -159.22 -18.12 0.07 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -157.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.34 -179.18 7.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.845 2.058 . . . . 0.0 110.573 -172.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.76 143.87 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 120.877 1.672 . . . . 0.0 107.34 156.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.39 146.29 25.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.409 1.083 . . . . 0.0 110.941 -168.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 113' ' ' ALA . 18.3 m -141.14 157.41 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.222 158.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.75 -165.16 14.86 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 114.836 0.694 . . . . 0.0 114.836 170.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER 76.01 -5.47 2.17 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 127.205 2.202 . . . . 0.0 113.262 -172.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' CD1' HD21 ' A' ' 84' ' ' ASN . 0.2 OUTLIER -94.63 46.24 1.14 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.639 1.576 . . . . 0.0 113.316 -150.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.36 -29.7 75.32 Favored Glycine 0 CA--C 1.537 1.466 0 N-CA-C 118.418 2.127 . . . . 0.0 118.418 -160.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -70.87 -35.01 72.18 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.239 2.019 . . . . 0.0 113.682 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.431 HD21 ' CD1' ' A' ' 81' ' ' LEU . 1.6 p-10 -129.35 -16.69 3.89 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.95 108.17 0.15 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -157.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -138.66 169.04 18.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.833 2.053 . . . . 0.0 111.003 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -66.87 -47.91 70.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.2 m -76.14 -30.93 58.35 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -160.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -58.76 -34.71 71.73 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.034 -1.041 . . . . 0.0 112.411 169.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.46 -35.14 40.79 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 111.778 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 100' ' ' LEU . 49.7 mt-10 -58.07 -29.46 65.44 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.442 0.697 . . . . 0.0 111.595 171.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -87.47 -48.94 7.54 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.01 -23.6 54.82 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -117.54 -19.04 9.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 113.25 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.28 -38.16 18.99 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.644 1.116 . . . . 0.0 114.048 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -55.94 -36.95 68.35 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.84 1.42 55.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.186 1.394 . . . . 0.0 112.29 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.34 166.77 12.32 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.773 1.178 . . . . 0.0 114.779 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.87 116.15 4.61 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.334 2.689 . . . . 0.0 111.505 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 91' ' ' GLU . 10.5 mp -63.83 138.58 58.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.466 0.651 . . . . 0.0 110.528 176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -14.31 7.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.136 2.174 . . . . 0.0 112.665 -167.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -151.92 150.04 29.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.265 1.826 . . . . 0.0 108.539 159.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 100' ' ' LEU . 91.5 t -155.58 128.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.27 1.028 . . . . 0.0 110.987 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -150.21 148.25 28.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.12 2.168 . . . . 0.0 110.19 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -147.69 155.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.156 -0.965 . . . . 0.0 112.296 168.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -130.41 161.5 31.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.74 1.616 . . . . 0.0 112.718 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -111.38 12.34 21.56 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.033 1.333 . . . . 0.0 113.279 169.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -142.03 104.74 5.68 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.683 1.593 . . . . 0.0 108.568 157.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.74 153.05 16.41 Favored 'Cis proline' 0 CA--C 1.546 1.119 0 CA-C-N 120.792 1.318 . . . . 0.0 115.336 -1.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.55 84.32 0.99 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.469 3.446 . . . . 0.0 113.947 -166.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.07 53.73 1.85 Allowed Glycine 0 N--CA 1.466 0.685 0 C-N-CA 123.885 0.755 . . . . 0.0 112.585 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -124.99 129.43 50.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.97 1.308 . . . . 0.0 109.025 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -123.32 160.85 25.84 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.41 1.484 . . . . 0.0 112.228 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -141.34 148.89 40.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.387 164.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.99 171.95 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 -165.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.97 141.95 36.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.442 1.497 . . . . 0.0 109.311 163.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -151.76 157.39 41.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.202 1.401 . . . . 0.0 110.701 150.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -104.77 47.4 0.88 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.053 0.93 . . . . 0.0 113.016 -148.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -142.0 142.33 24.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.409 1.884 . . . . 0.0 110.602 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.65 -28.47 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.085 2.523 . . . . 0.0 114.836 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.67 -57.49 3.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.96 1.255 . . . . 0.0 113.09 -164.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.4 -27.18 65.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.585 1.154 . . . . 0.0 111.647 174.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -49.21 68.84 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.96 -31.42 70.98 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.662 -1.274 . . . . 0.0 110.562 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.36 -45.83 82.58 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.769 -0.582 . . . . 0.0 112.55 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.71 -15.9 54.88 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.2 t -79.27 -52.89 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.768 -1.208 . . . . 0.0 109.673 159.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -25.29 65.96 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.033 1.733 . . . . 0.0 115.017 -175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -97.37 -19.64 18.35 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.339 1.856 . . . . 0.0 112.018 -174.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.28 -18.1 0.34 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -148.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.69 130.28 37.53 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.149 -0.969 . . . . 0.0 113.285 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.49 0.25 86.54 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.076 1.322 . . . . 0.0 115.05 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -78.63 -161.37 0.28 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 128.028 2.531 . . . . 0.0 112.678 -173.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.9 m -112.8 137.52 51.0 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.716 1.606 . . . . 0.0 107.969 155.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.75 133.4 35.99 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 110.398 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 8.6 t 58.52 -55.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.983 2.513 . . . . 0.0 115.151 -170.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.58 18.24 0.05 OUTLIER Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.509 1.528 . . . . 0.0 115.432 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 1.2 p -151.38 159.82 44.06 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.999 1.399 . . . . 0.0 112.659 171.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -58.04 144.35 40.18 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.494 1.117 . . . . 0.0 110.475 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 2.5 p -128.88 159.59 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.243 1.417 . . . . 0.0 112.793 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.53 135.96 40.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 164.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -143.92 138.86 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.337 0.971 . . . . 0.0 110.917 -162.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -153.54 126.12 8.17 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.88 -1.137 . . . . 0.0 111.824 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -135.16 109.06 8.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 m 131.44 134.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 129.439 3.096 . . . . 0.0 114.693 134.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.518 ' H ' ' CA ' ' A' ' 147' ' ' GLY . 17.7 p-10 -154.38 -23.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.082 2.953 . . . . 0.0 115.36 -12.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.518 ' CA ' ' H ' ' A' ' 146' ' ' ASN . . . -158.78 -65.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 130.021 3.676 . . . . 0.0 112.109 -19.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -88.75 54.5 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.455 -1.027 . . . . 0.0 112.607 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.65 19.89 6.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.574 1.949 . . . . 0.0 113.203 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.323 0 C-N-CA 127.636 2.374 . . . . 0.0 112.517 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -152.42 162.56 41.02 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.15 2.58 . . . . 0.0 111.357 -6.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -131.76 112.85 12.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 157.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 16.2 ttmm -130.05 146.13 51.7 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 127.199 2.2 . . . . 0.0 108.885 -171.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 34' ' ' ALA . 24.6 tp -122.16 99.38 6.4 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.559 1.944 . . . . 0.0 109.305 162.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 mt -62.12 130.31 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.759 1.624 . . . . 0.0 109.514 160.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.63 132.09 48.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 112.945 -1.934 . . . . 0.0 110.646 171.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -145.62 54.96 1.19 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.811 1.244 . . . . 0.0 111.296 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.52 179.89 17.78 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 117.405 1.722 . . . . 0.0 117.405 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -73.67 15.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 128.499 2.72 . . . . 0.0 112.954 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -142.22 -57.34 0.45 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 127.533 2.333 . . . . 0.0 108.932 -144.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -156.6 146.77 21.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.869 2.068 . . . . 0.0 109.321 162.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -128.83 142.41 50.98 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.884 1.274 . . . . 0.0 111.828 167.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.66 -136.55 6.28 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 125.149 1.357 . . . . 0.0 109.985 -159.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -160.83 -158.92 0.63 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.483 1.513 . . . . 0.0 110.113 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -143.84 -47.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 154.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 3.9 p 57.09 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.774 1.63 . . . . 0.0 115.263 -158.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 t -157.93 -18.0 0.08 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 52.59 141.63 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.627 2.371 . . . . 0.0 116.942 -163.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.28 -164.24 1.97 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.354 1.461 . . . . 0.0 111.47 -174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.44 -15.76 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.407 1.883 . . . . 0.0 111.676 -163.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -145.22 -9.08 0.59 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.19 30.97 19.25 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.989 1.316 . . . . 0.0 113.337 -167.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.1 -37.52 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.765 1.626 . . . . 0.0 112.012 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.84 -24.61 66.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.51 2.724 . . . . 0.0 112.456 158.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.83 -53.82 9.38 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.85 -0.531 . . . . 0.0 109.813 171.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -49.96 -46.86 52.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 125.525 1.53 . . . . 0.0 109.229 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -54.88 -25.02 26.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -112.21 -40.32 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 109.146 -169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -50.72 -48.45 58.89 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.289 1.436 . . . . 0.0 112.431 165.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HE3' ' CE2' ' A' ' 43' ' ' TRP . 1.6 mmpt? -43.8 -55.03 4.74 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.867 1.667 . . . . 0.0 112.089 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -73.52 -35.25 65.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -63.48 -41.23 98.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.863 0.756 . . . . 0.0 110.99 172.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 39' ' ' VAL . . . -74.49 -36.4 63.25 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.314 -0.866 . . . . 0.0 109.926 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -65.33 -33.21 75.43 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 118.283 0.492 . . . . 0.0 111.543 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.78 -36.44 78.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.031 1.332 . . . . 0.0 113.603 169.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.59 -20.78 64.52 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.01 20.12 7.33 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.904 1.716 . . . . 0.0 113.385 175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HB ' ' HB1' ' A' ' 34' ' ' ALA . 5.3 t -120.59 123.03 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.942 1.297 . . . . 0.0 111.925 -161.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.61 69.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 124.924 2.297 . . . . 0.0 108.897 155.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.16 -149.98 0.24 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 109.413 -3.54 . . . . 0.0 114.046 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.88 24.38 0.4 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.371 1.868 . . . . 0.0 111.954 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.536 ' CE2' ' HE3' ' A' ' 31' ' ' LYS . 32.5 m95 -6.42 81.75 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.451 3.501 . . . . 0.0 115.368 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.9 m -103.4 158.68 16.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 109.298 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -137.14 143.76 42.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.591 1.556 . . . . 0.0 109.826 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.13 60.01 1.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.439 1.496 . . . . 0.0 110.012 -155.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.89 -25.71 0.83 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 129.608 3.163 . . . . 0.0 117.372 -172.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.88 -21.64 66.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.147 2.179 . . . . 0.0 112.559 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -131.27 -3.42 3.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.366 1.867 . . . . 0.0 112.86 168.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.299 35.6 mttm 54.94 20.03 2.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.415 2.686 . . . . 0.0 114.732 -169.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.7 m -60.34 165.04 3.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.754 1.621 . . . . 0.0 111.682 157.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -132.84 152.63 51.79 Favored 'General case' 0 C--N 1.324 -0.534 1 C-N-CA 132.327 4.251 . . . . 0.0 108.03 173.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -145.82 116.11 7.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.696 0.284 . . . . 0.0 110.247 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.9 m -96.98 88.21 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-O 122.144 0.973 . . . . 0.0 112.081 164.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 p -69.96 113.74 7.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.18 156.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -116.78 -20.27 9.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.511 1.125 . . . . 0.0 112.289 173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.58 -3.83 62.53 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 121.212 -0.93 . . . . 0.0 115.224 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.3 p -33.23 -37.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 129.477 3.111 . . . . 0.0 118.041 -167.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 -19.14 61.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.408 2.283 . . . . 0.0 114.122 -172.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -159.19 -44.67 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.683 1.193 . . . . 0.0 112.55 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.29 62.12 0.93 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.169 1.787 . . . . 0.0 110.03 159.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -53.99 169.07 0.18 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.424 1.49 . . . . 0.0 114.741 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -66.38 -33.8 76.53 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.616 -1.303 . . . . 0.0 111.375 164.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.43 174.75 3.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.929 1.292 . . . . 0.0 111.917 164.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 58.6 mtp -56.27 133.47 52.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.987 -1.071 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -67.1 150.03 49.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.41 -0.806 . . . . 0.0 112.319 -166.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -0.21 50.94 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 173.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -121.63 -5.59 9.2 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.929 1.691 . . . . 0.0 114.773 -169.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.0 m -145.99 152.41 39.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.676 1.191 . . . . 0.0 112.243 -167.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m -129.12 154.93 80.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.533 1.533 . . . . 0.0 108.241 160.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.71 -42.9 42.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.609 1.539 . . . . 0.0 111.164 168.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 145' ' ' SER . 8.8 tt -158.49 -50.28 0.06 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.501 2.32 . . . . 0.0 109.385 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.26 19.3 t70 135.92 136.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 1 C-N-CA 133.6 4.76 . . . . 0.0 111.464 161.384 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . 0.313 1.5 t 61.81 21.13 12.0 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 121.479 3.881 . . . . 0.0 121.479 154.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp 75.98 159.86 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 120.256 1.389 . . . . 0.0 109.176 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.511 ' CG1' HG22 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -95.91 150.65 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 121.098 -1.001 . . . . 0.0 111.357 -169.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -125.98 139.09 53.72 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.765 0.826 . . . . 0.0 110.098 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -138.64 136.29 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.413 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.94 31.96 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 121.524 -0.735 . . . . 0.0 114.672 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t30 63.63 17.6 10.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.474 1.11 . . . . 0.0 113.96 -170.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -33.91 76.89 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.163 -0.96 . . . . 0.0 111.622 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.79 -60.38 0.34 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.652 2.549 . . . . 0.0 116.215 167.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -80.57 -29.32 37.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.434 1.894 . . . . 0.0 112.957 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HB2' ' H ' ' A' ' 85' ' ' GLY . 1.1 p-10 -153.67 -153.65 0.48 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.703 2.401 . . . . 0.0 109.044 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 84' ' ' ASN . . . 131.18 -17.52 5.11 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 128.068 2.747 . . . . 0.0 112.58 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -37.37 74.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.158 1 C-N-CA 132.421 4.288 . . . . 0.0 116.781 169.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' H ' HG11 ' A' ' 105' ' ' VAL . 55.2 tttm 52.11 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.626 3.171 . . . . 0.0 116.847 167.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.9 m -66.96 -26.86 67.04 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 121.07 1.759 . . . . 0.0 114.648 -158.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.73 -30.6 70.88 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.435 -1.416 . . . . 0.0 113.198 168.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.9 mt -90.83 -25.21 20.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.85 1.66 . . . . 0.0 111.998 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.41 -30.63 69.73 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.384 0.993 . . . . 0.0 109.81 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -87.87 -47.23 8.74 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.685 1.194 . . . . 0.0 113.085 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.76 -25.09 64.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.085 1.311 . . . . 0.0 113.373 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -105.24 -31.09 9.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.592 1.157 . . . . 0.0 110.943 174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.23 -32.92 44.7 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.345 1.45 . . . . 0.0 115.512 168.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -57.36 -39.49 76.1 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.329 1.064 . . . . 0.0 112.589 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -75.31 -25.9 58.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.865 0.466 . . . . 0.0 111.944 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.95 -176.5 40.71 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -174.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 147.6 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.851 3.034 . . . . 0.0 112.493 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.5 mp -113.79 141.42 47.33 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.041 1.736 . . . . 0.0 110.671 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -114.94 -16.22 11.71 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.402 1.881 . . . . 0.0 114.434 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 m -159.68 150.96 19.72 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.065 1.346 . . . . 0.0 110.347 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.7 t -154.86 134.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 126.158 1.783 . . . . 0.0 109.81 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -153.79 158.55 41.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.493 1.517 . . . . 0.0 111.455 166.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -149.29 143.67 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.15 130.72 38.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.648 1.979 . . . . 0.0 111.059 166.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 -1.69 5.71 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.22 -46.68 85.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.333 158.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.81 173.85 13.29 Favored 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.071 2.514 . . . . 0.0 111.571 162.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -57.22 35.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.554 1.491 1 C-N-CA 126.663 4.909 . . . . 0.0 119.677 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.47 63.43 1.56 Allowed Glycine 0 N--CA 1.47 0.939 0 O-C-N 119.686 -1.884 . . . . 0.0 112.101 168.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -109.72 112.74 24.98 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.005 1.322 . . . . 0.0 109.961 -174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.02 158.06 16.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.554 1.169 . . . . 0.0 112.092 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -139.34 130.34 26.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.013 163.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.511 HG22 ' CG1' ' A' ' 76' ' ' VAL . 1.2 m -139.42 -178.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.689 0.795 . . . . 0.0 111.235 -171.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -154.01 136.06 14.7 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.452 -1.405 . . . . 0.0 110.797 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.87 154.2 27.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.441 1.497 . . . . 0.0 112.548 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -79.88 -7.6 58.82 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.101 -0.999 . . . . 0.0 112.595 164.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.05 109.43 27.47 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.815 1.646 . . . . 0.0 110.805 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.75 -31.7 95.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.154 3.236 . . . . 0.0 115.718 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -73.66 -41.88 62.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 110.547 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.54 -30.28 71.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.802 0.728 . . . . 0.0 112.415 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.78 78.64 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.762 0.825 . . . . 0.0 112.189 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.08 -37.25 74.12 Favored 'General case' 0 C--N 1.343 0.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.496 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -49.97 48.17 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.68 -11.03 31.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.552 1.541 . . . . 0.0 114.465 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.28 -52.8 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.154 -0.967 . . . . 0.0 110.322 157.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -31.53 69.66 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.833 1.253 . . . . 0.0 114.089 -172.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.61 -0.8 20.03 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.634 1.574 . . . . 0.0 111.924 -163.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.89 -23.64 0.5 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.577 1.551 . . . . 0.0 113.233 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.31 125.18 23.01 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.138 -0.977 . . . . 0.0 111.436 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.7 9.1 87.36 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -84.78 -176.23 6.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.319 1.448 . . . . 0.0 112.44 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.7 m -134.9 93.07 2.96 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.042 1.737 . . . . 0.0 108.806 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.1 mp -79.59 -39.51 31.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.754 1.222 . . . . 0.0 112.686 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.402 ' CB ' HD21 ' A' ' 84' ' ' ASN . 76.3 m -144.49 46.1 1.4 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.822 1.249 . . . . 0.0 112.926 -162.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.31 72.58 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.139 -0.976 . . . . 0.0 113.119 -173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 30.5 p -112.04 -166.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.456 2.303 . . . . 0.0 111.862 -171.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -147.03 53.07 1.08 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.2 1.0 . . . . 0.0 111.373 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.56 156.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 126.98 2.112 . . . . 0.0 113.936 -170.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.23 152.11 42.76 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.35 1.46 . . . . 0.0 110.183 158.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.2 t -144.51 128.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.891 0.876 . . . . 0.0 109.531 -162.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.7 170.51 8.72 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.026 1.73 . . . . 0.0 110.219 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -130.56 140.78 50.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.218 -1.552 . . . . 0.0 112.481 -145.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -174.67 -28.59 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 1 C-N-CA 132.068 4.147 . . . . 0.0 115.315 -7.254 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.19 129.98 4.55 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 119.694 -1.879 . . . . 0.0 113.064 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.62 102.46 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.043 0.83 . . . . 0.0 112.525 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.02 54.17 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.622 1.569 . . . . 0.0 110.934 162.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -105.26 149.6 25.86 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.189 1.796 . . . . 0.0 113.879 -161.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.254 1.339 0 C-N-CA 128.236 2.614 . . . . 0.0 110.565 162.488 . . . . . . . . 0 0 . 1 stop_ save_